Index of /wp-content/uploads/2021/02

[ICO]NameLast modifiedSizeDescription
[PARENTDIR]Parent Directory  -  
[ ]19m13228.pdf2022-11-07 22:21 245K 
[IMG]19m13228F1-94x64.gif2022-11-08 14:53 2.6K 
[IMG]19m13228F1-100x100.gif2022-11-12 04:09 3.0K 
[IMG]19m13228F1-150x150.gif2022-11-12 04:09 4.9K 
[IMG]19m13228F1-300x188.gif2022-11-11 02:21 9.3K 
[IMG]19m13228F1-768x481.gif2022-11-08 14:53 35K 
[IMG]19m13228F1-1024x641.gif2022-11-11 02:21 49K 
[IMG]19m13228F1.bak.gif2022-11-11 02:21 34K 
[IMG]19m13228F1.gif2022-11-08 14:53 34K 
[IMG]19m13228T1-94x64.gif2022-11-08 14:53 2.7K 
[IMG]19m13228T1-100x100.gif2022-11-12 04:09 4.1K 
[IMG]19m13228T1-150x150.gif2022-11-11 02:21 8.5K 
[IMG]19m13228T1-300x166.gif2022-11-08 14:53 16K 
[IMG]19m13228T1-768x425.gif2022-11-12 04:09 70K 
[IMG]19m13228T1-1024x567.gif2022-11-12 04:09 106K 
[IMG]19m13228T1-1536x851.gif2022-11-08 14:53 189K 
[IMG]19m13228T1-2048x1134.gif2022-11-12 04:09 291K 
[IMG]19m13228T1.bak.gif2022-11-11 02:21 128K 
[IMG]19m13228T1.gif2022-11-08 14:53 128K 
[IMG]19nr02572T1-94x64.gif2022-11-08 14:53 2.5K 
[IMG]19nr02572T1-100x100.gif2022-11-11 02:21 3.3K 
[IMG]19nr02572T1-150x150.gif2022-11-08 14:53 7.1K 
[IMG]19nr02572T1-300x110.gif2022-11-11 02:21 9.2K 
[IMG]19nr02572T1-768x281.gif2022-11-08 14:53 41K 
[IMG]19nr02572T1-1024x375.gif2022-11-12 04:09 60K 
[IMG]19nr02572T1-1536x562.gif2022-11-08 14:53 108K 
[IMG]19nr02572T1-2048x749.gif2022-11-08 14:53 163K 
[IMG]19nr02572T1.bak.gif2022-11-11 02:21 67K 
[IMG]19nr02572T1.gif2022-11-08 14:53 67K 
[IMG]19nr02572T2-94x64.gif2022-11-12 04:09 3.4K 
[IMG]19nr02572T2-100x100.gif2022-11-12 04:09 4.8K 
[IMG]19nr02572T2-150x150.gif2022-11-12 04:09 8.9K 
[IMG]19nr02572T2-300x206.gif2022-11-12 04:09 20K 
[IMG]19nr02572T2-768x528.gif2022-11-08 14:53 74K 
[IMG]19nr02572T2.bak.gif2022-11-11 02:21 48K 
[IMG]19nr02572T2.gif2022-11-08 14:53 48K 
[ ]20ac13787.pdf2022-11-07 22:30 1.0M 
[ ]20br02621-SM-1.pdf2022-11-07 22:18 566K 
[ ]20br02621-SM-2.pdf2022-11-07 22:19 566K 
[ ]20br02621-SM.pdf2022-11-07 22:51 566K 
[IMG]20br02621F1-94x64.gif2022-11-11 02:21 1.9K 
[IMG]20br02621F1-100x100.gif2022-11-08 14:49 3.5K 
[IMG]20br02621F1-150x150.gif2022-11-12 04:09 6.8K 
[IMG]20br02621F1-287x300.gif2022-11-11 02:21 19K 
[IMG]20br02621F1-300x313.gif2022-11-12 04:09 20K 
[IMG]20br02621F1-768x802.gif2022-11-08 14:49 78K 
[IMG]20br02621F1-981x1024.gif2022-11-08 14:49 110K 
[IMG]20br02621F1.bak.gif2022-11-11 02:21 50K 
[IMG]20br02621F1.gif2022-11-08 14:49 50K 
[IMG]20br02621F2-94x64.gif2022-11-08 14:49 2.1K 
[IMG]20br02621F2-100x100.gif2022-11-12 04:09 4.0K 
[IMG]20br02621F2-150x150.gif2022-11-12 04:09 6.9K 
[IMG]20br02621F2-297x300.gif2022-11-11 02:21 19K 
[IMG]20br02621F2-300x303.gif2022-11-12 04:09 20K 
[IMG]20br02621F2-768x776.gif2022-11-12 04:09 77K 
[IMG]20br02621F2.bak.gif2022-11-11 02:21 52K 
[IMG]20br02621F2.gif2022-11-08 14:49 52K 
[IMG]20br02621F3-94x64.gif2022-11-08 14:49 1.8K 
[IMG]20br02621F3-100x100.gif2022-11-11 02:21 3.2K 
[IMG]20br02621F3-150x150.gif2022-11-12 04:09 6.5K 
[IMG]20br02621F3-300x278.gif2022-11-12 04:09 16K 
[IMG]20br02621F3-768x713.gif2022-11-11 02:21 61K 
[IMG]20br02621F3.bak.gif2022-11-11 02:21 41K 
[IMG]20br02621F3.gif2022-11-08 14:49 41K 
[IMG]20br02621F4-94x64.gif2022-11-11 02:21 1.5K 
[IMG]20br02621F4-100x100.gif2022-11-11 02:21 2.1K 
[IMG]20br02621F4-150x150.gif2022-11-08 14:49 4.0K 
[IMG]20br02621F4-300x91.gif2022-11-08 14:49 4.9K 
[IMG]20br02621F4-768x232.gif2022-11-11 02:21 20K 
[IMG]20br02621F4-1024x309.gif2022-11-08 14:49 29K 
[IMG]20br02621F4-1536x464.gif2022-11-08 14:49 50K 
[IMG]20br02621F4-2048x619.gif2022-11-08 14:49 74K 
[IMG]20br02621F4.bak.gif2022-11-11 02:21 35K 
[IMG]20br02621F4.gif2022-11-08 14:49 35K 
[IMG]20br02663F1-94x64.gif2022-11-11 02:21 1.6K 
[IMG]20br02663F1-100x100.gif2022-11-11 02:21 2.4K 
[IMG]20br02663F1-150x150.gif2022-11-12 04:09 4.2K 
[IMG]20br02663F1-254x300.gif2022-11-08 14:51 13K 
[IMG]20br02663F1-300x355.gif2022-11-12 04:09 17K 
[IMG]20br02663F1-768x909.gif2022-11-11 02:21 68K 
[IMG]20br02663F1-865x1024.gif2022-11-08 14:51 81K 
[IMG]20br02663F1.bak.gif2022-11-11 02:21 48K 
[IMG]20br02663F1.gif2022-11-08 14:51 48K 
[ ]20cr13633.pdf2022-11-07 22:35 106K 
[IMG]20f02744F1-94x64.gif2022-11-08 14:51 2.5K 
[IMG]20f02744F1-100x100.gif2022-11-12 04:09 3.4K 
[IMG]20f02744F1-150x150.gif2022-11-12 04:09 5.7K 
[IMG]20f02744F1-225x300.gif2022-11-11 02:21 15K 
[IMG]20f02744F1-300x401.gif2022-11-12 04:09 23K 
[IMG]20f02744F1-767x1024.gif2022-11-12 04:09 100K 
[IMG]20f02744F1-768x1026.gif2022-11-12 04:09 94K 
[IMG]20f02744F1.bak.gif2022-11-11 02:21 71K 
[IMG]20f02744F1.gif2025-01-13 19:58 70K 
[IMG]20f02744T1-94x64.gif2022-11-08 14:51 2.3K 
[IMG]20f02744T1-100x100.gif2022-11-08 14:51 3.3K 
[IMG]20f02744T1-150x150.gif2022-11-08 14:51 6.2K 
[IMG]20f02744T1-193x300.gif2022-11-08 14:51 17K 
[IMG]20f02744T1-300x467.gif2022-11-08 14:51 36K 
[IMG]20f02744T1-658x1024.gif2022-11-08 14:51 111K 
[IMG]20f02744T1-768x1194.gif2022-11-08 14:51 138K 
[IMG]20f02744T1-988x1536.gif2022-11-08 14:51 200K 
[IMG]20f02744T1.bak.gif2022-11-11 02:21 83K 
[IMG]20f02744T1.gif2022-11-08 14:51 83K 
[IMG]20f02744T2-94x64.gif2022-11-08 14:51 2.7K 
[IMG]20f02744T2-100x100.gif2022-11-11 02:21 3.8K 
[IMG]20f02744T2-150x150.gif2022-11-11 02:21 7.8K 
[IMG]20f02744T2-300x116.gif2022-11-08 14:51 11K 
[IMG]20f02744T2-768x298.gif2022-11-08 14:51 51K 
[IMG]20f02744T2-1024x397.gif2022-11-08 14:51 79K 
[IMG]20f02744T2-1536x596.gif2022-11-08 14:51 142K 
[IMG]20f02744T2-2048x795.gif2022-11-11 02:21 216K 
[IMG]20f02744T2.bak.gif2022-11-11 02:21 93K 
[IMG]20f02744T2.gif2022-11-08 14:51 93K 
[ ]20l02610.pdf2022-11-07 22:21 1.7M 
[IMG]20l02610F1-1-94x64.jpg2022-11-08 14:53 1.8K 
[IMG]20l02610F1-1-100x100.jpg2022-11-08 14:53 2.4K 
[IMG]20l02610F1-1-150x150.jpg2022-11-08 14:53 3.7K 
[IMG]20l02610F1-1-206x300.jpg2022-11-08 14:53 12K 
[IMG]20l02610F1-1-300x437.jpg2022-11-11 02:21 22K 
[IMG]20l02610F1-1-703x1024.jpg2022-11-08 14:53 76K 
[IMG]20l02610F1-1-768x1119.jpg2022-11-08 14:53 89K 
[IMG]20l02610F1-1.bak.jpg2022-11-11 02:21 96K 
[IMG]20l02610F1-1.jpg2022-11-08 14:53 96K 
[IMG]20l02610F1-94x64.jpg2022-11-08 14:51 1.8K 
[IMG]20l02610F1-100x100.jpg2022-11-08 14:51 2.4K 
[IMG]20l02610F1-150x150.jpg2022-11-08 14:51 3.7K 
[IMG]20l02610F1-206x300.jpg2022-11-08 14:51 12K 
[IMG]20l02610F1-300x437.jpg2022-11-11 02:21 22K 
[IMG]20l02610F1-703x1024.jpg2022-11-08 14:52 76K 
[IMG]20l02610F1-768x1119.jpg2022-11-08 14:51 89K 
[IMG]20l02610F1.bak.jpg2022-11-11 02:21 96K 
[IMG]20l02610F1.jpg2022-11-08 14:51 96K 
[IMG]20l02610F2-1-94x64.jpg2022-11-08 14:53 2.2K 
[IMG]20l02610F2-1-100x100.jpg2022-11-08 14:53 3.1K 
[IMG]20l02610F2-1-150x150.jpg2022-11-08 14:53 5.0K 
[IMG]20l02610F2-1-300x223.jpg2022-11-08 14:53 11K 
[IMG]20l02610F2-1-768x571.jpg2022-11-08 14:53 49K 
[IMG]20l02610F2-1-1024x761.jpg2022-11-08 14:53 74K 
[IMG]20l02610F2-1-1536x1142.jpg2022-11-08 14:53 127K 
[IMG]20l02610F2-1.bak.jpg2022-11-11 02:21 90K 
[IMG]20l02610F2-1.jpg2022-11-08 14:53 90K 
[IMG]20l02610F2-94x64.jpg2022-11-08 14:52 2.2K 
[IMG]20l02610F2-100x100.jpg2022-11-08 14:52 3.1K 
[IMG]20l02610F2-150x150.jpg2022-11-08 14:52 5.0K 
[IMG]20l02610F2-300x223.jpg2022-11-08 14:52 11K 
[IMG]20l02610F2-768x571.jpg2022-11-08 14:52 49K 
[IMG]20l02610F2-1024x761.jpg2022-11-08 14:52 74K 
[IMG]20l02610F2-1536x1142.jpg2022-11-08 14:52 127K 
[IMG]20l02610F2.bak.jpg2022-11-11 02:21 90K 
[IMG]20l02610F2.jpg2022-11-08 14:52 90K 
[IMG]20l02610F3-1-94x64.gif2022-11-11 02:21 3.4K 
[IMG]20l02610F3-1-100x100.gif2022-11-08 14:53 5.3K 
[IMG]20l02610F3-1-150x150.gif2022-11-08 14:53 11K 
[IMG]20l02610F3-1-300x162.gif2022-11-08 14:53 23K 
[IMG]20l02610F3-1-768x415.gif2022-11-12 04:09 96K 
[IMG]20l02610F3-1-1024x554.gif2022-11-08 14:53 158K 
[IMG]20l02610F3-1-1536x831.gif2022-11-12 04:09 298K 
[IMG]20l02610F3-1.bak.gif2022-11-11 02:21 194K 
[IMG]20l02610F3-1.gif2024-12-30 21:21 194K 
[IMG]20l02610F3-94x64.gif2022-11-11 02:21 3.4K 
[IMG]20l02610F3-100x100.gif2022-11-08 14:52 5.3K 
[IMG]20l02610F3-150x150.gif2022-11-08 14:52 11K 
[IMG]20l02610F3-300x162.gif2022-11-08 14:52 23K 
[IMG]20l02610F3-768x415.gif2022-11-12 04:09 96K 
[IMG]20l02610F3-1024x554.gif2022-11-08 14:52 158K 
[IMG]20l02610F3-1536x831.gif2022-11-12 04:09 298K 
[IMG]20l02610F3.bak.gif2022-11-11 02:21 194K 
[IMG]20l02610F3.gif2024-12-30 21:21 194K 
[IMG]20l02618T1-94x64.gif2022-11-12 04:09 1.8K 
[IMG]20l02618T1-100x100.gif2022-11-08 14:50 2.7K 
[IMG]20l02618T1-150x150.gif2022-11-08 14:50 4.2K 
[IMG]20l02618T1-300x96.gif2022-11-11 02:21 7.1K 
[IMG]20l02618T1-768x245.gif2022-11-12 04:09 26K 
[IMG]20l02618T1.bak.gif2022-11-11 02:21 16K 
[IMG]20l02618T1.gif2022-11-08 14:50 16K 
[ ]20l02680.pdf2022-11-07 22:39 103K 
[ ]20l13702.pdf2022-11-07 22:57 239K 
[IMG]20l13702F1-94x64.gif2022-11-11 02:21 2.3K 
[IMG]20l13702F1-100x100.gif2022-11-12 04:09 2.9K 
[IMG]20l13702F1-150x150.gif2022-11-12 04:09 4.5K 
[IMG]20l13702F1-300x185.gif2022-11-07 22:44 10K 
[IMG]20l13702F1-768x473.gif2022-11-12 04:09 31K 
[IMG]20l13702F1-1024x630.gif2022-11-11 02:21 48K 
[IMG]20l13702F1.bak.gif2022-11-11 02:21 36K 
[IMG]20l13702F1.gif2022-11-08 14:53 36K 
[IMG]20m02705F1-94x64.gif2022-11-11 02:20 2.0K 
[IMG]20m02705F1-100x100.gif2022-11-12 04:09 3.7K 
[IMG]20m02705F1-150x150.gif2022-11-12 04:09 5.9K 
[IMG]20m02705F1-300x279.gif2022-11-12 04:09 15K 
[IMG]20m02705F1-768x714.gif2022-11-12 04:09 71K 
[IMG]20m02705F1.bak.gif2022-11-11 02:20 33K 
[IMG]20m02705F1.gif2022-11-08 14:49 33K 
[IMG]20m02705F2-94x64.gif2022-11-08 18:43 1.4K 
[IMG]20m02705F2-100x100.gif2022-11-08 14:49 1.8K 
[IMG]20m02705F2-150x150.gif2022-11-08 18:43 3.7K 
[IMG]20m02705F2-300x156.gif2022-11-08 14:49 7.2K 
[IMG]20m02705F2-768x398.gif2022-11-08 14:49 25K 
[IMG]20m02705F2-1024x531.gif2022-11-08 14:49 35K 
[IMG]20m02705F2-1536x796.gif2022-11-08 18:43 63K 
[IMG]20m02705F2.bak.gif2022-11-11 02:20 30K 
[IMG]20m02705F2.gif2022-11-08 14:49 30K 
[IMG]20m02705T1-94x64.gif2022-11-08 14:49 1.6K 
[IMG]20m02705T1-100x100.gif2022-11-08 18:43 2.9K 
[IMG]20m02705T1-150x150.gif2022-11-08 14:49 5.8K 
[IMG]20m02705T1-287x300.gif2022-11-08 14:49 16K 
[IMG]20m02705T1-300x314.gif2022-11-08 18:43 18K 
[IMG]20m02705T1-768x804.gif2022-11-08 14:49 72K 
[IMG]20m02705T1-979x1024.gif2022-11-08 18:43 102K 
[IMG]20m02705T1.bak.gif2022-11-11 02:20 61K 
[IMG]20m02705T1.gif2022-11-08 14:49 61K 
[IMG]20m02705T2-94x64.gif2022-11-11 02:20 2.4K 
[IMG]20m02705T2-100x100.gif2022-11-11 02:20 3.4K 
[IMG]20m02705T2-150x150.gif2022-11-11 02:20 6.6K 
[IMG]20m02705T2-300x172.gif2022-11-12 04:09 13K 
[IMG]20m02705T2-768x440.gif2022-11-08 14:49 50K 
[IMG]20m02705T2-1024x586.gif2022-11-08 14:49 75K 
[IMG]20m02705T2.bak.gif2022-11-11 02:20 39K 
[IMG]20m02705T2.gif2022-11-08 14:49 39K 
[IMG]20m02705T3-94x64.gif2022-11-11 02:20 2.1K 
[IMG]20m02705T3-100x100.gif2022-11-08 14:49 3.2K 
[IMG]20m02705T3-150x150.gif2022-11-08 14:49 5.1K 
[IMG]20m02705T3-300x126.gif2022-11-12 04:09 8.6K 
[IMG]20m02705T3-768x322.gif2022-11-08 14:49 29K 
[IMG]20m02705T3.bak.gif2022-11-11 02:20 20K 
[IMG]20m02705T3.gif2022-11-08 14:49 20K 
[IMG]20m02712F1-94x64.gif2022-11-11 02:21 2.3K 
[IMG]20m02712F1-100x100.gif2022-11-12 04:09 3.3K 
[IMG]20m02712F1-131x300.gif2022-11-11 02:21 10K 
[IMG]20m02712F1-150x150.gif2022-11-08 14:50 5.4K 
[IMG]20m02712F1-300x686.gif2022-11-12 04:09 30K 
[IMG]20m02712F1-448x1024.gif2022-11-12 04:09 56K 
[IMG]20m02712F1-672x1536.gif2022-11-08 14:50 105K 
[IMG]20m02712F1-768x1755.gif2022-11-08 14:50 124K 
[IMG]20m02712F1-896x2048.gif2022-11-08 14:50 146K 
[IMG]20m02712F1-scaled.gif2022-11-11 02:21 91K 
[IMG]20m02712F1.bak.gif2022-11-11 02:21 126K 
[IMG]20m02712F1.gif2022-11-08 14:50 126K 
[IMG]20m02712F2-94x64.gif2022-11-11 02:21 2.0K 
[IMG]20m02712F2-100x100.gif2022-11-12 04:09 2.6K 
[IMG]20m02712F2-150x150.gif2022-11-08 14:50 4.2K 
[IMG]20m02712F2-300x218.gif2022-11-12 04:09 8.6K 
[IMG]20m02712F2-768x558.gif2022-11-08 14:50 30K 
[IMG]20m02712F2-1024x743.gif2022-11-08 14:50 43K 
[IMG]20m02712F2.bak.gif2022-11-11 02:21 25K 
[IMG]20m02712F2.gif2022-11-08 14:50 25K 
[IMG]20m02712T1-94x64.gif2022-11-11 02:21 2.2K 
[IMG]20m02712T1-100x100.gif2022-11-12 04:09 3.3K 
[IMG]20m02712T1-150x150.gif2022-11-08 14:51 6.1K 
[IMG]20m02712T1-300x225.gif2022-11-11 02:21 16K 
[IMG]20m02712T1-768x576.gif2022-11-11 02:21 73K 
[IMG]20m02712T1-1024x768.gif2022-11-08 14:50 112K 
[IMG]20m02712T1-1536x1151.gif2022-11-11 02:21 208K 
[IMG]20m02712T1.bak.gif2022-11-11 02:21 82K 
[IMG]20m02712T1.gif2022-11-07 22:11 82K 
[IMG]20m02712T2-94x64.gif2022-11-11 02:21 1.6K 
[IMG]20m02712T2-100x100.gif2022-11-08 14:51 3.0K 
[IMG]20m02712T2-150x150.gif2022-11-12 04:09 6.0K 
[IMG]20m02712T2-300x271.gif2022-11-12 04:09 16K 
[IMG]20m02712T2-768x695.gif2022-11-08 14:51 64K 
[IMG]20m02712T2.bak.gif2022-11-11 02:21 42K 
[IMG]20m02712T2.gif2022-11-08 14:51 42K 
[IMG]20m02712T3-94x64.gif2022-11-08 14:51 2.8K 
[IMG]20m02712T3-100x100.gif2022-11-12 04:09 4.0K 
[IMG]20m02712T3-150x150.gif2022-11-08 14:51 8.2K 
[IMG]20m02712T3-300x194.gif2022-11-11 02:21 20K 
[IMG]20m02712T3-768x496.gif2022-11-08 14:51 87K 
[IMG]20m02712T3-1024x662.gif2022-11-08 14:51 136K 
[IMG]20m02712T3-1536x993.gif2022-11-12 04:09 243K 
[IMG]20m02712T3.bak.gif2022-11-11 02:21 141K 
[IMG]20m02712T3.gif2022-11-07 22:35 141K 
[IMG]20m02802F1-94x64.gif2022-11-08 14:52 2.0K 
[IMG]20m02802F1-100x100.gif2022-11-11 02:21 2.5K 
[IMG]20m02802F1-150x150.gif2022-11-08 14:52 5.0K 
[IMG]20m02802F1-300x226.gif2022-11-08 14:52 10K 
[IMG]20m02802F1-768x579.gif2022-11-11 02:21 39K 
[IMG]20m02802F1-1024x773.gif2022-11-08 14:52 59K 
[IMG]20m02802F1.bak.gif2022-11-11 02:21 45K 
[IMG]20m02802F1.gif2022-11-07 22:26 45K 
[IMG]20m02802T1-94x64.gif2022-11-11 02:21 1.4K 
[IMG]20m02802T1-100x100.gif2022-11-08 14:52 1.9K 
[IMG]20m02802T1-150x150.gif2022-11-11 02:21 3.8K 
[IMG]20m02802T1-212x300.gif2022-11-08 14:52 11K 
[IMG]20m02802T1-300x424.gif2022-11-12 04:09 19K 
[IMG]20m02802T1-724x1024.gif2022-11-08 14:52 66K 
[IMG]20m02802T1-768x1086.gif2022-11-12 04:09 72K 
[IMG]20m02802T1.bak.gif2022-11-11 02:21 45K 
[IMG]20m02802T1.gif2022-11-08 14:52 45K 
[IMG]20m02802T2-94x64.gif2022-11-11 02:21 1.7K 
[IMG]20m02802T2-100x100.gif2022-11-08 14:53 2.5K 
[IMG]20m02802T2-122x300.gif2022-11-12 04:09 8.1K 
[IMG]20m02802T2-150x150.gif2022-11-11 02:21 5.0K 
[IMG]20m02802T2-300x739.gif2022-11-08 14:53 39K 
[IMG]20m02802T2-416x1024.gif2022-11-12 04:09 64K 
[IMG]20m02802T2-624x1536.gif2022-11-12 04:09 120K 
[IMG]20m02802T2-768x1892.gif2022-11-11 02:21 161K 
[IMG]20m02802T2-831x2048.gif2022-11-11 02:21 185K 
[IMG]20m02802T2-scaled.gif2022-11-08 14:53 105K 
[IMG]20m02802T2.bak.gif2022-11-11 02:21 125K 
[IMG]20m02802T2.gif2022-11-08 14:53 125K 
[IMG]20m02802T2small-94x64.gif2022-11-08 14:53 1.7K 
[IMG]20m02802T2small-100x100.gif2022-11-08 14:53 2.6K 
[IMG]20m02802T2small-122x300.gif2022-11-08 14:53 8.6K 
[IMG]20m02802T2small-150x150.gif2022-11-12 04:09 5.0K 
[IMG]20m02802T2small-300x739.gif2022-11-11 02:21 40K 
[IMG]20m02802T2small-416x1024.gif2022-11-11 02:21 67K 
[IMG]20m02802T2small-623x1536.gif2022-11-11 02:21 121K 
[IMG]20m02802T2small-768x1892.gif2022-11-11 02:21 174K 
[IMG]20m02802T2small-831x2048.gif2022-11-11 02:21 195K 
[IMG]20m02802T2small.bak.gif2022-11-11 02:21 88K 
[IMG]20m02802T2small.gif2022-11-11 02:21 88K 
[IMG]20m02802T3-94x64.gif2022-11-11 02:21 2.2K 
[IMG]20m02802T3-100x100.gif2022-11-12 04:09 2.9K 
[IMG]20m02802T3-150x150.gif2022-11-08 14:52 4.8K 
[IMG]20m02802T3-300x98.gif2022-11-12 04:09 7.4K 
[IMG]20m02802T3-768x251.gif2022-11-11 02:21 24K 
[IMG]20m02802T3.bak.gif2022-11-11 02:21 16K 
[IMG]20m02802T3.gif2022-11-07 22:28 16K 
[IMG]20m02847T1-94x64.gif2022-11-12 04:09 3.4K 
[IMG]20m02847T1-100x100.gif2022-11-12 04:09 4.8K 
[IMG]20m02847T1-150x150.gif2022-11-12 04:09 8.7K 
[IMG]20m02847T1-300x133.gif2022-11-12 04:09 13K 
[IMG]20m02847T1-768x340.gif2022-11-08 14:49 47K 
[IMG]20m02847T1.bak.gif2022-11-11 02:21 30K 
[IMG]20m02847T1.gif2022-11-08 14:49 30K 
[IMG]20m02847T2-94x64.gif2022-11-08 14:49 2.3K 
[IMG]20m02847T2-100x100.gif2022-11-08 18:44 3.5K 
[IMG]20m02847T2-150x150.gif2022-11-08 14:49 6.7K 
[IMG]20m02847T2-248x300.gif2022-11-12 04:09 20K 
[IMG]20m02847T2-300x363.gif2022-11-08 14:49 27K 
[IMG]20m02847T2-768x929.gif2022-11-08 14:49 108K 
[IMG]20m02847T2-846x1024.gif2022-11-08 14:49 125K 
[IMG]20m02847T2.bak.gif2022-11-11 02:21 64K 
[IMG]20m02847T2.gif2022-11-08 14:50 64K 
[IMG]20m02847T3-94x64.gif2022-11-12 04:09 3.1K 
[IMG]20m02847T3-100x100.gif2022-11-12 04:09 4.3K 
[IMG]20m02847T3-150x150.gif2022-11-12 04:09 7.3K 
[IMG]20m02847T3-300x119.gif2022-11-11 02:21 11K 
[IMG]20m02847T3-768x304.gif2022-11-08 14:50 40K 
[IMG]20m02847T3.bak.gif2022-11-11 02:21 25K 
[IMG]20m02847T3.gif2022-11-08 14:50 25K 
[IMG]20m02847T4-94x64.gif2022-11-08 14:50 2.7K 
[IMG]20m02847T4-100x100.gif2022-11-08 14:50 4.6K 
[IMG]20m02847T4-150x150.gif2022-11-11 02:21 8.7K 
[IMG]20m02847T4-300x201.gif2022-11-11 02:21 18K 
[IMG]20m02847T4-768x514.gif2022-11-08 14:50 67K 
[IMG]20m02847T4.bak.gif2022-11-11 02:21 40K 
[IMG]20m02847T4.gif2022-11-07 22:09 40K 
[ ]20m13511-SM.pdf2022-11-07 22:17 447K 
[ ]20m13511.pdf2022-11-07 22:21 751K 
[IMG]20m13511T1-94x64.gif2022-11-12 04:09 2.5K 
[IMG]20m13511T1-100x100.gif2022-11-11 02:21 3.4K 
[IMG]20m13511T1-150x150.gif2022-11-08 14:53 6.1K 
[IMG]20m13511T1-300x196.gif2022-11-08 14:53 16K 
[IMG]20m13511T1-768x502.gif2022-11-08 14:53 72K 
[IMG]20m13511T1-1024x669.gif2022-11-11 02:21 110K 
[IMG]20m13511T1-1536x1003.gif2022-11-11 02:21 200K 
[IMG]20m13511T1-2048x1338.gif2022-11-08 14:54 306K 
[IMG]20m13511T1.bak.gif2022-11-11 02:21 129K 
[IMG]20m13511T1.gif2022-11-08 14:53 129K 
[IMG]20m13511T2-94x64.gif2022-11-11 02:21 2.8K 
[IMG]20m13511T2-100x100.gif2022-11-11 02:21 4.5K 
[IMG]20m13511T2-150x150.gif2022-11-12 04:09 8.4K 
[IMG]20m13511T2-300x173.gif2022-11-08 14:54 17K 
[IMG]20m13511T2-768x442.gif2022-11-08 14:54 64K 
[IMG]20m13511T2-1024x589.gif2022-11-11 02:21 100K 
[IMG]20m13511T2.bak.gif2022-11-11 02:21 51K 
[IMG]20m13511T2.gif2022-11-08 14:54 51K 
[IMG]20m13511T3-94x64.gif2022-11-12 04:09 2.1K 
[IMG]20m13511T3-100x100.gif2022-11-11 02:21 3.1K 
[IMG]20m13511T3-150x150.gif2022-11-08 14:54 5.8K 
[IMG]20m13511T3-300x118.gif2022-11-11 02:21 9.7K 
[IMG]20m13511T3-768x302.gif2022-11-11 02:21 37K 
[IMG]20m13511T3-1024x402.gif2022-11-12 04:09 57K 
[IMG]20m13511T3.bak.gif2022-11-11 02:21 43K 
[IMG]20m13511T3.gif2022-11-08 14:54 43K 
[IMG]20m13511T4-94x64.gif2022-11-08 14:54 2.3K 
[IMG]20m13511T4-100x100.gif2022-11-11 02:21 3.1K 
[IMG]20m13511T4-150x150.gif2022-11-08 14:54 6.0K 
[IMG]20m13511T4-300x110.gif2022-11-12 04:09 10K 
[IMG]20m13511T4-768x281.gif2022-11-08 14:54 41K 
[IMG]20m13511T4-1024x375.gif2022-11-08 14:54 64K 
[IMG]20m13511T4-1536x562.gif2022-11-08 14:54 113K 
[IMG]20m13511T4.bak.gif2022-11-11 02:21 70K 
[IMG]20m13511T4.gif2022-11-07 22:16 70K 
[IMG]20m13511T5-94x64.gif2022-11-11 02:21 2.4K 
[IMG]20m13511T5-100x100.gif2022-11-08 14:54 4.2K 
[IMG]20m13511T5-150x150.gif2022-11-12 04:09 7.7K 
[IMG]20m13511T5-300x288.gif2022-11-08 14:54 21K 
[IMG]20m13511T5-768x736.gif2022-11-11 02:21 81K 
[IMG]20m13511T5.bak.gif2022-11-11 02:21 47K 
[IMG]20m13511T5.gif2022-11-11 02:21 47K 
[IMG]20m13589F1-94x64.gif2022-11-08 18:43 1.4K 
[IMG]20m13589F1-100x100.gif2022-11-08 18:43 2.4K 
[IMG]20m13589F1-150x150.gif2022-11-11 02:21 4.6K 
[IMG]20m13589F1-300x245.gif2022-11-12 04:09 10K 
[IMG]20m13589F1-768x628.gif2022-11-08 14:49 39K 
[IMG]20m13589F1-1024x837.gif2022-11-08 18:43 59K 
[IMG]20m13589F1-1536x1255.gif2022-11-08 14:49 103K 
[IMG]20m13589F1.bak.gif2022-11-11 02:21 69K 
[IMG]20m13589F1.gif2022-11-08 14:49 69K 
[IMG]20m13589F2-94x64.gif2022-11-11 02:21 1.4K 
[IMG]20m13589F2-100x100.gif2022-11-08 18:43 2.7K 
[IMG]20m13589F2-150x150.gif2022-11-08 18:43 4.4K 
[IMG]20m13589F2-300x254.gif2022-11-11 02:21 11K 
[IMG]20m13589F2-768x651.gif2022-11-11 02:21 36K 
[IMG]20m13589F2-1024x868.gif2022-11-08 14:49 55K 
[IMG]20m13589F2-1536x1302.gif2022-11-08 14:49 96K 
[IMG]20m13589F2.bak.gif2022-11-11 02:21 72K 
[IMG]20m13589F2.gif2022-11-08 14:49 72K 
[IMG]20m13589F3-94x64.gif2022-11-08 14:49 876  
[IMG]20m13589F3-100x100.gif2022-11-12 04:09 2.0K 
[IMG]20m13589F3-150x150.gif2022-11-08 18:44 3.8K 
[IMG]20m13589F3-300x264.gif2022-11-12 04:09 9.7K 
[IMG]20m13589F3-768x675.gif2022-11-08 14:49 35K 
[IMG]20m13589F3-1024x900.gif2022-11-12 04:09 53K 
[IMG]20m13589F3-1536x1350.gif2022-11-11 02:21 93K 
[IMG]20m13589F3.bak.gif2022-11-11 02:21 59K 
[IMG]20m13589F3.gif2022-11-08 14:49 59K 
[IMG]20m13589T1-94x64.gif2022-11-08 18:44 1.7K 
[IMG]20m13589T1-100x100.gif2022-11-08 14:49 2.4K 
[IMG]20m13589T1-150x150.gif2022-11-08 14:49 4.4K 
[IMG]20m13589T1-187x300.gif2022-11-08 14:49 12K 
[IMG]20m13589T1-300x481.gif2022-11-11 02:21 26K 
[IMG]20m13589T1-639x1024.gif2022-11-12 04:09 81K 
[IMG]20m13589T1-768x1231.gif2022-11-08 14:49 106K 
[IMG]20m13589T1-959x1536.gif2022-11-08 14:49 147K 
[IMG]20m13589T1.bak.gif2022-11-11 02:21 73K 
[IMG]20m13589T1.gif2022-11-08 14:49 73K 
[IMG]20m13685F1-94x64.gif2022-11-12 04:09 1.3K 
[IMG]20m13685F1-100x100.gif2022-11-11 02:20 1.8K 
[IMG]20m13685F1-150x150.gif2022-11-11 02:20 3.4K 
[IMG]20m13685F1-186x300.gif2022-11-11 02:20 10K 
[IMG]20m13685F1-300x484.gif2022-11-12 04:09 20K 
[IMG]20m13685F1-635x1024.gif2022-11-12 04:09 53K 
[IMG]20m13685F1-768x1238.gif2022-11-08 14:47 69K 
[IMG]20m13685F1-953x1536.gif2022-11-12 04:09 98K 
[IMG]20m13685F1-1271x2048.gif2022-11-08 14:48 151K 
[IMG]20m13685F1.bak.gif2022-11-11 02:20 68K 
[IMG]20m13685F1.gif2022-11-08 14:47 68K 
[IMG]20m13685T1-94x64.gif2022-11-08 14:48 2.4K 
[IMG]20m13685T1-100x100.gif2022-11-08 14:48 4.1K 
[IMG]20m13685T1-150x150.gif2022-11-08 14:48 7.7K 
[IMG]20m13685T1-300x263.gif2022-11-08 18:43 22K 
[IMG]20m13685T1-768x674.gif2022-11-08 18:43 94K 
[IMG]20m13685T1-1024x898.gif2022-11-12 04:09 142K 
[IMG]20m13685T1.bak.gif2022-11-11 02:20 81K 
[IMG]20m13685T1.gif2022-11-08 14:48 81K 
[IMG]20m13685T2-94x64.gif2022-11-08 14:48 2.5K 
[IMG]20m13685T2-100x100.gif2022-11-08 14:48 3.8K 
[IMG]20m13685T2-150x150.gif2022-11-08 14:48 6.7K 
[IMG]20m13685T2-166x300.gif2022-11-12 04:09 15K 
[IMG]20m13685T2-300x543.gif2022-11-12 04:09 41K 
[IMG]20m13685T2-565x1024.gif2022-11-08 14:48 110K 
[IMG]20m13685T2-768x1391.gif2022-11-08 14:48 175K 
[IMG]20m13685T2-848x1536.gif2022-11-08 14:48 199K 
[IMG]20m13685T2-1131x2048.gif2022-11-08 18:43 307K 
[IMG]20m13685T2.bak.gif2022-11-11 02:20 137K 
[IMG]20m13685T2.gif2022-11-08 14:48 137K 
[IMG]20m13685T3-94x64.gif2022-11-11 02:20 2.7K 
[IMG]20m13685T3-100x100.gif2022-11-08 14:48 3.8K 
[IMG]20m13685T3-150x150.gif2022-11-08 14:48 7.5K 
[IMG]20m13685T3-300x197.gif2022-11-12 04:09 16K 
[IMG]20m13685T3-768x504.gif2022-11-08 14:48 66K 
[IMG]20m13685T3-1024x672.gif2022-11-08 14:48 100K 
[IMG]20m13685T3.bak.gif2022-11-11 02:20 45K 
[IMG]20m13685T3.gif2022-11-08 14:48 45K 
[IMG]20r02770F1-94x64.gif2022-11-12 04:09 1.6K 
[IMG]20r02770F1-100x100.gif2022-11-11 02:21 3.1K 
[IMG]20r02770F1-150x150.gif2022-11-12 04:09 5.1K 
[IMG]20r02770F1-290x300.gif2022-11-12 04:09 14K 
[IMG]20r02770F1-300x310.gif2022-11-11 02:21 15K 
[IMG]20r02770F1-768x795.gif2022-11-12 04:09 64K 
[IMG]20r02770F1-990x1024.gif2022-11-08 14:51 98K 
[IMG]20r02770F1.bak.gif2022-11-11 02:21 53K 
[IMG]20r02770F1.gif2022-11-07 22:56 53K 
[IMG]20r02770T1-94x64.gif2022-11-12 04:09 1.9K 
[IMG]20r02770T1-100x100.gif2022-11-08 14:51 2.5K 
[IMG]20r02770T1-150x150.gif2022-11-12 04:09 4.6K 
[IMG]20r02770T1-300x187.gif2022-11-08 14:51 9.8K 
[IMG]20r02770T1-768x479.gif2022-11-08 14:51 36K 
[IMG]20r02770T1.bak.gif2022-11-11 02:21 22K 
[IMG]20r02770T1.gif2022-11-07 22:49 22K 
[IMG]20r02770T2-94x64.gif2022-11-12 04:09 2.2K 
[IMG]20r02770T2-100x100.gif2022-11-12 04:09 4.0K 
[IMG]20r02770T2-150x150.gif2022-11-08 14:51 7.7K 
[IMG]20r02770T2-300x240.gif2022-11-11 02:21 21K 
[IMG]20r02770T2-768x613.gif2022-11-12 04:09 100K 
[IMG]20r02770T2-1024x818.gif2022-11-08 14:51 156K 
[IMG]20r02770T2-1536x1226.gif2022-11-08 14:51 282K 
[IMG]20r02770T2-2048x1635.gif2022-11-08 14:51 426K 
[IMG]20r02770T2.bak.gif2022-11-11 02:21 172K 
[IMG]20r02770T2.gif2022-11-08 14:51 172K 
[ ]20r13503-SM.pdf2022-11-07 22:21 659K 
[ ]20r13503.pdf2022-11-07 22:08 938K 
[IMG]20r13503F1-1-94x64.gif2022-11-12 04:09 1.8K 
[IMG]20r13503F1-1-100x100.gif2022-11-12 04:09 3.1K 
[IMG]20r13503F1-1-150x150.gif2022-11-12 04:09 5.2K 
[IMG]20r13503F1-1-300x263.gif2022-11-11 02:21 13K 
[IMG]20r13503F1-1-768x674.gif2022-11-08 14:52 58K 
[IMG]20r13503F1-1-1024x899.gif2022-11-12 04:09 92K 
[IMG]20r13503F1-1.bak.gif2022-11-11 02:21 54K 
[IMG]20r13503F1-1.gif2022-11-08 14:52 54K 
[IMG]20r13503F1-94x64.gif2022-11-12 04:09 1.8K 
[IMG]20r13503F1-100x100.gif2022-11-12 04:09 3.1K 
[IMG]20r13503F1-150x150.gif2022-11-12 04:09 5.2K 
[IMG]20r13503F1-300x263.gif2022-11-11 02:21 13K 
[IMG]20r13503F1-768x674.gif2022-11-08 14:52 58K 
[IMG]20r13503F1-1024x899.gif2022-11-12 04:09 92K 
[IMG]20r13503F1.bak.gif2022-11-11 02:21 54K 
[IMG]20r13503F1.gif2022-11-08 14:52 54K 
[IMG]20r13503F2-92x300.gif2022-11-08 14:52 6.1K 
[IMG]20r13503F2-94x64.gif2022-11-08 14:52 1.5K 
[IMG]20r13503F2-100x100.gif2022-11-11 02:21 2.3K 
[IMG]20r13503F2-150x150.gif2022-11-11 02:21 4.4K 
[IMG]20r13503F2-300x982.gif2022-11-08 14:52 44K 
[IMG]20r13503F2-313x1024.gif2022-11-08 14:52 46K 
[IMG]20r13503F2-469x1536.gif2022-11-08 14:52 89K 
[IMG]20r13503F2-626x2048.gif2022-11-11 02:21 137K 
[IMG]20r13503F2-768x2514.gif2022-11-11 02:21 186K 
[IMG]20r13503F2-scaled.gif2022-11-11 02:21 103K 
[IMG]20r13503F2.bak.gif2022-11-11 02:21 385K 
[IMG]20r13503F2.gif2022-11-07 22:51 385K 
[IMG]20r13503F3-94x64.gif2022-11-08 14:52 1.9K 
[IMG]20r13503F3-100x100.gif2022-11-08 14:52 2.1K 
[IMG]20r13503F3-150x150.gif2022-11-11 02:21 3.7K 
[IMG]20r13503F3-300x166.gif2022-11-08 14:52 9.8K 
[IMG]20r13503F3-768x424.gif2022-11-08 14:52 42K 
[IMG]20r13503F3-1024x565.gif2022-11-08 14:52 64K 
[IMG]20r13503F3-1536x847.gif2022-11-08 14:52 113K 
[IMG]20r13503F3-2048x1130.gif2022-11-08 14:52 173K 
[IMG]20r13503F3.bak.gif2022-11-11 02:21 76K 
[IMG]20r13503F3.gif2022-11-08 14:52 76K 
[IMG]20r13503F4-94x64.gif2022-11-08 14:52 1.6K 
[IMG]20r13503F4-100x100.gif2022-11-08 14:52 2.7K 
[IMG]20r13503F4-150x150.gif2022-11-11 02:21 4.9K 
[IMG]20r13503F4-300x239.gif2022-11-08 14:52 13K 
[IMG]20r13503F4-768x611.gif2022-11-11 02:21 53K 
[IMG]20r13503F4-1024x815.gif2022-11-08 14:52 79K 
[IMG]20r13503F4-1536x1222.gif2022-11-08 14:52 141K 
[IMG]20r13503F4-2048x1629.gif2022-11-08 14:52 211K 
[IMG]20r13503F4.bak.gif2022-11-11 02:21 98K 
[IMG]20r13503F4.gif2022-11-07 23:02 98K 
[IMG]20r13503T1-94x64.gif2022-11-12 04:09 2.1K 
[IMG]20r13503T1-100x100.gif2022-11-08 14:53 2.9K 
[IMG]20r13503T1-150x150.gif2022-11-12 04:09 5.9K 
[IMG]20r13503T1-300x208.gif2022-11-08 14:53 15K 
[IMG]20r13503T1-768x532.gif2022-11-08 14:53 68K 
[IMG]20r13503T1-1024x709.gif2022-11-08 14:53 106K 
[IMG]20r13503T1-1536x1064.gif2022-11-08 14:53 196K 
[IMG]20r13503T1-2048x1418.gif2022-11-08 14:53 306K 
[IMG]20r13503T1-scaled.gif2022-11-11 02:21 159K 
[IMG]20r13503T1.bak.gif2022-11-11 02:21 384K 
[IMG]20r13503T1.gif2022-11-08 14:53 384K 
[IMG]20r13503T1small-94x64.gif2022-11-11 02:21 2.2K 
[IMG]20r13503T1small-100x100.gif2022-11-11 02:21 3.0K 
[IMG]20r13503T1small-150x150.gif2022-11-12 04:09 6.3K 
[IMG]20r13503T1small-300x208.gif2022-11-08 14:53 16K 
[IMG]20r13503T1small-768x532.gif2022-11-08 14:53 72K 
[IMG]20r13503T1small-1024x709.gif2022-11-11 02:21 114K 
[IMG]20r13503T1small-1536x1064.gif2022-11-08 14:53 223K 
[IMG]20r13503T1small-2048x1418.gif2022-11-11 02:21 357K 
[IMG]20r13503T1small.bak.gif2022-11-11 02:21 149K 
[IMG]20r13503T1small.gif2022-11-08 14:53 149K 
[ ]21ed02938.pdf2022-11-07 22:44 118K 
[IMG]21f13891T1-94x64.gif2022-11-11 02:20 3.1K 
[IMG]21f13891T1-100x100.gif2022-11-08 14:49 4.5K 
[IMG]21f13891T1-150x150.gif2022-11-08 14:49 9.1K 
[IMG]21f13891T1-252x300.gif2022-11-08 14:49 27K 
[IMG]21f13891T1-300x357.gif2022-11-08 14:49 36K 
[IMG]21f13891T1-768x913.gif2022-11-12 04:09 145K 
[IMG]21f13891T1-861x1024.gif2022-11-08 14:49 170K 
[IMG]21f13891T1.bak.gif2022-11-11 02:20 84K 
[IMG]21f13891T1.gif2022-11-07 22:34 84K 
[IMG]2011_commentary-100x40.gif2022-11-08 14:43 222  
[IMG]2011_commentary-150x40.gif2022-11-08 14:43 276  
[IMG]2011_commentary-300x20.gif2022-11-08 14:43 807  
[IMG]2011_commentary.bak.gif2022-11-11 02:20 2.4K 
[IMG]2011_commentary.gif2022-11-12 04:08 2.4K 
[ ]2021-Classified-Ads-Rate-Sheet-10-21-20.pdf2022-11-07 22:15 124K 
[ ]2021_Rate_Sheet_102020-1.pdf2022-11-07 22:32 1.3M 
[ ]2021_Rate_Sheet_102020.pdf2022-11-07 22:34 1.3M 
[ ]2021_Rate_Sheet_102020_p1.pdf2022-11-07 22:16 545K 
[ ]2021_Rate_Sheet_102020_p2.pdf2022-11-07 22:38 95K 
[ ]2021_Rate_Sheet_102020_p3.pdf2022-11-07 22:34 479K 
[ ]2021_Rate_Sheet_102020_p4.pdf2022-11-07 22:38 362K 
[ ]10372_7-habits-highly-effective-psychopharmacologists-part-2-begin-end-mind.pdf2022-11-07 22:03 46K 
[ ]10373_7-habits-highly-effective-psychopharmacologists-part-3-selective-choices-cme.pdf2022-11-07 22:51 43K 
[ ]10374_7-habits-highly-effective-psychopharmacologists-part-4-developing-implementing-visioin.pdf2022-11-07 23:03 39K 
[ ]10376_abcs-suicide.pdf2022-11-07 22:42 92K 
[ ]10377_abecarnil-treatment-generalized-anxiety-disorder-placebo.pdf2022-11-07 22:59 36K 
[ ]10378_abetting-madness-role-illicit-prescribed-drug-promoting.pdf2022-11-07 22:53 82K 
[ ]10380_abnormalities-glucose-metabolism-associated-atypical.pdf2022-11-07 22:12 84K 
[ ]10381_abnormal-regional-cerebral-blood-flow-systemic-lupus.pdf2022-11-07 22:20 187K 
[ ]10382_abortion-facts-feelings-handbook-women-care.pdf2022-11-07 22:01 19K 
[ ]10383_absence-changes-antidiuretic-hormone-angiotensin-ii.pdf2022-11-07 22:59 41K 
[ ]10384_abt-for-cognitive-impairment-in-schizophrenia.pdf2022-11-07 22:31 475K 
[ ]10385_academic-highlights-ongoing-needs-depression.pdf2022-11-07 22:03 66K 
[ ]10386_academic-highlights-optimizing-clinical-outcomes-across.pdf2022-11-07 22:07 596K 
[ ]10387_academic-highlights-panic-disorder-making-clinical.pdf2022-11-07 22:59 92K 
[ ]10388_academic-highlights-pharmacologic-rationale-clinical.pdf2022-11-07 22:26 54K 
[ ]10389_academic-highlights-recognition-assessment-shift-disorder.pdf2022-11-07 22:55 358K 
[ ]10390_a-call-to-action-addressing-the-problem-of-psychotropic-drugs-acquired-via-the-internet.pdf2022-11-07 22:30 91K 
[ ]10391_acamprosate-alcoholism-abstinence.pdf2022-11-07 22:15 110K 
[ ]10392_a-case-of-creutzfeldt-jakob-disease-presenting-as-catatonia.pdf2022-11-07 22:51 499K 
[ ]10393_a-case-of-lurasidone-induced-rabbit-syndrome.pdf2022-11-07 22:17 89K 
[ ]10394_a-case-report-highlighting-the-impact-of-covid-in-mental-illness-and-its-physical-consequences.pdf2022-11-07 22:05 117K 
[ ]10395_acceleration-augmentation-antidepressants-lithium.pdf2022-11-07 22:59 167K 
[ ]10396_acceptance-commitment-therapy.pdf2022-11-07 22:44 81K 
[ ]10397_accomplishments.pdf2022-11-07 22:08 50K 
[ ]10399_accurate-meta-analytical-assessment-true-antidepressant.pdf2022-11-07 22:33 92K 
[ ]10400_acetaminophen-paracetamol-during-pregnancy-risk-attention.pdf2022-11-07 22:46 286K 
[ ]10401_acetaminophen-paracetamol-during-pregnancy-risk-autism.pdf2022-11-07 22:46 284K 
[ ]10402_acetaminophen-preferable-ibuprofen-pretreatment-electroconvulsive.pdf2022-11-07 22:29 67K 
[ ]10403_acetyl-oxo-dehydroepiandrosterone-healing-treatment.pdf2022-11-07 22:52 99K 
[ ]10404_achieving-remission-managing-relapse-depression.pdf2022-11-07 22:40 61K 
[ ]10406_acquainted-night-again-again-key-factors-associated.pdf2022-11-07 22:26 138K 
[ ]10407_acronyms-substance-disorders.pdf2022-11-07 22:39 72K 
[ ]10408_actigraphically-assessed-activity-unipolar-depression.pdf2022-11-07 22:19 221K 
[ ]10409_activating-and-sedating-properties-of-medications-used-for-mdd.pdf2022-11-07 22:24 462K 
[ ]10410_activation-induced-high-dose-ziprasidone-case-report.pdf2022-11-07 22:47 744K 
[ ]10411_activity-in-depressed-inpatients-sprint-or-run.pdf2022-11-07 22:18 125K 
[ ]10412_actual-driving-performance-psychomotor-function-healthy.pdf2022-11-07 22:51 147K 
[ ]10413_acupuncture-depression-randomized-controlled-trial.pdf2022-11-07 22:36 127K 
[ ]10414_acupuncture-for-sleep-in-mild-tbi-and-ptsd-veterans.pdf2022-11-07 22:53 926K 
[ ]10415_acupuncture-major-depressive-disorder-has-efficacy.pdf2022-11-07 23:00 155K 
[ ]10416_acupuncture-residual-insomnia-associated-major-depressive.pdf2022-11-07 22:43 1.1M 
[ ]10417_acupuncture-treatment-major-depressive-disorder-randomized.pdf2022-11-07 22:41 347K 
[ ]10418_acute-angle-closure-glaucoma-paroxetine.pdf2022-11-07 22:21 73K 
[ ]10419_acute-dystonia-olanzapine.pdf2022-11-07 22:40 44K 
[ ]10420_acute-efficacy-aripiprazole-across-symptom-spectrum.pdf2022-11-07 22:31 309K 
[ ]10421_acute-efficacy-divalproex-sodium-versus-placebo-mood.pdf2022-11-07 22:49 351K 
[ ]10422_acute-liver-failure-administration-herbal-tranquilizer.pdf2022-11-07 22:37 67K 
[ ]10423_acute-long-term-behavioral-outcome-infants-children.pdf2022-11-07 22:27 452K 
[ ]10424_acute-long-term-treatment-prevention-relapse-obsessive.pdf2022-11-07 22:15 88K 
[ ]10425_acute-maintenance-treatment-chronic-depression.pdf2022-11-07 22:26 59K 
[ ]10427_acute-posttraumatic-stress-nonacceptance-early-intervention.pdf2022-11-07 22:22 53K 
[ ]10428_acute-psychosis-associated-antinmda-receptor-antibodies.pdf2022-11-07 22:59 90K 
[ ]10429_acute-stress-disorder-predictor-posttraumatic-stress.pdf2022-11-07 22:39 229K 
[ ]10430_acute-transient-psychosis.pdf2022-11-07 22:51 52K 
[ ]10432_acute-treatment-pediatric-bipolar-i-disorder-manic.pdf2022-11-07 22:11 472K 
[ ]10433_acute-treatment-psychotic-agitation-randomized-comparison.pdf2022-11-07 22:36 74K 
[ ]10434_acute-worsening-chronic-depression-during-double-blind.pdf2022-11-07 22:29 204K 
[ ]10435_adaptive-changes-related-medication-treatment-adhd.pdf2022-11-07 22:23 64K 
[ ]10436_adaptive-functioning-psychiatric-symptoms-adolescents.pdf2022-11-07 22:09 206K 
[ ]10437_addiction-casebook.pdf2022-11-07 22:38 76K 
[ ]10438_adding-antipsychotics-clozapine.pdf2022-11-07 22:10 45K 
[ ]10439_adding-lithium-anticonvulsants-antipsychotics-treatment.pdf2022-11-07 22:06 79K 
[ ]10440_adding-psychotherapy-pharmacotherapy-treatment-depressive.pdf2022-11-07 22:51 1.0M 
[ ]10441_ad-discontinuation-and-depression-relapse-in-pregnancy.pdf2022-11-07 22:59 831K 
[ ]10442_addition-atomoxetine-depression-incompletely-responsive.pdf2022-11-07 22:36 143K 
[ ]10443_addition-cognitive-behavioral-therapy-nonresponders.pdf2022-11-07 22:34 135K 
[ ]10444_addition-lamotrigine-clozapine-inpatients-chronic.pdf2022-11-07 22:50 165K 
[ ]10445_addition-risperidone-clozapine-therapy-chronically.pdf2022-11-07 22:14 59K 
[ ]10449_addressing-comorbidity-adults-attention-deficit-hyperactivity.pdf2022-11-07 22:18 101K 
[ ]10450_addressing-concerns-inclusion-premenstrual-dysphoric.pdf2022-11-07 22:44 355K 
[ ]10451_addressing-nonadherence-to-treatment.pdf2022-11-07 22:16 122K 
[ ]10453_addressing-ptsd-suicide-veterans.pdf2022-11-07 22:11 72K 
[ ]10456_addressing-the-experience-of-children-and-adolescents-during-the-covid-pandemic.pdf2022-11-07 22:14 74K 
[ ]10458_add-rtms-medication-resistant-depression-randomized.pdf2022-11-07 22:55 168K 
[ ]10459_adequacy-treatment-received-diagnosed-undiagnosed.pdf2022-11-07 22:34 90K 
[ ]10460_adhd-and-disruptive-behavior-disorders.pdf2022-11-07 22:59 256K 
[ ]10461_adhd-and-type-diabetes-mellitus.pdf2022-11-07 22:31 229K 
[ ]10462_adhd-applying-practice-guidelines-improve-patient.pdf2022-11-07 22:44 160K 
[ ]10463_adhd-comorbid-disorders-adults.pdf2022-11-07 22:54 238K 
[ ]10464_adhd-comorbidity-childhood.pdf2022-11-07 22:02 70K 
[ ]10465_adhd-medication-and-malformations-in-pregnancy.pdf2022-11-07 22:39 278K 
[ ]10466_adhd-through-life-span-role-bupropion-treatment.pdf2022-11-07 22:12 30K 
[ ]10467_adhd-treatment-across-life-cycle.pdf2022-11-07 22:34 58K 
[ ]10468_adherence-antidepressants-is-associated-lower-mortality.pdf2022-11-07 22:57 847K 
[ ]10469_adherence-antipsychotic-medications.pdf2022-11-07 22:38 55K 
[ ]10470_adherence-assessments-depot-antipsychotics-patients.pdf2022-11-07 22:13 103K 
[ ]10471_adherence-atypical-antipsychotic-treatment-among-newly.pdf2022-11-07 22:29 196K 
[ ]10472_adherence-conventional-atypical-antipsychotics-hospital.pdf2022-11-07 22:32 58K 
[ ]10473_adherence-pharmacotherapy-bipolar-disorder-patients.pdf2022-11-07 22:22 132K 
[ ]10474_adherence-problems-patients-serious-persistent-mental.pdf2022-11-07 22:11 515K 
[ ]10475_adiponectin-potential-biomarker-metabolic-syndrome.pdf2022-11-07 22:39 247K 
[ ]10476_adjunctive-anti-inflammatory-treatments-for-bipolar-depression.pdf2022-11-07 22:34 910K 
[ ]10477_adjunctive-aripiprazole-major-depressive-disorder.pdf2022-11-07 22:12 312K 
[ ]10478_adjunctive-armodafinil-major-depressive-episodes-associated.pdf2022-11-07 22:16 381K 
[ ]10479_adjunctive-brexpiprazole-mg-patients-major-depressive.pdf2022-11-07 22:47 562K 
[ ]10480_adjunctive-decoglurant-in-partially-refractory-mdd.pdf2022-11-07 22:12 827K 
[ ]10481_adjunctive-fluvoxamine-inhibits-clozapine-related.pdf2022-11-07 22:34 60K 
[ ]10482_adjunctive-modafinil-initiation-treatment-selective.pdf2022-11-07 22:36 64K 
[ ]10483_adjunctive-nadolol-treatment-acutely-aggressive-schizophrenic.pdf2022-11-07 22:19 37K 
[ ]10484_adjunctive-oral-ziprasidone-patients-acute-mania-treated-protocol-specific-eligibility-criteria-sign.pdf2022-11-07 22:43 422K 
[ ]10485_adjunctive-oral-ziprasidone-patients-acute-mania-treated-randomized-double-blind-placebo-controlled-.pdf2022-11-07 22:19 314K 
[ ]10486_adjunctive-pimavanserin-and-sleep-wakefulness-in-mdd.pdf2022-11-07 22:55 501K 
[ ]10487_adjunctive-pimavanserin-in-treatment-resistant-mdd.pdf2022-11-07 22:33 762K 
[ ]10488_adjunctive-quetiapine-treatment-polydipsia-intermittent.pdf2022-11-07 22:15 79K 
[ ]10489_adjunctive-recombinant-human-interferon-gamma-b-treatment.pdf2022-11-07 22:34 157K 
[ ]10490_adjunctive-repetitive-transcranial-magnetic-stimulation.pdf2022-11-07 23:02 328K 
[ ]10491_adjunctive-risperidone-generalized-anxiety-disorder.pdf2022-11-07 22:56 133K 
[ ]10492_adjunctive-topiramate-therapy-patients-receiving-mood.pdf2022-11-07 23:01 118K 
[ ]10493_adjunctive-yoga-for-mdd.pdf2022-11-07 22:30 213K 
[ ]10494_adjunct-modafinil-short-term-treatment-fatigue-sleepiness.pdf2022-11-07 22:49 70K 
[ ]10495_adjusting-amisulpride-dose-in-patients-with-alzheimers-disease.pdf2022-11-07 22:12 2.8M 
[ ]10496_adjuvant-aspirin-therapy-reduces-symptoms-schizophrenia.pdf2022-11-07 22:30 374K 
[ ]10497_adjuvant-therapeutic-effects-galantamine-apathy-schizophrenia.pdf2022-11-07 22:15 62K 
[ ]10499_adolescent-depressing-guide-parents.pdf2022-11-07 22:07 21K 
[ ]10501_adolescent-substance-abuse-psychiatric-comorbidities-epidemiology-survey-assessment-comorbidity-outc.pdf2022-11-07 22:49 92K 
[ ]10502_adrenergic-antagonist-prazosin-ameliorates-combat.pdf2022-11-07 22:04 63K 
[ ]10503_adrenergic-mediation-dissociative-symptoms-posttraumatic.pdf2022-11-07 22:17 88K 
[ ]10504_adulthood-self-reported-cardiovascular-risk-adhd-medications.pdf2022-11-07 22:42 135K 
[ ]10505_adult-outcome-attention-deficit-hyperactivity-disorder.pdf2022-11-07 22:07 599K 
[ ]10506_adults-attention-deficit-hyperactivity-disorder-controversial.pdf2022-11-07 23:01 127K 
[ ]10507_advanced-glycation-end-products-in-early-psychosis.pdf2022-11-07 22:09 259K 
[ ]10508_advanced-statistical-techniques-really-help-diagnosis.pdf2022-11-07 22:11 302K 
[ ]10509_advanced-treatment-bipolar-disorder.pdf2022-11-07 22:58 54K 
[ ]10510_advancements-treating-intimate-partner-violence-veterans.pdf2022-11-07 22:43 127K 
[ ]10511_advances-management-treatment-depression.pdf2022-11-07 22:49 35K 
[ ]10512_advances-treatment-alcohol-dependence.pdf2022-11-07 22:34 311K 
[ ]10514_advancing-treatment-mental-illness-call-action-management.pdf2022-11-07 22:23 161K 
[ ]10515_adverse-cardiac-events-older-patients-receiving-venlafaxine.pdf2022-11-07 22:58 1.4M 
[ ]10516_adverse-effect-profile-efficacy-divalproex-sodium.pdf2022-11-07 22:52 59K 
[ ]10517_adverse-effects-antipsychotics-prevention-treatment.pdf2022-11-07 22:28 47K 
[ ]10518_adverse-effects-atypical-antipsychotics-cns-weight-gain-sedation-anticholinergic.pdf2022-11-07 22:27 95K 
[ ]10519_adverse-effects-atypical-antipsychotics-weight-gain-lipid-diabetes.pdf2022-11-07 22:39 48K 
[ ]10520_adverse-effects-st-johns-wort-systematic-review.pdf2022-11-07 22:55 76K 
[ ]10521_adverse-events-fluoxetine-postmarketing-compared-premarketing.pdf2022-11-07 22:51 54K 
[ ]10522_adverse-events-related-olanzapine.pdf2022-11-07 22:34 54K 
[ ]10523_adverse-gestational-outcomes-associated-with-adhd-medication-exposure-during-pregnancy.pdf2022-11-07 22:19 313K 
[ ]10524_adversely-affects-unbornpsychotropic-drugs-maternal.pdf2022-11-07 22:03 117K 
[ ]10525_adverse-neuropsychiatric-reactions-herbal-counter.pdf2022-11-07 22:36 51K 
[ ]10526_adverse-outcomes-following-serotonin-reuptake-inhibitor.pdf2022-11-07 22:28 116K 
[ ]10527_adverse-pregnancy-outcomes-associated-with-antiepileptic-drugs.pdf2022-11-07 22:30 285K 
[ ]10528_adverse-reactions-antidepressants-elderly-patients.pdf2022-11-07 22:38 53K 
[ ]10529_aerobic-endurance-exercise-improves-executive-functions.pdf2022-11-07 22:30 69K 
[ ]10530_aesthetic-brain-evolved-desire-beauty-enjoy-art.pdf2022-11-07 22:15 81K 
[ ]10531_affective-illness-epilepsy.pdf2022-11-07 23:03 44K 
[ ]10532_affect-regulation-development-psychopathology.pdf2022-11-07 22:12 41K 
[ ]10534_african-patient-ziprasidone-intolerance.pdf2022-11-07 22:50 105K 
[ ]10535_age-gender-considerations-psychiatric-diagnosis-research.pdf2022-11-07 22:30 97K 
[ ]10536_age-gender-predict-illness-course-episode-nonaffective.pdf2022-11-07 22:30 380K 
[ ]10537_age-melancholy-major-depression-social-origins.pdf2022-11-07 22:45 47K 
[ ]10538_age-school-cohort-borderline-personality-disorder.pdf2022-11-07 22:57 138K 
[ ]10539_age-sex-analyses-somatic-complaints-symptom-presentation.pdf2022-11-07 22:52 312K 
[ ]10540_aggression-elderly.pdf2022-11-07 22:46 77K 
[ ]10541_aggressive-behavior-patients-attention-deficit-hyperactivity.pdf2022-11-07 22:12 62K 
[ ]10542_aging-male-androgens-erectile-dysfunction-depression.pdf2022-11-07 22:53 74K 
[ ]10543_aging-psychiatric-disorders-and-suicide-attempt.pdf2022-11-07 23:02 433K 
[ ]10544_agitated-depression-panic-anxiety-clonazepam.pdf2022-11-07 23:00 88K 
[ ]10545_agitated-unipolar-major-depression-prevalence-phenomenology.pdf2022-11-07 22:42 96K 
[ ]10546_agitation-inpatient-suicide.pdf2022-11-07 22:06 48K 
[ ]10547_agitation-patients-dementia-practical-guide-diagnosis.pdf2022-11-07 22:23 31K 
[ ]10548_agomelatine-generalized-anxiety-disorder-active-comparator.pdf2022-11-07 22:39 524K 
[ ]10549_agomelatine-prevents-relapse-generalized-anxiety-disorder.pdf2022-11-07 22:42 278K 
[ ]10550_agomelatine-prevents-relapse-patients-major-depressive.pdf2022-11-07 22:10 433K 
[ ]10551_agomelatine-treatment-major-depressive-disorder-week.pdf2022-11-07 22:16 490K 
[ ]10553_aidshiv-infection-comorbid-psychiatric-illness-risk.pdf2022-11-07 22:28 246K 
[ ]10554_akathisia-updated-review-focusing-second-generation.pdf2022-11-07 22:55 448K 
[ ]10555_akathisia-violence.pdf2022-11-07 22:31 79K 
[ ]10556_alcohol-abuse-alcoholism-overview.pdf2022-11-07 22:40 63K 
[ ]10557_alcohol-addiction-christian-ethics.pdf2022-11-07 23:01 101K 
[ ]10558_alcohol-cannabis-urban-african-american-episode-schizophrenia.pdf2022-11-07 22:50 135K 
[ ]10559_alcohol-disorder-comorbidity-eating-disorders-multicenter.pdf2022-11-07 22:05 65K 
[ ]10560_alcohol-disorders-panic-disorder-review-evidence-direct.pdf2022-11-07 22:29 166K 
[ ]10561_alcohol-disorders-schizophrenia-national-cohort-study.pdf2022-11-07 22:45 243K 
[ ]10562_alcohol-substance-abuse-panic-disorder.pdf2022-11-07 22:37 30K 
[ ]10563_alcohol-substance-abuse-parentally-bereaved-youth.pdf2022-11-07 22:02 339K 
[ ]10564_alcohol-use-disorder-co-occurring-with-depressive-and-anxiety-symptoms.pdf2022-11-07 23:02 147K 
[ ]10565_algorithm-based-approach-episode-schizophrenia-response.pdf2022-11-07 23:00 329K 
[ ]10566_algorithms-treat-anxiety-primary-care.pdf2022-11-07 22:21 47K 
[ ]10567_algorithm-treatment-chronic-depression.pdf2022-11-07 22:14 75K 
[ ]10568_algorithm-treatment-schizophrenia-correctional-setting.pdf2022-11-07 22:04 145K 
[ ]10569_allergic-reaction-depot-risperidone-oral-risperidone.pdf2022-11-07 22:03 102K 
[ ]10570_allergic-reactions-sudden-death-asenapine.pdf2022-11-07 22:16 81K 
[ ]10571_allergy-tartrazine-psychotropic-drugs.pdf2022-11-07 22:41 45K 
[ ]10572_altered-topological-patterns-brain-networks-remitted.pdf2022-11-07 22:19 1.3M 
[ ]10573_alternative-perspectives-psychiatric-validation-dsm.pdf2022-11-07 22:42 82K 
[ ]10574_alternative-pharmacotherapy-trichotillomania-report.pdf2022-11-07 22:06 115K 
[ ]10576_alternatives-line-therapy-depression-are-effective.pdf2022-11-07 22:27 347K 
[ ]10577_alternative-treatments-depression-empirical-support.pdf2022-11-07 22:33 102K 
[ ]10578_alzheimer-disease-dementias-practical-guide-second.pdf2022-11-07 22:49 714K 
[ ]10579_alzheimers-disease-century-later.pdf2022-11-07 22:47 166K 
[ ]10581_alzheimers-disease-management.pdf2022-11-07 22:52 21K 
[ ]10582_alzheimers-disease-translating-neurochemical-insights.pdf2022-11-07 22:56 109K 
[ ]10583_alzheimers-prevention-initiative-composite-cognitive.pdf2022-11-07 22:44 506K 
[ ]10584_american-health-care-systems-depression-past-present.pdf2022-11-07 22:35 42K 
[ ]10585_american-idols.pdf2022-11-07 22:35 54K 
[ ]10586_american-psychiatrc-publishing-textbook-geriatric.pdf2022-11-07 22:58 72K 
[ ]10587_american-psychiatric-association-practice-guidelines.pdf2022-11-07 22:10 61K 
[ ]10588_american-psychiatric-association-textbook-psychiatry.pdf2022-11-07 22:04 40K 
[ ]10589_american-psychiatric-press-practice-guidelines-treatment.pdf2022-11-07 22:30 39K 
[ ]10590_american-psychiatric-press-textbook-geriatric-neuropsychiatry.pdf2022-11-07 23:02 55K 
[ ]10591_american-psychiatric-press-textbook-substance-abuse.pdf2022-11-07 22:53 39K 
[ ]10592_american-psychiatric-publishing-textbook-anxiety-disorders.pdf2022-11-07 22:43 39K 
[ ]10593_american-psychiatric-publishing-textbook-forensic.pdf2022-11-07 23:02 133K 
[ ]10594_american-psychiatric-publishing-textbook-psychosomatic.pdf2022-11-07 22:54 55K 
[ ]10595_american-psychiatric-publishing-textbook-suicide-assessment.pdf2022-11-07 22:27 72K 
[ ]10596_american-psychiatric-publishing-textbool-forensic.pdf2022-11-07 22:06 33K 
[ ]10597_amitriptyline-dual-action-antidepressant.pdf2022-11-07 22:28 50K 
[ ]10598_ampa-blockade-may-mechanism-underlying-efficacy-topiramate.pdf2022-11-07 22:19 67K 
[ ]10599_analgesic-effect-antidepressants.pdf2022-11-07 22:59 62K 
[ ]10600_analyses-treatment-emergent-mania-olanzapinefluoxetine.pdf2022-11-07 22:57 120K 
[ ]10601_analysis-efficacy-treatments-bipolar-depression.pdf2022-11-07 22:37 167K 
[ ]10602_analysis-gene-variants-previously-associated-iloperidone.pdf2022-11-07 22:24 419K 
[ ]10603_analysis-qtc-interval-during-olanzapine-treatment.pdf2022-11-07 23:03 74K 
[ ]10604_analysis-suicidality-pooled-data-double-blind-placebo.pdf2022-11-07 22:57 413K 
[ ]10605_anatomy-epidemic-magic-bullets-psychiatric-drugs-astonishing.pdf2022-11-07 22:47 132K 
[ ]10606_andrade-replies-antidepressant-response-dissociative-effects-ketamine.pdf2022-11-07 22:17 109K 
[ ]10607_andrade-replies-number-needed-to-treat.pdf2022-11-07 22:07 107K 
[ ]10608_androgen-deficiency-association-increased-anxiety.pdf2022-11-07 22:19 192K 
[ ]10609_anemia-among-schizophrenic-patients-influence-clozapine.pdf2022-11-07 22:14 133K 
[ ]10610_anetholtrithion-stabilizes-body-weight-fluctuation-excessive-water-drinking-schizophrenia.pdf2022-11-07 22:13 45K 
[ ]10611_a-new-decade.pdf2022-11-07 22:56 300K 
[ ]10612_anger-aggression-psychiatric-outpatients.pdf2022-11-07 23:02 73K 
[ ]10613_anger-and-impulsivity-among-adolescents.pdf2022-11-07 22:40 239K 
[ ]10614_anger-attacks-bipolar-depression-predictors-response.pdf2022-11-07 22:37 63K 
[ ]10615_anger-attacks-correlates-significance-underrecognized.pdf2022-11-07 22:48 54K 
[ ]10616_anger-attacks-patients-depression.pdf2022-11-07 22:53 50K 
[ ]10617_anger-bipolar-depression.pdf2022-11-07 22:04 72K 
[ ]10618_anger-depressive-mixed-states.pdf2022-11-07 22:10 52K 
[ ]10619_an-infanticide-trial.pdf2022-11-07 22:31 126K 
[ ]10620_annual-gratitude.pdf2022-11-07 22:33 24K 
[ ]10621_annual-health-outcomes-treatment-costs-schizophrenia.pdf2022-11-07 22:10 55K 
[ ]10622_anosognosia-in-mci-and-ad.pdf2022-11-07 22:47 1.1M 
[ ]10623_another-passes.pdf2022-11-07 22:32 106K 
[ ]10624_antecedents-panic-disorder-nonreferred-adults.pdf2022-11-07 22:42 115K 
[ ]10625_antecedent-trauma-exposure-risk-depression-perinatal.pdf2022-11-07 22:04 361K 
[ ]10626_antenatal-anxiety-and-adverse-perinatal-outcomes.pdf2022-11-07 22:57 622K 
[ ]10627_antenatal-exposure-selective-serotonin-reuptake-inhibitors.pdf2022-11-07 22:31 531K 
[ ]10628_antenatal-ssri-exposure-and-autism.pdf2022-11-07 23:00 1.2M 
[ ]10629_antiadrenergic-treatment-antidepressant-induced-excessive.pdf2022-11-07 22:12 170K 
[ ]10630_antiaggressive-effect-cyproterone-versus-haloperidol.pdf2022-11-07 22:20 157K 
[ ]10631_antiaggressive-effect-quetiapine-patient-schizoaffective.pdf2022-11-07 22:16 46K 
[ ]10632_antibiotic-exposure-risk-depression-anxiety-psychosis.pdf2022-11-07 23:01 842K 
[ ]10633_antibiotics-infection-itself-possible-importance-inflammatory.pdf2022-11-07 22:16 84K 
[ ]10634_anticholinergic-burden-and-cognition-in-schizophrenia.pdf2022-11-07 22:26 341K 
[ ]10635_anticholinergic-drug-exposure-and-the-risk-of-dementia.pdf2022-11-07 22:14 329K 
[ ]10636_anticholinergic-effects-medication-elderly-patients.pdf2022-11-07 22:59 45K 
[ ]10637_anticholinergic-mechanisms-forgotten-cause-switch.pdf2022-11-07 22:21 108K 
[ ]10638_anticipated-reward-obsessive-compulsive-disorder-are.pdf2022-11-07 22:51 148K 
[ ]10639_anticonvulsants-antipsychotics-treatment-bipolar-disorder.pdf2022-11-07 22:28 101K 
[ ]10640_anticonvulsants-anxiolytics-part-tiagabine-anticonvulsants.pdf2022-11-07 22:18 37K 
[ ]10641_anticonvulsants-augment-antidepressant-medication.pdf2022-11-07 22:12 51K 
[ ]10642_anticonvulsants-in-ptsd.pdf2022-11-07 22:42 244K 
[ ]10643_anticonvulsants-mood-stabilizers-adjuncts-antipsychotics.pdf2022-11-07 22:53 37K 
[ ]10644_anticonvulsant-therapy-suicide-risk-affective-disorders.pdf2022-11-07 22:01 53K 
[ ]10645_antidepressant-absence-common-mental-disorders-general.pdf2022-11-07 22:47 309K 
[ ]10646_antidepressant-action-atypical-antipsychotics-focus.pdf2022-11-07 22:03 549K 
[ ]10647_antidepressant-adherence-in-psychiatry-and-primary-care.pdf2022-11-07 22:18 294K 
[ ]10648_antidepressant-associated-mania-psychosis-resulting.pdf2022-11-07 22:35 39K 
[ ]10649_antidepressant-associated-mood-elevations-bipolar.pdf2022-11-07 22:35 350K 
[ ]10650_antidepressant-augmentation-anti-inflammatory-agents.pdf2022-11-07 22:57 520K 
[ ]10651_antidepressant-augmentation-conclusions-recommendations.pdf2022-11-07 22:37 25K 
[ ]10652_antidepressant-augmentation-news-limitations-stumbling.pdf2022-11-07 22:38 109K 
[ ]10653_antidepressant-augmentation-using-ltemgtnltemgt-methyl.pdf2022-11-07 22:31 473K 
[ ]10654_antidepressant-discontinuation-bipolar-depression.pdf2022-11-07 22:07 309K 
[ ]10655_antidepressant-discontinuation-related-mania-critical.pdf2022-11-07 22:20 68K 
[ ]10656_antidepressant-discontinuation-review-literature.pdf2022-11-07 22:43 34K 
[ ]10657_antidepressant-discontinuation-risk-suicide-attempt.pdf2022-11-07 22:53 441K 
[ ]10658_antidepressant-discontinuation-syndrome-consensus.pdf2022-11-07 22:50 77K 
[ ]10659_antidepressant-dosing-switching-guidelines-focus-nefazodone.pdf2022-11-07 22:46 57K 
[ ]10660_antidepressant-double-antidepressant-treatment-affective.pdf2022-11-07 22:11 95K 
[ ]10661_antidepressant-drug-consumption-public-health-indicators.pdf2022-11-07 22:57 126K 
[ ]10662_antidepressant-drugs-disturbing-potentially-dangerous.pdf2022-11-07 22:13 88K 
[ ]10663_antidepressant-drugs-patients-heart-disease.pdf2022-11-07 22:03 87K 
[ ]10664_antidepressant-effectiveness-severe-depression-melancholia.pdf2022-11-07 22:28 64K 
[ ]10665_antidepressant-effects-nicotine.pdf2022-11-07 22:41 45K 
[ ]10666_antidepressant-effects-of-sleep-deprivation.pdf2022-11-07 22:41 433K 
[ ]10667_antidepressant-efficacy-and-safety-in-bipolar-depression.pdf2022-11-07 22:52 122K 
[ ]10669_antidepressant-efficacy-hiv-seropositive-outpatients.pdf2022-11-07 22:44 65K 
[ ]10670_antidepressant-efficacy-tolerability-selective-norepinephrine.pdf2022-11-07 22:07 92K 
[ ]10671_antidepressant-elderly-suicide-victims-york-city-analysis.pdf2022-11-07 22:12 175K 
[ ]10672_antidepressant-exposure-during-pregnancy-congenital.pdf2022-11-07 22:25 1.1M 
[ ]10673_antidepressant-exposure-during-pregnancy-risk-autism-offspring-part-1-meta-review-of-meta-analysis.pdf2022-11-07 22:44 317K 
[ ]10674_antidepressant-exposure-during-pregnancy-risk-autism-part-2-new-studies.pdf2022-11-07 22:41 328K 
[ ]10675_antidepressant-exposure-may-protect-against-decrement.pdf2022-11-07 23:01 103K 
[ ]10676_antidepressant-induced-mania-bipolar-patients-identification.pdf2022-11-07 22:03 64K 
[ ]10677_antidepressant-induced-mania-in-bipolar-disorder.pdf2022-11-07 22:02 238K 
[ ]10678_antidepressant-induced-sexual-dysfunction.pdf2022-11-07 22:13 50K 
[ ]10679_antidepressant-induced-sexual-dysfunction-during-treatment.pdf2022-11-07 22:11 109K 
[ ]10680_antidepressant-lifetime-history-mental-disorders-community.pdf2022-11-07 22:47 192K 
[ ]10681_antidepressant-medication-change-clinical-treatment.pdf2022-11-07 22:49 34K 
[ ]10682_antidepressant-medication-management-health-plan-employer.pdf2022-11-07 22:16 65K 
[ ]10683_antidepressant-medication-treatment-during-pregnancy.pdf2022-11-07 22:58 150K 
[ ]10684_antidepressant-medication-treatment-failure-does-predict.pdf2022-11-07 22:34 152K 
[ ]10685_antidepressant-nonadherence-in-older-veterans.pdf2022-11-07 22:35 230K 
[ ]10686_antidepressant-nonadherence-routine-clinical-settings.pdf2022-11-07 22:17 82K 
[ ]10687_antidepressant-noncompliance-factor-discontinuation.pdf2022-11-07 22:01 31K 
[ ]10688_antidepressant-pharmacotherapy-treatment-depression.pdf2022-11-07 22:55 49K 
[ ]10689_antidepressant-prescription-and-anemia-in-pregnancy.pdf2022-11-07 22:16 295K 
[ ]10691_antidepressant-related-erectile-dysfunction-management.pdf2022-11-07 22:17 81K 
[ ]10692_antidepressant-response-dissociative-effects-ketamine.pdf2022-11-07 23:03 109K 
[ ]10693_antidepressant-response-late-life-depression.pdf2022-11-07 22:03 83K 
[ ]10694_antidepressant-risk-recurrent-stroke-population-based.pdf2022-11-07 22:03 795K 
[ ]10695_antidepressant-risk-suicide-attempts-bipolar-disorder.pdf2022-11-07 22:59 134K 
[ ]10696_antidepressants.pdf2022-11-07 22:42 116K 
[ ]10697_antidepressants-acute-bipolar-depression-inconclusive.pdf2022-11-07 22:12 150K 
[ ]10698_antidepressants-acute-treatment-bipolar-depression.pdf2022-11-07 22:01 554K 
[ ]10699_antidepressants-adult-suicides-york-city.pdf2022-11-07 22:10 132K 
[ ]10700_antidepressants-alcohol-dependent-veterans.pdf2022-11-07 22:29 54K 
[ ]10701_antidepressants-and-atrial-fibrillation-statistical-approaches-to-control-for-confounding.pdf2022-11-07 22:22 293K 
[ ]10703_antidepressants-and-dementia-risk.pdf2022-11-07 22:29 275K 
[ ]10704_antidepressants-and-glucose-insulin-homeostasis.pdf2022-11-07 22:29 205K 
[ ]10705_antidepressants-and-risk-of-fracture-in-youth.pdf2022-11-07 22:24 433K 
[ ]10706_antidepressants-and-risk-of-hip-fracture-in-the-elderly.pdf2022-11-07 22:53 281K 
[ ]10707_antidepressants-antipsychotics-long-term-treatment.pdf2022-11-07 22:35 73K 
[ ]10708_antidepressants-are-overprescribed-mild-depression.pdf2022-11-07 22:46 561K 
[ ]10709_antidepressants-bipolar-disorder.pdf2022-11-07 22:07 328K 
[ ]10710_antidepressants-bipolar-disorder-caveats-interpreting.pdf2022-11-07 22:30 103K 
[ ]10711_antidepressants-blue-chip-psychotropic-modern-treatment.pdf2022-11-07 22:44 33K 
[ ]10712_antidepressants-body-weight-comprehensive-review-meta.pdf2022-11-07 22:55 2.4M 
[ ]10713_antidepressants-driver-impairment-empirical-evidence.pdf2022-11-07 22:45 100K 
[ ]10714_antidepressants-driving-ability-results-clinical-study.pdf2022-11-07 22:45 100K 
[ ]10716_antidepressants-faster-others.pdf2022-11-07 22:03 48K 
[ ]10717_antidepressants-help-depression-mechanisms-action.pdf2022-11-07 22:39 60K 
[ ]10718_antidepressant-side-effects-and-panic.pdf2022-11-07 22:24 261K 
[ ]10719_antidepressant-signal-detection-clinical-trials-vortex.pdf2022-11-07 23:03 138K 
[ ]10720_antidepressants-induce-rapid-cycling-gender-specific.pdf2022-11-07 22:34 53K 
[ ]10721_antidepressants-major-depressive-disorder-dysthymic.pdf2022-11-07 23:00 367K 
[ ]10722_antidepressants-mood-stabilizers-antipsychotics-and-the-risk-of-cataract.pdf2022-11-07 22:27 303K 
[ ]10723_antidepressants-novel-combination-therapies.pdf2022-11-07 22:14 61K 
[ ]10724_antidepressants-panic-disorder.pdf2022-11-07 22:49 36K 
[ ]10725_antidepressants-panic-disorder-clinical-preclinical.pdf2022-11-07 22:34 40K 
[ ]10726_antidepressants-really-beget-more-depressive-episodes.pdf2022-11-07 22:37 145K 
[ ]10727_antidepressants-risk-dementia-methodology-is-essential.pdf2022-11-07 22:13 103K 
[ ]10728_antidepressants-risks-suicide-suicide-attempts-observational.pdf2022-11-07 22:46 279K 
[ ]10729_antidepressants-somatic-symptoms-therapeutic-actions.pdf2022-11-07 22:55 36K 
[ ]10730_antidepressants-suicidal-risk.pdf2022-11-07 22:47 60K 
[ ]10731_antidepressants-suicide-rate-finland-ecological-study.pdf2022-11-07 22:48 167K 
[ ]10732_antidepressants-suicide-risk-united-states.pdf2022-11-07 23:02 63K 
[ ]10733_antidepressants-testicular-cancer-cause-versus-association.pdf2022-11-07 22:27 502K 
[ ]10734_antidepressants-treatment-attention-deficit-hyperactivity.pdf2022-11-07 22:01 1.0M 
[ ]10735_antidepressants-treatment-premenstrual-dysphoric-disorder.pdf2022-11-07 22:47 920K 
[ ]10736_antidepressants-used-treat-schizophrenia-prodrome.pdf2022-11-07 22:56 265K 
[ ]10737_antidepressant-therapy-dawn-third-millennium.pdf2022-11-07 22:26 20K 
[ ]10738_antidepressant-treatment-depressed-patient-insomnia.pdf2022-11-07 22:17 57K 
[ ]10739_antidepressant-treatment-depression-hiv-seropositive.pdf2022-11-07 22:56 36K 
[ ]10740_antidepressant-treatment-global-tests-coagulation.pdf2022-11-07 22:40 59K 
[ ]10741_antidepressant-treatment-outcomes-psychogenic-movement.pdf2022-11-07 22:42 127K 
[ ]10742_antidepressant-treatment-posttraumatic-stress-disorder.pdf2022-11-07 22:24 40K 
[ ]10743_antidepressant-withdrawal-mania-critical-review-synthesis.pdf2022-11-07 22:54 51K 
[ ]10744_antidepressive-treatment-monoamine-oxidase-inhibitors.pdf2022-11-07 22:58 359K 
[ ]10745_antiepileptic-drug-augmentation-treatment-resistant.pdf2022-11-07 22:38 43K 
[ ]10746_antihypertensives-tranylcypromine-safer-three-case.pdf2022-11-07 22:09 117K 
[ ]10747_anti-inflammatory-treatments-for-depression.pdf2022-11-07 22:22 329K 
[ ]10749_anti-inflammatory-treatments-for-mdd.pdf2022-11-07 22:41 167K 
[ ]10750_antimanic-efficacy-topiramate-patients-open-trial.pdf2022-11-07 22:02 57K 
[ ]10751_antimanic-response-aripiprazole-bipolar-i-disorder.pdf2022-11-07 22:25 188K 
[ ]10752_antipsychotic-adherence-among-patients-receiving-treatment.pdf2022-11-07 22:41 100K 
[ ]10753_antipsychotic-agents-bipolar-disorder.pdf2022-11-07 22:35 63K 
[ ]10754_antipsychotic-agents-emerging-clinical-profiles.pdf2022-11-07 22:55 52K 
[ ]10755_antipsychotic-associated-weight-gain-clinical-outcome.pdf2022-11-07 22:34 91K 
[ ]10756_antipsychotic-changes-affecting-tardive-dyskinesia-and-parkinsonism.pdf2022-11-07 22:46 223K 
[ ]10757_antipsychotic-drug-interactions-and-mortality.pdf2022-11-07 22:37 343K 
[ ]10758_antipsychotic-drug-side-effect-issues-bipolar-manic.pdf2022-11-07 22:59 70K 
[ ]10759_antipsychotic-drugs-insulin-resistance-hyperglycemia.pdf2022-11-07 22:14 123K 
[ ]10760_antipsychotic-drugs-may-worsen-metabolic-control-type.pdf2022-11-07 22:44 55K 
[ ]10761_antipsychotic-drugs-mood-stabilizers-risk-pneumonia.pdf2022-11-07 22:52 543K 
[ ]10762_antipsychotic-drugs-receptor-binding-profiles-compare.pdf2022-11-07 22:42 154K 
[ ]10763_antipsychotic-drug-treatment-episode-mania-month.pdf2022-11-07 22:37 66K 
[ ]10764_antipsychotic-free-patients-with-schizophrenia.pdf2022-11-07 22:38 245K 
[ ]10765_antipsychotic-induced-hyperprolactinemia-inhibits.pdf2022-11-07 22:18 209K 
[ ]10766_antipsychotic-induced-sexual-dysfunction-strength.pdf2022-11-07 22:59 140K 
[ ]10767_antipsychotic-induced-weight-gain-review-literature.pdf2022-11-07 22:14 103K 
[ ]10768_antipsychotic-induced-weight-gain-stabilization.pdf2022-11-07 22:22 337K 
[ ]10769_antipsychotic-maintenance-treatment-for-schizophrenia.pdf2022-11-07 22:45 280K 
[ ]10770_antipsychotic-medication-diabetes-mellitusrs.pdf2022-11-07 22:20 134K 
[ ]10771_antipsychotic-medication-oxidative-cell-stress-systematic.pdf2022-11-07 22:39 454K 
[ ]10772_antipsychotic-medications-decrease-risk-suicide-patients.pdf2022-11-07 22:29 43K 
[ ]10773_antipsychotic-medications-in-adult-depression.pdf2022-11-07 22:18 517K 
[ ]10774_antipsychotic-medications-metabolic-cardiovascular.pdf2022-11-07 22:44 143K 
[ ]10775_antipsychotic-polypharmacy-in-schizophrenia-why-not.pdf2022-11-07 22:45 213K 
[ ]10776_antipsychotic-polypharmacy-part-shotgun-approach-targeted.pdf2022-11-07 22:24 76K 
[ ]10777_antipsychotic-polypharmacy-part-therapeutic-option.pdf2022-11-07 22:10 34K 
[ ]10778_antipsychotic-polypharmacy-part-tips-misuse.pdf2022-11-07 22:40 40K 
[ ]10779_antipsychotic-polypharmacy-part-why-antipsychotics.pdf2022-11-07 22:19 79K 
[ ]10780_antipsychotic-polypharmacy-risk-death-natural-causes.pdf2022-11-07 23:03 210K 
[ ]10781_antipsychotic-polypharmacy-squandering-precious-resources.pdf2022-11-07 22:27 41K 
[ ]10782_antipsychotic-prescriptions-in-outpatients-with-mdd.pdf2022-11-07 22:51 239K 
[ ]10783_antipsychotic-prescriptions-iraq-afghanistan-veterans.pdf2022-11-07 23:00 817K 
[ ]10784_antipsychotic-reexposure-recurrent-pneumonia-schizophrenia.pdf2022-11-07 22:17 434K 
[ ]10785_antipsychotic-safety-efficacy-concerns.pdf2022-11-07 22:56 143K 
[ ]10786_antipsychotics-and-mortality-in-patients-with-dementia.pdf2022-11-07 22:02 530K 
[ ]10788_antipsychotics-and-recurrent-venous-thromboembolism.pdf2022-11-07 22:26 669K 
[ ]10789_antipsychotics-and-risk-of-hip-fractures.pdf2022-11-07 22:11 1.0M 
[ ]10790_antipsychotics-are-equal-are-more-equal-others.pdf2022-11-07 22:41 77K 
[ ]10791_antipsychotics-cause-hip-fractures-promise-pitfalls.pdf2022-11-07 22:22 108K 
[ ]10792_antipsychotics-children-adolescents.pdf2022-11-07 22:30 230K 
[ ]10793_antipsychotics-cocaine-psychostimulant-dependence.pdf2022-11-07 22:50 823K 
[ ]10794_antipsychotics-for-homeless-and-unstably-housed-veterans.pdf2022-11-07 23:02 622K 
[ ]10796_antipsychotics-mood-stabilizers-stahls-essential-psychopharmacology.pdf2022-11-07 22:40 101K 
[ ]10797_antipsychotics-primary-alcohol-dependence-systematic.pdf2022-11-07 22:20 726K 
[ ]10798_antipsychotics-theory-practice-integrating-clinical.pdf2022-11-07 22:03 77K 
[ ]10799_antipsychotics-treatment-delirium-systematic-review.pdf2022-11-07 22:50 108K 
[ ]10800_antipsychotics-treatment-major-depressive-disorder.pdf2022-11-07 22:55 200K 
[ ]10801_antipsychotics-treatment-mood-disorders-risk-tardive.pdf2022-11-07 22:28 53K 
[ ]10802_antipsychotics-treatment-schizophrenia-overview.pdf2022-11-07 22:51 270K 
[ ]10803_antipsychotic-treatment-adults-united-states.pdf2022-11-07 22:22 1.1M 
[ ]10804_antipsychotic-treatment-occurrence-venous-thromboembolism.pdf2022-11-07 22:38 607K 
[ ]10805_antipsychotic-treatment-psychosis-agitation-elderly.pdf2022-11-07 22:48 48K 
[ ]10806_antipsychotic-treatment-risk-hip-fracture-subjects.pdf2022-11-07 22:26 859K 
[ ]10807_antipsychotic-use-and-cardiovascular-outcomes.pdf2022-11-07 22:44 1.1M 
[ ]10808_antipsychotic-use-and-stroke-risk.pdf2022-11-07 22:03 230K 
[ ]10809_antisocial-behavioral-syndromes-in-adults.pdf2022-11-07 22:31 131K 
[ ]10810_antisocial-behavioral-syndromes-past-physical-health.pdf2022-11-07 22:14 355K 
[ ]10811_anxiety-associated-comorbid-depression.pdf2022-11-07 22:41 74K 
[ ]10812_anxiety-disorders-adults-clinical-guide-nd-ed.pdf2022-11-07 22:03 142K 
[ ]10813_anxiety-disorders-bipolar-patients-prevalence-impact.pdf2022-11-07 22:36 61K 
[ ]10814_anxiety-disorders-during-pregnancy-postpartum-period.pdf2022-11-07 22:38 131K 
[ ]10815_anxiety-disorders-during-pregnancy-systematic-review.pdf2022-11-07 22:09 1.9M 
[ ]10816_anxiety-disorders-following-miscarriage.pdf2022-11-07 22:51 64K 
[ ]10817_anxiety-disorders-in-pregnant-and-postpartum-women.pdf2022-11-07 22:08 731K 
[ ]10818_anxiety-disorders-introduction-clinical-management.pdf2022-11-07 22:27 54K 
[ ]10819_anxiety-disorders-nature-treatment-anxiety-panic-nd.pdf2022-11-07 22:41 37K 
[ ]10820_anxiety-disorders-syndrome-chest-pain-normal-coronary.pdf2022-11-07 22:29 39K 
[ ]10821_anxiety-disruptive-behavior-mediate-pathways-attention.pdf2022-11-07 22:33 366K 
[ ]10822_anxiety-inflammatory-markers-antipsychotics.pdf2022-11-07 22:07 114K 
[ ]10823_anxiety-irritable-bowel-syndrome-psychiatric-medical.pdf2022-11-07 22:09 46K 
[ ]10824_anxiety-symptoms-anxiety-disorders-are-related-premenstrual.pdf2022-11-07 22:36 35K 
[ ]10825_anxiety-symptoms-quality-life-middle-aged-older-outpatients.pdf2022-11-07 22:25 63K 
[ ]10826_anxiety-youth.pdf2022-11-07 22:16 106K 
[ ]10827_anxiolytic-antidepressant-augmentation.pdf2022-11-07 22:57 42K 
[ ]10828_anxiolytics-past-present-future-agents.pdf2022-11-07 22:39 51K 
[ ]10829_anxious-depression.pdf2022-11-07 22:12 44K 
[ ]10830_anxious-distress-as-predictor-of-mdd-outcome.pdf2022-11-07 23:02 812K 
[ ]10831_apathy-predicts-frailty-in-older-adults.pdf2022-11-07 22:34 576K 
[ ]10832_apoe-cerebrovascular-burden-and-depression.pdf2022-11-07 23:01 281K 
[ ]10833_apologies-thanks-reviewers.pdf2022-11-07 22:20 125K 
[ ]10834_apoptosis-neuronal-death-design.pdf2022-11-07 22:22 28K 
[ ]10835_apparent-commercial-bias-supplement.pdf2022-11-07 22:52 210K 
[ ]10836_apparent-discrepancy-between-published-study-gabapentin.pdf2022-11-07 22:37 114K 
[ ]10837_apparent-effects-ziprasidone-plasma-lipids-glucose.pdf2022-11-07 22:15 35K 
[ ]10838_appease-appetite-psychotropic-drugs.pdf2022-11-07 22:55 29K 
[ ]10839_appetite-regulatory-hormones-women-anorexia-nervosa.pdf2022-11-07 22:34 248K 
[ ]10840_applicability-genetic-signature-enhanced-iloperidone.pdf2022-11-07 22:42 342K 
[ ]10841_applicability-oral-glucose-tolerance-test-assessing.pdf2022-11-07 22:02 256K 
[ ]10842_applicability-telemedicine-assessing-patients-schizophrenia.pdf2022-11-07 22:57 74K 
[ ]10843_application-neuroimaging-techniques-drug-development.pdf2022-11-07 22:50 61K 
[ ]10844_application-positron-emission-tomography-study-normal.pdf2022-11-07 22:59 51K 
[ ]10846_applying-parsimony-african-patient-ziprasidone-intolerance.pdf2022-11-07 22:56 141K 
[ ]10847_applying-rdoc-to-clinical-practice.pdf2022-11-07 22:54 273K 
[ ]10848_approaches-enhancement-patient-adherence-antidepressant.pdf2022-11-07 22:30 56K 
[ ]10849_approaches-managing-bipolar-depression.pdf2022-11-07 22:54 59K 
[ ]10850_approaches-managing-difficult-treat-depressions.pdf2022-11-07 22:08 42K 
[ ]10851_approaches-managing-psychotic-depression.pdf2022-11-07 22:40 61K 
[ ]10853_approaches-treatment-refractory-depression.pdf2022-11-07 22:10 80K 
[ ]10854_approach-psychiatric-patient-case-based-essays.pdf2022-11-07 22:54 721K 
[ ]10857_are-analyzing.pdf2022-11-07 22:19 60K 
[ ]10858_are-antidepressant-mechanisms-better.pdf2022-11-07 22:07 54K 
[ ]10859_are-antidepressant-mechanisms-better-issues-clinical.pdf2022-11-07 22:11 76K 
[ ]10860_are-antidepressants-associated-onset-suicidality.pdf2022-11-07 22:34 112K 
[ ]10861_are-antidepressants-carcinogenic-review-preclinical.pdf2022-11-07 22:39 70K 
[ ]10862_are-antidepressants-effective-whats-clinician.pdf2022-11-07 22:12 82K 
[ ]10863_are-antidepressants-really-same-case-fluoxetine-systematic.pdf2022-11-07 22:45 156K 
[ ]10864_are-antidepressants-same.pdf2022-11-07 22:03 55K 
[ ]10865_are-antipsychotics-antidepressants-needed-psychotic.pdf2022-11-07 22:29 406K 
[ ]10866_are-antipsychotics-effective-treatment-anorexia-nervosa.pdf2022-11-07 22:20 447K 
[ ]10867_are-antipsychotics-really-associated-with-uterine-cancer.pdf2022-11-07 22:27 428K 
[ ]10868_are-beslans-children-learning-cope-prospective-study.pdf2022-11-07 22:07 390K 
[ ]10869_are-comparative-benefits-harms-augmentation-treatments.pdf2022-11-07 22:23 132K 
[ ]10870_are-depressed-outpatients-without-family-history-substance.pdf2022-11-07 22:48 154K 
[ ]10871_are-girls-boys-different-planets.pdf2022-11-07 22:54 58K 
[ ]10872_are-hospitals-effective-acutely-ill-psychiatric-patients.pdf2022-11-07 22:43 240K 
[ ]10873_are-illness-concepts-powerful-predictor-adherence.pdf2022-11-07 22:30 77K 
[ ]10874_are-looking-antipsychotics.pdf2022-11-07 22:48 268K 
[ ]10875_are-maternal-depression-symptom-severity-associated.pdf2022-11-07 22:56 397K 
[ ]10877_are-mood-disorders-obesity-related-review-mental-health.pdf2022-11-07 22:45 126K 
[ ]10878_are-nutritional-supplements-ready-prime.pdf2022-11-07 22:47 82K 
[ ]10879_are-overweight-obesity-extreme-obesity-associated.pdf2022-11-07 22:08 275K 
[ ]10880_are-psychological-pharmacologic-interventions-equally.pdf2022-11-07 22:33 315K 
[ ]10881_are-ptsd-symptoms-related-to-mental-health-service-use.pdf2022-11-07 22:24 249K 
[ ]10882_are-selective-serotonin-reuptake-inhibitors-associated.pdf2022-11-07 22:29 323K 
[ ]10883_are-sides-every-question-exploring-construct-sleep.pdf2022-11-07 22:28 110K 
[ ]10884_are-some-antipsychotics-depressogenic-in-bipolar-disorder.pdf2022-11-07 23:02 119K 
[ ]10885_are-specific-symptoms-depression-predictive-alzheimers.pdf2022-11-07 22:29 300K 
[ ]10886_are-there-effective-psychopharmacologic-treatments-for-ptsd.pdf2022-11-07 23:02 143K 
[ ]10887_are-weight-gain-metabolic-side-effects-atypical-antipsychotics.pdf2022-11-07 22:34 315K 
[ ]10888_aripiprazole-and-worsening-psychosis.pdf2022-11-07 22:59 503K 
[ ]10889_aripiprazole-associated-seizure.pdf2022-11-07 22:23 86K 
[ ]10890_aripiprazole-augmentation-antidepressants-treatment.pdf2022-11-07 22:47 131K 
[ ]10891_aripiprazole-augmentation-clomipramine-refractory.pdf2022-11-07 22:45 196K 
[ ]10892_aripiprazole-augmentation-clozapine-treated-patients.pdf2022-11-07 22:17 338K 
[ ]10893_aripiprazole-augmentation-selective-serotonin-reuptake.pdf2022-11-07 22:27 135K 
[ ]10894_aripiprazole-augmentation-venlafaxine-treatment-psychogenic.pdf2022-11-07 22:43 80K 
[ ]10895_aripiprazole-children-adolescents-bipolar-disorder.pdf2022-11-07 22:49 382K 
[ ]10896_aripiprazole-effects-patients-acute-schizophrenia.pdf2022-11-07 22:31 189K 
[ ]10897_aripiprazole-induced-agitation-clozapine-discontinuation.pdf2022-11-07 22:32 124K 
[ ]10898_aripiprazole-induced-gray-matter-growth-patient-major.pdf2022-11-07 22:06 475K 
[ ]10899_aripiprazole-induced-hyponatremia-case-report.pdf2022-11-07 22:25 170K 
[ ]10900_aripiprazole-induced-psychosis-case-report-reexposure.pdf2022-11-07 22:17 153K 
[ ]10901_aripiprazole-intramuscular-depot-maintenance-treatment.pdf2022-11-07 23:02 360K 
[ ]10902_aripiprazole-joins-family-second-generation-mood-stabilizers.pdf2022-11-07 23:02 185K 
[ ]10903_aripiprazole-monotherapy-maintenance-therapy-bipolar.pdf2022-11-07 22:33 284K 
[ ]10904_aripiprazole-obsessive-compulsive-disorder-preliminary.pdf2022-11-07 22:16 92K 
[ ]10905_aripiprazole-once-monthly-acute-treatment-schizophrenia.pdf2022-11-07 22:10 449K 
[ ]10906_aripiprazole-once-monthly-for-bipolar-i.pdf2022-11-07 22:03 763K 
[ ]10907_aripiprazole-perphenazine-difference.pdf2022-11-07 22:33 158K 
[ ]10908_aripiprazole-prevention-relapse-stabilized-patients.pdf2022-11-07 22:39 75K 
[ ]10909_aripiprazole-schizophrenia-patients-comorbid-obsessive.pdf2022-11-07 22:03 125K 
[ ]10910_aripiprazole-therapy-older-adults-bipolar-disorder.pdf2022-11-07 22:09 175K 
[ ]10911_aripiprazole-treatment-patients-borderline-personality.pdf2022-11-07 22:17 158K 
[ ]10912_aripiprazole-treatment-resistant-schizophrenia-results.pdf2022-11-07 22:33 244K 
[ ]10913_aripiprazole-treatment-risperidone-induced-hyperprolactinemia.pdf2022-11-07 22:57 283K 
[ ]10914_aripiprazole-worsening-psychosis-case-report.pdf2022-11-07 22:46 221K 
[ ]10915_armodafinil-adjunctive-therapy-adults-cognitive-deficits.pdf2022-11-07 22:51 373K 
[ ]10916_aromatherapy-safe-effective-treatment-management-agitation.pdf2022-11-07 22:05 69K 
[ ]10917_art-blood-sport-psychopharmacology-research-has-dog.pdf2022-11-07 22:38 61K 
[ ]10918_article-commended.pdf2022-11-07 22:22 80K 
[ ]10920_artifactual-rediagnosis-psychotic-depression-schizophrenia.pdf2022-11-07 22:32 81K 
[ ]10921_art-science-brief-psychotherapies-illustrated-guide.pdf2022-11-07 22:54 94K 
[ ]10924_ascp-administers-th-certification-exam.pdf2022-11-07 22:05 49K 
[ ]10925_ascp-corner-antidepressant-pregnancy-risk-autism-spectrum.pdf2022-11-07 22:39 151K 
[ ]10926_ascp-corner-ascp-annual-meeting-ncdeu-history.pdf2022-11-07 22:15 239K 
[ ]10927_ascp-corner-assessing-adequacy-past-antidepressant.pdf2022-11-07 22:50 233K 
[ ]10928_ascp-corner-changes-diagnostic-criteria-autism-ltemgtdsm.pdf2022-11-07 22:19 153K 
[ ]10929_ascp-corner-current-status-ketamine-related-compounds.pdf2022-11-07 22:29 163K 
[ ]10930_ascp-corner-decision-making-antipsychotic-medication.pdf2022-11-07 22:24 226K 
[ ]10931_ascp-corner-discordance-between-researchers-patients.pdf2022-11-07 22:41 126K 
[ ]10932_ascp-corner-endocannabinoid-system-schizophrenia-links.pdf2022-11-07 22:54 203K 
[ ]10933_ascp-corner-lessons-learned-ltspan-stylefont-variantsmall.pdf2022-11-07 22:42 160K 
[ ]10934_ascp-corner-monoamine-oxidase-inhibitors-revisited.pdf2022-11-07 22:06 130K 
[ ]10935_ascp-corner-pulsed-intravenous-administration-scopolamine.pdf2022-11-07 22:21 153K 
[ ]10936_ascp-corner-reconsidering-chronic-hyponatremia-psychosis.pdf2022-11-07 22:36 134K 
[ ]10937_ascp-corner-rediscovering-adverse-anticholinergic.pdf2022-11-07 22:53 174K 
[ ]10938_ascp-corner-role-vitamin-d-depression-curious-idea.pdf2022-11-07 22:35 179K 
[ ]10939_ascp-corner-stepping-step-forward-lessons-systematic.pdf2022-11-07 22:54 203K 
[ ]10940_asd-and-treatment-failure-in-early-onset-psychosis.pdf2022-11-07 22:39 416K 
[ ]10941_asenapine-clinical-overview.pdf2022-11-07 22:51 313K 
[ ]10942_asenapine-once-daily-versus-twice-daily-impact-patient.pdf2022-11-07 22:03 123K 
[ ]10943_asenapine-transdermal-system-for-schizophrenia.pdf2022-11-07 22:52 1.0M 
[ ]10945_asperger-syndrome-assessing-treating-high-functioning.pdf2022-11-07 22:43 76K 
[ ]10946_assertive-community-treatment-part-integrated-care.pdf2022-11-07 22:27 394K 
[ ]10948_assessing-attention-deficit-hyperactivity-disorder.pdf2022-11-07 22:35 62K 
[ ]10949_assessing-cardiovascular-risks-versus-clinical-benefits.pdf2022-11-07 22:37 47K 
[ ]10950_assessing-cognitive-function-bipolar-disorder-challenges.pdf2022-11-07 22:47 285K 
[ ]10951_assessing-cognitive-impairment-patients-schizophrenia.pdf2022-11-07 22:01 171K 
[ ]10952_assessing-comparative-effectiveness-antidepressant.pdf2022-11-07 22:36 67K 
[ ]10953_assessing-competency-for-physician-assisted-suicide-is-unethical.pdf2022-11-07 22:55 117K 
[ ]10954_assessing-demoralization-depression-setting-medical.pdf2022-11-07 22:11 101K 
[ ]10957_assessing-effects-atypical-antipsychotics-negative.pdf2022-11-07 22:15 109K 
[ ]10958_assessing-efficacy-desvenlafaxine-improving-functioning.pdf2022-11-07 22:49 476K 
[ ]10959_assessing-explanatory-models-common-mental-disorders.pdf2022-11-07 22:49 93K 
[ ]10961_assessing-managing-suicide-risk-guidelines-clinically.pdf2022-11-07 22:55 82K 
[ ]10962_assessing-maximizing-safety-tolerability-antipsychotics.pdf2022-11-07 23:02 323K 
[ ]10964_assessing-onset-antidepressant-induced-sexual-dysfunction.pdf2022-11-07 22:07 193K 
[ ]10965_assessing-onset-treatment-benefit-depression-anxiety.pdf2022-11-07 22:41 442K 
[ ]10968_assessing-risk-factors-difficult-treat-depression.pdf2022-11-07 22:50 207K 
[ ]10969_assessing-the-interest-activity-dimension-in-mdd-studies.pdf2022-11-07 22:14 109K 
[ ]10972_assessing-utility-atypical-antipsychotic-medication.pdf2022-11-07 22:54 242K 
[ ]10973_assessment-eps-tardive-dyskinesia-clinical-trials.pdf2022-11-07 22:51 100K 
[ ]10974_assessment-excessive-sleepiness-insomnia-relate-circadian.pdf2022-11-07 22:47 61K 
[ ]10975_assessment-resilience-aftermath-trauma.pdf2022-11-07 22:43 82K 
[ ]10976_assessments-suicidality-double-blind-placebo-controlled.pdf2022-11-07 22:57 330K 
[ ]10977_assessment-treatment-algorithms-including-amantadine.pdf2022-11-07 22:37 623K 
[ ]10978_assessment-treatment-associated-changes-behavior-cholinergic.pdf2022-11-07 22:53 49K 
[ ]10979_associated-symptoms-attention-deficit-hyperactivity.pdf2022-11-07 22:35 132K 
[ ]10980_association-adverse-childhood-environment-httlpr.pdf2022-11-07 22:06 428K 
[ ]10981_association-akt-gene-polymorphisms-risk-schizophrenia.pdf2022-11-07 22:26 232K 
[ ]10982_association-benzodiazepine-increased-cancer-risk-is.pdf2022-11-07 22:05 86K 
[ ]10983_association-between-accessibility-lethal-methods-method.pdf2022-11-07 23:01 101K 
[ ]10984_association-between-antenatal-exposure-selective-serotonin.pdf2022-11-07 22:41 125K 
[ ]10985_association-between-attention-deficit-hyperactivity-ADHD-bulimia-case.pdf2022-11-07 22:49 65K 
[ ]10986_association-between-attention-deficit-hyperactivity-sleep-impairment-adult-large-controlled-study.pdf2022-11-07 22:01 354K 
[ ]10987_association-between-borderline-personality-disorder.pdf2022-11-07 22:42 51K 
[ ]10988_association-between-clozapine-induced-agranulocytosis.pdf2022-11-07 22:29 81K 
[ ]10989_association-between-dh-insertiondeletion-polymorphism.pdf2022-11-07 22:23 268K 
[ ]10990_association-between-enhanced-soluble-cd-ligand-proinflammatory.pdf2022-11-07 22:25 110K 
[ ]10991_association-between-glyca-and-depressive-symptoms.pdf2022-11-07 22:10 203K 
[ ]10992_association-between-high-nicotine-dependence-severe.pdf2022-11-07 22:06 59K 
[ ]10993_association-between-income-distress-mental-disorders.pdf2022-11-07 22:15 325K 
[ ]10994_association-between-mental-health-status-sleep-status.pdf2022-11-07 22:34 237K 
[ ]10995_association-between-moderate-alcohol-illness-severity.pdf2022-11-07 22:19 78K 
[ ]10996_association-between-number-deployments-iraq-mental.pdf2022-11-07 22:37 307K 
[ ]10997_association-between-pain-depression-among-older-adults.pdf2022-11-07 23:00 160K 
[ ]10998_association-between-patient-beliefs-regarding-assigned.pdf2022-11-07 22:21 336K 
[ ]10999_association-between-premenstrual-dysphoric-disorder.pdf2022-11-07 22:10 522K 
[ ]11000_association-between-premenstrual-syndrome-depression.pdf2022-11-07 22:46 51K 
[ ]11001_association-between-ptsd-adhd-does-association-reveal.pdf2022-11-07 22:40 116K 
[ ]11002_association-between-social-isolation-ltemgtdsm-ivltemgt.pdf2022-11-07 22:35 346K 
[ ]11003_association-between-substance-abuse-antidepressant.pdf2022-11-07 22:58 66K 
[ ]11004_association-between-white-matter-hyperintensity-severity.pdf2022-11-07 22:04 162K 
[ ]11005_association-between-working-alliance-clinical-functional.pdf2022-11-07 22:14 246K 
[ ]11006_association-childhood-trauma-personality-disorders.pdf2022-11-07 22:15 382K 
[ ]11007_association-common-variations-norepinephrine-transporter.pdf2022-11-07 22:49 1.7M 
[ ]11008_association-depressive-symptoms-worse-functioning.pdf2022-11-07 22:38 70K 
[ ]11009_association-disaster-related-experiences-self-reported.pdf2022-11-07 22:17 130K 
[ ]11010_association-internalizing-disorders-allergies-child.pdf2022-11-07 22:20 192K 
[ ]11011_association-mild-traumatic-brain-injury-bipolar-disorder.pdf2022-11-07 22:20 50K 
[ ]11012_association-obesity-inflammatory-marker-levels-treatment.pdf2022-11-07 22:01 1.1M 
[ ]11013_association-ptsd-depression-medical-specialist-care.pdf2022-11-07 22:32 82K 
[ ]11014_association-pulmonary-tuberculosis-ethambutol-incident.pdf2022-11-07 22:33 309K 
[ ]11015_association-rs-polymorphism-norepinephrine-transporter.pdf2022-11-07 22:02 125K 
[ ]11016_associations-anxiety-related-symptoms-reported-history.pdf2022-11-07 22:06 133K 
[ ]11017_associations-between-bipolar-disorder-metabolic-syndrome.pdf2022-11-07 22:35 112K 
[ ]11018_associations-between-cognitive-impairment-tardive.pdf2022-11-07 22:56 50K 
[ ]11019_associations-between-serum-lipids-major-depressive.pdf2022-11-07 22:43 470K 
[ ]11020_association-small-life-events-self-reports-tic-severity.pdf2022-11-07 22:23 53K 
[ ]11021_association-study-decreased-serum-bdnf-concentrations.pdf2022-11-07 22:41 232K 
[ ]11022_association-study-httlpr-polymorphism-depression.pdf2022-11-07 22:03 103K 
[ ]11023_association-study-trauma-load-slca-promoter-polymorphism.pdf2022-11-07 22:34 248K 
[ ]11024_association-subjective-being-symptoms-side-effects.pdf2022-11-07 22:42 78K 
[ ]11025_association-suicide-antidepressant-prescription-rates.pdf2022-11-07 22:52 233K 
[ ]11026_association-weight-gain-metabolic-syndrome-patients.pdf2022-11-07 22:56 209K 
[ ]11027_association-zolpidem-subsequent-increased-risk-epilepsy.pdf2022-11-07 22:26 314K 
[ ]11028_asymptomatic-qtc-prolongation-during-coadministration.pdf2022-11-07 22:55 154K 
[ ]11029_asystole-ect.pdf2022-11-07 22:45 35K 
[ ]11030_atherogenic-metabolic-risk-factor-profile-atypical-antipsychotics.pdf2022-11-07 22:04 124K 
[ ]11031_atomoxetine-adult-attention-deficit-hyperactivity-disorder.pdf2022-11-07 22:22 84K 
[ ]11032_atomoxetine-associated-hemospermia-case-report.pdf2022-11-07 22:23 204K 
[ ]11033_atomoxetine-tolerability-pediatric-adult-patients.pdf2022-11-07 22:33 425K 
[ ]11034_atomoxetine-treatment-binge-eating-disorder-randomized.pdf2022-11-07 22:09 212K 
[ ]11035_attachment-pets-integrative-view-human-animal-relationships.pdf2022-11-07 23:02 68K 
[ ]11036_attacks-jealousy-responded-clomipramine.pdf2022-11-07 22:46 38K 
[ ]11037_attaining-remission-generalized-anxiety-disorder-venlafaxine.pdf2022-11-07 22:35 61K 
[ ]11038_attending-anxiety-disorders-primary-care.pdf2022-11-07 22:39 53K 
[ ]11039_attention-deficit-hyperactivity-disorder-advances-diagnostic.pdf2022-11-07 22:04 44K 
[ ]11040_attention-deficit-hyperactivity-disorder-binge-eating.pdf2022-11-07 22:43 196K 
[ ]11041_attention-deficit-hyperactivity-disorder-clinical.pdf2022-11-07 22:46 39K 
[ ]11042_attention-deficit-hyperactivity-disorder-clinical-guide.pdf2022-11-07 22:38 19K 
[ ]11043_attention-deficit-hyperactivity-disorder-handbook.pdf2022-11-07 22:27 100K 
[ ]11044_attention-deficit-hyperactivity-disorder-life-span.pdf2022-11-07 22:44 130K 
[ ]11045_attention-deficit-hyperactivity-disorder-males-paraphilias.pdf2022-11-07 22:48 65K 
[ ]11046_attention-deficit-hyperactivity-disorder-specific-quality.pdf2022-11-07 22:15 358K 
[ ]11047_attention-deficit-hyperactivity-disorder-symptom-expression.pdf2022-11-07 22:13 466K 
[ ]11048_attenuation-antipsychotic-induced-weight-gain-early.pdf2022-11-07 22:46 118K 
[ ]11049_attitudes-college-students-toward-mental-illness-stigma.pdf2022-11-07 22:37 270K 
[ ]11050_attitudes-patients-schizophrenia-toward-placebo-controlled.pdf2022-11-07 22:44 46K 
[ ]11051_attitudes-psychiatrists-toward-antipsychotic-depot.pdf2022-11-07 22:08 95K 
[ ]11052_attitudes-schizophrenia-outpatients-toward-psychiatric.pdf2022-11-07 22:39 49K 
[ ]11053_attitudes-toward-antipsychotics-among-outpatient-clinic.pdf2022-11-07 22:06 65K 
[ ]11054_attitudes-toward-benzodiazepines-years.pdf2022-11-07 22:52 103K 
[ ]11056_attribution-somatization-schizophrenia-patients-naturalistic.pdf2022-11-07 22:43 72K 
[ ]11057_atypical-antipsychotic-agents-treatment-schizophrenia-part-1-unique-patient-populations.pdf2022-11-07 22:01 63K 
[ ]11058_atypical-antipsychotic-agents-treatment-schizophrenia-part-2-special-considerations-psychiatric-diso.pdf2022-11-07 22:38 55K 
[ ]11059_atypical-antipsychotic-augmentation-mood-stabilizer.pdf2022-11-07 22:19 153K 
[ ]11060_atypical-antipsychotic-medications-psychiatric-emergency.pdf2022-11-07 22:37 59K 
[ ]11061_atypical-antipsychotics-bipolar-depression-potential.pdf2022-11-07 22:10 171K 
[ ]11062_atypical-antipsychotics-children-adolescents-autistic.pdf2022-11-07 22:14 179K 
[ ]11063_atypical-antipsychotics-effectively-treat-co-occurring.pdf2022-11-07 22:54 293K 
[ ]11064_atypical-antipsychotics-efficacy-across-bipolar-disorder.pdf2022-11-07 22:39 152K 
[ ]11065_atypical-antipsychotic-sertindole-case-series-cme.pdf2022-11-07 22:16 48K 
[ ]11066_atypical-antipsychotics-glucose-homeostasis.pdf2022-11-07 22:47 193K 
[ ]11067_atypical-antipsychotics-in-pregnant-women.pdf2022-11-07 22:28 399K 
[ ]11068_atypical-antipsychotics-nursing-homes.pdf2022-11-07 22:06 61K 
[ ]11069_atypical-antipsychotics-observations-clinical-practice.pdf2022-11-07 22:59 52K 
[ ]11070_atypical-antipsychotics-pediatric-bipolar-disorder.pdf2022-11-07 22:35 163K 
[ ]11071_atypical-antipsychotics-refractory-depression-anxiety.pdf2022-11-07 22:10 192K 
[ ]11072_atypical-antipsychotics-sedation-versus-efficacy.pdf2022-11-07 22:35 384K 
[ ]11073_atypical-antipsychotics-treatment-children-adolescents.pdf2022-11-07 22:06 105K 
[ ]11074_atypical-antipsychotics-treatment-depression-schizophrenia.pdf2022-11-07 22:03 102K 
[ ]11075_atypical-antipsychotics-treatment-mania-meta-analysis.pdf2022-11-07 22:40 115K 
[ ]11076_atypical-antipsychotics-treatment-mixed-depression.pdf2022-11-07 23:01 49K 
[ ]11077_atypical-antipsychotics-weight-gain-chinese-patients.pdf2022-11-07 22:49 35K 
[ ]11078_atypical-antipsychotic-treatment-disruptive-behavior.pdf2022-11-07 22:31 189K 
[ ]11079_atypical-depression-category-specifier.pdf2022-11-07 22:23 86K 
[ ]11082_atypical-neuroleptics-child-adolescent-psychiatry.pdf2022-11-07 22:44 83K 
[ ]11083_auditory-hallucinations-associated-topiramate.pdf2022-11-07 22:41 98K 
[ ]11084_auditory-hallucinations-in-dementia-with-lewy-bodies.pdf2022-11-07 22:49 233K 
[ ]11085_auditory-pseudohallucinations-united-kingdom-war-veterans.pdf2022-11-07 22:36 232K 
[ ]11087_augmentation-antidepressants-atypical-antipsychotic.pdf2022-11-07 22:07 163K 
[ ]11088_augmentation-citalopram-suicidal-ideation-middle-aged.pdf2022-11-07 22:40 452K 
[ ]11089_augmentation-clozapine-treatment-aripiprazole.pdf2022-11-07 22:54 221K 
[ ]11092_augmentation-combination-strategies-treatment-resistant.pdf2022-11-07 22:57 67K 
[ ]11093_augmentation-dopaminergic-agents-major-depressive.pdf2022-11-07 22:52 124K 
[ ]11094_augmentation-open-label-atomoxetine-partial-nonresponse.pdf2022-11-07 22:59 131K 
[ ]11095_augmentation-risperidone-valproic-acid.pdf2022-11-07 22:22 36K 
[ ]11096_augmentation-serotonin-reuptake-inhibitors-refractory.pdf2022-11-07 22:26 44K 
[ ]11097_augmentation-strategies-depression.pdf2022-11-07 22:45 82K 
[ ]11098_augmentation-strategies-increase-antidepressant-efficacy.pdf2022-11-07 22:16 139K 
[ ]11099_augmentation-strategies-increase-antidepressant-tolerability.pdf2022-11-07 22:56 143K 
[ ]11100_augmentation-strategies-serotonergic-noradrenergic.pdf2022-11-07 23:01 29K 
[ ]11101_augmentation-venlafaxine-bupropion-risks-associated.pdf2022-11-07 22:41 487K 
[ ]11102_augmentation-with-memantine-in-ocd.pdf2022-11-07 22:01 273K 
[ ]11103_augmenting-antidepressants-folate-clinical-perspective.pdf2022-11-07 22:37 132K 
[ ]11104_augmenting-selective-serotonin-reuptake-inhibitors.pdf2022-11-07 22:45 676K 
[ ]11105_autism-spectrum-disorder-and-suicide-attempts.pdf2022-11-07 22:10 240K 
[ ]11106_autism-spectrum-disorder-book-review.pdf2022-11-07 22:45 92K 
[ ]11107_autism-spectrum-disorder-research-rewview-practitioners.pdf2022-11-07 22:16 46K 
[ ]11108_autism-spectrum-disorders-infants-toddlers-diagnosis.pdf2022-11-07 22:20 743K 
[ ]11109_autism-spectrum-disorder-symptoms-juvenile-suspects.pdf2022-11-07 22:29 201K 
[ ]11110_autonomy-mental-disorder.pdf2022-11-07 22:35 86K 
[ ]11112_a-viewpoint-from-paris-on-covid.pdf2022-11-07 22:53 92K 
[ ]11113_awakening-psychopharmacology-sleep-arousal-novel-neurotransmitters.pdf2022-11-07 22:52 37K 
[ ]11114_awakening-schizophrenia-intramolecular-polypharmacy.pdf2022-11-07 22:06 54K 
[ ]11115_axis-i-dissociative-disorder-comorbidity-borderline.pdf2022-11-07 22:47 96K 
[ ]11116_axis-i-ii-disorders-quality-life-bariatric-surgery.pdf2022-11-07 22:42 199K 
[ ]11117_axis-i-psychopathology-functional-impairment-third.pdf2022-11-07 22:10 230K 
[ ]11118_azithromycin-catatonic-symptoms.pdf2022-11-07 22:02 153K 
[ ]11119_bad-men-men-dream-forensic-psychiatrist-illuminates.pdf2022-11-07 22:59 57K 
[ ]11120_balancing-risk-benefit-heavy-drinkers-treated-topiramate.pdf2022-11-07 22:56 188K 
[ ]11121_balancing-risks-dosing-strategies-antidepressants.pdf2022-11-07 22:20 81K 
[ ]11122_barriers-care-hispanic-adults-adhd.pdf2022-11-07 22:20 228K 
[ ]11123_barriers-diagnosis-depression-primary-care.pdf2022-11-07 22:05 36K 
[ ]11124_barriers-help-seeking-detection-adequate-treatment.pdf2022-11-07 22:14 164K 
[ ]11125_barriers-loving-clinicians-perspective.pdf2022-11-07 22:27 98K 
[ ]11126_baseline-blood-levels-omega-depression-remission.pdf2022-11-07 22:49 215K 
[ ]11127_baseline-characteristics-outcomes-patients-episode.pdf2022-11-07 22:38 227K 
[ ]11128_baseline-disability-poor-functioning-bipolar-disorder.pdf2022-11-07 22:48 668K 
[ ]11129_baseline-metabolic-status-in-early-onset-psychosis.pdf2022-11-07 22:58 563K 
[ ]11130_baseline-predictors-response-divalproex-conduct-disorder.pdf2022-11-07 22:24 180K 
[ ]11131_basic-psychopharmacology-antidepressants-part-antidepressants.pdf2022-11-07 23:02 186K 
[ ]11132_basic-psychopharmacology-antidepressants-part-estrogen.pdf2022-11-07 22:32 99K 
[ ]11133_bathe-approach-interview-process-primary-care-setting.pdf2022-11-07 22:58 28K 
[ ]11134_bdnf-variants-and-cognition-in-schizophrenia.pdf2022-11-07 22:17 253K 
[ ]11135_be-afraid-be-very-afraid.pdf2022-11-07 22:14 255K 
[ ]11136_beautiful-mind-biography-john-forbes-nash-jr.pdf2022-11-07 22:43 33K 
[ ]11137_becoming-center-attention-social-anxiety-disorder.pdf2022-11-07 22:29 611K 
[ ]11138_becoming-therapist-i-why.pdf2022-11-07 22:54 50K 
[ ]11139_beginnings-art-science-planning-psychotherapy.pdf2022-11-07 22:45 32K 
[ ]11140_behavioral-emerging-pharmacologic-treatment-options.pdf2022-11-07 22:34 197K 
[ ]11141_behavioral-healthcare-informatics-health-informatics.pdf2022-11-07 22:27 55K 
[ ]11142_behavioral-interventions-antipsychotic-medicationassociated.pdf2022-11-07 22:34 264K 
[ ]11143_behavioral-neurology-practical-science-mind-brain.pdf2022-11-07 22:23 34K 
[ ]11144_behavioral-pharmacology-olanzapine-novel-antipsychotic.pdf2022-11-07 22:26 61K 
[ ]11145_behavioral-physiologic-effects-genetic-pharmacologic.pdf2022-11-07 22:36 125K 
[ ]11146_behavioral-psychological-symptoms-dementia-current.pdf2022-11-07 22:07 47K 
[ ]11147_behavioral-psychological-symptoms-dementia-role-atypical.pdf2022-11-07 22:04 63K 
[ ]11148_behavioral-psychological-symptoms-patients-dementia.pdf2022-11-07 22:49 51K 
[ ]11149_behavioral-psychopharmacologic-pain-management.pdf2022-11-07 22:04 88K 
[ ]11150_behavioral-symptoms-improve-prediction-models-of-mortality-in-patients-with-dementia.pdf2022-11-07 22:43 111K 
[ ]11151_behavioral-therapy-weight-loss-patients-schizophrenia.pdf2022-11-07 22:55 159K 
[ ]11152_behavioral-treatment-chronic-insomnia-psychiatrically.pdf2022-11-07 22:32 73K 
[ ]11153_behavioral-treatment-obesity-patients-taking-antipsychotic.pdf2022-11-07 22:13 148K 
[ ]11154_behavior-medicine-rd-ed.pdf2022-11-07 22:11 59K 
[ ]11155_behavior-mood-disorder-focal-brain-lesions.pdf2022-11-07 23:03 39K 
[ ]11156_behavior-therapy-attenuates-clozapine-induced-obsessions.pdf2022-11-07 22:21 83K 
[ ]11157_behavior-therapy-augments-response-patients-obsessive.pdf2022-11-07 22:10 162K 
[ ]11158_behavior-therapy-obsessive-compulsive-disorder-guided.pdf2022-11-07 22:20 93K 
[ ]11159_behavior-therapy-serotonin-dysregulation.pdf2022-11-07 22:27 45K 
[ ]11160_beliefs-voices-aggressive-behavior-inpatients-acute.pdf2022-11-07 22:02 179K 
[ ]11161_beneficial-effect-donepezil-treatment-elderly-patients.pdf2022-11-07 22:23 106K 
[ ]11162_beneficial-effects-antiglutamatergic-agent-riluzole.pdf2022-11-07 22:31 110K 
[ ]11163_beneficial-effects-gonadotropin-releasing-hormone.pdf2022-11-07 22:36 58K 
[ ]11164_beneficial-effects-prazosin-visual-hallucinations.pdf2022-11-07 22:43 103K 
[ ]11166_benign-ethnic-neutropenia-and-clozapine-use.pdf2022-11-07 22:16 307K 
[ ]11167_benzodiazepine-abuse-dependence.pdf2022-11-07 22:30 118K 
[ ]11168_benzodiazepine-cognitive-impairment-cognitive-behavioral.pdf2022-11-07 22:12 100K 
[ ]11169_benzodiazepine-driving-meta-analysis.pdf2022-11-07 22:08 310K 
[ ]11170_benzodiazepine-monotherapy-in-patients-with-depression.pdf2022-11-07 22:50 232K 
[ ]11171_benzodiazepine-possibly-increases-cancer-risk-population.pdf2022-11-07 22:27 262K 
[ ]11172_benzodiazepine-prescription-practices-substance-abuse.pdf2022-11-07 23:02 44K 
[ ]11173_benzodiazepine-risk-recurrence-bipolar-disorder-step.pdf2022-11-07 22:13 361K 
[ ]11174_benzodiazepine-safety-mortality-risk-multiple-chronic.pdf2022-11-07 22:25 133K 
[ ]11175_benzodiazepines-and-congenital-malformations.pdf2022-11-07 22:17 454K 
[ ]11176_benzodiazepines-anticonvulsants-social-phobia-social.pdf2022-11-07 22:59 59K 
[ ]11177_benzodiazepines-clinical-practice-consideration-long.pdf2022-11-07 22:19 134K 
[ ]11178_benzodiazepines-in-older-adults-receiving-antidepressants-for-anxiety-and-depression.pdf2022-11-07 22:23 247K 
[ ]11179_benzodiazepines-panic-disorder.pdf2022-11-07 22:52 31K 
[ ]11180_benzodiazepines-reduce-effectiveness-exposure-therapy.pdf2022-11-07 22:24 592K 
[ ]11181_benzodiazepines-social-anxiety-disorder-generalized.pdf2022-11-07 22:57 54K 
[ ]11182_benzodiazepine-stigma-persists.pdf2022-11-07 22:41 766K 
[ ]11183_benzodiazepine-use-and-mortality-in-schizophrenia.pdf2022-11-07 22:22 275K 
[ ]11184_benzodiazepine-use-delays-the-antidepressant-effect-of-ketamine.pdf2022-11-07 22:58 119K 
[ ]11185_benzodiazepine-use-misuse-and-use-disorders-in-the-us.pdf2022-11-07 22:19 442K 
[ ]11186_benztropine-treatment-venlafaxine-induced-sweating.pdf2022-11-07 22:45 92K 
[ ]11187_bereavement-complicated-grief-dsm-part-complicated.pdf2022-11-07 22:34 165K 
[ ]11188_bereavement-complicated-grief-dsm-part-depression.pdf2022-11-07 22:42 165K 
[ ]11189_bereavement-diagnosis-major-depressive-episode-national.pdf2022-11-07 22:03 431K 
[ ]11190_bereavement-traumatic-death-helping-survivors.pdf2022-11-07 22:16 70K 
[ ]11191_best-clinical-practice-guidelines-managing-major-depression.pdf2022-11-07 22:29 67K 
[ ]11192_best-treat-patients-schizophrenia-co-occurring-alcohol.pdf2022-11-07 22:03 119K 
[ ]11194_beyond-categorical-classifications-importance-identifying.pdf2022-11-07 22:22 193K 
[ ]11195_beyond-monoamine-based-therapies-clues-approaches.pdf2022-11-07 22:12 65K 
[ ]11197_beyond-statistical-significance-an-underrated-suicide-prevention-intervention.pdf2022-11-07 22:12 127K 
[ ]11198_beyond-white-blood-cell-monitoring-screening-initial.pdf2022-11-07 22:29 227K 
[ ]11199_biased-reporting-results-patients-ultra-high-risk.pdf2022-11-07 22:01 90K 
[ ]11200_bilateral-prefrontal-repetitive-transcranial-magnetic.pdf2022-11-07 22:21 51K 
[ ]11201_bilirubin-concentration-correlates-positive-symptoms.pdf2022-11-07 22:48 180K 
[ ]11202_binge-drinking-axis-i-psychiatric-disorders-community.pdf2022-11-07 22:15 300K 
[ ]11203_binge-eating-disorder-clinical-foundations-treatment.pdf2022-11-07 22:42 78K 
[ ]11204_binge-eating-disorder-comorbid-conditions-differential.pdf2022-11-07 22:11 199K 
[ ]11205_bioavailability-ltemgtsltemgt-adenosyl-methionine.pdf2022-11-07 23:02 260K 
[ ]11206_biochemical-basis-neuropharmacology-th-ed.pdf2022-11-07 22:54 13K 
[ ]11207_bioequivalence-generic-drugs.pdf2022-11-07 22:48 250K 
[ ]11208_bioequivalence-generic-drugs-simple-explanation-food.pdf2022-11-07 22:46 304K 
[ ]11209_biological-basis-generalized-anxiety-disorder.pdf2022-11-07 22:09 58K 
[ ]11210_biological-basis-schizophrenia-directions.pdf2022-11-07 22:41 77K 
[ ]11211_biological-differences-depression-anxiety-across-races.pdf2022-11-07 23:02 64K 
[ ]11212_biological-marker-for-bipolar-disorder-and-mdd.pdf2022-11-07 22:07 952K 
[ ]11213_biological-therapies-posttraumatic-stress-disorder.pdf2022-11-07 22:37 31K 
[ ]11214_biology-posttraumatic-stress-disorder-HPA-axis-alterations-neuroendocrine-PTSD.pdf2022-11-07 22:45 60K 
[ ]11215_biology-posttraumatic-stress-disorder-relationship-stress-trauma-biology-fear.pdf2022-11-07 22:12 72K 
[ ]11216_biopsychosocial-vulnerabilities-women.pdf2022-11-07 22:47 165K 
[ ]11217_biotin-treatment-for-valproate-induced-hair-loss.pdf2022-11-07 23:03 83K 
[ ]11218_bipolar-affective-disorder-idiopathic-pulmonary-fibrosis.pdf2022-11-07 23:03 86K 
[ ]11219_bipolar-brain-integrating-neuroimaging-genetics.pdf2022-11-07 22:12 93K 
[ ]11220_bipolar-choice-clinical-health-outcomes-initiative.pdf2022-11-07 22:34 319K 
[ ]11221_bipolar-depression-antidepressant-induced-mania-naturalistic.pdf2022-11-07 22:18 41K 
[ ]11222_bipolar-depression-associated-fenfluramine-phentermine.pdf2022-11-07 22:53 44K 
[ ]11223_bipolar-depression-specific-treatments.pdf2022-11-07 22:08 44K 
[ ]11224_bipolar-disorder-and-borderline-personality-disorder.pdf2022-11-07 22:20 224K 
[ ]11225_bipolar-disorder-and-sexually-transmitted-infection.pdf2022-11-07 22:40 282K 
[ ]11226_bipolar-disorder-attention-deficit-hyperactivity-disorder-children-adolescents.pdf2022-11-07 22:41 42K 
[ ]11227_bipolar-disorder-attention-deficit-hyperactivity-disorder-children-adolescents-evidence-based-diagno.pdf2022-11-07 22:18 155K 
[ ]11228_bipolar-disorder-beyond-weeks-treatment-term-ltemgtantidepressantsltemgt.pdf2022-11-07 22:07 137K 
[ ]11229_bipolar-disorder-childhood-early-adolescence.pdf2022-11-07 22:46 106K 
[ ]11230_bipolar-disorder-clinical-neurobiological-foundations.pdf2022-11-07 23:01 155K 
[ ]11231_bipolar-disorder-comorbid-anxiety-disorders-children.pdf2022-11-07 22:15 67K 
[ ]11232_bipolar-disorder-comorbid-cluster-b-personality-disorder.pdf2022-11-07 22:51 137K 
[ ]11233_bipolar-disorder-comorbid-personality-psychopathology.pdf2022-11-07 22:43 279K 
[ ]11235_bipolar-disorder-diagnostic-challenges-treatment-considerations.pdf2022-11-07 22:53 55K 
[ ]11237_bipolar-disorder-family-focused-treatment-approach.pdf2022-11-07 22:10 22K 
[ ]11238_bipolar-disorder-guide-patients-families.pdf2022-11-07 23:01 29K 
[ ]11239_bipolar-disorder-guide-patients-families-nd-ed.pdf2022-11-07 22:27 73K 
[ ]11240_bipolar-disorder-later-life.pdf2022-11-07 23:02 716K 
[ ]11242_bipolar-disorder-obesity-pharmacotherapy-associated.pdf2022-11-07 22:41 82K 
[ ]11243_bipolar-disorder-perspectives-health-care-prevention.pdf2022-11-07 22:39 235K 
[ ]11244_bipolar-disorder-recent-issues-diagnosis-classification.pdf2022-11-07 22:29 87K 
[ ]11245_bipolar-disorder-schizoaffective-disorder-schizophrenia.pdf2022-11-07 22:29 401K 
[ ]11246_bipolar-disorder-schizophrenia-distinct-illnesses.pdf2022-11-07 22:32 61K 
[ ]11247_bipolar-disorders-clinical-course-outcome.pdf2022-11-07 22:33 14K 
[ ]11248_bipolar-disorders-effectiveness-novel-anticonvulsants.pdf2022-11-07 22:13 80K 
[ ]11250_bipolar-disorders-mixed-states-rapid-cycling-atypical.pdf2022-11-07 22:43 47K 
[ ]11251_bipolar-ii-disorder-modelling-measuring-managing.pdf2022-11-07 22:10 102K 
[ ]11252_bipolar-ii-disorder-modelling-measuring-managing-nd.pdf2022-11-07 22:32 76K 
[ ]11253_bipolar-ii-disorder-reasons-recognize.pdf2022-11-07 22:45 103K 
[ ]11254_bipolar-ii-disorder-vs-premenstrual-dysphoric-disorder.pdf2022-11-07 22:20 45K 
[ ]11255_bipolar-medications-mechanisms-action.pdf2022-11-07 22:43 55K 
[ ]11257_bipolar-onset-related-to-family-illness-burden.pdf2022-11-07 22:10 253K 
[ ]11258_bipolar-patients-suicidal-behavior-toward-identification.pdf2022-11-07 22:37 129K 
[ ]11259_bipolar-rapid-cycling-focus-depression-hallmark.pdf2022-11-07 22:31 81K 
[ ]11261_bipolar-spectrum-disorder-improving-recognition-diagnosis.pdf2022-11-07 22:48 52K 
[ ]11262_bipolar-symptoms-adult-attention-deficit-hyperactivity.pdf2022-11-07 22:23 595K 
[ ]11263_bipolar-therapeutics-update-tale-treatments.pdf2022-11-07 22:29 125K 
[ ]11264_birth-outcomes-following-prenatal-exposure-antidepressants.pdf2022-11-07 22:26 156K 
[ ]11265_black-psychiatrists-american-psychiatry.pdf2022-11-07 22:32 39K 
[ ]11266_bl-aminobutyric-acidenhanced-antipsychotic-results.pdf2022-11-07 23:01 610K 
[ ]11269_blood-clozapine-levels-elevated-fluvoxamine-potential.pdf2022-11-07 22:49 44K 
[ ]11270_blood-glucose-schizophrenia-systematic-review-prospective.pdf2022-11-07 22:18 213K 
[ ]11271_blood-pressure-changes-associated-medication-treatment.pdf2022-11-07 22:57 145K 
[ ]11272_blood-test-depression.pdf2022-11-07 22:04 106K 
[ ]11273_blue-genes-mechanism-action-antidepressants.pdf2022-11-07 22:04 64K 
[ ]11274_blue-genes-monoamine-hypothesis-depression.pdf2022-11-07 22:02 97K 
[ ]11275_bmi-and-remission-in-depressed-patients-receiving-iv-ketamine.pdf2022-11-07 22:27 357K 
[ ]11276_boarding-psychiatry-candidates-guide-part-ii-abpn.pdf2022-11-07 22:38 30K 
[ ]11277_body-dysmorphic-disorder-proxy.pdf2022-11-07 22:03 86K 
[ ]11278_body-image-dissatisfaction-gay-versus-heterosexual.pdf2022-11-07 22:50 53K 
[ ]11279_body-mass-index-future-schizophrenia-israeli-male.pdf2022-11-07 22:01 44K 
[ ]11280_body-mass-index-identified-independent-predictor-psychiatric.pdf2022-11-07 22:36 283K 
[ ]11281_body-mass-index-response-antidepressants-depressed.pdf2022-11-07 22:14 743K 
[ ]11282_body-weight-gain-insulin-leptin-olanzapine-treated.pdf2022-11-07 22:05 46K 
[ ]11283_borderline-personality-disorderan-evidence-based-guide.pdf2022-11-07 22:55 84K 
[ ]11284_borderline-personality-disorder-clinical-guide-nd.pdf2022-11-07 22:16 699K 
[ ]11285_borderline-personality-disorder-reckless-driving.pdf2022-11-07 22:31 91K 
[ ]11286_borderline-personality-disorders-clinical-guide.pdf2022-11-07 22:51 34K 
[ ]11287_borderline-personality-disorder-symptoms-treatment.pdf2022-11-07 22:22 160K 
[ ]11288_borderline-personality-symptomatology-experience-multiple.pdf2022-11-07 22:21 73K 
[ ]11289_bottle-psychosocial-treatments-addiction-role-oxytocin.pdf2022-11-07 22:43 157K 
[ ]11290_botulinum-toxin-treatment-social-anxiety-disorder.pdf2022-11-07 22:59 85K 
[ ]11291_boundary-between-hypochondriasis-obsessive-compulsive.pdf2022-11-07 22:12 109K 
[ ]11292_brain-calipers-nd-ed-descriptive-psychopathology-psychiatric.pdf2022-11-07 22:23 45K 
[ ]11293_brain-circuitry-signaling-psychiatry-based-science.pdf2022-11-07 22:29 32K 
[ ]11294_brain-circuits-determine-destiny-depression-novel.pdf2022-11-07 22:14 101K 
[ ]11295_brain-derived-neurotrophic-factor-initial-antidepressant.pdf2022-11-07 23:01 347K 
[ ]11296_brain-fumes-yes-brain-gas.pdf2022-11-07 22:49 33K 
[ ]11297_brain-imaging-correlates.pdf2022-11-07 22:13 49K 
[ ]11298_brain-imaging-in-adolescents-with-first-episode-psychosis.pdf2022-11-07 22:42 215K 
[ ]11299_brain-injury-mental-retardation-psychopharmacology.pdf2022-11-07 22:31 36K 
[ ]11300_brain-organization-patterns-in-suicidal-behavior.pdf2022-11-07 22:12 727K 
[ ]11301_brain-serotonin-neurotransmission-overview-update.pdf2022-11-07 22:17 58K 
[ ]11302_brain-stimulation-psychiatric-treatment.pdf2022-11-07 22:05 50K 
[ ]11303_brain-stimulation-psychiatry-ect-dbs-tms-modalities.pdf2022-11-07 22:53 89K 
[ ]11304_brainstorms-anticonvulsants-anxiolytics-part-pregabalin.pdf2022-11-07 22:50 37K 
[ ]11305_brainstorms-anticonvulsants-relief-chronic-pain-pregabalin.pdf2022-11-07 22:13 36K 
[ ]11306_brainstorms-mechanism-action-ligands-voltage-sensitive.pdf2022-11-07 23:01 196K 
[ ]11307_brainstorms-years-counting.pdf2022-11-07 22:56 47K 
[ ]11308_brain-structure-function-outcomes-treatment-depression.pdf2022-11-07 23:00 471K 
[ ]11309_brain-takes-shape-early-history.pdf2022-11-07 22:41 105K 
[ ]11310_brain-tonics-brain-sprouts-neurotrophic-factors-fertilize.pdf2022-11-07 22:17 68K 
[ ]11311_brain-volume-depression.pdf2022-11-07 23:02 88K 
[ ]11312_brain-volume-increase-sustained-remission-patients.pdf2022-11-07 22:45 1.0M 
[ ]11313_branched-chain-amino-acid-treatment-tardive-dyskinesia.pdf2022-11-07 22:39 47K 
[ ]11314_branded-versus-generic-clozapine-bioavailability-comparison.pdf2022-11-07 22:41 55K 
[ ]11315_breakthroughs-antipsychotic-medications-guide-consumers.pdf2022-11-07 22:39 31K 
[ ]11316_breakthrough-treatment-major-depression.pdf2022-11-07 22:53 112K 
[ ]11317_breast-cancer-antidepressant.pdf2022-11-07 22:30 544K 
[ ]11318_breastfeeding-antidepressants-clinical-dilemmas-expert.pdf2022-11-07 22:58 77K 
[ ]11319_breastfeeding-during-maternal-antidepressant-treatment.pdf2022-11-07 22:49 74K 
[ ]11320_brexpiprazole-in-mdd-and-irritability.pdf2022-11-07 22:07 114K 
[ ]11321_brexpiprazole-in-mddmetabolic-parameters-and-weight.pdf2022-11-07 23:01 738K 
[ ]11322_bridging-efficacy-effectiveness-gap-antipsychotic.pdf2022-11-07 22:16 136K 
[ ]11323_bridging-gap-between-mental-physical-health-multidisciplinary.pdf2022-11-07 23:00 184K 
[ ]11324_bridging-the-gap-between-mixed-and-atypical-depression.pdf2022-11-07 22:02 713K 
[ ]11325_brief-behavioral-therapy-refractory-insomnia-residual.pdf2022-11-07 22:14 434K 
[ ]11326_brief-commentary-bipolar-choice-study.pdf2022-11-07 23:01 108K 
[ ]11327_brief-contact-interventions-as-suicide-prevention-strategies.pdf2022-11-07 22:56 427K 
[ ]11328_brief-eclectic-psychotherapy-ptsd-randomized-controlled.pdf2022-11-07 22:12 203K 
[ ]11329_brief-psychiatric-rating-scale-acute-inpatient-outcome.pdf2022-11-07 22:17 46K 
[ ]11330_brief-psychiatric-rating-scale-facilitate-differential.pdf2022-11-07 22:42 83K 
[ ]11331_brief-pulse-ultrabrief-pulse-right-unilateral-electroconvulsive.pdf2022-11-07 22:52 140K 
[ ]11332_bright-light-therapy-negative-symptoms-schizophrenia.pdf2022-11-07 22:47 139K 
[ ]11333_bright-light-therapy-side-effects-benefits-across.pdf2022-11-07 22:14 55K 
[ ]11334_brown-longitudinal-obsessive-compulsive-study-clinical.pdf2022-11-07 22:22 113K 
[ ]11335_brown-longitudinal-obsessive-compulsive-study-treatments.pdf2022-11-07 22:41 98K 
[ ]11336_bruxism-respond-serotonin-reuptake-inhibitors.pdf2022-11-07 22:25 80K 
[ ]11337_buddha-were-treatment.pdf2022-11-07 22:18 140K 
[ ]11338_buprenorphine-and-ptsd.pdf2022-11-07 22:34 99K 
[ ]11339_buprenorphine-naloxone-treatment-prescription-opioid.pdf2022-11-07 22:58 148K 
[ ]11340_buprenorphine-reflections-addictions-psychiatrist.pdf2022-11-07 22:28 58K 
[ ]11341_bupropion-amantadine-associated-neurotoxicity.pdf2022-11-07 22:45 57K 
[ ]11342_bupropion-antidote-serotonin-reuptake-inhibitor-induced.pdf2022-11-07 22:59 73K 
[ ]11343_bupropion-breastfeeding-case-possible-infant-seizure.pdf2022-11-07 22:18 62K 
[ ]11344_bupropion-clarification.pdf2022-11-07 22:05 38K 
[ ]11345_bupropion-extended-release-compared-escitalopram-effects.pdf2022-11-07 22:54 123K 
[ ]11346_bupropion-levels-breast-milk-mother-infant-pairs-more.pdf2022-11-07 22:43 181K 
[ ]11347_bupropion-overweight-women-binge-eating-disorder-randomized.pdf2022-11-07 22:07 505K 
[ ]11348_bupropion-patients-obsessive-compulsive-disorder-open.pdf2022-11-07 22:48 75K 
[ ]11349_bupropion-sr-reduces-periodic-limb-movements-associated.pdf2022-11-07 23:01 47K 
[ ]11350_bupropion-sr-sertraline-differ-effects-anxiety-depressed.pdf2022-11-07 23:00 63K 
[ ]11351_bupropion-ssri-induced-fatigue.pdf2022-11-07 22:33 92K 
[ ]11352_bupropion-sustained-release-added-group-support-smoking.pdf2022-11-07 22:54 504K 
[ ]11353_bupropion-sustained-release-bereavement-results-open.pdf2022-11-07 22:32 45K 
[ ]11354_bupropion-sustained-release-side-effect-profile.pdf2022-11-07 22:41 34K 
[ ]11355_bupropion-sustained-release-smoking-cessation.pdf2022-11-07 22:40 51K 
[ ]11356_bupropion-sustained-release-smoking-cessation-treatment.pdf2022-11-07 22:26 105K 
[ ]11357_bupropion-sustained-release-therapeutic-overview.pdf2022-11-07 22:20 46K 
[ ]11358_bupropion-sustained-release-versus-paroxetine-treatment.pdf2022-11-07 22:07 79K 
[ ]11359_bupropion-tranylcypromine-combination-treatment-refractory.pdf2022-11-07 23:01 66K 
[ ]11360_burden-depression-anxiety-general-medicine.pdf2022-11-07 22:48 55K 
[ ]11361_burden-disease-treatment-resistant-depression.pdf2022-11-07 22:52 55K 
[ ]11362_burden-recurrent-depression-causes-consequences-future.pdf2022-11-07 22:58 76K 
[ ]11363_burning-charcoal-indigenous-method-committing-suicide.pdf2022-11-07 22:06 98K 
[ ]11364_burning-mouth-syndrome-side-effect-ssris.pdf2022-11-07 22:28 79K 
[ ]11365_busmans-holiday.pdf2022-11-07 22:15 40K 
[ ]11366_buspirone-antidote-ssri-induced-bruxism-cases.pdf2022-11-07 22:06 36K 
[ ]11367_buspirone-imipramine-treatment-major-depression-elderly.pdf2022-11-07 22:53 116K 
[ ]11368_buspirone-management-anxiety-irritability-children.pdf2022-11-07 22:05 75K 
[ ]11369_cabergoline-treatment-risperidone-induced-hyperprolactinemia.pdf2022-11-07 22:11 39K 
[ ]11370_cacnac-genomewide-supported-psychosis-genetic-variation.pdf2022-11-07 22:16 1.2M 
[ ]11371_cad-mdd-diagnostic-lacks-screening-data.pdf2022-11-07 22:50 98K 
[ ]11372_cadmium-lead-and-depression.pdf2022-11-07 22:24 224K 
[ ]11373_call-clinical-action.pdf2022-11-07 22:24 28K 
[ ]11374_call-papers-early-career-psychiatrists.pdf2022-11-07 22:14 51K 
[ ]11375_camdex-r-cambridge-examination-mental-disorders-elderly.pdf2022-11-07 22:39 40K 
[ ]11376_can-an-ancient-art-have-a-modern-use.pdf2022-11-07 22:08 268K 
[ ]11377_can-bind-outcomes-and-early-response-prediction-in-mdd.pdf2022-11-07 22:57 680K 
[ ]11379_cancer-mortality-in-the-seriously-mentally-ill.pdf2022-11-07 22:04 248K 
[ ]11380_candidate-gene-analysis-identifies-polymorphism-ltemgthla.pdf2022-11-07 22:02 77K 
[ ]11381_candidate-gene-studies-attention-deficit-hyperactivity.pdf2022-11-07 22:25 102K 
[ ]11382_can-foods-or-fasting-be-psychopharmacologic-therapies.pdf2022-11-07 22:54 195K 
[ ]11383_cannabinoids-for-agitation-and-aggression-in-ad.pdf2022-11-07 22:23 691K 
[ ]11384_cannabis-and-anxiety-and-mood-disorders.pdf2022-11-07 22:44 347K 
[ ]11385_cannabis-neuropsychiatry-part-1-benefits-risks.pdf2022-11-07 22:02 307K 
[ ]11386_cannabis-neuropsychiatry-part-2-longitudinal-risk-psychosis-adverse-outcome.pdf2022-11-07 22:24 305K 
[ ]11387_cannabis-use-and-cigarette-smoking.pdf2022-11-07 22:29 245K 
[ ]11388_cannabis-use-and-use-disorders-among-us-youth.pdf2022-11-07 22:04 310K 
[ ]11389_cannabis-withdrawal-united-states-results-nesarc.pdf2022-11-07 22:43 276K 
[ ]11390_capitation.pdf2022-11-07 22:07 38K 
[ ]11391_carbamazepine-augmentation-clomipramine-treatment.pdf2022-11-07 22:27 53K 
[ ]11392_carbamazepine-augmentation-schizophrenia-is-evidence.pdf2022-11-07 22:11 75K 
[ ]11393_carbamazepine-treatment-adverse-psychiatric-effects.pdf2022-11-07 22:11 81K 
[ ]11394_carbamazepine-valproate-maintenance-treatment-bipolar.pdf2022-11-07 22:17 68K 
[ ]11395_cardiac-safety-parameters-olanzapine-comparison-atypical.pdf2022-11-07 22:31 67K 
[ ]11396_cardiometabolic-health-in-psychiatry.pdf2022-11-07 22:36 679K 
[ ]11397_cardiometabolic-risks-in-schizophrenia-and-directions-for-intervention-part-2-nonpharmacological-int.pdf2022-11-07 22:45 296K 
[ ]11398_cardiometabolic-risks-in-schizophrenia-and-directions-for-intervention-part-3-pharmacological-interv.pdf2022-11-07 22:58 318K 
[ ]11399_cardiopulmonary-complications-ergot-derivative-dopamine.pdf2022-11-07 22:23 52K 
[ ]11400_cardiorespiratory-problems-clozapine.pdf2022-11-07 22:38 37K 
[ ]11401_cardiovascular-disease-bipolar-disorder-risk-clinical.pdf2022-11-07 22:35 145K 
[ ]11402_cardiovascular-disease-mortality-patients-chronic.pdf2022-11-07 22:17 290K 
[ ]11403_cardiovascular-disease-patients-schizophrenia-saskatchewan.pdf2022-11-07 22:07 48K 
[ ]11404_cardiovascular-effects-antidepressant-drugs-updated.pdf2022-11-07 22:24 35K 
[ ]11405_cardiovascular-effects-antipsychotics-used-bipolar.pdf2022-11-07 22:44 80K 
[ ]11406_care-competencies-psychiatric-education-defining-teaching.pdf2022-11-07 23:00 83K 
[ ]11407_care-depressed-patients-anxiety-symptoms.pdf2022-11-07 22:18 53K 
[ ]11408_caregiver-burden-in-pans.pdf2022-11-07 22:09 248K 
[ ]11409_care-mentally-disordered-offender-community.pdf2022-11-07 22:24 28K 
[ ]11410_care-of-youth-at-first-emergency-department-presentation-for-psychosis.pdf2022-11-07 22:27 252K 
[ ]11411_care-sexually-active-depressed-patient.pdf2022-11-07 22:23 55K 
[ ]11412_caring-depression-primary-care-defining-illustrating.pdf2022-11-07 22:08 22K 
[ ]11413_caring-for-the-patient.pdf2022-11-07 22:41 120K 
[ ]11414_caring-returning-veterans-meeting-mental-health-needs.pdf2022-11-07 22:53 561K 
[ ]11415_cariprazine-acute-exacerbation-schizophrenia-fixed.pdf2022-11-07 22:09 678K 
[ ]11416_cariprazine-bipolar-disorders.pdf2022-11-07 22:56 151K 
[ ]11417_carnitine-levels-valproic-acid-treated-psychiatric.pdf2022-11-07 22:56 89K 
[ ]11418_case-aripiprazole-related-tardive-akathisia-treatment.pdf2022-11-07 22:56 158K 
[ ]11419_casebook-interpersonal-psychotherapy.pdf2022-11-07 22:54 126K 
[ ]11420_case-complex-movement-disorder-induced-fluoxetine.pdf2022-11-07 22:28 123K 
[ ]11421_case-control-analyses-impact-pharmacotherapy-prospectively.pdf2022-11-07 23:02 206K 
[ ]11422_case-controlled-study-successful-aging-older-hiv-infected.pdf2022-11-07 22:38 288K 
[ ]11423_case-control-study-antidepressants-attempted-suicide.pdf2022-11-07 22:33 231K 
[ ]11424_case-delirium-subsequent-pancytopenia-associated-oral.pdf2022-11-07 22:09 105K 
[ ]11425_case-folie-trois-induced-child.pdf2022-11-07 22:50 86K 
[ ]11426_case-gynecomastia-during-paroxetine-therapy.pdf2022-11-07 22:50 50K 
[ ]11427_case-hyponatremia-associated-escitalopram.pdf2022-11-07 22:58 62K 
[ ]11428_case-individual-approach-treatment-depression.pdf2022-11-07 22:03 60K 
[ ]11429_case-kleptomania-correlating-premenstrual-dysphoria.pdf2022-11-07 22:33 67K 
[ ]11430_case-mirtazapine-associated-hair-loss.pdf2022-11-07 22:48 111K 
[ ]11431_case-olanzapine-induced-gestational-diabetes-mellitus.pdf2022-11-07 22:31 140K 
[ ]11432_case-olfactory-groove-meningioma-misdiagnosed-schizophrenia.pdf2022-11-07 22:36 149K 
[ ]11433_case-parenteral-zolpidem-dependence-opioid-withdrawal.pdf2022-11-07 22:28 115K 
[ ]11434_case-probable-bipolar-vi-disorder.pdf2022-11-07 22:56 80K 
[ ]11435_case-prolonged-peyote-induced-psychosis-resolved-sleep.pdf2022-11-07 22:20 53K 
[ ]11436_case-psychosis-associated-pai-guo-slimming-capsules.pdf2022-11-07 22:32 113K 
[ ]11437_case-pulmonary-thromboembolism-rhabdomyolysis-during.pdf2022-11-07 22:19 82K 
[ ]11438_case-report-adjunctive-oxycodone-treatment-refractory.pdf2022-11-07 22:54 90K 
[ ]11439_case-report-bath-saltsinduced-psychosis-serotonin.pdf2022-11-07 22:39 85K 
[ ]11440_case-report-case-acute-psychosis-buprenorphine-withdrawal.pdf2022-11-07 22:09 84K 
[ ]11441_case-report-case-agranulocytosis-secondary-rechallenge.pdf2022-11-07 22:19 138K 
[ ]11442_case-report-case-akathisia-switching-branded-generic.pdf2022-11-07 22:12 84K 
[ ]11443_case-report-case-atypical-antipsychoticinduced-somnambulism.pdf2022-11-07 22:22 141K 
[ ]11444_case-report-case-persistent-genital-arousal-disorder.pdf2022-11-07 22:03 100K 
[ ]11445_case-report-hypomania-following-vagus-nerve-stimulation.pdf2022-11-07 22:51 72K 
[ ]11446_case-report-lebers-hereditary-optic-neuropathy-associated.pdf2022-11-07 22:46 718K 
[ ]11447_case-report-lyme-neuroborreliosis-presenting-alexithymia.pdf2022-11-07 22:20 147K 
[ ]11448_case-report-making-lemonade-lemons-case-report-literature.pdf2022-11-07 22:15 234K 
[ ]11449_case-report-mania-related-discontinuation-bupropion.pdf2022-11-07 22:55 67K 
[ ]11450_case-report-olanzapine-induced-fecal-incontinence.pdf2022-11-07 22:23 79K 
[ ]11451_case-report-quetiapine-related-tic-symptoms.pdf2022-11-07 22:21 83K 
[ ]11452_case-report-reduction-alcohol-craving-protection-against.pdf2022-11-07 22:53 31K 
[ ]11453_case-report-reemergence-antipsychotic-induced-dyskinesia.pdf2022-11-07 22:04 221K 
[ ]11454_case-report-serotonin-syndrome-associated-combined.pdf2022-11-07 22:09 49K 
[ ]11455_case-report-single-photon-emission-computed-tomography.pdf2022-11-07 22:34 457K 
[ ]11456_case-reports-postmarketing-adverse-event-experiences.pdf2022-11-07 22:43 340K 
[ ]11457_case-risperidone-induced-priapism.pdf2022-11-07 22:50 72K 
[ ]11458_cases-acneiform-eruption-associated-lamotrigine.pdf2022-11-07 22:26 61K 
[ ]11459_cases-alcohol-craving-curbed-topiramate.pdf2022-11-07 22:05 67K 
[ ]11460_case-seasonal-trichotillomania.pdf2022-11-07 22:57 38K 
[ ]11461_case-sodium-oxybate-treatment-tardive-dyskinesia-bipolar.pdf2022-11-07 22:30 185K 
[ ]11462_cases-perospirone-induced-mania-schizophrenia.pdf2022-11-07 22:17 51K 
[ ]11463_cases-quetiapine-augmentation-donepezil-refractory.pdf2022-11-07 22:14 49K 
[ ]11464_case-sustained-remission-following-acute-course-ketamine.pdf2022-11-07 22:53 174K 
[ ]11465_case-tardive-dystonia-successfully-managed-quetiapine.pdf2022-11-07 22:13 50K 
[ ]11466_case-unexpected-selective-remission-history-ephedrine.pdf2022-11-07 22:31 156K 
[ ]11467_case-venous-thromboembolism-probably-associated-hyperprolactinemia.pdf2022-11-07 22:39 51K 
[ ]11468_case-zaleplon-induced-amnestic-sleep-related-eating.pdf2022-11-07 23:02 109K 
[ ]11469_case-ziprasidone-induced-mania-role-hta-mood-changes.pdf2022-11-07 22:05 83K 
[ ]11470_cast-sr-psychometrics-in-stimulant-use-disorder.pdf2022-11-07 22:29 250K 
[ ]11471_casualties-beyond-the-battlefield.pdf2022-11-07 22:48 143K 
[ ]11472_cataplexy-anxious-patients-is-subclinical-narcolepsy.pdf2022-11-07 22:08 201K 
[ ]11473_catatonia-is-risk-factor-neuroleptic-malignant-syndrome.pdf2022-11-07 22:07 62K 
[ ]11474_catatonia-psychoparhology-neurobiology.pdf2022-11-07 22:53 62K 
[ ]11475_categorical-dimensional-stability-comorbid-personality.pdf2022-11-07 22:24 267K 
[ ]11477_causality-psychopathology-finding-determinants-disorders.pdf2022-11-07 22:43 101K 
[ ]11478_cause-mortality-associated-atypical-conventional.pdf2022-11-07 22:14 388K 
[ ]11479_cause-rate-death-schizophrenia-across-lifespan-population.pdf2022-11-07 22:35 534K 
[ ]11480_causes-aggressive-behavior-patients-dementia.pdf2022-11-07 22:28 304K 
[ ]11481_cause-versus-association-observational-studies-psychopharmacology.pdf2022-11-07 22:52 580K 
[ ]11482_cautionary-note-using-zonisamide-youths-case-report.pdf2022-11-07 23:02 61K 
[ ]11483_cbt-adults-practical-guide-clinicians.pdf2022-11-07 22:49 72K 
[ ]11484_cbt-for-insomnia-in-patients-with-comorbid-depression-and-insomnia.pdf2022-11-07 22:02 525K 
[ ]11485_cbt-for-olfactory-reference-syndrome-a-case-report.pdf2022-11-07 22:50 120K 
[ ]11486_cbt-for-pharmacotherapy-resistant-depression.pdf2022-11-07 22:26 1.2M 
[ ]11487_cbt-psychosis-symptom-based-approach.pdf2022-11-07 23:01 83K 
[ ]11488_celebrating-jcps-th-year.pdf2022-11-07 22:05 367K 
[ ]11489_central-and-peripheral-pharmacokinetics-of-antipsychotics.pdf2022-11-07 22:04 866K 
[ ]11491_cerebral-blood-flow-after-late-life-depression-treatment.pdf2022-11-07 22:23 1.0M 
[ ]11492_cerebral-blood-flow-during-anxiety-provocation.pdf2022-11-07 22:51 221K 
[ ]11493_cerebrovascular-effects-selective-serotonin-reuptake.pdf2022-11-07 22:44 85K 
[ ]11494_cerebrovascular-events-among-elderly-nursing-home.pdf2022-11-07 22:23 150K 
[ ]11495_cessation-self-mutilation-patient-borderline-personality.pdf2022-11-07 22:55 79K 
[ ]11496_chairmans-overviewthe-place-reboxetine-antidepressant.pdf2022-11-07 22:43 81K 
[ ]11497_challenge-offering-long-acting-antipsychotic-therapies.pdf2022-11-07 22:53 231K 
[ ]11500_challenges-in-determining-outcomes-of-prenatal-exposure-to-antidepressants.pdf2022-11-07 22:20 113K 
[ ]11501_challenges-in-testing-intranasal-ketamine-in-ocd.pdf2022-11-07 22:10 117K 
[ ]11502_challenges-management-bipolar-depression.pdf2022-11-07 22:02 123K 
[ ]11503_challenges-opportunities-teaching-psychopharmacology.pdf2022-11-07 22:05 49K 
[ ]11504_challenges-solutions-developing-medications-schizophrenia.pdf2022-11-07 22:10 527K 
[ ]11506_change-employment-status-bipolar-disorder-longitudinal.pdf2022-11-07 22:53 301K 
[ ]11507_change-in-cognition-with-sustained-cannabis-abstinence.pdf2022-11-07 22:43 637K 
[ ]11508_changes-adverse-events-reported-patients-during-months.pdf2022-11-07 22:24 55K 
[ ]11509_changes-antidepressant-metabolism-dosing-across-pregnancy.pdf2022-11-07 22:28 207K 
[ ]11510_changes-in-cortisol-during-psychotherapy-for-ptsd.pdf2022-11-07 23:03 218K 
[ ]11511_changes-inpatient-postdischarge-suicide-rates-nationwide.pdf2022-11-07 22:49 285K 
[ ]11512_changes-metabolic-parameters-switching-aripiprazole.pdf2022-11-07 22:16 105K 
[ ]11513_changes-perceived-health-functioning-cost-effectiveness.pdf2022-11-07 22:32 83K 
[ ]11514_changes-serum-interleukin-levels-before-during.pdf2022-11-07 22:59 63K 
[ ]11515_changes-weight-plasma-lipids-glucose-adults-treated.pdf2022-11-07 22:03 326K 
[ ]11516_changing-landscape-psychiatry.pdf2022-11-07 22:53 156K 
[ ]11517_changing-paradigms-depressed-patients-treatment-partners.pdf2022-11-07 22:24 72K 
[ ]11518_changing-perspective-chronic-insomnia-management.pdf2022-11-07 22:12 54K 
[ ]11519_chapter.pdf2022-11-07 22:32 39K 
[ ]11520_characteristics-adults-psychogenic-excoriation.pdf2022-11-07 22:57 40K 
[ ]11521_characteristics-and-risk-factors-for-college-suicide.pdf2022-11-07 22:54 346K 
[ ]11522_characteristics-children-elevated-symptoms-mania-longitudinal.pdf2022-11-07 22:48 313K 
[ ]11523_characteristics-determinants-normal-sleep.pdf2022-11-07 22:36 46K 
[ ]11524_characteristics-e-therapy-web-sites.pdf2022-11-07 22:45 74K 
[ ]11525_characteristics-of-synthetic-cannabinoid-users.pdf2022-11-07 22:23 228K 
[ ]11526_characteristics-opiate-dependent-patients-attempt.pdf2022-11-07 22:22 96K 
[ ]11527_characteristics-primary-anxiety-disorders-predict.pdf2022-11-07 22:15 68K 
[ ]11528_characteristics-retrospectively-assessed-prodromal.pdf2022-11-07 22:57 274K 
[ ]11529_characteristics-social-phobia-among-persons-essential.pdf2022-11-07 22:41 58K 
[ ]11530_characterizing-ideal-antidepressant-therapy-achieve.pdf2022-11-07 23:03 62K 
[ ]11531_characterizing-impaired-driving-adults-attention-deficit-hyperactivity.pdf2022-11-07 22:23 107K 
[ ]11532_characterizing-internet-addiction-in-adolescents.pdf2022-11-07 22:31 256K 
[ ]11533_charles-bonnet-syndrome-visual-hallucinations-childhood.pdf2022-11-07 23:01 50K 
[ ]11534_chart-review-impact-attention-deficit-hyperactivity.pdf2022-11-07 22:56 153K 
[ ]11535_chemical-dependence-treatment-documentation-sourcebook.pdf2022-11-07 22:08 44K 
[ ]11536_chilaiditi-syndromeassociated-schizophrenia-case-reports.pdf2022-11-07 22:43 69K 
[ ]11537_child-adolescent-psychiatical-guide.pdf2022-11-07 22:01 70K 
[ ]11538_child-adolescent-psychiatry-developmental-approach.pdf2022-11-07 22:28 87K 
[ ]11539_child-adolescent-psychiatry-essentials.pdf2022-11-07 22:52 67K 
[ ]11540_child-behavior-checklist-pediatric-bipolar-disorder.pdf2022-11-07 22:38 359K 
[ ]11541_child-every-parent-needs-whats-normal-whats-seek-help.pdf2022-11-07 22:16 36K 
[ ]11542_childhood-abuse-platelet-tritiated-paroxetine-binding.pdf2022-11-07 22:16 80K 
[ ]11543_childhood-adversity-and-depression-onset-in-menopause.pdf2022-11-07 22:35 1.2M 
[ ]11544_childhood-adversity-and-schizophrenia-the-role-of-resilience.pdf2022-11-07 22:15 308K 
[ ]11545_childhood-adversity-depression.pdf2022-11-07 22:31 118K 
[ ]11546_childhood-attention-deficit-hyperactivity-disorder.pdf2022-11-07 22:51 231K 
[ ]11547_childhood-early-onset-anxiety-treatment-biomarker.pdf2022-11-07 22:46 43K 
[ ]11548_childhood-maltreatment-and-suicidality-among-new-soldiers-in-the-us-army.pdf2022-11-07 22:47 608K 
[ ]11549_childhood-maltreatment-risk-factor-adult-cardiovascular.pdf2022-11-07 22:24 52K 
[ ]11550_childhood-maltreatment-risk-suicide-attempt-nationally.pdf2022-11-07 22:03 1.9M 
[ ]11551_childhood-onset-adult-psychopathology-clinical-research.pdf2022-11-07 22:44 34K 
[ ]11552_childhood-sexual-abuse-psychiatric-disorders-middle.pdf2022-11-07 22:46 246K 
[ ]11553_childhood-stimulant-treatment-risk-later-substance.pdf2022-11-07 22:09 57K 
[ ]11554_childhood-trauma-and-cognition.pdf2022-11-07 22:27 413K 
[ ]11555_childhood-trauma-and-criminal-justice-involvement.pdf2022-11-07 22:51 270K 
[ ]11556_childhood-trauma-depressive-symptoms-type-diabetes.pdf2022-11-07 22:22 208K 
[ ]11557_childhood-trauma-is-associated-severe-clinical-characteristics.pdf2022-11-07 22:09 524K 
[ ]11558_childhood-trauma-psychiatric-disorders-criminal-behavior.pdf2022-11-07 22:01 100K 
[ ]11559_child-psychology-psychiatry-frameworks-practice-nd.pdf2022-11-07 22:27 89K 
[ ]11560_children-currently-depressed-mothers-stard-ancillary.pdf2022-11-07 22:45 114K 
[ ]11561_children-divorce-practical-guide-parents-therapists.pdf2022-11-07 22:06 99K 
[ ]11562_child-therapy-concepts-strategies-decision-making.pdf2022-11-07 22:03 57K 
[ ]11563_chips-childrens-interview-psychiatric-syndromes.pdf2022-11-07 22:41 57K 
[ ]11564_chlorpromazine-equivalent-doses-newer-atypical-antipsychotics.pdf2022-11-07 22:19 43K 
[ ]11565_choice-antipsychotic-hiv-infected-patients.pdf2022-11-07 22:50 75K 
[ ]11566_choice-maintenance-medication-schizophrenia.pdf2022-11-07 22:22 82K 
[ ]11567_cholesterol-lithium-levels-were-correlated-serum-hdl.pdf2022-11-07 22:59 134K 
[ ]11568_cholinergic-deficit-alzheimers-disease.pdf2022-11-07 22:44 27K 
[ ]11569_cholinergic-therapies-treatment-tools-psychiatrist.pdf2022-11-07 22:07 33K 
[ ]11570_cholinesterase-inhibitor-discontinuation-patients.pdf2022-11-07 22:45 1.3M 
[ ]11571_cholinesterase-inhibitors-alzheimers-disease-part-1-similarities-different.pdf2022-11-07 22:02 40K 
[ ]11572_cholinesterase-inhibitors-alzheimers-disease-part-2-illustrating-mechanisms-action.pdf2022-11-07 22:27 110K 
[ ]11573_choose-second-line-treatment-option-depression.pdf2022-11-07 22:13 294K 
[ ]11574_choosing-dosing-strategy-electrical-stimulation-ect.pdf2022-11-07 22:20 42K 
[ ]11575_choosing-medications-for-treatment-resistant-depression.pdf2022-11-07 23:02 292K 
[ ]11576_chorea-tardive-dyskinesia-patient-taking-risperidone.pdf2022-11-07 22:18 47K 
[ ]11577_choreiform-dyskinesia-acute-onset-protracted-course.pdf2022-11-07 22:06 35K 
[ ]11578_chromium-potentiation-antidepressant-pharmacotherapy.pdf2022-11-07 22:27 41K 
[ ]11579_chronic-assaultive-behavior-improved-sleep-apnea-treatment.pdf2022-11-07 22:44 86K 
[ ]11580_chronic-depression-comorbid-personality-disorders.pdf2022-11-07 22:05 74K 
[ ]11581_chronic-depression-women.pdf2022-11-07 22:29 73K 
[ ]11582_chronic-leukocytosis-associated-clozapine-case-series.pdf2022-11-07 22:24 185K 
[ ]11583_chronic-neuroleptic-exposure-bipolar-outpatients.pdf2022-11-07 22:59 26K 
[ ]11584_chronological-assessment-suicide-events-practical.pdf2022-11-07 22:04 79K 
[ ]11585_cigarette-smoking-onset-persistence-panic-attacks.pdf2022-11-07 22:30 189K 
[ ]11586_cigarette-smoking-panic-critical-review-literature.pdf2022-11-07 22:28 283K 
[ ]11587_circadian-pattern-of-suicides-in-alcohol-dependent-individuals.pdf2022-11-07 22:54 289K 
[ ]11589_circadian-rhythm-dysfunction-predicts-relapse-in-bd.pdf2022-11-07 22:17 253K 
[ ]11590_circadian-rhythms-mood-disorders-guide-perplexed.pdf2022-11-07 22:45 135K 
[ ]11591_circle-honor.pdf2022-11-07 22:01 34K 
[ ]11592_circuits-sexual-desire-hypoactive-sexual-desire-disorder.pdf2022-11-07 22:08 226K 
[ ]11593_citalopram-adjunctive-therapy-bipolar-depression.pdf2022-11-07 22:09 62K 
[ ]11594_citalopram-augmentation-subsyndromal-symptoms-depression.pdf2022-11-07 22:45 276K 
[ ]11595_citalopram-bupropion-sr-combining-versus-switching.pdf2022-11-07 22:11 43K 
[ ]11596_citalopram-clozapine-potential-drug-interaction.pdf2022-11-07 22:57 69K 
[ ]11597_citalopram-compulsive-shopping-disorder-open-label.pdf2022-11-07 22:55 62K 
[ ]11598_citalopram-intravenous-infusion-resistant-obsessive.pdf2022-11-07 22:57 67K 
[ ]11599_citalopram-maintenance-treatment-major-depressive.pdf2022-11-07 22:10 38K 
[ ]11600_citalopram-therapy-depression-review-years-european.pdf2022-11-07 22:51 97K 
[ ]11601_citalopram-treatment-binge-eating-disorder-placebo.pdf2022-11-07 22:36 69K 
[ ]11602_citalopram-treatment-compulsive-shopping-open-label.pdf2022-11-07 22:40 58K 
[ ]11603_citalopram-treatment-fluoxetine-intolerant-depressed.pdf2022-11-07 22:32 91K 
[ ]11604_citalopram-treatment-fluoxetine-nonresponders.pdf2022-11-07 22:41 52K 
[ ]11605_citalopram-versus-sertraline-late-life-nonmajor-clinically.pdf2022-11-07 22:56 182K 
[ ]11606_clarification-anticholinergic-effects-quetiapine.pdf2022-11-07 22:20 51K 
[ ]11607_clarifying-safety-maoi-diet-pizza.pdf2022-11-07 22:18 49K 
[ ]11608_classics-community-psychiatry-fifty-years-public-mental.pdf2022-11-07 22:48 102K 
[ ]11609_classification-trees-distinguish-suicide-attempters.pdf2022-11-07 22:12 254K 
[ ]11610_classifying-insomnia-clinically-useful.pdf2022-11-07 22:34 69K 
[ ]11611_climate-prevalence-mood-disorders-cross-national-correlation.pdf2022-11-07 22:59 202K 
[ ]11612_clinical-and-practical-psychopharmacology-cardiometabolic-risks-in-schizophrenia-and-directions-for-.pdf2022-11-07 22:17 313K 
[ ]11613_clinical-assessment-child-adolescent-behavior.pdf2022-11-07 22:07 89K 
[ ]11615_clinical-biological-findings-case-hour-bipolar-ultrarapid.pdf2022-11-07 23:01 87K 
[ ]11616_clinical-characteristics-bipolar-vs-unipolar-depression.pdf2022-11-07 22:08 282K 
[ ]11617_clinical-characteristics-depressive-symptoms-children.pdf2022-11-07 22:18 60K 
[ ]11618_clinical-characteristics-management-treatment-resistant.pdf2022-11-07 22:30 136K 
[ ]11619_clinical-characteristics-psychiatric-comorbidity-males.pdf2022-11-07 22:18 118K 
[ ]11620_clinical-characteristics-psychiatric-comorbidity-pyromania.pdf2022-11-07 22:02 147K 
[ ]11621_clinical-cognitive-correlates-suicide-attempts-bipolar.pdf2022-11-07 22:37 375K 
[ ]11622_clinical-correlates-inpatient-suicide.pdf2022-11-07 22:31 57K 
[ ]11623_clinical-correlates-of-ogtt-performance-in-olanzapine-treated-patients.pdf2022-11-07 22:08 116K 
[ ]11624_clinical-correlates-patients-rapid-cycling-bipolar.pdf2022-11-07 22:27 203K 
[ ]11625_clinical-correlates-zolpidem-associated-complex-sleep.pdf2022-11-07 22:01 250K 
[ ]11627_clinical-course-illness-women-early-onset-puerperal.pdf2022-11-07 22:14 453K 
[ ]11628_clinical-decision-making-treatment-mania.pdf2022-11-07 22:06 189K 
[ ]11629_clinical-demographic-features-atypical-depression.pdf2022-11-07 22:11 201K 
[ ]11630_clinical-development-atypical-antipsychotics-research.pdf2022-11-07 22:31 93K 
[ ]11631_clinical-differences-between-suicidal-nonsuicidal.pdf2022-11-07 22:49 134K 
[ ]11632_clinical-domains-psychosomatic-medicine.pdf2022-11-07 22:22 197K 
[ ]11633_clinical-drug-evaluation-unit-ncdeu-annual-meeting.pdf2022-11-07 22:10 110K 
[ ]11634_clinical-dsm-categorical-diagnostic-system-during.pdf2022-11-07 22:19 259K 
[ ]11635_clinical-effects-buspirone-social-phobia-double-blind.pdf2022-11-07 22:07 97K 
[ ]11636_clinical-effects-randomized-switch-patients-clozaril.pdf2022-11-07 22:41 47K 
[ ]11637_clinical-efficacy-reboxetine-major-depression.pdf2022-11-07 22:24 72K 
[ ]11638_clinical-ethical-considerations-pharmacogenetic-testing.pdf2022-11-07 22:32 276K 
[ ]11639_clinical-evidence-potential-neurobiological-underpinnings.pdf2022-11-07 22:06 389K 
[ ]11640_clinical-experience-gabapentin-patients-bipolar-schizoaffective.pdf2022-11-07 22:07 51K 
[ ]11641_clinical-experience-insulin-resistance-diabetic-ketoacidosis.pdf2022-11-07 22:47 60K 
[ ]11642_clinical-experience-substance-p-receptor-nk-antagonists.pdf2022-11-07 23:00 76K 
[ ]11643_clinical-expression-bipolar-disorder-type-i-function.pdf2022-11-07 22:03 226K 
[ ]11644_clinical-factors-associated-treatment-noncompliance.pdf2022-11-07 23:03 64K 
[ ]11645_clinical-factors-associated-treatment-resistance-major.pdf2022-11-07 22:50 215K 
[ ]11646_clinical-features-associated-poor-pharmacologic-adherence.pdf2022-11-07 22:36 470K 
[ ]11647_clinical-features-bipolar-depression.pdf2022-11-07 22:23 64K 
[ ]11648_clinical-features-bipolar-depression-comparison-matched.pdf2022-11-07 22:07 92K 
[ ]11649_clinical-features-delusional-jealousy-elderly-patients.pdf2022-11-07 22:10 194K 
[ ]11650_clinical-features-depressed-children-adolescents-various.pdf2022-11-07 22:51 119K 
[ ]11651_clinical-features-distinguishing-patients-tourettes.pdf2022-11-07 22:13 30K 
[ ]11652_clinical-features-psychiatric-comorbidity-health-related.pdf2022-11-07 22:15 35K 
[ ]11653_clinical-features-treatment-resistant-depression.pdf2022-11-07 22:01 65K 
[ ]11654_clinical-geriatric-psychopharmacology-rd-ed.pdf2022-11-07 22:09 20K 
[ ]11655_clinical-geriatric-psychopharmacology-th-ed.pdf2022-11-07 22:24 82K 
[ ]11656_clinical-guidance-on-treatment-resistant-schizophrenia.pdf2022-11-07 22:44 380K 
[ ]11657_clinical-guidelines-dosing-switching-strategies-long.pdf2022-11-07 22:14 60K 
[ ]11658_clinical-guidelines-establishing-remission-patients.pdf2022-11-07 22:42 61K 
[ ]11659_clinical-guide-treatment-mentally-ill-homeless-person.pdf2022-11-07 22:20 69K 
[ ]11660_clinical-handbook-couple-therapy-th-ed.pdf2022-11-07 23:00 700K 
[ ]11661_clinical-handbook-obsessive-compulsive-disorder-related.pdf2022-11-07 22:32 102K 
[ ]11662_clinical-handbook-psychiatry-law-th-ed.pdf2022-11-07 22:14 101K 
[ ]11663_clinical-handbook-psychological-disorders-fifth-edition-book-review.pdf2022-11-07 22:11 73K 
[ ]11664_clinical-handbook-psychological-disorders-fourth-edition-book-review.pdf2022-11-07 22:52 714K 
[ ]11665_clinical-handbook-psychotropic-drugs-children-adolescents.pdf2022-11-07 22:59 67K 
[ ]11666_clinical-handbook-psychotropic-drugs-childrenand-adolescents.pdf2022-11-07 22:43 99K 
[ ]11667_clinical-handbook-psychotropic-drugs-eighteenth-edition-book-review.pdf2022-11-07 22:21 85K 
[ ]11668_clinical-handbook-psychotropic-drugs-seventeenth-edition-book-review.pdf2022-11-07 22:19 98K 
[ ]11669_clinical-handbook-psychotropic-drugs-th-ed-revised.pdf2022-11-07 22:46 42K 
[ ]11670_clinical-handbook-schizophrenia.pdf2022-11-07 22:36 118K 
[ ]11671_clinical-highlights-bipolar-depression-focus-atypical.pdf2022-11-07 22:15 159K 
[ ]11673_clinical-implications-weight-gain-schizophrenia.pdf2022-11-07 22:15 60K 
[ ]11674_clinical-insights-pharmacogenetics-schizophrenia-part-1-implementing-using-pharmacogenetics-adherenc.pdf2022-11-07 22:11 243K 
[ ]11675_clinical-insights-pharmacogenetics-schizophrenia-part-2-gene-candidates-neurocognitive-function.pdf2022-11-07 22:18 237K 
[ ]11676_clinical-interface-depression-dementia.pdf2022-11-07 22:58 82K 
[ ]11677_clinical-issues-long-term-treatment-antidepressants.pdf2022-11-07 22:02 62K 
[ ]11678_clinical-legal-correlates-inmates-bipolar-disorder.pdf2022-11-07 22:41 52K 
[ ]11679_clinically-useful-anxiety-outcome-scale.pdf2022-11-07 22:19 270K 
[ ]11680_clinically-useful-self-report-measure-dsm-anxious.pdf2022-11-07 22:26 330K 
[ ]11681_clinical-management-antidepressant-discontinuation.pdf2022-11-07 22:59 26K 
[ ]11682_clinical-management-cardiovascular-risks-during-treatment.pdf2022-11-07 22:57 53K 
[ ]11683_clinical-manifestations-dystonia-dyskinesia-ssri-administration.pdf2022-11-07 22:28 43K 
[ ]11684_clinical-manual-addiction-psychopharmacology.pdf2022-11-07 23:02 54K 
[ ]11685_clinical-manual-addiction-psychopharmacology-nd-ed.pdf2022-11-07 22:59 71K 
[ ]11686_clinical-manual-adolescent-substance-abuse-treatment.pdf2022-11-07 22:08 145K 
[ ]11687_clinical-manual-anxiety-disorders.pdf2022-11-07 23:02 46K 
[ ]11688_clinical-manual-child-adolescent-psychopharmacology-book-review.pdf2022-11-07 22:35 86K 
[ ]11689_clinical-manual-child-adolescent-psychopharmacology-second-edition-book-reivew.pdf2022-11-07 22:12 71K 
[ ]11690_clinical-manual-couples-family-therapy.pdf2022-11-07 22:38 95K 
[ ]11691_clinical-manual-drug-interaction-principles-medical.pdf2022-11-07 22:34 98K 
[ ]11692_clinical-manual-electroconvulsive-therapy.pdf2022-11-07 22:54 83K 
[ ]11693_clinical-manual-evaluation-treatment-sleep-disorders.pdf2022-11-07 22:53 114K 
[ ]11694_clinical-manual-geriatric-psychiatry-book-review.pdf2022-11-07 22:01 72K 
[ ]11695_clinical-manual-geriatric-psychopharmacology.pdf2022-11-07 22:23 97K 
[ ]11696_clinical-manual-geriatric-psychopharmacology-nd-ed.pdf2022-11-07 22:08 67K 
[ ]11697_clinical-manual-impulse-control-disorder.pdf2022-11-07 22:27 53K 
[ ]11698_clinical-manual-management-ptsd.pdf2022-11-07 22:56 76K 
[ ]11699_clinical-manual-neuropsychiatry.pdf2022-11-07 22:13 80K 
[ ]11700_clinical-manual-prevention-mental-health.pdf2022-11-07 22:28 106K 
[ ]11701_clinical-manual-psychiatry-law.pdf2022-11-07 22:51 72K 
[ ]11702_clinical-manual-psychosmatic-medicine-guide-consultation.pdf2022-11-07 22:42 54K 
[ ]11703_clinical-manual-psychosomatic-medicine-guide-consultation.pdf2022-11-07 22:21 93K 
[ ]11704_clinical-manual-sexual-disorders.pdf2022-11-07 22:06 108K 
[ ]11705_clinical-manual-treatment-alcoholism-addictions.pdf2022-11-07 22:58 74K 
[ ]11706_clinical-markers-identify-metabolic-syndrome-antipsychotic.pdf2022-11-07 22:17 219K 
[ ]11707_clinical-methods-transcultural-psychiatry.pdf2022-11-07 22:47 50K 
[ ]11708_clinical-nefazodone-major-depression-perspective.pdf2022-11-07 22:30 103K 
[ ]11709_clinical-neuroanatomy-neurobehavioral-approach.pdf2022-11-07 22:36 98K 
[ ]11710_clinical-neurocognitive-effects-clozapine-risperidone.pdf2022-11-07 22:12 46K 
[ ]11711_clinical-neuropsychiatry-stroke.pdf2022-11-07 22:49 38K 
[ ]11712_clinical-outcome-antipsychotic-treatment-discontinuation.pdf2022-11-07 22:36 251K 
[ ]11713_clinical-outcome-psychopharmacologic-treatment-borderline.pdf2022-11-07 22:46 38K 
[ ]11714_clinical-outcomes-associated-comorbid-posttraumatic.pdf2022-11-07 22:10 294K 
[ ]11715_clinical-perspective-attention-deficit-hyperactivity.pdf2022-11-07 22:17 97K 
[ ]11716_clinical-perspectives-atypical-antipsychotics-treatment.pdf2022-11-07 22:37 97K 
[ ]11717_clinical-pharmacodynamics-pharmacokinetics-antimanic.pdf2022-11-07 22:37 101K 
[ ]11718_clinical-pharmacokinetics-fluvoxamine-applications.pdf2022-11-07 22:05 43K 
[ ]11719_clinical-picture-alzheimers-disease-decade-before.pdf2022-11-07 22:54 570K 
[ ]11720_clinical-polysomnographic-features-sleep-related-eating.pdf2022-11-07 22:37 41K 
[ ]11721_clinical-practice-guidelines-bipolar-disorder-department.pdf2022-11-07 22:46 73K 
[ ]11722_clinical-practice-guidelines-praise-problems.pdf2022-11-07 22:05 18K 
[ ]11723_clinical-predictors-acute-response-olanzapine-psychotic.pdf2022-11-07 22:05 32K 
[ ]11724_clinical-predictors-acute-response-quetiapine-psychotic.pdf2022-11-07 22:15 61K 
[ ]11725_clinical-predictors-drug-nonresponse-obsessive-compulsive.pdf2022-11-07 22:45 149K 
[ ]11726_clinical-predictors-ketamine-response-treatment-resistant.pdf2022-11-07 22:09 381K 
[ ]11727_clinical-predictors-response-clozapine-treatment-ambulatory.pdf2022-11-07 22:57 97K 
[ ]11728_clinical-predictors-suicide-primary-major-depressive.pdf2022-11-07 22:35 116K 
[ ]11729_clinical-presentation-generalized-anxiety-primary.pdf2022-11-07 22:31 36K 
[ ]11730_clinical-presentations-adult-patients-adhd.pdf2022-11-07 22:02 47K 
[ ]11731_clinical-process-psychiatry-clinimetric-approach.pdf2022-11-07 22:10 379K 
[ ]11732_clinical-psychopharmacologic-factors-influencing-family.pdf2022-11-07 22:45 61K 
[ ]11733_clinical-psychopharmacology-pediatric-mood-stabilizer-antipsychotic-treatment-challenges-development.pdf2022-11-07 22:54 76K 
[ ]11734_clinical-psychopharmacology-pediatric-mood-stabilizer-antipsychotic-treatment-methodology-part-2-asc.pdf2022-11-07 22:35 74K 
[ ]11735_clinical-quetiapine-disease-states-schizophrenia.pdf2022-11-07 22:47 79K 
[ ]11736_clinical-risk-factors-serotonin-transporter-gene-variants.pdf2022-11-07 22:52 264K 
[ ]11737_clinical-risk-factors-weight-gain-during-psychopharmacologic.pdf2022-11-07 22:16 251K 
[ ]11738_clinical-significance-monitoring-early-symptom-change.pdf2022-11-07 22:40 245K 
[ ]11739_clinical-significance-proposed-developmental-trauma.pdf2022-11-07 22:58 391K 
[ ]11740_clinical-socioeconomic-correlates-insomnia.pdf2022-11-07 22:29 54K 
[ ]11741_clinical-staging-bipolar-disorder-focus-cognition.pdf2022-11-07 22:38 735K 
[ ]11742_clinical-staging-major-depressive-disorder-empirical.pdf2022-11-07 22:29 335K 
[ ]11743_clinical-textbook-addictive-disorders-nd-ed.pdf2022-11-07 22:01 19K 
[ ]11744_clinical-trial-adjuvant-allopurinol-therapy-moderately.pdf2022-11-07 22:47 145K 
[ ]11745_clinical-trial-design-issues-schizophrenic-research.pdf2022-11-07 22:37 49K 
[ ]11746_clinical-trials-psychopharmacology-better-brain-nd.pdf2022-11-07 22:14 125K 
[ ]11747_clinical-trials-treatment-alcohol-dependence-adequately.pdf2022-11-07 22:59 332K 
[ ]11748_clinical-trials-tribulations.pdf2022-11-07 22:15 62K 
[ ]11749_clinical-trials-tribulations-perspectives-research.pdf2022-11-07 22:25 69K 
[ ]11750_clinical-trials-with-suicidal-individuals-can-be-conducted-safely.pdf2022-11-07 22:21 90K 
[ ]11751_clinical-usefulness-diagnostic-manual-intellectual.pdf2022-11-07 22:49 259K 
[ ]11752_clinical-utility-early-improvement-predict-response.pdf2022-11-07 22:22 321K 
[ ]11753_clinical-utility-magnetic-resonance-imaging-radiographs.pdf2022-11-07 22:46 131K 
[ ]11755_clinician-perspective-achieving-maintaining-remission.pdf2022-11-07 22:17 66K 
[ ]11756_clinician-rated-versus-self-rated-screening-bipolar.pdf2022-11-07 22:10 470K 
[ ]11757_clinicians-guide-bipolar-disorder-integrating-pharmacology.pdf2022-11-07 22:13 70K 
[ ]11758_clinicians-guide-mental-illness.pdf2022-11-07 22:56 46K 
[ ]11759_clinicians-guide-monitoring-kidney-function-lithium.pdf2022-11-07 22:09 206K 
[ ]11760_clinicians-guide-sleep-disorders.pdf2022-11-07 23:03 73K 
[ ]11762_clinicians-reasons-antipsychotic-coprescribing.pdf2022-11-07 22:06 45K 
[ ]11763_clinicians-respond-patients-miss-appointments.pdf2022-11-07 22:32 76K 
[ ]11765_clomipramine-treatment-panic-disorder-pros-cons.pdf2022-11-07 22:02 28K 
[ ]11766_clonidine-acute-aversive-inner-tension-self-injurious.pdf2022-11-07 22:40 55K 
[ ]11767_clonidine-induced-gynecomastia-hyperprolactinemia.pdf2022-11-07 22:19 147K 
[ ]11768_closer-depression-mothers-kill-children-is-unipolar.pdf2022-11-07 22:35 201K 
[ ]11769_closing-efficacy-effectiveness-gap-translating-both.pdf2022-11-07 22:46 129K 
[ ]11770_clozapine-and-blood-monitoringis-less-better.pdf2022-11-07 22:24 280K 
[ ]11771_clozapine-anemia-follow-study.pdf2022-11-07 22:33 1.0M 
[ ]11772_clozapine-associated-diabetes-mellitus.pdf2022-11-07 22:21 71K 
[ ]11773_clozapine-augmentation-aripiprazole-negative-symptoms.pdf2022-11-07 22:20 88K 
[ ]11774_clozapine-augmentation-with-antiepileptic-drugs.pdf2022-11-07 22:34 525K 
[ ]11775_clozapine-benzodiazepine-interactions.pdf2022-11-07 22:07 35K 
[ ]11776_clozapine-commitment-patient-safety.pdf2022-11-07 22:34 45K 
[ ]11777_clozapine-comparison-novel-antipsychotics.pdf2022-11-07 22:45 50K 
[ ]11778_clozapine-diabetes-mellitus-hyperlipidemia-cardiovascular.pdf2022-11-07 22:50 151K 
[ ]11779_clozapine-diabetes-mellitus-weight-gain-lipid-abnormalities.pdf2022-11-07 22:27 74K 
[ ]11780_clozapine-diminishes-suicidal-behavior-retrospective.pdf2022-11-07 22:11 90K 
[ ]11781_clozapine-full-term-pregnancies.pdf2022-11-07 22:37 43K 
[ ]11782_clozapine-hypertension-chart-review-patients.pdf2022-11-07 22:54 42K 
[ ]11783_clozapine-induced-agranulocytosis-finland-long-term.pdf2022-11-07 22:53 260K 
[ ]11784_clozapine-induced-eosinophilia-subsequent-neutropenia.pdf2022-11-07 22:33 125K 
[ ]11785_clozapine-induced-fevers-clozapine-discontinuation.pdf2022-11-07 22:39 63K 
[ ]11786_clozapine-induced-pericarditis-pericardial-tamponade.pdf2022-11-07 22:23 141K 
[ ]11787_clozapine-induced-rabbit-syndrome.pdf2022-11-07 22:37 67K 
[ ]11788_clozapine-induced-urinary-incontinence-incidence-treatment.pdf2022-11-07 22:42 35K 
[ ]11789_clozapine-interchangeability-issues.pdf2022-11-07 22:55 256K 
[ ]11790_clozapine-more-side-effects-still-best-antipsychotic.pdf2022-11-07 22:06 136K 
[ ]11791_clozapine-obsessions-patients-recent-onset-schizophrenia.pdf2022-11-07 22:25 37K 
[ ]11792_clozapine-pregnancy.pdf2022-11-07 22:42 81K 
[ ]11793_clozapine-rechallenge-following-clozapine-induced.pdf2022-11-07 22:02 157K 
[ ]11794_clozapine-reduces-severe-self-mutilation-aggression.pdf2022-11-07 22:17 70K 
[ ]11795_clozapine-reduces-violence-persistent-aggression-schizophrenia.pdf2022-11-07 22:59 43K 
[ ]11796_clozapine-refractory-schizophrenia-illinois-experience.pdf2022-11-07 22:27 49K 
[ ]11797_clozapine-related-speech-disturbance.pdf2022-11-07 22:48 38K 
[ ]11798_clozapine-risperidone-moderately-refractory-schizophrenia.pdf2022-11-07 22:30 136K 
[ ]11799_clozapine-tardive-dyskinesia.pdf2022-11-07 22:39 55K 
[ ]11800_clozapine-treatment-aggression-adolescent-autistic.pdf2022-11-07 22:18 72K 
[ ]11801_clozapine-treatment-hypomania-neurosyphilis.pdf2022-11-07 22:13 72K 
[ ]11802_clozapine-treatment-neuroleptic-induced-blepharospasm.pdf2022-11-07 22:20 47K 
[ ]11803_clozapine-treatment-neuroleptic-induced-tardive-dyskinesia.pdf2022-11-07 22:16 38K 
[ ]11804_clozapine-treatment-population-adults-mental-retardation.pdf2022-11-07 22:18 45K 
[ ]11805_clozapine-treatment-refractory-schizophrenia-schizoaffective.pdf2022-11-07 22:35 69K 
[ ]11806_clozapine-treatment-resistant-patients-schizophrenia.pdf2022-11-07 22:13 67K 
[ ]11807_clozapine-use-in-first-episode-psychosis.pdf2022-11-07 22:59 268K 
[ ]11808_clozapine-use-in-patients-with-benign-neutropenia.pdf2022-11-07 22:38 268K 
[ ]11809_clozapine-utilization-outcomes-race-public-mental.pdf2022-11-07 22:02 112K 
[ ]11810_clozapine-venous-thromboembolism-further-evidence.pdf2022-11-07 22:24 69K 
[ ]11811_clozapine-versus-chlorpromazine-geriatric-patients.pdf2022-11-07 22:10 57K 
[ ]11812_clozapine-versus-risperidone-treatment-refractory.pdf2022-11-07 22:01 47K 
[ ]11813_clozapine-withdrawalemergent-dystonias-dyskinesias.pdf2022-11-07 22:28 39K 
[ ]11814_clozapine-withdrawal-resulting-delirium-psychosis.pdf2022-11-07 22:36 30K 
[ ]11815_cluster-cholesterol-related-genes-confers-susceptibility.pdf2022-11-07 22:24 185K 
[ ]11816_clusters-of-suicide-attempters.pdf2022-11-07 22:46 284K 
[ ]11817_cns-job-market-service-readers.pdf2022-11-07 22:08 713K 
[ ]11818_coadministration-isoniazid-antidepressant-drugs.pdf2022-11-07 22:53 37K 
[ ]11819_cocaine-heavy-drinkers-increases-vulnerability-developing.pdf2022-11-07 22:58 237K 
[ ]11820_cocaine-methamphetamine-dependence-advances-treatment.pdf2022-11-07 22:21 79K 
[ ]11821_cocaine-risk-factor-neuroleptic-induced-acute-dystonia.pdf2022-11-07 22:50 69K 
[ ]11822_code-status-discussions-psychiatric-medical-inpatients.pdf2022-11-07 22:46 172K 
[ ]11823_co-donepezil-hypnotics-among-alzheimers-disease-patients.pdf2022-11-07 22:36 58K 
[ ]11824_cognition-enhancing-effect-vagus-nerve-stimulation.pdf2022-11-07 22:53 77K 
[ ]11825_cognition-in-amenorrheic-athletes-receiving-estrogen.pdf2022-11-07 22:58 382K 
[ ]11827_cognitive-behavioral-approaches-adhd-treatment-adulthood.pdf2022-11-07 22:02 87K 
[ ]11828_cognitive-behavioral-approaches-treatment-insomnia.pdf2022-11-07 22:54 71K 
[ ]11829_cognitive-behavioral-group-therapy-panic-disorder.pdf2022-11-07 22:13 51K 
[ ]11830_cognitive-behavioral-management-drug-resistant-major.pdf2022-11-07 23:03 44K 
[ ]11831_cognitive-behavioral-management-patients-bipolar-disorder.pdf2022-11-07 22:21 97K 
[ ]11832_cognitive-behavioral-therapy-adjunct-serotonin-reuptake.pdf2022-11-07 22:02 41K 
[ ]11833_cognitive-behavioral-therapy-adult-anxiety-disorders.pdf2022-11-07 22:43 336K 
[ ]11834_cognitive-behavioral-therapy-medication-nonresponders.pdf2022-11-07 22:45 78K 
[ ]11835_cognitive-behavioral-therapy-panic-disorder-current.pdf2022-11-07 22:26 39K 
[ ]11836_cognitive-behavioral-therapy-ptsd-case-formulation.pdf2022-11-07 22:53 101K 
[ ]11837_cognitive-behavioral-therapy-social-anxiety-disorder.pdf2022-11-07 22:13 59K 
[ ]11838_cognitive-behavioral-therapy-treatment-anxiety-disorders.pdf2022-11-07 22:06 72K 
[ ]11839_cognitive-behavioral-therapy-treatment-panic-disorder.pdf2022-11-07 22:38 99K 
[ ]11840_cognitive-behavioral-therapy-youths-misophonia.pdf2022-11-07 22:39 110K 
[ ]11841_cognitive-behavior-therapy-basics-beyond-nd-ed.pdf2022-11-07 22:26 77K 
[ ]11842_cognitive-behavior-therapy-children-adolescents.pdf2022-11-07 22:32 91K 
[ ]11843_cognitive-behavior-therapy-eating-disorders.pdf2022-11-07 22:47 733K 
[ ]11844_cognitive-behavior-therapy-severe-mental-illness-illustrated.pdf2022-11-07 22:10 147K 
[ ]11845_cognitive-behaviour-therapy-chronic-medical-problems.pdf2022-11-07 23:02 49K 
[ ]11846_cognitive-change-manic-episode-association-between.pdf2022-11-07 22:36 359K 
[ ]11847_cognitive-control-and-adolescent-suicidality.pdf2022-11-07 22:45 294K 
[ ]11848_cognitive-deficits-patients-schizophrenia-effects.pdf2022-11-07 22:17 129K 
[ ]11849_cognitive-development-adults-attention-deficit-hyperactivity.pdf2022-11-07 22:56 340K 
[ ]11850_cognitive-dysfunction-psychiatric-illness-neglected.pdf2022-11-07 22:04 131K 
[ ]11851_cognitive-dysfunction-schizophrenia-importance-outcome.pdf2022-11-07 22:45 48K 
[ ]11852_cognitive-effects-paroxetine-older-depressed-patients.pdf2022-11-07 22:13 49K 
[ ]11853_cognitive-effects-pharmacotherapy-major-depressive.pdf2022-11-07 22:55 845K 
[ ]11854_cognitive-facilitation-behavioral-disinhibition-benzodiazepine.pdf2022-11-07 22:28 256K 
[ ]11856_cognitive-functioning-acute-sedative-effects-risperidone.pdf2022-11-07 22:49 233K 
[ ]11857_cognitive-functioning-late-life-schizophrenia-importance.pdf2022-11-07 22:22 61K 
[ ]11858_cognitive-functioning-schizophrenia-consensus-statement.pdf2022-11-07 22:52 81K 
[ ]11859_cognitive-impairment-assessment-brain-magnetic-resonance.pdf2022-11-07 22:24 83K 
[ ]11860_cognitive-impairment-associated-depression-elderly.pdf2022-11-07 22:38 300K 
[ ]11862_cognitive-impairment-functional-outcome-schizophrenia-bipolar-endophenotype-MATRICS.pdf2022-11-07 22:37 82K 
[ ]11863_cognitive-impairment-in-depression.pdf2022-11-07 22:50 496K 
[ ]11865_cognitive-impairment-schizophrenia-characteristics.pdf2022-11-07 22:09 71K 
[ ]11866_cognitive-inhibition-suicidal-depressed-elderly-case.pdf2022-11-07 22:10 166K 
[ ]11867_cognitive-planning-neural-correlates-pediatric-monozygotic.pdf2022-11-07 22:44 285K 
[ ]11868_cognitive-processing-therapy-posttraumatic-stress.pdf2022-11-07 23:01 401K 
[ ]11869_cognitive-reactivity-versus-dysfunctional-cognitions.pdf2022-11-07 22:45 442K 
[ ]11870_cognitive-remediation-and-lurasidone-in-schizophrenia.pdf2022-11-07 22:35 927K 
[ ]11871_cognitive-remediation-in-bipolar-disorder.pdf2022-11-07 22:20 582K 
[ ]11872_cognitive-side-effects-anticonvulsants.pdf2022-11-07 22:32 62K 
[ ]11873_cognitive-symptoms-patients-major-depressive-disorder.pdf2022-11-07 22:11 356K 
[ ]11874_cognitive-therapy-exposure-vivo-alone-combination.pdf2022-11-07 22:04 166K 
[ ]11875_cognitive-therapy-schizoephrenia.pdf2022-11-07 22:37 60K 
[ ]11876_cognitive-therapy-techniques-practitioners-guide.pdf2022-11-07 22:36 33K 
[ ]11877_cognitive-vulnerability-depression.pdf2022-11-07 22:12 31K 
[ ]11878_cognizance-cognition-older-primary-care-patients-depression.pdf2022-11-07 22:36 164K 
[ ]11879_cohort-effect-in-bipolar-disorder.pdf2022-11-07 22:15 309K 
[ ]11880_cohort-study-prevalence-impact-comorbid-medical-conditions.pdf2022-11-07 22:53 291K 
[ ]11881_collaborative-management-achieve-depression-treatment.pdf2022-11-07 22:16 25K 
[ ]11882_college-overwhelmed-campus-mental-health-crisis.pdf2022-11-07 22:41 35K 
[ ]11883_colon-perforation-peritonitis-associated-clozapine.pdf2022-11-07 23:00 59K 
[ ]11884_combination-donepezil-gabapentin-behavioral-disorders.pdf2022-11-07 22:12 57K 
[ ]11885_combination-therapy-is-clinical-practice-leading.pdf2022-11-07 22:14 62K 
[ ]11887_combination-therapy-zonisamide-bupropion-weight-reduction.pdf2022-11-07 22:47 126K 
[ ]11888_combination-treatment-nefazodone-cognitive-behavioral.pdf2022-11-07 22:10 68K 
[ ]11889_combined-antidepressant-treatment-risk-factor-switching.pdf2022-11-07 22:26 47K 
[ ]11890_combined-dialectical-behavior-therapy-fluoxetine-treatment.pdf2022-11-07 22:32 57K 
[ ]11891_combined-effects-depressive-symptoms-resting-heart.pdf2022-11-07 22:06 285K 
[ ]11892_combined-total-sleep-deprivation-light-therapy-treatment.pdf2022-11-07 22:33 156K 
[ ]11893_combined-treatment-methylphenidate-citalopram-accelerated.pdf2022-11-07 23:00 43K 
[ ]11894_combined-treatment-venlafaxine-tricyclic-antidepressants.pdf2022-11-07 23:00 61K 
[ ]11895_combining-antidepressants-treatment-resistant-depression.pdf2022-11-07 23:00 83K 
[ ]11896_combining-antidepressant-therapies-initiation-treatment.pdf2022-11-07 22:03 194K 
[ ]11897_combining-bupropion-sr-venlafaxine-paroxetine-fluoxetine.pdf2022-11-07 22:20 71K 
[ ]11898_combining-medication-psychosocial-treatments-addictions.pdf2022-11-07 22:54 43K 
[ ]11899_combining-pharmacologic-nonpharmacologic-therapies.pdf2022-11-07 22:42 149K 
[ ]11900_combining-pharmacotherapy-psychotherapeutic-management.pdf2022-11-07 22:36 57K 
[ ]11901_combining-serotonin-reuptake-inhibitors-bupropion.pdf2022-11-07 22:11 95K 
[ ]11902_combining-serum-protein-concentrations-diagnose-schizophrenia.pdf2022-11-07 22:01 539K 
[ ]11903_combining-stimulants-monoamine-oxidase-inhibitors.pdf2022-11-07 22:57 48K 
[ ]11904_command-hallucinations-self-stabbing-associated-zolpidem.pdf2022-11-07 22:39 753K 
[ ]11905_commentaries-peer-review-evolving-journal.pdf2022-11-07 22:40 162K 
[ ]11906_commentary-achieving-balance-treating-depressed-pregnant.pdf2022-11-07 22:19 183K 
[ ]11907_commentary-advocacy-perspective.pdf2022-11-07 22:20 32K 
[ ]11908_commentary-alzheimers-disease-implications-updated.pdf2022-11-07 22:53 322K 
[ ]11909_commentary-another-point-view-superiority-noninferiority.pdf2022-11-07 22:45 206K 
[ ]11910_commentary-bath-salts-return-serotonin-syndrome.pdf2022-11-07 22:13 115K 
[ ]11911_commentary-benzodiazepines-posttraumatic-stress-disorder.pdf2022-11-07 22:20 135K 
[ ]11912_commentary-broadening-diagnostic-criteria-bipolar.pdf2022-11-07 22:53 310K 
[ ]11913_commentary-changes-product-label-pimozide-illustrate.pdf2022-11-07 22:34 148K 
[ ]11914_commentary-child-murder-mental-illness-parents-implications.pdf2022-11-07 22:52 160K 
[ ]11915_commentary-circadian-rhythm-prediction-relapse-bipolar-disorder.pdf2022-11-07 22:04 127K 
[ ]11916_commentary-clinical-antipsychotic-trials-intervention.pdf2022-11-07 22:54 54K 
[ ]11917_commentary-clinical-trial-designs-examine-personalized.pdf2022-11-07 22:07 181K 
[ ]11918_commentary-concerns-regarding-inclusion-temper-dysregulation.pdf2022-11-07 22:35 263K 
[ ]11919_commentary-current-crisis-confidence-antidepressants.pdf2022-11-07 22:17 367K 
[ ]11920_commentary-depression-risk-dementia-exploring-interface.pdf2022-11-07 22:08 131K 
[ ]11921_commentary-depression-women-windows-vulnerability.pdf2022-11-07 22:04 326K 
[ ]11922_commentary-dimensional-diagnosis-ltemgtdsm-ltemgt.pdf2022-11-07 23:03 146K 
[ ]11923_commentary-effect-marijuana-risk-schizophrenia-cme.pdf2022-11-07 22:12 361K 
[ ]11924_commentary-emerging-bias-treatment-posttraumatic-stress.pdf2022-11-07 22:59 152K 
[ ]11925_commentary-expert-consensus-guidelines-using-antipsychotic.pdf2022-11-07 23:00 50K 
[ ]11926_commentary-gauging-second-generation-antipsychotics-medicaid-benefits-need-improvement.pdf2022-11-07 22:25 164K 
[ ]11927_commentary-government-perspective.pdf2022-11-07 22:26 34K 
[ ]11928_commentary-growing-crisis-schizophrenia-drug-development-failing-signal-detection-North-American-oth.pdf2022-11-07 22:49 118K 
[ ]11929_commentary-health-care-organization-perspective.pdf2022-11-07 22:42 32K 
[ ]11930_commentary-impact-omega-fatty-acids-depressive-disorders.pdf2022-11-07 22:57 184K 
[ ]11931_commentary-incorporate-psychosocial-treatment-interventions.pdf2022-11-07 22:32 118K 
[ ]11932_commentary-jonathan-o-cole-md-innovator-clinical-psychopharmacology.pdf2022-11-07 22:20 688K 
[ ]11933_commentary-law-diminishing-intent-getting-excited.pdf2022-11-07 22:32 133K 
[ ]11934_commentary-lowering-diagnostic-threshold-bipolar-disorder.pdf2022-11-07 22:14 309K 
[ ]11935_commentary-methodologies-avoid-enrollment-ineligible.pdf2022-11-07 22:05 106K 
[ ]11936_commentary-monitoring-clozapine-adverse-effects-calls.pdf2022-11-07 22:08 112K 
[ ]11937_commentary-national-epidemic-unintentional-prescription.pdf2022-11-07 22:03 291K 
[ ]11938_commentary-on-a-network-meta-analysis-of-antidepressant-efficacy-and-acceptability.pdf2022-11-07 22:22 333K 
[ ]11939_commentary-paradigm-shift-preliminary-clinical-categorization.pdf2022-11-07 22:19 141K 
[ ]11940_commentary-pervasive-persistent-neurobiological-clinical.pdf2022-11-07 22:31 171K 
[ ]11941_commentary-preventing-domestic-violence-families-veterans.pdf2022-11-07 22:58 476K 
[ ]11942_commentary-problematic-ltemgtdsm-ltemgt-personality.pdf2022-11-07 22:08 194K 
[ ]11943_commentary-publishing-statistically-significant-results.pdf2022-11-07 22:02 180K 
[ ]11944_commentary-purchasing-community-perspective.pdf2022-11-07 22:46 30K 
[ ]11945_commentary-randomized-controlled-trials-olanzapine.pdf2022-11-07 22:32 527K 
[ ]11946_commentary-studying-antidepressants-were-light-end.pdf2022-11-07 22:48 57K 
[ ]11947_commentary-teaching-teacher-report-third-annual-american.pdf2022-11-07 22:04 151K 
[ ]11948_commentarythe-contemporary-lithium.pdf2022-11-07 22:09 70K 
[ ]11949_commentary-veterans-deserve-better-care.pdf2022-11-07 22:19 89K 
[ ]11950_comment-lithium-clozapine-rechallenge-retrospective.pdf2022-11-07 22:34 170K 
[ ]11951_comment-on-pharmacogenetics-section-of-recent-genetics-guideline.pdf2022-11-07 22:24 89K 
[ ]11952_comments-consensus-regarding-diagnostic-criteria-neuroleptic.pdf2022-11-07 22:17 84K 
[ ]11953_comments-cost-analysis-risperidone-versus-olanzapine.pdf2022-11-07 22:29 62K 
[ ]11954_comments-randomized-double-blind-comparison-sertraline.pdf2022-11-07 22:05 208K 
[ ]11955_comments-role-character-dimension-self-transcendence.pdf2022-11-07 22:28 85K 
[ ]11957_common-is-obsessive-compulsive-disorder-dermatology.pdf2022-11-07 22:23 47K 
[ ]11958_common-pathways-depression-pain.pdf2022-11-07 22:50 57K 
[ ]11959_common-treatment-goals-antipsychotics-acute-treatment.pdf2022-11-07 22:17 24K 
[ ]11961_community-child-adolescent-psychiatry-manual-clinical.pdf2022-11-07 22:50 108K 
[ ]11962_comorbid-alcoholism-depression-treatment-issues.pdf2022-11-07 22:58 78K 
[ ]11963_comorbid-anxiety-children-adolescents-bipolar-spectrum.pdf2022-11-07 22:36 241K 
[ ]11964_comorbid-anxiety-depression.pdf2022-11-07 22:15 176K 
[ ]11965_comorbidity-attention-deficit-hyperactivity-disorder.pdf2022-11-07 22:12 105K 
[ ]11966_comorbidity-axis-i-disorders-patients-traumatic-grief.pdf2022-11-07 22:39 39K 
[ ]11967_comorbidity-dsm-iv-pathological-gambling-psychiatric.pdf2022-11-07 22:41 190K 
[ ]11968_comorbidity-fibromyalgia-psychiatric-disorders.pdf2022-11-07 22:33 101K 
[ ]11969_comorbidity-generalized-anxiety-disorder-impact-implications.pdf2022-11-07 22:47 59K 
[ ]11970_comorbidity-generalized-anxiety-disorder-substance.pdf2022-11-07 22:44 297K 
[ ]11971_comorbidity-neurobiology-pharmacotherapy-social-anxiety.pdf2022-11-07 22:48 52K 
[ ]11972_comorbidity-obsessive-compulsive-disorder-depression.pdf2022-11-07 22:27 72K 
[ ]11973_comorbidity-patterns-anxiety-depressive-disorders.pdf2022-11-07 23:03 327K 
[ ]11974_comorbidity-posttraumatic-stress-disorder-irritable.pdf2022-11-07 22:53 26K 
[ ]11975_comorbidity-primary-care-presentation-consequences.pdf2022-11-07 22:25 67K 
[ ]11976_comorbidity-psychiatric-disorders-posttraumatic-stress.pdf2022-11-07 23:00 75K 
[ ]11977_comorbid-personality-disorders-moderate-panic-focused.pdf2022-11-07 22:57 165K 
[ ]11979_comorbid-social-anxiety-body-dysmorphic-disorder-managing.pdf2022-11-07 22:01 55K 
[ ]11980_comorbid-somatic-illnesses-patients-severe-mental.pdf2022-11-07 22:23 177K 
[ ]11981_comorbid-substance-disorders-among-youth-bipolar-disorder.pdf2022-11-07 22:38 364K 
[ ]11982_comorbid-symptom-severity-attention-deficit-hyperactivity.pdf2022-11-07 22:50 535K 
[ ]11983_comparative-assessment-incidence-severity-tardive.pdf2022-11-07 22:59 128K 
[ ]11984_comparative-effectiveness-clinical-trials-psychiatry.pdf2022-11-07 22:33 316K 
[ ]11985_comparative-effectiveness-study-risperidone-olanzapine.pdf2022-11-07 22:14 39K 
[ ]11986_comparative-effects-mirtazapine-fluoxetine-sleep-physiology.pdf2022-11-07 22:02 62K 
[ ]11987_comparative-efficacy-acceptability-tolerability-augmentation.pdf2022-11-07 22:25 2.0M 
[ ]11988_comparative-efficacy-risperidone-clozapine-treatment.pdf2022-11-07 23:00 66K 
[ ]11989_comparative-efficacy-ssris-amisulpride-burning-mouth.pdf2022-11-07 22:44 54K 
[ ]11990_comparative-efficacy-typical-atypical-antipsychotics.pdf2022-11-07 22:40 518K 
[ ]11991_comparative-prophylactic-efficacy-lithium-carbamazepine.pdf2022-11-07 22:16 60K 
[ ]11992_comparative-risk-of-antipsychotic-related-seizure.pdf2022-11-07 22:20 529K 
[ ]11993_comparative-study-online-suicide-related-information.pdf2022-11-07 23:00 229K 
[ ]11994_comparing-abuse-potential-methylphenidate-versus-stimulants.pdf2022-11-07 22:33 56K 
[ ]11995_comparing-acute-toxicity-second-generation-antipsychotic.pdf2022-11-07 22:33 227K 
[ ]11996_comparing-discontinuation-antipsychotics-clinical.pdf2022-11-07 23:00 172K 
[ ]11997_comparing-effectiveness-aripiprazole-quetiapine-schizophrenia.pdf2022-11-07 22:57 198K 
[ ]11998_comparing-efficacy-of-antipsychotic-drugs-in-schizophrenia.pdf2022-11-07 22:42 320K 
[ ]11999_comparing-efficacy-safety-fluoxetine-venlafaxine-outpatient.pdf2022-11-07 22:34 67K 
[ ]12000_comparing-impulsiveness-hostility-depression-borderline.pdf2022-11-07 22:23 186K 
[ ]12001_comparing-phenomenology-depressive-episodes-bipolar.pdf2022-11-07 22:49 307K 
[ ]12002_comparing-psychotherapy-pharmacotherapy-adult-depression.pdf2022-11-07 22:01 115K 
[ ]12003_comparing-rapidity-response-during-treatment-major.pdf2022-11-07 22:08 121K 
[ ]12004_comparing-rtms-devices-old-vs-new.pdf2022-11-07 22:35 275K 
[ ]12005_comparing-safety-efficacy-atypical-antipsychotics.pdf2022-11-07 22:52 262K 
[ ]12007_comparing-the-effectiveness-of-medications-for-ptsd.pdf2022-11-07 22:33 322K 
[ ]12009_comparison-antidepressant-between-subjects-bipolar.pdf2022-11-07 22:21 203K 
[ ]12010_comparison-between-effects-atypical-traditional-antipsychotics.pdf2022-11-07 22:26 98K 
[ ]12011_comparison-capacity-dsm-iv-dsm-acute-stress-disorder.pdf2022-11-07 22:38 226K 
[ ]12012_comparison-clinical-characteristics-comorbidity-schizophrenia.pdf2022-11-07 22:49 81K 
[ ]12013_comparison-effects-different-routes-antipsychotic.pdf2022-11-07 22:37 78K 
[ ]12014_comparison-effects-serotonin-norepinephrine-reuptake.pdf2022-11-07 22:33 422K 
[ ]12015_comparison-efficacy-medications-adult-attention-deficit-hyperactivity.pdf2022-11-07 22:42 433K 
[ ]12016_comparison-efficacy-safety-tolerability-divalproex.pdf2022-11-07 22:17 81K 
[ ]12017_comparison-initial-duloxetine-dosing-strategies-patients.pdf2022-11-07 23:02 188K 
[ ]12018_comparison-intramuscular-ziprasidone-olanzapine-aripiprazole.pdf2022-11-07 22:27 183K 
[ ]12019_comparison-longer-term-safety-effectiveness-atypical.pdf2022-11-07 22:01 355K 
[ ]12020_comparison-long-term-outcome-episode-schizophrenia.pdf2022-11-07 22:41 59K 
[ ]12021_comparison-managed-care-charges-among-patients-treated.pdf2022-11-07 22:09 49K 
[ ]12022_comparison-metabolic-syndrome-incidence-among-schizophrenia.pdf2022-11-07 22:27 176K 
[ ]12023_comparison-nefazodone-fluoxetine-mood-objective-subjective.pdf2022-11-07 22:19 55K 
[ ]12024_comparison-once-daily-divided-doses-modafinil-children.pdf2022-11-07 22:15 115K 
[ ]12025_comparison-persons-early-versus-late-onset-panic.pdf2022-11-07 22:08 64K 
[ ]12026_comparison-pharmacokinetic-profiles-brand-name-generic.pdf2022-11-07 22:32 402K 
[ ]12027_comparison-quetiapine-risperidone-treatment-schizophrenia.pdf2022-11-07 22:57 128K 
[ ]12028_comparison-rapid-cycling-nonrapid-cycling-bipolar.pdf2022-11-07 22:50 74K 
[ ]12029_comparison-rates-residual-insomnia-symptoms-following.pdf2022-11-07 22:19 167K 
[ ]12030_comparison-risperidone-olanzapine-control-negative.pdf2022-11-07 22:02 63K 
[ ]12031_comparison-risperidone-placebo-psychosis-behavioral.pdf2022-11-07 23:01 85K 
[ ]12032_comparison-selected-risk-factors-unipolar-depressive.pdf2022-11-07 23:00 227K 
[ ]12033_comparison-sexual-dysfunction-male-schizophrenic-patients.pdf2022-11-07 22:48 79K 
[ ]12034_comparison-study-body-dysmorphic-disorder-obsessive.pdf2022-11-07 22:21 54K 
[ ]12035_comparison-treatment-emergent-extrapyramidal-symptoms.pdf2022-11-07 22:42 105K 
[ ]12036_comparison-treatment-strategies-depressed-inpatients.pdf2022-11-07 22:08 45K 
[ ]12037_comparison-valproic-acid-lithium-mania.pdf2022-11-07 22:48 42K 
[ ]12038_comparison-venlafaxine-alone-versus-venlafaxine-plus.pdf2022-11-07 22:53 318K 
[ ]12039_comparison-weight-change-during-treatment-olanzapine.pdf2022-11-07 22:57 87K 
[ ]12040_comparison-women-confirmed-versus-presumably-misdiagnosed.pdf2022-11-07 22:23 253K 
[ ]12041_compensation-seeking-disability-injury-role-compensation.pdf2022-11-07 22:13 376K 
[ ]12042_compensatory-cognitive-training-psychosis-effects.pdf2022-11-07 22:44 638K 
[ ]12043_competency-combining-pharmacotherapy-psychotherapy.pdf2022-11-07 22:14 100K 
[ ]12044_complementary-alternative-medicine-cam-considerations.pdf2022-11-07 22:47 131K 
[ ]12045_complementary-alternative-medicine-major-depressive.pdf2022-11-07 22:04 303K 
[ ]12046_complementary-alternative-medicine-major-depressive-disorder-APA-task-force-report.pdf2022-11-07 22:48 408K 
[ ]12047_complementary-alternative-medicine-psychiatry.pdf2022-11-07 23:03 100K 
[ ]12048_complementary-alternative-treatments-late-life-depression.pdf2022-11-07 22:32 249K 
[ ]12049_completed-attempted-suicides-among-subjects-schizophrenia.pdf2022-11-07 22:50 356K 
[ ]12050_complex-chemical-concoctions.pdf2022-11-07 22:48 58K 
[ ]12051_complexity-pharmacologic-treatment-required-sustained.pdf2022-11-07 22:58 368K 
[ ]12052_complex-trauma-among-psychiatrically-impaired-children.pdf2022-11-07 22:48 386K 
[ ]12053_compliance-antidepressants-primary-care-setting-beyond.pdf2022-11-07 22:26 48K 
[ ]12054_compliance-antidepressants-primary-care-setting-influence.pdf2022-11-07 23:01 60K 
[ ]12055_compliance-rehabilitation-alliance.pdf2022-11-07 23:03 48K 
[ ]12056_compliance-schizophrenia-psychopathology-side-effects.pdf2022-11-07 22:17 72K 
[ ]12057_complicated-grief-correlates-patients-bipolar-disorder.pdf2022-11-07 22:44 142K 
[ ]12058_complications-risperidone-treatment-before-throughout.pdf2022-11-07 22:35 64K 
[ ]12060_comprehensive-approach-tobacco-cessation-homeless.pdf2022-11-07 22:50 131K 
[ ]12061_comprehensive-care-schizophrenia-textbook-clinical-book-review.pdf2022-11-07 22:40 45K 
[ ]12062_comprehensive-care-schizophrenia-textbook-clinical-second-edition-book-review.pdf2022-11-07 22:29 84K 
[ ]12063_comprehensive-textbook-suicidology.pdf2022-11-07 22:17 55K 
[ ]12064_computer-algorithm-calculating-adequacy-antidepressant.pdf2022-11-07 22:37 83K 
[ ]12065_computer-assisted-cbt-for-depression.pdf2025-02-17 17:11 905K 
[ ]12066_computer-assisted-self-assessment-persons-severe-mental.pdf2022-11-07 22:52 74K 
[ ]12067_computer-interviews-depression-management.pdf2022-11-07 22:19 99K 
[ ]12068_computerized-adaptive-diagnostic-test-major-depressive.pdf2022-11-07 22:36 341K 
[ ]12069_computerized-adaptive-test-suicide-scale.pdf2022-11-07 22:37 399K 
[ ]12071_concept-psychiatry-pluralistic-approach-mind-mental.pdf2022-11-07 22:23 66K 
[ ]12072_conceptual-evolution-ltemgtdsm-ltemgt.pdf2022-11-07 22:41 96K 
[ ]12073_concise-associated-symptoms-tracking-scale-brief-self.pdf2022-11-07 22:30 483K 
[ ]12074_concise-guide-anxiety-disorders.pdf2022-11-07 22:05 41K 
[ ]12075_concise-guide-child-adolescent-psychiatry-third-edition.pdf2022-11-07 22:09 82K 
[ ]12076_concise-guide-computers-clinical-psychiatry.pdf2022-11-07 22:51 44K 
[ ]12077_concise-guide-evaluation-management-sleep-disorders.pdf2022-11-07 22:13 35K 
[ ]12078_concise-guide-geriatic-psychiatry-rd-ed.pdf2022-11-07 22:06 60K 
[ ]12079_concise-guide-managing-behavioral-health-care-within.pdf2022-11-07 22:28 42K 
[ ]12080_concise-guide-psychiatric-interview-children-adolescents.pdf2022-11-07 22:21 34K 
[ ]12081_concise-guide-psychiatry-law-clinicians-rd-ed.pdf2022-11-07 22:55 46K 
[ ]12082_concise-guide-psychodynamic-psychotherapy-principles.pdf2022-11-07 22:41 104K 
[ ]12083_concise-guide-psychopharmacology.pdf2022-11-07 22:12 42K 
[ ]12084_concise-health-risk-tracking-scale-brief-self-report.pdf2022-11-07 23:00 336K 
[ ]12085_concluding-discussion-clinical-management-depression.pdf2022-11-07 22:15 49K 
[ ]12086_concluding-discussion-metabolic-disturbances-associated.pdf2022-11-07 22:16 27K 
[ ]12087_concluding-discussion-schizophrenia-outcomes.pdf2022-11-07 22:38 22K 
[ ]12088_concluding-remarks.pdf2022-11-07 22:31 9.8K 
[ ]12089_conclusion.pdf2022-11-07 22:52 10K 
[ ]12090_conclusioncomparsion-bieoquvalence-generic-versus.pdf2022-11-07 22:26 38K 
[ ]12091_conclusiondepression-subtypes-treatment-update.pdf2022-11-07 22:18 17K 
[ ]12092_conclusions-bipolar-disorder-origin-recognition-treatment.pdf2022-11-07 22:23 29K 
[ ]12093_conclusions-cardiovascular-disease-metabolic-risk-factors-antipsychotics.pdf2022-11-07 22:17 123K 
[ ]12094_conclusions-learning-patients-key-issues-clinical.pdf2022-11-07 22:37 25K 
[ ]12095_conclusions-side-effects-antipsychotics-patient-compliance.pdf2022-11-07 22:16 27K 
[ ]12096_concomitant-medications-may-improve-outcome-antipsychotic.pdf2022-11-07 22:34 76K 
[ ]12097_conducting-insanity-evaluations-nd-ed.pdf2022-11-07 22:02 35K 
[ ]12098_confidence-iron-dome-missile-defense-system-combined.pdf2022-11-07 22:50 380K 
[ ]12099_congenital-malformations-associated-with-antiepileptic-drugs.pdf2022-11-07 22:44 295K 
[ ]12100_consensus-development-conference-antipsychotic-drugs.pdf2022-11-07 22:39 140K 
[ ]12101_consensus-discussion-medical-interventions-suicide-genetics-depression-CNS-pathways-screening-risk.pdf2022-11-07 22:22 30K 
[ ]12102_consensus-discussion-pharmacoeconomics-treatment-resistant-schizophrenia.pdf2022-11-07 22:54 30K 
[ ]12103_consensus-guidelines-treatment-major-depressive-disorder.pdf2022-11-07 22:35 165K 
[ ]12104_consensus-on-monitoring-blood-antipsychotic-levels.pdf2022-11-07 22:44 471K 
[ ]12105_consensus-recommendations-for-applying-rtms-in-mdd.pdf2022-11-07 22:20 556K 
[ ]12106_consensus-recommendations-for-assessing-suicidal-ideation-and-behavior.pdf2022-11-07 22:21 835K 
[ ]12107_consensus-recommendations-rtms-depression-entirely.pdf2022-11-07 22:33 149K 
[ ]12108_consensus-statement-benefit-community-esemed-european.pdf2022-11-07 22:33 175K 
[ ]12109_consensus-statement-consensus-development-conference.pdf2022-11-07 22:21 605K 
[ ]12110_consensus-statement-depression-anxiety-cardiovascular.pdf2022-11-07 22:09 46K 
[ ]12111_consensus-statement-depression-anxiety-functional.pdf2022-11-07 22:39 41K 
[ ]12112_consensus-statement-depression-anxiety-oncology.pdf2022-11-07 22:24 44K 
[ ]12113_consensus-statement-generalized-anxiety-disorder-international.pdf2022-11-07 23:02 53K 
[ ]12114_consensus-statement-panic-disorder-international-consensus.pdf2022-11-07 22:44 49K 
[ ]12115_consensus-statement-posttraumatic-stress-disorder.pdf2022-11-07 22:28 55K 
[ ]12116_consensus-statement-primary-care-management-depression.pdf2022-11-07 23:00 65K 
[ ]12117_consensus-statement-research-needs-role-dopamine-norepinephrine.pdf2022-11-07 22:40 67K 
[ ]12118_consensus-statement-transcultural-issues-depression.pdf2022-11-07 22:46 67K 
[ ]12119_consensus-statement-update-posttraumatic-stress-disorder.pdf2022-11-07 22:04 73K 
[ ]12120_consequences-insomnia-therapies.pdf2022-11-07 22:27 51K 
[ ]12122_considering-a-study-on-arbs-and-suicide-risk.pdf2022-11-07 22:35 289K 
[ ]12124_considering-complexity-treatment-response-psychiatric.pdf2022-11-07 22:08 88K 
[ ]12125_constitutes-evidence-based-pharmacotherapy-bipolar-disorder-part-1-first-line-treatments.pdf2022-11-07 22:35 61K 
[ ]12126_constitutes-evidence-based-pharmacotherapy-bipolar-disorder-part-2-complex-presentations-clinical-co.pdf2022-11-07 22:32 82K 
[ ]12127_consumer-perspective-diagnosis-treatment-chronic-major.pdf2022-11-07 22:51 45K 
[ ]12128_contagion.pdf2022-11-07 23:00 41K 
[ ]12129_contemporary-issues-treatment-alzheimers-disease-tangible.pdf2022-11-07 22:06 123K 
[ ]12130_contemporary-management-comorbid-anxiety-depression.pdf2022-11-07 22:05 57K 
[ ]12131_contemporary-psychoanalysis-america-leading-analysts.pdf2022-11-07 22:19 72K 
[ ]12132_contesting-psychiatry-social-movements-mental-health.pdf2022-11-07 22:27 99K 
[ ]12133_contingency-management-substance-abuse-treatment.pdf2022-11-07 22:15 97K 
[ ]12134_continuation-maintenance-pharmacotherapy-geriatric.pdf2022-11-07 22:40 61K 
[ ]12135_continuation-quetiapine-versus-switching-placebo-lithium.pdf2022-11-07 22:23 645K 
[ ]12136_continued-cannabis-outcome-episode-psychosis-data.pdf2022-11-07 22:11 281K 
[ ]12137_continuing-dialogue-incentive-bias.pdf2022-11-07 22:30 45K 
[ ]12138_continuing-problem-extrapyramidal-symptoms-strategies.pdf2022-11-07 23:00 56K 
[ ]12139_continuity-between-dsm-obsessive-compulsive-personality.pdf2022-11-07 22:53 445K 
[ ]12140_continuity-care-inpatient-discharge-patients-schizophrenia.pdf2022-11-07 22:50 277K 
[ ]12141_continuity-is-main-challenge-treating-major-depressive.pdf2022-11-07 22:17 149K 
[ ]12142_continuous-care-for-schizophrenia.pdf2022-11-07 22:15 395K 
[ ]12143_continuum-hypothesis-mood-disorders.pdf2022-11-07 22:26 204K 
[ ]12144_controlled-clinical-treatment-trial-interpersonal.pdf2022-11-07 22:17 375K 
[ ]12145_controlled-double-blind-trial-phenytoin-vs-fluoxetine.pdf2022-11-07 22:50 99K 
[ ]12146_controlled-prospective-trial-citalopram-treatment.pdf2022-11-07 22:17 50K 
[ ]12147_controlled-release-paroxetine-treatment-patients-social.pdf2022-11-07 22:58 71K 
[ ]12148_controlled-trial-methylphenidate-transdermal-system.pdf2022-11-07 22:36 341K 
[ ]12149_controversial-issues-child-psychiatry.pdf2022-11-07 22:58 128K 
[ ]12150_controversies-diagnosis-treatment-severe-depression.pdf2022-11-07 22:42 57K 
[ ]12152_conventional-antipsychotic-prescription-unipolar-depression-part-1-audit-recommendations-practice.pdf2022-11-07 23:03 66K 
[ ]12153_conventional-antipsychotic-prescription-unipolar-nonpsychotic-patients.pdf2022-11-07 23:02 59K 
[ ]12154_conventional-atypical-antipsychotics-risk-femur-fracture.pdf2022-11-07 22:56 151K 
[ ]12155_conventional-atypical-combination-antipsychotic-prescriptions.pdf2022-11-07 22:30 65K 
[ ]12156_co-occuring-bipolar-disorder-and-ptsd.pdf2022-11-07 22:49 295K 
[ ]12157_co-occurrence-binge-eating-disorder-psychiatric-medical.pdf2022-11-07 22:46 226K 
[ ]12158_co-occurrence-major-depressive-episode-posttraumatic.pdf2022-11-07 22:04 251K 
[ ]12159_co-occurrence-serious-undiagnosed-medical-conditions.pdf2022-11-07 22:29 220K 
[ ]12160_coping-and-defenses-during-the-covid-pandemic.pdf2022-11-07 22:05 115K 
[ ]12162_coping-trauma-guide-self-understanding.pdf2022-11-07 22:11 36K 
[ ]12163_coprescription-of-opioids-and-benzodiazepines.pdf2022-11-07 22:29 256K 
[ ]12164_core-competencies-psychiatric-practice-clinicians.pdf2022-11-07 22:08 30K 
[ ]12165_corpus-callosum-dysplasia-adult-attention-deficit-hyperactivity.pdf2022-11-07 23:01 140K 
[ ]12166_correction-academic-highlights-roadmap-key-pharmacologic-principles-antipsychotics-older-patients.pdf2022-11-07 22:05 124K 
[ ]12167_correction-aripiprazole-QTc-case.pdf2022-11-07 22:11 58K 
[ ]12168_correction-challenges-solutions-new-medications-schizophrenia.pdf2022-11-07 22:44 67K 
[ ]12169_correction-clinical-cognitive-correlates-suicide-attempts-bipolar-disorder.pdf2022-11-07 22:54 130K 
[ ]12170_correction-clonidine-dose-tourette.pdf2022-11-07 22:01 44K 
[ ]12172_correction-exploratory-analyses-efficacy-data-major-depressive-disorder-FDA-new-drug-applications.pdf2022-11-07 22:04 244K 
[ ]12173_correction-familiality-pediatric-bipolar-1-disorder-meta-analysis.pdf2022-11-07 22:27 107K 
[ ]12174_correction-long-term-outcome-adolescent-depression-resistant-SSRI-TORDIA.pdf2022-11-07 22:37 63K 
[ ]12175_correction-nocturnal-wakefulness-next-day-suicidal-ideation-major-depressive-disoder-bipolar.pdf2022-11-07 22:17 69K 
[ ]12176_correction-oral-ketamine-depression-review.pdf2022-11-07 22:45 63K 
[ ]12177_correction-postprandial-oxytocin-anxiety-depression-severity-anorexia.pdf2022-11-07 22:05 105K 
[ ]12178_correction-prevalence-negative-symptoms-outpatients-schizophrenia-antipsychotics-clinical-practice-C.pdf2022-11-07 22:38 110K 
[ ]12179_correction-prolonged-grief-disorder-RCT.pdf2022-11-07 22:17 65K 
[ ]12180_correction-randomized-double-blind-placebo-controlled-schizophrenia-smoking-cessation.pdf2022-11-07 22:25 79K 
[ ]12181_correction-real-world-outcomes-paliperidone-palmitate-schizophrenia.pdf2022-11-07 22:08 63K 
[ ]12182_correction-reduction-alcohol-drinking-young-adults-naltrexone-RCT.pdf2022-11-07 22:25 63K 
[ ]12183_correction-residual-symptoms-major-depressive-disorder.pdf2022-11-07 22:23 68K 
[ ]12184_corrections-august-2011.pdf2022-11-07 22:35 115K 
[ ]12185_corrections-empirical-examination-DSM-IV-PTSD-criteria-antidepressant-trials-proof-of-concept.pdf2022-11-07 22:32 161K 
[ ]12186_correction-september-2016.pdf2022-11-07 22:29 62K 
[ ]12187_corrections-january-2010.pdf2022-11-07 22:29 409K 
[ ]12188_corrections-pegylated-interferon-ribavirin-induced-depression-chronic-hepatitis-C-role-personality.pdf2022-11-07 23:02 408K 
[ ]12189_corrections-symbol-dropouts-4-articles-publishing-error.pdf2022-11-07 22:47 42K 
[ ]12190_correction-sublingual-ketamine-option-accessibility-depression.pdf2022-11-07 23:01 62K 
[ ]12191_correction-suicide-risk-hospital-expert-system-based-triage-tool.pdf2022-11-07 22:46 61K 
[ ]12192_correlates-anticholinergic-activity-patients-dementia.pdf2022-11-07 22:19 67K 
[ ]12193_correlates-historical-suicide-attempt-rapid-cycling.pdf2022-11-07 22:23 289K 
[ ]12194_correlates-incident-bipolar-disorder-children-adolescents.pdf2022-11-07 22:11 285K 
[ ]12195_correlates-overweight-obesity-patients-bipolar-disorder.pdf2022-11-07 22:14 70K 
[ ]12196_correlates-suicidal-behavior-lithium-treatment-bipolar.pdf2022-11-07 22:26 58K 
[ ]12197_correlation-between-different-levels-placebo-response.pdf2022-11-07 23:03 377K 
[ ]12198_correlation-clinical-response-homocysteine-reduction.pdf2022-11-07 22:53 208K 
[ ]12199_cortical-stimulation-prefrontal-cortex-transcranial.pdf2022-11-07 22:12 260K 
[ ]12200_cortical-subcortical-dissociation-in-bipolar-disorder.pdf2022-11-07 22:23 1.5M 
[ ]12201_cortical-thickness-change-during-donepezil-treatment-in-suspected-prodromal-alzheimers-disease.pdf2022-11-07 22:36 1.8M 
[ ]12202_corticotropin-releasing-factor-interleukin-brain.pdf2022-11-07 22:39 195K 
[ ]12203_cortisol-and-bdnf-levels-in-children-with-ocd.pdf2022-11-07 22:59 229K 
[ ]12204_cost-consequences-treatment-resistant-depression.pdf2022-11-07 22:05 58K 
[ ]12205_cost-cost-effectiveness-randomized-trial-long-acting-risperidone-schizophrenia-VA-schizophrenia-prac.pdf2022-11-07 22:57 281K 
[ ]12206_cost-effectiveness-divalproex-versus-lithium.pdf2022-11-07 22:34 43K 
[ ]12208_cost-effectiveness-month-therapeutic-assertive-community.pdf2022-11-07 22:04 334K 
[ ]12209_cost-effectiveness-newer-antidepressants.pdf2022-11-07 22:09 122K 
[ ]12210_cost-effectiveness-of-internet-based-cbt.pdf2022-11-07 22:24 861K 
[ ]12211_cost-effectiveness-of-next-step-depression-treatment-strategies.pdf2022-11-07 22:16 954K 
[ ]12212_cost-effectiveness-of-psychotherapy-via-telehealth.pdf2022-11-07 23:02 254K 
[ ]12213_cost-effectiveness-of-treatments-for-ocd-in-adults.pdf2022-11-07 22:43 413K 
[ ]12214_cost-effectiveness-prolonged-exposure-therapy-versus.pdf2022-11-07 22:41 566K 
[ ]12215_cost-effectiveness-psychotherapy-cluster-c-personality.pdf2022-11-07 22:57 1.0M 
[ ]12217_cost-effectiveness-smoking-cessation-treatment-initiated.pdf2022-11-07 22:11 647K 
[ ]12218_cost-efficacy-individual-combined-treatments-panic.pdf2022-11-07 22:52 177K 
[ ]12219_cost-outcome-implications-using-typical-atypical-antipsychotics.pdf2022-11-07 22:52 59K 
[ ]12220_cost-outcome-methods-mental-health.pdf2022-11-07 22:26 39K 
[ ]12221_cost-reductions-associated-long-acting-injectable.pdf2022-11-07 22:02 161K 
[ ]12222_cost-restricting-knowledge.pdf2022-11-07 22:08 190K 
[ ]12223_cost-savings-intramuscular-anticholinergics.pdf2022-11-07 22:48 48K 
[ ]12224_cost-savings-nefazodone-treating-depression.pdf2022-11-07 22:40 56K 
[ ]12225_costs-depression-direct-indirect-treatment-versus.pdf2022-11-07 22:57 34K 
[ ]12226_costs-schizophrenia.pdf2022-11-07 22:32 94K 
[ ]12227_costs-second-line-therapies-depression.pdf2022-11-07 22:44 76K 
[ ]12228_cost-treating-mental-illness-managed-care-perspective.pdf2022-11-07 22:50 45K 
[ ]12229_cost-treatment-placebo-effect-psychopharmacology-importance.pdf2022-11-07 22:31 334K 
[ ]12230_cost-utility-analysis-schizophrenia.pdf2022-11-07 22:38 49K 
[ ]12231_countertransference-issues-psychiatric-treatment-review.pdf2022-11-07 22:19 44K 
[ ]12232_course-and-predictors-of-postdeployment-fatigue.pdf2022-11-07 23:00 214K 
[ ]12233_course-chronic-pain-without-psychiatric-disorders.pdf2022-11-07 22:47 298K 
[ ]12235_course-major-depressive-disorder-suicide-outcome-psychological.pdf2022-11-07 22:52 154K 
[ ]12236_course-mood-anxiety-disorders-during-pregnancy-postpartum.pdf2022-11-07 22:56 32K 
[ ]12237_course-of-schizophrenia-with-alcohol-use-disorder.pdf2022-11-07 22:19 383K 
[ ]12238_course-predictors-outcome-adolescent-depression.pdf2022-11-07 22:15 279K 
[ ]12239_course-psychiatric-substance-abuse-syndromes-co-occurring.pdf2022-11-07 23:02 45K 
[ ]12240_course-trajectories-anxiety-disorders-dsm-classifications.pdf2022-11-07 22:09 425K 
[ ]12241_course-treatment-atypical-depression.pdf2022-11-07 22:31 29K 
[ ]12242_covid-diary-from-a-psychiatry-department-in-italy.pdf2022-11-07 22:05 106K 
[ ]12243_covid-from-a-psychiatry-perspective.pdf2022-11-07 22:57 310K 
[ ]12244_covid-humanitarian-and-health-care-crisis-in-a-third-world-country.pdf2022-11-07 22:04 265K 
[ ]12245_covid-mental-health-and-suicide-risk-among-health-care-workers.pdf2022-11-07 22:09 113K 
[ ]12246_crack-cocaine-use-in-adolescents.pdf2022-11-07 23:02 224K 
[ ]12247_c-reactive-protein-alterations-bipolar-disorder-meta.pdf2022-11-07 23:03 414K 
[ ]12248_creating-health-care-team-manage-chronic-medical-illnesses.pdf2022-11-07 22:56 207K 
[ ]12249_creatinine-clearance-estimation-package-inserts-and-therapeutic-drug-monitoring.pdf2022-11-07 22:12 117K 
[ ]12250_creation-psychopharmacology.pdf2022-11-07 22:07 51K 
[ ]12251_crest-for-hoarding-disorder-in-older-adults.pdf2022-11-07 22:54 298K 
[ ]12254_critical-examination-studies-curcumin-depression.pdf2022-11-07 22:22 458K 
[ ]12255_critical-issues-treatment-schizophrenia.pdf2022-11-07 22:15 60K 
[ ]12256_critical-overview-adverse-cutaneous-reactions-psychotropic.pdf2022-11-07 22:08 212K 
[ ]12257_critical-review-selective-serotonin-reuptake-inhibitorassociated.pdf2022-11-07 22:56 67K 
[ ]12258_crossover-study-prolactin-changes-associated-risperidone.pdf2022-11-07 22:09 88K 
[ ]12260_cross-sectional-evaluation-effect-risperidone-selective.pdf2022-11-07 22:21 715K 
[ ]12261_cross-sectional-evaluation-perimenopausal-depression.pdf2022-11-07 22:13 230K 
[ ]12262_cross-sectional-study-patients-perspectives-adherence.pdf2022-11-07 22:52 250K 
[ ]12263_cross-sectional-study-plasma-risperidone-levels-risperidone.pdf2022-11-07 22:37 262K 
[ ]12264_cross-sectional-study-prevalence-cognitive-physical.pdf2022-11-07 22:22 248K 
[ ]12265_cross-sectional-study-prevalences-psychiatric-disorders.pdf2022-11-07 22:19 210K 
[ ]12266_cross-sectional-study-problem-pathological-gambling.pdf2022-11-07 22:03 337K 
[ ]12267_cross-sectional-study-vitamin-d-deficiency-among-immigrants.pdf2022-11-07 22:33 255K 
[ ]12268_csf-monoamine-metabolites-and-depression.pdf2022-11-07 22:21 539K 
[ ]12270_cultural-assement-clinical-psychiatry-gap-report.pdf2022-11-07 22:10 36K 
[ ]12271_cultural-background-barriers-mental-health-care-african.pdf2022-11-07 22:23 259K 
[ ]12272_cultural-competence-clinical-psychopharmacology.pdf2022-11-07 22:25 37K 
[ ]12273_cultural-competence-health-care-guide-professionals.pdf2022-11-07 22:20 88K 
[ ]12274_cultural-contradictions-motherhood.pdf2022-11-07 22:15 44K 
[ ]12278_culturally-competent-strategies-assessing-treating.pdf2022-11-07 22:42 261K 
[ ]12279_cultural-psychiatry-euro-international-perspectives.pdf2022-11-07 22:47 35K 
[ ]12280_cultural-sensitivity-making-trauma-assessment-treatment.pdf2022-11-07 22:33 78K 
[ ]12281_cultural-variations-clinical-presentation-depression.pdf2022-11-07 22:46 63K 
[ ]12282_culture-psychotherapy-guide-clinical-practice.pdf2022-11-07 22:37 46K 
[ ]12283_current-comorbidity-psychiatric-disorders-among-dsm.pdf2022-11-07 22:07 98K 
[ ]12284_current-concepts-treatment-panic-disorder.pdf2022-11-07 22:45 60K 
[ ]12285_current-diagnosis-treatment-psychiatry.pdf2022-11-07 22:15 36K 
[ ]12286_current-diagnosis-treatment-psychiatry-nd-ed.pdf2022-11-07 22:50 733K 
[ ]12288_current-prescription-patterns-safety-profile-irreversible.pdf2022-11-07 22:15 326K 
[ ]12289_current-remitted-depression-anxiety-disorders-risk.pdf2022-11-07 22:25 1.0M 
[ ]12291_current-status-psychotherapeutic-interventions-social.pdf2022-11-07 22:02 65K 
[ ]12292_current-treatments-alzheimers-disease-cholinesterase.pdf2022-11-07 22:20 77K 
[ ]12293_current-understanding-lamotrigine-mood-stabilizer.pdf2022-11-07 22:20 101K 
[ ]12294_cursing-brain-histories-tourette-syndrome.pdf2022-11-07 22:41 55K 
[ ]12295_customized-adherence-enhancement-for-bipolar-disorder.pdf2022-11-07 22:06 350K 
[ ]12296_cutaneous-adverse-reactions-psychotropic-drugs-data.pdf2022-11-07 22:41 646K 
[ ]12297_cutaneous-reactions-anticonvulsant-medications.pdf2022-11-07 22:08 75K 
[ ]12298_cyberbullying-and-adolescent-mental-health.pdf2022-11-07 22:41 227K 
[ ]12299_cypd-genotype-information-guide-pimozide-treatment.pdf2022-11-07 22:51 284K 
[ ]12300_cypd-poor-metabolizer-phenotype-may-associated-risperidone.pdf2022-11-07 23:02 272K 
[ ]12301_cytochrome-p-d-phenoconversion-is-common-patients.pdf2022-11-07 22:22 360K 
[ ]12302_cytochrome-p-d-phenotype-predicts-antidepressant-efficacy.pdf2022-11-07 22:25 265K 
[ ]12303_cytochrome-p-d-polymorphism-impact-decision-making.pdf2022-11-07 22:16 268K 
[ ]12304_cytokines-mark-poor-antidepressant-response.pdf2022-11-07 22:44 377K 
[ ]12305_dangerous-sex-offenders-task-force-american-psychiatric.pdf2022-11-07 22:16 44K 
[ ]12306_database-studies-and-the-pitfall-of-imputing-complex-clinical-causality.pdf2022-11-07 22:10 117K 
[ ]12307_data-inform-riskbenefit-analysis-antenatal-depression.pdf2022-11-07 22:34 65K 
[ ]12308_dawn-simulation-treatment-abstinent-alcoholics-winter.pdf2022-11-07 22:03 52K 
[ ]12309_days.pdf2022-11-07 22:31 40K 
[ ]12310_daytime-impactof-ltemgtdsm-ltemgt-insomnia-disorder.pdf2022-11-07 23:02 292K 
[ ]12311_daytime-sleepiness-insomnia-correlates-depression.pdf2022-11-07 22:22 61K 
[ ]12312_dbt-in-high-risk-suicidal-veterans.pdf2022-11-07 22:54 460K 
[ ]12313_d-cycloserine-facilitation-exposure-therapy-improves.pdf2022-11-07 22:03 313K 
[ ]12314_d-cycloserine-in-exposure-therapy.pdf2022-11-07 22:49 432K 
[ ]12315_death-buddha.pdf2022-11-07 23:01 42K 
[ ]12316_deaths-in-borderline-personality-disorder-patients.pdf2022-11-07 22:43 269K 
[ ]12317_debate-discussion-antidepressants-faster-onset-action.pdf2022-11-07 22:08 41K 
[ ]12318_debate-discussion-treatment-depression-does-selectivity.pdf2022-11-07 22:45 29K 
[ ]12319_decisional-capacity-consent-research-among-patients.pdf2022-11-07 22:58 201K 
[ ]12320_decisionally-capable-individuals-determined-to-die.pdf2022-11-07 22:52 215K 
[ ]12321_decision-analysis-approach-neuroleptic-dosing-insights.pdf2022-11-07 22:51 136K 
[ ]12322_decision-is-without-risk.pdf2022-11-07 22:36 319K 
[ ]12323_decision-making-competence-attempted-suicide.pdf2022-11-07 22:40 1.4M 
[ ]12324_decision-tree-treatment-bipolar-disorder.pdf2022-11-07 22:03 57K 
[ ]12325_declining-benzodiazepine-veterans-posttraumatic-stress.pdf2022-11-07 22:52 252K 
[ ]12326_deconstructing-psychiatric-disorders-part-emerging.pdf2022-11-07 22:29 41K 
[ ]12327_deconstructing-psychiatric-disorders-part-genotypes.pdf2022-11-07 22:14 34K 
[ ]12328_decreased-lipoprotein-lipase-risk-factor-atypical.pdf2022-11-07 22:42 221K 
[ ]12329_decreased-nocturnal-oxytocin-levels-anorexia-nervosa.pdf2022-11-07 22:49 387K 
[ ]12330_deep-brain-stimulation-in-refractory-ocd.pdf2022-11-07 22:34 428K 
[ ]12333_defining-achieving-recovery-bipolar-disorder.pdf2022-11-07 22:24 83K 
[ ]12335_defining-improving-response-treatment-patients-bipolar.pdf2022-11-07 22:30 56K 
[ ]12336_defining-managing-suicidal-risk-patients-taking-psychotropic.pdf2022-11-07 23:02 233K 
[ ]12337_defining-psychopathology-st-centurt-dsm-v-beyond.pdf2022-11-07 23:01 42K 
[ ]12338_defining-psychosis-ptsd.pdf2022-11-07 22:36 67K 
[ ]12339_defining-remission-montgomery-asberg-depression-rating.pdf2022-11-07 22:18 59K 
[ ]12340_defining-response-clinical-trials-obsessive-compulsive.pdf2022-11-07 22:21 192K 
[ ]12342_definition-meaning-treatment-resistant-depression.pdf2022-11-07 22:46 62K 
[ ]12343_definition-psychological-trauma-threshold-functional.pdf2022-11-07 22:04 152K 
[ ]12344_definitions-antidepressant-treatment-response-remission.pdf2022-11-07 22:42 51K 
[ ]12345_delayed-drug-interactions-psychiatry-armodafinil-risperidone.pdf2022-11-07 22:38 261K 
[ ]12346_delayed-posttraumatic-stress-disorder-systematic-review.pdf2022-11-07 22:45 500K 
[ ]12347_delayed-remission-after-antidepressant-treatment.pdf2022-11-07 23:01 1.0M 
[ ]12348_delayed-sleep-phase-syndrome-adhd-bright-light-therapy.pdf2022-11-07 23:02 153K 
[ ]12349_deliberate-self-harm-young-characteristics-subsequent.pdf2022-11-07 22:32 254K 
[ ]12350_deliberate-self-poisoning-following-fluvoxamine-neuroleptics.pdf2022-11-07 22:50 35K 
[ ]12351_deliberate-self-poisoning-prescribed-drugs-is-related.pdf2022-11-07 22:09 102K 
[ ]12352_delirium-and-polypharmacy.pdf2022-11-07 22:38 759K 
[ ]12353_delirium-caused-donepezil-case-study.pdf2022-11-07 22:42 75K 
[ ]12354_delirium-manic-symptoms-induced-diet-pills.pdf2022-11-07 22:07 100K 
[ ]12355_delirium-preventive-effects-of-suvorexant-in-real-world-settings.pdf2022-11-07 22:37 303K 
[ ]12356_delta-tetrahydrocannabinol-thc-is-effective-treatment.pdf2022-11-07 22:57 94K 
[ ]12357_delusionality-response-open-label-fluvoxamine-body.pdf2022-11-07 22:40 63K 
[ ]12358_delusional-jealousy-dementia.pdf2022-11-07 22:16 25K 
[ ]12359_delusions-associated-quetiapine-related-weight-redistribution.pdf2022-11-07 22:20 75K 
[ ]12360_dementia-in-older-antidepressant-treated-adults.pdf2022-11-07 22:45 135K 
[ ]12361_dementia-mind-meaning-person.pdf2022-11-07 22:13 101K 
[ ]12362_dementia-practical-guide.pdf2022-11-07 22:42 28K 
[ ]12364_demographic-clinical-characteristics-individuals-bipolar.pdf2022-11-07 22:27 70K 
[ ]12365_demographic-clinical-features-adult-pathological-gamblers.pdf2022-11-07 22:50 58K 
[ ]12366_demographic-economic-clinical-correlates-depression.pdf2022-11-07 22:40 464K 
[ ]12367_demo-trial-randomized-parallel-group-observer-blinded.pdf2022-11-07 22:51 326K 
[ ]12368_de-novo-emergence-obsessive-compulsive-symptoms-atypical.pdf2022-11-07 22:13 107K 
[ ]12369_depressed-parents-attachment-effects-offspring-suicidal.pdf2022-11-07 22:13 314K 
[ ]12370_depressed-patients-co-occurring-alcohol-disorders.pdf2022-11-07 22:48 252K 
[ ]12371_depressed-patients-respond-nefazodone.pdf2022-11-07 22:45 62K 
[ ]12372_depressed-subjects-failed-both-fluoxetine-tricyclic.pdf2022-11-07 22:48 24K 
[ ]12373_depression-addressing-partial-response-line-antidepressant.pdf2022-11-07 23:02 332K 
[ ]12374_depression-and-bone-mineral-density.pdf2022-11-07 22:28 211K 
[ ]12375_depression-anger-attacks.pdf2022-11-07 22:58 30K 
[ ]12376_depression-anxiety-cardiovascular-system-cardiologists.pdf2022-11-07 22:06 55K 
[ ]12377_depression-anxiety-cardiovascular-system-psychiatrists.pdf2022-11-07 22:57 58K 
[ ]12378_depression-anxiety-gastrointestinal-system.pdf2022-11-07 22:10 102K 
[ ]12379_depression-anxiety-oncology-oncologists-perspective.pdf2022-11-07 22:33 45K 
[ ]12380_depression-anxiety-oncology-psychiatrists-perspective.pdf2022-11-07 22:24 43K 
[ ]12381_depression-as-a-factor-in-nonadherence-in-schizophrenia.pdf2022-11-07 22:41 83K 
[ ]12382_depression-beget-obesity-beget-depression.pdf2022-11-07 22:23 139K 
[ ]12383_depression-cancer.pdf2022-11-07 22:07 75K 
[ ]12384_depression-case-monoamine-deficiency.pdf2022-11-07 22:46 49K 
[ ]12385_depression-cognition-and-functional-impairment.pdf2022-11-07 23:02 790K 
[ ]12386_depression-community-physician-patient-perspective.pdf2022-11-07 22:01 54K 
[ ]12387_depression-comorbidity-antidepressant-veterans-chronic.pdf2022-11-07 22:50 206K 
[ ]12388_depression-diabetes.pdf2022-11-07 23:00 143K 
[ ]12389_depression-diabetes-glycemic-control-american-indian.pdf2022-11-07 22:08 284K 
[ ]12390_depression-during-pegylated-interferon-alpha-plus.pdf2022-11-07 22:38 203K 
[ ]12391_depression-during-pregnancy-diagnosis-treatment-options.pdf2022-11-07 22:56 60K 
[ ]12392_depression-during-pregnancy-is-developmental-impact.pdf2022-11-07 22:19 371K 
[ ]12393_depression-during-pregnancy-puerperium.pdf2022-11-07 22:08 523K 
[ ]12394_depression-dysphoria-adult-adolescent-patients-tourettes.pdf2022-11-07 22:22 62K 
[ ]12396_depression-family-physicians-office-psychiatrist-needs.pdf2022-11-07 23:01 41K 
[ ]12397_depression-free-days-summary-measure-temporal-pattern.pdf2022-11-07 22:48 84K 
[ ]12398_depression-heart-disease.pdf2022-11-07 22:02 142K 
[ ]12399_depression-linked-to-high-crp-and-low-exhaled-nitric-oxide-levels.pdf2022-11-07 22:13 200K 
[ ]12400_depression-links-ischemic-heart-disease-erectile-dysfunction.pdf2022-11-07 22:11 53K 
[ ]12401_depression-managed-appropriately-primary-care.pdf2022-11-07 22:31 35K 
[ ]12402_depression-may-moderate-cognitive-decline.pdf2022-11-07 22:36 502K 
[ ]12403_depression-medical-setting-biopsychological-interactions.pdf2022-11-07 22:57 110K 
[ ]12404_depression-mood-disease-rd-ed.pdf2022-11-07 22:13 72K 
[ ]12405_depression-multimorbidity-cross-sectional-study-patients.pdf2022-11-07 22:18 1.3M 
[ ]12406_depression-multimorbidity-psychiatry-primary-care.pdf2022-11-07 22:30 131K 
[ ]12407_depression-obesity-metabolic-syndrome-prevalence-risks.pdf2022-11-07 22:21 235K 
[ ]12408_depression-older-adults-is-another-reason-worry.pdf2022-11-07 23:02 117K 
[ ]12409_depression-pain.pdf2022-11-07 22:46 290K 
[ ]12411_depression-physical-symptoms-mind-body-connection.pdf2022-11-07 22:38 87K 
[ ]12412_depression-physical-symptoms-treating-remission.pdf2022-11-07 22:40 62K 
[ ]12413_depression-physicians-hyperfunctioning-depression.pdf2022-11-07 23:00 83K 
[ ]12414_depression-population-during-periods-surrounding-great.pdf2022-11-07 22:23 232K 
[ ]12415_depression-precipitated-alcohol-patients-co-occurring.pdf2022-11-07 22:49 173K 
[ ]12416_depression-predicts-cognitive-disorders-older-primary.pdf2022-11-07 22:07 331K 
[ ]12417_depression-quality-life-patients-perspective.pdf2022-11-07 22:47 22K 
[ ]12418_depression-remission-on-scales.pdf2022-11-07 22:11 285K 
[ ]12419_depression-risk-factor-diabetes-meta-analysis-longitudinal.pdf2022-11-07 22:05 319K 
[ ]12420_depression-risk-nursing-home-admission-among-older.pdf2022-11-07 22:03 201K 
[ ]12421_depression-screening-intervention-against-suicide.pdf2022-11-07 22:07 46K 
[ ]12422_depression-screening-suicide-risk.pdf2022-11-07 22:46 22K 
[ ]12423_depression-severity-guide-treatment-selection-measures.pdf2022-11-07 22:06 203K 
[ ]12424_depression-sleep-antidepressants.pdf2022-11-07 22:42 85K 
[ ]12425_depression-smoking-cessation-case-reports.pdf2022-11-07 22:51 23K 
[ ]12426_depression-spiritual-modern-art-homage-mir.pdf2022-11-07 22:30 27K 
[ ]12427_depression-stroke-investigation-through-catamnesis.pdf2022-11-07 22:44 33K 
[ ]12428_depression-subtyping-treatment-implications.pdf2022-11-07 22:23 116K 
[ ]12430_depression-whats-sex-got.pdf2022-11-07 22:43 44K 
[ ]12431_depression-with-mixed-features.pdf2022-11-07 22:37 745K 
[ ]12432_depression-women-findings.pdf2022-11-07 22:30 116K 
[ ]12433_depressive-anxiety-disorders-predicting-incidence.pdf2022-11-07 22:16 393K 
[ ]12434_depressive-anxiety-symptoms-patients-schizophrenia.pdf2022-11-07 22:34 32K 
[ ]12435_depressive-disorders-are-related-nicotine-dependence.pdf2022-11-07 22:57 71K 
[ ]12436_depressive-illness-burden-associated-complex-polypharmacy.pdf2022-11-07 22:28 224K 
[ ]12437_depressive-markers-characterized-by-striatal-connectivity.pdf2022-11-07 22:09 1.5M 
[ ]12438_depressive-switch-in-patients-with-bipolar-i-disorder.pdf2022-11-07 22:06 227K 
[ ]12439_depressive-symptoms-and-telomere-length.pdf2022-11-07 22:10 238K 
[ ]12440_depressive-symptoms-following-stroke-transient-ischemic.pdf2022-11-07 22:42 345K 
[ ]12441_depressive-symptoms-healthy-apolipoprotein-e-carriers.pdf2022-11-07 22:40 313K 
[ ]12442_depressive-symptoms-suicidal-thoughts-among-former.pdf2022-11-07 22:40 178K 
[ ]12443_dermatology-precautions-slower-titration-yield-low.pdf2022-11-07 22:36 85K 
[ ]12444_design-interpretability-findings-family-study-investigate.pdf2022-11-07 22:16 47K 
[ ]12445_design-rationale-paliperidone-palmitate-research-demonstrating.pdf2022-11-07 22:08 335K 
[ ]12446_desvenlafaxine-mgd-versus-placebo-treatment-major.pdf2022-11-07 22:48 329K 
[ ]12447_detection-classification-suicidal-behavior-nonsuicidal.pdf2022-11-07 22:48 408K 
[ ]12448_detection-consequences-anxiety-clinical-depression.pdf2022-11-07 22:47 35K 
[ ]12449_detection-insomnia-primary-care.pdf2022-11-07 22:24 66K 
[ ]12450_detection-subclinical-depression-bipolar-disorder.pdf2022-11-07 22:35 99K 
[ ]12451_deterioration-cognitive-performance-aggressive-unilateral.pdf2022-11-07 22:08 76K 
[ ]12452_determinants-antipsychotic-response-schizophrenia.pdf2022-11-07 22:24 561K 
[ ]12453_determinants-overweight-obesity-patients-bipolar-disorder.pdf2022-11-07 22:40 70K 
[ ]12454_determinants-patient-rated-clinician-rated-illness.pdf2022-11-07 22:14 243K 
[ ]12455_determinants-pharmacologic-treatment-failure-panic.pdf2022-11-07 22:53 57K 
[ ]12456_determinants-poor-dental-care-patients-schizophrenia.pdf2022-11-07 22:01 164K 
[ ]12457_determinants-suicidal-ideation-role-substance-disorders.pdf2022-11-07 22:05 53K 
[ ]12458_determining-achieving-therapeutic-targets-attention.pdf2022-11-07 22:03 96K 
[ ]12459_developing-a-digital-medicine-system-in-psychiatry.pdf2022-11-07 22:55 1.0M 
[ ]12460_developing-brief-scales-clinical-practice-reliability.pdf2022-11-07 22:57 84K 
[ ]12461_developing-concepts-negative-symptoms-primary-vs-secondary.pdf2022-11-07 22:23 268K 
[ ]12462_developing-forensic-practice-operations-ethics-experts.pdf2022-11-07 22:07 85K 
[ ]12463_developing-individualized-treatment-plan-patients.pdf2022-11-07 22:53 400K 
[ ]12464_developing-item-mania-scale-parent-general-behavior.pdf2022-11-07 22:41 262K 
[ ]12465_developing-mind-toward-neurobiology-interpersonal.pdf2022-11-07 22:13 45K 
[ ]12466_developing-outcomes-oriented-approach-treatment-schizophrenia.pdf2022-11-07 22:33 53K 
[ ]12468_developing-treatment-guidelines-alzheimers-disease.pdf2022-11-07 22:05 75K 
[ ]12469_developmental-disabilities-childhood-adulthood-works.pdf2022-11-07 22:21 77K 
[ ]12470_developmental-outcomes-of-infants-of-mothers-with-bipolar-disorder.pdf2022-11-07 22:53 694K 
[ ]12471_developmental-pathways-different-subtypes-early-onset.pdf2022-11-07 22:42 249K 
[ ]12472_developmental-psychobiology.pdf2022-11-07 22:01 48K 
[ ]12473_developmental-psychopathology-wellness-genetic-environmental.pdf2022-11-07 22:36 106K 
[ ]12474_developmental-trauma-disorder-advancing-toward-an-empirically-based-diagnosis.pdf2022-11-07 22:56 573K 
[ ]12475_development-antidepressants.pdf2022-11-07 22:59 148K 
[ ]12476_development-atherogenic-metabolic-risk-factor-profile-associated-atypical-antipsychotics.pdf2022-11-07 22:57 67K 
[ ]12477_development-clonazepam-psychotropic-massachusetts.pdf2022-11-07 22:36 47K 
[ ]12478_development-depression-during-placebo-controlled-trials.pdf2022-11-07 22:42 57K 
[ ]12479_development-guidelines-preventing-managing-obesity.pdf2022-11-07 22:36 151K 
[ ]12480_development-major-depressive-disorder-during-smoking.pdf2022-11-07 22:06 32K 
[ ]12481_development-mania-carbamazepine-treatment-seizure.pdf2022-11-07 22:19 96K 
[ ]12482_development-ptsd-prevented-acute-trauma.pdf2022-11-07 22:01 106K 
[ ]12483_developments.pdf2022-11-07 22:57 82K 
[ ]12484_developments-addiction-treatment.pdf2022-11-07 22:59 154K 
[ ]12485_developments-antipsychotic-therapy.pdf2022-11-07 22:52 98K 
[ ]12486_developments-pediatric-psychopharmacology-focus-stimulants.pdf2022-11-07 22:12 730K 
[ ]12487_developments-treatment-adhd.pdf2022-11-07 22:43 141K 
[ ]12488_developments-treatment-alzheimers-disease.pdf2022-11-07 22:30 293K 
[ ]12489_developments-treatment-depression.pdf2022-11-07 22:19 56K 
[ ]12490_developments-treatment-obsessive-compulsive-disorder.pdf2022-11-07 22:47 912K 
[ ]12491_developments-treatment-schizophrenia.pdf2022-11-07 22:51 347K 
[ ]12492_development-study-exit-criteria-evaluating-antimanic.pdf2022-11-07 22:53 77K 
[ ]12493_development-subtle-psychotic-symptoms-memantine-case.pdf2022-11-07 22:46 117K 
[ ]12494_dexamethasone-suppression-test-patients-mood-disorders.pdf2022-11-07 22:45 112K 
[ ]12495_d-ht-receptor-effects-antipsychotics-bridging-basic.pdf2022-11-07 22:30 62K 
[ ]12496_diabetes-mellitus-among-outpatients-receiving-clozapine.pdf2022-11-07 22:24 149K 
[ ]12497_diabetes-mellitus-during-olanzapine-quetiapine-treatment.pdf2022-11-07 22:30 123K 
[ ]12498_diabetic-ketoacidosis-neuroleptic-malignant-syndrome.pdf2022-11-07 22:22 67K 
[ ]12501_diagnosing-attention-deficithyperactivity-disorder-chiuldren-pediatric.pdf2022-11-07 22:56 117K 
[ ]12502_diagnosing-attention-deficithyperactivity-disorder-substance-use-disorder.pdf2022-11-07 22:40 144K 
[ ]12504_diagnosing-bipolar-disorder-effect-antidepressants.pdf2022-11-07 22:22 66K 
[ ]12506_diagnosing-co-occurring-substance-related-disorders.pdf2022-11-07 22:07 186K 
[ ]12508_diagnosing-managing-complicated-adhd.pdf2022-11-07 22:12 160K 
[ ]12510_diagnosing-melancholia.pdf2022-11-07 22:20 54K 
[ ]12515_diagnosing-smartphone-addiction-with-an-app.pdf2022-11-07 22:04 294K 
[ ]12518_diagnosing-treating-comorbid-complicated-bipolar-disorder.pdf2022-11-07 22:06 83K 
[ ]12519_diagnosing-treating-depression-elderly.pdf2022-11-07 22:21 56K 
[ ]12521_diagnosis-classification-pathogenesis-diabetes-mellitus.pdf2022-11-07 22:50 82K 
[ ]12522_diagnosis-evaluation-pervasive-developmental-disorders.pdf2022-11-07 22:54 149K 
[ ]12525_diagnosis-management-bipolar-disorder-comorbid-anxiety.pdf2022-11-07 22:07 86K 
[ ]12526_diagnosis-management-patients-bipolar-ii-disorder.pdf2022-11-07 22:08 108K 
[ ]12529_diagnosis-right-assessment-treatment-selection-mental.pdf2022-11-07 22:15 128K 
[ ]12530_diagnosis-treatment-adhd-adults-primary-care.pdf2022-11-07 22:25 48K 
[ ]12531_diagnosis-treatment-alzheimers-disease.pdf2022-11-07 22:13 49K 
[ ]12532_diagnosis-treatment-bipolar-disorder-children-adolescents.pdf2022-11-07 22:46 55K 
[ ]12534_diagnosis-treatment-chronic-depression.pdf2022-11-07 22:42 30K 
[ ]12535_diagnosis-treatment-depression-late-life.pdf2022-11-07 22:29 72K 
[ ]12536_diagnosis-treatment-depression-patients-alzheimers.pdf2022-11-07 23:00 43K 
[ ]12538_diagnosis-treatment-premenstrual-dysphoria.pdf2022-11-07 22:21 71K 
[ ]12540_diagnosis-treatment-strategies-mixed-episodes-bipolar.pdf2022-11-07 22:01 299K 
[ ]12541_diagnosis-unipolar-depression-following-initial-identification.pdf2022-11-07 22:45 276K 
[ ]12542_diagnostic-assessment-child-adolescent-psychopathology.pdf2022-11-07 22:54 44K 
[ ]12544_diagnostic-challenge-of-late-onset-frontal-lobe-syndrome.pdf2022-11-07 22:33 313K 
[ ]12545_diagnostic-challenge-psychiatric-symptoms-neurodegenerative.pdf2022-11-07 22:30 324K 
[ ]12546_diagnostic-challenges-children-adolescents-psychotic.pdf2022-11-07 22:36 66K 
[ ]12547_diagnostic-characteristics-child-bipolar-i-disorder.pdf2022-11-07 22:44 180K 
[ ]12548_diagnostic-characteristics-clozapine-induced-myocarditis.pdf2022-11-07 22:36 261K 
[ ]12549_diagnostic-consistency-major-depression-psychosis.pdf2022-11-07 23:00 434K 
[ ]12552_diagnostic-stability-months-treatment-initiation.pdf2022-11-07 22:02 159K 
[ ]12553_diagnostic-therapeutic-challenges-narcolepsy-related.pdf2022-11-07 22:27 102K 
[ ]12554_diagnostic-therapeutic-dilemmas-management-pediatric.pdf2022-11-07 22:41 56K 
[ ]12555_dialectical-behavior-therapy-binge-eating-bulimia.pdf2022-11-07 22:39 146K 
[ ]12556_dialogue.pdf2022-11-07 22:04 40K 
[ ]12557_diary-my-first-day.pdf2022-11-07 23:02 125K 
[ ]12558_dietary-restrictions-drug-interactions-monoamine-oxidase-ingibitors-state-art-MAOI.pdf2022-11-07 22:34 134K 
[ ]12559_dietary-restrictions-drug-interactions-monoamine-oxidase-update-MAOI.pdf2022-11-07 22:23 262K 
[ ]12560_differences-among-major-depressive-disorder-without.pdf2022-11-07 22:27 290K 
[ ]12561_differences-axis-i-ii-comorbidity-between-bipolar.pdf2022-11-07 22:01 124K 
[ ]12562_differences-between-minimally-depressed-patients-consider.pdf2022-11-07 22:36 125K 
[ ]12563_differences-mechanism-action-between-current-future.pdf2022-11-07 22:18 54K 
[ ]12564_differences-prolactin-elevation-related-symptoms-atypical.pdf2022-11-07 22:21 130K 
[ ]12565_differences-quality-life-domains-psychopathologic.pdf2022-11-07 22:43 94K 
[ ]12566_differences-self-reported-sleep-complaints-elderly.pdf2022-11-07 22:38 117K 
[ ]12567_different-effects-mirtazapine-venlafaxine-brain-activation.pdf2022-11-07 22:44 1.9M 
[ ]12570_differential-diagnosis-fatigue-executive-dysfunction.pdf2022-11-07 22:35 48K 
[ ]12571_differential-diagnosis-multiple-sclerosis-bipolar.pdf2022-11-07 22:04 73K 
[ ]12574_differential-effects-nefazodone-cognitive-behavioral.pdf2022-11-07 22:55 73K 
[ ]12575_differential-effects-risperidone-olanzapine-clozapine.pdf2022-11-07 22:10 113K 
[ ]12576_differential-efficacy-olanzapine-lithium-preventing.pdf2022-11-07 22:55 116K 
[ ]12577_differential-modulation-cerebrospinal-fluid-neurotrophins.pdf2022-11-07 22:06 92K 
[ ]12578_differential-pharmacology-newer-antidepressants.pdf2022-11-07 22:30 55K 
[ ]12579_differential-prediction-clinical-response-serotonergic.pdf2022-11-07 23:01 183K 
[ ]12580_differential-prescription-maintenance-antipsychotics.pdf2022-11-07 22:41 70K 
[ ]12581_differential-roles-trauma-posttraumatic-stress-disorder.pdf2022-11-07 22:33 255K 
[ ]12582_differentiating-ictal-panic-low-grade-temporal-lobe.pdf2022-11-07 23:00 479K 
[ ]12583_different-influences-classical-antipsychotics-clozapine.pdf2022-11-07 22:55 62K 
[ ]12584_different-mechanism-understand-activationsedation.pdf2022-11-07 22:15 196K 
[ ]12585_difficulties-diagnosis-management-bipolar-disorder.pdf2022-11-07 22:20 52K 
[ ]12586_difficult-treat-depressions-primary-care-perspective.pdf2022-11-07 22:02 68K 
[ ]12587_dilemma-unmodified-electroconvulsive-therapy.pdf2022-11-07 22:09 48K 
[ ]12588_dimensional-approaches-diagnostic-classification-refining.pdf2022-11-07 22:45 132K 
[ ]12589_dimensional-structure-dsm-posttraumatic-stress-disorder.pdf2022-11-07 23:02 283K 
[ ]12590_dipeptidyl-peptidase-activity-and-prevalence-of-depression-in-middle-aged-and-older-adults.pdf2022-11-07 22:26 218K 
[ ]12591_direct-comparison-psychometric-properties-multiple.pdf2022-11-07 23:02 235K 
[ ]12592_direct-controlled-blind-family-study-ltemgtdsm-ivltemgt.pdf2022-11-07 22:10 329K 
[ ]12594_disability-and-functioning-of-emergency-services-users.pdf2022-11-07 22:08 811K 
[ ]12595_disability-injury-cumulative-burden-physical-mental.pdf2022-11-07 22:09 309K 
[ ]12596_disability-schizophrenia-contributing-factors-validated.pdf2022-11-07 22:33 359K 
[ ]12598_disclosure-statements.pdf2022-11-07 22:48 20K 
[ ]12599_discontinuation-antidepressant-therapy-emerging-complications.pdf2022-11-07 22:40 56K 
[ ]12600_discontinuation-maintenance-selective-serotonin-reuptake.pdf2022-11-07 22:53 209K 
[ ]12601_discontinuation-symptoms-ssris.pdf2022-11-07 22:40 38K 
[ ]12602_discontinuation-symptoms-treatment-serotonin-reuptake.pdf2022-11-07 22:38 44K 
[ ]12603_discontinuing-antidepressants-how-can-clinicians-guide-patients-and-drive-research.pdf2022-11-07 22:36 223K 
[ ]12604_discontinuing-switching-antipsychotic-medications.pdf2022-11-07 22:52 190K 
[ ]12606_discussion-comparsion-bieoquvalence-generic-versus.pdf2022-11-07 22:09 24K 
[ ]12607_discussion-double-blind-studies-comparing-risperidone.pdf2022-11-07 22:10 153K 
[ ]12608_discussion-fresh-monoamine-oxidase-inhibitors-depression.pdf2022-11-07 22:22 151K 
[ ]12609_discussion-improving-cognitive-function-functional.pdf2022-11-07 22:30 72K 
[ ]12610_discussion-scientific-expert-meeting.pdf2022-11-07 22:37 28K 
[ ]12611_discussion-using-benzodiazepines-clinical-practice.pdf2022-11-07 22:55 94K 
[ ]12612_disorders-brain-mind.pdf2022-11-07 22:03 30K 
[ ]12613_disparities-psychiatric-care-clinical-cross-cultural.pdf2022-11-07 22:59 130K 
[ ]12614_disrupted-antioxidant-enzyme-activity-elevated-lipid.pdf2022-11-07 22:01 190K 
[ ]12615_disrupted-default-mode-network-and-heroin-addiction.pdf2022-11-07 22:54 745K 
[ ]12616_dissociation-children-adolescents-developmental-perspective.pdf2022-11-07 23:01 14K 
[ ]12617_dissociation-posttraumatic-stress-world-trade-center.pdf2022-11-07 22:28 129K 
[ ]12618_dissociative-disorders-among-inpatients-drug-alcohol.pdf2022-11-07 22:23 146K 
[ ]12619_dissolving-burden-generalized-anxiety-disorder.pdf2022-11-07 22:36 55K 
[ ]12620_distinguishing-between-borderline-personality-disorder.pdf2022-11-07 22:03 129K 
[ ]12621_distinguishing-bipolar-ii-depression-major-depressive.pdf2022-11-07 22:37 459K 
[ ]12622_distinguishing-bipolar-major-depression-unipolar-major.pdf2022-11-07 22:13 99K 
[ ]12623_distinguishing-functional-syndromal-recovery-implications.pdf2022-11-07 22:51 128K 
[ ]12624_distinguishing-roles-norepinephrine-serotonin-behavioral.pdf2022-11-07 22:04 100K 
[ ]12625_distressing-sexual-problems-united-states-women-revisited.pdf2022-11-07 22:30 401K 
[ ]12626_distribution-body-mass-index-among-individuals-without.pdf2022-11-07 22:07 56K 
[ ]12627_disulfiram-patients-abnormal-liver-function-test-results.pdf2022-11-07 22:43 32K 
[ ]12628_diurnal-mood-variation-outpatients-major-depressive.pdf2022-11-07 22:37 224K 
[ ]12629_diurnal-variation-direction-mood-switches-patients.pdf2022-11-07 22:01 97K 
[ ]12630_divalproex-monotherapy-treatment-bipolar-offspring.pdf2022-11-07 22:40 69K 
[ ]12631_divalproex-sodium-alcohol-withdrawal-relapse-prevention.pdf2022-11-07 22:44 58K 
[ ]12632_divalproex-sodium-impulsive-aggressive-behavior-patients.pdf2022-11-07 22:32 34K 
[ ]12633_divalproex-sodium-substance-abusers-mood-disorder.pdf2022-11-07 22:27 48K 
[ ]12634_divalproex-sodium-treatment-conduct-disorder-randomized.pdf2022-11-07 22:40 77K 
[ ]12635_divalproex-sodium-treatment-women-borderline-personality.pdf2022-11-07 22:08 91K 
[ ]12636_divalproex-sodium-versus-olanzapine-treatment-acute.pdf2022-11-07 22:32 68K 
[ ]12637_divalproex-treatment-acute-bipolar-depression-preliminary.pdf2022-11-07 22:37 102K 
[ ]12638_divalproex-treatment-disruptive-adolescents-report.pdf2022-11-07 22:38 74K 
[ ]12639_divalproex-versus-olanzapine-mania.pdf2022-11-07 22:04 54K 
[ ]12640_docosahexaenoic-acid-selective-prevention-posttraumatic.pdf2022-11-07 22:16 263K 
[ ]12641_does-acute-stress-disorder-predict-subsequent-posttraumatic.pdf2022-11-07 22:46 193K 
[ ]12642_does-adequacy-clinicians-diagnostic-practice-routine.pdf2022-11-07 22:34 147K 
[ ]12643_does-adhd-diagnosis-at-preschool-age-affect-treatment.pdf2022-11-07 22:30 557K 
[ ]12644_does-combat-trauma-cause-majority-ptsd-symptoms-combat.pdf2022-11-07 22:57 145K 
[ ]12645_does-comorbid-posttraumatic-stress-disorder-affect.pdf2022-11-07 22:59 362K 
[ ]12646_does-conduct-disorder-mediate-development-substance.pdf2022-11-07 22:18 202K 
[ ]12647_does-depression-hurt.pdf2022-11-07 22:24 41K 
[ ]12648_does-depressive-state-influence-reported-attachment.pdf2022-11-07 22:34 719K 
[ ]12649_does-duration-index-episode-affect-treatment-outcome.pdf2022-11-07 22:06 310K 
[ ]12650_does-evidence-clinical-trials-psychopharmacology-apply.pdf2022-11-07 22:34 39K 
[ ]12651_does-inclusion-placebo-arm-influence-response-active.pdf2022-11-07 22:28 428K 
[ ]12652_does-indication-drive-does-drive-indication.pdf2022-11-07 22:21 109K 
[ ]12653_does-interpersonal-loss-preceding-panic-disorder-onset.pdf2022-11-07 23:01 173K 
[ ]12654_does-lorazepam-impair-antidepressant-response-nortriptyline.pdf2022-11-07 22:55 47K 
[ ]12655_does-loxapine-atypical-properties-clinical-evidence.pdf2022-11-07 22:37 55K 
[ ]12656_does-ltemgtdsm-ivltemgt-already-capture-dimensional.pdf2022-11-07 22:28 304K 
[ ]12657_does-meta-analysis-sleep-deprivation-studies-demonstrate.pdf2022-11-07 22:11 105K 
[ ]12658_does-mirtazapine-more-rapid-onset-ssris.pdf2022-11-07 22:33 44K 
[ ]12659_does-negative-affectivity-predict-differential-response.pdf2022-11-07 22:10 348K 
[ ]12660_does-nitrous-oxide-help-veterans-with-ptsd.pdf2022-11-07 23:02 122K 
[ ]12661_does-presence-feature-borderline-personality-disorder.pdf2022-11-07 22:58 262K 
[ ]12662_does-presence-open-label-antidepressant-treatment.pdf2022-11-07 22:02 370K 
[ ]12663_does-randomized-evidence-support-sertraline-line.pdf2022-11-07 22:20 318K 
[ ]12664_does-recovery-substance-disorder-matter-patients-bipolar.pdf2022-11-07 22:44 128K 
[ ]12665_does-rtms-hasten-response-escitalopram-sertraline.pdf2022-11-07 22:14 168K 
[ ]12666_does-stimulant-treatment-lead-substance-disorders.pdf2022-11-07 22:02 65K 
[ ]12667_does-the-clinical-benefit-of-ketamine-treatment-offer-any-clues-to-autism-spectrum-disorder-etiology.pdf2022-11-07 22:03 91K 
[ ]12668_does-therapy-manual-therapist-matter-treatment-obsessive.pdf2022-11-07 22:43 362K 
[ ]12671_does-varenicline-worsen-psychiatric-symptoms-patients.pdf2022-11-07 22:21 325K 
[ ]12672_does-venlafaxine-maintenance-therapy-prevent-depression.pdf2022-11-07 22:26 185K 
[ ]12673_doing-psychoanalysis-tehran.pdf2022-11-07 22:03 69K 
[ ]12674_doing-right-thing-approach-moral-issues-mental-health.pdf2022-11-07 22:51 104K 
[ ]12675_donald-f-klein-md-dsc.pdf2022-11-07 22:52 190K 
[ ]12677_donepezil-concurrent-sertraline-treatment-is-associated.pdf2022-11-07 22:13 211K 
[ ]12678_donepezil-considered-mild-antipsychotic-dementia-treatment.pdf2022-11-07 22:09 51K 
[ ]12679_donepezil-overdose.pdf2022-11-07 22:10 38K 
[ ]12680_donepezil-psychotropic-induced-memory-loss.pdf2022-11-07 22:59 44K 
[ ]12681_dont-ask-dont-tell-benzodiazepines-are-still-leading.pdf2022-11-07 22:52 43K 
[ ]12682_dont-succeed-sequential-strategies-antidepressant.pdf2022-11-07 22:50 44K 
[ ]12683_dopamine-dependent-side-effects-selective-serotonin.pdf2022-11-07 22:08 124K 
[ ]12684_dopaminergic-agents-stimulants-antidepressant-augmentation.pdf2022-11-07 22:25 29K 
[ ]12685_dopamine-system-stabilizers-aripiprazole-next-generation-part-1-goldilocks-actions-dopamine-receptor.pdf2022-11-07 22:33 38K 
[ ]12686_dopamine-system-stabilizers-aripiprazole-next-generation-part-2-mechanism-action.pdf2022-11-07 22:48 96K 
[ ]12687_dose-comparison-olanzapine-treatment-borderline-personality.pdf2022-11-07 22:01 532K 
[ ]12688_dose-dependent-effect-lithium-cognition-mild-cognitive.pdf2022-11-07 22:32 118K 
[ ]12689_dose-outcome-analysis-risperidone.pdf2022-11-07 22:26 35K 
[ ]12690_dose-reduction-risperidone-olanzapine-estimated-dopamine.pdf2022-11-07 22:01 328K 
[ ]12691_dose-related-thrombocytopenia-macrocytic-anemia-associated.pdf2022-11-07 22:53 73K 
[ ]12692_dose-response-efficacy-paroxetine-preventing-depressive.pdf2022-11-07 22:21 32K 
[ ]12693_dose-selection-comparator-drugs-schizophrenia-research.pdf2022-11-07 22:14 45K 
[ ]12694_doses-initial-untreated-hallucinations-delusions-proof.pdf2022-11-07 22:14 301K 
[ ]12695_dosing-antipsychotic-medication-olanzapine.pdf2022-11-07 22:52 36K 
[ ]12696_dosing-differences-between-valproic-acid-concentrate.pdf2022-11-07 22:03 67K 
[ ]12697_dosing-divalproex-extended-release.pdf2022-11-07 22:27 139K 
[ ]12698_dosing-quetiapine-drug-naive-episode-psychosis-controlled.pdf2022-11-07 22:15 365K 
[ ]12699_dosing-quetiapine-schizophrenia-clinical-practice.pdf2022-11-07 22:20 130K 
[ ]12700_dosing-side-effect-threshold-cases-panic-disorder.pdf2022-11-07 22:29 761K 
[ ]12701_dosing-ziprasidone-state-hospital-system-differs-product.pdf2022-11-07 22:05 306K 
[ ]12702_double-blind-comparison-bupropion-sustained-release.pdf2022-11-07 22:40 47K 
[ ]12703_double-blind-comparison-escitalopram-venlafaxine-extended.pdf2022-11-07 22:58 63K 
[ ]12704_double-blind-comparison-fluvoxamine-paroxetine-treatment.pdf2022-11-07 22:56 101K 
[ ]12705_double-blind-comparison-olanzapine-versus-risperidone.pdf2022-11-07 22:34 55K 
[ ]12706_double-blind-comparison-sertraline-fluoxetine-depressed.pdf2022-11-07 22:45 87K 
[ ]12707_double-blind-comparison-sertraline-placebo-stroke.pdf2022-11-07 22:01 168K 
[ ]12708_double-blind-controlled-study-adjunctive-treatment.pdf2022-11-07 22:42 232K 
[ ]12709_double-blind-crossover-study-cognitive-effects-lorazepam.pdf2022-11-07 22:44 439K 
[ ]12710_double-blind-evaluation-safety-efficacy-abecarnil.pdf2022-11-07 22:42 45K 
[ ]12711_double-blind-multicenter-parallel-group-study-paroxetine.pdf2022-11-07 22:24 117K 
[ ]12712_double-blind-multicenter-study-primary-care-comparing.pdf2022-11-07 22:28 107K 
[ ]12713_double-blind-placebo-controlled-assessment-combined.pdf2022-11-07 22:28 57K 
[ ]12714_double-blind-placebo-controlled-crossover-study-osmotic.pdf2022-11-07 22:12 94K 
[ ]12715_double-blind-placebo-controlled-parallel-group-flexible.pdf2022-11-07 22:44 323K 
[ ]12716_double-blind-placebo-controlled-pilot-trial-paliperidone.pdf2022-11-07 22:53 318K 
[ ]12717_double-blind-placebo-controlled-prophylaxis-study.pdf2022-11-07 22:19 95K 
[ ]12718_double-blind-placebo-controlled-study-armodafinil.pdf2022-11-07 22:07 367K 
[ ]12719_double-blind-placebo-controlled-study-comparing-effects.pdf2022-11-07 23:02 51K 
[ ]12720_double-blind-placebo-controlled-study-efficacy-reboxetine.pdf2022-11-07 22:16 426K 
[ ]12721_double-blind-placebo-controlled-study-efficacy-safety-desvenlafaxine-MDD-depression.pdf2022-11-07 22:49 273K 
[ ]12722_double-blind-placebo-controlled-study-efficacy-safety-fluvoxamine-OCD-obsessive-compulsive-disorder.pdf2022-11-07 22:19 73K 
[ ]12723_double-blind-placebo-controlled-study-efficacy-safety-lisdexamfetamine-adults-ADHD-attention-deficit.pdf2022-11-07 22:48 283K 
[ ]12724_double-blind-placebo-controlled-study-efficacy-safety-paroxetine-pathological-gambling.pdf2022-11-07 22:39 61K 
[ ]12725_double-blind-placebo-controlled-study-lamotrigine.pdf2022-11-07 22:16 86K 
[ ]12726_double-blind-placebo-controlled-study-modafinil-fatigue.pdf2022-11-07 22:24 123K 
[ ]12727_double-blind-placebo-controlled-study-opiate-antagonist.pdf2022-11-07 22:01 206K 
[ ]12728_double-blind-placebo-controlled-study-quetiapine-lithium.pdf2022-11-07 22:40 503K 
[ ]12729_double-blind-placebo-controlled-study-quetiapine-paroxetine.pdf2022-11-07 22:25 486K 
[ ]12730_double-blind-placebo-controlled-trial-divalproex-monotherapy.pdf2022-11-07 22:16 214K 
[ ]12731_double-blind-placebo-controlled-trial-doses-abecarnil.pdf2022-11-07 23:01 35K 
[ ]12732_double-blind-placebo-controlled-trial-extract-ginkgo.pdf2022-11-07 22:45 66K 
[ ]12733_double-blind-placebo-controlled-trial-lamotrigine.pdf2022-11-07 22:04 449K 
[ ]12734_double-blind-placebo-controlled-trial-nefazodone-treatment.pdf2022-11-07 22:04 54K 
[ ]12735_double-blind-placebo-controlled-trial-safety-efficacy.pdf2022-11-07 22:46 70K 
[ ]12736_double-blind-placebo-controlled-trial-topiramate-augmentation.pdf2022-11-07 22:41 305K 
[ ]12737_double-blind-randomized-comparison-memantine-escitalopram.pdf2022-11-07 22:56 233K 
[ ]12738_double-blind-randomized-comparison-nortriptyline-paroxetine.pdf2022-11-07 22:42 54K 
[ ]12739_double-blind-randomized-comparison-nortriptyline-plus.pdf2022-11-07 22:56 86K 
[ ]12740_double-blind-randomized-controlled-clinical-trial.pdf2022-11-07 22:44 761K 
[ ]12741_double-blind-randomized-controlled-trial-ethyl-eicosapentaenoate.pdf2022-11-07 22:11 405K 
[ ]12742_double-blind-randomized-group-comparative-study-tolerability.pdf2022-11-07 22:33 66K 
[ ]12743_double-blind-randomized-placebo-controlled-clinical.pdf2022-11-07 22:30 49K 
[ ]12744_double-blind-randomized-placebo-controlled-long-term.pdf2022-11-07 22:02 371K 
[ ]12745_double-blind-randomized-placebo-controlled-prophylaxis.pdf2022-11-07 22:28 91K 
[ ]12746_double-blind-randomized-placebo-controlled-trial-augmentation.pdf2022-11-07 22:39 77K 
[ ]12747_double-blind-randomized-placebo-controlled-trial-fluoxetine.pdf2022-11-07 22:50 277K 
[ ]12748_double-blind-randomized-placebo-controlled-trial-quetiapine.pdf2022-11-07 22:51 171K 
[ ]12749_double-blind-randomized-placebo-controlled-trial-topiramate.pdf2022-11-07 22:04 231K 
[ ]12750_double-blind-randomized-placebo-controlled-week-study.pdf2022-11-07 22:42 258K 
[ ]12751_double-blind-randomized-study-comparing-efficacy-safety.pdf2022-11-07 22:34 420K 
[ ]12752_double-blind-randomized-study-minocycline-treatment.pdf2022-11-07 22:16 529K 
[ ]12753_double-blind-study-citalopram-versus-placebo-treatment.pdf2022-11-07 22:42 80K 
[ ]12754_double-blind-study-combination-clozapine-risperidone.pdf2022-11-07 22:50 98K 
[ ]12755_double-blind-study-dextroamphetamine-versus-caffeine.pdf2022-11-07 22:16 276K 
[ ]12756_double-blind-study-doses-long-acting-risperidone.pdf2022-11-07 22:49 122K 
[ ]12757_double-blind-study-long-term-treatment-sertraline.pdf2022-11-07 22:21 91K 
[ ]12758_double-blind-switch-study-paroxetine-venlafaxine-obsessive.pdf2022-11-07 22:36 64K 
[ ]12759_double-blind-treatment-oral-morphine-treatment-resistant.pdf2022-11-07 22:14 132K 
[ ]12760_double-blind-trial-fluoxetine-pathologic-skin-picking.pdf2022-11-07 22:11 50K 
[ ]12761_doubting-efficacyeffectiveness-electroencephalographic.pdf2022-11-07 22:15 132K 
[ ]12762_doxazosin-xl-for-ptsd.pdf2022-11-07 22:59 219K 
[ ]12763_doxepin-treatment-primary-insomnia-placebo-controlled.pdf2022-11-07 22:15 95K 
[ ]12764_do-you-order-pharmacogenetic-testing-why.pdf2022-11-07 22:15 132K 
[ ]12765_dr-addington-colleagues-reply-methodological-issues.pdf2022-11-07 22:53 92K 
[ ]12766_dr-aman-replies.pdf2022-11-07 23:02 88K 
[ ]12767_dr-ananth-replies-drs-carroll-lee-catatonia-is-risk.pdf2022-11-07 22:30 127K 
[ ]12768_dr-andrade-replies.pdf2022-11-07 22:12 85K 
[ ]12769_dr-bauer-replies.pdf2022-11-07 22:18 81K 
[ ]12770_dr-berman-replies.pdf2022-11-07 22:40 210K 
[ ]12771_dr-berrouiguet-and-colleagues-reply.pdf2022-11-07 22:22 118K 
[ ]12772_dr-brawman-mintzer-colleagues-reply-sedative-effects.pdf2022-11-07 22:27 80K 
[ ]12773_dr-brown-colleagues-reply.pdf2022-11-07 22:14 125K 
[ ]12774_dr-capehart-replies.pdf2022-11-07 22:21 88K 
[ ]12775_dr-chand-colleagues-reply.pdf2022-11-07 22:51 98K 
[ ]12776_dr-cheng-and-colleagues-reply.pdf2022-11-07 22:51 113K 
[ ]12777_dr-chengappa-colleagues-reply.pdf2022-11-07 22:03 103K 
[ ]12778_dr-cohen-colleagues-reply.pdf2022-11-07 22:01 81K 
[ ]12779_dr-correll-colleagues-reply.pdf2022-11-07 22:31 161K 
[ ]12780_dr-cox-colleagues-reply.pdf2022-11-07 22:05 92K 
[ ]12781_dream-drugstore-chemically-altered-states-consciousness.pdf2022-11-07 22:32 42K 
[ ]12782_dreams-nightmares-theory-origins-meanings-dreams.pdf2022-11-07 22:24 33K 
[ ]12783_dr-findling-replies.pdf2022-11-07 22:18 88K 
[ ]12784_dr-finn-colleagues-reply.pdf2022-11-07 22:25 98K 
[ ]12785_dr-fombonne-replies.pdf2022-11-07 22:14 87K 
[ ]12786_dr-gibbons-colleagues-reply.pdf2022-11-07 23:00 130K 
[ ]12787_dr-gilman-colleagues-reply.pdf2022-11-07 22:27 168K 
[ ]12788_dr-gonzalez-pinto-colleagues-reply.pdf2022-11-07 22:52 112K 
[ ]12789_dr-green-colleagues-reply.pdf2022-11-07 22:22 113K 
[ ]12790_dr-grilo-replies.pdf2022-11-07 22:10 161K 
[ ]12791_dr-hamann-colleagues-reply.pdf2022-11-07 22:30 154K 
[ ]12792_dried-blood-spot-analysis-for-drug-monitoring-of-clozapine.pdf2022-11-07 22:28 563K 
[ ]12793_driving-safety-and-serious-mental-illness.pdf2022-11-07 22:15 219K 
[ ]12794_dr-joksovic-colleagues-reply.pdf2022-11-07 22:50 121K 
[ ]12795_dr-kao-replies.pdf2022-11-07 23:01 104K 
[ ]12796_dr-lindenmayer-replies.pdf2022-11-07 22:36 153K 
[ ]12797_dr-lund-colleagues-reply.pdf2022-11-07 22:26 122K 
[ ]12798_dr-lurie-colleagues-reply.pdf2022-11-07 22:13 81K 
[ ]12799_dr-macking-young-reply.pdf2022-11-07 22:11 82K 
[ ]12800_dr-mazereeuw-colleagues-reply.pdf2022-11-07 22:25 114K 
[ ]12801_dr-mcgorry-colleagues-reply.pdf2022-11-07 22:34 98K 
[ ]12802_dr-mischoulon-colleagues-reply.pdf2022-11-07 22:40 134K 
[ ]12803_dr-miskowiak-colleagues-reply.pdf2022-11-07 22:07 118K 
[ ]12804_dr-mota-and-colleagues-reply.pdf2022-11-07 22:06 123K 
[ ]12805_dr-nielsen-colleagues-reply.pdf2022-11-07 22:09 119K 
[ ]12806_dr-novick-replies.pdf2022-11-07 22:20 86K 
[ ]12807_droperidol-efficacy-side-effects-psychiatric-emergencies.pdf2022-11-07 22:41 29K 
[ ]12808_dr-preskorn-replies.pdf2022-11-07 22:07 117K 
[ ]12809_dr-rado-colleagues-reply.pdf2022-11-07 22:08 204K 
[ ]12810_drs-aprahamian-forlenza-reply.pdf2022-11-07 22:54 122K 
[ ]12811_drs-boland-gehrman-reply.pdf2022-11-07 22:32 105K 
[ ]12812_drs-bschor-baethge-reply.pdf2022-11-07 22:22 120K 
[ ]12813_drs-glick-marder-reply.pdf2022-11-07 22:29 99K 
[ ]12814_drs-goodman-hazlett-reply.pdf2022-11-07 22:18 124K 
[ ]12815_drs-han-compton-reply.pdf2022-11-07 22:01 113K 
[ ]12816_drs-haq-mickey-reply.pdf2022-11-07 22:13 119K 
[ ]12817_drs-hung-kuo-reply.pdf2022-11-07 22:18 118K 
[ ]12818_drs-ionescu-cusin-reply.pdf2022-11-07 22:58 77K 
[ ]12819_drs-kane-and-correll-reply.pdf2022-11-07 22:39 83K 
[ ]12820_drs-lee-remington-reply.pdf2022-11-07 22:05 133K 
[ ]12821_drs-meltzer-jayathilake-reply.pdf2022-11-07 22:09 82K 
[ ]12822_dr-spaans-colleagues-reply.pdf2022-11-07 22:20 140K 
[ ]12823_drs-puzantian-shaw-reply.pdf2022-11-07 23:03 43K 
[ ]12824_drs-rosenblat-and-mcintyre-reply.pdf2022-11-07 22:50 83K 
[ ]12825_drs-sanchez-gistau-castro-fornieles-reply.pdf2022-11-07 22:43 125K 
[ ]12826_drs-schwenk-leja-reply.pdf2022-11-07 22:38 83K 
[ ]12827_drs-spencer-biederman-reply.pdf2022-11-07 23:03 107K 
[ ]12828_drs-sysko-walsh-reply.pdf2022-11-07 22:40 208K 
[ ]12829_dr-stricker-replies-methodological-concerns-regarding.pdf2022-11-07 22:53 92K 
[ ]12830_drug-action-central-nervous-system.pdf2022-11-07 22:48 19K 
[ ]12831_drug-alcohol-abuse-clinical-guide-diagnosis-treatment.pdf2022-11-07 22:29 89K 
[ ]12832_drug-combinations-bipolar-spectrum-disorders-evidence.pdf2022-11-07 22:18 34K 
[ ]12833_drug-combinations-mania.pdf2022-11-07 22:49 69K 
[ ]12834_drug-craving-negative-reactions-abrupt-substitution.pdf2022-11-07 22:07 42K 
[ ]12835_drug-development-process-product-primary-pediatric.pdf2022-11-07 23:00 68K 
[ ]12836_drug-diet-interactions-avoiding-therapeutic-paralysis.pdf2022-11-07 22:30 123K 
[ ]12837_drug-discovery-postgenomic-era-genomics-proteomics.pdf2022-11-07 22:55 36K 
[ ]12838_drug-initiatives-improve-cognitive-function.pdf2022-11-07 22:59 87K 
[ ]12839_drug-interactionsfriend-foe.pdf2022-11-07 22:24 68K 
[ ]12840_drug-interactions-lithium-antimanicmood-stabilizing.pdf2022-11-07 22:17 70K 
[ ]12841_drug-interactions-newer-antidepressants-role-human.pdf2022-11-07 22:38 56K 
[ ]12842_drug-interactions-psychiatry-nd-ed.pdf2022-11-07 22:05 22K 
[ ]12843_drug-interactions-treatment-depression-patients-ischemic.pdf2022-11-07 22:57 500K 
[ ]12844_drug-interactions-treatment-depression-patients-receiving.pdf2022-11-07 22:41 547K 
[ ]12845_drugs-escape-hepatic-metabolism.pdf2022-11-07 22:47 551K 
[ ]12846_drug-utilization-trends-patients-posttraumatic-stress.pdf2022-11-07 22:15 234K 
[ ]12847_dr-van-dongen-boomsma-colleagues-reply.pdf2022-11-07 22:19 98K 
[ ]12848_dr-van-dongen-boomsma-replies.pdf2022-11-07 22:01 132K 
[ ]12849_dr-vieta-replies.pdf2022-11-07 23:01 88K 
[ ]12850_dr-yager-and-colleagues-reply.pdf2022-11-07 22:35 117K 
[ ]12851_dsm-autism-spectrum-disorders-changes-havent-heard.pdf2022-11-07 22:54 123K 
[ ]12852_dsm-iv-guidebook.pdf2022-11-07 22:01 59K 
[ ]12853_dsm-iv-intermittent-explosive-disorder-report-cases.pdf2022-11-07 22:44 131K 
[ ]12854_dsm-iv-primary-care-version.pdf2022-11-07 22:01 61K 
[ ]12855_dsm-iv-sourcebook-vol.pdf2022-11-07 22:12 35K 
[ ]12856_dsm-iv-tr-case-book-vol-experts-tell-treated-own-patients.pdf2022-11-07 22:44 75K 
[ ]12857_dsm-iv-vs-dsm-effect-on-bipolar-disorder-diagnosis.pdf2022-11-07 22:31 278K 
[ ]12858_dual-action-hypothesis-does-pharmacology-matter.pdf2022-11-07 22:42 61K 
[ ]12859_dual-dependency-cocaine-alcohol-opiate-addicts-treatment.pdf2022-11-07 22:09 83K 
[ ]12860_dual-diagnosis-treatment-substance-abuse-comorbid.pdf2022-11-07 22:18 23K 
[ ]12861_dual-epidemic-tobacco-dependence-obesity-among-those.pdf2022-11-07 22:23 118K 
[ ]12862_dual-reuptake-inhibitors-incur-lower-rates-tachyphylaxis.pdf2022-11-07 22:05 69K 
[ ]12863_duloxetine-dosing-strategies-and-smoking-status.pdf2022-11-07 22:13 230K 
[ ]12864_duloxetine-efficacy-major-depressive-disorder-male.pdf2022-11-07 22:28 125K 
[ ]12865_duloxetine-long-term-treatment-major-depressive-disorder.pdf2022-11-07 22:02 67K 
[ ]12866_duloxetine-mg-once-daily-major-depressive-disorder.pdf2022-11-07 22:49 80K 
[ ]12867_duloxetine-prevention-depressive-recurrences-randomized.pdf2022-11-07 22:32 364K 
[ ]12868_duloxetines-role-treatment-depression-associated-painful.pdf2022-11-07 22:19 58K 
[ ]12869_duloxetine-treatment-dysthymia-double-depression-open.pdf2022-11-07 22:55 145K 
[ ]12870_duloxetine-treatment-major-depressive-disorder-comparisons.pdf2022-11-07 22:08 131K 
[ ]12871_duloxetine-treatment-major-depressive-disorder-double.pdf2022-11-07 22:46 74K 
[ ]12872_duloxetine-treatment-role-functioning-improvement.pdf2022-11-07 22:47 195K 
[ ]12873_duration-and-relevance-of-untreated-psychiatric-disorders-psychotic-disorders.pdf2022-11-07 22:22 129K 
[ ]12874_duration-suicidal-process-much-is-left-intervention.pdf2022-11-07 22:39 172K 
[ ]12875_duration-therapy-health-care-costs-fluoxetine-paroxetine.pdf2022-11-07 22:47 70K 
[ ]12876_dyadic-treatments-low-level-partner-aggression.pdf2022-11-07 22:05 112K 
[ ]12877_dyskinesia-fluoxetine-tardive-late-onset-persistent.pdf2022-11-07 22:52 86K 
[ ]12878_dyslipidemia-atypical-antipsychotic-drugs.pdf2022-11-07 22:24 82K 
[ ]12879_dysthymia-spectrum-chronic-depressions.pdf2022-11-07 22:40 19K 
[ ]12880_dystonia-induced-mirtazapine.pdf2022-11-07 22:26 122K 
[ ]12881_early-augmentation-sertraline-methylphenidate.pdf2022-11-07 22:20 50K 
[ ]12882_early-bicarbonate-loading-dantroline-ziprasidonehaloperidol.pdf2022-11-07 22:33 88K 
[ ]12883_early-career-psychiatrists-section.pdf2022-11-07 22:44 43K 
[ ]12884_early-career-psychiatry.pdf2022-11-07 22:17 153K 
[ ]12885_early-careers-data.pdf2022-11-07 23:02 45K 
[ ]12886_early-clinical-experience-risperidone-long-acting.pdf2022-11-07 22:26 173K 
[ ]12887_early-delayed-onset-response-antidepressants-individual.pdf2022-11-07 22:26 636K 
[ ]12888_early-diagnosis-management-alzheimers-disease-definition-criteria-assessment-flowchart-recognition.pdf2022-11-07 22:35 41K 
[ ]12890_early-diagnosis-of-frontotemporal-dementia.pdf2022-11-07 22:59 189K 
[ ]12891_early-discontinuation-suboptimal-dosing-prazosin-potential.pdf2022-11-07 22:31 228K 
[ ]12892_early-improvements-predict-treatment-response-in-alzheimers.pdf2022-11-07 22:34 243K 
[ ]12893_early-improvement-under-mirtazapine-paroxetine-predicts.pdf2022-11-07 22:02 71K 
[ ]12894_early-improvement-weeks-predictor-treatment-outcome.pdf2022-11-07 22:56 279K 
[ ]12895_early-intervention-following-trauma-may-mitigate-genetic.pdf2022-11-07 22:35 530K 
[ ]12896_early-interventions-to-prevent-ptsd.pdf2022-11-07 22:58 277K 
[ ]12897_early-intervention-trauma-loss.pdf2022-11-07 22:53 51K 
[ ]12898_early-longitudinal-course-cognitive-deficits-schizophrenia.pdf2022-11-07 22:18 476K 
[ ]12899_early-nonresponse-to-antipsychotics-in-acute-mania.pdf2022-11-07 22:07 338K 
[ ]12900_early-onset-antidepressant-action-impact-primary-care.pdf2022-11-07 22:47 36K 
[ ]12901_early-onset-bipolar-disorder-treatment-delay-are-risk.pdf2022-11-07 22:06 515K 
[ ]12902_early-onset-dementia-multidisciplinary-approach.pdf2022-11-07 22:49 41K 
[ ]12903_early-prediction-antipsychotic-nonresponse-among-patients.pdf2022-11-07 22:08 263K 
[ ]12904_early-prediction-clinical-response-schizophrenia-patients.pdf2022-11-07 22:42 166K 
[ ]12905_early-recognition-alzheimers-disease-is-consensual.pdf2022-11-07 22:31 2.7M 
[ ]12907_early-response-in-adolescents-with-bipolar-disorder.pdf2022-11-07 22:02 387K 
[ ]12908_early-response-remission-predictors-outcome-major.pdf2022-11-07 22:19 459K 
[ ]12909_early-sleep-and-autism-screening-scores.pdf2022-11-07 22:25 566K 
[ ]12910_early-symptomatic-worsening-during-treatment-fluoxetine.pdf2022-11-07 23:03 88K 
[ ]12911_early-treatment-response-alcohol-dependence-extended.pdf2022-11-07 22:04 182K 
[ ]12912_easing-burden-social-anxiety-disorder.pdf2022-11-07 22:15 349K 
[ ]12913_easing-burden-treatment-resistant-depression.pdf2022-11-07 22:12 238K 
[ ]12914_easy-low-cost-identification-metabolic-syndrome-patients.pdf2022-11-07 22:50 371K 
[ ]12915_eating-disorders-addictions-substance-disorders-research.pdf2022-11-07 22:52 70K 
[ ]12916_economic-burden-adults-major-depressive-disorder-united.pdf2022-11-07 23:01 1.3M 
[ ]12917_economic-burden-and-employment-status-change-in-treatment-resistant-depression.pdf2022-11-07 22:50 846K 
[ ]12918_economic-burden-anxiety-disorders-s.pdf2022-11-07 22:38 74K 
[ ]12919_economic-burden-bipolar-disease.pdf2022-11-07 23:00 47K 
[ ]12920_economic-burden-depression-painful-symptoms.pdf2022-11-07 22:57 67K 
[ ]12921_economic-burden-depression-united-states-did-change.pdf2022-11-07 23:02 77K 
[ ]12922_economic-burden-personality-disorders-mental-health.pdf2022-11-07 22:35 203K 
[ ]12923_economic-burden-schizophrenia-united-states-2002.pdf2022-11-07 22:34 171K 
[ ]12924_economic-burden-schizophrenia-united-states-2013.pdf2022-11-07 22:25 1.0M 
[ ]12925_economic-consequences-recognizing-bipolar-disorder.pdf2022-11-07 22:02 67K 
[ ]12926_economic-evaluation-schema-therapy-clarification-oriented.pdf2022-11-07 22:35 1.7M 
[ ]12927_economic-human-impact-drugs.pdf2022-11-07 22:55 53K 
[ ]12928_economic-impact-bipolar-disorder-employed-population.pdf2022-11-07 22:50 112K 
[ ]12929_economic-impact-schizophrenia.pdf2022-11-07 22:46 37K 
[ ]12930_economic-outcomes-antidepressant-pharmacotherapy-retrospective.pdf2022-11-07 22:08 29K 
[ ]12931_economic-social-burden-depression.pdf2022-11-07 22:28 45K 
[ ]12932_ect-among-older-adults-in-the-us.pdf2022-11-07 22:24 298K 
[ ]12933_ect-and-insomnia.pdf2022-11-07 23:01 355K 
[ ]12934_ect-for-schizophrenia.pdf2022-11-07 22:52 317K 
[ ]12935_ect-induced-premature-labor-case-report.pdf2022-11-07 22:31 38K 
[ ]12936_ect-onset-action.pdf2022-11-07 22:13 37K 
[ ]12937_ect-proven-atypical-depression.pdf2022-11-07 23:01 83K 
[ ]12938_ect-texas-months-mandatory-reporting.pdf2022-11-07 22:58 39K 
[ ]12939_ect-with-dbs-in-ocd.pdf2022-11-07 22:04 107K 
[ ]12940_ect-without-failing-medication.pdf2022-11-07 22:06 114K 
[ ]12941_edema-associated-addition-risperidone-valproate-treatment.pdf2022-11-07 22:21 38K 
[ ]12942_editorial-gratitude.pdf2022-11-07 22:41 26K 
[ ]12943_editorial-magnanimity.pdf2022-11-07 22:36 123K 
[ ]12944_editorial-standing-guard.pdf2022-11-07 22:50 17K 
[ ]12945_editors-thank.pdf2022-11-07 22:26 123K 
[ ]12946_educational-occupational-underattainment-adults-attention.pdf2022-11-07 23:01 174K 
[ ]12947_ed-visits-for-mental-health-conditions-in-the-us.pdf2022-11-07 22:44 576K 
[ ]12948_eeg-characteristics-of-suicidal-behavior.pdf2022-11-07 22:13 3.9M 
[ ]12949_e-etiquette.pdf2022-11-07 22:22 44K 
[ ]12950_effect-adjunctive-l-methylfolate-mg-among-inadequate.pdf2022-11-07 22:22 432K 
[ ]12951_effect-antidepressant-medication-treatment-suicidal.pdf2022-11-07 23:02 438K 
[ ]12952_effect-anxiety-symptoms-adherence-highly-active-antiretroviral.pdf2022-11-07 22:13 740K 
[ ]12953_effect-baseline-anxious-depression-initial-sustained.pdf2022-11-07 22:57 1.1M 
[ ]12954_effect-bupropion-extended-release-negative-emotion.pdf2022-11-07 22:57 213K 
[ ]12955_effect-bupropion-sexual-dysfunction-induced-fluoxetine.pdf2022-11-07 22:29 55K 
[ ]12956_effect-cannabis-cognitive-functions-driving-ability.pdf2022-11-07 22:18 60K 
[ ]12957_effect-cariprazine-hostility-associated-schizophrenia.pdf2022-11-07 22:20 302K 
[ ]12958_effect-clozapine-factors-controlling-glucose-homeostasis.pdf2022-11-07 22:14 40K 
[ ]12960_effect-dermatologic-precautions-incidence-rash-addition.pdf2022-11-07 22:26 105K 
[ ]12961_effect-duloxetine-painful-physical-symptoms-depressed.pdf2022-11-07 22:18 88K 
[ ]12962_effect-electroconvulsive-therapy-neurocognitive-function.pdf2022-11-07 22:50 396K 
[ ]12963_effect-exercise-clinically-depressed-adults-systematic.pdf2022-11-07 22:27 438K 
[ ]12964_effect-financial-incentives-adherence-antipsychotic.pdf2022-11-07 22:18 230K 
[ ]12965_effect-gender-age-onset-depression-mortality.pdf2022-11-07 23:00 49K 
[ ]12969_effective-is-st-johns-wort-evidence-revisited.pdf2022-11-07 22:56 60K 
[ ]12971_effective-management-approaches-psychosis-patients.pdf2022-11-07 22:06 343K 
[ ]12972_effective-mood-stabilization-chelated-mineral-supplement.pdf2022-11-07 22:37 65K 
[ ]12973_effectiveness-antidepressants-comparative-remission.pdf2022-11-07 22:52 63K 
[ ]12974_effectiveness-antidepressants-elderly-depressed-outpatients.pdf2022-11-07 22:20 47K 
[ ]12976_effectiveness-antipsychotic-therapy-naturalistic-setting.pdf2022-11-07 22:21 48K 
[ ]12977_effectiveness-antipsychotic-treatments-schizophrenia.pdf2022-11-07 22:16 75K 
[ ]12978_effectiveness-aripiprazole-olanzapine-quetiapine-risperidone.pdf2022-11-07 22:05 1.1M 
[ ]12979_effectiveness-brief-behavioral-treatment-inner-city.pdf2022-11-07 22:42 231K 
[ ]12980_effectiveness-brief-cognitive-behavioral-therapy-schizophrenia.pdf2022-11-07 22:54 207K 
[ ]12981_effectiveness-citalopram-idiopathic-chronic-fatigue.pdf2022-11-07 23:01 78K 
[ ]12982_effectiveness-close-watch-precautions-suicidal-patients.pdf2022-11-07 22:13 49K 
[ ]12983_effectiveness-combining-atypical-antipsychotics-psychosocial.pdf2022-11-07 22:18 47K 
[ ]12984_effectiveness-combining-lithium-olanzapine-treatment.pdf2022-11-07 22:30 59K 
[ ]12985_effectiveness-criterion-balancing-efficacy-against.pdf2022-11-07 22:56 177K 
[ ]12986_effectiveness-feasibility-standardized-stepwise-drug.pdf2022-11-07 22:43 94K 
[ ]12987_effectiveness-integrated-care-including-therapeutic.pdf2022-11-07 22:21 388K 
[ ]12988_effectiveness-low-doses-paroxetine-controlled-release.pdf2022-11-07 22:08 70K 
[ ]12989_effectiveness-lurasidone-patients-schizophrenia-following.pdf2022-11-07 22:29 761K 
[ ]12990_effectiveness-lurasidone-patients-schizophrenia-schizoaffective.pdf2022-11-07 22:51 1.8M 
[ ]12991_effectiveness-of-suicide-prevention-programs.pdf2022-11-07 22:29 609K 
[ ]12992_effectiveness-olanzapine-risperidone-quetiapine-ziprasidone.pdf2022-11-07 22:34 55K 
[ ]12993_effectiveness-outcomes-attention-deficit-hyperactivity.pdf2022-11-07 22:46 83K 
[ ]12994_effectiveness-pharmacotherapy-body-dysmorphic-disorder.pdf2022-11-07 22:34 64K 
[ ]12995_effectiveness-quetiapine-versus-conventional-antipsychotics.pdf2022-11-07 22:08 70K 
[ ]12996_effectiveness-risperidone-simple-schizophrenia-single.pdf2022-11-07 22:32 69K 
[ ]12997_effectiveness-safety-long-term-antidepressant-treatment.pdf2022-11-07 23:00 85K 
[ ]12998_effectiveness-safety-vagus-nerve-stimulation-severe.pdf2022-11-07 22:29 351K 
[ ]12999_effectiveness-st-johns-wort-major-depressive-disorder.pdf2022-11-07 22:10 150K 
[ ]13000_effectiveness-switching-long-acting-injectable-fluphenazine.pdf2022-11-07 22:56 416K 
[ ]13001_effectiveness-switching-ziprasidone-stable-symptomatic.pdf2022-11-07 22:26 78K 
[ ]13002_effectiveness-tolerability-oral-ziprasidone-psychiatric.pdf2022-11-07 22:06 254K 
[ ]13003_effectiveness-transcranial-magnetic-stimulation-clinical.pdf2022-11-07 22:56 358K 
[ ]13004_effective-resolution-olanzapine-acute-presentation.pdf2022-11-07 22:46 61K 
[ ]13006_effective-treatments-ptsd-practice-guidelines-international.pdf2022-11-07 22:20 20K 
[ ]13007_effect-lamotrigine-cognitive-complaints-patients-bipolar.pdf2022-11-07 22:27 64K 
[ ]13008_effect-mental-illness-psychotropic-medication-gametes.pdf2022-11-07 22:16 333K 
[ ]13009_effect-metformin-anthropometrics-insulin-resistance.pdf2022-11-07 22:42 389K 
[ ]13010_effect-mirtazapine-treatment-body-composition-metabolism.pdf2022-11-07 22:32 82K 
[ ]13011_effect-mirtazapine-versusfluoxetine-sleep-quality.pdf2022-11-07 22:25 151K 
[ ]13012_effect-moderate-excessive-alcohol-course-outcome-patients.pdf2022-11-07 22:18 309K 
[ ]13013_effect-nefazodone-subjective-objective-sleep-quality.pdf2022-11-07 23:03 69K 
[ ]13014_effect-of-combat-and-ptsd-trajectories-on-mets-and-crp.pdf2022-11-07 22:45 295K 
[ ]13015_effect-of-spn-812-viloxazine-extended-release-on-qtc-interval.pdf2022-11-07 22:53 277K 
[ ]13016_effect-olanzapine-risperidone-haloperidol-treatment.pdf2022-11-07 22:14 156K 
[ ]13017_effect-ondansetron-ht-receptor-antagonist-chronic.pdf2022-11-07 22:26 250K 
[ ]13018_effect-prenatal-antidepressant-exposure-neonatal-adaptation.pdf2022-11-07 22:20 590K 
[ ]13019_effect-psychostimulants-brain-structure-function-adhd.pdf2022-11-07 22:12 687K 
[ ]13020_effect-reboxetine-depression-parkinsons-disease-patients.pdf2022-11-07 22:59 50K 
[ ]13021_effect-reboxetine-major-depressive-disorder-breast.pdf2022-11-07 22:42 53K 
[ ]13022_effect-ribavirin-combination-interferon-patients-hepatitis.pdf2022-11-07 22:43 208K 
[ ]13023_effect-risperidone-behavioral-psychological-symptoms.pdf2022-11-07 22:06 67K 
[ ]13024_effects-acute-hydrocortisone-administration-declarative.pdf2022-11-07 22:06 352K 
[ ]13025_effects-adjunctive-metformin-metabolic-traits-nondiabetic.pdf2022-11-07 22:51 288K 
[ ]13026_effects-affordable-care-act-practice-psychiatry-cme.pdf2022-11-07 22:41 459K 
[ ]13027_effects-antidepressants-longevity-dementia-onset-among.pdf2022-11-07 22:58 186K 
[ ]13028_effects-antidepressants-sexual-functioning-depressed.pdf2022-11-07 22:29 100K 
[ ]13029_effects-antidepressant-treatment-quality-daily-life.pdf2022-11-07 22:17 77K 
[ ]13030_effects-antipsychotic-treatment-tardive-dyskinesia.pdf2022-11-07 22:14 104K 
[ ]13031_effects-aripiprazole-qtc-case-report.pdf2022-11-07 22:04 116K 
[ ]13032_effects-asenapine-bipolar-i-patients-meeting-proxy.pdf2022-11-07 22:30 1.0M 
[ ]13033_effects-atomoxetine-without-behavior-therapy-school.pdf2022-11-07 22:31 582K 
[ ]13034_effects-atypical-antipsychotics-syndromal-profile.pdf2022-11-07 22:37 59K 
[ ]13035_effects-atypical-antipsychotics-weight-serum-lipid.pdf2022-11-07 22:41 81K 
[ ]13036_effects-behavioral-therapy-weight-loss-overweight.pdf2022-11-07 22:16 148K 
[ ]13037_effects-benzodiazepines-cognition.pdf2022-11-07 22:18 108K 
[ ]13038_effects-breathing-related-sleep-disorders-mood-disturbances.pdf2022-11-07 22:36 63K 
[ ]13039_effects-bupropion-augmentation-escitalopram-resistant.pdf2022-11-07 22:14 281K 
[ ]13040_effects-changing-typical-atypical-antipsychotic-drugs.pdf2022-11-07 22:03 56K 
[ ]13041_effects-chronic-lithium-treatment-peripheral-nervous.pdf2022-11-07 22:55 45K 
[ ]13042_effects-cigarette-smoking-neuropsychological-performance.pdf2022-11-07 22:48 258K 
[ ]13043_effects-clozapine-aggression-substance-abuse-schizophrenic.pdf2022-11-07 22:50 46K 
[ ]13044_effects-clozapine-cognitive-functioning-schizophrenia.pdf2022-11-07 22:28 61K 
[ ]13045_effects-clozapine-therapy-schizophrenic-individuals.pdf2022-11-07 22:28 43K 
[ ]13046_effects-clozapine-versus-haloperidol-measures-impulsive.pdf2022-11-07 22:57 59K 
[ ]13047_effects-co-occurring-depression-treatment-anxiety.pdf2022-11-07 22:17 130K 
[ ]13048_effects-dextroamphetamine-depression-fatigue-men-hiv.pdf2022-11-07 22:11 55K 
[ ]13049_effects-donepezil-emotionalbehavioral-symptoms-alzheimers.pdf2022-11-07 22:22 66K 
[ ]13050_effect-second-generation-antipsychotics-caregiver.pdf2022-11-07 22:38 359K 
[ ]13051_effects-ecstasy-blocked-serotonin-reuptake-inhibitors.pdf2022-11-07 22:10 49K 
[ ]13052_effect-selective-serotonin-reuptake-inhibitor-treatment.pdf2022-11-07 22:34 48K 
[ ]13053_effect-serotonin-reuptake-inhibitor-irritability-apathy.pdf2022-11-07 22:34 124K 
[ ]13054_effect-sertraline-add-brief-dynamic-psychotherapy.pdf2022-11-07 22:25 340K 
[ ]13055_effect-sertraline-plasma-nortriptyline-levels-depressed.pdf2022-11-07 22:16 35K 
[ ]13056_effects-escitalopram-prophylaxis-during-antiviral.pdf2022-11-07 22:11 413K 
[ ]13057_effects-estrogen-central-nervous-system.pdf2022-11-07 22:03 69K 
[ ]13059_effects-exogenous-melatonin-administration-withdrawal.pdf2022-11-07 22:20 105K 
[ ]13060_effects-fluvoxamine-paroxetine-sleep-structure-normal.pdf2022-11-07 22:05 125K 
[ ]13061_effects-gender-age-plasma-levels-clozapine-metabolites.pdf2022-11-07 22:54 40K 
[ ]13062_effects-integrated-treatment-antipsychotic-medication.pdf2022-11-07 22:08 154K 
[ ]13063_effects-levetiracetam-tardive-dyskinesia-randomized.pdf2022-11-07 22:23 263K 
[ ]13064_effects-light-therapy-suicidal-ideation-patients-winter.pdf2022-11-07 22:56 50K 
[ ]13065_effects-lithium-cognitive-performance-meta-analysis.pdf2022-11-07 22:37 500K 
[ ]13066_effects-lithium-treatment-discontinuation-suicidal.pdf2022-11-07 22:16 72K 
[ ]13067_effects-long-term-clozapine-add-therapy-rehospitalization.pdf2022-11-07 22:01 105K 
[ ]13068_effects-management-menopausal-transition-women-depression.pdf2022-11-07 22:50 170K 
[ ]13069_effects-menstrual-cycle-measures-personality-women.pdf2022-11-07 22:45 57K 
[ ]13070_effects-metrifonate-cognitive-behavioral-functional.pdf2022-11-07 22:45 77K 
[ ]13071_effects-mind-body-interventions-sleep-cancer-patients.pdf2022-11-07 22:47 471K 
[ ]13072_effects-mirtazapine-plasma-lipid-profiles-healthy.pdf2022-11-07 22:16 68K 
[ ]13073_effects-n-acetyl-cysteine-suicidal-ideation-bipolar.pdf2022-11-07 22:02 88K 
[ ]13074_effects-nefazodone-body-weight-pooled-analysis-selective.pdf2022-11-07 22:25 51K 
[ ]13075_effects-newer-antidepressants-low-density-lipoprotein.pdf2022-11-07 22:08 58K 
[ ]13076_effects-novel-antipsychotics-glucose-lipid-levels.pdf2022-11-07 22:42 90K 
[ ]13077_effects-of-antipsychotics-on-mortality-trends-in-ad.pdf2022-11-07 22:22 240K 
[ ]13078_effects-of-bilateral-rtms-on-suicidal-ideation-in-depression.pdf2022-11-07 22:40 275K 
[ ]13079_effects-of-direct-to-consumer-advertising.pdf2022-11-07 22:09 281K 
[ ]13080_effects-of-herpesviridae-and-toxoplasma-gondii-infection-on-cognition.pdf2022-11-07 22:54 298K 
[ ]13081_effects-of-lai-paliperidone-based-on-illness-duration.pdf2022-11-07 22:51 370K 
[ ]13083_effects-of-maternal-postnatal-depression-on-a-childs-iq.pdf2022-11-07 22:41 1.3M 
[ ]13084_effects-of-rapastinel-on-serum-bdnf-in-obsessive-compulsive-disorder.pdf2022-11-07 22:30 348K 
[ ]13085_effects-olanzapine-dimensions-schizophrenia-derived.pdf2022-11-07 22:16 116K 
[ ]13086_effects-olanzapine-polydipsia-intermittent-hyponatremia.pdf2022-11-07 22:35 35K 
[ ]13087_effects-olanzapine-prolactin-levels-female-patients.pdf2022-11-07 22:46 94K 
[ ]13088_effects-olanzapine-reducing-emergence-psychosis-among.pdf2022-11-07 22:22 63K 
[ ]13089_effects-olanzapine-risperidone-glucose-metabolism.pdf2022-11-07 22:53 521K 
[ ]13090_effects-patient-demographics-risperidone-dosage-clinical.pdf2022-11-07 22:54 61K 
[ ]13091_effects-psychiatric-disorders-psychotropic-medications.pdf2022-11-07 22:25 98K 
[ ]13092_effects-race-information-variance-disagreement-between.pdf2022-11-07 23:01 56K 
[ ]13093_effects-rate-discontinuing-lithium-maintenance-treatment.pdf2022-11-07 22:06 78K 
[ ]13094_effects-repetitive-transcranial-magnetic-stimulation.pdf2022-11-07 22:33 151K 
[ ]13095_effects-risperidone-five-dimensions-schizophrenia.pdf2022-11-07 22:51 69K 
[ ]13096_effects-stimulant-medication-neuropsychological-functioning.pdf2022-11-07 22:04 201K 
[ ]13097_effects-stroke-rehabilitation-incidence-poststroke.pdf2022-11-07 23:03 607K 
[ ]13098_effect-staff-training-agitation-restraint-nursing.pdf2022-11-07 22:37 412K 
[ ]13099_effect-stimulant-medications-attention-deficit-hyperactivity.pdf2022-11-07 23:00 186K 
[ ]13100_effect-stimulants-nocturnal-motor-activity-sleep-quality.pdf2022-11-07 22:20 45K 
[ ]13102_effects-traditional-chinese-herbal-medicine-yi-gan.pdf2022-11-07 22:14 147K 
[ ]13103_effects-treatment-highly-purified-omega-fatty-acids.pdf2022-11-07 22:33 501K 
[ ]13104_effect-sudden-clozapine-discontinuation-management.pdf2022-11-07 22:35 88K 
[ ]13105_effects-undertreated-chronic-medical-illnesses-patients.pdf2022-11-07 22:38 289K 
[ ]13106_effects-venlafaxine-blood-pressure-meta-analysis-original.pdf2022-11-07 22:22 53K 
[ ]13107_effects-venlafaxine-social-activity-level-depressed.pdf2022-11-07 22:57 69K 
[ ]13108_effect-switch-ziprasidone-adult-population-autistic.pdf2022-11-07 22:28 51K 
[ ]13109_effect-tryptophan-hydroxylase-gene-polymorphism-aggression.pdf2022-11-07 22:54 271K 
[ ]13110_efficacy-acamprosate-treatment-alcohol-dependence.pdf2022-11-07 22:35 183K 
[ ]13111_efficacy-acute-electroconvulsive-therapy-atypical.pdf2022-11-07 22:37 185K 
[ ]13112_efficacy-adjunctive-n-acetylcysteine-major-depressive.pdf2022-11-07 22:48 1.3M 
[ ]13113_efficacy-adverse-events-treatment-discontinuations.pdf2022-11-07 22:09 66K 
[ ]13115_efficacy-agomelatine-elderly-patients-recurrent-major.pdf2022-11-07 23:00 390K 
[ ]13116_efficacy-analysis-olanzapine-treatment-data-schizophrenia.pdf2022-11-07 22:52 38K 
[ ]13117_efficacy-and-safety-of-adjunctive-brexpiprazole-in-mdd.pdf2022-11-07 22:36 437K 
[ ]13118_efficacy-and-safety-of-aripiprazole-lauroxil.pdf2022-11-07 22:46 730K 
[ ]13119_efficacy-and-safety-of-dasotraline-in-adults-with-binge-eating-disorder.pdf2022-11-07 23:00 898K 
[ ]13120_efficacy-and-safety-of-olanzapinesamidorphan.pdf2022-11-07 22:03 836K 
[ ]13121_efficacy-antidepressants-dysthymia-meta-analysis-placebo.pdf2022-11-07 22:21 290K 
[ ]13122_efficacy-antidepressants-late-life-depression-meta.pdf2022-11-07 22:29 434K 
[ ]13123_efficacy-antipsychotic-drugs-against-hostility-european.pdf2022-11-07 22:13 346K 
[ ]13124_efficacy-aripiprazole-against-hostility-schizophrenia.pdf2022-11-07 22:57 131K 
[ ]13125_efficacy-atypical-antipsychotics-bipolar-disorders.pdf2022-11-07 22:43 70K 
[ ]13126_efficacy-atypical-antipsychotics-early-onset-schizophrenia.pdf2022-11-07 22:17 164K 
[ ]13127_efficacy-atypical-antipsychotics-elderly-patients.pdf2022-11-07 22:16 61K 
[ ]13128_efficacy-atypical-antipsychotics-treatment-depressive.pdf2022-11-07 22:42 75K 
[ ]13129_efficacy-auditory-processingfocused-cognitive-remediation.pdf2022-11-07 23:00 120K 
[ ]13130_efficacy-bupropion-selective-serotonin-reuptake-inhibitors.pdf2022-11-07 22:47 178K 
[ ]13131_efficacy-citalopram-monotherapy-adjunctive-treatment.pdf2022-11-07 22:20 71K 
[ ]13132_efficacy-cognitive-behavioral-therapy-bipolar-disorder.pdf2022-11-07 22:33 331K 
[ ]13133_efficacy-cognitive-side-effects-brief-pulse-ultrabrief.pdf2022-11-07 22:28 415K 
[ ]13134_efficacy-cognitive-side-effects-electroconvulsive.pdf2022-11-07 22:27 283K 
[ ]13135_efficacy-continuation-treatment-hypericum-perforatum.pdf2022-11-07 22:48 122K 
[ ]13136_efficacy-controlled-release-paroxetine-treatment-late.pdf2022-11-07 22:51 85K 
[ ]13137_efficacy-dose-increase-among-nonresponders-low-dose.pdf2022-11-07 22:18 244K 
[ ]13138_efficacy-effectiveness-depot-versus-oral-antipsychotics.pdf2022-11-07 22:39 408K 
[ ]13139_efficacy-effectiveness-samples-differ-antidepressant.pdf2022-11-07 22:10 384K 
[ ]13140_efficacy-effectiveness-second-generation-antipsychotics.pdf2022-11-07 22:12 45K 
[ ]13141_efficacy-estradiol-depression-is-estrogen-deficiency.pdf2022-11-07 22:09 121K 
[ ]13142_efficacy-fluvoxamine-treatment-major-depression-comorbid.pdf2022-11-07 22:45 29K 
[ ]13143_efficacy-issues-antidepressants.pdf2022-11-07 22:28 43K 
[ ]13144_efficacy-lithium-mania-maintenance-therapy-bipolar.pdf2022-11-07 22:24 54K 
[ ]13145_efficacy-lithium-vs-valproate-treatment-mania-elderly.pdf2022-11-07 22:36 61K 
[ ]13146_efficacy-mirtazapine-prevention-depressive-relapse.pdf2022-11-07 22:13 67K 
[ ]13147_efficacy-molindone-treatment-refractory-agitated-schizophrenia.pdf2022-11-07 22:28 210K 
[ ]13148_efficacy-newer-anticonvulsant-medications-bipolar.pdf2022-11-07 22:37 59K 
[ ]13149_efficacy-nonpharmacologic-interventions-agitation.pdf2022-11-07 22:06 329K 
[ ]13150_efficacy-novel-antidepressant-agomelatine-circadian.pdf2022-11-07 22:30 504K 
[ ]13151_efficacy-novel-biphasic-controlled-release-methylphenidate.pdf2022-11-07 22:27 224K 
[ ]13152_efficacy-of-citalopram-treatment-in-bipolar-depression.pdf2022-11-07 22:01 1.4M 
[ ]13153_efficacy-olanzapine-overview-pivotal-clinical-trials.pdf2022-11-07 22:37 51K 
[ ]13154_efficacy-omega-supplementation-major-depression-randomized.pdf2022-11-07 22:53 369K 
[ ]13155_efficacy-osmotic-release-oral-system-oros-methylphenidate.pdf2022-11-07 22:37 287K 
[ ]13156_efficacy-outcomes-clinical-trials-edivoxetine-adjunctive.pdf2022-11-07 22:34 309K 
[ ]13157_efficacy-piracetam-treatment-tardive-dyskinesia-schizophrenic.pdf2022-11-07 22:44 173K 
[ ]13158_efficacy-quetiapine-generalized-social-anxiety-disorder.pdf2022-11-07 22:14 110K 
[ ]13159_efficacy-quetiapine-monotherapy-treatment-depressive.pdf2022-11-07 22:27 391K 
[ ]13160_efficacy-quetiapine-risperidone-against-depressive.pdf2022-11-07 22:40 82K 
[ ]13161_efficacy-rapid-acting-intramuscular-formulation-olanzapine.pdf2022-11-07 22:52 38K 
[ ]13162_efficacy-response-sertraline-versus-fluoxetine-treatment.pdf2022-11-07 22:06 49K 
[ ]13163_efficacy-risperidone-augmentation-antidepressants.pdf2022-11-07 22:03 253K 
[ ]13164_efficacy-risperidone-reducing-positive-negative-symptoms.pdf2022-11-07 22:12 41K 
[ ]13165_efficacy-safety-adjunctive-armodafinil-adults-major.pdf2022-11-07 22:02 1.2M 
[ ]13166_efficacy-safety-adjunctive-brexpiprazole-mg-major.pdf2022-11-07 22:50 443K 
[ ]13167_efficacy-safety-adjunctive-cariprazine-inadequate.pdf2022-11-07 22:29 1.6M 
[ ]13168_efficacy-safety-adjunctive-oral-ziprasidone-acute.pdf2022-11-07 22:26 464K 
[ ]13169_efficacy-safety-aripiprazole-acute-treatment-schizophrenia.pdf2022-11-07 22:53 110K 
[ ]13170_efficacy-safety-aripiprazole-adjunctive-therapy-major.pdf2022-11-07 22:10 263K 
[ ]13171_efficacy-safety-aripiprazole-haloperidol-versus-placebo.pdf2022-11-07 22:08 88K 
[ ]13172_efficacy-safety-bilateral-rtms-medication-resistant.pdf2022-11-07 22:03 67K 
[ ]13173_efficacy-safety-clozapine-versus-chlorpromazine-geriatric.pdf2022-11-07 22:59 30K 
[ ]13174_efficacy-safety-deep-brain-stimulation-patients-medication.pdf2022-11-07 22:09 198K 
[ ]13175_efficacy-safety-desvenlafaxine-mgd-prevention-relapse.pdf2022-11-07 22:03 385K 
[ ]13176_efficacy-safety-desvenlafaxine-mgd-randomized-placebo.pdf2022-11-07 22:42 442K 
[ ]13177_efficacy-safety-doxepin-mg-mg-mg-elderly-patients.pdf2022-11-07 22:08 229K 
[ ]13178_efficacy-safety-duloxetine-mg-mg-daily-patients-hospitalized.pdf2022-11-07 22:19 481K 
[ ]13179_efficacy-safety-duloxetine-mg-once-daily-treatment.pdf2022-11-07 22:45 253K 
[ ]13180_efficacy-safety-enteric-coated-formulation-fluoxetine.pdf2022-11-07 22:43 59K 
[ ]13181_efficacy-safety-fluvoxamine-body-dysmorphic-disorder.pdf2022-11-07 22:37 104K 
[ ]13182_efficacy-safety-gradual-discontinuation-clonazepam.pdf2022-11-07 22:25 49K 
[ ]13183_efficacy-safety-hydroxyzine-treatment-generalized.pdf2022-11-07 22:16 82K 
[ ]13184_efficacy-safety-intramuscular-aripiprazole-patients.pdf2022-11-07 22:20 107K 
[ ]13185_efficacy-safety-lamotrigine-add-treatment-lithium.pdf2022-11-07 22:33 252K 
[ ]13186_efficacy-safety-levomilnacipran-sustained-release-major-depressive-disorder-phase-3-RCT.pdf2022-11-07 22:08 311K 
[ ]13187_efficacy-safety-levomilnacipran-sustained-release-moderate-severe-major-depressive-disorder-RCT-proo.pdf2022-11-07 22:46 422K 
[ ]13188_efficacy-safety-low-high-dose-cariprazine-acute-mixed.pdf2022-11-07 22:57 318K 
[ ]13189_efficacy-safety-loxapine-inhalation-treatment-agitation.pdf2022-11-07 22:45 806K 
[ ]13190_efficacy-safety-melatonin-agonist-beta-methyl-chloromelatonin.pdf2022-11-07 22:21 133K 
[ ]13191_efficacy-safety-mirtazapine-major-depressive-disorder.pdf2022-11-07 22:45 70K 
[ ]13192_efficacy-safety-neuroleptics-behavioral-disorders.pdf2022-11-07 22:26 89K 
[ ]13193_efficacy-safety-pregabalin-treatment-generalized-anxiety.pdf2022-11-07 22:04 140K 
[ ]13194_efficacy-safety-quetiapine-children-adolescents-mania.pdf2022-11-07 22:43 495K 
[ ]13195_efficacy-safety-quetiapine-xr-monotherapy-adjunctive.pdf2022-11-07 22:36 372K 
[ ]13196_efficacy-safety-risperidone-treatment-schizoaffective.pdf2022-11-07 22:18 101K 
[ ]13197_efficacy-safety-sildenafil-men-serotonergic-antidepressant.pdf2022-11-07 22:53 110K 
[ ]13198_efficacy-safety-tolerability-antipsychotics-elderly.pdf2022-11-07 22:59 95K 
[ ]13199_efficacy-safety-tolerability-quetiapine-patients-schizophrenia.pdf2022-11-07 22:26 87K 
[ ]13200_efficacy-safety-tolerability-venlafaxine-extended.pdf2022-11-07 22:09 81K 
[ ]13201_efficacy-safety-topiramate-monotherapy-civilian-posttraumatic.pdf2022-11-07 22:50 158K 
[ ]13202_efficacy-safety-vilazodone-major-depressive-disorder.pdf2022-11-07 22:22 439K 
[ ]13203_efficacy-safety-weekly-treatment-enteric-coated-fluoxetine.pdf2022-11-07 22:41 60K 
[ ]13204_efficacy-sertraline-severe-generalized-social-anxiety.pdf2022-11-07 22:55 72K 
[ ]13205_efficacy-slow-repetitive-transcranial-magnetic-stimulation.pdf2022-11-07 22:51 144K 
[ ]13206_efficacy-ssris-newer-antidepressants-severe-depression.pdf2022-11-07 22:27 79K 
[ ]13207_efficacy-tolerability-adjunctive-ziprasidone-treatment.pdf2022-11-07 22:05 196K 
[ ]13208_efficacy-tolerability-asenapine-acute-schizophrenia.pdf2022-11-07 22:32 239K 
[ ]13209_efficacy-tolerability-controlled-release-immediate.pdf2022-11-07 22:45 84K 
[ ]13210_efficacy-tolerability-controlled-release-paroxetine.pdf2022-11-07 22:39 176K 
[ ]13211_efficacy-tolerability-duloxetine-novel-dual-reuptake.pdf2022-11-07 22:17 75K 
[ ]13212_efficacy-tolerability-once-daily-extended-release.pdf2022-11-07 22:25 260K 
[ ]13213_efficacy-tolerability-once-daily-venlafaxine-extended.pdf2022-11-07 22:06 38K 
[ ]13214_efficacy-tolerability-open-label-topiramate-treatment.pdf2022-11-07 22:43 83K 
[ ]13215_efficacy-tolerability-oral-paliperidone-extended-release.pdf2022-11-07 22:38 372K 
[ ]13216_efficacy-tolerability-paroxetine-long-term-treatment.pdf2022-11-07 22:12 80K 
[ ]13217_efficacy-tolerability-quetiapine-treatment-borderline.pdf2022-11-07 22:24 74K 
[ ]13219_efficacy-tolerability-tranylcypromine-versus-phenelzine.pdf2022-11-07 22:58 54K 
[ ]13220_efficacy-tolerability-ziprasidone-versus-risperidone.pdf2022-11-07 22:28 101K 
[ ]13221_efficacy-topiramate-treatment-crack-cocaine-dependence.pdf2022-11-07 22:27 343K 
[ ]13222_efficacy-typical-atypical-antipsychotics-primary-comorbid.pdf2022-11-07 23:00 128K 
[ ]13223_efficacy-varenicline-smoking-cessation-bipolar-disorder.pdf2022-11-07 22:49 133K 
[ ]13224_efficacy-venlafaxine-extended-release-patients-major.pdf2022-11-07 22:12 113K 
[ ]13225_efficacy-ziprasidone-against-hostility-schizophrenia.pdf2022-11-07 22:36 87K 
[ ]13226_efficiently-maintain-own-electronic-resource-library.pdf2022-11-07 22:25 126K 
[ ]13227_ehealth-interventions-for-perinatal-anxiety.pdf2022-11-07 22:14 448K 
[ ]13228_elcectroconvulsive-therapy-th-ed.pdf2022-11-07 22:05 17K 
[ ]13229_elderly-patients-dementia-related-symptoms-severe.pdf2022-11-07 22:22 279K 
[ ]13230_electroacupuncture-treating-residual-insomnia-associated.pdf2022-11-07 22:22 114K 
[ ]13231_electrocardiographic-abnormalities-patients-treated.pdf2022-11-07 22:42 77K 
[ ]13232_electroconvulsive-therapy-bipolar-disorder-evidence.pdf2022-11-07 22:44 115K 
[ ]13233_electroconvulsive-therapy-bipolar-mixed-states-overlooked.pdf2022-11-07 22:54 116K 
[ ]13234_electroconvulsive-therapy-cardiovascular-complications.pdf2022-11-07 22:20 38K 
[ ]13235_electroconvulsive-therapy-coexistent-schizophrenia.pdf2022-11-07 22:08 111K 
[ ]13237_electroconvulsive-therapy-device-classification-response.pdf2022-11-07 22:56 201K 
[ ]13238_electroconvulsive-therapy-guide-professionals-patients.pdf2022-11-07 22:30 97K 
[ ]13239_electroconvulsive-therapy-medication-nonresponsive.pdf2022-11-07 22:13 84K 
[ ]13240_electroconvulsive-therapy-obsessive-compulsive-disorder.pdf2022-11-07 22:05 321K 
[ ]13241_electroconvulsive-therapy-patients-severe-drug-resistant.pdf2022-11-07 22:45 216K 
[ ]13242_electroconvulsive-therapy-state-hospital-review.pdf2022-11-07 22:16 84K 
[ ]13243_electroconvulsive-therapy-suicide-risk.pdf2022-11-07 22:09 60K 
[ ]13244_electroconvulsive-therapy-update-recognizing-treating.pdf2022-11-07 22:03 31K 
[ ]13245_electroencephalographic-abnormalities-associated-antidepressant.pdf2022-11-07 22:50 98K 
[ ]13246_elements-clinical-research-psychiatry.pdf2022-11-07 22:03 60K 
[ ]13247_elevated-cardiovascular-risk-patients-bipolar-disorder.pdf2022-11-07 22:26 165K 
[ ]13248_elevated-hemoglobin-ac-possible-indicator-diabetes.pdf2022-11-07 22:51 191K 
[ ]13249_elevated-levels-insulin-leptin-blood-lipids-olanzapine.pdf2022-11-07 22:52 74K 
[ ]13250_elevated-plasma-clozapine-concentrations-phenobarbital.pdf2022-11-07 22:57 80K 
[ ]13251_elevated-serum-levels-high-sensitivity-c-reactive.pdf2022-11-07 22:25 112K 
[ ]13252_emdr-treatment-ptsd.pdf2022-11-07 23:03 44K 
[ ]13253_emdr-women-experience-traumatic-events.pdf2022-11-07 22:53 68K 
[ ]13254_emergence-darkness-phobia-bipolar-patient-during-quetiapine.pdf2022-11-07 22:08 88K 
[ ]13255_emergence-koro-abrupt-cessation-olanzapine.pdf2022-11-07 22:37 100K 
[ ]13256_emergence-ptsd-trauma-survivors-dementia.pdf2022-11-07 22:31 63K 
[ ]13257_emergence-social-phobia-during-clozapine-treatment.pdf2022-11-07 22:39 32K 
[ ]13258_emergency-treatment-acute-psychosis.pdf2022-11-07 22:40 30K 
[ ]13259_emergency-treatment-depression-complicated-psychosis.pdf2022-11-07 22:14 53K 
[ ]13260_emerging-differential-roles-gabaergic-antiglutamatergic.pdf2022-11-07 22:09 73K 
[ ]13261_emerging-pharmacologic-treatments-alcohol-dependence.pdf2022-11-07 22:17 107K 
[ ]13262_emerging-role-atypical-antipsychotics-treatment-tardive.pdf2022-11-07 22:21 133K 
[ ]13263_emerging-therapeutic-strategies-alzheimers-disease.pdf2022-11-07 22:06 145K 
[ ]13264_emerging-therapies-bipolar-depression.pdf2022-11-07 22:20 139K 
[ ]13266_emotional-experience-estimates-dltsubgtltsubgt-receptor.pdf2022-11-07 22:39 495K 
[ ]13267_emotional-numbing-posttraumatic-stress-disorder-functional.pdf2022-11-07 22:04 946K 
[ ]13268_emotion-dysregulation-negative-affect-association.pdf2022-11-07 22:24 296K 
[ ]13269_empathic-healer-endangered-species.pdf2022-11-07 22:04 80K 
[ ]13270_empirical-characterization-heterogeneous-posttraumatic.pdf2022-11-07 22:40 414K 
[ ]13271_empirical-examination-proposed-refinement-dsm-iv-posttraumatic.pdf2022-11-07 22:37 177K 
[ ]13272_employing-pharmacologic-treatment-bipolar-disorder.pdf2022-11-07 22:45 63K 
[ ]13273_empowering-women-collaborate-mental-health-care.pdf2022-11-07 22:11 35K 
[ ]13274_endpoints-preclinical-alzheimers-disease-trials.pdf2022-11-07 22:23 141K 
[ ]13276_enhanced-prefrontal-function-pharmacotherapy-response.pdf2022-11-07 22:10 804K 
[ ]13278_enhancing-patient-outcomes-treatment-adherence.pdf2022-11-07 22:05 25K 
[ ]13279_enhancing-pharmacologic-effects-treatment-depression.pdf2022-11-07 22:15 95K 
[ ]13280_enhancing-treatment-response-depression.pdf2022-11-07 22:17 93K 
[ ]13281_enlargement-brain-cerebrospinal-fluid-spaces-predictor.pdf2022-11-07 22:27 73K 
[ ]13282_enriching-heritage.pdf2022-11-07 22:04 64K 
[ ]13283_environmental-factors-panic-disorder.pdf2022-11-07 22:39 55K 
[ ]13284_environment-schizophrenia-innovations-practice-policy.pdf2022-11-07 22:05 49K 
[ ]13285_eos-as-a-predictor-of-response-to-cognitive-training.pdf2022-11-07 22:24 243K 
[ ]13286_eosinophilia-associated-olanzapine.pdf2022-11-07 22:54 75K 
[ ]13287_eosinophilia-indicating-subclinical-clozapine-induced.pdf2022-11-07 22:40 140K 
[ ]13288_epidemic-depression-obesity.pdf2022-11-07 23:01 132K 
[ ]13289_epidemiologic-perspective-social-anxiety-disorder.pdf2022-11-07 22:58 89K 
[ ]13290_epidemiology-anxiety-disorders-prevalence-societal.pdf2022-11-07 22:55 65K 
[ ]13291_epidemiology-autistic-disorder-pervasive-developmental.pdf2022-11-07 23:02 140K 
[ ]13292_epidemiology-burden-disability-depression-anxiety.pdf2022-11-07 22:11 62K 
[ ]13293_epidemiology-cardiovascular-disease-major-metabolic.pdf2022-11-07 22:18 126K 
[ ]13294_epidemiology-chronic-major-depressive-disorder-dysthymic.pdf2022-11-07 22:53 353K 
[ ]13295_epidemiology-clinical-consequences-psychosocial-treatment.pdf2022-11-07 22:18 95K 
[ ]13296_epidemiology-daytime-sleepiness-definitions-symptomatology.pdf2022-11-07 22:42 57K 
[ ]13297_epidemiology-depression-evolution-treatment.pdf2022-11-07 22:15 248K 
[ ]13298_epidemiology-depression-throughout-female-life-cycle.pdf2022-11-07 22:49 64K 
[ ]13299_epidemiology-diagnosis-depression-late-life.pdf2022-11-07 22:02 63K 
[ ]13300_epidemiology-dsm-iv-panic-disorder-agoraphobia-united.pdf2022-11-07 23:01 127K 
[ ]13301_epidemiology-etiology-treatment-geriatric-mania.pdf2022-11-07 22:49 79K 
[ ]13302_epidemiology-fears-specific-phobia-adolescence-results.pdf2022-11-07 22:38 244K 
[ ]13303_epidemiology-major-depression-atypical-features-results.pdf2022-11-07 22:03 420K 
[ ]13304_epidemiology-morbidity-treatment-overweight-obesity.pdf2022-11-07 22:18 125K 
[ ]13305_epidemiology-obsessive-compulsive-disorder-world-view.pdf2022-11-07 22:55 28K 
[ ]13306_epidemiology-of-dsm-nicotine-use-disorder.pdf2022-11-07 22:45 269K 
[ ]13307_epidemiology-posttraumatic-stress-disorder-is-extent.pdf2022-11-07 22:32 63K 
[ ]13308_epidemiology-prevention-and-assessment-of-td.pdf2022-11-07 22:16 416K 
[ ]13310_epidemiology-proposed-ltemgtdsm-ltemgt-hoarding-disorder.pdf2022-11-07 22:13 364K 
[ ]13311_epidemiology-recognition-binge-eating-disorder-psychiatry.pdf2022-11-07 22:29 226K 
[ ]13313_epidemiology-social-anxiety-disorder-united-states.pdf2022-11-07 22:45 221K 
[ ]13314_epigenetics-methylomics-psychiatry.pdf2022-11-07 22:58 952K 
[ ]13315_episode-schizophrenia-importance-early-intervention.pdf2022-11-07 22:50 54K 
[ ]13316_episode-self-harm-older-age-report-prospective-manchester.pdf2022-11-07 22:03 352K 
[ ]13317_eppic-follow-study-episode-psychosis-longer-term.pdf2022-11-07 22:21 427K 
[ ]13318_eps-fever-versus-nms.pdf2022-11-07 22:45 42K 
[ ]13319_equivalent-switching-dose-oral-risperidone-risperidone.pdf2022-11-07 22:14 211K 
[ ]13320_erik-erikson-reader-book-review.pdf2022-11-07 22:45 55K 
[ ]13321_erotomanic-delusions-focused-child.pdf2022-11-07 22:01 43K 
[ ]13322_erythropoietin-for-cognitive-function-in-mood-disorder.pdf2022-11-07 22:30 101K 
[ ]13323_escitalopram-continuation-treatment-prevents-relapse.pdf2022-11-07 22:16 56K 
[ ]13324_escitalopram-in-adolescents-with-gad.pdf2022-11-07 22:55 373K 
[ ]13325_escitalopram-maintenance-treatment-prevention-recurrent.pdf2022-11-07 22:28 115K 
[ ]13326_escitalopram-treatment-depressive-disorder-following.pdf2022-11-07 22:42 469K 
[ ]13327_escitalopram-treatment-impulsive-compulsive-internet.pdf2022-11-07 22:39 152K 
[ ]13328_escitalopram-treatment-kleptomania-open-label-trial.pdf2022-11-07 22:27 155K 
[ ]13329_escitalopram-treatment-panic-disorder-randomized-double.pdf2022-11-07 22:37 59K 
[ ]13330_esketamine-augmentation-in-major-depressive-disorder.pdf2022-11-07 22:03 647K 
[ ]13331_esketamine-nasal-spray-rapidly-reduces-depression.pdf2022-11-07 22:24 1.1M 
[ ]13332_essential-cns-drug-development.pdf2022-11-07 22:56 78K 
[ ]13333_essential-evidence-based-psychopharmacology-nd-ed.pdf2022-11-07 23:02 74K 
[ ]13334_essential-psychopharmacology-antipsychotics-mood-stabilizers.pdf2022-11-07 22:40 29K 
[ ]13335_essential-psychopharmacology-neuroscientific-basis.pdf2022-11-07 22:38 13K 
[ ]13336_essential-psychopharmacology-prescribers-guide-antidepressants.pdf2022-11-07 22:11 104K 
[ ]13337_essentials-child-adolescent-psychiatry.pdf2022-11-07 22:28 72K 
[ ]13338_essentials-clinical-psychiatry-based-american-psychiatric.pdf2022-11-07 22:23 39K 
[ ]13339_essentials-clinical-psychopharmacology.pdf2022-11-07 22:50 42K 
[ ]13340_essentials-geriatric-psychiatry-nd-ed.pdf2022-11-07 22:30 66K 
[ ]13341_essentials-global-mental-health.pdf2022-11-07 22:05 68K 
[ ]13342_essentials-postgradute-psychiatry-rd-ed.pdf2022-11-07 22:06 36K 
[ ]13343_essentials-psychiatric-diagnosis-revised-edition-responding.pdf2022-11-07 22:54 86K 
[ ]13344_essentials-schizophrenia.pdf2022-11-07 22:04 74K 
[ ]13345_establishment-national-pregnancy-registry-atypical.pdf2022-11-07 22:31 175K 
[ ]13346_establishment-remission-criteria-anxiety-disorders.pdf2022-11-07 22:25 57K 
[ ]13347_estimating-prevalence-impact-antidepressant-induced.pdf2022-11-07 22:53 90K 
[ ]13348_estimating-ptsd-prevalence-veterans-considering-combat.pdf2022-11-07 22:35 178K 
[ ]13349_estimating-risk-suicide-following-suicide-deaths-asian.pdf2022-11-07 22:35 274K 
[ ]13350_estrogen-administration-does-reduce-rate-recurrence.pdf2022-11-07 22:37 66K 
[ ]13351_estrogen-augmentation-antidepressants-perimenopausal.pdf2022-11-07 22:33 135K 
[ ]13352_estrogen-deficiency-severe-postpartum-depression-successful.pdf2022-11-07 22:50 54K 
[ ]13353_estrogen-makes-brain-sex-organ.pdf2022-11-07 22:24 36K 
[ ]13354_estrogen-replacement-therapy-treatment-major-depressive.pdf2022-11-07 22:52 50K 
[ ]13355_eszopiclone-treatment-posttraumatic-stress-disorder.pdf2022-11-07 22:13 254K 
[ ]13356_ethical-issues-forensic-psychiatry-minimizing-harm.pdf2022-11-07 22:22 108K 
[ ]13357_ethics-bioethics-mapping-moral-landscape.pdf2022-11-07 22:21 100K 
[ ]13358_ethics-culture-society-international-perspectives.pdf2022-11-07 22:58 60K 
[ ]13359_ethics-electroconvulsive-therapy.pdf2022-11-07 22:31 55K 
[ ]13360_ethics-psychiatric-research-resource-manual-human.pdf2022-11-07 22:36 32K 
[ ]13361_ethnic-differences-antipsychotic-medication-among.pdf2022-11-07 22:27 48K 
[ ]13362_ethnic-differences-in-mental-illness-severity.pdf2022-11-07 22:47 1.0M 
[ ]13363_ethnicity-diagnosis-patients-affective-disorders.pdf2022-11-07 22:32 70K 
[ ]13364_ethnicity-effects-clinical-diagnoses-compared-best.pdf2022-11-07 22:44 151K 
[ ]13365_ethnicity-psychopharmacology-review-psychiatry-series.pdf2022-11-07 22:27 89K 
[ ]13366_ethnicity-treatment-response-schizophrenia-comparison.pdf2022-11-07 22:26 64K 
[ ]13367_ethnoracial-disparities-sexual-assault-among-asian.pdf2022-11-07 22:21 253K 
[ ]13368_ethyl-eicosapentaenoic-acid-episode-psychosis-randomized.pdf2022-11-07 22:36 173K 
[ ]13369_etiology-neurobiology-social-anxiety-disorder.pdf2022-11-07 22:45 95K 
[ ]13370_evaluating-and-treating-tardive-dyskinesia.pdf2022-11-07 22:35 572K 
[ ]13371_evaluating-antidepressant-therapies-remission-optimal.pdf2022-11-07 22:48 81K 
[ ]13372_evaluating-aspects-of-apps-and-mobile-technology-in-psychiatry.pdf2022-11-07 22:40 183K 
[ ]13374_evaluating-characteristics-patient-selection-dropout.pdf2022-11-07 22:48 55K 
[ ]13375_evaluating-clinical-trial-data-outcome-measures.pdf2022-11-07 23:01 44K 
[ ]13377_evaluating-effects-antipsychotics-cognition-schizophrenia.pdf2022-11-07 22:55 108K 
[ ]13378_evaluating-efficacy-habit-reversal-comparison-placebo.pdf2022-11-07 22:58 89K 
[ ]13383_evaluating-response-metrifonate.pdf2022-11-07 22:44 46K 
[ ]13384_evaluation-glycine-transporter-inhibitor-org-augmentation.pdf2022-11-07 22:46 331K 
[ ]13385_evaluation-interchangeability-switch-patients-treated.pdf2022-11-07 22:38 108K 
[ ]13386_evaluation-management-aggressive-behavior-elderly.pdf2022-11-07 22:23 51K 
[ ]13387_evaluation-management-breakthrough-depressive-episodes.pdf2022-11-07 22:35 51K 
[ ]13388_evaluation-management-depression-women-across-life.pdf2022-11-07 22:31 71K 
[ ]13389_evaluation-sexual-changes-stroke.pdf2022-11-07 22:35 57K 
[ ]13390_ever-increasing-pharmacopoeia-management-patients.pdf2022-11-07 22:56 57K 
[ ]13391_everyday-biological-stress-mechanisms.pdf2022-11-07 22:53 37K 
[ ]13392_every-patient-family-friend-caregiver-needs-psychiatry.pdf2022-11-07 22:50 50K 
[ ]13393_evidence-antidepressant-bipolar-depression.pdf2022-11-07 22:56 82K 
[ ]13395_evidence-based-long-term-treatment-bipolar-ii-disorder.pdf2022-11-07 22:44 64K 
[ ]13396_evidence-based-medicine-strategy-achieving-remission.pdf2022-11-07 22:13 214K 
[ ]13398_evidence-based-psychiatry-pregnancy.pdf2022-11-07 23:02 46K 
[ ]13401_evidence-based-strategy-remission-schizophrenia.pdf2022-11-07 22:04 185K 
[ ]13402_evidence-based-treatment-of-pmdd.pdf2022-11-07 22:22 198K 
[ ]13404_evidence-biochemical-lesion-depression.pdf2022-11-07 22:42 59K 
[ ]13405_evidence-early-onset-antidepressant-effect-randomized.pdf2022-11-07 22:32 77K 
[ ]13406_evidence-effectiveness-olanzapine-among-patients-nonresponsive.pdf2022-11-07 22:12 70K 
[ ]13407_evidence-efficacy-tolerability-vilazodone-treatment.pdf2022-11-07 22:42 229K 
[ ]13408_evidence-eicosapentaenoic-acid-is-effective-treating.pdf2022-11-07 22:36 81K 
[ ]13410_evidence-internet-addiction-disorder-internet-exposure.pdf2022-11-07 22:41 744K 
[ ]13411_evidence-involvement-mitochondrial-inheritance-schizophrenia.pdf2022-11-07 22:45 447K 
[ ]13414_evidence-patients-single-versus-recurrent-depressive.pdf2022-11-07 22:48 388K 
[ ]13415_evidence-s-adenosyl-l-methionine-sam-e-treatment-major.pdf2022-11-07 22:58 260K 
[ ]13416_evidence-short-term-psychodynamic-psychotherapy-depression.pdf2022-11-07 22:17 92K 
[ ]13418_evidence-synthesis-care-models-improve-general-medical.pdf2022-11-07 22:13 452K 
[ ]13419_evolution-psychiatry-research-journal.pdf2022-11-07 22:27 325K 
[ ]13420_evolution-psychopharmacology-trial-design-analysis.pdf2022-11-07 22:30 385K 
[ ]13421_evolution-remission-standard-treatment-depression.pdf2022-11-07 22:27 52K 
[ ]13422_evolving-definition-treatment-resistance.pdf2022-11-07 22:27 49K 
[ ]13423_evolving-paradigm-bipolar-disorder.pdf2022-11-07 22:31 136K 
[ ]13424_exacerbation-idiopathic-priapism-risperidone-citalopram.pdf2022-11-07 22:51 75K 
[ ]13425_exacerbation-ptsd-symptoms-duloxetine.pdf2022-11-07 22:08 99K 
[ ]13426_exaggerated-acquisition-resistance-extinction-avoidance.pdf2022-11-07 22:14 1.3M 
[ ]13427_exaggerated-tsh-responses-trh-depressed-patients-normal.pdf2022-11-07 22:41 37K 
[ ]13428_examination-participant-flow-consort-diagram-improve.pdf2022-11-07 22:33 267K 
[ ]13429_examining-association-between-posttraumatic-stress.pdf2022-11-07 22:56 653K 
[ ]13430_examining-comorbidity-bipolar-disorder-autism-spectrum.pdf2022-11-07 22:12 560K 
[ ]13431_examining-proposed-disruptive-mood-dysregulation-disorder.pdf2022-11-07 22:15 330K 
[ ]13432_examining-relation-between-combat-related-concussion.pdf2022-11-07 22:48 297K 
[ ]13433_examining-risperidone-those-diagnosed-autism-fda-approval.pdf2022-11-07 22:25 118K 
[ ]13434_examining-why-patients-attention-deficit-hyperactivity.pdf2022-11-07 22:04 341K 
[ ]13435_excessive-antipsychotic-dosing-state-hospitals.pdf2022-11-07 22:33 65K 
[ ]13436_excessive-daytime-sleepiness-adult-patients-adhd-measured.pdf2022-11-07 23:02 242K 
[ ]13437_excessive-daytime-sleepiness-young-adults-prospective.pdf2022-11-07 22:16 163K 
[ ]13438_excessive-premature-onset-cardiovascular-disease.pdf2022-11-07 22:05 294K 
[ ]13439_excess-suicides-in-taiwan-during-the-1918-1920-influenza-pandemic.pdf2022-11-07 22:12 579K 
[ ]13440_excitotoxicity-neuroprotection.pdf2022-11-07 22:03 236K 
[ ]13441_excretion-paroxetine-breast-milk.pdf2022-11-07 22:37 61K 
[ ]13442_executive-function-dysfunction-identification-assessment.pdf2022-11-07 22:03 82K 
[ ]13443_executive-function-predicts-antidepressant-treatment-noncompletion-in-late-life-depression.pdf2022-11-07 23:00 451K 
[ ]13444_executive-function-predicts-response-antiaggression.pdf2022-11-07 23:00 335K 
[ ]13445_executive-functions-attention-deficit-hyperactivity.pdf2022-11-07 22:52 87K 
[ ]13446_exercise-augmentation-treatment-nonremitted-major.pdf2022-11-07 22:41 499K 
[ ]13447_exercise-for-late-life-depression.pdf2022-11-07 22:07 1.1M 
[ ]13448_exercise-for-youth-at-risk-for-psychosis.pdf2022-11-07 22:47 372K 
[ ]13449_exercise-induced-orgasms-associated-fluoxetine-treatment.pdf2022-11-07 22:53 42K 
[ ]13450_exercise-mental-illness-results-national-epidemiologic.pdf2022-11-07 22:16 282K 
[ ]13451_exercise-mood-anxiety-disorders.pdf2022-11-07 22:26 216K 
[ ]13452_exercise-vs-health-education-for-treating-stimulant-use-disorder.pdf2022-11-07 22:48 775K 
[ ]13453_existential-psychopharmacologic-clinical-practice-humanistic-approach-med-check.pdf2022-11-07 22:19 129K 
[ ]13454_expected-incidence-tardive-dyskinesia-associated-atypical.pdf2022-11-07 22:25 53K 
[ ]13455_experiences-mental-health-patient-care-narratives.pdf2022-11-07 23:02 97K 
[ ]13456_experience-wireless-system-incorporating-physiologic.pdf2022-11-07 22:55 2.5M 
[ ]13457_experiential-avoidance-in-adolescent-mdd-and-gad.pdf2022-11-07 22:24 7.4M 
[ ]13458_expert-consensus-guidelines-treating-depression-bipolar.pdf2022-11-07 22:31 47K 
[ ]13459_expert-consensus-survey-adherence-and-digital-medicine.pdf2022-11-07 22:07 6.5M 
[ ]13460_expert-psychiatric-evidence.pdf2022-11-07 22:20 75K 
[ ]13461_expert-survey-results-guideline-references-optimitizing-pharmacologic-treatment-psychotic-disorders.pdf2022-11-07 22:28 233K 
[ ]13462_expert-survey-results-guideline-references-using-antipsychotic-agents-older-adults-geriatric.pdf2022-11-07 22:41 364K 
[ ]13463_explanatory-therapy-hypochondriasis.pdf2022-11-07 22:06 72K 
[ ]13464_exploration-resilience-construct-posttraumatic-stress.pdf2022-11-07 22:43 385K 
[ ]13465_exploratory-analyses-efficacy-data-major-depressive.pdf2022-11-07 22:27 1.0M 
[ ]13466_exploratory-analyses-efficacy-data-schizophrenia-trials.pdf2022-11-07 22:14 824K 
[ ]13467_exploratory-data-mining-analysis-identifying-subgroups.pdf2022-11-07 22:48 339K 
[ ]13468_exploratory-randomized-controlled-study-healthy-living.pdf2022-11-07 22:59 418K 
[ ]13469_exploring-construct-subjective-sleep-quality-patients.pdf2022-11-07 22:26 1.0M 
[ ]13470_exploring-correlates-suicide-attempts-among-individuals.pdf2022-11-07 22:55 304K 
[ ]13471_exploring-regional-variation-antipsychotic-coprescribing.pdf2022-11-07 22:17 278K 
[ ]13472_exploring-relationship-between-depression-erectile.pdf2022-11-07 22:42 66K 
[ ]13473_exploring-treatment-alternatives-weekly-dosing-fluoxetine.pdf2022-11-07 22:45 58K 
[ ]13474_exposure-and-ritual-prevention-therapy-for-trichotillomania.pdf2022-11-07 22:46 85K 
[ ]13475_exposure-based-cbt-extend-effects-intravenous-ketamine.pdf2022-11-07 22:50 134K 
[ ]13476_exposure-mirtazapine-during-pregnancy-prospective.pdf2022-11-07 22:38 78K 
[ ]13477_exposure-response-prevention-helps-adults-obsessive.pdf2022-11-07 22:28 189K 
[ ]13478_exposure-therapy-ltspan-stylefont-variantsmall-capsgtdltspangt.pdf2022-11-07 22:10 765K 
[ ]13479_expression-myristoylated-alanine-rich-c-kinase-substrate.pdf2022-11-07 22:03 178K 
[ ]13480_extended-antipsychotic-dosing-maintenance-treatment.pdf2022-11-07 22:11 275K 
[ ]13481_extended-release-bupropion-patients-major-depressive.pdf2022-11-07 22:29 120K 
[ ]13482_extended-release-carbamazepine-capsules-monotherapy.pdf2022-11-07 22:05 154K 
[ ]13483_extended-release-quetiapine-adjunct-antidepressant.pdf2022-11-07 22:32 311K 
[ ]13484_extended-release-quetiapine-fumarate-monotherapy-major.pdf2022-11-07 22:59 482K 
[ ]13485_extended-release-quetiapine-fumarate-patients-major.pdf2022-11-07 22:07 503K 
[ ]13486_extending-antidepressant-treatment-how-long-to-wait-for-response.pdf2022-11-07 22:48 331K 
[ ]13487_extending-imprint.pdf2022-11-07 22:34 45K 
[ ]13488_extensive-white-matter-abnormalities-clinical-symptoms.pdf2022-11-07 22:17 660K 
[ ]13489_extent-impact-mental-health-problems-disaster.pdf2022-11-07 22:14 79K 
[ ]13490_extract-ltspan-classbold-italicgtginkgo-bilobaltspangt.pdf2022-11-07 22:19 298K 
[ ]13491_extrapyramidal-side-effects-and-antipsychotics.pdf2022-11-07 22:50 350K 
[ ]13492_extrapyramidal-side-effects-associated-aripiprazole.pdf2022-11-07 22:41 124K 
[ ]13493_extrapyramidal-side-effects-tardive-dyskinesia-concept.pdf2022-11-07 22:02 67K 
[ ]13494_extrapyramidal-symptoms-tolerability-olanzapine-versus.pdf2022-11-07 22:51 48K 
[ ]13495_extreme-attributions-predict-course-bipolar-depression.pdf2022-11-07 22:32 304K 
[ ]13496_extreme-creatine-phosphokinase-elevation-old-man.pdf2022-11-07 23:02 155K 
[ ]13497_facial-emotion-recognition-in-dementia-and-depression.pdf2022-11-07 22:19 2.6M 
[ ]13498_facial-hyperhidrosis-induced-social-fear-alleviated.pdf2022-11-07 22:37 81K 
[ ]13499_facilitating-compliance-antipsychotic-medication.pdf2022-11-07 22:15 33K 
[ ]13500_facility-level-factors-associated-guideline-concordant.pdf2022-11-07 22:49 91K 
[ ]13501_factors-affecting-exits-homelessness-among-persons.pdf2022-11-07 22:59 280K 
[ ]13502_factors-affecting-return-symptoms-treatment-week.pdf2022-11-07 22:38 79K 
[ ]13503_factors-associated-health-related-quality-life-among.pdf2022-11-07 22:22 118K 
[ ]13504_factors-associated-medication-adherence-african-american.pdf2022-11-07 22:34 140K 
[ ]13505_factors-associated-persistence-onset-anxiety-disorders.pdf2022-11-07 22:09 329K 
[ ]13506_factors-associated-suicide-attempts-patients-bipolar.pdf2022-11-07 22:08 92K 
[ ]13507_factors-associated-temporal-priority-comorbid-bipolar.pdf2022-11-07 22:12 91K 
[ ]13508_factors-contributing-failed-trials-agents-technology.pdf2022-11-07 22:37 53K 
[ ]13509_factors-influence-treatment-success-schizophrenia.pdf2022-11-07 22:10 216K 
[ ]13510_factors-influencing-acute-weight-change-patients-schizophrenia.pdf2022-11-07 22:22 71K 
[ ]13511_factors-influencing-compliance-schizophrenia-patients.pdf2022-11-07 22:53 51K 
[ ]13512_factors-modifying-efficacy-transcranial-magnetic-stimulation.pdf2022-11-07 22:31 113K 
[ ]13513_factors-play-faster-progression-female-pathological.pdf2022-11-07 22:33 61K 
[ ]13514_factors-predict-placebo-response-anxiety-disorders.pdf2022-11-07 22:27 83K 
[ ]13515_factors-related-to-suicide-mortality-in-young-adults.pdf2022-11-07 22:04 778K 
[ ]13516_faculty-disclosures.pdf2022-11-07 22:55 32K 
[ ]13517_failed-studies-should-used-malign-treatments.pdf2022-11-07 22:45 134K 
[ ]13518_failure-evidence-based-medicine-guide-treatment-antidepressant.pdf2022-11-07 22:49 59K 
[ ]13519_failure-rate-professional-subjects-clinical-trials.pdf2022-11-07 22:43 138K 
[ ]13520_false-positive-methadone-drug-screens-during-quetiapine.pdf2022-11-07 22:10 88K 
[ ]13521_false-positive-phencyclidine-drug-screenings-during.pdf2022-11-07 22:54 165K 
[ ]13522_familial-individual-correlates-nonsuicidal-self-injury.pdf2022-11-07 22:42 268K 
[ ]13523_familial-psychiatric-illness-posttraumatic-stress.pdf2022-11-07 22:46 56K 
[ ]13524_familial-transmission-suicidal-behavior-factors-mediating.pdf2022-11-07 22:03 362K 
[ ]13525_family-history-depression-therapeutic-outcome-findings.pdf2022-11-07 22:45 305K 
[ ]13526_family-history-early-psychotogenic-response-marijuana.pdf2022-11-07 22:11 126K 
[ ]13527_family-intervention-approach-loss-clinical-effect.pdf2022-11-07 22:25 107K 
[ ]13529_family-members-legal-experience-insurers-refusal-recertify.pdf2022-11-07 22:40 53K 
[ ]13530_family-outcomes-randomized-control-trial-relapse-prevention.pdf2022-11-07 22:13 308K 
[ ]13531_family-partner-psychopathology-risk-postpartum-mental.pdf2022-11-07 22:18 135K 
[ ]13532_family-problems-among-recently-returned-military-veterans.pdf2022-11-07 22:53 231K 
[ ]13533_family-treatment-bipolar-disorder-family-impairment.pdf2022-11-07 22:44 252K 
[ ]13534_famotidine-augmentation-schizophrenia-hope-hype.pdf2022-11-07 22:39 583K 
[ ]13535_fast-are-antidepressants.pdf2022-11-07 22:33 66K 
[ ]13536_fatal-body-dysmorphic-disorder-proxy.pdf2022-11-07 22:43 63K 
[ ]13537_fatal-flaws-navigating-destructive-relationships-disorders.pdf2022-11-07 22:17 109K 
[ ]13538_fat-distribution-major-depressive-disorder-late-adolescence.pdf2022-11-07 22:05 219K 
[ ]13540_fda-perspective-on-pimavanserin.pdf2022-11-07 22:49 331K 
[ ]13541_fda-post-marketing-safety-decisions.pdf2022-11-07 22:47 54K 
[ ]13542_fdas-approval-of-aripiprazole-tablets-with-sensor.pdf2022-11-07 23:03 106K 
[ ]13543_fear-anxiety-benefits-translational-research.pdf2022-11-07 22:32 51K 
[ ]13544_feasibility-pilot-efficacy-results-multisite-cognitive.pdf2022-11-07 22:03 301K 
[ ]13545_feasibility-utilizing-plasma-mirna-bace-messenger.pdf2022-11-07 22:49 292K 
[ ]13546_features-associated-delayed-initiation-mood-stabilizers.pdf2022-11-07 22:58 76K 
[ ]13547_feeling-unreal-depersonalization-disorder-update-cases.pdf2022-11-07 22:08 73K 
[ ]13549_female-reproductive-cycle-obsessive-compulsive-disorder.pdf2022-11-07 22:02 153K 
[ ]13550_female-reproductive-life-cycle-hormones-methodology.pdf2022-11-07 23:01 234K 
[ ]13551_female-sexual-dysfunctions-controversy.pdf2022-11-07 22:36 54K 
[ ]13552_fertility-reproduction-women-anorexia-nervosa-controlled.pdf2022-11-07 22:15 73K 
[ ]13553_fibromyalgia-cognition.pdf2022-11-07 22:26 157K 
[ ]13554_fibromyalgia-enigma-stigma.pdf2022-11-07 22:01 69K 
[ ]13555_filicide-offspring-parents-severe-psychiatric-disorders.pdf2022-11-07 22:19 244K 
[ ]13556_final-nightmare-sonia-reach-sons-memoir.pdf2022-11-07 22:36 72K 
[ ]13557_financial-disclosure-information.pdf2022-11-07 22:03 36K 
[ ]13558_financial-support-letter-writing.pdf2022-11-07 22:54 67K 
[ ]13559_findings-childhood-mania.pdf2022-11-07 23:00 98K 
[ ]13560_findings-interest.pdf2022-11-07 22:38 164K 
[ ]13561_findings-longitudinal-treatment-studies-youth.pdf2022-11-07 22:53 102K 
[ ]13562_finish-remembering-discontinuation-syndrome.pdf2022-11-07 23:02 37K 
[ ]13563_firesetting-mental-health.pdf2022-11-07 22:49 68K 
[ ]13564_first-episode-nonaffective-psychoses.pdf2022-11-07 22:39 254K 
[ ]13565_five-course-obsessive-compulsive-disorder-predictors.pdf2022-11-07 22:16 454K 
[ ]13566_five-year-course-of-medication-treatment-for-childhood-anxiety-disorders.pdf2022-11-07 22:13 316K 
[ ]13567_fixed-dose-trial-single-isomer-ssri-escitalopram-depressed.pdf2022-11-07 22:52 70K 
[ ]13568_flat-world-psychiatry.pdf2022-11-07 22:38 60K 
[ ]13569_florida-best-practice-psychotherapeutic-medication.pdf2022-11-07 22:37 226K 
[ ]13570_florida-medication-guidelines-for-mdd.pdf2022-11-07 22:04 418K 
[ ]13571_fluoxetine-augmentation-olanzapine-treatment-chronic.pdf2022-11-07 22:50 81K 
[ ]13572_fluoxetine-efficacy-social-phobia.pdf2022-11-07 22:30 73K 
[ ]13573_fluoxetine-induced-akathisia-does-reappear-switch.pdf2022-11-07 22:18 42K 
[ ]13574_fluoxetine-induced-genital-anesthesia-relieved-ginkgo.pdf2022-11-07 22:46 126K 
[ ]13575_fluoxetine-induced-sexual-dysfunction-reversed-loratadine.pdf2022-11-07 22:38 47K 
[ ]13576_fluoxetine-mirtazapine-interaction-may-induce-restless.pdf2022-11-07 22:44 103K 
[ ]13577_fluoxetine-suitable-long-term-treatment.pdf2022-11-07 22:56 61K 
[ ]13578_fluoxetine-treatment-alcoholic-perpetrators-domestic.pdf2022-11-07 22:37 640K 
[ ]13579_fluoxetine-treatment-patients-major-depressive-disorder.pdf2022-11-07 22:11 99K 
[ ]13580_fluoxetine-versus-placebo-posttraumatic-stress-disorder.pdf2022-11-07 23:03 71K 
[ ]13581_fluoxetine-versus-sertraline-paroxetine-major-depressive.pdf2022-11-07 22:28 54K 
[ ]13582_fluvoxamine-attenuates-panic-induced-co-challenge.pdf2022-11-07 22:05 33K 
[ ]13583_fluvoxamine-reduces-clozapine-dosage-needed-refractory.pdf2022-11-07 22:58 69K 
[ ]13584_fluvoxamine-review-controlled-trials-depression.pdf2022-11-07 22:45 46K 
[ ]13585_fluvoxamine-treatment-compulsive-buying.pdf2022-11-07 22:25 81K 
[ ]13586_fluvoxamine-treatment-japanese-patient-koro.pdf2022-11-07 22:26 83K 
[ ]13587_fluvoxamine-treatment-obsessive-compulsive-disorder.pdf2022-11-07 22:28 97K 
[ ]13588_fmri-changes-after-adhd-treatment.pdf2022-11-07 22:09 1.2M 
[ ]13589_focus-addiction-buspirone-cocaine-relapse-monitoring.pdf2022-11-07 23:01 140K 
[ ]13590_focus-alzheimers-disease-related-disorders.pdf2022-11-07 22:33 63K 
[ ]13591_focus-bipolar-disorder-treatment.pdf2022-11-07 23:01 255K 
[ ]13592_focus-childhood-adolescent-mental-health.pdf2022-11-07 22:15 51K 
[ ]13593_focus-womens-mental-health.pdf2022-11-07 22:05 37K 
[ ]13594_folate-depression-efficacy-safety-differences-formulations.pdf2022-11-07 22:42 336K 
[ ]13595_folate-supplementation-is-safe-effective.pdf2022-11-07 22:30 151K 
[ ]13596_fold-risk-metabolic-syndrome-patients-schizophrenia.pdf2022-11-07 22:19 98K 
[ ]13597_follow-attention-deficit-hyperactivity-disorder.pdf2022-11-07 22:29 298K 
[ ]13598_follow-diabetes-knowledge-persons-serious-mental.pdf2022-11-07 22:24 283K 
[ ]13599_follow-patients-treated-risperidone-topiramate.pdf2022-11-07 22:14 61K 
[ ]13600_follow-patient-successful-continuation-clozapine.pdf2022-11-07 23:01 114K 
[ ]13601_follow-smoking-cessation-trial-patients-schizophrenia.pdf2022-11-07 22:05 51K 
[ ]13602_follow-study-behavioral-psychological-symptoms.pdf2022-11-07 22:01 82K 
[ ]13603_follow-study-premenstrual-syndrome.pdf2022-11-07 22:06 27K 
[ ]13604_follow-subjects-obsessive-compulsive-disorder.pdf2022-11-07 22:11 118K 
[ ]13605_follow-successful-ect-naturalistic-study-depressed.pdf2022-11-07 22:47 68K 
[ ]13606_follow-up-appointments-for-patients-after-discharge.pdf2022-11-07 22:03 113K 
[ ]13607_food-drug-administrations-perspective-antidepressant.pdf2022-11-07 22:11 255K 
[ ]13608_food-drug-administrations-review-novel-antidepressant.pdf2022-11-07 22:45 110K 
[ ]13609_food-drug-administration-warning-risk-drug-reaction.pdf2022-11-07 22:19 107K 
[ ]13610_foreword-global-research-anxiety-depression-grad-network.pdf2022-11-07 22:44 22K 
[ ]13611_foreword-tsunami-mental-health-challenges-community.pdf2022-11-07 22:14 133K 
[ ]13612_formulary-decisions-health-economics.pdf2022-11-07 22:18 42K 
[ ]13613_four-outcome-psychopharmacologically-treated-adults.pdf2022-11-07 22:21 281K 
[ ]13614_fragile-alliance-orientation-psychotherapy-adolescent.pdf2022-11-07 22:43 41K 
[ ]13615_free-drug-fraction-versus-free-drug-concentration.pdf2022-11-07 22:09 66K 
[ ]13616_frequency-cognitive-impairment-patients-anxiety-depression.pdf2022-11-07 22:03 254K 
[ ]13617_frequency-correlates-dsm-attenuated-psychosis-syndrome.pdf2022-11-07 22:05 1.0M 
[ ]13618_frequency-correlates-inappropriate-pediatric-psychiatric.pdf2022-11-07 22:01 1.1M 
[ ]13619_frequency-painful-physical-symptoms-major-depressive.pdf2022-11-07 22:18 253K 
[ ]13620_frequently-asked-questions-maintenance-certification.pdf2022-11-07 22:12 183K 
[ ]13621_freud-life.pdf2022-11-07 22:26 55K 
[ ]13622_freud-man-intellectual-biography.pdf2022-11-07 23:02 47K 
[ ]13623_freud-st-century-essays-man-genius.pdf2022-11-07 22:22 720K 
[ ]13624_frontal-cerebral-perfusion-antidepressant-drug-treatment.pdf2022-11-07 22:28 53K 
[ ]13625_frontal-lobes-neuropsychiatric-illness.pdf2022-11-07 22:10 34K 
[ ]13626_frontal-subcortical-circuits-psychiatric-neurological.pdf2022-11-07 22:12 43K 
[ ]13627_frontostriatal-connectivity-after-rtms-in-depression.pdf2022-11-07 22:23 284K 
[ ]13628_frontotemporal-dementia-treatment-response-serotonin.pdf2022-11-07 22:14 40K 
[ ]13629_fruit-juice-organic-anion-transporting-polypeptides.pdf2022-11-07 22:59 463K 
[ ]13630_fulminant-hepatic-failure-acetaminophen-anorexic-patient.pdf2022-11-07 22:23 44K 
[ ]13631_functional-anatomy-neurochemistry-pharmacology-anxiety.pdf2022-11-07 22:41 60K 
[ ]13633_functional-impairments-adults-self-reports-diagnosed.pdf2022-11-07 22:11 172K 
[ ]13634_functional-magnetic-resonance-imaging-studies-emotional.pdf2022-11-07 22:21 231K 
[ ]13635_functional-neural-mechanism-internval-timing.pdf2022-11-07 22:31 104K 
[ ]13636_functional-neuroimaging-child-psychiatry.pdf2022-11-07 23:01 54K 
[ ]13637_functional-outcomes-schizophrenia.pdf2022-11-07 22:32 165K 
[ ]13638_functional-polymorphism-in-neuropeptides-and-resilience-to-traumatic-stress.pdf2022-11-07 22:23 117K 
[ ]13639_functional-psychiatric-disorders-elderly.pdf2022-11-07 22:26 24K 
[ ]13640_functional-recovery-after-postpartum-psychosis.pdf2022-11-07 22:09 6.3M 
[ ]13641_functional-status-depressed-patients-relationship.pdf2022-11-07 22:07 35K 
[ ]13642_functional-versus-syndromal-recovery-patients-major.pdf2022-11-07 22:38 230K 
[ ]13643_functioning-after-remission-of-an-anxiety-disorder.pdf2022-11-07 22:42 293K 
[ ]13644_fundamentals-attention-deficit-hyperactivity-disorder.pdf2022-11-07 22:26 103K 
[ ]13645_fundamental-structure-axis-ii-personality-disorders.pdf2022-11-07 22:53 154K 
[ ]13646_funding-conflicts-paradigms.pdf2022-11-07 22:11 37K 
[ ]13647_further-discussion-emdr-treatment-ptsd.pdf2022-11-07 22:43 45K 
[ ]13648_further-evidence-robust-familiality-pediatric-bipolar.pdf2022-11-07 22:54 283K 
[ ]13649_further-history.pdf2022-11-07 22:36 44K 
[ ]13650_future-directions-management-insomnia.pdf2022-11-07 22:15 66K 
[ ]13651_future-psychopharmacology-depression.pdf2022-11-07 22:20 248K 
[ ]13652_future-therapeutic-approaches-alzheimers-disease.pdf2022-11-07 22:51 80K 
[ ]13653_gaba-benzodiazepine-receptor-complex-structure-function.pdf2022-11-07 22:32 135K 
[ ]13654_gabapentin-abuse-delirium-tremens-upon-gabapentin.pdf2022-11-07 22:46 185K 
[ ]13655_gabapentin-augmentation-fluoxetine-treated-patients.pdf2022-11-07 22:26 35K 
[ ]13656_gabapentin-for-alcohol-related-disorders.pdf2022-11-07 22:21 282K 
[ ]13657_gabapentin-ptsd.pdf2022-11-07 22:40 48K 
[ ]13658_gabapentin-reduces-alcohol-consumption-craving-randomized.pdf2022-11-07 22:15 248K 
[ ]13659_gabapentin-reduces-cocaine-among-addicts-community.pdf2022-11-07 22:27 39K 
[ ]13660_gabapentin-treatment-cocaine-dependence-case-series.pdf2022-11-07 22:36 53K 
[ ]13661_gabapentin-treatment-mood-disorders-preliminary-study.pdf2022-11-07 22:54 30K 
[ ]13662_gabapentin-treatment-patients-somatization-disorder.pdf2022-11-07 22:20 72K 
[ ]13663_gaba-systems-benzodiazepines-substance-dependence.pdf2022-11-07 22:47 59K 
[ ]13664_gabbards-treatments-psychiatric-disorders-dsm-edition.pdf2022-11-07 22:10 103K 
[ ]13665_galantamine-and-computerized-cbt.pdf2022-11-07 22:53 429K 
[ ]13666_galantamine-induced-qtc-prolongation.pdf2022-11-07 22:56 92K 
[ ]13667_galantamine-qtc-prolongation.pdf2022-11-07 22:02 110K 
[ ]13668_gambling-acamprosate-case-report.pdf2022-11-07 22:28 136K 
[ ]13669_ganaxolone-for-persistent-depression.pdf2022-11-07 22:05 584K 
[ ]13670_gap-between-randomized-controlled-trialbased-evidence.pdf2022-11-07 22:08 129K 
[ ]13671_gastroesophageal-reflux-possible-result-clozapine.pdf2022-11-07 22:15 37K 
[ ]13672_gastrointestinal-adverse-effects-divalproex-sodium.pdf2022-11-07 22:03 69K 
[ ]13673_gastrointestinal-disorders-medical-depression.pdf2022-11-07 22:52 102K 
[ ]13674_gender-analysis-study-pharmacotherapy-psychotic-depression.pdf2022-11-07 22:31 345K 
[ ]13675_gender-bipolar-illness.pdf2022-11-07 22:36 58K 
[ ]13676_gender-differences-adult-attention-deficit-hyperactivity.pdf2022-11-07 22:54 250K 
[ ]13677_gender-differences-clinical-correlates-longitudinal.pdf2022-11-07 22:30 498K 
[ ]13678_gender-differences-clinical-manifestations-outcomes.pdf2022-11-07 22:31 324K 
[ ]13679_gender-differences-clinical-psychopharmacology.pdf2022-11-07 22:56 55K 
[ ]13680_gender-differences-clinical-trials-adults-attention.pdf2022-11-07 22:45 258K 
[ ]13681_gender-differences-depression-implications-treatment.pdf2022-11-07 22:47 529K 
[ ]13682_gender-differences-epidemiology-treatment-anxiety.pdf2022-11-07 22:43 90K 
[ ]13683_gender-difference-severity-schizophrenia.pdf2022-11-07 23:02 57K 
[ ]13684_gender-differences-generalized-anxiety-disorder-results.pdf2022-11-07 22:47 307K 
[ ]13685_gender-differences-never-medicated-episode-schizophrenia.pdf2022-11-07 22:29 312K 
[ ]13686_gender-differences-pathological-gambling.pdf2022-11-07 22:25 65K 
[ ]13687_gender-differences-presentation-management-social.pdf2022-11-07 22:47 58K 
[ ]13688_gender-effects-psychopathology.pdf2022-11-07 22:54 41K 
[ ]13689_gender-focused-perspective-health-service-utilization.pdf2022-11-07 22:52 98K 
[ ]13690_gender-hiv-status-psychiatric-disorders-results-national.pdf2022-11-07 22:22 319K 
[ ]13691_gender-imbalance-clinical-trials-schizophrenia.pdf2022-11-07 22:18 207K 
[ ]13692_gender-related-clinical-differences-older-patients.pdf2022-11-07 22:03 52K 
[ ]13693_gender-risk-factors-suicide-evidence-heterogeneity.pdf2022-11-07 22:46 84K 
[ ]13694_gender-schizophrenia.pdf2022-11-07 22:33 614K 
[ ]13695_gender-specific-considerations-treatment-mood-disorders.pdf2022-11-07 22:04 101K 
[ ]13696_gender-specific-suicide-risk-factors-case-control.pdf2022-11-07 22:58 411K 
[ ]13697_generalizability-clinical-trial-results-bipolar-disorder.pdf2022-11-07 22:06 242K 
[ ]13698_generalizability-clinical-trial-results-major-depression.pdf2022-11-07 22:30 150K 
[ ]13699_generalizability-in-clinical-trials-of-substance-abuse.pdf2022-11-07 22:32 1.3M 
[ ]13700_generalizability-neuroimaging-studies-common-psychiatric.pdf2022-11-07 22:27 250K 
[ ]13701_generalizability-of-clinical-trials-for-ptsd.pdf2022-11-07 22:16 233K 
[ ]13702_generalizability-of-placebo-controlled-studies-of-antidepressants.pdf2022-11-07 22:58 152K 
[ ]13703_generalizability-results-efficacy-trials-episode.pdf2022-11-07 22:33 1.0M 
[ ]13704_generalized-anxiety-depression-primary-care-prevalence.pdf2022-11-07 22:43 85K 
[ ]13705_generalized-anxiety-disorder-medical-illness.pdf2022-11-07 22:49 198K 
[ ]13706_generalized-anxiety-disorder-nature-course.pdf2022-11-07 22:12 54K 
[ ]13707_generalized-anxiety-disorder-primary-care-emerging.pdf2022-11-07 22:29 64K 
[ ]13708_generalized-anxiety-disorder-primary-care-precursormodifier.pdf2022-11-07 22:39 32K 
[ ]13709_generalized-anxiety-disorder-psychiatric-comorbidities.pdf2022-11-07 23:02 194K 
[ ]13710_genes-as-confounds-in-studies-of-neurodevelopmental-outcomes-after-antidepressant-prescription-durin.pdf2022-11-07 22:44 281K 
[ ]13711_genes-behavior-nature-nurture-interplay-explained.pdf2022-11-07 22:05 72K 
[ ]13712_genes-memes-culture-mental-illness-toward-integrative.pdf2022-11-07 22:19 123K 
[ ]13713_gene-temperament-interactions-might-distinguish-between.pdf2022-11-07 22:38 350K 
[ ]13714_genetic-association-study-treatment-response-olanzapinefluoxetine.pdf2022-11-07 22:06 248K 
[ ]13715_genetic-dissection-atypical-antipsychoticinduced-weight.pdf2022-11-07 23:01 218K 
[ ]13716_genetics-of-early-onset-bipolar-disorder.pdf2022-11-07 22:07 406K 
[ ]13717_genetics-of-schizophrenia.pdf2022-11-07 22:15 740K 
[ ]13718_genetics-suicide-depression.pdf2022-11-07 22:56 59K 
[ ]13719_genetics-transcriptomics-proteomics-alzheimers-disease.pdf2022-11-07 22:46 201K 
[ ]13720_genetic-studies-drug-response-side-effects-stard-study-part-1.pdf2022-11-07 22:49 436K 
[ ]13721_genetic-studies-drug-response-side-effects-stard-study-part-2.pdf2022-11-07 22:39 421K 
[ ]13722_genetic-studies-panic-disorder-review.pdf2022-11-07 22:35 88K 
[ ]13723_genome-wide-environment-interaction-between-depressive.pdf2022-11-07 22:23 1.3M 
[ ]13724_genomic-role-of-bdnf-in-schizophrenia.pdf2022-11-07 22:55 152K 
[ ]13725_gepirone-extended-release-evidence-efficacy-treatment.pdf2022-11-07 22:18 72K 
[ ]13726_gepirone-extended-release-treatment-adult-outpatients.pdf2022-11-07 23:00 209K 
[ ]13727_gepirone-extended-release-treatment-anxious-depression.pdf2022-11-07 22:18 166K 
[ ]13728_geriatric-depression-treatment-nonresponders-selective.pdf2022-11-07 22:57 63K 
[ ]13729_geriatric-dysthymia.pdf2022-11-07 22:45 73K 
[ ]13730_geriatric-mental-health-care-treatment-guide-health.pdf2022-11-07 22:31 39K 
[ ]13731_geriatric-psychiatry.pdf2022-11-07 22:27 30K 
[ ]13732_geriatric-psychopharmacology.pdf2022-11-07 22:24 23K 
[ ]13733_geriatric-psychopharmacology-evolution-discipline.pdf2022-11-07 22:01 318K 
[ ]13734_geropsychology-long-term-care-practitioners-guide.pdf2022-11-07 22:42 84K 
[ ]13735_gestational-exposure-to-benzodiazepines-part-1-risk-spontaneous-abortion-examined-through-prism-rese.pdf2022-11-07 22:36 275K 
[ ]13736_gestational-exposure-to-benzodiazepines-part-2-risk-congenital-malformations-examined-through-prism-.pdf2022-11-07 22:57 300K 
[ ]13737_gestational-exposure-to-benzodiazepines-part-3-clobazam-major-congenital-malformations.pdf2022-11-07 22:37 235K 
[ ]13738_getting-stoned-without-inhaling-anandamide-is-brains.pdf2022-11-07 22:22 27K 
[ ]13739_ghrelin-agonist-treatment-in-anorexia-nervosa.pdf2022-11-07 22:18 295K 
[ ]13740_global-burden-anxiety-mood-disorders-putting-european.pdf2022-11-07 22:41 243K 
[ ]13741_global-mental-health-principles-practice.pdf2022-11-07 22:38 72K 
[ ]13742_glucometabolic-hormones-cardiovascular-risk-markers.pdf2022-11-07 22:18 328K 
[ ]13743_glucose-metabolism-japanese-schizophrenia-patients.pdf2022-11-07 22:07 178K 
[ ]13744_glucose-metabolism-patients-schizophrenia-treated.pdf2022-11-07 22:40 118K 
[ ]13746_glutamatergic-agents-for-ocd.pdf2022-11-07 22:46 1.1M 
[ ]13747_glutamatergic-agents-represent-class-antidepressant-part-1.pdf2022-11-07 22:41 257K 
[ ]13748_glutamatergic-agents-represent-class-antidepressant-part-2.pdf2022-11-07 22:47 560K 
[ ]13749_glutamatergic-dysregulation-pediatric-psychiatric.pdf2022-11-07 23:00 1.4M 
[ ]13750_glycogen-synthase-kinase-target-novel-bipolar-disorder.pdf2022-11-07 22:40 123K 
[ ]13751_gold-versus-silver-issue-functional-versus-symptomatic.pdf2022-11-07 22:31 65K 
[ ]13752_googling-suicide-surfing-suicide-information-internet.pdf2022-11-07 22:55 304K 
[ ]13753_gray-matter-density-and-cortical-thickness-in-late-life-minor-depression.pdf2022-11-07 23:00 415K 
[ ]13754_gray-matter-volumes-treatment-response-psychotic-symptoms.pdf2022-11-07 22:07 315K 
[ ]13755_greater-than-even-greater-need.pdf2022-11-07 22:37 89K 
[ ]13756_greens-child-adolescent-clinical-psychopharmacology.pdf2022-11-07 22:56 79K 
[ ]13757_group-psychotherapy-psychological-trauma.pdf2022-11-07 23:00 31K 
[ ]13758_group-therapy-patients-bipolar-disorder-substance.pdf2022-11-07 22:44 74K 
[ ]13759_group-treatment-trichotillomania-cognitive-behavioral.pdf2022-11-07 22:23 544K 
[ ]13760_grow-market.pdf2022-11-07 22:06 25K 
[ ]13761_grumpy-old-men-women-mere-hassle-meaningful-clinical.pdf2022-11-07 22:22 73K 
[ ]13762_guanfacine-extended-release-improves-adhd-symptoms-in-japanese-adults.pdf2022-11-07 22:02 736K 
[ ]13763_guide-assessment-scales-schizophrenia.pdf2022-11-07 22:46 89K 
[ ]13764_guidebook-sexual-medicine.pdf2022-11-07 22:45 101K 
[ ]13765_guided-discontinuation-versus-maintenance-treatment.pdf2022-11-07 22:10 203K 
[ ]13766_guide-extrapyramidal-side-effects-antipsychotic-drugs.pdf2022-11-07 22:09 39K 
[ ]13767_guideline-combining-medications-older-patients.pdf2022-11-07 22:25 91K 
[ ]13768_guideline-delirium.pdf2022-11-07 22:09 50K 
[ ]13769_guideline-delusional-disorder.pdf2022-11-07 22:56 87K 
[ ]13770_guideline-dementia.pdf2022-11-07 22:48 28K 
[ ]13771_guideline-duration-antipsychotic-treatment.pdf2022-11-07 22:27 86K 
[ ]13772_guideline-frequency-follow-monitoring-patients-antipsychotics.pdf2022-11-07 22:13 87K 
[ ]13773_guideline-generalized-anxiety-disorder.pdf2022-11-07 22:49 105K 
[ ]13774_guideline-hypochondriasis.pdf2022-11-07 22:08 123K 
[ ]13775_guideline-implementation-patient-tailoring-strategies.pdf2022-11-07 22:53 197K 
[ ]13776_guideline-indications-antipsychotics.pdf2022-11-07 22:43 388K 
[ ]13777_guideline-mania-bipolar-i-disorder.pdf2022-11-07 22:14 127K 
[ ]13778_guideline-nonpsychotic-major-depressive-disorder.pdf2022-11-07 22:20 111K 
[ ]13779_guideline-organization-key-terms.pdf2022-11-07 22:40 221K 
[ ]13780_guideline-panic-disorder.pdf2022-11-07 22:58 123K 
[ ]13781_guideline-psychotic-major-depressive-disorder.pdf2022-11-07 22:43 122K 
[ ]13782_guidelines.pdf2022-11-07 22:36 222K 
[ ]13783_guideline-schizophrenia.pdf2022-11-07 22:25 13K 
[ ]13784_guideline-selecting-antipsychotics-patient-complicating.pdf2022-11-07 22:33 109K 
[ ]13785_guideline-selecting-antipsychotics-patient-history.pdf2022-11-07 22:15 103K 
[ ]13786_guideline-selecting-treatments-indications.pdf2022-11-07 22:17 121K 
[ ]13787_guideline-series-commentary.pdf2022-11-07 22:18 45K 
[ ]13788_guidelines-long-acting-injectable-atypical-antipsychotics.pdf2022-11-07 22:22 104K 
[ ]13789_guidelines-preventing-common-medical-complications.pdf2022-11-07 22:03 539K 
[ ]13790_guide-neuropsychiatric-therapeutics.pdf2022-11-07 22:37 100K 
[ ]13791_guide-treatment-adults-adhd.pdf2022-11-07 22:42 87K 
[ ]13793_gut-feelings-irritable-bowel-syndrome.pdf2022-11-07 22:55 56K 
[ ]13794_habits-highly-effective-psychopharmacologists-overview.pdf2022-11-07 22:59 41K 
[ ]13795_half-obsessive-compulsive-disorder-cases-misdiagnosed.pdf2022-11-07 22:10 1.0M 
[ ]13796_haloperidol-dose-used-active-comparator-randomized.pdf2022-11-07 22:43 97K 
[ ]13797_handbook-addicttive-disorder-practical-guide-diagnosis.pdf2022-11-07 22:40 82K 
[ ]13798_handbook-attachment-theory-research-clinical-applications.pdf2022-11-07 22:19 30K 
[ ]13799_handbook-child-adolescent-psychopharmacology.pdf2022-11-07 22:37 99K 
[ ]13800_handbook-clinical-alcoholism-treatment.pdf2022-11-07 22:31 29K 
[ ]13801_handbook-clinical-child-neuropsychology-rd-ed.pdf2022-11-07 22:28 132K 
[ ]13802_handbook-clinical-sexuality-mental-health-professionals.pdf2022-11-07 22:38 90K 
[ ]13803_handbook-consultation-liasion-psychiatry.pdf2022-11-07 22:23 100K 
[ ]13804_handbook-depression.pdf2022-11-07 22:15 36K 
[ ]13805_handbook-depression-rd-ed.pdf2022-11-07 22:40 79K 
[ ]13806_handbook-developmental-psychopathology-nd-ed.pdf2022-11-07 22:59 80K 
[ ]13807_handbook-diagnosis-treatment-bipolar-disorders.pdf2022-11-07 22:50 150K 
[ ]13808_handbook-diagnostic-structured-interviewing.pdf2022-11-07 22:28 45K 
[ ]13809_handbook-emergency-psychiatry.pdf2022-11-07 22:26 48K 
[ ]13810_handbook-essential-psychopharmacology.pdf2022-11-07 22:21 14K 
[ ]13811_handbook-essential-psychopharmacology-nd-ed.pdf2022-11-07 22:30 57K 
[ ]13812_handbook-geriatric-psychopharmacology.pdf2022-11-07 23:03 54K 
[ ]13813_handbook-headache.pdf2022-11-07 22:37 60K 
[ ]13814_handbook-integrated-short-term-psychotherapy.pdf2022-11-07 22:57 30K 
[ ]13815_handbook-obesity-treatment.pdf2022-11-07 22:32 34K 
[ ]13816_handbook-office-based-buprenorphine-treatment-opioid.pdf2022-11-07 22:28 76K 
[ ]13817_handbook-pediatric-neurology.pdf2022-11-07 22:45 67K 
[ ]13818_handbook-preschool-mental-health-development-disorders.pdf2022-11-07 22:25 100K 
[ ]13819_handbook-psychiatric-drug-therapy-lippincott-williams.pdf2022-11-07 22:49 86K 
[ ]13820_handbook-psychiatric-drug-therapy-th-ed.pdf2022-11-07 22:02 108K 
[ ]13821_handbook-psychiatric-management-borderline-personality.pdf2022-11-07 22:07 80K 
[ ]13822_handbook-psychiatric-measures.pdf2022-11-07 22:05 42K 
[ ]13823_handbook-psychology-aging-th-ed.pdf2022-11-07 22:54 29K 
[ ]13824_handbook-psychotherapy-cancer-care.pdf2022-11-07 22:07 80K 
[ ]13825_handbook-religion-mental-health.pdf2022-11-07 22:01 29K 
[ ]13826_handling-childrens-aggression-constructively-toward.pdf2022-11-07 22:43 137K 
[ ]13827_hands-help-computer-aided-psychotherapy-book-review.pdf2022-11-07 22:41 151K 
[ ]13828_happens-adverse-events-during-months-treatment-selective.pdf2022-11-07 22:20 133K 
[ ]13829_happens-importance-naturalistic-course-mania.pdf2022-11-07 22:19 141K 
[ ]13830_happiness-and-treatment-outcome-in-resistant-depression.pdf2022-11-07 22:17 119K 
[ ]13831_happiness-during-low-dose-ketamine-infusion-predicts-treatment-response.pdf2022-11-07 22:49 483K 
[ ]13832_happy.pdf2022-11-07 22:26 38K 
[ ]13833_harm-reduction-pragmatic-strategies-managing-high.pdf2022-11-07 22:42 32K 
[ ]13834_harvard-guide-psychiatry-rd-ed.pdf2022-11-07 22:47 44K 
[ ]13835_hats-off-reviewers.pdf2022-11-07 22:38 17K 
[ ]13836_hazardous-alcohol-receipt-risk-reduction-counseling.pdf2022-11-07 22:19 238K 
[ ]13837_healing-psychiatry-bridging-scienceshumanism-divide.pdf2022-11-07 22:55 100K 
[ ]13838_health-benefit-costs-absenteeism-due-insomnia-employers.pdf2022-11-07 22:53 324K 
[ ]13839_health-care-crisis-childhood-onset-bipolar-illness.pdf2022-11-07 22:07 113K 
[ ]13840_health-care-reform-primer-psychiatrists.pdf2022-11-07 22:06 66K 
[ ]13844_health-related-quality-life-across-anxiety-disorders.pdf2022-11-07 22:45 261K 
[ ]13845_health-related-quality-life-euthymic-bipolar-disorder.pdf2022-11-07 22:22 163K 
[ ]13846_health-related-quality-life-functioning-middle-aged.pdf2022-11-07 22:30 95K 
[ ]13847_health-related-quality-life-measure-enhances-acute.pdf2022-11-07 22:14 70K 
[ ]13848_health-related-quality-life-patients-schizophrenia.pdf2022-11-07 22:24 58K 
[ ]13849_helping-families-end-life-care-alzheimers-disease.pdf2022-11-07 22:28 133K 
[ ]13850_helping-parents-youth-teachers-understand-medications.pdf2022-11-07 22:57 100K 
[ ]13852_hemodialysis-treatment-valproic-acid-overdose.pdf2022-11-07 22:52 64K 
[ ]13853_hepatotoxicity-associated-antidepressants.pdf2022-11-07 22:30 48K 
[ ]13854_herbs-mind-science-tells-natures-remedies-depression.pdf2022-11-07 22:41 39K 
[ ]13855_here-today-gone-tomorrow-curse-chronic-pain-central.pdf2022-11-07 22:21 35K 
[ ]13856_herpes-zoster-and-dementia.pdf2022-11-07 22:34 250K 
[ ]13857_heterogeneity-in-the-timing-of-suicide-attempt-onset.pdf2022-11-07 22:59 349K 
[ ]13858_heterogeneity-of-treatment-effects-of-lai-antipsychotics.pdf2022-11-07 22:04 258K 
[ ]13859_heterogeneity-response-antipsychotics-multiple-disorders.pdf2022-11-07 22:31 93K 
[ ]13860_high-association-anticardiolipin-antibodies-psychosis.pdf2022-11-07 22:12 29K 
[ ]13861_high-degree-tolerability-monotherapy-high-doses-quetiapine.pdf2022-11-07 22:54 68K 
[ ]13862_high-density-whole-genome-association-study-reveals.pdf2022-11-07 22:05 204K 
[ ]13863_high-dose-aripiprazole-treatment-resistant-schizophrenia.pdf2022-11-07 22:51 88K 
[ ]13864_high-dose-baclofen-for-reduction-in-alcohol-intake.pdf2022-11-07 22:52 333K 
[ ]13865_high-dose-cholinergic-therapy-rivastigmine-patch-does.pdf2022-11-07 22:23 105K 
[ ]13866_high-dose-olanzapine-prolactin-levels.pdf2022-11-07 22:31 42K 
[ ]13867_high-dose-olanzapine-treatment-resistant-schizophrenia.pdf2022-11-07 23:01 79K 
[ ]13868_high-dose-olanzapine-versus-clozapine.pdf2022-11-07 23:01 82K 
[ ]13869_high-dose-sertraline-strategy-nonresponders-acute.pdf2022-11-07 22:37 111K 
[ ]13870_high-dose-sildenafil-citrate-selective-serotonin-reuptake.pdf2022-11-07 22:59 55K 
[ ]13871_higher-levels-anger-aggressiveness-major-depressive.pdf2022-11-07 22:04 55K 
[ ]13872_high-exposure-neuroleptics-bipolar-patients-retrospective.pdf2022-11-07 22:29 70K 
[ ]13873_high-false-positive-rate-putative-biomarker-test-aid.pdf2022-11-07 22:02 197K 
[ ]13874_high-frequency-repetitive-transcranial-magnetic-stimulation-clinical-response-antidepressants-depres.pdf2022-11-07 22:22 842K 
[ ]13875_high-frequency-repetitive-transcranial-magnetic-stimulation-decreases-cigarette-smoking.pdf2022-11-07 22:37 40K 
[ ]13876_high-frequency-residual-depressive-symptoms-bipolar.pdf2022-11-07 22:48 70K 
[ ]13878_high-potency-benzodiazepines-recent-clinical-results.pdf2022-11-07 22:18 65K 
[ ]13879_high-prevalence-bipolar-spectrum-disorders.pdf2022-11-07 22:48 53K 
[ ]13880_high-prevalence-herpes-zoster-patients-depression.pdf2022-11-07 22:31 1.0M 
[ ]13881_high-risk-groups-charcoal-burning-suicide-attempt.pdf2022-11-07 22:25 124K 
[ ]13882_high-risk-groups-charcoal-burning-suicide-taiwan.pdf2022-11-07 22:44 132K 
[ ]13883_high-serum-homocysteine-levels-young-male-schizophrenic.pdf2022-11-07 22:27 138K 
[ ]13884_hippocampal-amygdala-changes-patients-major-depressive.pdf2022-11-07 22:01 79K 
[ ]13885_hippocampal-volume-change-schizophrenia.pdf2022-11-07 22:38 452K 
[ ]13886_historical-comments-tardive-dyskinesia-neurologists.pdf2022-11-07 22:42 92K 
[ ]13887_historical-perspective-clozapine.pdf2022-11-07 22:05 34K 
[ ]13888_historical-perspective-movement-disorders.pdf2022-11-07 22:10 58K 
[ ]13890_history-concept-atypical-depression-concept-MAOI-response-classification-differentiation.pdf2022-11-07 22:52 146K 
[ ]13891_history-current-state-antidepressant-clinical-trial.pdf2022-11-07 22:50 512K 
[ ]13892_history-epidemiology-differential-diagnosis-social.pdf2022-11-07 22:56 50K 
[ ]13893_history-evolution-diagnosis-premenstrual-dysphoric.pdf2022-11-07 22:19 43K 
[ ]13894_history-evolution-monoamine-hypothesis-depression.pdf2022-11-07 22:24 41K 
[ ]13895_history-hypnotism.pdf2022-11-07 22:12 24K 
[ ]13896_history-major-depressive-disorder-influences-intent.pdf2022-11-07 22:27 50K 
[ ]13897_history-postpartum-depression-clinic-based-sample.pdf2022-11-07 22:05 215K 
[ ]13898_history-psychiatry-era-asylum-age-prozac.pdf2022-11-07 22:40 39K 
[ ]13899_history-psychiatry-medical-psychology-epilogue-psychiatry.pdf2022-11-07 22:13 99K 
[ ]13900_history-substance-abuse-complicates-remission-acute.pdf2022-11-07 22:55 43K 
[ ]13901_history-trauma-schizophrenia-predicts-need-seclusion.pdf2022-11-07 22:57 86K 
[ ]13902_hit-run-actions-dopamine-receptors-part-illustrating.pdf2022-11-07 22:06 111K 
[ ]13903_hit-run-actions-dopamine-receptors-part-mechanism.pdf2022-11-07 22:09 34K 
[ ]13904_hiv-depression-context-care-ucsf-aids-health-project.pdf2022-11-07 22:24 29K 
[ ]13905_hiv-psychiatry-training-resource-manual-nd-ed.pdf2022-11-07 22:15 66K 
[ ]13906_hoarding-disorder-more-problem-too-much-stuff.pdf2022-11-07 22:03 145K 
[ ]13907_hoarding-obsessive-compulsive-disorder-clinical-genetic.pdf2022-11-07 22:12 138K 
[ ]13908_hoarding-obsessive-compulsive-disorder-report-cases.pdf2022-11-07 22:05 41K 
[ ]13909_hoarding-symptom-syndrome.pdf2022-11-07 22:42 52K 
[ ]13910_hoarding-treatment-response-nondepressed-subjects.pdf2022-11-07 22:19 44K 
[ ]13911_homeopathic-treatments-psychiatry-systematic-review.pdf2022-11-07 22:36 426K 
[ ]13912_home-self-assessment-self-treatment-obsessive-compulsive.pdf2022-11-07 22:56 60K 
[ ]13913_homicide-dementia-older-adults-key-role-dysexecutive.pdf2022-11-07 22:21 110K 
[ ]13914_homicide-infants-cross-sectional-study.pdf2022-11-07 22:15 216K 
[ ]13915_homosexuality-mental-health-profession-impact-bias.pdf2022-11-07 22:22 39K 
[ ]13916_honoring-evidence-base.pdf2022-11-07 22:05 24K 
[ ]13917_hopelessness-in-suicidal-ideation.pdf2022-11-07 22:58 1.1M 
[ ]13918_hormonal-side-effects-women-typical-versus-atypical.pdf2022-11-07 22:37 69K 
[ ]13919_hospitalizations-emergency-department-visits-psychiatric.pdf2022-11-07 23:03 278K 
[ ]13920_hospital-personnel-reactions-haitis-earthquake-preliminary.pdf2022-11-07 22:02 116K 
[ ]13921_hostility-during-admission-interview-short-term-predictor.pdf2022-11-07 22:35 51K 
[ ]13922_hours-sleep-sufficiency-prevalence-depression-among.pdf2022-11-07 22:15 483K 
[ ]13923_how-to-read-a-research-paper-an-exercise-in-critical-thinking.pdf2022-11-07 22:49 336K 
[ ]13924_human-circadian-system-normal-disordered-sleep.pdf2022-11-07 22:18 169K 
[ ]13925_human-cost-management-failure-organizational-downsizing.pdf2022-11-07 22:46 15K 
[ ]13926_human-frontal-lobes-functions-disorders-nd-ed.pdf2022-11-07 22:37 68K 
[ ]13927_hundred-years-psychoanalysis-timeline.pdf2022-11-07 22:52 125K 
[ ]13928_hurricane-katrina-physicians-whirlwind-course-disaster.pdf2022-11-07 22:02 61K 
[ ]13929_hydroxyzine-generalized-anxiety-disorder.pdf2022-11-07 22:52 79K 
[ ]13930_hyperglycemia-antipsychotic-medications.pdf2022-11-07 22:51 98K 
[ ]13931_hyperglycemia-associated-atypical-antipsychotics.pdf2022-11-07 22:15 84K 
[ ]13932_hyperglycemia-associated-olanzapine.pdf2022-11-07 22:13 38K 
[ ]13933_hyperinsulinemia-psychiatric-patients-treated-olanzapine.pdf2022-11-07 22:15 66K 
[ ]13934_hyperlipidemia-persons-using-antipsychotic-medication.pdf2022-11-07 22:32 44K 
[ ]13935_hyperprolactinemia-in-older-patients-with-schizophrenia.pdf2022-11-07 22:14 419K 
[ ]13936_hyperprolactinemia-male-sexual-dysfunction.pdf2022-11-07 22:18 50K 
[ ]13937_hyperresponsivity-threat-stimuli-domestic-violence.pdf2022-11-07 22:42 334K 
[ ]13938_hypertriglyceridemia-associated-direct-effects-olanzapine.pdf2022-11-07 22:20 88K 
[ ]13939_hypnotic-medication-aftermath-trauma.pdf2022-11-07 22:41 83K 
[ ]13940_hypokalemia-following-rapid-titration-quetiapine-treatment.pdf2022-11-07 22:59 153K 
[ ]13941_hypokalemia-venlafaxine.pdf2022-11-07 22:57 68K 
[ ]13942_hypomania-associated-mirtazapine-augmentation-sertraline.pdf2022-11-07 22:45 38K 
[ ]13943_hypomania-handbook-challenge-elevated-mood.pdf2022-11-07 22:54 131K 
[ ]13944_hypomanic-episodes-receiving-ziprasidone-unintended.pdf2022-11-07 22:44 50K 
[ ]13945_hypotension-secondary-combination-intramuscular-olanzapine.pdf2022-11-07 22:40 147K 
[ ]13946_hypothermia-patients-treated-atypical-antipsychotic.pdf2022-11-07 22:43 69K 
[ ]13947_hypothesis-hypothesis-testing-clinical-trial.pdf2022-11-07 22:08 51K 
[ ]13948_hypouricemia-chronic-schizophrenic-patients-polydipsia.pdf2022-11-07 22:17 36K 
[ ]13950_ideal-ect-technique-ideal-ect-patient-should-focus.pdf2022-11-07 22:44 105K 
[ ]13951_ideal-trial-test-differential-onset-antidepressant.pdf2022-11-07 22:27 41K 
[ ]13952_identification-claims-data-signature-economic-consequences.pdf2022-11-07 22:04 87K 
[ ]13953_identification-high-risk-coronary-heart-disease-patients.pdf2022-11-07 22:03 176K 
[ ]13956_identifying-and-treating-tardive-dyskinesia.pdf2022-11-07 22:57 377K 
[ ]13958_identifying-borderline-personality-disorder.pdf2022-11-07 22:47 208K 
[ ]13959_identifying-depressive-subtypes-large-cohort-study.pdf2022-11-07 22:13 256K 
[ ]13961_identifying-difficult-treat-depression-differential.pdf2022-11-07 22:53 186K 
[ ]13962_identifying-managing-depression-primary-care-united.pdf2022-11-07 22:29 83K 
[ ]13963_identifying-managing-suicide-risk-bipolar-patients.pdf2022-11-07 22:48 52K 
[ ]13966_identifying-patients-bipolar-disorder--benefit-maintenance-therapy-long-acting-injectable-antipsycho.pdf2022-11-07 22:23 321K 
[ ]13967_identifying-patients-depression-require-change-treatment.pdf2022-11-07 22:33 256K 
[ ]13971_identifying-treating-panic-disorder-primary-care.pdf2022-11-07 22:10 54K 
[ ]13972_ileus-possible-result-bupropion-elderly-woman.pdf2022-11-07 22:30 67K 
[ ]13973_illicit-drug-use-in-cigarette-smokers.pdf2022-11-07 22:26 758K 
[ ]13974_illness-course-comorbidity-gender-suicidality-patients.pdf2022-11-07 22:17 82K 
[ ]13975_illustrating-circuits-sexual-desire.pdf2022-11-07 22:02 306K 
[ ]13976_iloperidone-clinical-overview.pdf2022-11-07 22:44 284K 
[ ]13977_imagery-rehearsal-therapy-addition-treatment-usual.pdf2022-11-07 23:00 1.1M 
[ ]13979_imaging-substance-p-receptors-nk-living-human-brain.pdf2022-11-07 22:35 470K 
[ ]13980_imipramine-is-effective-preventing-relapse-electroconvulsive.pdf2022-11-07 22:35 94K 
[ ]13981_immediate-effect-intravenous-diazepam-neuroleptic.pdf2022-11-07 22:12 38K 
[ ]13982_immediate-release-versus-controlled-release-formulations.pdf2022-11-07 22:27 66K 
[ ]13983_immediate-switching-moclobemide-duloxetine-may-induce.pdf2022-11-07 22:37 103K 
[ ]13984_immigration-acculturation-mourning-adaptation-next.pdf2022-11-07 22:23 82K 
[ ]13985_impact-adhd-treatment-substance-abuse-adults.pdf2022-11-07 22:59 75K 
[ ]13986_impact-age-onset-duration-illness-expression-comorbidities.pdf2022-11-07 22:16 57K 
[ ]13987_impact-antidepressant-continuation-acute-positive.pdf2022-11-07 22:16 224K 
[ ]13988_impact-antidepressant-discontinuation-versus-antidepressant.pdf2022-11-07 22:55 77K 
[ ]13989_impact-attempted-suicide-symptoms-course-mood-disorders.pdf2022-11-07 22:49 55K 
[ ]13990_impact-attention-deficit-hyperactivity-disorder-adhd.pdf2022-11-07 22:02 401K 
[ ]13991_impact-atypical-antipsychotics-weight-gain.pdf2022-11-07 22:54 139K 
[ ]13992_impact-bipolar-depression.pdf2022-11-07 22:54 121K 
[ ]13993_impact-bipolar-disorder-community-sample.pdf2022-11-07 22:26 69K 
[ ]13994_impact-body-worlds-exhibition-mental-health-indices.pdf2022-11-07 22:06 90K 
[ ]13995_impact-burnout-syndrome-gastroesophageal-reflux-disease.pdf2022-11-07 22:13 113K 
[ ]13996_impact-calories-fat-content-meals-oral-ziprasidone.pdf2022-11-07 22:35 152K 
[ ]13997_impact-cannabis-drugs-age-onset-psychosis.pdf2022-11-07 22:55 204K 
[ ]13998_impact-cannabis-stimulant-disorders-diagnostic-stability.pdf2022-11-07 22:02 1.0M 
[ ]13999_impact-changing-diagnostic-criteria-posttraumatic.pdf2022-11-07 22:54 307K 
[ ]14000_impact-childhood-life-events-childhood-trauma-onset.pdf2022-11-07 22:15 281K 
[ ]14001_impact-chronic-depression-acute-long-term-outcomes.pdf2022-11-07 22:21 883K 
[ ]14002_impact-clinical-antipsychotic-trials-intervention.pdf2022-11-07 22:03 295K 
[ ]14004_impact-cognitive-social-cognitive-impairment-functional.pdf2022-11-07 22:12 163K 
[ ]14005_impact-comorbid-anxiety-disorders-outcome-cohort-patients.pdf2022-11-07 22:09 159K 
[ ]14006_impact-comorbid-attention-deficit-disorder-direct.pdf2022-11-07 23:02 137K 
[ ]14007_impact-comorbidity-adults-attention-deficit-hyperactivity.pdf2022-11-07 22:06 57K 
[ ]14008_impact-comorbidity-treatment-panic-disorder.pdf2022-11-07 22:08 32K 
[ ]14009_impact-cypa-cypd-polymorphisms-drug-metabolism-insulin.pdf2022-11-07 22:13 212K 
[ ]14010_impact-deleting-ltemgtdsm-ivltemgt-personality-disorders.pdf2022-11-07 22:32 224K 
[ ]14011_impact-depressive-symptoms-compared-manic-symptoms.pdf2022-11-07 22:32 60K 
[ ]14012_impact-disasters-aftermath-mental-health.pdf2022-11-07 22:54 96K 
[ ]14013_impact-ethnicity-metabolic-outcomes-during-treatment.pdf2022-11-07 22:10 734K 
[ ]14014_impact-formularies-clinical-innovation.pdf2022-11-07 22:26 46K 
[ ]14015_impact-gastrointestinal-symptom-severity-response.pdf2022-11-07 22:31 69K 
[ ]14016_impact-homocysteine-levels-cognition-euthymic-bipolar.pdf2022-11-07 22:22 235K 
[ ]14017_impact-maternal-depression-during-pregnancy-perinatal.pdf2022-11-07 22:29 1.1M 
[ ]14018_impact-maternal-psychiatric-illness-infant-development.pdf2022-11-07 23:02 51K 
[ ]14019_impact-mentorship.pdf2022-11-07 22:30 74K 
[ ]14020_impact-mood-disorders.pdf2022-11-07 22:43 145K 
[ ]14021_impact-number-parents-alcohol-disorder-alcohol-disorder.pdf2022-11-07 22:25 459K 
[ ]14023_impact-of-captivity-and-ptsd-on-cognitive-performance.pdf2022-11-07 22:25 243K 
[ ]14024_impact-of-concurrent-ptsd-on-next-step-mdd-treatment.pdf2025-04-29 21:49 1.0M 
[ ]14026_impact-of-frailty-on-behavioral-and-psychological-symptoms-of-dementia-and-caregiver-burden.pdf2022-11-07 22:28 661K 
[ ]14027_impact-of-ptsd-on-tms-for-mdd.pdf2022-11-07 22:55 265K 
[ ]14028_impact-once-versus-twice-daily-perphenazine-dosing.pdf2022-11-07 22:59 773K 
[ ]14029_impact-physiologic-estrogen-replacement-anxiety-symptoms.pdf2022-11-07 22:44 419K 
[ ]14030_impact-posttraumatic-stress-disorder-military-situations.pdf2022-11-07 22:16 48K 
[ ]14031_impact-prenatal-exposure-psychotropic-drugs-neonatal.pdf2022-11-07 22:25 215K 
[ ]14032_impact-prenatal-exposure-serotonin-reuptake-inhibitors.pdf2022-11-07 22:19 1.5M 
[ ]14033_impact-psychiatric-comorbidity-cognitive-deficit-function.pdf2022-11-07 22:27 1.1M 
[ ]14034_impact-reboxetine-mirtazapine-driving-simulator-performance.pdf2022-11-07 22:39 212K 
[ ]14035_impact-reproductive-events-course-bipolar-disorder.pdf2022-11-07 22:46 53K 
[ ]14036_impact-second-generation-antipsychotics-perphenazine.pdf2022-11-07 22:30 258K 
[ ]14037_impact-severity-substance-disorder-symptomatic-functional.pdf2022-11-07 22:44 251K 
[ ]14038_impact-sleep-related-complaints-depressive-symptoms.pdf2022-11-07 22:21 166K 
[ ]14039_impact-smoking-ban-locked-psychiatric-unit.pdf2022-11-07 22:20 92K 
[ ]14040_impact-stimulant-pharmacotherapy-sleep-quality-post.pdf2022-11-07 22:14 347K 
[ ]14041_impact-stimuli-affect-persons-dementia-cme.pdf2022-11-07 22:45 326K 
[ ]14043_impact-treatment-resistant-depression-health-care.pdf2022-11-07 22:53 80K 
[ ]14045_impaired-insight-delusions-predicts-treatment-outcome.pdf2022-11-07 22:56 267K 
[ ]14046_impaired-neuropsychological-performance-euthymic-patients.pdf2022-11-07 22:17 74K 
[ ]14047_impairment-executive-function-attention-predicts-onset.pdf2022-11-07 22:19 331K 
[ ]14048_imperfect-literature-evidence-based-medicine.pdf2022-11-07 22:13 77K 
[ ]14049_implementation-monitoring-management-guidelines-second.pdf2022-11-07 22:19 125K 
[ ]14050_implementation-schizophrenia-practice-guideline-clinical.pdf2022-11-07 22:46 225K 
[ ]14051_implementation-texas-medication-algorithm-project.pdf2022-11-07 22:24 106K 
[ ]14053_implementing-digital-mental-health-interventions.pdf2022-11-07 22:15 142K 
[ ]14055_implementing-evidence-based-treatment-manic-mixed.pdf2022-11-07 22:24 97K 
[ ]14057_implementing-practice-guidelines-lessons-public-mental.pdf2022-11-07 22:07 103K 
[ ]14058_implementing-treatment-strategies-different-types.pdf2022-11-07 22:05 246K 
[ ]14059_implications-genetic-studies-major-mood-disorders.pdf2022-11-07 22:43 68K 
[ ]14060_implications-medical-psychiatric-comorbidity-panic.pdf2022-11-07 22:17 142K 
[ ]14062_importance-childhood-trauma-childhood-life-events.pdf2022-11-07 22:22 295K 
[ ]14064_importance-early-weight-changes-predict-long-term.pdf2022-11-07 22:48 1.4M 
[ ]14065_importance-establishing-diagnosis-persistent-anxiety.pdf2022-11-07 22:44 441K 
[ ]14067_importance-negative-comorbidity.pdf2022-11-07 22:02 759K 
[ ]14068_importance-of-perinatal-anxiety-screening-and-provider-training.pdf2022-11-07 22:14 144K 
[ ]14070_importance-subsyndromal-symptoms-bipolar-disorder.pdf2022-11-07 22:16 48K 
[ ]14072_improved-insomnia-symptoms-sleep-related-next-functioning.pdf2022-11-07 22:59 779K 
[ ]14073_improved-insulin-sensitivity-nondiabetic-patients.pdf2022-11-07 22:48 104K 
[ ]14074_improved-outcome-fluvoxamine-treated-patients-ssri.pdf2022-11-07 22:16 35K 
[ ]14075_improved-sleep-continuity-increased-slow-wave-sleep.pdf2022-11-07 22:58 180K 
[ ]14076_improvement-health-related-quality-life-among-adults.pdf2022-11-07 22:47 233K 
[ ]14077_improvement-in-mental-health-with-aging.pdf2022-11-07 22:28 672K 
[ ]14078_improvement-negative-positive-symptoms-treatment-refractory.pdf2022-11-07 22:49 606K 
[ ]14079_improvement-negative-symptoms-schizophrenia-antibodies.pdf2022-11-07 23:01 70K 
[ ]14080_improvement-psychosis-during-treatment-estrogen-progesterone.pdf2022-11-07 22:38 67K 
[ ]14081_improvement-refractory-psychosis-dronabinol-four-case.pdf2022-11-07 22:43 109K 
[ ]14082_improvement-severe-self-mutilation-following-limbic.pdf2022-11-07 22:44 78K 
[ ]14083_improvement-subjective-sleep-major-depressive-disorder.pdf2022-11-07 22:07 246K 
[ ]14084_improving-adherence-antidepressants-systematic-review.pdf2022-11-07 22:52 61K 
[ ]14087_improving-antidepressant-adherence.pdf2022-11-07 22:58 66K 
[ ]14088_improving-care-patients-treatment-resistant-depression.pdf2022-11-07 22:50 142K 
[ ]14089_improving-course-illness-promoting-continuation-treatment.pdf2022-11-07 22:22 52K 
[ ]14092_improving-medical-care-persons-serious-mental-illness.pdf2022-11-07 22:01 120K 
[ ]14093_improving-medication-adherence-alcohol-dependence.pdf2022-11-07 22:33 84K 
[ ]14094_improving-mental-health-care-commitment-quality.pdf2022-11-07 22:25 45K 
[ ]14095_improving-mental-healthcare-guide-measure-based-quality.pdf2022-11-07 22:57 66K 
[ ]14099_improving-physical-health-in-chronic-mental-disorders.pdf2022-11-07 22:29 309K 
[ ]14100_improving-practice-clinical-psychopharmacotherapy.pdf2022-11-07 22:34 120K 
[ ]14101_improving-recognition-treatment-childhood-adolescent.pdf2022-11-07 22:32 38K 
[ ]14103_improving-treatment-adherence-bipolar-disorder-through.pdf2022-11-07 22:17 114K 
[ ]14105_improving-understanding-posttraumatic-trajectories.pdf2022-11-07 22:28 113K 
[ ]14106_impulse-control-disorders.pdf2022-11-07 22:44 93K 
[ ]14107_impulse-control-disorders-adolescent-psychiatric-inpatients.pdf2022-11-07 22:07 207K 
[ ]14108_impulse-control-disorders-clinicians-guide-understanding.pdf2022-11-07 22:04 90K 
[ ]14109_impulse-control-disorders-in-elderly-parkinsons-patients.pdf2022-11-07 22:24 261K 
[ ]14110_impulsive-aggressive-behavior-open-label-treatment.pdf2022-11-07 22:44 61K 
[ ]14111_impulsive-versus-planned-suicide-attempts-different.pdf2022-11-07 23:01 114K 
[ ]14112_inability-cry-during-sri-treatment.pdf2022-11-07 22:38 42K 
[ ]14113_inaccurate-information-quetiapine.pdf2022-11-07 22:21 38K 
[ ]14114_inaccurate-prescribing-warnings-in-emr-systems-a-survey.pdf2022-11-07 22:13 1.0M 
[ ]14115_inadequate-response-antidepressant-treatment-major.pdf2022-11-07 22:59 164K 
[ ]14116_inappropriate-masturbation-schizophrenia.pdf2022-11-07 22:39 66K 
[ ]14117_incidence-cardiovascular-outcomes-diabetes-mellitus.pdf2022-11-07 22:18 358K 
[ ]14118_incidence-consistency-antiretroviral-among-hiv-infected.pdf2022-11-07 22:46 52K 
[ ]14119_incidence-course-subsyndromal-symptoms-patients-bipolar.pdf2022-11-07 22:34 92K 
[ ]14120_incidence-delirium-older-adults-newly-prescribed-lithium.pdf2022-11-07 22:51 92K 
[ ]14121_incidence-duration-side-effects-those-rated-bothersome.pdf2022-11-07 22:04 57K 
[ ]14122_incidence-hyperglycemia-patients-treated-olanzapine.pdf2022-11-07 22:59 55K 
[ ]14123_incidence-rates-of-mental-disorders-in-youth.pdf2022-11-07 22:11 1.2M 
[ ]14124_incidence-seizures-antipsychotics.pdf2022-11-07 22:24 81K 
[ ]14125_incidence-sexual-dysfunction-associated-antidepressant.pdf2022-11-07 22:25 101K 
[ ]14126_incidence-sexual-dysfunction-healthy-volunteers-fluvoxamine.pdf2022-11-07 22:38 49K 
[ ]14127_incidence-sexual-side-effects-refractory-depression.pdf2022-11-07 22:01 160K 
[ ]14128_incidence-tardive-dyskinesia-atypical-versus-conventional.pdf2022-11-07 22:12 346K 
[ ]14129_incidence-tardive-dyskinesia-episode-psychosis-patients.pdf2022-11-07 22:09 59K 
[ ]14130_incidence-tardive-dyskinesia-tardive-dystonia-african.pdf2022-11-07 22:38 93K 
[ ]14131_incident-diabetes-associated-antipsychotic-united.pdf2022-11-07 22:20 54K 
[ ]14132_incident-psychosis-in-alzheimers-disease.pdf2022-11-07 22:03 377K 
[ ]14133_incident-users-antipsychotic-agents-future-cholesterol.pdf2022-11-07 23:00 417K 
[ ]14134_inclusion-of-suicidal-individuals-in-research-studies.pdf2022-11-07 22:56 122K 
[ ]14135_inconclusive-evidence-efficacy-olanzapine-treatment.pdf2022-11-07 22:43 153K 
[ ]14137_increased-antipsychotic-sensitivity-elderly-patients.pdf2022-11-07 22:01 257K 
[ ]14138_increased-cholesterol-levels-during-paroxetine-administration.pdf2022-11-07 22:31 44K 
[ ]14139_increased-eating-and-treatment-response-in-depression.pdf2022-11-07 22:46 229K 
[ ]14140_increased-efficacy-addition-clozapine-aripiprazole.pdf2022-11-07 22:16 134K 
[ ]14141_increased-lithium-concentrations-reported-patients.pdf2022-11-07 22:01 53K 
[ ]14142_increased-mortality-among-patients-admitted-major.pdf2022-11-07 22:26 231K 
[ ]14143_increased-olanzapine-discontinuation-health-care-resource.pdf2022-11-07 23:02 514K 
[ ]14144_increased-plasma-concentration-brain-derived-neurotrophic.pdf2022-11-07 22:10 156K 
[ ]14145_increased-rate-non-right-handedness-patients-bipolar.pdf2022-11-07 22:38 185K 
[ ]14146_increased-risk-cerebrovascular-adverse-events-death.pdf2022-11-07 22:27 51K 
[ ]14147_increased-risk-diabetes-mellitus-among-persons-psychotic.pdf2022-11-07 22:05 417K 
[ ]14148_increased-risk-onset-depression-patients-traumatic.pdf2022-11-07 22:48 256K 
[ ]14149_increased-risk-suicidal-behavior-comorbid-bipolar.pdf2022-11-07 22:21 265K 
[ ]14150_increased-systemic-cortisol-metabolism-patients-schizophrenia.pdf2022-11-07 22:20 326K 
[ ]14151_increase-plasma-levels-clozapine-norclozapine-administration.pdf2022-11-07 22:44 53K 
[ ]14152_increasing-antidepressant-dose-after-initial-treatment-failure.pdf2022-11-07 22:35 407K 
[ ]14153_increasing-energy-expenditure-is-important-enhance.pdf2022-11-07 22:32 103K 
[ ]14154_increasing-global-burden-cardiovascular-disease-general.pdf2022-11-07 22:20 110K 
[ ]14155_increasing-polypharmacotherapy-refractory-mood-disorders.pdf2022-11-07 22:26 79K 
[ ]14156_increasing-rates-placebo-response-mania-studies.pdf2022-11-07 22:06 208K 
[ ]14157_increasing-versus-maintaining-dose-olanzapine-risperidone-in-schizophrenia-patients-modest-dosage.pdf2022-11-07 22:30 1.3M 
[ ]14158_independent-actions-fear-circuits-may-lead-therapeutic.pdf2022-11-07 22:36 84K 
[ ]14159_independent-data-safety-monitoring-psychiatric-intervention.pdf2022-11-07 22:31 244K 
[ ]14160_independent-effects-tobacco-abstinence-bupropion-cognitive.pdf2022-11-07 22:41 149K 
[ ]14161_independent-versus-substance-induced-major-depressive.pdf2022-11-07 22:55 102K 
[ ]14162_indexing-reports-aripiprazole-augmentation-clozapine.pdf2022-11-07 22:59 153K 
[ ]14163_indications-antidepressants.pdf2022-11-07 22:46 80K 
[ ]14164_indicators-mania-depressed-outpatients-retrospective.pdf2022-11-07 22:45 72K 
[ ]14165_indicators-suicide-years-specialist-mood-disorders.pdf2022-11-07 22:17 516K 
[ ]14166_indirect-self-destructive-behavior-overt-suicidality.pdf2022-11-07 22:09 91K 
[ ]14167_individualized-oros-methylphenidate-dosing-in-adult-adhd.pdf2022-11-07 22:50 328K 
[ ]14168_individualized-treatment-outpatients-withdrawing-alcohol.pdf2022-11-07 22:28 43K 
[ ]14170_infant-early-childhood-mental-health-comprehensive.pdf2022-11-07 22:07 109K 
[ ]14171_infanticide-psychosocial-legal-perspectives-mothers.pdf2022-11-07 22:06 30K 
[ ]14172_infant-related-intrusive-thoughts-of-harm.pdf2022-11-07 22:40 432K 
[ ]14173_infant-safety-antipsychotic-therapy-breast-feeding.pdf2022-11-07 22:56 224K 
[ ]14174_inflammation-and-response-to-ect.pdf2022-11-07 22:46 241K 
[ ]14175_inflammation-obesity-metabolic-syndrome-depression.pdf2022-11-07 22:06 298K 
[ ]14176_inflammation-phenomenology-pathophysiology-comorbidity.pdf2022-11-07 22:28 517K 
[ ]14177_inflammation-psychosis-and-cognition-in-q-deletion-syndrome.pdf2022-11-07 22:46 328K 
[ ]14178_inflammatory-biomarkers-depressed-inpatients-without.pdf2022-11-07 22:58 339K 
[ ]14180_inflammatory-markers-among-adolescents-young-adults.pdf2022-11-07 22:22 283K 
[ ]14181_inflammatory-markers-pathogenesis-pediatric-depression.pdf2022-11-07 22:15 519K 
[ ]14182_influence-anesthetic-drugs-concurrent-psychiatric.pdf2022-11-07 22:17 134K 
[ ]14183_influence-media-coverage-celebrity-suicide-subsequent.pdf2022-11-07 23:00 145K 
[ ]14184_influence-media-women-taking-antidepressants-during.pdf2022-11-07 22:23 202K 
[ ]14185_influence-pharmacokinetic-profiles-safety-efficacy.pdf2022-11-07 22:39 77K 
[ ]14186_influence-schizophrenia-diagnosis-providers-practice.pdf2022-11-07 22:17 267K 
[ ]14187_influence-sex-menopausal-status-response-remission.pdf2022-11-07 22:09 440K 
[ ]14188_informant-agreement-assessment-disruptive-behavior.pdf2022-11-07 22:10 227K 
[ ]14189_information-authors.pdf2022-11-07 22:51 68K 
[ ]14190_informative-are-open-label-studies-youth-bipolar-disorder.pdf2022-11-07 22:19 585K 
[ ]14191_infrequency-pure-culture-diagnoses-among-anxiety-disorders.pdf2022-11-07 22:40 44K 
[ ]14192_inhibitory-neural-activity-predicts-response-cognitive.pdf2022-11-07 22:41 1.6M 
[ ]14193_initial-dosing-strategies-long-acting-injectable-risperidone.pdf2022-11-07 22:23 80K 
[ ]14194_initial-evidence-beneficial-effects-glutamate-modulating.pdf2022-11-07 22:03 141K 
[ ]14195_initial-response-predictor-week-buprenorphine-naloxone.pdf2022-11-07 22:26 214K 
[ ]14198_injection-depot-antipsychotic-medications-patients.pdf2022-11-07 22:07 58K 
[ ]14199_injections-depot-antipsychotic-medications-patients.pdf2022-11-07 22:51 53K 
[ ]14200_injection-site-pain-long-acting-risperidone.pdf2022-11-07 22:43 117K 
[ ]14201_in-memoriam-frederick-k-goodwin-md.pdf2022-11-07 22:52 236K 
[ ]14202_inner-world-guide-psychodynamics-psychotherapy.pdf2022-11-07 22:05 84K 
[ ]14203_innovation-treatment-bipolar-depression.pdf2022-11-07 22:11 103K 
[ ]14204_inositol-treatment-trichotillomania-compulsive-skin.pdf2022-11-07 22:32 69K 
[ ]14205_inp-nasal-olanzapine-in-healthy-adults.pdf2022-11-07 22:38 1.7M 
[ ]14206_insanity-offense-americas-failure-treat-seriously.pdf2022-11-07 23:01 90K 
[ ]14207_insight-into-schizophrenia-in-earlier-and-later-life.pdf2022-11-07 22:34 2.7M 
[ ]14208_insight-mental-disorders-suicidal-behavior-qualitative.pdf2022-11-07 22:45 672K 
[ ]14209_insight-predictor-outcome-episode-nonaffective-psychosis.pdf2022-11-07 22:22 98K 
[ ]14210_insights-genetics-pathophysiology-alzheimers-disease.pdf2022-11-07 22:59 104K 
[ ]14211_insomnia-and-impaired-quality-of-life.pdf2022-11-07 22:38 350K 
[ ]14214_insomnia-objectively-measured-sleep-disturbances-predict.pdf2022-11-07 22:41 407K 
[ ]14215_insomnia-primary-care-perspective.pdf2022-11-07 22:51 111K 
[ ]14216_insomnia-risk-depression-longitudinal-epidemiologic.pdf2022-11-07 22:20 360K 
[ ]14217_insomnia-sleep-duration-large-cohort-patients-major.pdf2022-11-07 22:04 310K 
[ ]14218_insomnia-symptom-frequency-hypertension-risk-population.pdf2022-11-07 22:56 350K 
[ ]14219_insulin-resistance-glucose-metabolism-patients-schizophrenia.pdf2022-11-07 22:54 221K 
[ ]14220_insulin-resistance-increased-leptin-concentrations.pdf2022-11-07 22:34 63K 
[ ]14221_insurance-coverage-and-health-outcomes-in-young-adults-with-mental-illness-following-the-aca.pdf2022-11-07 23:02 460K 
[ ]14222_integrated-analysis-acute-treatment-emergent-extrapyramidal.pdf2022-11-07 22:10 119K 
[ ]14223_integrated-analysis-olanzapinefluoxetine-combination.pdf2022-11-07 22:41 279K 
[ ]14224_integrated-care-psychiatry-redefining-role-mental.pdf2022-11-07 22:09 75K 
[ ]14225_integrated-family-individual-therapy-bipolar-disorder.pdf2022-11-07 22:07 83K 
[ ]14226_integrated-medical-care-patients-bipolar-disorder.pdf2022-11-07 22:30 148K 
[ ]14227_integrated-psychological-therapy-schizophrenic-patients.pdf2022-11-07 22:55 30K 
[ ]14228_integrated-treatment-comorbid-depression-substance.pdf2022-11-07 22:35 59K 
[ ]14229_integrated-treatment-dual-disorders-guide-effective.pdf2022-11-07 22:01 30K 
[ ]14230_integrated-treatment-eating-disorders-beyond-body.pdf2022-11-07 22:53 80K 
[ ]14231_integrated-treatment-mood-substancee-disorders.pdf2022-11-07 22:28 106K 
[ ]14232_integrating-general-health-care-private-community-causes-excess-mortality-morbidity-SGA-related-meta.pdf2022-11-07 22:51 138K 
[ ]14235_integration-measurement-management-treatment-bipolar.pdf2022-11-07 22:41 72K 
[ ]14236_integration-pharmacotherapy-psychotherapy-bipolar.pdf2022-11-07 22:44 67K 
[ ]14237_integration-psychotherapy-models-methods.pdf2022-11-07 22:41 35K 
[ ]14238_integration-suicide-prevention-outpatient-management.pdf2022-11-07 22:50 70K 
[ ]14239_intellectual-disability-understanding-developmen-cauese.pdf2022-11-07 22:59 99K 
[ ]14240_intended-unintended-consequences-gabapentin-off-label.pdf2022-11-07 22:53 426K 
[ ]14241_intentional-weight-loss-overweight-obese-patients.pdf2022-11-07 22:54 304K 
[ ]14242_interactions-antidepressants-neurotransmitter-transporters.pdf2022-11-07 22:32 64K 
[ ]14243_interactions-between-tamoxifen-antidepressants-via.pdf2022-11-07 22:45 388K 
[ ]14244_interactions-borderline-personality-disorder-anxiety.pdf2022-11-07 22:22 211K 
[ ]14245_interactions-borderline-personality-disorder-mood.pdf2022-11-07 23:00 284K 
[ ]14246_interactions-cyclobenzaprine-tricyclic-antidepressants.pdf2022-11-07 22:56 127K 
[ ]14247_interactive-computer-administered-self-assessment.pdf2022-11-07 22:01 38K 
[ ]14248_interest-activity-dimension-and-response-to-aripiprazole.pdf2022-11-07 22:48 120K 
[ ]14250_interest-activity-levels-and-need-for-ad-augmentation-in-mdd.pdf2022-11-07 22:21 730K 
[ ]14251_interferon-induced-depression-chronic-hepatitis-c.pdf2023-07-18 15:18 760K 
[ ]14252_interferon-induced-depression-treated-citalopram.pdf2022-11-07 22:36 55K 
[ ]14253_intermittent-explosive-disorder.pdf2022-11-07 22:59 286K 
[ ]14254_intermittent-explosive-disorder-and-substance-use-disorder.pdf2022-11-07 22:45 237K 
[ ]14255_intermittent-luteal-phase-sertraline-treatment-dysphoric.pdf2022-11-07 22:01 31K 
[ ]14256_international-consensus-group-bipolar-i-depression.pdf2022-11-07 23:00 79K 
[ ]14257_international-consensus-group-depression-prevention.pdf2022-11-07 22:18 602K 
[ ]14258_international-consensus-group-evidence-based-pharmacologic.pdf2022-11-07 22:11 412K 
[ ]14260_international-consensus-study-neuroleptic-malignant.pdf2022-11-07 22:37 344K 
[ ]14261_internet-addiction-and-suicidal-behaviors.pdf2022-11-07 22:42 1.2M 
[ ]14262_internet-assessment-obsessive-compulsive-disorder.pdf2022-11-07 22:18 88K 
[ ]14263_internet-observed-suicide-attempts.pdf2022-11-07 22:43 72K 
[ ]14264_internet-pharmacy-prescription-phentermine-overdose.pdf2022-11-07 22:30 67K 
[ ]14265_internet-users-seek-depression-web-searches-descriptive.pdf2022-11-07 23:01 138K 
[ ]14266_interpersonal-psychotherapy-antidepressant-medication.pdf2022-11-07 22:12 73K 
[ ]14267_interpersonal-psychotherapy-dysthymic-disorder.pdf2022-11-07 22:20 19K 
[ ]14268_interpretations-conclusions-clinical-trial.pdf2022-11-07 22:25 47K 
[ ]14270_interventional-psychiatry-why.pdf2022-11-07 22:32 169K 
[ ]14271_intervention-individuals-ultra-high-risk-psychosis.pdf2022-11-07 22:23 423K 
[ ]14272_intervention-research-persons-high-risk-suicidality.pdf2022-11-07 22:46 73K 
[ ]14273_intervention-resilience-mass-trauma.pdf2022-11-07 22:19 741K 
[ ]14275_interventions-and-transition-in-youth-at-risk-of-psychosis.pdf2022-11-07 22:48 2.8M 
[ ]14276_interviewing-clients-across-cultures-practitioners.pdf2022-11-07 22:32 91K 
[ ]14277_interview-th-ed.pdf2022-11-07 22:32 73K 
[ ]14278_intimate-partner-violence-suicidal-intent-alcoholism.pdf2022-11-07 22:30 88K 
[ ]14279_intimate-partner-violence-victimization-among-adults.pdf2022-11-07 22:09 88K 
[ ]14280_intramuscular-ziprasidone-compared-intramuscular-haloperidol.pdf2022-11-07 22:12 76K 
[ ]14281_intramuscular-ziprasidone-mg-versus-mg-short-term.pdf2022-11-07 22:05 63K 
[ ]14282_intramuscular-ziprasidone-moving-beyond-conventional.pdf2022-11-07 22:58 68K 
[ ]14283_intranasal-drug-delivery-neuropsychiatry-focus-intranasal.pdf2022-11-07 22:44 379K 
[ ]14284_intranasal-ketamine-intermittent-explosive-disorder.pdf2022-11-07 22:53 256K 
[ ]14285_intranasal-ketamine-treatment-adult-autism-spectrum.pdf2022-11-07 22:46 183K 
[ ]14286_intravenous-fosphenytoin-acute-mania.pdf2022-11-07 22:16 30K 
[ ]14287_intrinsic-activity-aripiprazole-is-dopamine-under.pdf2022-11-07 22:25 185K 
[ ]14288_introducing-jcp-weekly.pdf2022-11-07 22:47 203K 
[ ]14289_introducing-pubweb.pdf2022-11-07 23:00 37K 
[ ]14290_introductiona-concept-treatment-anxiety.pdf2022-11-07 22:32 10K 
[ ]14291_introduction-acute-care-agitated-psychotic-patient.pdf2022-11-07 22:26 23K 
[ ]14292_introduction-advances-emerging-treatments-social-phobia.pdf2022-11-07 22:55 29K 
[ ]14293_introductionalzheimers-disease-management.pdf2022-11-07 22:52 15K 
[ ]14294_introductionalzheimers-disease-research-practice.pdf2022-11-07 22:37 51K 
[ ]14295_introductionantidepressant-discontinuation-syndrome.pdf2022-11-07 22:55 12K 
[ ]14296_introduction-antidepressants-PMDD-ADHD-OCD-borderline-personality-panic-disorder.pdf2022-11-07 22:08 476K 
[ ]14297_introduction-antipsychotic-agents-clinical-economic.pdf2022-11-07 22:59 24K 
[ ]14298_introduction-antipsychotic-standard-care-redefining.pdf2022-11-07 22:36 32K 
[ ]14299_introduction-anxiety-treatment-perspectives.pdf2022-11-07 22:54 38K 
[ ]14300_introduction-art-science-switching-antipsychotic-medications.pdf2022-11-07 22:40 45K 
[ ]14301_introduction-assessing-antidepressant-efficacy-reexamination.pdf2022-11-07 22:02 23K 
[ ]14302_introduction-atypical-antipsychotics-treatment-children.pdf2022-11-07 22:34 28K 
[ ]14303_introductionaugmentation-antidepressant-medication.pdf2022-11-07 22:11 18K 
[ ]14304_introduction-awakening-psychiatry-geriatrics-finagle.pdf2022-11-07 22:15 23K 
[ ]14305_introduction-balancing-equation-managing-comorbidities.pdf2022-11-07 22:35 64K 
[ ]14306_introduction-barriers-depression-diagnosis-patient-outcomes-clinical-practice-collaboration.pdf2022-11-07 23:00 11K 
[ ]14307_introduction-beyond-refractory-obsessions-anxiety.pdf2022-11-07 22:21 41K 
[ ]14308_introductionbeyond-ssris.pdf2022-11-07 22:59 19K 
[ ]14310_introduction-bipolar-disorder-gender-women-schizophrenia-pregnancy.pdf2022-11-07 22:58 483K 
[ ]14311_introduction-burden-bipolar-depression.pdf2022-11-07 22:42 51K 
[ ]14312_introduction-cardiovascular-metabolic-risks-associated.pdf2022-11-07 22:06 24K 
[ ]14313_introduction-challenges-dual-diagnosis-managing-substance.pdf2022-11-07 22:42 49K 
[ ]14314_introduction-childhood-adolescent-mental-health-ADHD-offspring-bipolar-SSRI-risperidone-boys-bipolar.pdf2022-11-07 22:10 114K 
[ ]14315_introduction-chronic-major-depression-review-update.pdf2022-11-07 22:53 30K 
[ ]14317_introduction-clinical-effectiveness-atypical-antipsychotics.pdf2022-11-07 22:03 30K 
[ ]14318_introduction-clinical-impact-agitation-various-psychiatric.pdf2022-11-07 22:13 46K 
[ ]14319_introduction-comparison-bioequivalence-generic-versus.pdf2022-11-07 23:00 23K 
[ ]14320_introductioncurrent-issues-attention-deficit-disorder.pdf2022-11-07 22:52 50K 
[ ]14321_introduction-defining-remission-patients-treated-antidepressants.pdf2022-11-07 22:12 42K 
[ ]14322_introduction-definitions-measurements-management-insomnia.pdf2022-11-07 22:16 34K 
[ ]14323_introductiondepression-anxiety-implications-nosology.pdf2022-11-07 22:06 19K 
[ ]14324_introductiondepression-anxiety-tools-diagnosis-treatment.pdf2022-11-07 22:49 14K 
[ ]14325_introduction-depression-relevance-factor.pdf2022-11-07 22:48 29K 
[ ]14326_introductiondepression-subtypes-treatment-update.pdf2022-11-07 22:33 11K 
[ ]14327_introductiondepressive-disorders-advances-clinical.pdf2022-11-07 22:41 53K 
[ ]14328_introduction-developmental-neurobiology-psychiatry.pdf2022-11-07 22:35 59K 
[ ]14329_introduction-developments-treating-sleep-disorders.pdf2022-11-07 22:56 33K 
[ ]14330_introduction-developments-treatment-attention-deficit-hyperactivity.pdf2022-11-07 22:57 70K 
[ ]14331_introduction-directions-treatment-atypical-depression.pdf2022-11-07 22:06 101K 
[ ]14332_introduction-dual-action-debate-does-pharmacology.pdf2022-11-07 22:06 32K 
[ ]14333_introduction-early-career-offerings.pdf2022-11-07 22:36 109K 
[ ]14334_introduction-early-career-psychiatrist-anxiety-depression-OCD-stimulants-bipolar-MDD.pdf2022-11-07 22:34 111K 
[ ]14335_introduction-early-career-psychiatrist-ECT-PTSD-psychiatric-comorbidity-cognitive-function-practice-.pdf2022-11-07 22:56 101K 
[ ]14336_introduction-early-career-psychiatrists-april-2015.pdf2022-11-07 22:33 96K 
[ ]14337_introduction-early-career-psychiatrists-february-2017.pdf2022-11-07 22:15 93K 
[ ]14338_introduction-early-career-psychiatrists-september-2017.pdf2022-11-07 22:41 134K 
[ ]14339_introduction-early-career-psychiatrist-stroke-depression-clozapine-pharmacokinetics-bipolar-PTSD-dox.pdf2022-11-07 22:39 103K 
[ ]14340_introduction-early-onset-antidepressant-action.pdf2022-11-07 22:33 30K 
[ ]14341_introduction-effects-medical-interventions-suicidal.pdf2022-11-07 22:13 37K 
[ ]14342_introduction-electronic-monitoring-internet-addiction-communication-smartphone-mobile-mood.pdf2022-11-07 22:28 95K 
[ ]14343_introduction-era-pharmacotherapy-psychotic-disorders.pdf2022-11-07 22:03 32K 
[ ]14344_introduction-erectile-dysfunction-comorbid-depression.pdf2022-11-07 23:02 32K 
[ ]14345_introduction-evaluating-clinical-trial-data-schizophrenia.pdf2022-11-07 22:02 32K 
[ ]14346_introduction-evaluating-evidence-clinical-antipsychotic.pdf2022-11-07 22:22 62K 
[ ]14347_introduction-exploring-boundaries-obsessive-compulsive.pdf2022-11-07 22:06 28K 
[ ]14348_introduction-fifty-years-lithium-treatment-bipolar.pdf2022-11-07 23:01 25K 
[ ]14349_introduction-focus-depression-anxiety-disorders-general.pdf2022-11-07 22:39 21K 
[ ]14350_introduction-focus-generalized-anxiety-disorder.pdf2022-11-07 23:01 23K 
[ ]14351_introduction-focus-on-childhood-and-adolescent-mental-health.pdf2022-11-07 22:39 119K 
[ ]14352_introduction-focus-on-suicide.pdf2022-11-07 22:09 122K 
[ ]14353_introductionfocus-panic-disorder-antidepressants-practice.pdf2022-11-07 22:13 16K 
[ ]14354_introduction-focus-posttraumatic-stress-disorder.pdf2022-11-07 22:31 21K 
[ ]14355_introduction-focus-primary-care-management-depression.pdf2022-11-07 22:16 23K 
[ ]14356_introduction-focus-transcultural-issues-depression.pdf2022-11-07 22:04 24K 
[ ]14357_introduction-fresh-monoamine-oxidase-inhibitors-depression.pdf2022-11-07 22:44 97K 
[ ]14358_introduction-frontiers-management-social-anxiety-disorder.pdf2022-11-07 22:48 28K 
[ ]14359_introductionfunctional-brain-alterations-depression.pdf2022-11-07 22:26 11K 
[ ]14360_introduction-generalized-anxiety-disorder-why-are.pdf2022-11-07 22:56 27K 
[ ]14361_introduction-geriatric-psychiary-december-2016.pdf2022-11-07 22:22 114K 
[ ]14362_introduction-geriatric-psychiatry-january-2016.pdf2022-11-07 22:39 103K 
[ ]14363_introduction-geriatric-psychiatry-july-2017.pdf2022-11-07 22:41 130K 
[ ]14364_introduction-goal-antidepressant-therapy-response.pdf2022-11-07 22:56 28K 
[ ]14365_introduction-identifying-patients-risk-suicide-beyond.pdf2022-11-07 22:49 176K 
[ ]14366_introduction-innovations-management-bipolar-disorders.pdf2022-11-07 22:47 31K 
[ ]14367_introductionlate-life-depression.pdf2022-11-07 22:32 50K 
[ ]14368_introductionlearning-patients-key-issues-clinical.pdf2022-11-07 22:50 24K 
[ ]14369_introductionlithium-treatment-manic-depressive-illness.pdf2022-11-07 22:41 66K 
[ ]14370_introduction-long-term-mood-stabilizers-bipolar-disorder.pdf2022-11-07 22:05 33K 
[ ]14371_introduction-makes-antipsychotic-atypical.pdf2022-11-07 22:17 27K 
[ ]14372_introduction-management-treatment-resistant-depression.pdf2022-11-07 22:41 28K 
[ ]14373_introduction-managing-bipolar-depression.pdf2022-11-07 23:03 27K 
[ ]14374_introduction-medication-diagnostic-issues.pdf2022-11-07 22:51 69K 
[ ]14375_introduction-metabolic-disturbances-associated-antipsychotic.pdf2022-11-07 22:10 31K 
[ ]14376_introduction-methods-commentary-summary-psychotic-disorders.pdf2022-11-07 22:03 236K 
[ ]14377_introduction-methods-commentary-summary-using-antipsychoatic-agents-older-patients-geriatric.pdf2022-11-07 22:15 263K 
[ ]14378_introduction-months-ecp-selections.pdf2022-11-07 22:38 67K 
[ ]14379_introduction-months-selections-commentary-academic.pdf2022-11-07 22:56 132K 
[ ]14380_introduction-mood-stabilizers-treatment-psychiatric.pdf2022-11-07 23:02 32K 
[ ]14381_introduction-narcolepsy-excessive-daytime-sleepiness.pdf2022-11-07 22:30 65K 
[ ]14382_introduction-neuropsychopharmacology.pdf2022-11-07 22:20 104K 
[ ]14383_introduction-newer-drugs-older-patients.pdf2022-11-07 22:59 27K 
[ ]14384_introductionnew-treatment-options-improve-clinical.pdf2022-11-07 22:10 12K 
[ ]14385_introduction-norepinephrine-neurotransmitter-millennium.pdf2022-11-07 22:57 24K 
[ ]14386_introductionobsessive-compulsive-disorder-hidden-epidemic.pdf2022-11-07 22:25 27K 
[ ]14387_introductionoptimizing-clinical-ssris-theory-practice.pdf2022-11-07 22:14 12K 
[ ]14388_introduction-optimizing-outcomes-treating-depression.pdf2022-11-07 22:32 28K 
[ ]14389_introduction-optimizing-treatment-outcome-depression.pdf2022-11-07 22:32 34K 
[ ]14390_introduction-optimizing-wakefulness-patients-fatigue.pdf2022-11-07 22:22 30K 
[ ]14391_introduction-overview-issues-surrounding-recognition.pdf2022-11-07 23:01 47K 
[ ]14392_introduction-panic-OCD-antidepressant-nonresponse-psychotherapeutic-approach-depression-anxiety.pdf2022-11-07 22:35 13K 
[ ]14393_introduction-pathophysiology-depression-emerging-role.pdf2022-11-07 22:27 35K 
[ ]14394_introduction-pharmacoeconomics-treatment-resistant.pdf2022-11-07 22:14 17K 
[ ]14395_introduction-pharmacologic-treatment-alcohol-abuse.pdf2022-11-07 22:20 21K 
[ ]14396_introduction-pharmacologic-treatments-major-depression.pdf2022-11-07 22:35 33K 
[ ]14397_introduction-phenomenology-treatment-aggression-across.pdf2022-11-07 22:54 27K 
[ ]14398_introduction-postpartum-depression.pdf2022-11-07 22:54 19K 
[ ]14399_introduction-practical-pharmacotherapeutic-management.pdf2022-11-07 22:24 57K 
[ ]14400_introduction-psychoneuroimmunology.pdf2022-11-07 22:14 50K 
[ ]14401_introduction-quetiapine-update.pdf2022-11-07 22:26 34K 
[ ]14402_introductionreboxetine-selective-antidepressant-treatment.pdf2022-11-07 22:46 51K 
[ ]14403_introduction-recent-advances-treatments-schizophrenia.pdf2022-11-07 22:42 130K 
[ ]14404_introduction-recent-developments-achieving-depression.pdf2022-11-07 22:09 22K 
[ ]14405_introduction-recognizing-treatment-resistant-depression.pdf2022-11-07 22:06 25K 
[ ]14406_introduction-relationship-chronic-pain-depression.pdf2022-11-07 22:22 32K 
[ ]14407_introduction-remission-anxiety-related-disorders.pdf2022-11-07 22:30 26K 
[ ]14408_introductionrepairing-shattered-self-recovering-trauma.pdf2022-11-07 22:29 11K 
[ ]14409_introduction-role-anticonvulsants-mood-stabilizers.pdf2022-11-07 22:04 33K 
[ ]14410_introduction-role-atypical-antipsychotics-treatment.pdf2022-11-07 22:16 49K 
[ ]14411_introduction-role-enteric-coated-fluoxetine-once-weekly.pdf2022-11-07 22:13 26K 
[ ]14412_introductionroutine-atypical-antipsychotic-agents.pdf2022-11-07 22:14 12K 
[ ]14413_introduction-scientific-expert-meeting.pdf2022-11-07 22:17 21K 
[ ]14414_introduction-sexual-dysfunction-associated-depression.pdf2022-11-07 22:53 25K 
[ ]14415_introduction-side-effects-antipsychotic-medications.pdf2022-11-07 22:53 27K 
[ ]14416_introduction-spectrum-depression-treatment-approaches.pdf2022-11-07 22:29 33K 
[ ]14417_introduction-strategies-improving-treatment-depression.pdf2022-11-07 23:01 35K 
[ ]14418_introduction-strategies-treatment-posttraumatic-stress.pdf2022-11-07 22:34 24K 
[ ]14419_introduction-supportive-psychotherapy.pdf2022-11-07 22:54 29K 
[ ]14420_introduction-TRD-comorbid-anxiety-depression-mechanisms-action.pdf2022-11-07 23:03 58K 
[ ]14421_introduction-treating-depression-anxiety-remission.pdf2022-11-07 22:35 26K 
[ ]14422_introduction-treating-sexual-dysfunction-psychiatrys.pdf2022-11-07 22:26 32K 
[ ]14423_introduction-treatment-depression-long-term-care-patients.pdf2022-11-07 22:07 23K 
[ ]14424_introductiontreatment-panic-disorder-state-art.pdf2022-11-07 22:58 8.5K 
[ ]14425_introduction-treatment-resistant-schizophrenia-beyond.pdf2022-11-07 23:00 26K 
[ ]14426_introduction-treatments-anxiety-disorders-clinical.pdf2022-11-07 22:41 23K 
[ ]14427_introduction-treatments-bipolar-disorder.pdf2022-11-07 22:10 24K 
[ ]14428_introduction-trends-treating-premenstrual-dysphoric.pdf2022-11-07 22:59 23K 
[ ]14429_introduction-understanding-depression-treatment-restoration.pdf2022-11-07 22:28 22K 
[ ]14430_introduction-understanding-neuronal-pathways-novel.pdf2022-11-07 22:42 75K 
[ ]14431_introduction-understanding-posttraumatic-stress-disorder.pdf2022-11-07 22:23 21K 
[ ]14432_introduction-untangling-roles-antidepressants-mood.pdf2022-11-07 22:43 75K 
[ ]14433_introduction-update-posttraumatic-stress-disorder.pdf2022-11-07 23:02 26K 
[ ]14434_introduction-update-tardive-dyskinesia.pdf2022-11-07 22:45 22K 
[ ]14435_introduction-using-newer-pharmacotherapeutic-agents.pdf2022-11-07 22:57 31K 
[ ]14436_introduction-weighing-evidence-weight-management-insights.pdf2022-11-07 22:46 52K 
[ ]14437_introduction-weight-gain-glucose-regulation-during.pdf2022-11-07 22:44 27K 
[ ]14438_introduction-weight-gain-growing-problem-schizophrenia.pdf2022-11-07 22:47 22K 
[ ]14439_introduction-weight-gain-psychotropics-size-does-matter.pdf2022-11-07 22:36 28K 
[ ]14440_introduction-women-depression.pdf2022-11-07 22:40 36K 
[ ]14441_introduction-womens-mental-health-childhood-trauma-pregnancy-registry-antipsychotics-exposure-neurod.pdf2022-11-07 22:15 120K 
[ ]14443_introduction-womens-mental-health-may-2017.pdf2022-11-07 22:31 96K 
[ ]14444_introduction-womens-mental-health-november-2016.pdf2022-11-07 22:23 97K 
[ ]14445_introduction-ziprasidone-schizophrenia-acute-treatment.pdf2022-11-07 22:01 42K 
[ ]14446_introductory-textbook-psychiatry-th-ed.pdf2022-11-07 22:52 135K 
[ ]14447_investigating-pathogenesis-posttraumatic-stress-disorder.pdf2022-11-07 22:01 133K 
[ ]14448_investigation-water-lithium-concentrations-rates-violent.pdf2022-11-07 22:20 154K 
[ ]14449_iron-homeostasis-during-risperidone-treatment-children.pdf2022-11-07 22:14 250K 
[ ]14450_iron-overload-among-psychiatric-outpatient-population.pdf2022-11-07 23:02 77K 
[ ]14451_irradiation-therapy-prevents-gynecomastia-sex-offenders.pdf2022-11-07 22:36 37K 
[ ]14452_irritability-elation-large-bipolar-youth-sample-relative.pdf2022-11-07 22:47 323K 
[ ]14453_irritability-with-psychostimulants-in-adhd.pdf2022-11-07 22:27 291K 
[ ]14454_irritable-bowel-syndrome-anxiety-depression-are-links.pdf2022-11-07 22:17 74K 
[ ]14455_is-age-onset-criterion-relevant-response-methylphenidate.pdf2022-11-07 22:54 204K 
[ ]14456_is-antipsychotic-drug-induced-weight-gain-associated.pdf2022-11-07 22:26 51K 
[ ]14457_is-aripiprazole-efficacious-adjunct-unipolar-depression.pdf2022-11-07 22:04 210K 
[ ]14458_is-baseline-medication-resistance-associated-potential.pdf2022-11-07 22:32 178K 
[ ]14459_is-bipolar-disorder-overdiagnosed.pdf2022-11-07 22:06 175K 
[ ]14460_is-bipolar-disorder-specifically-associated-panic.pdf2022-11-07 22:21 129K 
[ ]14461_is-clozapine-safe-patients-preexisting-epilepsy-report.pdf2022-11-07 22:01 154K 
[ ]14462_is-common-resilience-mechanism-underlying-antidepressant.pdf2022-11-07 22:35 336K 
[ ]14463_is-covid-19-associated-with-posttraumatic-stress-disorder.pdf2022-11-07 22:32 197K 
[ ]14465_is-delay-antidepressant-effect-meta-analysis.pdf2022-11-07 22:44 211K 
[ ]14466_is-depersonalization-disorder-initiated-illicit-drug.pdf2022-11-07 22:12 307K 
[ ]14467_is-depression-atypical-features-associated-trauma.pdf2022-11-07 22:22 465K 
[ ]14468_is-dialectical-dialectical-behavior-therapy.pdf2022-11-07 23:01 131K 
[ ]14469_is-divalproex-cost-effective-alternative-acute-prophylactic.pdf2022-11-07 22:26 44K 
[ ]14470_is-dsm-iv-bereavement-exclusion-major-depressive-episode.pdf2022-11-07 22:05 322K 
[ ]14471_is-evidence-based-psychiatry-ethical.pdf2022-11-07 22:49 76K 
[ ]14472_is-evidence-changes-cognition-functioning-lifespan.pdf2022-11-07 23:01 489K 
[ ]14473_is-flunarizine-long-acting-oral-atypical-antipsychotic.pdf2022-11-07 22:51 241K 
[ ]14474_is-generalized-anxiety-disorder.pdf2022-11-07 22:26 70K 
[ ]14475_is-generalized-anxiety-disorder-symptom-worry-another.pdf2022-11-07 22:49 291K 
[ ]14476_is-hypomania-tetrachoric-factor-analysis-kernel-estimation.pdf2022-11-07 22:42 425K 
[ ]14477_is-ltemgtdsm-ivltemgt-bereavement-exclusion-major.pdf2022-11-07 22:17 194K 
[ ]14478_is-melatonin-treatment-effective-tardive-dyskinesia.pdf2022-11-07 22:40 43K 
[ ]14479_isotretinoin-risk-depression.pdf2022-11-07 22:35 722K 
[ ]14480_isotretinoin-risk-depression-patients-acne-vulgaris.pdf2022-11-07 23:00 203K 
[ ]14481_isotretinoin-treatment-woman-bipolar-disorder.pdf2022-11-07 22:25 44K 
[ ]14482_is-perinatal-psychiatry-needed-specialty.pdf2022-11-07 22:55 84K 
[ ]14483_is-posttraumatic-stress-disorder.pdf2022-11-07 22:23 63K 
[ ]14484_is-problem-high-placebo-response-unique-antidepressant.pdf2022-11-07 23:03 80K 
[ ]14485_is-psychiatric-epidemiology-still-counting.pdf2022-11-07 22:48 116K 
[ ]14486_is-psychopharmacologic-inoculation-effective-preventing.pdf2022-11-07 22:09 82K 
[ ]14487_is-psychopharmacologic-treatment-associated-neuropsychological.pdf2022-11-07 22:30 387K 
[ ]14488_is-psychotherapy-personality-disorders-worth.pdf2022-11-07 22:51 105K 
[ ]14489_is-real-difference-between-onset-efficacy-atypical.pdf2022-11-07 22:39 165K 
[ ]14490_is-real-difference-severity-tardive-dyskinesia-between.pdf2022-11-07 22:24 106K 
[ ]14491_is-response-prophylactic-lithium-familial-trait.pdf2022-11-07 22:11 105K 
[ ]14492_is-right-pharmacotherapy-alcohol-disorder-patients.pdf2022-11-07 22:55 109K 
[ ]14493_is-risk-neuroleptic-malignant-syndrome-increased-postpartum.pdf2022-11-07 22:01 37K 
[ ]14494_is-role-long-acting-injectable-antipsychotics-treatment.pdf2022-11-07 22:59 159K 
[ ]14495_is-second-generation-antipsychoticinduced-hyperprolactinemia.pdf2022-11-07 22:50 181K 
[ ]14496_is-smoking-associated-suicide-bipolar-patients.pdf2022-11-07 23:01 153K 
[ ]14497_is-statin-safe-individuals-psychotic-disorders.pdf2022-11-07 22:22 132K 
[ ]14498_issue-entering-era-high-density-genome-wide-association.pdf2022-11-07 22:37 77K 
[ ]14499_issue-genetics-cholesterol-risk-alzheimers-disease.pdf2022-11-07 22:38 61K 
[ ]14500_issue-genetic-transcriptomic-proteomic-study-alzheimers.pdf2022-11-07 22:31 52K 
[ ]14501_issue-non-alzheimer-dementias.pdf2022-11-07 22:40 45K 
[ ]14502_issues-adherence-treatment-monoamine-oxidase-inhibitors.pdf2022-11-07 22:27 270K 
[ ]14503_issues-assessment-treatment-response-panic-disorder.pdf2022-11-07 22:22 43K 
[ ]14504_issues-clinical-benzodiazepines-potency-withdrawal.pdf2022-11-07 22:07 68K 
[ ]14505_issues-consider-assessment-treatment-paraphilic-patients.pdf2022-11-07 23:00 105K 
[ ]14506_issues-treatment-resistant-depression.pdf2022-11-07 22:04 178K 
[ ]14507_issues-treatment-women-bipolar-illness.pdf2022-11-07 22:06 531K 
[ ]14508_is-threshold-symptomatic-response-remission-major.pdf2022-11-07 22:26 102K 
[ ]14509_is-trauma-causal-agent-psychopathologic-symptoms-posttraumatic.pdf2022-11-07 22:15 305K 
[ ]14510_is-validity-bipolar-prodrome.pdf2022-11-07 22:55 116K 
[ ]14511_is-virtual-reality-effective-motivate-raise-interest.pdf2022-11-07 22:40 305K 
[ ]14512_j-clin-psychiatryrandomized-controlled-trial-interventions.pdf2022-11-07 23:02 344K 
[ ]14513_jcp-at-continuing-a-tradition-of-excellence.pdf2022-11-07 22:12 328K 
[ ]14515_jcp-forward.pdf2022-11-07 22:46 197K 
[ ]14516_jcps-circle-honor-peer-reviewers-2009.pdf2022-11-07 22:23 157K 
[ ]14517_jcps-circle-honor-peer-reviewers-2011.pdf2022-11-07 22:27 133K 
[ ]14518_journal.pdf2022-11-07 22:38 69K 
[ ]14519_journal-clinical-psychiatry-peer-review-circle-honor.pdf2022-11-07 22:17 50K 
[ ]14520_journal-clinical-psychiatry-subject-index-volume-january.pdf2022-11-07 22:58 108K 
[ ]14521_juvenile-maladaptive-aggression-review-prevention.pdf2022-11-07 22:29 134K 
[ ]14522_juvenile-sex-offender-nd-ed.pdf2022-11-07 22:14 100K 
[ ]14523_juvenile-sexual-homicide.pdf2022-11-07 22:07 44K 
[ ]14524_kantrowitz-reply-efficacy-auditory-processing-focused-cognitive-remediation-therapy.pdf2022-11-07 22:54 123K 
[ ]14525_kantrowitz-reply-low-dose-d-cycloserine-depression.pdf2022-11-07 22:29 135K 
[ ]14526_kaplan-sadocks-pocket-handbook-clinical-psychiatry-fifth-edition-book-reivew.pdf2022-11-07 22:04 150K 
[ ]14527_kaplan-sadocks-pocket-handbook-clinical-psychiatry-third-edition-book-review.pdf2022-11-07 22:20 43K 
[ ]14528_kaplan-sadocks-study-guide-self-examination-review.pdf2022-11-07 22:10 48K 
[ ]14529_kaplan-sadocks-synopsis-psychiatry-behavioral-sciencesclinical.pdf2022-11-07 23:02 100K 
[ ]14530_karolinska-interpersonal-violence-scale-predicts-suicide.pdf2022-11-07 22:55 320K 
[ ]14531_kazdin-method-parenting-defiant-child-pill-therapy.pdf2022-11-07 22:06 97K 
[ ]14532_keeping-em-honest-current-crisis-confidence-antidepressants.pdf2022-11-07 22:10 137K 
[ ]14533_ketamine-as-a-clinical-treatment-for-mood-disorders.pdf2022-11-07 22:39 473K 
[ ]14534_ketamine-for-depression-diagnostic-and-contextual-indications.pdf2022-11-07 22:10 310K 
[ ]14535_ketamine-for-depression-does-chirality-matter.pdf2022-11-07 22:58 317K 
[ ]14536_ketamine-for-depression-dosing-administration-and-duration.pdf2022-11-07 22:03 376K 
[ ]14537_ketamine-for-depression-efficacy-adverse-effects-and-mechanism-of-action.pdf2022-11-07 22:12 356K 
[ ]14538_ketamine-for-depression-part.pdf2022-11-07 22:38 305K 
[ ]14539_ketamine-for-depression-pharmacokinetic-and-pharmacodynamic-drug-interactions.pdf2022-11-07 22:59 338K 
[ ]14540_ketamine-for-suicidal-ideation.pdf2022-11-07 22:51 254K 
[ ]14541_ketamine-plus-prolonged-exposure-therapy-for-veterans-with-ptsd.pdf2022-11-07 22:44 428K 
[ ]14542_ketamine-safety-tolerability-clinical-trials-treatment.pdf2022-11-07 22:40 781K 
[ ]14543_key-competencies-brief-dynamicpsychotherapy-clinical.pdf2022-11-07 22:24 53K 
[ ]14544_key-treatment-studies-lithium-manic-depressive-illness.pdf2022-11-07 22:36 97K 
[ ]14546_kidney-function-and-serum-risperidone-concentrations.pdf2022-11-07 22:04 182K 
[ ]14547_killing-mother-ones-child-psychiatric-risk-factors.pdf2022-11-07 22:59 253K 
[ ]14548_lack-association-between-plasma-apolipoprotein-e-suicide.pdf2022-11-07 22:32 50K 
[ ]14549_lack-association-between-serum-brain-derived-neurotrophic.pdf2022-11-07 22:11 742K 
[ ]14550_lack-desipramine-toxicity-citalopram.pdf2022-11-07 22:41 49K 
[ ]14551_lack-effect-intravenous-immunoglobulins-tics-double.pdf2022-11-07 22:16 53K 
[ ]14552_lack-efficacy-grams-daily-creatine-schizophrenia-randomized.pdf2022-11-07 22:42 114K 
[ ]14553_lack-mania-prophylaxis-associated-lamotrigine-monotherapy.pdf2022-11-07 22:59 196K 
[ ]14554_lack-sertraline-efficacy-probably-due-interaction.pdf2022-11-07 22:51 52K 
[ ]14555_lai-acceptance-for-early-phase-schizophrenia-treatment.pdf2022-11-07 22:55 402K 
[ ]14556_lamotrigine-adjunct-paroxetine-acute-depression-placebo.pdf2022-11-07 22:45 74K 
[ ]14557_lamotrigine-associated-stevens-johnson-syndrome-discontinuation.pdf2022-11-07 22:19 170K 
[ ]14558_lamotrigine-augmentation-agent-treatment-resistant.pdf2022-11-07 22:14 51K 
[ ]14559_lamotrigine-induced-tactile-hallucination.pdf2022-11-07 22:21 90K 
[ ]14560_lamotrigine-patients-bipolar-disorder-cocaine-dependence.pdf2022-11-07 22:09 59K 
[ ]14561_lamotrigine-prophylaxis-against-steroid-induced-mania.pdf2022-11-07 22:05 46K 
[ ]14562_lamotrigine-psychiatric-disorders.pdf2022-11-07 22:20 375K 
[ ]14563_lamotrigine-rapid-cycling-bipolar-disorder.pdf2022-11-07 22:36 51K 
[ ]14564_lamotrigine-rash-scratching-beneath-surface.pdf2022-11-07 22:58 33K 
[ ]14565_lamotrigine-treatment-depersonalization-disorder.pdf2022-11-07 22:24 52K 
[ ]14566_lamotrigine-treatment-pathologic-skin-picking-open.pdf2022-11-07 22:25 188K 
[ ]14567_lamotrigine-treatment-refractory-bipolar-disorder.pdf2022-11-07 22:39 42K 
[ ]14568_language-alzheimers-disease.pdf2022-11-07 22:04 152K 
[ ]14569_large-open-label-study-venlafaxine-depressed-outpatients.pdf2022-11-07 22:06 165K 
[ ]14570_late-life-depression.pdf2022-11-07 22:36 35K 
[ ]14571_late-life-health-consequences-exposure-trauma-general.pdf2022-11-07 22:59 288K 
[ ]14572_late-life-ptsd-exacerbation.pdf2022-11-07 22:21 294K 
[ ]14573_late-night-wakefulness-and-suicidal-ideation.pdf2022-11-07 22:18 282K 
[ ]14574_latent-class-analysis-personality-disorders-adults.pdf2022-11-07 22:31 435K 
[ ]14575_latent-trajectories-trauma-symptoms-resilience-longitudinal.pdf2022-11-07 22:45 1.2M 
[ ]14576_late-onset-adrenoleukodystrophy-associated-long-standing.pdf2022-11-07 22:46 121K 
[ ]14577_late-onset-depression-elderly-subjects-vienna-transdanube.pdf2022-11-07 22:51 247K 
[ ]14578_late-onset-hypersensitivity-reaction-leukopenia-thrombocytopenia.pdf2022-11-07 22:40 208K 
[ ]14579_late-onset-manic-episode-old-man-without-previous.pdf2022-11-07 22:55 181K 
[ ]14580_late-onset-psychiatric-disorder-in-injury-survivors.pdf2022-11-07 22:21 218K 
[ ]14582_laying-groundwork-standardized-assessment-suicidal.pdf2022-11-07 22:40 153K 
[ ]14584_learning-cognitive-behavior-therapy-illustrated-guide.pdf2022-11-07 22:33 109K 
[ ]14585_learning-disabilities-implications-psychiatric-treatment.pdf2022-11-07 22:34 42K 
[ ]14586_learning-history-swallow-pill.pdf2022-11-07 22:54 527K 
[ ]14587_learning-psychotherapy-efficient-research-based.pdf2022-11-07 22:46 39K 
[ ]14588_learning-review.pdf2022-11-07 22:12 152K 
[ ]14589_legal-ethical-considerations-treatment-psychosis.pdf2022-11-07 22:54 55K 
[ ]14590_leisure-physical-activity-pregnancy-risk-postpartum.pdf2022-11-07 22:41 348K 
[ ]14591_length-between-onset-childhood-sexual-abuse-emergence.pdf2022-11-07 22:09 267K 
[ ]14592_leptin-abdominal-obesity-onset-depression-older-men.pdf2022-11-07 22:56 297K 
[ ]14593_leptin-concentrations-are-increased-subjects-treated.pdf2022-11-07 22:28 55K 
[ ]14594_leptospirosis-and-depression.pdf2022-11-07 22:13 227K 
[ ]14595_less-is-more-antidepressant-clinical-trials-meta-analysis.pdf2022-11-07 22:44 454K 
[ ]14596_lessons-from-the-latest-us-military-suicide-surveillance-data.pdf2022-11-07 23:03 89K 
[ ]14597_lessons-posttraumatic-stress-disorder-past-venezuela.pdf2022-11-07 22:39 117K 
[ ]14598_leucine-zipper-activate-gene-expression.pdf2022-11-07 22:58 64K 
[ ]14599_leukopenia-associated-addition-paroxetine-clozapine.pdf2022-11-07 22:06 140K 
[ ]14600_level-cardiovascular-risk-factors-bipolar-disorder.pdf2022-11-07 22:22 171K 
[ ]14601_levetiracetam-adjunctive-therapy-refractory-anxiety.pdf2022-11-07 22:43 114K 
[ ]14602_levetiracetam-generalized-social-anxiety-disorder.pdf2022-11-07 22:20 211K 
[ ]14603_levetiracetam-induced-depression-healthy-adult.pdf2022-11-07 22:56 81K 
[ ]14604_levetiracetam-management-bipolar-depression-randomized.pdf2022-11-07 22:32 396K 
[ ]14605_levetiracetam-patients-impulsive-aggression-double.pdf2022-11-07 22:49 176K 
[ ]14606_levetiracetam-treatment-acute-mania-open-add-study.pdf2022-11-07 22:40 47K 
[ ]14607_levetiracetam-treatment-refractory-posttraumatic-stress.pdf2022-11-07 22:47 74K 
[ ]14608_levothyroxine-psychiatry-issues-related-absorption.pdf2022-11-07 23:03 532K 
[ ]14609_lewiss-child-adolescent-psychiatry-comprehensive-textbook.pdf2022-11-07 22:41 98K 
[ ]14610_lewy-body-dementia-litmus-test-neuroleptic-sensitivity.pdf2022-11-07 22:59 70K 
[ ]14611_lies-lies-lies-psychology-defeat.pdf2022-11-07 22:02 57K 
[ ]14612_life-events-medical-comorbidity-somatic-symptoms-pediatric.pdf2022-11-07 22:21 178K 
[ ]14613_lifespan-persistence-adhd-life-transition-model-application.pdf2022-11-07 22:34 370K 
[ ]14614_life-threatening-clozapine-induced-gastrointestinal.pdf2022-11-07 22:21 286K 
[ ]14615_lifetime-comorbidity-dsm-iv-mood-anxiety-disorders.pdf2022-11-07 22:39 106K 
[ ]14616_lifetime-history-sexual-abuse-clinical-presentation.pdf2022-11-07 22:14 61K 
[ ]14617_lifetime-month-prevalence-rates-intermittent-explosive.pdf2022-11-07 22:47 50K 
[ ]14618_lifetime-prevalence-mood-anxiety-disorders-fragile.pdf2022-11-07 22:14 277K 
[ ]14619_lifetime-trauma-exposure-veterans-military-related.pdf2022-11-07 22:21 103K 
[ ]14620_likelihood-helped-harmed-assist-clinical-decision.pdf2022-11-07 22:05 146K 
[ ]14621_limbic-leucotomy-self-mutilation.pdf2022-11-07 22:30 83K 
[ ]14622_limbic-paroxysmal-magnetoencephalographic-activity.pdf2022-11-07 22:20 95K 
[ ]14623_limitations-contemporary-antidepressants-tolerability.pdf2022-11-07 22:30 187K 
[ ]14624_limitations-efficacy-antidepressant-monotherapy.pdf2022-11-07 22:08 88K 
[ ]14625_limiting-access-psychiatric-services-increase-total.pdf2022-11-07 22:25 60K 
[ ]14626_line-manuscript-submission-peer-review.pdf2022-11-07 22:05 53K 
[ ]14627_line-pharmacotherapy-approaches-generalized-anxiety.pdf2022-11-07 22:24 258K 
[ ]14628_linezolid-monoamine-oxidase-inhibiting-antibiotic.pdf2022-11-07 22:32 67K 
[ ]14629_linking-bipolar-disorder-and-cardiovascular-risk.pdf2022-11-07 22:09 311K 
[ ]14630_lipid-monitoring-patients-schizophrenia-prescribed.pdf2022-11-07 22:20 85K 
[ ]14631_lipid-worsening-in-adolescents-treated-with-sgas.pdf2022-11-07 22:03 2.5M 
[ ]14632_lippincotts-primary-care-psychiatry.pdf2022-11-07 22:15 83K 
[ ]14633_lisdexamfetamine-dimesylate-adults-attention-deficit.pdf2022-11-07 22:19 471K 
[ ]14634_lisdexamfetamine-effects-based-on-gender-and-age.pdf2022-11-07 22:55 280K 
[ ]14635_lishmans-organic-psychiatry-th-ed.pdf2022-11-07 22:51 148K 
[ ]14640_lithium-and-alzheimers-disease.pdf2022-11-07 22:58 158K 
[ ]14641_lithium-and-renal-function-in-older-adults.pdf2022-11-07 22:45 1.2M 
[ ]14642_lithium-augment-antidepressant-medication.pdf2022-11-07 22:39 51K 
[ ]14643_lithium-augmentation-antidepressants-treatment-refractory.pdf2022-11-07 22:32 106K 
[ ]14644_lithium-augmentation-compared-phenelzine-treatment.pdf2022-11-07 22:13 222K 
[ ]14645_lithium-augmentation-fails-reduce-symptoms-poorly.pdf2022-11-07 22:20 66K 
[ ]14646_lithium-carbonate-maintenance-studies-consequences.pdf2022-11-07 22:07 155K 
[ ]14647_lithium-carbonate-versus-cognitive-therapy-sequential.pdf2022-11-07 22:24 59K 
[ ]14648_lithium-clozapine-rechallenge-retrospective-case-analysis.pdf2022-11-07 22:07 87K 
[ ]14649_lithium-combinations-acute-maintenance-treatment-unipolar.pdf2022-11-07 22:57 104K 
[ ]14650_lithium-dosing-schedule-renal-insufficiency.pdf2022-11-07 22:59 134K 
[ ]14651_lithium-induced-subclinical-hypothyroidism-review.pdf2022-11-07 22:17 64K 
[ ]14652_lithium-in-tap-water-and-adolescent-mental-health.pdf2022-11-07 22:10 196K 
[ ]14653_lithium-interaction-cyclooxygenase-inhibitors-rofecoxib.pdf2022-11-07 22:16 55K 
[ ]14654_lithium-intoxication-administration-blockers.pdf2022-11-07 22:50 63K 
[ ]14655_lithium-management-women-bipolar-disorder-during-pregnancy.pdf2022-11-07 22:42 101K 
[ ]14656_lithium-monitoring-in-older-adults.pdf2022-11-07 22:39 622K 
[ ]14657_lithium-regulates-cytoprotective-protein-bcl-cns.pdf2022-11-07 23:00 291K 
[ ]14658_lithium-schizophrenia-revisited-systematic-review.pdf2022-11-07 22:31 78K 
[ ]14659_lithium-suicidal-behaviour-patients-bipolar-disorder.pdf2022-11-07 22:26 155K 
[ ]14660_lithium-therapy-corticosteroid-induced-mood-disorder.pdf2022-11-07 22:15 69K 
[ ]14661_lithium-therapy-suicide-risk.pdf2022-11-07 22:16 47K 
[ ]14662_lithium-treatment-effects-neuropsychological-functioning.pdf2022-11-07 22:09 242K 
[ ]14663_lithium-treatment-reduces-suicide-risk-recurrent-major.pdf2022-11-07 22:10 125K 
[ ]14664_lithium-treatment-risk-suicidal-behavior-bipolar-disorder.pdf2022-11-07 22:11 64K 
[ ]14665_lithium-treatment-suicide-risk-major-affective-disorders.pdf2022-11-07 22:01 93K 
[ ]14666_lithium-trial-alzheimers-disease-randomized-single.pdf2022-11-07 22:04 294K 
[ ]14667_lithium-unipolar-depression-prevention-suicide.pdf2022-11-07 23:02 51K 
[ ]14668_lithium-use-and-chronic-kidney-disease-in-older-adults.pdf2022-11-07 22:17 224K 
[ ]14669_lithium-valproate-treatment-pathological-gambling.pdf2022-11-07 22:06 63K 
[ ]14670_lithium-valproate-untie-tangles-alzheimers-disease.pdf2022-11-07 22:16 110K 
[ ]14671_little-psychotherapy-book-object-relations-practice.pdf2022-11-07 22:04 122K 
[ ]14672_living-longer-depression-free-family-guide-recognizing.pdf2022-11-07 22:55 30K 
[ ]14673_l-methylfolate-vitamin-monoamines.pdf2022-11-07 22:11 138K 
[ ]14674_location-location-location-role-place-career-development.pdf2022-11-07 22:16 115K 
[ ]14675_long-acting-injectable-antipsychotic-management-during-covid-19.pdf2022-11-07 22:57 106K 
[ ]14676_long-acting-injectable-antipsychotics-underutilized.pdf2022-11-07 22:53 164K 
[ ]14678_long-acting-injectable-antipsychotic-use-during-pregnancy.pdf2022-11-07 22:59 243K 
[ ]14679_long-acting-injectable-risperidone-control-agitation.pdf2022-11-07 22:34 81K 
[ ]14680_long-acting-injectable-risperidone-hospital-readmission.pdf2022-11-07 22:32 124K 
[ ]14681_long-acting-injectable-versus-oral-antipsychotics.pdf2022-11-07 23:00 900K 
[ ]14682_long-acting-injectable-versus-oral-naltrexone-maintenance.pdf2022-11-07 22:12 298K 
[ ]14683_long-acting-injectable-vs-oral-risperidone-schizophrenia.pdf2022-11-07 22:16 936K 
[ ]14684_long-chain-polyunsaturated-fatty-acid-status-during.pdf2022-11-07 22:49 1.4M 
[ ]14685_longer-antipsychotic-treatment-discontinuation-cause.pdf2022-11-07 22:37 227K 
[ ]14686_longitudinal-analysis-latent-classes-psychopathology.pdf2022-11-07 22:42 269K 
[ ]14687_longitudinal-assessment-manic-symptoms-lams-study.pdf2022-11-07 22:39 319K 
[ ]14688_longitudinal-course-bipolar-disorder.pdf2022-11-07 22:48 64K 
[ ]14689_longitudinal-course-cognitive-impairment-schizophrenia.pdf2022-11-07 23:01 392K 
[ ]14690_longitudinal-course-posttraumatic-stress-disorder.pdf2022-11-07 22:20 209K 
[ ]14691_longitudinal-effects-personality-disorders-psychosocial.pdf2022-11-07 22:01 194K 
[ ]14692_longitudinal-examination-skeletal-effects-selective.pdf2022-11-07 23:01 253K 
[ ]14693_longitudinal-follow-naturalistic-treatment-outcome.pdf2022-11-07 22:31 63K 
[ ]14694_longitudinal-investigation-role-self-medication-development.pdf2022-11-07 23:03 263K 
[ ]14695_longitudinal-relationships-of-ptsd-with-lep-rs.pdf2022-11-07 22:09 268K 
[ ]14696_longitudinal-study-effects-lithium-treatment-prefrontal.pdf2022-11-07 22:04 214K 
[ ]14697_longitudinal-study-low-serum-ldl-cholesterol-depressive.pdf2022-11-07 22:57 916K 
[ ]14698_longitudinal-study-medication-nonadherence-hospitalization.pdf2022-11-07 22:23 207K 
[ ]14699_longitudinal-study-nonsuicidal-self-injury-offspring.pdf2022-11-07 22:42 275K 
[ ]14700_longitudinal-trajectories-adhd-symptomatology-offspring.pdf2022-11-07 22:49 301K 
[ ]14701_longitudinal-view-triggers-thresholds-suicidal-behavior.pdf2022-11-07 22:32 88K 
[ ]14702_long-last-long-lasting-psychiatric-medications-overview.pdf2022-11-07 22:49 34K 
[ ]14703_long-run-longitudinal-studies-psychopathology-children.pdf2022-11-07 22:31 32K 
[ ]14704_long-should-patients-psychotic-depression-stay-antipsychotic.pdf2022-11-07 22:13 82K 
[ ]14705_long-term-acute-phase-treatment-with-antidepressants.pdf2022-11-07 22:33 1.4M 
[ ]14706_long-term-and-high-dose-use-of-zolpidem-in-veterans.pdf2022-11-07 22:58 594K 
[ ]14707_long-term-antidepressant-depressogenic.pdf2022-11-07 22:44 55K 
[ ]14708_long-term-antidepressant-efficacy-safety-olanzapinefluoxetine.pdf2022-11-07 22:53 75K 
[ ]14709_long-term-antidepressant-risk-type-diabetes-mellitus.pdf2022-11-07 22:20 177K 
[ ]14710_long-term-antidepressant-treatment-and-risk-of-dementia.pdf2022-11-07 22:05 360K 
[ ]14711_long-term-antipsychotic-monotherapy-schizophrenia.pdf2022-11-07 22:02 410K 
[ ]14712_long-term-clinical-course-generalized-anxiety-disorder.pdf2022-11-07 22:10 55K 
[ ]14713_long-term-combination-therapy-versus-monotherapy-lithium.pdf2022-11-07 22:07 163K 
[ ]14714_long-term-considerations-switching-antipsychotics.pdf2022-11-07 23:01 78K 
[ ]14715_long-term-course-outcome-panic-disorder.pdf2022-11-07 22:17 26K 
[ ]14716_long-term-deep-brain-stimulation-treatment-obsessive.pdf2022-11-07 22:06 109K 
[ ]14717_long-term-effectiveness-lithium-bipolar-disorder-multicenter.pdf2022-11-07 22:38 255K 
[ ]14718_long-term-effects-adhd-medication-adult-height-results.pdf2022-11-07 22:46 160K 
[ ]14719_long-term-effects-of-prenatal-antidepressant-exposure.pdf2022-11-07 22:18 750K 
[ ]14720_long-term-effects-preventive-cognitive-therapy-recurrent.pdf2022-11-07 22:08 1.0M 
[ ]14721_long-term-effects-terrorist-attack-beslan-adolescent.pdf2022-11-07 23:02 199K 
[ ]14722_long-term-efficacy-safety-tolerability-l-methylfolate.pdf2022-11-07 22:13 806K 
[ ]14723_long-term-follow-magnetic-resonance-detectable-choline.pdf2022-11-07 22:06 76K 
[ ]14724_long-term-follow-predictors-clinical-outcome-obsessive.pdf2022-11-07 22:11 98K 
[ ]14725_long-term-low-dose-lithium-treatment-does-impair-renal.pdf2022-11-07 22:21 386K 
[ ]14726_long-term-maintenance-therapy-major-depressive-disorder.pdf2022-11-07 22:20 122K 
[ ]14727_long-term-maintenance-therapy-quetiapine-versus-haloperidol.pdf2022-11-07 22:33 90K 
[ ]14728_long-term-management-chronic-depression.pdf2022-11-07 22:57 52K 
[ ]14729_long-term-management-depression-tips-adjusting-treatment.pdf2022-11-07 22:45 308K 
[ ]14730_long-term-management-major-depressive-disorder-are.pdf2022-11-07 22:15 59K 
[ ]14731_long-term-management-panic-disorder.pdf2022-11-07 22:44 57K 
[ ]14732_long-term-management-strategies-achieve-optimal-function-bipolar-predictors-psychosocial-pharmacolog.pdf2022-11-07 22:07 77K 
[ ]14734_long-term-mental-health-and-military-service.pdf2022-11-07 22:12 322K 
[ ]14735_long-term-mental-health-resource-utilization-cost.pdf2022-11-07 22:46 258K 
[ ]14736_long-term-nature-depression.pdf2022-11-07 22:06 66K 
[ ]14737_long-term-non-nightly-administration-zolpidem-treatment.pdf2022-11-07 22:24 195K 
[ ]14738_long-term-observation-multicomponent-cognitive-intervention.pdf2022-11-07 22:39 410K 
[ ]14739_long-term-olanzapine-therapy-treatment-bipolar-i-disorder.pdf2022-11-07 22:16 79K 
[ ]14740_long-term-olanzapine-treatment-weight-change-weight.pdf2022-11-07 22:05 103K 
[ ]14741_long-term-open-label-study-safety-efficacy-atomoxetine.pdf2022-11-07 22:30 115K 
[ ]14742_long-term-outcome-adolescent-depression-initially.pdf2022-11-07 22:01 317K 
[ ]14743_long-term-outcome-cognitive-impairment-bipolar-disorder.pdf2022-11-07 22:37 313K 
[ ]14744_long-term-outcome-dysthymia-private-practice-clinical.pdf2022-11-07 22:32 91K 
[ ]14745_long-term-outcome-major-depressive-disorder-psychiatric.pdf2022-11-07 22:36 282K 
[ ]14746_long-term-outcome-obsessive-compulsive-disorder-adults.pdf2022-11-07 22:56 574K 
[ ]14747_long-term-outcomes-of-postpartum-psychosis.pdf2022-11-07 22:41 683K 
[ ]14748_long-term-outcome-vagus-nerve-stimulation-rapid-cycling.pdf2022-11-07 22:04 82K 
[ ]14749_long-term-psychiatric-sequelae-severe-injury-follow.pdf2022-11-07 22:54 228K 
[ ]14750_long-term-psychodynamic-psychotherapy-basic-text-nd.pdf2022-11-07 22:30 129K 
[ ]14751_long-term-remission-with-cariprazine-in-patients-with-schizophrenia.pdf2022-11-07 22:47 257K 
[ ]14752_long-term-safety-efficacy-ziprasidone-subpopulations.pdf2022-11-07 22:28 304K 
[ ]14753_long-term-safety-of-aripiprazole-lauroxil.pdf2022-11-07 22:42 674K 
[ ]14754_long-term-safety-of-esketamine-nasal-spray.pdf2022-11-07 22:27 962K 
[ ]14755_long-term-safety-risperidone.pdf2022-11-07 22:52 38K 
[ ]14756_long-term-side-effects-matter-evaluating-risk-hip.pdf2022-11-07 22:42 105K 
[ ]14757_long-term-side-effects-ssris-sexual-dysfunction-weight.pdf2022-11-07 22:32 63K 
[ ]14758_long-term-stability-cognitive-impairment-bipolar-disorder.pdf2022-11-07 22:07 241K 
[ ]14759_long-term-trajectories-posttraumatic-stress-disorder.pdf2022-11-07 22:13 326K 
[ ]14760_long-term-treatment-antidepressant-drugs-worsen-course.pdf2022-11-07 22:31 92K 
[ ]14762_long-term-treatment-bipolar-disorder.pdf2022-11-07 22:39 118K 
[ ]14765_long-term-treatment-bipolar-disorder-lamotrigine.pdf2022-11-07 23:00 62K 
[ ]14766_long-term-treatment-depression.pdf2022-11-07 22:42 52K 
[ ]14767_long-term-treatment-outcomes-depression-associated.pdf2022-11-07 22:43 56K 
[ ]14768_long-term-treatment-panic-disorder.pdf2022-11-07 22:23 36K 
[ ]14769_long-term-treatment-prevention-posttraumatic-stress.pdf2022-11-07 22:45 65K 
[ ]14770_long-term-treatment-recurrent-chronic-depression.pdf2022-11-07 22:49 42K 
[ ]14771_long-term-trial-effectiveness-safety-atypical-antipsychotic.pdf2022-11-07 22:56 179K 
[ ]14772_long-term-valbenazine-for-tardive-dyskinesia.pdf2022-11-07 22:24 772K 
[ ]14773_long-term-weight-gain-patients-treated-open-label.pdf2022-11-07 22:41 207K 
[ ]14774_looking-ahead.pdf2022-11-07 22:21 183K 
[ ]14775_looking-beyond-posttraumatic-stress-disorder-children.pdf2022-11-07 22:36 201K 
[ ]14776_looking-beyond-sleep-complaints-link-suicidality.pdf2022-11-07 22:05 83K 
[ ]14777_looks-bradyphylaxis.pdf2022-11-07 22:18 140K 
[ ]14778_lori-l-altshuler-md.pdf2022-11-07 22:11 277K 
[ ]14779_loss-antidepressant-efficacy-during-maintenance-therapy.pdf2022-11-07 22:25 64K 
[ ]14780_loss-control-eating-predicts-outcomes-bariatric-surgery.pdf2022-11-07 22:34 455K 
[ ]14781_low-dose-amisulpride-elevation-serum-prolactin.pdf2022-11-07 22:26 529K 
[ ]14782_low-dose-amphetamine-salts-adult-attention-deficit-hyperactivity.pdf2022-11-07 22:50 55K 
[ ]14783_low-dose-clozapine-acute-continuation-treatment-severe.pdf2022-11-07 22:05 80K 
[ ]14784_low-dose-d-cycloserine-for-depression.pdf2022-11-07 22:26 123K 
[ ]14785_low-dose-lithium-augmentation-divalproex-geriatric.pdf2022-11-07 22:38 69K 
[ ]14786_low-dose-loxapine-treatment-schizophrenia-is-more.pdf2022-11-07 22:56 55K 
[ ]14787_low-dose-olanzapine-self-mutilation-behavior-patients.pdf2022-11-07 22:36 48K 
[ ]14788_low-dose-risperidone-quetiapine-monotherapy-comorbid.pdf2022-11-07 22:44 111K 
[ ]14789_low-doses-controlled-release-paroxetine-treatment.pdf2022-11-07 22:30 323K 
[ ]14790_low-dose-sertraline-treatment-moderate-severe-premenstrual.pdf2022-11-07 22:16 115K 
[ ]14791_low-hemoglobin-and-depression.pdf2022-11-07 22:48 316K 
[ ]14792_low-hour-adiponectin-high-nocturnal-leptin-concentrations.pdf2022-11-07 22:46 439K 
[ ]14793_low-nitric-oxide-high-c-reactive-protein-depression.pdf2022-11-07 22:46 111K 
[ ]14794_low-oxytocin-in-anorexia-nervosa-in-partial-recovery.pdf2022-11-07 22:41 314K 
[ ]14795_low-risk-male-suicide-lithium-drinking-water.pdf2022-11-07 22:51 1.4M 
[ ]14796_low-serum-cholesterol-may-associated-suicide-attempt.pdf2022-11-07 22:25 229K 
[ ]14797_low-testosterone-levels-predict-incident-depressive.pdf2022-11-07 22:44 196K 
[ ]14798_lsd-problem-child-insightsoutlooks.pdf2022-11-07 23:01 95K 
[ ]14799_ltemgtarvcfltemgt-genetic-influences-neurocognitive.pdf2022-11-07 22:23 637K 
[ ]14800_ltemgtpractical-neurologyltemgt-th-ed.pdf2022-11-07 23:00 86K 
[ ]14801_ltemgttoxoplasma-gondiiltemgt-immunoglobulin-g-antibodies.pdf2022-11-07 22:55 302K 
[ ]14802_l-theanine-relieves-positive-activation-anxiety-symptoms.pdf2022-11-07 22:19 423K 
[ ]14803_ltspan-classsmallcapsgtdltspangt-cycloserine-augmentation.pdf2022-11-07 22:49 274K 
[ ]14804_lumpers-splitters-statistics-bipolar-disorder-schizophrenia.pdf2022-11-07 22:14 108K 
[ ]14805_lupus-anticoagulant-anticardiolipin-antibodies-serum.pdf2022-11-07 22:04 151K 
[ ]14806_lurasidone-and-sexual-function.pdf2022-11-07 22:11 249K 
[ ]14807_lurasidone-clinical-overview.pdf2022-11-07 22:03 308K 
[ ]14808_lurasidone-in-early-nonresponding-schizophrenia.pdf2022-11-07 22:58 403K 
[ ]14809_lurasidone-in-older-adults-with-bipolar-depression.pdf2022-11-07 22:55 286K 
[ ]14810_lurasidone-treatment-acute-schizophrenia-double-blind.pdf2022-11-07 22:07 299K 
[ ]14811_lurasidone-treatment-bipolar-depression-mixed-subsyndromal.pdf2022-11-07 22:58 287K 
[ ]14812_luteal-phase-administration-paroxetine-treatment-premenstrual.pdf2022-11-07 22:58 230K 
[ ]14813_machine-learning-algorithms-and-suicide-risk.pdf2022-11-07 22:46 246K 
[ ]14815_madness-within-schizophrenia-neuronal-process.pdf2022-11-07 22:05 128K 
[ ]14816_magical-moments-change-psychotherapy-turns-kids-around.pdf2022-11-07 22:54 103K 
[ ]14817_magnetic-resonance-spectroscopy-studies-gaba-neuropsychiatric.pdf2022-11-07 22:33 94K 
[ ]14818_maintaining-antidepressant-effects-of-ketamine.pdf2022-11-07 22:53 219K 
[ ]14819_maintaining-initial-clinical-response-ketamine-bipolar.pdf2022-11-07 22:49 129K 
[ ]14820_maintaining-symptom-control-review-ziprasidone-long.pdf2022-11-07 22:58 74K 
[ ]14821_maintenance-certification-psychiatry-cme-commentary-history-components-core-competencies-incorporati.pdf2022-11-07 22:07 260K 
[ ]14823_maintenance-efficacy-lisdexamfetamine-dimesylate-adults.pdf2022-11-07 22:16 387K 
[ ]14825_maintenance-treatment-citalopram-mg-unipolar-subjects.pdf2022-11-07 22:32 31K 
[ ]14827_maintenance-treatment-long-acting-injectable-risperidone.pdf2022-11-07 22:35 445K 
[ ]14828_maintenance-treatment-risperidone-low-dose-haloperidol.pdf2022-11-07 22:17 286K 
[ ]14829_major-changes-glucose-metabolism-including-onset.pdf2022-11-07 22:08 225K 
[ ]14830_major-congenital-malformation-associated-with-gestational-exposure-to-ondansetron-weighing-the-risks.pdf2022-11-07 22:37 342K 
[ ]14831_major-depression-are-providing-optimal-therapy.pdf2022-11-07 22:02 54K 
[ ]14832_major-depressive-disorder-and-sexual-functioning-in-adolescents.pdf2022-11-07 22:34 234K 
[ ]14833_major-depressive-disorder-antidepressants-sexual-dysfunction.pdf2022-11-07 22:02 87K 
[ ]14834_major-depressive-disorder-antidepressant-subsequent.pdf2022-11-07 22:59 214K 
[ ]14835_major-depressive-disorder-axis-i-diagnostic-comorbidity.pdf2022-11-07 22:53 73K 
[ ]14836_major-depressive-disorder-borderline-personality-disorder.pdf2022-11-07 22:22 178K 
[ ]14837_major-depressive-disorder-children-adolescents-clinical.pdf2022-11-07 22:13 144K 
[ ]14838_major-depressive-disorder-is-associated-cardiovascular.pdf2022-11-07 22:07 287K 
[ ]14840_major-depressive-disorder-predicts-completion-adherence.pdf2022-11-07 22:54 426K 
[ ]14841_major-depressive-disorder-remission-associated-symptoms.pdf2022-11-07 22:51 100K 
[ ]14842_major-depressive-disorder-somatic-pain-health-care.pdf2022-11-07 23:02 108K 
[ ]14843_major-depressive-disorder-treat-disability-diagnosis.pdf2022-11-07 22:31 105K 
[ ]14847_major-life-activity-health-outcomes-associated-attention.pdf2022-11-07 22:55 64K 
[ ]14848_major-malformation-risk-pregnancy-outcomes-neurodevelopmental.pdf2022-11-07 22:33 243K 
[ ]14849_major-system-toxicities-side-effects-anticonvulsants.pdf2022-11-07 22:59 56K 
[ ]14850_makes-antipsychotic-atypical.pdf2022-11-07 22:49 29K 
[ ]14851_making-evidence-based-lifestyle-modification-programs.pdf2022-11-07 22:55 111K 
[ ]14853_making-optimal-combination-pharmacotherapy-bipolar.pdf2022-11-07 22:21 49K 
[ ]14854_making-patient-partner-communication-skills-doctors.pdf2022-11-07 22:07 30K 
[ ]14855_making-sense-autism.pdf2022-11-07 22:27 99K 
[ ]14856_male-sexual-dysfunction-quality-life-schizophrenia.pdf2022-11-07 22:19 143K 
[ ]14857_malingering-feigning-response-bias-psychiatricpsychological.pdf2022-11-07 22:19 76K 
[ ]14858_management-acute-mania.pdf2022-11-07 22:45 48K 
[ ]14859_management-adhd-adults.pdf2022-11-07 22:26 78K 
[ ]14860_management-adults-traumatic-brain-injury.pdf2022-11-07 22:26 116K 
[ ]14861_management-agitated-elderly-patient-nursing-home-role.pdf2022-11-07 22:27 35K 
[ ]14862_management-anxious-depression-primary-care.pdf2022-11-07 22:45 48K 
[ ]14863_management-chronic-psychotic-ambulatory-outpatients.pdf2022-11-07 22:33 39K 
[ ]14865_management-comorbid-bipolar-disorder-substance-abuse-impact-course.pdf2022-11-07 22:39 83K 
[ ]14866_management-effectiveness-psychopharmacology-emotionally.pdf2022-11-07 22:34 116K 
[ ]14867_management-fibromyalgia-comorbid-psychiatric-disorders.pdf2022-11-07 22:17 307K 
[ ]14869_management-nonresponse-intolerance-switching-strategies.pdf2022-11-07 22:05 49K 
[ ]14870_management-obsessive-compulsive-disorder-related-skin.pdf2022-11-07 22:23 191K 
[ ]14871_management-of-treatment-resistant-psychosis.pdf2022-11-07 22:36 383K 
[ ]14872_management-panic-disorder.pdf2022-11-07 22:57 60K 
[ ]14873_management-patients-depression-associated-anxiety.pdf2022-11-07 22:30 38K 
[ ]14875_management-posttraumatic-stress-disorder-diagnostic.pdf2022-11-07 22:21 57K 
[ ]14876_management-psychosis-agitation-elderly-patients-primary.pdf2022-11-07 22:10 42K 
[ ]14877_management-psychotic-aspects-parkinsons-disease.pdf2022-11-07 22:37 88K 
[ ]14878_management-sexual-side-effects-antidepressant-therapy.pdf2022-11-07 22:44 49K 
[ ]14879_management-strategies-treatment-schizophrenia.pdf2022-11-07 22:08 53K 
[ ]14880_management-trauma-special-populations-disaster.pdf2022-11-07 22:59 112K 
[ ]14881_management-treatment-resistant-depression-psychotherapeutic.pdf2022-11-07 22:30 58K 
[ ]14882_management-treatment-resistant-major-psychiatric-disorders.pdf2022-11-07 22:34 93K 
[ ]14883_management-weight-gain-patients-schizophrenia.pdf2022-11-07 22:18 82K 
[ ]14884_managing-adhd-children-adolescents-adults-comorbid.pdf2022-11-07 22:18 279K 
[ ]14887_managing-aggressive-behavior-patients-obsessive-compulsive.pdf2022-11-07 22:52 60K 
[ ]14888_managing-agitated-psychotic-patient-reappraisal-evidence.pdf2022-11-07 22:36 77K 
[ ]14889_managing-anger-aggression-patients-posttraumatic-stress.pdf2022-11-07 22:26 48K 
[ ]14890_managing-antipsychotic-medications-schizophrenia-comprehensive.pdf2022-11-07 22:51 119K 
[ ]14891_managing-attention-deficit-hyperactivity-disorder-presence.pdf2022-11-07 22:24 209K 
[ ]14892_managing-atypical-antipsychoticassociated-weight-gain.pdf2022-11-07 23:01 59K 
[ ]14893_managing-behavioral-health-care-employers-perspective.pdf2022-11-07 22:11 22K 
[ ]14895_managing-bipolar-disorder-urgent-situations-maintenance-part-1-acute.pdf2022-11-07 22:14 253K 
[ ]14896_managing-bipolar-disorder-urgent-situations-maintenance-part-2-maintenance.pdf2022-11-07 22:02 277K 
[ ]14897_managing-care-dollars-continuum-mental-health-services.pdf2022-11-07 22:42 51K 
[ ]14898_managing-cognition-in-mdd.pdf2022-11-07 22:59 329K 
[ ]14901_managing-excessive-daytime-sleepiness.pdf2022-11-07 22:57 218K 
[ ]14903_managing-medical-comorbidities-patients-depression-improve-prognosis-recognition-chronic-pain-thyroi.pdf2022-11-07 22:46 286K 
[ ]14904_managing-partial-response-nonresponse-switching-augmentation.pdf2022-11-07 22:39 400K 
[ ]14906_managing-patients-vascular-disease-depression.pdf2022-11-07 22:54 129K 
[ ]14907_managing-psychiatric-issues-elite-athletes-cme.pdf2022-11-07 22:10 229K 
[ ]14908_managing-suicidal-risk-collaborative-approach.pdf2022-11-07 22:57 99K 
[ ]14909_managing-treatment-resistant-major-depression.pdf2022-11-07 22:03 72K 
[ ]14912_mandibular-dystonia-associated-combination-sertraline.pdf2022-11-07 22:15 42K 
[ ]14913_mania-associated-initiation-ziprasidone.pdf2022-11-07 22:02 79K 
[ ]14914_mania-associated-serotonin-selective-reuptake-inhibitors.pdf2022-11-07 22:31 86K 
[ ]14915_mania-clinical-research-perspectives.pdf2022-11-07 22:12 19K 
[ ]14916_mania-dexfenfluramine.pdf2022-11-07 22:27 35K 
[ ]14917_mania-dose-related-ziprasidone-augmentation-ssri.pdf2022-11-07 22:13 51K 
[ ]14918_mania-induced-risperidone-dose-related.pdf2022-11-07 22:15 100K 
[ ]14919_manic-depressive-illness-bipolar-disorders-recurrent.pdf2022-11-07 22:43 96K 
[ ]14920_manic-psychosis-auditory-hallucinations-following.pdf2022-11-07 22:35 1.0M 
[ ]14921_manic-psychotic-symptoms-following-risperidone-withdrawal.pdf2022-11-07 22:23 44K 
[ ]14922_manic-psychotic-symptoms-following-subcutaneous-leuprolide.pdf2022-11-07 22:43 133K 
[ ]14923_manic-switch-patient-treatment-resistant-bipolar-depression.pdf2022-11-07 22:22 102K 
[ ]14924_mannitol-induced-acute-manic-state.pdf2022-11-07 22:05 58K 
[ ]14925_manual-based-group-psychotherapy-bipolar-disorder.pdf2022-11-07 22:47 45K 
[ ]14926_manual-clinical-psychopharmacology-th-ed.pdf2022-11-07 22:36 62K 
[ ]14927_manual-nursing-home-practices-psychiatrists.pdf2022-11-07 22:51 56K 
[ ]14928_manual-psychiatric-care-medically-ill.pdf2022-11-07 22:46 67K 
[ ]14929_manual-psychiatric-therapeutics-rd-ed.pdf2022-11-07 22:48 33K 
[ ]14933_manufacturer-support-outcome.pdf2022-11-07 22:07 50K 
[ ]14934_many-subjects-major-depressive-disorder-meet-eligibility.pdf2022-11-07 22:19 34K 
[ ]14935_many-thanks.pdf2022-11-07 22:47 23K 
[ ]14936_many-treatments-before-clozapine-medication-choices.pdf2022-11-07 22:05 244K 
[ ]14941_marijuana-is-associated-worse-outcomes-symptom-severity.pdf2022-11-07 22:12 282K 
[ ]14942_marijuana-madness-nd-ed.pdf2022-11-07 22:23 84K 
[ ]14943_marital-status-childhood-maltreatment-family-dysfunction.pdf2022-11-07 22:32 231K 
[ ]14944_marjuana-madness-psychiatry-neurobiology.pdf2022-11-07 22:01 104K 
[ ]14945_marshmallow-test-mastering-self-control.pdf2022-11-07 22:01 78K 
[ ]14946_massachusetts-general-hospital-comprehensive-clinical.pdf2022-11-07 22:51 100K 
[ ]14947_massachusetts-general-hospital-handbook-general-hospital.pdf2022-11-07 22:32 127K 
[ ]14948_massachusetts-general-hospital-psychiatry-update-board.pdf2022-11-07 22:17 30K 
[ ]14949_massage-monotherapy-remediates-symptoms-of-anxiety.pdf2022-11-07 22:10 1.0M 
[ ]14950_massage-therapy-children-autism-spectrum-disorders.pdf2022-11-07 22:23 250K 
[ ]14951_massive-previously-undetected-cancer-metastasis-revealed.pdf2022-11-07 22:54 245K 
[ ]14952_mastering-forensic-psychiatric-practice-advanced-stategies.pdf2022-11-07 22:56 31K 
[ ]14953_maternal-depression-anxiety-differentially-impact.pdf2022-11-07 22:09 257K 
[ ]14954_maternal-self-harm-and-mother-infant-interactions.pdf2022-11-07 22:48 596K 
[ ]14955_maudsley-bipolar-disorder-project-effect-medication.pdf2022-11-07 22:01 76K 
[ ]14956_maudsley-prescribing-guidelines-psychiatry-th-ed.pdf2022-11-07 22:42 77K 
[ ]14957_maudsley-reader-phenomenological-psychiatry.pdf2022-11-07 22:06 91K 
[ ]14958_maudsley-staging-method-treatment-resistant-depression.pdf2022-11-07 22:44 224K 
[ ]14959_maximizing-clozapine-therapy-managing-side-effects.pdf2022-11-07 22:49 39K 
[ ]14960_mbct-for-depression-in-patients-with-chronic-pain.pdf2022-11-07 22:14 324K 
[ ]14961_mcclintock-reply-consensus-recommendations-rTMS-depression.pdf2022-11-07 22:17 149K 
[ ]14962_mcclintock-reply-ECT-atypical-depression.pdf2022-11-07 22:09 83K 
[ ]14963_mcclintock-reply-roles-qualifications-TMS-treatment-team-members.pdf2022-11-07 22:49 110K 
[ ]14964_mclean-harvard-international-episode-project-icd-psychotic.pdf2022-11-07 22:39 375K 
[ ]14965_mclean-harvard-international-episode-project-stability.pdf2022-11-07 22:02 251K 
[ ]14966_mddscore-confirmation-blood-test-aid-diagnosis-major.pdf2022-11-07 22:59 326K 
[ ]14967_mde-recovery-definition.pdf2022-11-07 22:39 901K 
[ ]14968_mean-difference-standardized-mean-difference-smd-and-their-use-in-meta-analysis.pdf2022-11-07 22:54 291K 
[ ]14969_mean-dose-splitting-sertraline-tablets.pdf2022-11-07 22:58 52K 
[ ]14970_meaning-in-life-and-physical-mental-and-cognitive-functioning.pdf2022-11-07 22:46 1.5M 
[ ]14971_measurement-based-care-psychiatric-practice-policy.pdf2022-11-07 22:36 324K 
[ ]14972_measurement-based-psychiatry-definitions-response.pdf2022-11-07 22:50 60K 
[ ]14973_measurement-compliance-naltrexone-treatment-alcohol.pdf2022-11-07 22:07 61K 
[ ]14974_measurement-pain-medication-effect-study-duloxetine.pdf2022-11-07 22:18 210K 
[ ]14975_measurement-retardation-depression.pdf2022-11-07 22:38 110K 
[ ]14976_measurements-response-remission-recovery-schizophrenia.pdf2022-11-07 22:41 384K 
[ ]14977_measuring-clinical-outcome-with-lhh.pdf2022-11-07 22:28 275K 
[ ]14978_measuring-efficacy-polypharmacy-schizophrenic-inpatients.pdf2022-11-07 22:44 151K 
[ ]14979_measuring-onset-antidepressant-action-clinical-trials.pdf2022-11-07 22:43 57K 
[ ]14980_measuring-outcome-posttraumatic-stress-disorder.pdf2022-11-07 22:03 102K 
[ ]14981_measuring-outcome-schizophrenia-differences-among.pdf2022-11-07 22:44 114K 
[ ]14984_measuring-patient-symptom-change-rural-psychiatry.pdf2022-11-07 22:11 50K 
[ ]14986_measuring-treatment-efficacy-insomnia.pdf2022-11-07 22:15 55K 
[ ]14987_mechanism-action-adrenergic-agonists-attention-deficit-hyperactivity.pdf2022-11-07 22:51 509K 
[ ]14988_mechanism-action-agents-used-attention-deficit-hyperactivity.pdf2022-11-07 22:40 83K 
[ ]14989_mechanism-action-antidepressant-medications.pdf2022-11-07 22:30 67K 
[ ]14991_mechanism-action-newer-anticonvulsants.pdf2022-11-07 22:35 55K 
[ ]14992_mechanism-action-stimulants-attention-deficit-hyperactivity.pdf2022-11-07 22:21 1.0M 
[ ]14993_mechanism-action-voltage-sensitive-sodium-channel.pdf2022-11-07 22:40 86K 
[ ]14995_mechanisms-action-drugs-may-limit-suicide.pdf2022-11-07 22:52 23K 
[ ]14996_mechanisms-action-treatment-anxiety.pdf2022-11-07 22:06 55K 
[ ]14997_mechanisms-antipsychotic-induced-weight-gain.pdf2022-11-07 22:12 79K 
[ ]14998_mechanisms-risks-electrocardiographic-qt-interval.pdf2022-11-07 22:07 71K 
[ ]14999_mechanisms-sleep-induction-gabaa-receptor-agonists.pdf2022-11-07 22:42 255K 
[ ]15000_mechanisms-weight-gain-induced-antipsychotic-drugs.pdf2022-11-07 22:51 75K 
[ ]15001_mediators-between-childhood-trauma-and-suicidal-ideation.pdf2022-11-07 22:58 616K 
[ ]15002_mediators-between-insight-and-suicidality-in-schizophrenia.pdf2022-11-07 22:16 1.4M 
[ ]15003_medical-basis-psychiatry-rd-ed.pdf2022-11-07 22:19 104K 
[ ]15004_medical-comorbidity-among-youth-diagnosed-bipolar.pdf2022-11-07 22:41 305K 
[ ]15005_medical-education-mission-success.pdf2022-11-07 22:52 40K 
[ ]15006_medical-illness-patients-schizophrenia.pdf2022-11-07 22:19 56K 
[ ]15007_medical-illness-schizophrenia-nd-ed.pdf2022-11-07 22:02 100K 
[ ]15008_medical-intervention-suicide-risk.pdf2022-11-07 22:48 25K 
[ ]15009_medicalization-society-transformation-human-conditions.pdf2022-11-07 22:33 100K 
[ ]15010_medically-unexplained-symptoms-primary-care.pdf2022-11-07 22:47 53K 
[ ]15011_medical-management-obesity-associated-mental-disorders.pdf2022-11-07 22:23 110K 
[ ]15012_medical-marijuana-for-psychiatric-indications.pdf2022-11-07 22:45 1.1M 
[ ]15013_medical-marijuana-what-physicians-need-to-know.pdf2022-11-07 22:06 176K 
[ ]15016_medical-morbidity-mortality-schizophrenia-guidelines.pdf2022-11-07 22:19 222K 
[ ]15017_medical-psychiatric-comorbidity-course-life.pdf2022-11-07 22:51 52K 
[ ]15018_medical-psychiatry-quick-reference.pdf2022-11-07 22:15 73K 
[ ]15020_medical-risk-patients-bipolar-disorder-schizophrenia-adverse-events-medical-comorbidity.pdf2022-11-07 22:43 83K 
[ ]15021_medical-test-development-implementation-multistep.pdf2022-11-07 22:42 107K 
[ ]15023_medicare-part-d-prescription-drug-benefits-medication.pdf2022-11-07 22:43 312K 
[ ]15024_medicate-medicate.pdf2022-11-07 22:45 44K 
[ ]15025_medication-adherence-in-older-persons.pdf2022-11-07 23:00 280K 
[ ]15026_medication-adherence-long-term-functional-outcomes.pdf2022-11-07 22:21 107K 
[ ]15027_medication-compliance-among-patients-bipolar-disorder.pdf2022-11-07 22:44 69K 
[ ]15028_medication-continuation-compliance-comparison-patients.pdf2022-11-07 22:23 60K 
[ ]15029_medication-discontinuation-and-quality-of-life-in-adhd.pdf2022-11-07 22:28 731K 
[ ]15030_medication-discrepancies-in-psychiatric-outpatients.pdf2022-11-07 22:17 316K 
[ ]15031_medication-nonadherence-treatment-outcome-patients.pdf2022-11-07 22:09 237K 
[ ]15032_medications-for-dsm-5-ptsd.pdf2022-11-07 23:02 741K 
[ ]15033_medication-status-polycystic-ovary-syndrome-women.pdf2022-11-07 23:01 60K 
[ ]15034_medication-supervision-adherence-persons-psychotic.pdf2022-11-07 23:01 68K 
[ ]15035_medication-treatment-severely-persistently-mentally.pdf2022-11-07 22:15 64K 
[ ]15036_medicine-coming-challenges-opportunities.pdf2022-11-07 22:56 40K 
[ ]15037_medicolegal-issues-clinical-practice-primer-legally.pdf2022-11-07 22:07 60K 
[ ]15038_mefloquine-increases-risk-serious-psychiatric-events.pdf2022-11-07 22:26 115K 
[ ]15039_melancholia-diagnosis-pathophysiology-treatment-depressive.pdf2022-11-07 22:19 68K 
[ ]15040_melancholia-useful-subtype-major-depression.pdf2022-11-07 22:10 718K 
[ ]15041_melatonin-improves-sleep-quality-patients-chronic.pdf2022-11-07 22:34 62K 
[ ]15042_melatonin-medically-ill-patients-insomnia-double-blind.pdf2022-11-07 23:00 44K 
[ ]15043_melatonin-schizophrenic-outpatients-insomnia-double.pdf2022-11-07 22:16 124K 
[ ]15044_memantine-agitationaggression-psychosis-moderately.pdf2022-11-07 22:21 355K 
[ ]15045_memantine-as-an-augmentation-treatment-for-schizophrenia.pdf2022-11-07 22:51 289K 
[ ]15046_memantine-disruptive-behavior-autistic-disorder.pdf2022-11-07 22:36 86K 
[ ]15047_memantine-fragile-xassociated-tremorataxia-syndrome.pdf2022-11-07 22:25 405K 
[ ]15048_memantine-in-ocd.pdf2022-11-07 22:47 134K 
[ ]15049_memantine-related-psychotic-symptoms-patient-bipolar.pdf2022-11-07 22:18 91K 
[ ]15050_memoriam-andrew-c-leon-phd.pdf2022-11-07 22:06 313K 
[ ]15051_memoriam-franco-benazzi-md.pdf2022-11-07 22:15 279K 
[ ]15052_memoriam-leon-j-thal-md.pdf2022-11-07 22:13 46K 
[ ]15053_memory-disorders-psychiatric-practice.pdf2022-11-07 22:38 32K 
[ ]15054_memory-impairment-those-attempted-suicide-benzodiazepine.pdf2022-11-07 22:10 68K 
[ ]15055_memory-jonathon-o-cole.pdf2022-11-07 22:45 125K 
[ ]15056_memory-trauma-treatment-law.pdf2022-11-07 22:50 57K 
[ ]15057_memory-war-trauma.pdf2022-11-07 22:57 77K 
[ ]15058_menstrual-abnormalities-polycystic-ovary-syndrome.pdf2022-11-07 22:27 79K 
[ ]15059_menstrual-dysfunction-prior-onset-psychiatric-illness.pdf2022-11-07 22:27 111K 
[ ]15060_mental-disorder-serious-violence-victims.pdf2022-11-07 22:48 64K 
[ ]15061_mental-disorders-in-first-degree-relatives-of-adhd-patients.pdf2022-11-07 22:27 254K 
[ ]15062_mental-health-care-college-community.pdf2022-11-07 22:27 124K 
[ ]15063_mental-health-care-japan-recognition-treatment-depression.pdf2022-11-07 22:55 59K 
[ ]15064_mental-health-care-public-perspective-texas-medication.pdf2022-11-07 22:25 48K 
[ ]15065_mental-health-characteristics-pregnant-women-depressive.pdf2022-11-07 22:29 306K 
[ ]15066_mental-health-conditions-in-youth-with-autism-spectrum-disorder.pdf2022-11-07 22:01 283K 
[ ]15067_mental-health-consequences-torture-plenum-series-stress.pdf2022-11-07 22:14 56K 
[ ]15068_mental-health-extracurricular-education-korean-graders.pdf2022-11-07 22:42 108K 
[ ]15069_mental-health-multi-ethnic-society-multidisciplinary.pdf2022-11-07 22:22 86K 
[ ]15071_mental-health-outcome-evaluation.pdf2022-11-07 22:01 57K 
[ ]15072_mental-health-professional-court-survival-guide.pdf2022-11-07 22:56 65K 
[ ]15073_mental-health-public-health-next-years.pdf2022-11-07 22:25 81K 
[ ]15074_mental-health-quality-forum-ecosystem-approach-quality.pdf2022-11-07 22:50 1.3M 
[ ]15075_mental-health-service-utilization-borderline-personality.pdf2022-11-07 22:19 66K 
[ ]15076_mental-health-treatment-received-primary-care-patients.pdf2022-11-07 22:01 61K 
[ ]15077_mental-health-violent-youth-developmentallifecourse.pdf2022-11-07 22:53 100K 
[ ]15078_mental-illness-may-damaging-brain.pdf2022-11-07 22:39 76K 
[ ]15079_mental-illness-psychotropic-drug-among-prescription.pdf2022-11-07 22:09 208K 
[ ]15080_mental-illness-stigma-media.pdf2022-11-07 22:07 124K 
[ ]15081_mentalizing-clinical-practice.pdf2022-11-07 22:29 701K 
[ ]15082_mentor-chief.pdf2022-11-07 22:24 1.4M 
[ ]15083_mentorship-genuine-article.pdf2022-11-07 22:18 75K 
[ ]15084_mergers-acquisitions-among-psychotropics-antidepressant.pdf2022-11-07 23:03 32K 
[ ]15085_mesiotemporal-hypoactivity-in-klver-bucy-syndrome.pdf2022-11-07 22:18 2.6M 
[ ]15086_message-chemical-neurotransmission-presynaptic-postsynaptic-gene.pdf2022-11-07 22:42 72K 
[ ]15087_meta-analyses-efficacy-asenapine-acute-schizophrenia.pdf2022-11-07 22:48 575K 
[ ]15088_meta-analysis-computerized-cognitive-behavioral-therapy.pdf2022-11-07 22:14 613K 
[ ]15089_meta-analysis-effects-eicosapentaenoic-acid-epa-clinical.pdf2022-11-07 22:24 412K 
[ ]15090_meta-analysis-efficacy-treatment-emergent-suicidality.pdf2022-11-07 22:50 469K 
[ ]15091_meta-analysis-efficacy-treatments-posttraumatic-stress.pdf2022-11-07 22:47 562K 
[ ]15092_meta-analysis-eight-randomized-double-blind-controlled.pdf2022-11-07 22:20 94K 
[ ]15093_meta-analysis-epidemiologic-studies-pediatric-bipolar.pdf2022-11-07 22:21 385K 
[ ]15094_meta-analysis-of-bipolar-disorder-prevalence.pdf2022-11-07 22:45 715K 
[ ]15095_meta-analysis-of-clozapine-for-tardive-dyskinesia.pdf2022-11-07 22:15 328K 
[ ]15096_meta-analysis-risk-acute-extrapyramidal-symptoms-intramuscular.pdf2022-11-07 22:09 316K 
[ ]15097_meta-analysis-selective-serotonin-reuptake-inhibitorassociated.pdf2022-11-07 22:51 531K 
[ ]15098_meta-analysis-sleep-disturbance-suicidal-thoughts.pdf2022-11-07 22:54 261K 
[ ]15099_meta-analytic-review-double-blind-placebo-controlled.pdf2022-11-07 22:34 168K 
[ ]15100_meta-analytic-review-polyunsaturated-fatty-acid-compositions.pdf2022-11-07 22:52 570K 
[ ]15101_metabolic-considerations-antipsychotic-medications.pdf2022-11-07 22:44 176K 
[ ]15102_metabolic-depression-chronic-depressive-subtype-findings.pdf2022-11-07 22:35 340K 
[ ]15103_metabolic-effects-associated-atypical-antipsychotic.pdf2022-11-07 22:35 152K 
[ ]15104_metabolic-effects-of-aripiprazole-lauroxil.pdf2022-11-07 22:11 202K 
[ ]15105_metabolic-effects-treatment-atypical-antipsychotics.pdf2022-11-07 23:03 85K 
[ ]15106_metabolic-hormonal-side-effects-children-adolescents.pdf2022-11-07 22:20 284K 
[ ]15107_metabolic-risk-factors-drug-naive-patients-episode.pdf2022-11-07 22:03 165K 
[ ]15108_metabolic-risk-in-psychosis.pdf2022-11-07 22:51 426K 
[ ]15110_metabolic-side-effects-antipsychotics-focus-hyperglycemia.pdf2022-11-07 22:42 82K 
[ ]15111_metabolic-side-effects-second-generation-antipsychotics.pdf2022-11-07 22:22 79K 
[ ]15112_metabolic-syndrome-among-persons-schizophrenia-psychotic.pdf2022-11-07 22:24 244K 
[ ]15113_metabolic-syndrome-and-depressive-symptom-resolution.pdf2022-11-07 22:54 1.0M 
[ ]15114_metabolic-syndrome-bipolar-disorder-review-focus-bipolar.pdf2022-11-07 22:59 785K 
[ ]15115_metabolic-syndrome-depression-cross-sectional-analysis.pdf2022-11-07 22:08 94K 
[ ]15116_metabolic-syndrome-epidemiology-consequences.pdf2022-11-07 23:00 91K 
[ ]15117_metabolic-syndrome-french-cohort-patients-bipolar.pdf2022-11-07 22:51 569K 
[ ]15118_metabolic-syndrome-in-bipolar-disorder.pdf2022-11-07 23:02 324K 
[ ]15119_metabolic-syndrome-inpatients-treated-clozapine.pdf2022-11-07 22:24 147K 
[ ]15120_metabolic-syndrome-in-treatment-resistant-depression.pdf2022-11-07 22:33 306K 
[ ]15121_metabolic-syndrome-patients-bipolar-disorder.pdf2022-11-07 22:36 208K 
[ ]15122_metabolic-syndrome-patients-enrolled-clinical-trial.pdf2022-11-07 22:37 347K 
[ ]15123_metabolic-syndrome-patients-schizophrenia.pdf2022-11-07 22:11 49K 
[ ]15124_metabolic-syndrome-predicts-relapse-in-schizophrenia.pdf2022-11-07 22:26 253K 
[ ]15125_metabolic-syndrome-predisposes-depressive-symptoms.pdf2022-11-07 23:01 158K 
[ ]15126_metabolic-syndrome-psychiatric-illness-interactions.pdf2022-11-07 22:10 98K 
[ ]15127_metabolic-syndrome-psychopharmacologists-should-weigh.pdf2022-11-07 22:29 38K 
[ ]15128_metabolic-syndrome-risk-coronary-heart-disease-patients.pdf2022-11-07 23:01 118K 
[ ]15129_metabolism-amyloid-protein-may-affected-depression.pdf2022-11-07 22:20 294K 
[ ]15130_meta-review-lifestyle-interventions-cardiovascular.pdf2022-11-07 22:21 903K 
[ ]15131_metformin-for-cardiometabolic-risks-in-pediatric-subjects-exposed-to-antipsychotics.pdf2022-11-07 22:56 309K 
[ ]15132_metformin-obesity-associated-antipsychotic-drug-administration.pdf2022-11-07 22:31 98K 
[ ]15133_metformin-weight-loss-control-patients-mood-disorder.pdf2022-11-07 22:51 122K 
[ ]15134_methadone-and-qtc-in-pregnancy.pdf2022-11-07 22:48 274K 
[ ]15135_methadone-hydrochloride-prevent-impulsive-behavior.pdf2022-11-07 23:02 88K 
[ ]15136_methamphetamine-addiction-basic-science-treatment.pdf2022-11-07 22:42 132K 
[ ]15137_methamphetamine-and-cardiovascular-disease-and-stroke.pdf2022-11-07 22:08 821K 
[ ]15138_methamphetamine-associated-obsessional-symptoms-effective.pdf2022-11-07 22:25 67K 
[ ]15139_method-deciding-possible-safety-modafinil-armodafinil.pdf2022-11-07 22:41 316K 
[ ]15140_methodological-concerns-regarding-relation-between.pdf2022-11-07 22:33 92K 
[ ]15141_methodological-issues-comparative-study-ziprasidone.pdf2022-11-07 22:16 91K 
[ ]15142_methodological-issues-study-long-term-maintenance.pdf2022-11-07 22:22 99K 
[ ]15143_methodology-measure-onset-action.pdf2022-11-07 22:46 41K 
[ ]15144_methods-adolescent-suicide-prevention.pdf2022-11-07 22:59 57K 
[ ]15145_methods-cost-effectiveness-analysis-evaluation-antipsychotics.pdf2022-11-07 22:53 54K 
[ ]15146_method-suicide-attempt-reaction-survival-predictors.pdf2022-11-07 22:28 387K 
[ ]15147_methylene-blue-augmentation-of-exposure-therapy-for-ptsd.pdf2022-11-07 23:01 328K 
[ ]15148_methylphenidate-and-the-risk-of-new-onset-seizures.pdf2022-11-07 23:02 295K 
[ ]15149_methylphenidate-in-pregnancy.pdf2022-11-07 22:39 201K 
[ ]15150_methylphenidate-ssri-induced-sexual-side-effects.pdf2022-11-07 22:38 37K 
[ ]15151_methylphenidate-treatment-attention-deficit-hyperactivity.pdf2022-11-07 22:04 63K 
[ ]15152_methylphenidate-treatment-cocaine-abusers-adult-attention.pdf2022-11-07 22:48 42K 
[ ]15153_metrifonate-alzheimers-disease-patients.pdf2022-11-07 22:40 61K 
[ ]15154_metrifonate-update-antidementia-agent.pdf2022-11-07 22:49 46K 
[ ]15155_met-unmet-needs-management-depressive-disorder-community.pdf2022-11-07 22:42 66K 
[ ]15156_metyrapone-delirium-due-cushings-syndrome-induced.pdf2022-11-07 23:03 58K 
[ ]15157_mgh-guide-psychiatry-primary-care.pdf2022-11-07 22:11 39K 
[ ]15158_mid-term-long-term-efficacy-effectiveness-antipsychotic.pdf2022-11-07 22:52 709K 
[ ]15159_might-psychobiology-posttraumatic-stress-disorder.pdf2022-11-07 22:02 64K 
[ ]15160_migrant-women-and-antenatal-mental-health.pdf2022-11-07 22:52 595K 
[ ]15161_mild-behavioral-impairment-risk-dementia-prospective.pdf2022-11-07 22:54 257K 
[ ]15162_military-sexual-trauma-interacts-combat-exposure-increase.pdf2022-11-07 22:26 423K 
[ ]15163_military-sexual-trauma-veterans-results-national-health.pdf2022-11-07 22:42 337K 
[ ]15164_military-sports-related-mild-traumatic-brain-injury-clinical-presentation-management-long-term-conse.pdf2022-11-07 22:22 518K 
[ ]15166_millennial-musings.pdf2022-11-07 22:36 11K 
[ ]15167_millennial-thanks.pdf2022-11-07 22:48 29K 
[ ]15168_min-and-cognition-in-schizophrenia-patients.pdf2022-11-07 22:18 202K 
[ ]15169_mind-apart-poems-melancholy-madness-addiction.pdf2022-11-07 22:11 145K 
[ ]15170_mind-body-medicine-intergrative-text.pdf2022-11-07 22:36 54K 
[ ]15171_mind-brain-schizophrenia.pdf2022-11-07 22:19 100K 
[ ]15172_mindful-brain-reflection-attunement-cultivation-being.pdf2022-11-07 22:01 96K 
[ ]15173_mindfulness-based-cognitive-therapy-bipolar-disorder.pdf2022-11-07 22:20 72K 
[ ]15174_mindfulness-based-stress-reduction-for-older-adults.pdf2022-11-07 22:04 391K 
[ ]15175_mini-international-neuropsychiatric-interview-mini.pdf2022-11-07 22:27 60K 
[ ]15176_minimum-clinically-important-difference-positive-negative.pdf2022-11-07 23:02 403K 
[ ]15177_minocycline-augmentation-pharmacotherapy-obsessive.pdf2022-11-07 22:45 165K 
[ ]15178_minor-increase-risk-road-traffic-accidents-prescriptions.pdf2022-11-07 22:28 150K 
[ ]15179_mirror-mirror-wall-enantiomer-is-fairest.pdf2022-11-07 22:26 76K 
[ ]15180_mirtazapine-alcohol-dependence-case-report.pdf2022-11-07 22:50 110K 
[ ]15181_mirtazapine-associated-palinopsia.pdf2022-11-07 22:22 52K 
[ ]15182_mirtazapine-augmentation-treatment-refractory-depression.pdf2022-11-07 22:11 34K 
[ ]15183_mirtazapine-clinical-overview.pdf2022-11-07 22:56 55K 
[ ]15184_mirtazapine-compared-paroxetine-major-depression.pdf2022-11-07 22:19 70K 
[ ]15185_mirtazapine-efficacy-tolerability-comparison-fluoxetine.pdf2022-11-07 23:02 51K 
[ ]15186_mirtazapine-for-ptsd-in-veterans.pdf2022-11-07 22:54 290K 
[ ]15187_mirtazapine-indications.pdf2022-11-07 22:17 48K 
[ ]15188_mirtazapine-major-depression-comorbid-generalized.pdf2022-11-07 22:35 45K 
[ ]15189_mirtazapine-obsessive-compulsive-disorder-open-trial.pdf2022-11-07 22:50 119K 
[ ]15190_mirtazapine-sedating-antidepressant-improved-driving.pdf2022-11-07 22:58 224K 
[ ]15191_mirtazapine-substitution-ssri-induced-sexual-dysfunction.pdf2022-11-07 22:18 63K 
[ ]15192_mirtazapine-versus-antidepressants-acute-phase-treatment.pdf2022-11-07 22:13 330K 
[ ]15193_mirtazapine-versus-selective-serotonin-reuptake-inhibitors.pdf2022-11-07 22:50 55K 
[ ]15194_misdiagnosed-patients-bipolar-disorder-comorbidities.pdf2022-11-07 22:27 197K 
[ ]15196_misdiagnosis-bipolar-ii-disorder-major-depressive.pdf2022-11-07 22:48 207K 
[ ]15197_misidentification-rates-obsessive-compulsive-disorder.pdf2022-11-07 22:23 110K 
[ ]15198_missed-diagnosis-psychotic-depression-academic-medical.pdf2022-11-07 22:47 122K 
[ ]15199_misuse-naltrexone.pdf2022-11-07 22:59 42K 
[ ]15200_misuse-term-phenomenology.pdf2022-11-07 22:19 69K 
[ ]15201_mixed-anxiety-depression-theory-practice.pdf2022-11-07 22:08 44K 
[ ]15202_mixed-depression-anxiety-serotonina-receptors-common.pdf2022-11-07 22:42 93K 
[ ]15203_mixed-depression-drawbacks-dsm-polythetic-diagnostic.pdf2022-11-07 22:07 111K 
[ ]15204_mixed-depression-farewell-differential-diagnosis.pdf2022-11-07 22:46 136K 
[ ]15205_mixed-depression-suicidality-antidepressants.pdf2022-11-07 22:16 81K 
[ ]15206_mixed-features-patients-major-depressive-episode-bridge.pdf2022-11-07 22:15 226K 
[ ]15207_mixed-features-specifier-in-major-depressive-disorder-a-new-diagnosis-or-there-all-along.pdf2022-11-07 22:33 126K 
[ ]15208_modafinil-adjunctive-treatment-sedation-negative-symptoms.pdf2022-11-07 22:35 245K 
[ ]15209_modafinil-antipsychotic-induced-sedation.pdf2022-11-07 22:50 67K 
[ ]15210_modafinil-armodafinil-schizophrenia.pdf2022-11-07 22:58 574K 
[ ]15211_modafinil-augmentation-antidepressant-treatment-depression.pdf2022-11-07 22:22 49K 
[ ]15212_modafinil-augmentation-therapy-unipolar-bipolar-depression.pdf2022-11-07 22:49 486K 
[ ]15213_modafinil-clozapine-treated-schizophrenia-patients.pdf2022-11-07 22:32 527K 
[ ]15214_modafinil-film-coated-tablets-children-adolescents.pdf2022-11-07 22:52 136K 
[ ]15215_modafinil-mischaracterization.pdf2022-11-07 23:00 196K 
[ ]15216_modafinil-treatment-fatigue-hivaids-randomized-placebo.pdf2022-11-07 22:17 351K 
[ ]15217_modafinil-treatment-fatigue-hiv-patients-pilot-study.pdf2022-11-07 22:58 62K 
[ ]15218_model-economic-impact-bipolar-disorder-screening-program.pdf2022-11-07 22:29 356K 
[ ]15219_modeling-trajectory-depressive-symptoms-among-psychiatric.pdf2022-11-07 22:37 359K 
[ ]15220_model-of-prescription-opioid-use-disorder.pdf2022-11-07 22:56 220K 
[ ]15221_model-psychopharmacology-curriculum-psychiatric-residency.pdf2022-11-07 22:11 36K 
[ ]15222_models-antidepressant-action.pdf2022-11-07 22:47 51K 
[ ]15223_models-mind-framework-biopsychosocial-psychiatry.pdf2022-11-07 22:04 39K 
[ ]15224_moderating-impact-ethnicity-metabolic-outcomes-during.pdf2022-11-07 22:11 227K 
[ ]15226_moderators-mediators-symptoms-quality-life-outcomes.pdf2022-11-07 22:30 484K 
[ ]15227_modern-community-mental-health-interdisciplinary-approach.pdf2022-11-07 22:35 81K 
[ ]15228_modulation-cns-signal-transduction-pathways-gene-expression.pdf2022-11-07 22:35 204K 
[ ]15229_molecular-medicine-revolution-psychiatry-bridging.pdf2022-11-07 22:51 74K 
[ ]15230_molecular-neurobiology-children.pdf2022-11-07 22:54 105K 
[ ]15231_molecular-neurobiology-practicing-psychiatrists-part-1-overview-gene-activation-neurotransmitters.pdf2022-11-07 22:53 86K 
[ ]15232_molecular-neurobiology-practicing-psychiatrists-part-2-neurotransmitters-activate-second-messenger-s.pdf2022-11-07 22:24 51K 
[ ]15233_molecular-targets-antianxiety-interventions.pdf2022-11-07 22:11 77K 
[ ]15236_monitoring-metabolic-side-effects.pdf2022-11-07 22:46 123K 
[ ]15239_monoamine-based-therapies-improved.pdf2022-11-07 22:53 58K 
[ ]15240_monoamine-depletion-studies-implications-antidepressant.pdf2022-11-07 22:17 77K 
[ ]15241_monoamine-dysfunction-pathophysiology-treatment-depression.pdf2022-11-07 22:02 80K 
[ ]15242_monoamine-oxidase-inhibitors-primary-care.pdf2022-11-07 22:15 239K 
[ ]15243_monosymptomatic-hypochondriacal-psychosis-atypical.pdf2022-11-07 22:57 105K 
[ ]15244_monosymptomatic-hypochondriacal-psychosis-tardive.pdf2022-11-07 22:26 98K 
[ ]15245_monotherapy-in-mood-disorders.pdf2022-11-07 22:47 239K 
[ ]15246_monotherapy-versus-combined-treatment-second-generation.pdf2022-11-07 22:29 213K 
[ ]15247_month-double-blind-maintenance-trial-lithium-monotherapy.pdf2022-11-07 22:14 249K 
[ ]15248_month-follow-randomized-placebo-controlled-study.pdf2022-11-07 22:41 53K 
[ ]15249_month-follow-study-posttraumatic-stress-anxietydepressive.pdf2022-11-07 22:28 370K 
[ ]15250_monthly-administration-long-acting-injectable-risperidone.pdf2022-11-07 22:52 180K 
[ ]15251_month-multicenter-open-label-evaluation-beaded-extended.pdf2022-11-07 22:49 55K 
[ ]15252_month-prospective-follow-study-psychological-symptoms.pdf2022-11-07 22:48 424K 
[ ]15253_month-prospective-outcome-study-episode-schizophrenia.pdf2022-11-07 22:07 228K 
[ ]15254_month-randomized-open-label-study-metabolic-effects.pdf2022-11-07 22:16 501K 
[ ]15255_month-randomized-placebo-controlled-neuroleptic-discontinuation.pdf2022-11-07 22:51 61K 
[ ]15256_mood-alterations-during-interferon-alfa-therapy-patients.pdf2022-11-07 22:04 227K 
[ ]15257_mood-bmi-and-adipokines-in-bipolar-disorder.pdf2022-11-07 23:03 262K 
[ ]15258_mood-disorder-history-personality-assessment-premenstrual.pdf2022-11-07 22:46 54K 
[ ]15259_mood-disorders-and-antipsychotic-treatment-in-youth.pdf2022-11-07 22:39 354K 
[ ]15260_mood-disorders-assessment-risk-factors-outcome.pdf2022-11-07 22:15 46K 
[ ]15261_mood-disorders-restless-legs-syndrome-willis-ekbom.pdf2022-11-07 22:15 653K 
[ ]15262_mood-disorders-suicide.pdf2022-11-07 22:06 42K 
[ ]15263_mood-disorders-systematic-medication-management.pdf2022-11-07 22:08 38K 
[ ]15264_mood-disorders-women.pdf2022-11-07 22:48 49K 
[ ]15265_mood-sleep-parkinsons-disease.pdf2022-11-07 22:34 106K 
[ ]15266_mood-stabilization-destabilization-during-acute-continuation.pdf2022-11-07 22:22 426K 
[ ]15267_mood-stabilizers-and-placenta-mediated-complications.pdf2022-11-07 22:44 303K 
[ ]15268_mood-stabilizers-during-breastfeeding.pdf2022-11-07 22:27 168K 
[ ]15269_mood-stabilizers-during-breastfeeding-review.pdf2022-11-07 22:08 100K 
[ ]15270_mood-stabilizers-evolution-maintenance-study-designs.pdf2022-11-07 22:32 65K 
[ ]15271_mood-stabilizers-plasticity-enhancers-treatment-neuropsychiatric.pdf2022-11-07 22:04 212K 
[ ]15272_mood-stabilizing-drugs-depression.pdf2022-11-07 22:32 44K 
[ ]15273_mood-symptoms-functional-impairment-disability-bipolar.pdf2022-11-07 22:25 233K 
[ ]15274_moral-objections-suicide-counteract-suicidality-patients.pdf2022-11-07 22:13 89K 
[ ]15275_moral-religious-objections-suicide-may-protect-against.pdf2022-11-07 22:41 300K 
[ ]15276_morbidity-bipolar-outpatients-followed-daily-prospective.pdf2022-11-07 22:37 98K 
[ ]15277_more-mood-disorders-youth.pdf2022-11-07 22:53 95K 
[ ]15278_more-placebo-response.pdf2022-11-07 23:02 140K 
[ ]15279_morning-light-treatment-hastens-antidepressant-effect.pdf2022-11-07 22:57 69K 
[ ]15280_mortality-neuroleptic-malignant-syndrome-induced-typical.pdf2022-11-07 22:28 229K 
[ ]15281_mortality-prediction-model-for-dementia-patients.pdf2022-11-07 22:48 387K 
[ ]15282_mortality-risk-patients-schizophrenia-participating.pdf2022-11-07 22:07 118K 
[ ]15283_mother-infant-antidepressant-concentrations-maternal.pdf2022-11-07 22:02 316K 
[ ]15284_motivational-interviewing-overcoming-disparities.pdf2022-11-07 22:44 135K 
[ ]15285_motor-conversion-disorders-reviewed-neuropsychiatric.pdf2022-11-07 22:20 60K 
[ ]15286_movement-disorders-associated-atypical-antipsychotic.pdf2022-11-07 22:12 84K 
[ ]15287_movement-disorders-associated-neuroleptic-treatment.pdf2022-11-07 22:23 47K 
[ ]15288_movement-disorders-associated-serotonin-selective.pdf2022-11-07 22:46 44K 
[ ]15289_movement-disorders-psychotic-symptoms-treated-pyridoxine.pdf2022-11-07 22:50 44K 
[ ]15290_movies-mental-illness-using-films-understand-psychopathology-book-review.pdf2022-11-07 22:37 61K 
[ ]15291_movies-mental-illness-using-films-understand-psychopathology-fourth-edition-book-review.pdf2022-11-07 22:32 77K 
[ ]15292_moving-field-forward-data-regarding-womens-mental.pdf2022-11-07 22:15 47K 
[ ]15293_mr-jakubovski-dr-bloch-reply.pdf2022-11-07 22:50 107K 
[ ]15294_ms-phillips-dr-blier-reply.pdf2022-11-07 22:14 119K 
[ ]15295_mtis-mixed-blood-stories.pdf2022-11-07 22:32 97K 
[ ]15296_multicenter-add-randomized-controlled-trial-low-dose.pdf2022-11-07 22:38 299K 
[ ]15297_multicenter-placebo-controlled-fixed-dose-study-citalopram.pdf2022-11-07 22:49 40K 
[ ]15298_multicenter-placebo-controlled-study-modafinil-augmentation.pdf2022-11-07 22:22 224K 
[ ]15299_multicenter-randomized-double-blind-placebo-controlled-aripiprazole-children-adolescents-tourette.pdf2022-11-07 22:10 466K 
[ ]15300_multicenter-randomized-double-blind-study-effects.pdf2022-11-07 22:37 308K 
[ ]15302_multicomponent-smoking-cessation-treatment-including.pdf2022-11-07 22:43 221K 
[ ]15303_multidimensional-tool-quantify-treatment-resistance.pdf2022-11-07 22:28 222K 
[ ]15305_multidisciplinary-modalities-treatment-fibromyalgia.pdf2022-11-07 22:04 161K 
[ ]15306_multifactorial-presentation-depression-acute-care.pdf2022-11-07 22:13 350K 
[ ]15307_multiple-genetic-factors-olanzapine-induced-weight.pdf2022-11-07 22:34 207K 
[ ]15308_multiple-rib-fractures-secondary-severe-tardive-dystonia.pdf2022-11-07 22:17 61K 
[ ]15309_multiplicity-adjusted-sample-size-requirements-strategy.pdf2022-11-07 22:49 38K 
[ ]15310_multisite-naturalistic-observational-study-transcranial.pdf2022-11-07 22:53 466K 
[ ]15311_multisite-randomized-double-blind-placebo-controlled.pdf2022-11-07 22:24 437K 
[ ]15312_multisite-study-capacity-acute-stress-disorder-diagnosis.pdf2022-11-07 22:20 202K 
[ ]15313_multisite-study-initial-respiration-rate-heart-rate.pdf2022-11-07 22:15 243K 
[ ]15314_muscle-dysmorphia.pdf2022-11-07 22:17 43K 
[ ]15315_musical-hallucinations-prevalence-psychotic-nonpsychotic.pdf2022-11-07 22:12 64K 
[ ]15316_myxedema-madness-rapidly-reversed-levothyroxine.pdf2022-11-07 22:29 739K 
[ ]15317_n-acetylcysteine-augmentation-for-treatment-resistant-ocd.pdf2022-11-07 23:02 423K 
[ ]15318_n-acetylcysteine-depressive-symptoms-functionality.pdf2022-11-07 22:13 305K 
[ ]15319_nac-for-ptsd-and-sud.pdf2022-11-07 22:54 938K 
[ ]15320_naltrexone-induced-reduction-tobacco-intake.pdf2022-11-07 22:04 140K 
[ ]15321_naltrexone-mitigates-stimulant-induced-euphoria.pdf2022-11-07 22:03 293K 
[ ]15322_naltrexone-reduces-heavy-drinking-problem-drinkers.pdf2022-11-07 22:17 117K 
[ ]15323_naltrexone-treatment-adolescent-sexual-offenders.pdf2022-11-07 22:30 41K 
[ ]15324_naltrexone-treatment-dissociative-symptoms-patients.pdf2022-11-07 22:02 39K 
[ ]15325_named-bupopion.pdf2022-11-07 22:52 81K 
[ ]15326_narcolepsy-excessive-daytime-sleepiness-diagnostic.pdf2022-11-07 22:44 122K 
[ ]15327_narcolepsy-pathophysiology-pharmacology.pdf2022-11-07 22:53 239K 
[ ]15328_narcolepsy-treatment-issues.pdf2022-11-07 22:42 130K 
[ ]15329_narrowing-gaps-between-psychiatry.pdf2022-11-07 22:16 356K 
[ ]15330_national-patterns-antidepressant-treatment-psychiatrists.pdf2022-11-07 23:03 302K 
[ ]15331_national-survey-adherence-efficacy-side-effects-methylphenidate.pdf2022-11-07 22:57 276K 
[ ]15332_national-trends-long-term-antidepressant-medications.pdf2022-11-07 22:28 434K 
[ ]15333_national-trends-office-based-prescription-schedule.pdf2022-11-07 22:05 374K 
[ ]15334_national-trends-outpatient-treatment-anxiety-disorders.pdf2022-11-07 22:55 64K 
[ ]15335_national-trends-second-generation-antipsychotic-augmentation.pdf2022-11-07 22:42 591K 
[ ]15336_nativity-dsm-iv-psychiatric-disorders-among-puerto.pdf2022-11-07 22:59 100K 
[ ]15337_natural-course-and-clinical-practice-of-tic-related-ocd.pdf2022-11-07 22:31 1.0M 
[ ]15338_natural-course-bulimia-nervosa-eating-disorder-otherwise.pdf2022-11-07 22:41 241K 
[ ]15339_natural-course-posttraumatic-stress-disorder-month.pdf2022-11-07 22:56 112K 
[ ]15340_natural-estrogen-antidepressant-women.pdf2022-11-07 22:55 46K 
[ ]15341_natural-history-mania-depression-schizophrenia.pdf2022-11-07 22:19 15K 
[ ]15342_natural-history-psychosis-depression-dementia-lewy.pdf2022-11-07 22:58 47K 
[ ]15343_naturalistic-comparison-clozapine-risperidone-olanzapine.pdf2022-11-07 22:19 54K 
[ ]15344_naturalistic-course-pharmacologic-treatment-children.pdf2022-11-07 22:05 70K 
[ ]15345_naturalistic-follow-patients-compulsive-shopping.pdf2022-11-07 22:17 55K 
[ ]15346_naturalistic-multicenter-trial-week-weight-management.pdf2022-11-07 22:14 238K 
[ ]15347_naturalistic-retrospective-comparison-between-second.pdf2022-11-07 22:58 188K 
[ ]15348_naturalistic-study-association-between-antidepressant.pdf2022-11-07 22:41 343K 
[ ]15349_naturalistic-study-preschool-children-pervasive.pdf2022-11-07 22:30 72K 
[ ]15350_naturalistic-study-risperidone-treatment-outcome-using.pdf2022-11-07 22:42 67K 
[ ]15351_naturally-occurring-low-dose-lithium-drinking-water.pdf2022-11-07 22:53 133K 
[ ]15352_nature-bipolar-disorder.pdf2022-11-07 22:40 129K 
[ ]15353_nature-discontinuation-syndrome-associated-antidepressant.pdf2022-11-07 22:57 86K 
[ ]15354_nature-placebo-response-clinical-studies-major-depressive.pdf2022-11-07 22:44 495K 
[ ]15355_nature-relationship-between-attention-deficit-hyperactivity.pdf2022-11-07 22:52 149K 
[ ]15356_navigating-patients-caregivers-through-course-alzheimers.pdf2022-11-07 22:08 113K 
[ ]15357_ncdeus-golden-anniversary.pdf2022-11-07 22:54 104K 
[ ]15358_need-clinically-relevant-research-treatment-resistant.pdf2022-11-07 22:30 36K 
[ ]15359_need-framework-understand-mechanism-antipsychotics.pdf2022-11-07 22:24 48K 
[ ]15360_nefazodone-associated-subjective-complaints-burning.pdf2022-11-07 22:13 61K 
[ ]15361_nefazodone-mood-disorder-associated-epilepsy.pdf2022-11-07 22:40 38K 
[ ]15362_nefazodone-patients-treatment-refractory-posttraumatic.pdf2022-11-07 22:51 72K 
[ ]15363_nefazodone-social-phobia.pdf2022-11-07 22:33 54K 
[ ]15364_nefazodone-symptoms-suggesting-neurotoxicity-case.pdf2022-11-07 22:28 42K 
[ ]15365_nefazodone-treatment-generalized-social-phobia-randomized.pdf2022-11-07 22:26 188K 
[ ]15366_nefazodone-treatment-nonparaphilic-compulsive-sexual.pdf2022-11-07 22:26 42K 
[ ]15367_nefazodone-treatment-panic.pdf2022-11-07 22:31 37K 
[ ]15368_nefazodone-treatment-pathological-gambling-prospective.pdf2022-11-07 22:10 70K 
[ ]15369_negative-life-events-children-adolescents-bipolar.pdf2022-11-07 22:11 411K 
[ ]15370_negative-symptoms-depressed-schizophrenic-patients.pdf2022-11-07 22:59 80K 
[ ]15371_negative-symptoms-schizophrenia-are-improved-paroxetine.pdf2022-11-07 22:30 86K 
[ ]15372_neonatal-discontinuation-syndrome-in-sri-exposed-infants.pdf2022-11-07 22:20 237K 
[ ]15373_neural-behavioral-correlates-peritraumatic-dissociation.pdf2022-11-07 22:35 1.6M 
[ ]15374_neural-correlates-affect-regulation-model-schizophrenia.pdf2022-11-07 22:48 149K 
[ ]15375_neural-correlates-predictive-power-trait-resilience.pdf2022-11-07 22:36 525K 
[ ]15376_neural-processing-emotional-overinvolvement-borderline.pdf2022-11-07 22:57 318K 
[ ]15377_neural-responsiveness-to-reward-in-depression.pdf2022-11-07 22:08 391K 
[ ]15378_neuroanatomical-and-serotonergic-hypotheses-of-ocd.pdf2022-11-07 22:15 1.3M 
[ ]15380_neurobiological-consequences-childhood-trauma.pdf2022-11-07 22:46 117K 
[ ]15381_neurobiological-mechanisms-generalized-anxiety-disorder.pdf2022-11-07 22:54 67K 
[ ]15382_neurobiology-attention-deficit-hyperactivity-disorder.pdf2022-11-07 22:39 94K 
[ ]15383_neurobiology-autism-nd-ed.pdf2022-11-07 22:04 51K 
[ ]15385_neurobiology-cognition-schizophrenia-pharmacologic-systems.pdf2022-11-07 22:28 83K 
[ ]15386_neurobiology-depression-inroads-treatment-drug-discovery.pdf2022-11-07 22:15 207K 
[ ]15388_neurobiology-etiology-panic-disorder.pdf2022-11-07 22:21 103K 
[ ]15389_neurobiology-generalized-anxiety-disorder.pdf2022-11-07 22:28 196K 
[ ]15390_neurobiology-genetics-suicide-risk.pdf2022-11-07 22:36 28K 
[ ]15391_neurobiology-lithium-update.pdf2022-11-07 22:56 122K 
[ ]15393_neurobiology-substance-p-nk-receptor.pdf2022-11-07 22:37 105K 
[ ]15394_neurobiology-suicide-risk-review-clinician.pdf2022-11-07 22:39 49K 
[ ]15395_neurobiology-switch-process-bipolar-disorder-review.pdf2022-11-07 22:20 463K 
[ ]15396_neurobiology-violence-second-edition.pdf2022-11-07 23:03 35K 
[ ]15397_neurochemistry-pathophysiology-autism.pdf2022-11-07 22:31 198K 
[ ]15398_neurocognition-in-clinical-high-risk-for-psychosis.pdf2022-11-07 22:24 1.2M 
[ ]15399_neurocognitive-dysfunctions-euthymic-bipolar-patients.pdf2022-11-07 22:40 480K 
[ ]15400_neurocognitive-effectiveness-haloperidol-risperidone.pdf2022-11-07 22:09 352K 
[ ]15401_neurocognitive-effects-neurofeedback-adolescents-adhd.pdf2022-11-07 22:24 1.2M 
[ ]15402_neurocognitive-functioning-intermediary-phenotype.pdf2022-11-07 22:35 326K 
[ ]15403_neurocognitive-functioning-patients-bipolar-i-disorder.pdf2022-11-07 22:08 346K 
[ ]15404_neurocognitive-impairment-bipolar-patients-without.pdf2022-11-07 22:37 201K 
[ ]15405_neurocognitive-impairment-psychosis-bipolar-i-disorder.pdf2022-11-07 22:48 203K 
[ ]15406_neurodevelopment-children-prenatally-exposed-selective.pdf2022-11-07 22:43 228K 
[ ]15407_neurofeedback-as-an-adhd-treatment.pdf2022-11-07 22:24 302K 
[ ]15408_neuroimaging-diagnosis-dementia.pdf2022-11-07 22:05 83K 
[ ]15409_neurolepic-malignant-syndrome-related-conditions-nd.pdf2022-11-07 22:44 35K 
[ ]15410_neuroleptic-malignant-syndrome-associated-atypical.pdf2022-11-07 22:38 252K 
[ ]15411_neuroleptic-malignant-syndrome-atypical-antipsychotic.pdf2022-11-07 23:02 56K 
[ ]15412_neuroleptic-related-dyskinesias-children-adolescents.pdf2022-11-07 22:17 74K 
[ ]15413_neuroleptic-sensitivity-parkinsons-disease-parkinsonian.pdf2022-11-07 22:23 102K 
[ ]15414_neurologic-comorbidities-schizophrenia.pdf2022-11-07 22:45 526K 
[ ]15415_neurologic-soft-signs-borderline-personality-disorder.pdf2022-11-07 22:25 87K 
[ ]15416_neurology-non-neurologist-th-ed.pdf2022-11-07 22:27 149K 
[ ]15417_neuropathologic-changes-alzheimers-disease.pdf2022-11-07 22:36 52K 
[ ]15418_neuropathologic-changes-alzheimers-disease-potential.pdf2022-11-07 22:22 106K 
[ ]15419_neuropharmacology-obesity-receptors-made-eat.pdf2022-11-07 22:26 28K 
[ ]15421_neuropsychiatric-assessment.pdf2022-11-07 22:06 67K 
[ ]15422_neuropsychiatric-symptoms-expenditure-complementary.pdf2022-11-07 22:23 270K 
[ ]15423_neuropsychiatric-symptoms-mind-body-therapies.pdf2022-11-07 22:40 568K 
[ ]15424_neuropsychiatry-introductory-approach.pdf2022-11-07 22:23 38K 
[ ]15425_neuropsychological-profile-of-behavioral-variant-frontotemporal-dementia.pdf2022-11-07 22:40 313K 
[ ]15426_neuropsychology-of-bvftd-and-psychiatric-disorders.pdf2022-11-07 22:06 352K 
[ ]15427_neuropsychology-women.pdf2022-11-07 22:22 149K 
[ ]15428_neuroreceptor-mechanisms-aggression-treatment.pdf2022-11-07 22:38 87K 
[ ]15429_neuroscience-clinical-psychiatry-pathophysiology-behavior.pdf2022-11-07 22:59 76K 
[ ]15430_neuroscience-exploring-brain.pdf2022-11-07 22:05 24K 
[ ]15431_neuroscience-psychological-therapies.pdf2022-11-07 22:20 97K 
[ ]15432_neurosyphilis-newly-admitted-psychiatric-patients.pdf2022-11-07 22:25 33K 
[ ]15433_neurotransmission-cognition-part-dopamine-is-hitchhiker.pdf2022-11-07 22:04 39K 
[ ]15434_neurotransmission-cognition-part-mechanism-action.pdf2022-11-07 22:16 60K 
[ ]15435_neurotransmission-cognition-part-selective-nris-are.pdf2022-11-07 22:30 34K 
[ ]15436_neurotransmitters-sleep.pdf2022-11-07 22:05 50K 
[ ]15437_neurotransmitters-sleep-editor's-choice-supplement.pdf2022-11-07 22:24 72K 
[ ]15438_neurotransmitter-targeting-treatment-depression.pdf2022-11-07 22:01 346K 
[ ]15439_neurotrophic-factors-nerves-therapy-neurodegenerative.pdf2022-11-07 22:14 52K 
[ ]15440_newer-anticonvulsants-dosing-strategies-cognition.pdf2022-11-07 22:50 52K 
[ ]15441_newer-anticonvulsants-treatment-bipolar-disorder.pdf2022-11-07 22:06 68K 
[ ]15442_newer-antidepressants-discontinuation-syndrome.pdf2022-11-07 22:05 33K 
[ ]15443_newer-antidepressants-panic-disorder.pdf2022-11-07 22:02 897K 
[ ]15444_newer-antidepressants-review-efficacy-safety-escitalopram.pdf2022-11-07 22:55 70K 
[ ]15445_newer-antiretroviral-treatments-among-hiv-infected.pdf2022-11-07 22:52 78K 
[ ]15447_new-onset-psychosis-in-the-postpartum-period.pdf2022-11-07 22:34 125K 
[ ]15448_news-american-society-clinical-psychopharmacology.pdf2022-11-07 22:27 33K 
[ ]15449_next-step-strategies-panic-disorder-refractory-initial.pdf2022-11-07 22:06 365K 
[ ]15450_nicotine-induced-angiogenesis.pdf2022-11-07 22:37 43K 
[ ]15451_nicotine-psychiatry-psychopathology-emerging-therapeutics.pdf2022-11-07 22:30 41K 
[ ]15452_nightmares-predict-self-harm.pdf2022-11-07 22:17 563K 
[ ]15453_night-terrors-sleepwalking-confusional-arousals-general.pdf2022-11-07 22:47 625K 
[ ]15454_nimh-drug-trials-for-schizophrenia.pdf2022-11-07 22:35 91K 
[ ]15455_nimh-supports-evidence-based-treatments-for-schizophrenia.pdf2022-11-07 22:16 115K 
[ ]15456_nitric-oxide-physiology-pharmacology.pdf2022-11-07 22:33 111K 
[ ]15457_nizatidine-induced-delirium-nonagenarian.pdf2022-11-07 22:01 45K 
[ ]15458_nocebo-effects-treatment-major-depression-results.pdf2022-11-07 22:09 508K 
[ ]15459_nocturnal-sleep-disturbances-predictor-suicide-attempts.pdf2022-11-07 22:43 311K 
[ ]15460_nocturnal-wakefulness-and-season-and-method-of-suicide.pdf2022-11-07 22:28 332K 
[ ]15461_nocturnal-wakefulness-and-suicide.pdf2022-11-07 22:54 283K 
[ ]15462_nomenclature-drug-induced-movement-disorders-including.pdf2022-11-07 22:35 131K 
[ ]15463_nonadherence-mood-stabilizers-prevalence-predictors.pdf2022-11-07 22:48 130K 
[ ]15464_nonalcoholic-steatohepatitis-possible-side-effect.pdf2022-11-07 22:19 81K 
[ ]15465_non-antidepressant-treatment-premenstrual-syndrome.pdf2022-11-07 22:22 65K 
[ ]15466_noncholinergic-treatment-options-alzheimers-disease.pdf2022-11-07 22:54 64K 
[ ]15467_nonhuman-primate-studies-fear-anxiety-temperament.pdf2022-11-07 22:43 57K 
[ ]15468_noninvasive-brain-stimulation-high-frequency-low-intensity.pdf2022-11-07 22:50 443K 
[ ]15469_nonmedical-prescription-opioid-use-and-its-dsm-disorder.pdf2022-11-07 22:20 349K 
[ ]15470_nonmedical-stimulant-use-in-college-students.pdf2022-11-07 22:32 331K 
[ ]15472_nonpharmacologic-pharmacologic-management-weight-gain.pdf2022-11-07 22:22 68K 
[ ]15473_nonpsychotic-psychiatric-disorders-and-substance-use-disorders.pdf2022-11-07 22:28 126K 
[ ]15474_nonsevere-major-depression-benefit-antidepressant.pdf2022-11-07 22:05 324K 
[ ]15475_nonsteroidal-anti-inflammatory-drugs-htltsubgtltsubgt.pdf2022-11-07 22:15 535K 
[ ]15476_nonsteroidal-anti-inflammatory-drugs-schizophrenia.pdf2022-11-07 22:40 377K 
[ ]15477_nonverbal-learning-disabilities-clinical-perspective.pdf2022-11-07 22:44 99K 
[ ]15478_noradrenergic-approaches-antidepressant-therapy.pdf2022-11-07 22:55 64K 
[ ]15479_noradrenergic-symptom-cluster-and-mdd.pdf2022-11-07 22:57 414K 
[ ]15480_noradrenergic-versus-serotonergic-antidepressants.pdf2022-11-07 22:44 98K 
[ ]15481_norepinephrine-dopamine-regulate-signals-noise-prefrontal.pdf2022-11-07 22:47 220K 
[ ]15482_norepinephrine-dysfunction-depression.pdf2022-11-07 22:32 87K 
[ ]15483_norepinephrine-involvement-antidepressant-action.pdf2022-11-07 22:05 64K 
[ ]15484_normal-bereavement.pdf2022-11-07 22:39 133K 
[ ]15485_normal-p-gating-children-autism.pdf2022-11-07 22:11 61K 
[ ]15486_norms-for-time-sensitive-measures-of-function-in-adhd.pdf2022-11-07 22:38 1.0M 
[ ]15487_nortriptyline-treatment-resistant-depression.pdf2022-11-07 22:28 69K 
[ ]15488_nosology-compulsive-skin-picking.pdf2022-11-07 22:16 31K 
[ ]15490_note-ascp-president.pdf2022-11-07 22:38 60K 
[ ]15491_novel-alternatives-supplements-lithium-anticonvulsants.pdf2022-11-07 22:12 121K 
[ ]15492_novel-antidepressant-strategies-optimize-outcome.pdf2022-11-07 22:32 88K 
[ ]15493_novel-antipsychotic-schizophrenia.pdf2022-11-07 22:32 90K 
[ ]15494_novel-antipsychotics-comparison-weight-gain-liabilities.pdf2022-11-07 22:59 65K 
[ ]15495_novel-approaches-study-design-intervention-residual.pdf2022-11-07 22:45 136K 
[ ]15496_novel-examination-atypical-major-depressive-disorder.pdf2022-11-07 22:55 250K 
[ ]15497_novel-mutation-arylsulfatase-gene-late-onset-metachromatic.pdf2022-11-07 22:06 961K 
[ ]15499_novel-placebo-lead-behavior-strategy-sertraline-dosing.pdf2022-11-07 22:39 43K 
[ ]15500_novel-point-care-test-lithium-levels-description.pdf2022-11-07 22:14 43K 
[ ]15501_novel-tramadol-hydrochloride-treatment-tourettes-syndrome.pdf2022-11-07 22:20 92K 
[ ]15502_novel-transdermal-delivery-formulation-monoamine-oxidase.pdf2022-11-07 22:45 62K 
[ ]15503_novel-treatments-attention-deficit-hyperactivity-disorder.pdf2022-11-07 22:08 73K 
[ ]15504_now-you-do-now-you-dont.pdf2022-11-07 22:09 219K 
[ ]15505_number-needed-treat-harm-discontinuation-due-adverse.pdf2022-11-07 22:45 299K 
[ ]15506_number-needed-treat-helpful-response-andrade.pdf2022-11-07 22:43 112K 
[ ]15507_number-needed-treat-is-isnt-why-every-clinician-should.pdf2022-11-07 22:51 170K 
[ ]15508_numbers-needed-treat-harm-nnt-nnh-statistics-tell.pdf2022-11-07 22:34 357K 
[ ]15509_nurnberger-and-colleagues-reply.pdf2022-11-07 22:15 88K 
[ ]15510_nutritional-approach-bipolar-disorder.pdf2022-11-07 22:57 79K 
[ ]15511_obesity-and-cognition-in-bipolar-disorder.pdf2022-11-07 22:12 323K 
[ ]15512_obesity-associated-complications-patients-severe-mental.pdf2022-11-07 22:20 131K 
[ ]15513_obesity-binge-eating-disorder.pdf2022-11-07 22:20 63K 
[ ]15514_obesity-comorbidity-unipolar-major-depressive-disorder.pdf2022-11-07 22:04 226K 
[ ]15515_obesity-dyslipidemia-diabetes-selective-serotonin.pdf2022-11-07 22:11 94K 
[ ]15516_obesity-genes-risk-major-depressive-disorder-multiethnic.pdf2022-11-07 22:04 453K 
[ ]15517_obesity-mood-disorders-complex-problem-insight.pdf2022-11-07 22:18 123K 
[ ]15518_obesity-onset-significant-depressive-symptoms-results.pdf2022-11-07 22:30 427K 
[ ]15519_obesity-patients-bipolar-disorder-biopsychosocial.pdf2022-11-07 22:01 130K 
[ ]15520_obesity-patients-severe-mental-illness-overview-management.pdf2022-11-07 22:53 363K 
[ ]15522_observations-cases-clozapine-rechallenge-development.pdf2022-11-07 22:25 123K 
[ ]15523_obsessions-compulsions-women-postpartum-depression.pdf2022-11-07 22:45 48K 
[ ]15524_obsessive-compulsivebipolar-comorbidity-systematic.pdf2022-11-07 22:01 75K 
[ ]15526_obsessive-compulsive-disorder-defining-phenotype.pdf2022-11-07 22:28 36K 
[ ]15527_obsessive-compulsive-disorder-diagnosis-treatment.pdf2022-11-07 22:53 60K 
[ ]15528_obsessive-compulsive-disorder-non-hour-sleep-wake.pdf2022-11-07 22:30 59K 
[ ]15529_obsessive-compulsive-disorder-pregnancy-puerperium.pdf2022-11-07 22:31 41K 
[ ]15530_obsessive-compulsive-disorder-strategies-optimal-treatment.pdf2022-11-07 22:31 314K 
[ ]15532_obsessive-compulsive-hoarding-symptom-severity-response.pdf2022-11-07 22:34 70K 
[ ]15533_obsessive-compulsive-personality-disorder-suicidal.pdf2022-11-07 22:45 278K 
[ ]15534_obsessive-compulsive-related-disorders-adults-comprehensive.pdf2022-11-07 22:36 57K 
[ ]15535_obsessive-compulsive-spectrum-disorders-refining-research.pdf2022-11-07 22:32 135K 
[ ]15536_obsessive-compulsive-spectrum-disorders-rheumatic.pdf2022-11-07 22:42 54K 
[ ]15537_obsessive-compulsive-symptoms-during-treatment-olanzapine.pdf2022-11-07 22:58 53K 
[ ]15538_obsessive-compulsive-symptoms-patients-schizophrenia.pdf2022-11-07 22:42 272K 
[ ]15539_obsessive-compulsive-symptoms-prediagnosed-huntingtons.pdf2022-11-07 22:28 235K 
[ ]15540_obsessive-compulsive-symptoms-risperidone.pdf2022-11-07 22:36 55K 
[ ]15541_obstructive-sleep-apneahypopnea-syndrome-poor-response.pdf2022-11-07 22:04 328K 
[ ]15542_occult-mood-disorders-consecutively-presenting-children.pdf2022-11-07 22:26 56K 
[ ]15543_occurrence-clinical-correlates-psychiatric-comorbidity.pdf2022-11-07 22:03 98K 
[ ]15544_occurrence-reversible-bilateral-scotoma-hour-single.pdf2022-11-07 22:59 185K 
[ ]15545_ocd-prevalence-and-gender.pdf2022-11-07 22:26 896K 
[ ]15546_odd-odds.pdf2022-11-07 22:27 142K 
[ ]15547_offensive-subtype-taijin-kyofu-sho-york-city-phenomenology.pdf2022-11-07 22:10 34K 
[ ]15548_off-label-antidepressant-anticonvulsant-antipsychotic.pdf2022-11-07 22:56 118K 
[ ]15549_offspring-of-depressed-and-anxious-patients.pdf2022-11-07 22:36 189K 
[ ]15550_offspring-outcomes-in-antidepressant-treated-pregnancies.pdf2022-11-07 22:17 307K 
[ ]15551_often-ssris-generation-antidepressants-lose-effect.pdf2022-11-07 22:59 153K 
[ ]15552_olanzapine-addition-obsessive-compulsive-disorder.pdf2022-11-07 22:12 42K 
[ ]15553_olanzapine-anorexia-nervosa.pdf2022-11-07 22:59 117K 
[ ]15554_olanzapine-associated-bilateral-pedal-edema.pdf2022-11-07 22:03 50K 
[ ]15555_olanzapine-augmentation-treatment-resistant-obsessive.pdf2022-11-07 22:19 55K 
[ ]15556_olanzapine-blepharoclonus.pdf2022-11-07 22:37 152K 
[ ]15557_olanzapine-cocaine-craving-relapse-prevention-patients.pdf2022-11-07 22:27 51K 
[ ]15558_olanzapine-cocaine-cravings-relapse-prevention.pdf2022-11-07 22:18 52K 
[ ]15559_olanzapine-divalproex-combination-versus-divalproex.pdf2022-11-07 22:33 666K 
[ ]15560_olanzapine-elevation-serum-creatine-kinase.pdf2022-11-07 22:10 72K 
[ ]15561_olanzapinefluoxetine-combination-patients-treatment.pdf2022-11-07 22:19 640K 
[ ]15562_olanzapinefluoxetine-combination-treatment-mixed-depression.pdf2022-11-07 22:47 328K 
[ ]15563_olanzapinefluoxetine-combination-treatment-resistant.pdf2022-11-07 22:33 180K 
[ ]15564_olanzapine-generation-antipsychotic-agents-patterns.pdf2022-11-07 22:34 27K 
[ ]15565_olanzapine-increases-slow-wave-sleep-sleep-continuity.pdf2022-11-07 22:59 99K 
[ ]15566_olanzapine-increases-weight-serum-triglyceride-levels.pdf2022-11-07 22:42 30K 
[ ]15567_olanzapine-induced-hyperprolactinemia-galactorrhea.pdf2022-11-07 22:46 123K 
[ ]15568_olanzapine-induced-manic-syndrome.pdf2022-11-07 22:59 38K 
[ ]15569_olanzapine-induced-neutropenia-patients-history-clozapine.pdf2022-11-07 22:37 54K 
[ ]15570_olanzapine-induced-urinary-incontinence-treatment.pdf2022-11-07 22:56 55K 
[ ]15571_olanzapine-induces-insulin-resistance-results-prospective.pdf2022-11-07 22:58 49K 
[ ]15572_olanzapine-lamotrigine-addition-lithium-remitted-bipolar.pdf2022-11-07 22:17 233K 
[ ]15573_olanzapine-may-cause-delirium-geriatric-patients.pdf2022-11-07 22:31 50K 
[ ]15574_olanzapine-negative-symptoms.pdf2022-11-07 22:21 38K 
[ ]15575_olanzapine-onset-diabetes-mellitus-risk-insulin-overdose.pdf2022-11-07 22:04 38K 
[ ]15576_olanzapine-plus-dialectical-behavior-therapy-women.pdf2022-11-07 22:08 203K 
[ ]15577_olanzapine-plus-samidorphan-in-schizophrenia-with-aud.pdf2022-11-07 22:49 798K 
[ ]15578_olanzapine-refractory-schizophrenia-failure-typical.pdf2022-11-07 22:29 61K 
[ ]15579_olanzapine-response-psychotic-depression.pdf2022-11-07 22:29 41K 
[ ]15580_olanzapinerisperidone-diabetes-risk.pdf2022-11-07 22:11 81K 
[ ]15581_olanzapine-self-injurious-aggressive-disruptive-behaviors.pdf2022-11-07 22:04 65K 
[ ]15582_olanzapine-sertraline-combination-schizophrenia-obsessive.pdf2022-11-07 22:56 67K 
[ ]15583_olanzapine-therapy-treatment-resistant-psychotic-mood.pdf2022-11-07 22:57 99K 
[ ]15584_olanzapine-treatment-apathy-previously-depressed-participants.pdf2022-11-07 22:14 98K 
[ ]15585_olanzapine-treatment-clozapine-induced-granulocytopenia.pdf2022-11-07 22:21 35K 
[ ]15586_olanzapine-treatment-female-borderline-personality.pdf2022-11-07 22:18 54K 
[ ]15587_olanzapine-treatment-monosymptomatic-hypochondriacal.pdf2022-11-07 22:24 55K 
[ ]15588_olanzapine-treatment-pathological-gambling-negative.pdf2022-11-07 22:08 233K 
[ ]15589_olanzapine-treatment-patients-schizophrenia-cocaine.pdf2022-11-07 22:02 83K 
[ ]15590_olanzapine-treatment-refractory-schizophrenia-results.pdf2022-11-07 22:31 39K 
[ ]15591_olanzapine-treatment-tardive-dyskinesia.pdf2022-11-07 22:11 44K 
[ ]15592_olanzapine-treatment-tardive-dyskinesia-report-cases.pdf2022-11-07 22:21 48K 
[ ]15593_olanzapine-versus-antipsychotics-treatment-schizophrenia.pdf2022-11-07 22:29 52K 
[ ]15594_olanzapine-versus-divalproex-versus-placebo-treatment.pdf2022-11-07 22:36 386K 
[ ]15595_olanzapine-versus-placebo-treatment-borderline-personality.pdf2022-11-07 22:53 56K 
[ ]15596_olanzapine-versus-risperidone-newly-admitted-acutely.pdf2022-11-07 22:37 139K 
[ ]15597_olanzapine-versus-risperidone-treatment-manic-mixed.pdf2022-11-07 22:12 105K 
[ ]15599_older-adult-opioid-misuse-psychopathology-and-health.pdf2022-11-07 22:40 300K 
[ ]15600_older-patient-ongoing-challenge-efficacy-tolerability.pdf2022-11-07 22:27 54K 
[ ]15601_olfaction-traumatic-reminder-posttraumatic-stress.pdf2022-11-07 22:04 53K 
[ ]15602_olfactory-impairments-child-attention-deficit-hyperactivity.pdf2022-11-07 22:40 205K 
[ ]15603_olfactory-reference-syndrome-responds-clomipramine.pdf2022-11-07 22:16 44K 
[ ]15604_olfactory-reference-syndrome-subtype-body-dysmorphic.pdf2022-11-07 22:34 789K 
[ ]15605_omega-bipolar-disorder-meta-analyses-mania-bipolar.pdf2022-11-07 22:33 403K 
[ ]15606_omega-eicosapentaenoic-acid-bipolar-depression-report.pdf2022-11-07 22:43 78K 
[ ]15607_omega-fatty-acids-are-more-beneficial-depressive.pdf2022-11-07 22:31 147K 
[ ]15608_omega-fatty-acids-depression-cellular-mechanisms.pdf2022-11-07 22:26 176K 
[ ]15609_omega-fatty-acids-evidence-basis-treatment-future.pdf2022-11-07 22:37 150K 
[ ]15610_omega-fatty-acids-for-perinatal-depression.pdf2022-11-07 22:56 1.0M 
[ ]15611_omega-fatty-acids-for-youth-depression.pdf2022-11-07 22:27 495K 
[ ]15612_omega-fatty-acids-major-depressive-disorder.pdf2022-11-07 22:27 196K 
[ ]15613_omega-fatty-acids-major-depressive-disorder-during.pdf2022-11-07 22:46 233K 
[ ]15614_omega-fatty-acid-supplementation-for-perinatal-depression-and-other-subpopulations.pdf2022-11-07 22:15 143K 
[ ]15615_omega-polyunsaturated-fatty-acid-pufa-status-major.pdf2022-11-07 22:14 278K 
[ ]15616_omega-treatment-for-depression-in-chd.pdf2022-11-07 22:56 295K 
[ ]15617_omission-bupropion-recommended-treatment-ptsd.pdf2022-11-07 22:22 45K 
[ ]15618_once-daily-venlafaxine-extended-release-xr-compared.pdf2022-11-07 22:06 49K 
[ ]15619_once-daily-venlafaxine-xr-compared-fluoxetine-outpatients.pdf2022-11-07 22:54 37K 
[ ]15620_once-versus-twice-daily-venlafaxine-therapy-major.pdf2022-11-07 22:56 38K 
[ ]15621_once-weekly-dosing-fluoxetine-maintenance-remission.pdf2022-11-07 22:36 34K 
[ ]15622_ondansetron-augmentation-serotonin-reuptake-inhibitors.pdf2022-11-07 22:26 371K 
[ ]15623_ondansetron-treatment-tourettes-disorder-week-randomized.pdf2022-11-07 22:24 105K 
[ ]15624_one-year-follow-up-of-psychotherapies-for-panic.pdf2022-11-07 22:13 189K 
[ ]15625_onset-depressive-episodes-is-faster-patients-bipolar.pdf2022-11-07 22:52 179K 
[ ]15626_onset-diabetes-mellitus-associated-initiation-quetiapine.pdf2022-11-07 22:11 67K 
[ ]15627_onset-diabetes-mellitus-ziprasidone-case-report.pdf2022-11-07 22:33 123K 
[ ]15628_onset-exacerbation-obsessive-compulsive-disorder-pregnancy.pdf2022-11-07 22:28 287K 
[ ]15629_onset-psychosis-occurring-postpartum-period-prospective.pdf2022-11-07 22:45 380K 
[ ]15630_onset-unipolar-depression-bipolar-depression-prior.pdf2022-11-07 22:54 88K 
[ ]15631_open-label-adjunctive-zonisamide-treatment-bipolar.pdf2022-11-07 22:19 147K 
[ ]15632_open-label-flexible-dose-study-olanzapine-treatment.pdf2022-11-07 22:36 54K 
[ ]15633_open-label-pilot-trial-adjunctive-tocilizumab-schizophrenia.pdf2022-11-07 22:40 122K 
[ ]15634_open-label-prospective-study-repetitive-transcranial.pdf2022-11-07 22:16 157K 
[ ]15635_open-label-risperidone-aspergers-disorder-negative.pdf2022-11-07 22:07 146K 
[ ]15636_open-label-study-adjunctive-modafinil-patients-sedation.pdf2022-11-07 22:24 51K 
[ ]15637_open-label-study-amisulpride-treatment-mania.pdf2022-11-07 22:23 81K 
[ ]15638_open-label-study-atypical-neuroleptic-quetiapine-treatment.pdf2022-11-07 23:02 134K 
[ ]15639_open-label-study-citalopram-body-dysmorphic-disorder.pdf2022-11-07 22:40 62K 
[ ]15640_open-label-study-citalopram-treatment-pathological.pdf2022-11-07 22:19 59K 
[ ]15641_open-label-study-efficacy-tolerability-aripiprazole.pdf2022-11-07 22:50 170K 
[ ]15642_open-label-study-levetiracetam-treatment-social-anxiety.pdf2022-11-07 22:49 46K 
[ ]15643_open-label-study-ssri-treatment-depressed-hispanic.pdf2022-11-07 22:18 79K 
[ ]15644_open-label-study-tolerability-mixed-amphetamine-salts.pdf2022-11-07 22:36 107K 
[ ]15645_open-label-study-treatment-efficacy-olanzapine-tourettes.pdf2022-11-07 22:05 50K 
[ ]15646_open-label-tiagabine-monotherapy-major-depressive.pdf2022-11-07 22:25 101K 
[ ]15647_open-label-topiramate-primary-adjunctive-therapy-chronic.pdf2022-11-07 22:40 60K 
[ ]15648_open-label-trial-citalopram-major-depression-patients.pdf2022-11-07 22:27 60K 
[ ]15649_open-label-trial-escitalopram-treatment-posttraumatic.pdf2022-11-07 22:29 75K 
[ ]15650_open-label-trial-risperidone-augmentation-refractory.pdf2022-11-07 22:47 82K 
[ ]15651_open-label-trial-sibutramine-obese-patients-binge.pdf2022-11-07 22:51 37K 
[ ]15652_open-label-trial-sildenafil-addition-risperidone-treated.pdf2022-11-07 22:01 62K 
[ ]15653_open-label-trial-st-johns-wort-hypericum-perforatum.pdf2022-11-07 22:23 57K 
[ ]15654_open-label-week-clinical-sleep-eeg-study-nefazodone.pdf2022-11-07 22:09 76K 
[ ]15655_open-pilot-study-combining-risperidone-selective-serotonin.pdf2022-11-07 23:01 52K 
[ ]15656_open-study-creatine-monohydrate-treatment-resistant.pdf2022-11-07 22:47 82K 
[ ]15657_open-study-olanzapine-fluoxetine-psychotic-major-depressive.pdf2022-11-07 22:37 72K 
[ ]15658_open-study-triiodothyronine-augmentation-selective.pdf2022-11-07 22:59 130K 
[ ]15659_open-trial-adjunctive-escitalopram-bipolar-depression.pdf2022-11-07 22:53 96K 
[ ]15660_open-trial-divalproex-sodium-autism-spectrum-disorders.pdf2022-11-07 22:52 85K 
[ ]15661_open-trial-flutamide-treatment-obsessive-compulsive.pdf2022-11-07 22:36 46K 
[ ]15662_open-trial-light-therapy-adult-attention-deficit-hyperactivity.pdf2022-11-07 22:43 105K 
[ ]15663_open-trial-light-therapy-women-seasonal-affective.pdf2022-11-07 23:01 59K 
[ ]15664_open-trial-nefazodone-combat-related-posttraumatic.pdf2022-11-07 22:04 34K 
[ ]15665_open-trial-olanzapine-anorexia-nervosa.pdf2022-11-07 22:48 37K 
[ ]15666_open-trial-reboxetine-hiv-seropositive-outpatients.pdf2022-11-07 22:21 45K 
[ ]15667_open-trial-topiramate-treatment-generalized-social.pdf2022-11-07 22:44 48K 
[ ]15668_opiate-antagonist-interference-with-stimulants.pdf2022-11-07 22:39 275K 
[ ]15669_opioid-abstinence-over-month-follow-up.pdf2022-11-07 22:55 277K 
[ ]15670_opioid-antagonists-treatment-impulse-control-disorders.pdf2022-11-07 22:07 86K 
[ ]15671_opportunities-smartphones-clinical-care-future-mobile.pdf2022-11-07 22:56 129K 
[ ]15672_opposing-breathing-therapies-panic-disorder-randomized.pdf2022-11-07 22:30 411K 
[ ]15673_optimal-dosing-risperidone-updated-recommendations.pdf2022-11-07 22:31 73K 
[ ]15674_optimization-of-a-digital-medicine-system.pdf2022-11-07 22:52 1.9M 
[ ]15675_optimizing-clozapine-treatment.pdf2022-11-07 22:12 50K 
[ ]15677_optimizing-detection-bipolar-ii-disorder-outpatient.pdf2022-11-07 22:04 165K 
[ ]15678_optimizing-lithium-treatment.pdf2022-11-07 22:29 56K 
[ ]15679_optimizing-outcomes-clozapine-rechallenge-following.pdf2022-11-07 22:35 509K 
[ ]15680_optimizing-pharmacotherapy-generalized-anxiety-disorder.pdf2022-11-07 22:48 58K 
[ ]15681_optimizing-pharmacotherapy-maximize-outcome-schizophrenia.pdf2022-11-07 22:42 289K 
[ ]15682_optimizing-schizophrenia-treatment-choices.pdf2022-11-07 22:12 873K 
[ ]15683_optimizing-treatment-clozapine.pdf2022-11-07 22:43 32K 
[ ]15684_optimizing-treatment-outcomes-bipolar-disorder-under.pdf2022-11-07 22:11 268K 
[ ]15685_oral-divalproex-sodium-loading-adolescent-outpatients.pdf2022-11-07 22:25 209K 
[ ]15686_oral-ketamine-for-depression.pdf2022-11-07 22:35 265K 
[ ]15688_oral-ketamine-for-depression-pharmacologic-considerations-and-clinical-evidence.pdf2022-11-07 22:41 319K 
[ ]15689_oral-ketamine-for-depression-practical-considerations.pdf2022-11-07 22:11 325K 
[ ]15690_oral-long-acting-injectable-naltrexone-removal-boxed.pdf2022-11-07 22:31 67K 
[ ]15691_orally-disintegrating-antipsychotics-may-promote-compliance.pdf2022-11-07 22:40 141K 
[ ]15692_orally-disintegrating-oral-standard-olanzapine-tablets.pdf2022-11-07 22:32 323K 
[ ]15693_oral-magnesium-ion-shortens-prolonged-qtc-interval.pdf2022-11-07 22:46 70K 
[ ]15694_oral-scopolamine-augmentation-moderate-severe-major.pdf2022-11-07 22:58 400K 
[ ]15695_oral-ziprasidone-treatment-schizophrenia-review-short.pdf2022-11-07 22:26 76K 
[ ]15696_organic-hypomania-secondary-sibutramine-citalopram.pdf2022-11-07 22:33 57K 
[ ]15698_orlistat-clozapine-olanzapine-treated-patients-overweight.pdf2022-11-07 23:03 266K 
[ ]15699_orlistat-clozapine-olanzapine-treated-patients-overweight-16-week-RCT-randomized-controlled-trial.pdf2022-11-07 22:15 188K 
[ ]15700_osmotic-release-oral-system-methylphenidate-augmentation.pdf2022-11-07 22:54 225K 
[ ]15701_ounce-prevention-is-worth-pound-cure.pdf2022-11-07 22:44 44K 
[ ]15702_outcome-evaluation-structured-educational-wellness.pdf2022-11-07 23:03 531K 
[ ]15703_outcome-following-clozapine-discontinuation-retrospective.pdf2022-11-07 22:27 126K 
[ ]15704_outcome-measures-in-a-study-of-tdcs-for-negative-symptoms-of-schizophrenia.pdf2022-11-07 22:36 305K 
[ ]15705_outcome-patients-major-depressive-disorder-serious.pdf2022-11-07 22:34 346K 
[ ]15706_outcome-preconception-consultation-women-bipolar.pdf2022-11-07 22:34 93K 
[ ]15707_outcome-prediction-in-treatment-resistant-depression.pdf2022-11-07 22:55 497K 
[ ]15708_outcome-schizophrenia-beyond-symptom-reduction.pdf2022-11-07 22:11 51K 
[ ]15709_outcomes-late-life-anxiety-disorders-during-weeks.pdf2022-11-07 22:15 92K 
[ ]15711_outcomes-neurodevelopment-genetic-disorders.pdf2022-11-07 22:04 30K 
[ ]15712_outcomes-of-nms-with-depot-versus-oral-antipsychotics.pdf2022-11-07 22:52 1.6M 
[ ]15713_outcomes-posttraumatic-stress-disorder.pdf2022-11-07 22:05 53K 
[ ]15714_outcome-step-treatment-algorithm-depressed-inpatients.pdf2022-11-07 22:23 86K 
[ ]15715_outcome-treatment-central-stimulant-medication-adult.pdf2022-11-07 22:20 283K 
[ ]15716_outcome-vagus-nerve-stimulation-vns-treatment-major.pdf2022-11-07 22:25 180K 
[ ]15717_outer-directed-irritability-distinct-mood-syndrome.pdf2022-11-07 22:52 44K 
[ ]15719_overcoming-obstacles-effective-treatment-clinical.pdf2022-11-07 22:02 26K 
[ ]15720_overcoming-treatment-resistance-depression.pdf2022-11-07 22:47 99K 
[ ]15721_overdiagnosis-bipolar-disorder-among-substance-disorder.pdf2022-11-07 22:51 260K 
[ ]15722_overdiagnosis-underdiagnosis-bipolar-disorder.pdf2022-11-07 22:27 124K 
[ ]15723_overestimating-prevalence-subtherapeutic-dosing-atypical.pdf2022-11-07 22:07 736K 
[ ]15724_overlap-anxiety-depression-managed-care-population.pdf2022-11-07 22:41 86K 
[ ]15725_overview-antidepressants-currently-used-treat-anxiety.pdf2022-11-07 22:38 50K 
[ ]15726_overview-common-medical-comorbidities-patients-schizophrenia.pdf2022-11-07 22:44 56K 
[ ]15727_overview-different-pharmacotherapies-attaining-remission.pdf2022-11-07 22:46 78K 
[ ]15728_overview-generalized-anxiety-disorder-epidemiology.pdf2022-11-07 23:02 210K 
[ ]15729_overview-importance-recognizing-treating-insomnia.pdf2022-11-07 22:40 57K 
[ ]15730_overview-key-data-european-study-epidemiology-mental.pdf2022-11-07 22:13 185K 
[ ]15732_overview-mechanism-action-lithium-brain-fifty-update.pdf2022-11-07 22:35 90K 
[ ]15733_overview-neurobiology-attention-deficit-hyperactivity.pdf2022-11-07 22:45 79K 
[ ]15734_overview-panic-social-anxiety-disorders.pdf2022-11-07 22:52 57K 
[ ]15735_overview-partial-compliance.pdf2022-11-07 22:21 68K 
[ ]15737_overview-psychiatric-disorders-role-newer-antidepressants.pdf2022-11-07 22:44 70K 
[ ]15738_overview-side-effects-caused-typical-antipsychotics.pdf2022-11-07 22:44 61K 
[ ]15740_overview-ssris-depressive-disorders-specific-women.pdf2022-11-07 22:12 57K 
[ ]15742_overview-treatment-schizoaffective-disorder.pdf2022-11-07 22:17 60K 
[ ]15743_overview-violence-self-others-during-episode-psychosis.pdf2022-11-07 22:59 280K 
[ ]15744_overview-vortioxetine.pdf2022-11-07 22:32 455K 
[ ]15745_oxcarbazepine-induced-syndrome-inappropriate-secretion.pdf2022-11-07 22:19 47K 
[ ]15746_oxcarbazepine-panic-disorder-occurring-grand-mal-seizures.pdf2022-11-07 22:43 43K 
[ ]15747_oxcarbazepine-treatment-bipolar-disorder.pdf2022-11-07 22:47 44K 
[ ]15748_oxcarbazepine-treatment-borderline-personality-disorder.pdf2022-11-07 22:25 117K 
[ ]15749_oxford-handbook-psychiatric-ethics.pdf2022-11-07 22:45 84K 
[ ]15750_oxford-handbook-psychiatry.pdf2022-11-07 22:25 60K 
[ ]15751_oxford-handbook-suicide-self-injury.pdf2022-11-07 22:27 75K 
[ ]15752_oxford-textbook-old-age-psychiatry-th-edition-formerly.pdf2022-11-07 22:21 733K 
[ ]15753_oxford-textbook-philosophy-psychiatry.pdf2022-11-07 22:28 99K 
[ ]15754_oxidative-stress-antioxidant-parameters-patients-major.pdf2022-11-07 22:51 1.8M 
[ ]15755_oxybutynin-intranasal-desmopressin-clozapine-induced.pdf2022-11-07 22:51 43K 
[ ]15756_package-care-patients-bipolar-depression.pdf2022-11-07 22:57 117K 
[ ]15757_pain-and-opioid-dependence.pdf2022-11-07 22:07 245K 
[ ]15763_pain-inhibition-is-deficient-chronic-widespread-pain.pdf2022-11-07 23:01 238K 
[ ]15764_pain-predicts-longer-remission-during-treatment-recurrent.pdf2022-11-07 22:46 131K 
[ ]15765_palinopsia-paroxetine-withdrawal.pdf2022-11-07 22:21 47K 
[ ]15766_paliperidone-palmitate-once-monthly-reduces-risk-relapse.pdf2022-11-07 22:43 542K 
[ ]15767_paliperidone-palmitate-vs-oral-atypical-antipsychotics.pdf2022-11-07 22:34 317K 
[ ]15768_panel-cost-effectiveness-health-medicine-recommendations.pdf2022-11-07 22:15 41K 
[ ]15769_panel-discussion.pdf2022-11-07 22:19 36K 
[ ]15770_panel-discussion-changing-insomnia.pdf2022-11-07 22:42 30K 
[ ]15771_panic-attacks-associated-topiramate.pdf2022-11-07 22:06 98K 
[ ]15772_panic-attacks-dimension-psychopathology-evidence-associations.pdf2022-11-07 22:25 370K 
[ ]15773_panic-attacks-panic-disorder-population-based-sample.pdf2022-11-07 22:27 340K 
[ ]15774_panic-disorder-chronic-illness.pdf2022-11-07 22:25 24K 
[ ]15775_panic-disorder-managed-care-environment.pdf2022-11-07 22:08 34K 
[ ]15776_panic-disorder-medical-setting.pdf2022-11-07 22:28 37K 
[ ]15777_panic-disorder-primary-care-setting-comorbidity-disability.pdf2022-11-07 22:18 88K 
[ ]15778_panic-disorder-treatment.pdf2022-11-07 22:40 36K 
[ ]15779_panic-disorder-treatment-update.pdf2022-11-07 22:18 75K 
[ ]15780_panic-independent-risk-factor-suicide-attempt-depressive.pdf2022-11-07 22:30 365K 
[ ]15781_panic-paranoia.pdf2022-11-07 22:47 45K 
[ ]15782_papageno-effect-of-suicide-prevention-articles.pdf2022-11-07 22:23 333K 
[ ]15783_paradigm-facilitating-pharmacotherapy-distance-sertraline.pdf2022-11-07 22:48 90K 
[ ]15784_paradigms-treatment-alzheimers-disease.pdf2022-11-07 22:33 163K 
[ ]15785_paranoia-prejudice.pdf2022-11-07 22:21 61K 
[ ]15786_parasomnia-among-psychiatric-outpatients-clinical.pdf2022-11-07 22:55 263K 
[ ]15787_parental-alienation-handbook-mental-health-legal-professionals.pdf2022-11-07 22:27 83K 
[ ]15788_parental-alienation-ltemgtdsm-ltemgt-ltemgticd-ltemgt.pdf2022-11-07 22:06 84K 
[ ]15789_parental-antecedents-of-psychosis-and-symptom-severity-in-schizophrenia.pdf2022-11-07 22:28 117K 
[ ]15790_parent-general-behavior-inventory-subscale-measure.pdf2022-11-07 22:31 129K 
[ ]15792_parkinsonism-akathisia-quetiapine-three-case-reports.pdf2022-11-07 22:30 204K 
[ ]15793_parotid-gland-swelling-clozapine.pdf2022-11-07 22:58 42K 
[ ]15794_paroxetine-antidepressants-youth-suicide-york-city.pdf2022-11-07 22:01 38K 
[ ]15795_paroxetine-clomipramine-cognitive-therapy-treatment.pdf2022-11-07 22:13 45K 
[ ]15796_paroxetine-cognitive-behavioral-therapy-postpartum.pdf2022-11-07 22:09 54K 
[ ]15797_paroxetine-cr-augmentation-posttraumatic-stress-disorder.pdf2022-11-07 22:24 175K 
[ ]15798_paroxetine-fluoxetine-effects-mood-cognitive-functions.pdf2022-11-07 22:59 126K 
[ ]15799_paroxetine-induced-angioedema-tongue-swelling.pdf2022-11-07 22:14 42K 
[ ]15800_paroxetine-induced-anorexia-patient-bulimia-nervosa.pdf2022-11-07 22:33 38K 
[ ]15801_paroxetine-induced-somnambulism.pdf2022-11-07 22:06 72K 
[ ]15802_paroxetine-levels-postpartum-depressed-women-breast.pdf2022-11-07 22:31 57K 
[ ]15803_paroxetine-prevents-migraines.pdf2022-11-07 22:28 79K 
[ ]15804_paroxetine-primary-insomnia-possible-placebo-effect.pdf2022-11-07 22:10 37K 
[ ]15805_paroxetine-response-tolerability-among-ethnic-minority.pdf2022-11-07 22:54 150K 
[ ]15806_paroxetine-social-phobia.pdf2022-11-07 23:02 31K 
[ ]15807_paroxetine-treatment-chronic-posttraumatic-stress.pdf2022-11-07 22:53 74K 
[ ]15808_paroxetine-treatment-episodic-rages-associated-tourettes.pdf2022-11-07 22:01 36K 
[ ]15809_paroxetine-treatment-generalized-anxiety-disorder.pdf2022-11-07 22:58 135K 
[ ]15810_paroxetine-treatment-primary-insomnia-preliminary.pdf2022-11-07 22:57 70K 
[ ]15811_paroxetine-versus-placebo-agents-depressive-disorders.pdf2022-11-07 22:42 284K 
[ ]15812_paroxysmal-anxiety-douard-brissaud.pdf2022-11-07 22:32 570K 
[ ]15813_partial-compliance-patient-consequences-schizophrenia.pdf2022-11-07 22:51 89K 
[ ]15815_partial-response-antipsychotic-treatment-patient-enduring.pdf2022-11-07 23:02 48K 
[ ]15816_partial-response-nonresponse-antidepressant-therapy.pdf2022-11-07 22:21 106K 
[ ]15817_partial-response-nonresponse-relapse-selective-serotonin.pdf2022-11-07 22:34 57K 
[ ]15818_participants-schizophrenia-retain-information-necessary.pdf2022-11-07 22:47 82K 
[ ]15819_passive-suicidal-ideation-in-the-early-stage-of-the-covid-19-pandemic-and-lockdown-in-a-spanish-samp.pdf2022-11-07 22:33 146K 
[ ]15820_past-anabolic-androgenic-steroid-among-men-admitted.pdf2022-11-07 22:25 60K 
[ ]15821_past-future-present-childhood-adolescent-mental-health.pdf2022-11-07 22:36 39K 
[ ]15822_past-present-progress-pharmacologic-treatment-schizophrenia.pdf2022-11-07 22:58 368K 
[ ]15823_paternal-depression-as-a-risk-factor-for-neurodevelopmental-disorders-in-offspring.pdf2022-11-07 23:00 265K 
[ ]15824_pathogenesis-alzheimers-disease.pdf2022-11-07 22:28 47K 
[ ]15825_pathological-anxiety-emotional-processing-ethology.pdf2022-11-07 22:06 69K 
[ ]15826_pathological-gambling-clinical-guide-treatment.pdf2022-11-07 22:36 69K 
[ ]15827_pathological-stealing-dementia-poor-response-ssri.pdf2022-11-07 22:10 151K 
[ ]15828_pathophysiologic-mechanisms-fibromyalgia-related-disorders.pdf2022-11-07 22:45 261K 
[ ]15829_pathophysiologic-mechanisms-pathogenesis-clinical.pdf2022-11-07 22:42 41K 
[ ]15830_pathophysiology-agitation.pdf2022-11-07 22:39 67K 
[ ]15831_pathophysiology-antipsychotic-druginduced-movement.pdf2022-11-07 22:18 69K 
[ ]15832_patient.pdf2022-11-07 22:21 39K 
[ ]15833_patient-adherence-cognitive-behavioral-therapy-predicts.pdf2022-11-07 22:17 114K 
[ ]15835_patient-centered-care-for-alzheimer-disease.pdf2022-11-07 23:00 467K 
[ ]15837_patient-comorbid-depression-anxiety-unmet-need.pdf2022-11-07 22:33 54K 
[ ]15838_patient-compliance-enteric-coated-weekly-fluoxetine.pdf2022-11-07 22:11 60K 
[ ]15839_patient-compliance-enteric-coated-weekly-formulation.pdf2022-11-07 22:35 54K 
[ ]15840_patient-level-predictors-clinical-correlates-duration.pdf2022-11-07 22:37 358K 
[ ]15841_patient-needs-psychiatric-medication.pdf2022-11-07 22:41 55K 
[ ]15842_patient-outcomes-within-schizophrenia-treatment-role.pdf2022-11-07 22:19 241K 
[ ]15843_patient-overcrowding-hospital-wards-predictor-diagnosis.pdf2022-11-07 22:42 187K 
[ ]15844_patient-perspectives-once-weekly-fluoxetine.pdf2022-11-07 22:12 67K 
[ ]15845_patient-preference-moderator-outcome-chronic-forms.pdf2022-11-07 22:26 231K 
[ ]15846_patient-preference-psychological-vs-pharmacologic.pdf2022-11-07 22:27 337K 
[ ]15847_patient-preferences-obsessive-compulsive-disorder.pdf2022-11-07 23:01 267K 
[ ]15848_patient-primary-care-perspective-patients-perspective.pdf2022-11-07 22:17 55K 
[ ]15849_patients-clinicians-report-higher-average-satisfaction.pdf2022-11-07 22:19 157K 
[ ]15850_patients-coping-skills-environmental-stress-important.pdf2022-11-07 22:36 67K 
[ ]15851_patients-excluded-antidepressant-efficacy-trial.pdf2022-11-07 22:31 33K 
[ ]15852_patients-preference-complementary-alternative-medicine.pdf2022-11-07 22:45 104K 
[ ]15853_patients-schizophrenia-risk-excessive-antipsychotic.pdf2022-11-07 22:02 62K 
[ ]15854_patients-severe-depression-may-benefit-buspirone-augmentation.pdf2022-11-07 22:47 55K 
[ ]15855_patients-substance-abuse-problems-effective-identification.pdf2022-11-07 22:44 102K 
[ ]15856_patients-successfully-discontinue-ssris.pdf2022-11-07 22:01 754K 
[ ]15857_patterns-antipsychotic-medications-medicaid-patients.pdf2022-11-07 23:00 61K 
[ ]15858_patterns-atypical-antipsychotic-subtherapeutic-dosing.pdf2022-11-07 22:11 224K 
[ ]15859_patterns-concomitant-psychotropic-medication-during.pdf2022-11-07 22:49 73K 
[ ]15860_patterns-correlates-generalized-anxiety-disorder-community.pdf2022-11-07 23:00 65K 
[ ]15861_patterns-remission-relapse-obsessive-compulsive-disorder.pdf2022-11-07 22:42 73K 
[ ]15862_patterns-temperament-character-subjects-obsessive.pdf2022-11-07 22:02 79K 
[ ]15863_pattern-symptom-improvement-following-treatment-venlafaxine.pdf2022-11-07 22:56 55K 
[ ]15864_paying-attention-acetylcholine-part-function-nicotinic.pdf2022-11-07 22:24 56K 
[ ]15865_paying-attention-acetylcholine-part-structural-organization.pdf2022-11-07 22:36 68K 
[ ]15866_pediatric-anxiety-initial-pharmacotherapy.pdf2022-11-07 23:01 568K 
[ ]15867_pediatric-bipolar-disorder-and-substance-use-disorder.pdf2022-11-07 22:27 177K 
[ ]15869_pediatric-bipolar-disorder-diagnosis-and-treatment.pdf2022-11-07 22:13 312K 
[ ]15870_pediatric-psychopharmacology-principles-practice.pdf2022-11-07 22:37 29K 
[ ]15871_pediatric-psychopharmacology-principles-practice-nd.pdf2022-11-07 22:28 91K 
[ ]15872_peer-peer-psychoeducation-schizophrenia-approach.pdf2022-11-07 22:01 127K 
[ ]15873_peer-review-early-career-psychiatrists-opportunity.pdf2022-11-07 22:19 341K 
[ ]15874_peer-review-early-career-yes.pdf2022-11-07 22:39 190K 
[ ]15875_peer-review-perspective-early-career-psychiatrists.pdf2022-11-07 22:14 174K 
[ ]15876_peer-review-whos-on-the-list.pdf2022-11-07 22:07 177K 
[ ]15877_pegylated-interferon-ribavirin-induced-depression.pdf2022-11-07 22:53 337K 
[ ]15878_penile-anesthesia-associated-sertraline.pdf2022-11-07 22:56 35K 
[ ]15879_peptides-psychiatry-part-substance-p-serendipity-novel.pdf2022-11-07 22:58 34K 
[ ]15880_peptides-psychiatry-part-synthesis-neuropeptides-differs.pdf2022-11-07 22:22 66K 
[ ]15881_perceived-health-control-and-treatment-adherence.pdf2022-11-07 22:36 257K 
[ ]15882_perceptions-impact-bipolar-disorder-far-really-results.pdf2022-11-07 22:40 94K 
[ ]15891_perfusion-pattern-patient-lithium-intoxication-mimicking.pdf2022-11-07 22:18 371K 
[ ]15892_perinatal-depression-hiv-infected-african-women-systematic.pdf2022-11-07 22:45 365K 
[ ]15893_perinatal-depression-searching-specific-tools-closer.pdf2022-11-07 22:09 190K 
[ ]15894_perinatal-disorders-advancing-public-health-opportunities.pdf2022-11-07 22:22 125K 
[ ]15895_perinatal-mental-health-data-regarding-risk-factors.pdf2022-11-07 22:12 156K 
[ ]15896_perinatal-mental-health-edinburgh-postnatal-depression.pdf2022-11-07 22:40 81K 
[ ]15897_perinatal-psychiatry-emerging-specialty.pdf2022-11-07 22:48 142K 
[ ]15898_perinatal-psychiatry-risk-factors-treatment-data-specific.pdf2022-11-07 22:47 74K 
[ ]15899_perioperative-buprenorphine-administration-simultaneous-with-full-opioid-agonist.pdf2022-11-07 22:01 549K 
[ ]15900_peritraumatic-heart-rate-posttraumatic-stress-disorder.pdf2022-11-07 22:40 488K 
[ ]15901_persecutory-delusions-dementia.pdf2022-11-07 23:00 48K 
[ ]15902_persistence-with-risperidone-and-aripiprazole-therapy-in-pediatric-outpatients.pdf2022-11-07 22:47 89K 
[ ]15903_persistent-antipsychotic-polypharmacy-excessive-dosing.pdf2022-11-07 22:08 394K 
[ ]15904_persistent-depressive-symptoms-cognitive-function.pdf2022-11-07 22:29 237K 
[ ]15905_persistent-negative-symptoms-in-first-episode-psychosis.pdf2022-11-07 22:15 472K 
[ ]15906_persistent-neuropsychological-deficit-euthymic-bipolar.pdf2022-11-07 22:04 219K 
[ ]15907_persistent-posttraumatic-stress-disorder-following.pdf2022-11-07 22:08 99K 
[ ]15908_persisting-low-antipsychotics-treatment-major-depressive.pdf2022-11-07 22:52 174K 
[ ]15909_personal-identity-fractured-selves-perspectives-philosophy.pdf2022-11-07 23:01 129K 
[ ]15910_personality-and-long-term-outcome-of-depression.pdf2022-11-07 22:58 406K 
[ ]15911_personality-changes-adult-subjects-major-depressive.pdf2022-11-07 22:22 73K 
[ ]15912_personality-disorder-cardiovascular-disease-results.pdf2022-11-07 22:38 80K 
[ ]15913_personality-disorder-culture-clinical-conceptual-interactions.pdf2022-11-07 22:10 31K 
[ ]15914_personality-disorder-experts-recognize-ltemgtdsm-ivltemgt.pdf2022-11-07 22:55 511K 
[ ]15915_personality-disorder-patients-treatable-untreatable.pdf2022-11-07 22:44 47K 
[ ]15916_personality-disorders-burden-community-neglected-clinic.pdf2022-11-07 22:05 138K 
[ ]15917_personality-disorders-modern-life.pdf2022-11-07 22:56 39K 
[ ]15918_personality-disorders-precusrors-course-outcome.pdf2022-11-07 22:51 32K 
[ ]15919_personality-disorders-predict-relapse-remission-episode.pdf2022-11-07 22:02 281K 
[ ]15920_personality-guided-therapy.pdf2022-11-07 22:50 45K 
[ ]15921_personality-impairment-male-pedophiles.pdf2022-11-07 22:40 71K 
[ ]15922_personality-modulates-efficacy-treatment-patients.pdf2022-11-07 22:48 466K 
[ ]15923_personality-psychopatholoogy.pdf2022-11-07 22:20 35K 
[ ]15924_personality-self-portrait-why-love-act.pdf2022-11-07 22:06 23K 
[ ]15925_personalized-medicine-in-an-ambulatory-setting.pdf2022-11-07 22:16 249K 
[ ]15926_personalized-medicine-omega-fatty-acids-depression.pdf2022-11-07 22:14 195K 
[ ]15927_perspective-measurement-costs-benefits-cost-effectiveness.pdf2022-11-07 22:33 41K 
[ ]15928_perspectives-on-covid-and-individuals-with-serious-mental-illness.pdf2022-11-07 22:52 184K 
[ ]15929_perspectives-on-the-new-fda-pregnancy-and-lactation-labeling-rule.pdf2022-11-07 22:59 240K 
[ ]15930_perspectives-perinatal-depression-treatment-perinatal.pdf2022-11-07 22:24 210K 
[ ]15931_pharmacists-lack-knowledge-antidepressant-discontinuation.pdf2022-11-07 22:35 46K 
[ ]15932_pharmacoeconomic-analysis-sertraline-treatment-depression.pdf2022-11-07 22:27 131K 
[ ]15933_pharmacoeconomic-evaluation-antipsychotic-therapy.pdf2022-11-07 22:18 30K 
[ ]15934_pharmacoeconomic-evaluation-treatments-refractory.pdf2022-11-07 22:39 48K 
[ ]15935_pharmacoeconomics-schizophrenia-st-century.pdf2022-11-07 23:02 31K 
[ ]15936_pharmacoepidemiology-recent-findings-challenges-child.pdf2022-11-07 22:15 75K 
[ ]15937_pharmacogenic-testing-antidepressant-treatment-outcomes-hepatically-metabolized-drugs.pdf2022-11-07 22:55 117K 
[ ]15938_pharmacogenomic-associations-weight-gain-olanzapine.pdf2022-11-07 22:24 69K 
[ ]15939_pharmacogenomic-testing-and-mdd-outcomes.pdf2022-11-07 23:00 303K 
[ ]15940_pharmacokinetic-clinical-evaluation-switching-patients.pdf2022-11-07 22:03 160K 
[ ]15941_pharmacokinetic-considerations-antidepressant-elderly.pdf2022-11-07 23:01 67K 
[ ]15942_pharmacokinetic-drug-drug-interactions-between-olanzapine.pdf2022-11-07 22:54 135K 
[ ]15943_pharmacokinetic-interactions-antidepressants.pdf2022-11-07 22:35 84K 
[ ]15944_pharmacokinetics-sertraline-excretion-human-breast.pdf2022-11-07 22:34 79K 
[ ]15945_pharmacokinetics-tolerability-clinical-effectiveness.pdf2022-11-07 22:44 93K 
[ ]15946_pharmacokinetic-studies-antipsychotics-healthy-volunteers.pdf2022-11-07 22:46 46K 
[ ]15947_pharmacologic-activation-limbic-structures-neuroimaging.pdf2022-11-07 22:42 22K 
[ ]15948_pharmacologic-approaches-cognitive-deficits-alzheimers.pdf2022-11-07 22:13 36K 
[ ]15949_pharmacologic-approaches-management-alcoholism.pdf2022-11-07 23:00 64K 
[ ]15950_pharmacologic-behavioral-interventions-improve-cardiovascular.pdf2022-11-07 22:06 771K 
[ ]15951_pharmacologic-characteristics-ideal-antidepressants.pdf2022-11-07 22:40 54K 
[ ]15952_pharmacologic-factors-associated-transient-neonatal.pdf2022-11-07 22:32 62K 
[ ]15953_pharmacologic-interventions-suicide-prevention.pdf2022-11-07 22:06 55K 
[ ]15954_pharmacologic-management-daytime-sleepiness.pdf2022-11-07 22:03 48K 
[ ]15955_pharmacologic-management-insomnia.pdf2022-11-07 22:11 58K 
[ ]15956_pharmacologic-management-psychosis-dementia.pdf2022-11-07 22:16 61K 
[ ]15957_pharmacologic-pharmacokinetic-considerations-choosing.pdf2022-11-07 22:28 97K 
[ ]15958_pharmacologic-properties-venlafaxine.pdf2022-11-07 22:21 92K 
[ ]15960_pharmacologic-treatment-acute-chronic-stress-following.pdf2022-11-07 22:46 83K 
[ ]15961_pharmacologic-treatment-anxiety-disorders-review-progress.pdf2022-11-07 22:33 522K 
[ ]15962_pharmacologic-treatment-anxiety-disorders-versus-results.pdf2022-11-07 22:37 44K 
[ ]15963_pharmacologic-treatment-behavioral-symptoms-autism.pdf2022-11-07 22:04 138K 
[ ]15964_pharmacologic-treatment-bipolar-disorder.pdf2022-11-07 22:02 640K 
[ ]15965_pharmacologic-treatment-considerations-co-occurring.pdf2022-11-07 22:26 97K 
[ ]15966_pharmacologic-treatment-depression-is-gender-critical.pdf2022-11-07 22:39 71K 
[ ]15967_pharmacologic-treatment-episode-schizophrenia-early.pdf2022-11-07 22:04 50K 
[ ]15968_pharmacologic-treatment-obsessive-compulsive-disorder.pdf2022-11-07 22:34 35K 
[ ]15969_pharmacologic-treatment-of-tardive-dyskinesia.pdf2022-11-07 22:26 475K 
[ ]15970_pharmacologic-treatment-patients-hospitalized-diagnosis.pdf2022-11-07 22:54 69K 
[ ]15971_pharmacologic-treatment-postpartum-women-onset-major.pdf2022-11-07 22:49 203K 
[ ]15972_pharmacologic-treatments-binge-eating-disorder.pdf2022-11-07 22:58 259K 
[ ]15973_pharmacology-antidepressants-focus-nefazodone.pdf2022-11-07 22:01 72K 
[ ]15974_pharmacology-antidepressants-selectivity-multiplicity.pdf2022-11-07 22:55 61K 
[ ]15975_pharmacology-rapid-onset-antidepressant-treatment.pdf2022-11-07 22:38 83K 
[ ]15976_pharmacology-weight-gain-antipsychotics.pdf2022-11-07 22:53 77K 
[ ]15979_pharmacotherapy-attention-deficit-hyperactivity-disorder-ADHD-adults.pdf2022-11-07 22:34 81K 
[ ]15980_pharmacotherapy-attention-deficit-hyperactivity-disorder-ADHD-substance-abuse-longitudinal-youths.pdf2022-11-07 22:33 57K 
[ ]15981_pharmacotherapy-borderline-patients-business-usual.pdf2022-11-07 23:00 117K 
[ ]15982_pharmacotherapy-borderline-personality-disorder.pdf2022-11-07 22:39 898K 
[ ]15983_pharmacotherapy-child-adolescent-psychiatric-disorders.pdf2022-11-07 22:43 101K 
[ ]15984_pharmacotherapy-depressive-illness-adolescents-open.pdf2022-11-07 22:44 62K 
[ ]15985_pharmacotherapy-for-pediatric-anxiety-disorders-a-network-meta-analysis.pdf2022-11-07 22:50 925K 
[ ]15986_pharmacotherapy-for-severe-personality-disorders.pdf2022-11-07 22:03 1.1M 
[ ]15987_pharmacotherapy-generalized-anxiety-disorder-characteristics-GAD-pharmacologic-options-treatment-alg.pdf2022-11-07 22:17 81K 
[ ]15988_pharmacotherapy-generalized-anxiety-disorder-pharmacologic-heart-rate-variability.pdf2022-11-07 23:02 58K 
[ ]15990_pharmacotherapy-mood-anxiety-cognitive-disorders.pdf2022-11-07 22:43 44K 
[ ]15991_pharmacotherapy-panic-disorder.pdf2022-11-07 22:04 107K 
[ ]15992_pharmacotherapy-panic-disorder-differential-efficacy.pdf2022-11-07 22:19 46K 
[ ]15993_pharmacotherapy-paraphilias-long-acting-agonists-luteinizing.pdf2022-11-07 22:10 70K 
[ ]15994_pharmacotherapy-patients-fibromyalgia.pdf2022-11-07 22:08 158K 
[ ]15995_pharmacotherapy-posttraumatic-stress-disorder-treatment.pdf2022-11-07 22:39 50K 
[ ]15996_pharmacotherapy-ptsd-department-veterans-affairs-diagnostic.pdf2022-11-07 22:01 196K 
[ ]15997_pharmacotherapy-schizophrenia.pdf2022-11-07 23:00 18K 
[ ]15998_pharmacotherapy-social-anxiety-disorder-does-evidence.pdf2022-11-07 22:30 88K 
[ ]15999_pharmacotherapy-treatment-acute-bipolar-ii-depression.pdf2022-11-07 22:42 321K 
[ ]16000_pharmacotherapy-treatment-aggressive-behavior-general.pdf2022-11-07 22:44 144K 
[ ]16001_pharmacotherapy-treatment-resistant-ocd-ascp.pdf2022-11-07 22:32 194K 
[ ]16003_pharmacotherapy-untreated-antenatal-depression-false.pdf2022-11-07 22:23 326K 
[ ]16004_phenoconversion-cytochrome-p-d-need-identifying-intermediate.pdf2022-11-07 22:06 105K 
[ ]16005_phenomenological-considerations-childhood-adolescent.pdf2022-11-07 22:41 37K 
[ ]16006_phenomenology-assessment-childhood-adolescent-mental.pdf2022-11-07 22:34 44K 
[ ]16007_phenomenology-epidemiology-childhood-psychiatric-disorders.pdf2022-11-07 22:17 75K 
[ ]16008_phenomenology-prognostic-significance-delusions-major.pdf2022-11-07 22:20 163K 
[ ]16009_phenomenology-treatment-agitation.pdf2022-11-07 22:29 49K 
[ ]16010_phenotypic-differences-between-pregnancy-onset-postpartum.pdf2022-11-07 22:59 248K 
[ ]16011_phenylpropanolamine-appears-promote-weight-loss-patients.pdf2022-11-07 22:14 54K 
[ ]16012_philosophical-issues-psychiatry-ii-nosology.pdf2022-11-07 22:12 84K 
[ ]16013_phobic-anxiety-disorders-children-adolescents.pdf2022-11-07 23:02 74K 
[ ]16014_physical-activity-fitness-and-depression-and-anxiety.pdf2022-11-07 22:34 246K 
[ ]16015_physical-activity-interventions-mental-illness-systematic.pdf2022-11-07 22:41 895K 
[ ]16016_physical-activity-sedentary-behavior-measured-objectively.pdf2022-11-07 22:48 269K 
[ ]16017_physical-components-depression-psychomotor-retardation.pdf2022-11-07 22:22 73K 
[ ]16018_physical-psychological-consequences-weight-gain.pdf2022-11-07 22:53 50K 
[ ]16019_physical-restraints-thromboembolism-death-patients.pdf2022-11-07 23:00 63K 
[ ]16020_physical-symptoms-depression-public-health-concern.pdf2022-11-07 22:12 36K 
[ ]16021_physical-symptoms-depression-unmet-needs.pdf2022-11-07 22:21 63K 
[ ]16022_physical-symptoms-depression-unmet-needs-special-populations.pdf2022-11-07 23:00 50K 
[ ]16023_physician-assisted-suicide-in-psychiatry.pdf2022-11-07 22:37 266K 
[ ]16024_physician-characteristics-associated-prescription.pdf2022-11-07 22:30 161K 
[ ]16025_physician-patient-clinical-handbookfor-mental-health.pdf2022-11-07 23:01 102K 
[ ]16026_physician-sexual-misconduct.pdf2022-11-07 22:08 39K 
[ ]16027_physicians-knowledge-antidepressant-withdrawal-effects.pdf2022-11-07 22:13 22K 
[ ]16028_physicians-postgraduate-press-earns-full-cme-accreditation.pdf2022-11-07 22:35 20K 
[ ]16029_physicians-postgraduate-press-st-century.pdf2022-11-07 22:30 49K 
[ ]16030_physicians-veterans-administration-hospitals-need.pdf2022-11-07 22:30 87K 
[ ]16031_physiologic-basis-evolution-pharmacotherapy-insomnia.pdf2022-11-07 22:30 172K 
[ ]16032_physiologic-mechanisms-underlying-antidepressant-discontinuation.pdf2022-11-07 22:48 102K 
[ ]16033_physiologic-sleep-disorders-among-treatment-responsive.pdf2022-11-07 22:20 153K 
[ ]16034_pilot-double-blind-dose-comparison-study-risperidone.pdf2022-11-07 22:57 38K 
[ ]16035_pilot-observational-crossover-study-qtc-interval-changes.pdf2022-11-07 22:13 221K 
[ ]16036_pilot-randomized-clinical-trial-evaluating-impact.pdf2022-11-07 22:49 387K 
[ ]16037_pilot-randomized-controlled-trial-interpersonal-counseling.pdf2022-11-07 22:16 86K 
[ ]16038_pilot-study-augmentation-aripiprazole-incomplete-response.pdf2022-11-07 22:05 176K 
[ ]16039_pilot-study-barriers-medication-adherence-schizophrenia.pdf2022-11-07 22:32 55K 
[ ]16040_pilot-study-cranial-electrotherapy-stimulation-generalized.pdf2022-11-07 22:17 178K 
[ ]16041_pilot-study-differences-aggression-york-city-madrid.pdf2022-11-07 22:59 101K 
[ ]16042_pilot-study-electronic-adolescent-version-quick-inventory.pdf2022-11-07 22:01 148K 
[ ]16043_pilot-study-lithium-carbonate-plus-divalproex-sodium.pdf2022-11-07 22:11 95K 
[ ]16044_pilot-study-risperidone-metabolism-role-cytochromes.pdf2022-11-07 22:30 69K 
[ ]16045_pilot-study-vagus-nerve-stimulation-treatment-resistant.pdf2022-11-07 22:17 215K 
[ ]16046_pilot-trial-ondansetron-treatment-patients-obsessive.pdf2022-11-07 22:27 58K 
[ ]16047_pimozide-induced-depression-men-stutter.pdf2022-11-07 22:21 31K 
[ ]16048_pindolol-augmentation-depressed-patients-resistant.pdf2022-11-07 22:25 61K 
[ ]16049_pindolol-augmentation-treatment-resistant-depressed.pdf2022-11-07 22:18 26K 
[ ]16050_pindolol-potentiate-antidepressant-medication.pdf2022-11-07 22:19 67K 
[ ]16051_pindolol-really-enhance-antidepressant-effect.pdf2022-11-07 22:27 129K 
[ ]16052_pisa-syndrome-due-cholinesterase-inhibitor-donepezil.pdf2022-11-07 22:02 86K 
[ ]16053_pisa-syndrome-pleurothotonus-report-multicenter-drug.pdf2022-11-07 22:24 62K 
[ ]16054_pitfalls-with-the-unquestioning-use-of-statistics.pdf2022-11-07 22:02 114K 
[ ]16055_placebo-and-treatment-effects-in-schizophrenia-trials.pdf2022-11-07 22:42 938K 
[ ]16056_placebo-controlled-adjunctive-aripiprazole-schizophrenia.pdf2022-11-07 22:41 1.1M 
[ ]16057_placebo-controlled-adjunctive-trial-pramipexole-patients.pdf2022-11-07 22:45 493K 
[ ]16058_placebo-controlled-antidepressant-clinical-trials.pdf2022-11-07 22:19 229K 
[ ]16059_placebo-controlled-carbamazepine-bipolar-disorder-manic.pdf2022-11-07 22:17 61K 
[ ]16060_placebo-controlled-crossover-trial-granisetron-sri.pdf2022-11-07 22:02 53K 
[ ]16061_placebo-controlled-month-trial-lamotrigine-lithium.pdf2022-11-07 22:24 90K 
[ ]16062_placebo-controlled-randomized-double-blind-study-adjunctive.pdf2022-11-07 22:46 111K 
[ ]16063_placebo-controlled-randomized-trial-fluoxetine-treatment.pdf2022-11-07 22:15 67K 
[ ]16064_placebo-controlled-study-divalproex=mania.pdf2022-11-07 22:57 123K 
[ ]16065_placebo-controlled-trial-bupropion-sr-antidote-selective.pdf2022-11-07 23:00 56K 
[ ]16066_placebo-controlled-trial-cognitive-behavioral-therapy.pdf2022-11-07 22:37 49K 
[ ]16067_placebo-controlled-trial-risperidone-augmentation.pdf2022-11-07 22:10 179K 
[ ]16068_placebo-effects-in-lai-trials-for-schizophrenia.pdf2022-11-07 22:33 579K 
[ ]16069_placebo-effects-in-the-treatment-of-alzheimers-disease.pdf2022-11-07 22:25 507K 
[ ]16070_placebo-response-generalized-anxiety-effect-outcome.pdf2022-11-07 22:53 52K 
[ ]16071_placebo-response-psychotic-depression.pdf2022-11-07 22:12 147K 
[ ]16072_plasma-adiponectin-predicts-incident-depression.pdf2022-11-07 22:30 220K 
[ ]16073_plasma-l-tryptophan-concentration-major-depressive.pdf2022-11-07 22:16 623K 
[ ]16074_plasma-sodium-level-is-associated-bone-loss-severity.pdf2022-11-07 22:43 254K 
[ ]16075_playing-safe-video-game-probing-relationship-between.pdf2022-11-07 22:27 152K 
[ ]16076_plotting-course-remission-search-better-outcomes-treatment.pdf2022-11-07 23:02 68K 
[ ]16077_pocket-reference-psychiatrists-rd-ed.pdf2022-11-07 22:04 60K 
[ ]16078_points-view-stories-psychopathology.pdf2022-11-07 22:07 30K 
[ ]16079_pollen-and-self-directed-violence.pdf2022-11-07 22:07 394K 
[ ]16080_polygraphy-vs-fmri-in-lie-detection.pdf2022-11-07 22:40 1.3M 
[ ]16081_polymorphism-angiotensin-converting-enzyme-gene-is.pdf2022-11-07 22:57 161K 
[ ]16082_polymorphisms-haplotypes-ltemgtywhaeltemgt-gene-increase.pdf2022-11-07 22:43 971K 
[ ]16083_polypharmacy-and-cognitive-impairment-and-capacity.pdf2022-11-07 22:13 344K 
[ ]16084_polypharmacy-atypical-antipsychotics.pdf2022-11-07 22:08 51K 
[ ]16085_polypharmacy-children-adolescents-treated-major-depressive.pdf2022-11-07 22:40 197K 
[ ]16086_polypharmacy-patients-schizophrenia.pdf2022-11-07 22:07 55K 
[ ]16087_polypharmacy-schizophrenia-fuzzy-concept.pdf2022-11-07 22:11 50K 
[ ]16088_polyunsaturated-fatty-acids-in-bipolar-disorder.pdf2022-11-07 22:11 299K 
[ ]16089_pooled-analysis-gender-trauma-type-effects-responsiveness.pdf2022-11-07 22:49 303K 
[ ]16090_pooled-analysis-placebo-controlled-month-trials-lamotrigine.pdf2022-11-07 22:47 77K 
[ ]16091_pooled-analysis-suicidality-double-blind-placebo-controlled.pdf2022-11-07 23:02 270K 
[ ]16092_poor-long-term-prognosis-mixed-bipolar-patients.pdf2022-11-07 22:36 240K 
[ ]16093_poor-sleep-baseline-predicts-worse-mood-outcomes-patients.pdf2022-11-07 22:30 234K 
[ ]16094_population-trends-substances-used-deliberate-self.pdf2022-11-07 22:30 1.2M 
[ ]16095_portable-lawyer-mental-health-professionals-z-guide.pdf2022-11-07 22:45 35K 
[ ]16096_positive-affect-survival-patients-stable-coronary.pdf2022-11-07 22:19 293K 
[ ]16097_positive-childhood-experiences-resilience-recovery.pdf2022-11-07 22:18 182K 
[ ]16098_positive-isnt-positive-hopes-disappointments-clinical.pdf2022-11-07 22:43 132K 
[ ]16099_positive-psychiatry-has.pdf2022-11-07 22:52 283K 
[ ]16100_positive-psychology-movies-using-films-build-character.pdf2022-11-07 22:59 90K 
[ ]16101_positive-treatment-effect-estradiol-postpartum-psychosis.pdf2022-11-07 22:47 58K 
[ ]16102_positron-emission-tomography-measurement-dopamine.pdf2022-11-07 22:31 670K 
[ ]16103_possible-antidepressant-associated-activation-mania.pdf2022-11-07 22:20 72K 
[ ]16104_possible-basal-ganglia-pathology-children-complex.pdf2022-11-07 22:32 66K 
[ ]16105_possible-biological-mechanisms-serotonin-reuptake.pdf2022-11-07 22:28 32K 
[ ]16106_possible-bipolar-nature-irritability-major-depressive.pdf2022-11-07 22:27 140K 
[ ]16107_possible-case-quetiapine-withdrawal-syndrome.pdf2022-11-07 22:07 55K 
[ ]16108_possible-case-venlafaxine-induced-stevens-johnson.pdf2022-11-07 22:36 53K 
[ ]16109_possible-connection-between-panic-disorder-epilepsy.pdf2022-11-07 22:42 55K 
[ ]16110_possible-dose-response-relationship-risperidone-obsessive.pdf2022-11-07 22:43 80K 
[ ]16111_possible-effects-ibuprofen-pretreatment-seizure-duration.pdf2022-11-07 22:53 55K 
[ ]16112_possible-impact-dropout-study-high-dose-olanzapine.pdf2022-11-07 22:32 151K 
[ ]16113_possible-increased-efficacy-low-dose-clozapine-combined.pdf2022-11-07 22:44 115K 
[ ]16114_possible-induction-mania-hypomania-atypical-antipsychotics.pdf2022-11-07 22:52 67K 
[ ]16115_possible-induction-mania-hypomania-olanzapine-risperidone.pdf2022-11-07 22:09 51K 
[ ]16116_possible-link-between-childhood-separation-anxiety.pdf2022-11-07 22:47 92K 
[ ]16117_possible-neurobiological-mechanisms-underlying-faster.pdf2022-11-07 22:30 75K 
[ ]16118_possible-pharmacokinetic-interaction-between-fluoxetine.pdf2022-11-07 22:31 35K 
[ ]16119_possible-risks-associated-valproate-treatment-aids.pdf2022-11-07 22:37 38K 
[ ]16120_possible-role-divalproex-sodium-sedation-induced-antipsychotic.pdf2022-11-07 23:00 51K 
[ ]16121_postdeployment-suicidal-ideations-trajectories-posttraumatic.pdf2022-11-07 22:35 468K 
[ ]16122_post-discharge-suicide-attempts-in-veterans-treated-for-ptsd.pdf2022-11-07 22:06 232K 
[ ]16123_postexercise-affect-as-predictor-of-response-in-depression.pdf2022-11-07 22:13 275K 
[ ]16124_post-hoc-analysis-effect-nightly-administration-eszopiclone.pdf2022-11-07 22:05 309K 
[ ]16125_post-hoc-comparison-paroxetine-nortriptyline-symptoms.pdf2022-11-07 22:02 39K 
[ ]16126_postictal-psychosis-treated-successfully-olanzapine.pdf2022-11-07 22:27 111K 
[ ]16127_postpartum-affective-disorders-and-risk-of-bipolar-disorder.pdf2022-11-07 22:39 1.1M 
[ ]16128_postpartum-depression-recurrence-versus-discontinuation.pdf2022-11-07 22:11 39K 
[ ]16130_postpartum-mood-disorder.pdf2022-11-07 22:26 37K 
[ ]16131_postpartum-mood-disorders-diagnosis-treatment-guidelines.pdf2022-11-07 22:02 41K 
[ ]16132_postpartum-onset-obsessive-compulsive-disorder-incidence.pdf2022-11-07 22:17 83K 
[ ]16133_postprandial-oxytocin-secretion-is-associated-severity.pdf2022-11-07 23:00 312K 
[ ]16134_posttest.pdf2022-11-07 22:11 44K 
[ ]16135_posttraumatic-residues-captivity-follow-israeli-exprisoners.pdf2022-11-07 22:06 73K 
[ ]16136_posttraumatic-stress-and-binge-eating.pdf2022-11-07 22:59 247K 
[ ]16138_posttraumatic-stress-disorder.pdf2022-11-07 23:01 26K 
[ ]16139_posttraumatic-stress-disorder-adult-attention-deficit-hyperactivity.pdf2022-11-07 22:27 340K 
[ ]16140_posttraumatic-stress-disorder-among-hospital-surgical.pdf2022-11-07 22:42 97K 
[ ]16141_posttraumatic-stress-disorder-among-israeli-ex-prisoners.pdf2022-11-07 22:55 173K 
[ ]16142_posttraumatic-stress-disorder-burden-individual-society.pdf2022-11-07 22:31 76K 
[ ]16144_posttraumatic-stress-disorder-cognitive-function-findings.pdf2022-11-07 22:02 507K 
[ ]16145_posttraumatic-stress-disorder-comorbidity-recognizing.pdf2022-11-07 22:37 25K 
[ ]16146_posttraumatic-stress-disorder-diagnosis-management.pdf2022-11-07 22:23 56K 
[ ]16147_posttraumatic-stress-disorder-epidemiology-health.pdf2022-11-07 22:17 68K 
[ ]16148_posttraumatic-stress-disorder-general-population-children.pdf2022-11-07 22:34 59K 
[ ]16149_posttraumatic-stress-disorder-health-related-quality.pdf2022-11-07 22:49 182K 
[ ]16150_posttraumatic-stress-disorder-impact-economic-health.pdf2022-11-07 22:57 66K 
[ ]16151_posttraumatic-stress-disorder-model-longitudinal-course.pdf2022-11-07 22:16 57K 
[ ]16152_posttraumatic-stress-disorder-primary-care-hidden.pdf2022-11-07 22:08 64K 
[ ]16153_posttraumatic-stress-disorder-psychological-factors.pdf2022-11-07 22:23 60K 
[ ]16154_posttraumatic-stress-disorder-quality-life-results.pdf2022-11-07 22:33 88K 
[ ]16155_posttraumatic-stress-disorder-result-mass-trauma.pdf2022-11-07 22:13 67K 
[ ]16156_posttraumatic-stress-disorder-risk-obesity-systematic.pdf2022-11-07 22:52 1.2M 
[ ]16157_posttraumatic-stress-disorder-veteran-population-results.pdf2022-11-07 22:03 516K 
[ ]16158_potential-detection-bias-association-between-olanzapine.pdf2022-11-07 22:24 67K 
[ ]16159_potential-drug-delivery-systems-antidepressants-overview.pdf2022-11-07 22:32 47K 
[ ]16160_potential-gap-perinatal-depression-treatment-cascade.pdf2022-11-07 22:21 92K 
[ ]16161_potentially-significant-versus-clinically-significant.pdf2022-11-07 22:01 481K 
[ ]16162_potential-mechanisms-action-atypical-antipsychotic.pdf2022-11-07 22:33 257K 
[ ]16163_potential-mental-health-needs-adult-residents-under.pdf2022-11-07 22:31 399K 
[ ]16164_potpourri-timely-topics.pdf2022-11-07 22:08 146K 
[ ]16165_practical-applications-recent-antipsychotic-effectiveness.pdf2022-11-07 22:03 140K 
[ ]16166_practical-art-suicide-assessment-guide-mental-health.pdf2022-11-07 22:21 44K 
[ ]16167_practical-assessment-evaluation-mental-health-problems.pdf2022-11-07 22:22 93K 
[ ]16168_practical-child-adolescent-psychiatry-pediatrics-primary.pdf2022-11-07 22:12 107K 
[ ]16169_practical-clinical-trial-comparing-haloperidol-risperidone.pdf2022-11-07 22:27 126K 
[ ]16170_practical-considerations-treatment-depression-elderly.pdf2022-11-07 22:26 43K 
[ ]16172_practical-psychiatry-long-term-care-facility-handbook.pdf2022-11-07 22:31 42K 
[ ]16173_practical-psychoanalysis-therapists-patients.pdf2022-11-07 22:54 100K 
[ ]16177_practice-guidelines-treatment-patients-delirium.pdf2022-11-07 22:20 30K 
[ ]16178_practice-guideline-treatment-patients-major-depressive.pdf2022-11-07 22:41 49K 
[ ]16179_pramipexole-psychiatry-systematic-review-literature.pdf2022-11-07 22:10 172K 
[ ]16180_prazosin-reduces-nightmares-combat-veterans-posttraumatic.pdf2022-11-07 22:51 55K 
[ ]16181_precursors-bipolar-disorders-systematic-literature.pdf2022-11-07 22:49 1.2M 
[ ]16182_prediabetes-patients-treated-antipsychotic-drugs.pdf2022-11-07 22:53 321K 
[ ]16183_predicted-risk-diabetes-coronary-heart-disease-patients.pdf2022-11-07 22:50 231K 
[ ]16184_predicting-course-illness-patients-severe-obsessive.pdf2022-11-07 22:22 219K 
[ ]16185_predicting-diagnostic-change-among-patients-diagnosed.pdf2022-11-07 22:39 579K 
[ ]16186_predicting-initial-specialist-care-in-adolescence.pdf2022-11-07 22:57 538K 
[ ]16187_predicting-outcome-episode-psychosis-construction.pdf2022-11-07 22:05 113K 
[ ]16188_predicting-outcome-in-treatment-resistant-depression.pdf2022-11-07 22:21 441K 
[ ]16189_predicting-pharmacotherapy-outcome-retrospective-chart.pdf2022-11-07 22:39 109K 
[ ]16190_predicting-recovery-in-bipolar-depression.pdf2022-11-07 22:11 226K 
[ ]16191_predicting-remission-in-late-life-depression.pdf2022-11-07 22:42 881K 
[ ]16192_predicting-short-term-outcome-episodes-recurrences.pdf2022-11-07 22:55 59K 
[ ]16193_predicting-suicide-attempt-risk-logistic-regression.pdf2022-11-07 22:28 130K 
[ ]16194_predicting-suicide-attempts-sad-persons-scale-longitudinal.pdf2022-11-07 22:28 261K 
[ ]16195_predicting-treatment-response-posttraumatic-stress.pdf2022-11-07 22:23 109K 
[ ]16196_prediction-alzheimers-disease-using-midregional-proadrenomedullin.pdf2022-11-07 22:02 403K 
[ ]16197_prediction-nonremission-antidepressant-therapy-using.pdf2022-11-07 22:47 639K 
[ ]16198_prediction-of-delirium-outcomes-by-bispectral-eeg.pdf2022-11-07 22:37 700K 
[ ]16199_prediction-placebo-response-clinical-trials-lisdexamfetamine.pdf2022-11-07 22:51 396K 
[ ]16200_prediction-recurrence-recurrent-depression-influence.pdf2022-11-07 22:29 105K 
[ ]16201_prediction-recurrence-recurrent-depression-prospective.pdf2022-11-07 22:17 296K 
[ ]16202_prediction-remission-combination-symptomatic-functional.pdf2022-11-07 22:12 92K 
[ ]16203_prediction-response-paroxetine-venlafaxine-serotonin.pdf2022-11-07 22:35 171K 
[ ]16204_prediction-suicidal-behavior-clinical-research-lifetime.pdf2022-11-07 22:20 422K 
[ ]16205_predictive-validity-beck-depression-inventory-suicide.pdf2022-11-07 22:07 192K 
[ ]16206_predictive-value-eosinophilia-neutropenia-during-clozapine.pdf2022-11-07 22:11 24K 
[ ]16207_predictors-aripiprazole-treatment-continuation-hospitalized.pdf2022-11-07 22:53 152K 
[ ]16208_predictors-course-response-among-panic-disorder-patients.pdf2022-11-07 22:12 205K 
[ ]16209_predictors-criteria-treatment-response.pdf2022-11-07 22:53 89K 
[ ]16210_predictors-development-phobic-avoidance.pdf2022-11-07 22:41 96K 
[ ]16211_predictors-early-abstinence-smokers-schizophrenia.pdf2022-11-07 22:41 230K 
[ ]16212_predictors-efficacy-electroconvulsive-therapy-chart.pdf2022-11-07 22:56 141K 
[ ]16213_predictors-everyday-functioning-among-older-mexican.pdf2022-11-07 22:25 162K 
[ ]16214_predictors-functional-clinical-outcome-early-onset.pdf2022-11-07 22:32 1.0M 
[ ]16215_predictors-impact-nonpharmacologic-interventions-agitation.pdf2022-11-07 22:31 312K 
[ ]16216_predictors-longitudinal-changes-schizophrenia-role.pdf2022-11-07 22:12 245K 
[ ]16217_predictors-long-term-return-symptom-remission-sick.pdf2022-11-07 22:32 287K 
[ ]16218_predictors-long-term-treatment-outcome-combat-peacekeeping.pdf2022-11-07 22:31 357K 
[ ]16219_predictors-nonadherence-continuation-maintenance-antidepressant.pdf2022-11-07 22:51 204K 
[ ]16220_predictors-noncompliance-patients-schizophrenia.pdf2022-11-07 22:07 367K 
[ ]16221_predictors-of-bipolar-disorder-in-first-psychotic-episode.pdf2022-11-07 22:59 379K 
[ ]16222_predictors-of-citalopram-induced-suicidal-ideation.pdf2022-11-07 22:26 957K 
[ ]16223_predictors-of-ect-treatment-response-in-depression.pdf2022-11-07 22:41 695K 
[ ]16224_predictors-of-eps-with-aripiprazole-in-lld.pdf2022-11-07 22:33 250K 
[ ]16225_predictors-of-loneliness-by-age-decade.pdf2022-11-07 22:45 1.1M 
[ ]16226_predictors-of-poor-mental-health-in-adolescents.pdf2022-11-07 22:26 284K 
[ ]16227_predictors-of-postpartum-depression.pdf2022-11-07 22:17 237K 
[ ]16228_predictors-of-relapse-in-youth-with-major-depressive-disorder.pdf2022-11-07 22:51 232K 
[ ]16229_predictors-of-suicide-attempt-in-depressed-individuals.pdf2022-11-07 22:31 746K 
[ ]16230_predictors-of-the-persistence-and-emergence-of-adhd-over-a-year-period.pdf2022-11-07 22:50 272K 
[ ]16231_predictors-persistence-comorbid-generalized-anxiety.pdf2022-11-07 22:37 250K 
[ ]16232_predictors-placebo-response-adults-attention-deficit-hyperactivity.pdf2022-11-07 22:37 280K 
[ ]16233_predictors-psychiatric-inpatient-suicide-national.pdf2022-11-07 23:00 386K 
[ ]16234_predictors-quality-life-major-psychoses-naturalistic.pdf2022-11-07 22:07 72K 
[ ]16235_predictors-relapse-during-fluoxetine-continuation.pdf2022-11-07 23:00 90K 
[ ]16236_predictors-remission-electroconvulsive-therapy-unipolar.pdf2022-11-07 22:21 153K 
[ ]16237_predictors-response-acute-treatment-chronic-double.pdf2022-11-07 22:19 47K 
[ ]16238_predictors-response-pharmacotherapy-social-anxiety.pdf2022-11-07 22:02 45K 
[ ]16239_predictors-response-sertraline-treatment-severe-premenstrual.pdf2022-11-07 22:14 66K 
[ ]16240_predictors-suicide-attempt-early-onset-episode-psychoses.pdf2022-11-07 22:39 278K 
[ ]16241_predictors-suicide-attempt-early-onset-psychosis-methodological.pdf2022-11-07 22:31 99K 
[ ]16242_predictors-suicide-episode-affective-nonaffective.pdf2022-11-07 22:55 161K 
[ ]16243_predictors-suicide-patient-charts-among-patients-depression.pdf2022-11-07 22:47 247K 
[ ]16244_predictors-switch-unipolar-major-depressive-disorder.pdf2022-11-07 22:07 243K 
[ ]16245_predictors-treatment-discontinuation-medication-nonadherence.pdf2022-11-07 22:51 226K 
[ ]16246_predictors-treatment-outcomes.pdf2022-11-07 22:47 130K 
[ ]16247_predictors-treatment-response-bipolar-disorders-evidence.pdf2022-11-07 23:01 91K 
[ ]16248_predominance-anger-depressive-disorders-compared-anxiety.pdf2022-11-07 22:28 62K 
[ ]16249_predominance-symptoms-early-onset-psychosis-principal.pdf2022-11-07 22:41 361K 
[ ]16250_preemptive-analgesia-is-pain-less-costly-pre-pay.pdf2022-11-07 22:30 41K 
[ ]16251_prefrontal-cortex-is-tune-attention-deficit-hyperactivity.pdf2022-11-07 22:29 441K 
[ ]16252_pregabalin-and-opioid-addiction.pdf2022-11-07 22:45 109K 
[ ]16253_pregnancy-bipolar-disorder-systematic-review.pdf2022-11-07 22:57 302K 
[ ]16254_pregnancy-major-determinant-discontinuation-antidepressants.pdf2022-11-07 22:57 327K 
[ ]16255_pregnancy-outcome-women-using-atypical-antipsychotic.pdf2022-11-07 22:14 122K 
[ ]16256_pregnancy-psychiatric-disorders-inherent-risks-treatment.pdf2022-11-07 22:36 146K 
[ ]16257_pregnenolone-dehydroepiandrosterone-adjunctive-treatment.pdf2022-11-07 23:01 627K 
[ ]16258_preliminary-double-blind-placebo-controlled-trial.pdf2022-11-07 23:00 54K 
[ ]16259_preliminary-findings-regarding-overweight-obesity.pdf2022-11-07 22:14 204K 
[ ]16260_preliminary-observations-effectiveness-levetiracetam.pdf2022-11-07 22:16 108K 
[ ]16261_preliminary-open-label-study-zonisamide-treatment.pdf2022-11-07 22:23 78K 
[ ]16262_preliminary-outcomes-implementing-cognitive-processing.pdf2022-11-07 22:05 187K 
[ ]16263_preliminary-randomized-trial-fluoxetine-olanzapine.pdf2022-11-07 22:16 45K 
[ ]16264_preliminary-study-fMRI-guided-rTMS-treatment-generalized-anxiety-disorder.pdf2022-11-07 22:49 211K 
[ ]16265_preliminary-study-fMRI-guided-rTMS-treatment-generalized-anxiety-disorder-6-month-follow-up.pdf2022-11-07 22:14 124K 
[ ]16266_preliminary-study-luteal-phase-versus-symptom-onset.pdf2022-11-07 22:20 104K 
[ ]16267_preliminary-study-risperidone-treatment-posttraumatic.pdf2022-11-07 22:31 50K 
[ ]16268_preliminary-survey-rhinotillexomania-adolescent-sample.pdf2022-11-07 22:21 48K 
[ ]16269_premature-conclusions-psychotherapy-dysthymia.pdf2022-11-07 22:31 722K 
[ ]16270_premenstrual-dysphoria-serotonin-system-pathophysiology.pdf2022-11-07 22:23 56K 
[ ]16271_prenatal-acetaminophen-exposure-and-adhd-risk.pdf2022-11-07 23:01 295K 
[ ]16272_prenatal-care-adverse-pregnancy-outcomes-among-women.pdf2022-11-07 22:25 319K 
[ ]16273_prenatal-depression-women-hospitalized-obstetric-risk.pdf2022-11-07 22:59 260K 
[ ]16274_prepregnancy-body-mass-index-gestational-weight-gain.pdf2022-11-07 22:44 388K 
[ ]16275_prepubertal-bipolar-i-disorder-bipolar-disorder-nos.pdf2022-11-07 22:32 41K 
[ ]16276_prepubertal-early-adolescent-bipolar-i-disorder-review.pdf2022-11-07 22:31 189K 
[ ]16277_preschool-outcomes-following-prenatal-serotonin-reuptake.pdf2022-11-07 22:23 252K 
[ ]16278_prescribed-medication-availability-deliberate-self.pdf2022-11-07 22:59 308K 
[ ]16279_prescribed-writing-filling-using-abusing-prescription.pdf2022-11-07 22:25 87K 
[ ]16280_prescriber-intent-off-label-usage-early-discontinuation.pdf2022-11-07 22:13 73K 
[ ]16282_prescribing-benzodiazepines-patients-substance-disorders.pdf2022-11-07 22:36 52K 
[ ]16283_prescribing-patterns-depression-anxiety-worldwide.pdf2022-11-07 22:49 61K 
[ ]16284_prescribing-patterns-in-youth-with-asd.pdf2022-11-07 23:00 284K 
[ ]16285_prescribing-trends-in-active-military-with-ptsd.pdf2022-11-07 22:32 235K 
[ ]16286_prescribing-trends-veterans-posttraumatic-stress-disorder.pdf2022-11-07 23:03 263K 
[ ]16287_prescription-drug-monitoring-program-inquiry-psychiatric.pdf2022-11-07 22:04 453K 
[ ]16288_prescription-opioid-medication-patients-borderline.pdf2022-11-07 22:22 263K 
[ ]16289_prescription-opioid-use-and-motivations-for-misuse-among-us-adults.pdf2022-11-07 22:07 291K 
[ ]16290_prescription-psychotropic-medications-patients-discharged.pdf2022-11-07 22:49 100K 
[ ]16291_prescription-sleeping-pills-insomnia-suicidality-national.pdf2022-11-07 22:02 236K 
[ ]16292_prescriptions-nonmedical-emergency-department-visits.pdf2022-11-07 23:00 334K 
[ ]16295_presenting-adhd-symptoms-subtypes-comorbid-disorders.pdf2022-11-07 22:33 345K 
[ ]16296_presurgical-psychiatric-evaluations-candidates-bariatric.pdf2022-11-07 22:17 145K 
[ ]16297_pretreatment-ibuprofen-prevent-electroconvulsive-therapyinduced.pdf2022-11-07 23:02 38K 
[ ]16298_prevalence-acute-extrapyramidal-signs-symptoms-patients.pdf2022-11-07 22:58 106K 
[ ]16299_prevalence-and-correlates-of-perinatal-self-harm.pdf2022-11-07 22:17 735K 
[ ]16301_prevalence-antidepressant-associated-erectile-dysfunction.pdf2022-11-07 22:45 57K 
[ ]16302_prevalence-associated-risks-treatment-patterns-insomnia.pdf2022-11-07 22:05 112K 
[ ]16303_prevalence-attention-deficit-hyperactivity-disorder.pdf2022-11-07 22:39 77K 
[ ]16304_prevalence-attenuated-psychotic-symptoms-relationship.pdf2022-11-07 22:56 263K 
[ ]16305_prevalence-baseline-serum-glucose-lipid-testing-users.pdf2022-11-07 22:21 203K 
[ ]16306_prevalence-bone-mineral-density-loss-korean-patients.pdf2022-11-07 22:48 95K 
[ ]16307_prevalence-burden-general-medical-conditions-among.pdf2022-11-07 22:06 378K 
[ ]16308_prevalence-clinical-correlates-irritability-major.pdf2022-11-07 22:57 151K 
[ ]16309_prevalence-clinical-correlates-medical-comorbidities.pdf2022-11-07 22:46 80K 
[ ]16310_prevalence-clinical-features-body-dysmorphic-disorder.pdf2022-11-07 22:38 83K 
[ ]16311_prevalence-comorbidity-social-anxiety-disorder-among.pdf2022-11-07 22:04 355K 
[ ]16313_prevalence-consequences-dual-diagnosis-substance-abuse.pdf2022-11-07 22:04 83K 
[ ]16314_prevalence-correlates-comorbidity-bipolar-i-disorder.pdf2022-11-07 22:14 217K 
[ ]16315_prevalence-correlates-comorbidity-dsm-iv-antisocial.pdf2022-11-07 22:22 159K 
[ ]16316_prevalence-correlates-comorbidity-nonmedical-prescription.pdf2022-11-07 22:46 126K 
[ ]16317_prevalence-correlates-disability-comorbidity-dsm-iv-borderline-personality-disorder-wave-2-NESARC.pdf2022-11-07 22:25 357K 
[ ]16318_prevalence-correlates-disability-comorbidity-dsm-iv-narcissistic-personality-disorder-wave-2-NESARC.pdf2022-11-07 22:30 351K 
[ ]16319_prevalence-correlates-disability-personality-disorders.pdf2022-11-07 22:05 80K 
[ ]16320_prevalence-correlates-fire-setting-united-states-results.pdf2022-11-07 22:36 280K 
[ ]16321_prevalence-correlates-lifetime-suicidal-ideation-suicide.pdf2022-11-07 22:36 207K 
[ ]16322_prevalence-correlates-past-month-suicide-attempt.pdf2022-11-07 22:48 313K 
[ ]16323_prevalence-diabetes-impaired-glucose-tolerance-patients.pdf2022-11-07 22:48 46K 
[ ]16324_prevalence-diabetes-mellitus-among-outpatients-severe.pdf2022-11-07 22:58 45K 
[ ]16325_prevalence-features-intermittent-explosive-disorder.pdf2022-11-07 22:52 154K 
[ ]16326_prevalence-hepatitis-hepatitis-b-hiv-among-hepatitis.pdf2022-11-07 22:41 53K 
[ ]16327_prevalence-hyperprolactinemia-schizophrenia-association.pdf2022-11-07 22:59 64K 
[ ]16329_prevalence-impact-alcohol-dependence.pdf2022-11-07 22:25 106K 
[ ]16330_prevalence-impact-comorbid-anxiety-bipolar-disorder.pdf2022-11-07 22:31 60K 
[ ]16332_prevalence-impact-obsessive-compulsive-symptoms-depression.pdf2022-11-07 22:31 292K 
[ ]16333_prevalence-management-treatment-resistant-depression.pdf2022-11-07 22:43 221K 
[ ]16334_prevalence-maternal-depressive-symptoms-low-income.pdf2022-11-07 22:38 114K 
[ ]16335_prevalence-mood-disorders-service-among-mothers-race.pdf2022-11-07 22:26 327K 
[ ]16336_prevalence-negative-symptoms-outpatients-schizophrenia.pdf2022-11-07 22:31 259K 
[ ]16338_prevalence-obesity-weight-change-during-treatment.pdf2022-11-07 22:30 53K 
[ ]16339_prevalence-obsessive-compulsive-disorder-patients.pdf2022-11-07 23:00 50K 
[ ]16340_prevalence-of-binge-eating-disorder-in-the-us-comparing-dsm-iv-tr-and-dsm-criteria.pdf2022-11-07 22:38 103K 
[ ]16341_prevalence-of-mdd-in-dementia.pdf2022-11-07 22:16 1.3M 
[ ]16342_prevalence-of-ptsd-according-to-the-dsm.pdf2022-11-07 22:32 290K 
[ ]16343_prevalence-olfactory-reference-syndrome-obsessive.pdf2022-11-07 22:58 97K 
[ ]16344_prevalence-overweight-obesity-adolescents-severe-mental.pdf2022-11-07 22:49 268K 
[ ]16345_prevalence-overweight-obesity-bipolar-patients.pdf2022-11-07 22:09 70K 
[ ]16346_prevalence-personality-disorders-hypochondriasis.pdf2022-11-07 22:46 356K 
[ ]16347_prevalence-predictors-parenting-outcomes-cohort-mothers.pdf2022-11-07 22:35 163K 
[ ]16348_prevalence-predictors-type-diabetes-mellitus-bipolar.pdf2022-11-07 22:58 1.2M 
[ ]16349_prevalence-recognition-treatment-comorbid-depression.pdf2022-11-07 22:05 46K 
[ ]16350_prevalence-risk-factors-medication-nonadherence-patients.pdf2022-11-07 22:47 135K 
[ ]16351_prevalence-severity-depressive-symptoms-along-spectrum.pdf2022-11-07 22:37 391K 
[ ]16352_prevalence-severity-intimate-partner-violence-associations.pdf2022-11-07 22:52 98K 
[ ]16353_prevalence-sexual-dysfunction-among-newer-antidepressants.pdf2022-11-07 22:09 84K 
[ ]16354_prevalence-spontaneous-dyskinesia-schizophrenia.pdf2022-11-07 22:17 52K 
[ ]16355_prevalence-study-urinary-tract-infections-acute-relapse.pdf2022-11-07 22:13 263K 
[ ]16356_prevalence-treatment-outcome-anxious-versus-nonanxious.pdf2022-11-07 22:38 333K 
[ ]16357_prevalence-trends-factors-associated-antipsychotic.pdf2022-11-07 22:08 80K 
[ ]16358_preventing-boundary-violations-clinical-practice.pdf2022-11-07 22:33 84K 
[ ]16359_preventing-bullying-school-violence.pdf2022-11-07 22:05 87K 
[ ]16360_preventing-clinical-deterioration-course-schizophrenia.pdf2022-11-07 23:01 155K 
[ ]16361_preventing-depression-stroke-results-randomized-placebo.pdf2022-11-07 22:43 96K 
[ ]16362_preventing-inpatient-suicide.pdf2022-11-07 22:09 31K 
[ ]16363_preventing-recurrent-depression-long-term-treatment-mdd.pdf2022-11-07 22:16 276K 
[ ]16364_preventing-suicide-in-the-age-of-covid.pdf2022-11-07 22:16 146K 
[ ]16366_prevention-of-ptsd-with-escitalopram.pdf2022-11-07 22:21 292K 
[ ]16367_prevention-recurrent-episodes-depression-venlafaxine-1-year-PREVENT-outcome-maintenance-phase.pdf2022-11-07 22:40 247K 
[ ]16368_prevention-recurrent-episodes-depression-venlafaxine-PREVENT-2-years-outcome-combined-maintenance-ph.pdf2022-11-07 22:12 267K 
[ ]16369_prevention-recurrent-postpartum-depression-randomized.pdf2022-11-07 22:03 57K 
[ ]16370_prevention-relapse-recurrence-depression-role-long.pdf2022-11-07 22:58 56K 
[ ]16371_prevention-treatment-poststroke-depression-mirtazapine.pdf2022-11-07 22:16 47K 
[ ]16372_preventive-cognitive-therapy-with-antidepressant-discontinuation-during-pregnancy-an-rct.pdf2022-11-07 22:25 477K 
[ ]16373_preventive-effects-of-lamotrigine-in-bipolar-ii-versus-bipolar-i-disorder.pdf2022-11-07 22:05 629K 
[ ]16374_preventive-effects-of-suvorexant-on-delirium.pdf2022-11-07 22:08 581K 
[ ]16375_priapism-associated-conventional-atypical-antipsychotic.pdf2022-11-07 22:27 52K 
[ ]16376_priapism-associated-polypharmacy.pdf2022-11-07 22:40 59K 
[ ]16377_priapism-associated-risperidone-case-report.pdf2022-11-07 22:13 67K 
[ ]16378_priapism-patient-taking-sertraline.pdf2022-11-07 22:04 38K 
[ ]16379_priapism-trazodone-versus-nefazodone.pdf2022-11-07 22:30 37K 
[ ]16380_primary-care-commentary-fatigue-executive-dysfunction.pdf2022-11-07 22:38 21K 
[ ]16381_primary-care-issues-related-treatment-depression-elderly.pdf2022-11-07 22:47 69K 
[ ]16382_primary-care-mental-health.pdf2022-11-07 22:59 133K 
[ ]16383_primary-care-perspectives-generalized-anxiety-disorder.pdf2022-11-07 22:29 66K 
[ ]16384_primary-care-physicians-guide-common-psychiatric-neurologic.pdf2022-11-07 22:38 56K 
[ ]16385_primary-care-treatment-attention-deficit-hyperactivity.pdf2022-11-07 22:09 93K 
[ ]16386_primary-health-care-utilization-prior-suicide-retrospective.pdf2022-11-07 22:29 312K 
[ ]16387_primary-outcome-measure-importance-clinical-trials.pdf2022-11-07 22:22 289K 
[ ]16388_primate-models-understand-human-aggression.pdf2022-11-07 22:40 45K 
[ ]16389_prime-maximizing-therapeutic-experience-primer-psychiatric.pdf2022-11-07 22:54 128K 
[ ]16390_primer-beginning-psychotheraphy-nd-ed.pdf2022-11-07 22:40 49K 
[ ]16391_primer-conceptualization-mechanism-action-electroconvulsive-part-1-defining-question-ECT.pdf2022-11-07 22:25 525K 
[ ]16392_primer-conceptualization-mechanism-action-electroconvulsive-therapy-part-2-organizing-information-EC.pdf2022-11-07 22:05 592K 
[ ]16393_primer-confidence-intervals-psychopharmacology.pdf2022-11-07 22:08 366K 
[ ]16394_principles-behavioral-cognitive-neurology-nd-ed.pdf2022-11-07 22:43 39K 
[ ]16395_principles-medical-ethics-annotations-especially-applicable.pdf2022-11-07 22:08 46K 
[ ]16396_principles-practice-child-adolescent-forensic-psychiatry.pdf2022-11-07 22:14 48K 
[ ]16397_principles-practice-psychopharmacotherapy-rd-ed.pdf2022-11-07 22:44 56K 
[ ]16398_principles-practices-military-forensic-psychiatry.pdf2022-11-07 22:54 16K 
[ ]16399_principles-social-psychiatry-nd-ed.pdf2022-11-07 22:47 147K 
[ ]16400_print-e-ternity.pdf2022-11-07 22:53 137K 
[ ]16401_prior-antipsychotic-prescribing-patients-currently.pdf2022-11-07 22:16 56K 
[ ]16402_prior-benzodiazepine-buspirone-response-treatment.pdf2022-11-07 22:37 54K 
[ ]16403_prior-benzodiazepine-exposure-benzodiazepine-treatment.pdf2022-11-07 22:22 90K 
[ ]16404_probability-correlates-dependence-among-regular-users.pdf2022-11-07 22:22 309K 
[ ]16405_probability-predictors-treatment-contact-anxiety-disorders.pdf2022-11-07 22:42 412K 
[ ]16406_probing-safety-medications-frail-elderly-evidence.pdf2022-11-07 22:41 72K 
[ ]16407_problematic-internet-health-adolescents-data-high.pdf2022-11-07 23:02 352K 
[ ]16408_problematic-video-game-scale-initial-psychometric.pdf2022-11-07 22:46 295K 
[ ]16409_problem-based-behavioral-science-psychiatry.pdf2022-11-07 22:41 699K 
[ ]16410_problem-gambling-and-alcohol-dependence-treatment.pdf2022-11-07 22:30 256K 
[ ]16411_problem-patient-heterogeneity-lack-proper-training.pdf2022-11-07 22:10 128K 
[ ]16412_problems-applying-dsm-iv-eating-disorders-diagnostic.pdf2022-11-07 22:42 121K 
[ ]16413_problems-assessing-musical-hallucinations.pdf2022-11-07 22:25 124K 
[ ]16414_problems-currently-available-antidepressants.pdf2022-11-07 22:46 84K 
[ ]16415_problems-ensuring-double-blind.pdf2022-11-07 22:55 48K 
[ ]16416_problems-switching-rapidly-maoi-another.pdf2022-11-07 22:50 100K 
[ ]16417_proceedings-data-schizophrenia-summit-critical-appraisal.pdf2022-11-07 22:48 1.4M 
[ ]16418_procognitive-effects-of-modafinil-in-depression.pdf2022-11-07 22:54 415K 
[ ]16419_procognitive-effects-of-therapeutic-agents-in-mdd.pdf2022-11-07 22:58 497K 
[ ]16421_prodromal-symptoms-relapse-sample-egyptian-schizophrenic.pdf2022-11-07 22:27 65K 
[ ]16422_professionalism-ethics-q-self-study-guide-mental-health.pdf2022-11-07 22:12 83K 
[ ]16423_professionalism-psychiatry.pdf2022-11-07 22:45 89K 
[ ]16424_professional-sexual-misconduct-institutions-causes.pdf2022-11-07 22:33 75K 
[ ]16425_profile-medically-serious-suicide-attempts.pdf2022-11-07 23:00 36K 
[ ]16426_prognostic-significance-regular-binge-eating-extremely.pdf2022-11-07 22:40 109K 
[ ]16427_prognostic-subgroups-citalopram-response-stard-trial.pdf2022-11-07 22:38 1.4M 
[ ]16428_prognostic-subgroups-remission-response-coordinated.pdf2022-11-07 22:50 386K 
[ ]16429_prognostic-subgroups-remission-response-treatment.pdf2022-11-07 22:20 326K 
[ ]16430_progression-abnormal-involuntary-movements-during.pdf2022-11-07 22:58 35K 
[ ]16431_prolactin-elevation-antipsychotic-medications-mechanisms.pdf2022-11-07 22:43 97K 
[ ]16432_prolactin-levels-during-long-term-risperidone-treatment-children-adolescents-reanalysis-data.pdf2022-11-07 23:00 593K 
[ ]16433_prolactin-levels-long-term-risperidone-treatment-children.pdf2022-11-07 22:06 66K 
[ ]16434_prolactin-levels-schizophrenia-schizoaffective-disorder.pdf2022-11-07 22:14 43K 
[ ]16435_prolactin-related-metabolic-adverse-effects-atypical.pdf2022-11-07 22:18 356K 
[ ]16436_prolonged-erections-associated-ziprasidone-treatment.pdf2022-11-07 22:37 62K 
[ ]16437_prolonged-exposure-therapy-combat-terror-related.pdf2022-11-07 22:34 326K 
[ ]16438_prolonged-qt-associated-overdose-trazodone.pdf2022-11-07 22:42 256K 
[ ]16439_propensity-score-matching-in-nonrandomized-studies.pdf2022-11-07 22:53 299K 
[ ]16440_prophylactic-antidepressant-treatment-interferon-induced.pdf2022-11-07 22:54 793K 
[ ]16441_prophylactic-antipsychotic-postoperative-delirium.pdf2022-11-07 22:06 123K 
[ ]16442_prophylactic-antipsychotics-keep-catching-schizophrenia.pdf2022-11-07 22:14 50K 
[ ]16443_prophylactic-efficacy-lithium-versus-carbamazepine.pdf2022-11-07 22:49 73K 
[ ]16444_prophylactic-treatment-escitalopram-pegylated-interferon.pdf2022-11-07 22:52 359K 
[ ]16445_propofol-alcohol-withdrawal-delirium-case-report.pdf2022-11-07 22:03 51K 
[ ]16446_propofol-severe-refractory-mania-case-report.pdf2022-11-07 22:54 92K 
[ ]16447_proposal-refine-definition-military-sexual-trauma.pdf2022-11-07 22:56 139K 
[ ]16448_propranolol-traumatic-memories-amnesia-study-cases.pdf2022-11-07 22:28 134K 
[ ]16450_prosodic-semantic-affect-perception-remitted-patients.pdf2022-11-07 22:08 281K 
[ ]16451_prospective-follow-study-course-obsessive-compulsive.pdf2022-11-07 22:47 327K 
[ ]16452_prospective-long-term-multicenter-study-naturalistic.pdf2022-11-07 22:17 109K 
[ ]16453_prospective-naturalistic-blinded-study-early-neurobehavioral.pdf2022-11-07 23:02 260K 
[ ]16454_prospective-naturalistic-follow-treatment-outcome.pdf2022-11-07 22:10 725K 
[ ]16455_prospective-observational-study-obesity-body-composition.pdf2022-11-07 22:36 258K 
[ ]16456_prospective-observational-study-treatments-unexplained.pdf2022-11-07 22:51 143K 
[ ]16457_prospective-open-label-flexible-dose-study-quetiapine.pdf2022-11-07 22:25 58K 
[ ]16458_prospective-safety-surveillance-study-bupropion-sustained.pdf2022-11-07 22:55 51K 
[ ]16459_prospective-studies-adverse-events-related-antidepressant.pdf2022-11-07 22:55 106K 
[ ]16460_prospective-study-hormone-therapy-depression-community.pdf2022-11-07 22:02 235K 
[ ]16461_prospective-study-offspring-bipolar-parents-responsive.pdf2022-11-07 22:53 73K 
[ ]16462_prospective-study-paradoxical-relationship-between.pdf2022-11-07 22:51 87K 
[ ]16463_prospective-study-parentally-bereaved-youth-caregiver.pdf2022-11-07 22:48 158K 
[ ]16464_prospective-study-risk-factors-nonadherence-antipsychotic.pdf2022-11-07 22:38 120K 
[ ]16465_prospective-trial-customized-adherence-enhancement.pdf2022-11-07 22:45 394K 
[ ]16466_protective-factors-risk-modification-violence-iraq.pdf2022-11-07 22:29 313K 
[ ]16467_provider-patient-characteristics-associated-antidepressant.pdf2022-11-07 22:14 166K 
[ ]16469_prozac-antidepressants-revised-ed-need-prozac-zoloft.pdf2022-11-07 22:30 25K 
[ ]16470_pseudohallucinations-versus-true-hallucinations-prodromal.pdf2022-11-07 22:02 283K 
[ ]16471_pseudoresistant-bipolar-depression.pdf2022-11-07 23:00 734K 
[ ]16472_psoriasis-and-risk-of-dementia.pdf2022-11-07 22:57 285K 
[ ]16473_psychiatric-care-medical-patient-nd-ed.pdf2022-11-07 22:57 49K 
[ ]16474_psychiatric-care-patients-depression-comorbid-substance.pdf2022-11-07 22:27 86K 
[ ]16475_psychiatric-comorbidity-assessed-korean-children-adolescents.pdf2022-11-07 22:47 84K 
[ ]16476_psychiatric-comorbidity-binge-eating-disorder-function.pdf2022-11-07 22:02 101K 
[ ]16477_psychiatric-comorbidity-hospitalized-adolescents-borderline.pdf2022-11-07 23:01 360K 
[ ]16478_psychiatric-comorbidity-predictor-clinical-response.pdf2022-11-07 22:01 47K 
[ ]16479_psychiatric-complications-deep-brain-stimulation-parkinsons.pdf2022-11-07 22:42 46K 
[ ]16480_psychiatric-consultations-stiffman-syndrome.pdf2022-11-07 22:29 40K 
[ ]16481_psychiatric-diagnoses-patients-previously-overdiagnosed.pdf2022-11-07 22:50 304K 
[ ]16482_psychiatric-diagnosis-independent-risk-factor-metabolic.pdf2022-11-07 23:02 255K 
[ ]16483_psychiatric-discharge-against-medical-advice-is-risk.pdf2022-11-07 22:04 116K 
[ ]16484_psychiatric-disorder-comorbidity-association-eating.pdf2022-11-07 22:37 81K 
[ ]16485_psychiatric-disorders-and-cannabis-use.pdf2022-11-07 22:09 171K 
[ ]16486_psychiatric-disorders-and-comorbid-cannabis-use-what-can-we-do-about-it.pdf2022-11-07 22:40 171K 
[ ]16487_psychiatric-disorders-and-crime.pdf2022-11-07 22:58 696K 
[ ]16488_psychiatric-features-men-convicted-sexual-offenses.pdf2022-11-07 22:49 76K 
[ ]16489_psychiatric-genetics.pdf2022-11-07 22:24 98K 
[ ]16490_psychiatric-genetics-survey-psychiatrists-knowledge.pdf2022-11-07 22:48 185K 
[ ]16491_psychiatric-hospital-utilization-patients-treated.pdf2022-11-07 22:10 96K 
[ ]16492_psychiatric-intensive-care-nd-ed.pdf2022-11-07 22:12 99K 
[ ]16493_psychiatric-interview-evaluation-diagnosis.pdf2022-11-07 22:22 88K 
[ ]16494_psychiatric-legal-features-men-convicted-sexual-offenses.pdf2022-11-07 22:43 66K 
[ ]16495_psychiatric-management-neurological-disease-st-ed.pdf2022-11-07 22:38 41K 
[ ]16496_psychiatric-manifestations-mitochondrial-disorders.pdf2022-11-07 22:26 408K 
[ ]16497_psychiatric-medication-older-adults-concise-guide.pdf2022-11-07 22:26 39K 
[ ]16498_psychiatric-neuroimaging-research-contemporary-strategies.pdf2022-11-07 22:02 46K 
[ ]16499_psychiatric-perspective-insomnia.pdf2022-11-07 22:14 57K 
[ ]16500_psychiatric-pharmacogenomics.pdf2022-11-07 22:30 135K 
[ ]16501_psychiatric-phenotype-fragile-x-associated-tremorataxia.pdf2022-11-07 22:13 104K 
[ ]16502_psychiatric-services-jails-prisons-task-force-report.pdf2022-11-07 22:29 60K 
[ ]16503_psychiatric-side-effects-of-chloroquine.pdf2022-11-07 22:16 91K 
[ ]16504_psychiatric-side-effects-prescription-counter-medications.pdf2022-11-07 22:28 24K 
[ ]16505_psychiatric-symptoms-patients-chronic-hepatitis-c.pdf2022-11-07 22:32 67K 
[ ]16506_psychiatric-symptoms-patients-sporadic-creutzfeldt.pdf2022-11-07 22:40 234K 
[ ]16507_psychiatric-symptoms-systemic-lupus-erythematosus.pdf2022-11-07 22:25 331K 
[ ]16508_psychiatristcom.pdf2022-11-07 22:52 58K 
[ ]16509_psychiatrist-court-survival-guide-psychiatrist-expert.pdf2022-11-07 22:12 58K 
[ ]16510_psychiatrist-expert-witness-nd-ed.pdf2022-11-07 22:24 142K 
[ ]16511_psychiatrists-build-therapies-impotence.pdf2022-11-07 22:23 69K 
[ ]16512_psychiatrists-nonpsychiatrist-physicians-reported.pdf2022-11-07 22:17 157K 
[ ]16513_psychiatry-aids-guide-diagnosis-treatment.pdf2022-11-07 22:07 72K 
[ ]16514_psychiatry-cinema-nd-ed.pdf2022-11-07 22:35 20K 
[ ]16515_psychiatry-clinical-neuroscience-primer.pdf2022-11-07 22:38 83K 
[ ]16516_psychiatry-heart-disease-mind-brain-heart.pdf2022-11-07 22:56 92K 
[ ]16517_psychiatry-house-officer-series-th-ed.pdf2022-11-07 22:32 31K 
[ ]16518_psychiatry-intellectual-disability-practical-manual.pdf2022-11-07 22:38 86K 
[ ]16519_psychiatry-lawlaw-psychiatry-nd-ed.pdf2022-11-07 23:02 82K 
[ ]16520_psychiatry-millennium.pdf2022-11-07 22:26 39K 
[ ]16521_psychiatry-psychology-medieval-persia.pdf2022-11-07 22:42 121K 
[ ]16522_psychiatry-psychonanalysis-biology-mind.pdf2022-11-07 22:03 50K 
[ ]16523_psychiatry-questions-help-pass-boards.pdf2022-11-07 22:33 54K 
[ ]16524_psychiatry-rd-ed.pdf2022-11-07 22:32 81K 
[ ]16525_psychiatrys-niche-role-in-the-covid-pandemic.pdf2022-11-07 22:55 132K 
[ ]16526_psychiatry-vols-nd-ed.pdf2022-11-07 22:16 84K 
[ ]16527_psychiatry-vols-rd-ed.pdf2022-11-07 22:46 737K 
[ ]16528_psychoanalysis-major-concepts.pdf2022-11-07 22:54 39K 
[ ]16529_psychoanalytic-diagnosis-understanding-personality.pdf2022-11-07 22:09 76K 
[ ]16530_psychobible-behavior-religion-holy-book.pdf2022-11-07 22:16 30K 
[ ]16531_psychobiology-posttraumatic-stress-disorder.pdf2022-11-07 22:36 139K 
[ ]16532_psychobiology-posttraumatic-stress-disorder-glutamatergic-gaba-pathways-amine-neurotransmitters-stru.pdf2022-11-07 22:57 61K 
[ ]16534_psychodynamic-diagnostic-manual-pdm.pdf2022-11-07 22:34 765K 
[ ]16535_psychodynamic-formulation.pdf2022-11-07 22:20 92K 
[ ]16536_psychodynamic-psychiatry-clinical-practice-rd-ed.pdf2022-11-07 22:51 36K 
[ ]16537_psychodynamic-psychotherapy-personality-disorders.pdf2022-11-07 22:05 153K 
[ ]16538_psychodynamic-psychotherapy-ptsd.pdf2022-11-07 22:56 45K 
[ ]16539_psychodynamic-therapy-guide-evidence-based-practice.pdf2022-11-07 22:11 146K 
[ ]16540_psychoeducational-interventions-family-members-schizophrenia.pdf2022-11-07 22:30 1.0M 
[ ]16541_psychoeducation-compliance-treatment-schizophrenia.pdf2022-11-07 22:06 119K 
[ ]16542_psychoeducation-efficacy-bipolar-disorders-beyond.pdf2022-11-07 22:50 50K 
[ ]16543_psychoeducation-for-borderline-personality-disorder.pdf2022-11-07 22:52 266K 
[ ]16544_psychoeducation-for-borderline-personality-disorder-patients.pdf2022-11-07 22:31 214K 
[ ]16545_psychoeducation-in-the-management-of-bipolar-disorder.pdf2022-11-07 22:04 288K 
[ ]16546_psychoeducation-schizophrenia-follow-concerning.pdf2022-11-07 23:00 211K 
[ ]16547_psychological-adjustment-adolescents-months-terrorist.pdf2022-11-07 22:10 181K 
[ ]16548_psychological-aspects-womens-health-care-interface.pdf2022-11-07 22:21 89K 
[ ]16549_psychological-behavioral-treatments-binge-eating-disorder.pdf2022-11-07 22:47 190K 
[ ]16550_psychological-characteristics-chronic-depression-longitudinal.pdf2022-11-07 22:40 351K 
[ ]16551_psychological-characterization-demoralization-setting.pdf2022-11-07 22:51 232K 
[ ]16552_psychological-debriefing-theory-practice-evidence.pdf2022-11-07 22:32 30K 
[ ]16553_psychological-distress-common-mental-disorders-among.pdf2022-11-07 22:26 183K 
[ ]16554_psychological-outcomes-predictors-initial-weight-loss.pdf2022-11-07 22:23 311K 
[ ]16555_psychological-pain-in-suicidality.pdf2022-11-07 22:03 684K 
[ ]16556_psychological-reactions-following-the-november-paris-attacks.pdf2022-11-07 22:09 120K 
[ ]16557_psychological-resilience-frontline-health-care-workers-covid.pdf2022-11-07 22:01 565K 
[ ]16559_psychological-response-cortisol-reactivity-vitro-fertilization.pdf2022-11-07 22:02 373K 
[ ]16560_psychological-responses-of-health-care-workers-toward-infectious-disease-outbreaks-implications-for-.pdf2022-11-07 23:02 573K 
[ ]16561_psychological-trauma-review-psychiatry-series-vol.pdf2022-11-07 22:11 20K 
[ ]16562_psychometric-evaluation-alcohol-disorders-identification.pdf2022-11-07 22:54 75K 
[ ]16563_psychometric-reevaluation-of-the-c-ssrs.pdf2022-11-07 22:24 235K 
[ ]16564_psychopathology-age-onset-conduct-problems-juvenile.pdf2022-11-07 22:53 72K 
[ ]16565_psychopathology-evolving-science-mental-disorder.pdf2022-11-07 22:02 22K 
[ ]16566_psychopathology-seasonal-affective-disorder-patients.pdf2022-11-07 22:57 60K 
[ ]16567_psychopharmacologic-specificity-lithium-ion-origins.pdf2022-11-07 22:39 64K 
[ ]16568_psychopharmacologic-treatment-dissociative-fugue-ptsd.pdf2022-11-07 22:15 89K 
[ ]16569_psychopharmacologic-treatment-posttraumatic-stress.pdf2022-11-07 22:05 336K 
[ ]16570_psychopharmacologic-treatment-response-hiv-infected.pdf2022-11-07 22:56 75K 
[ ]16571_psychopharmacologic-treatments-relieve-symptoms-prevent.pdf2022-11-07 22:37 46K 
[ ]16572_psychopharmacology-adhd-children-adolescents.pdf2022-11-07 22:01 119K 
[ ]16573_psychopharmacology-anticonvulsants-anticonvulsants.pdf2022-11-07 22:58 39K 
[ ]16574_psychopharmacology-anticonvulsants-levetiracetam-synaptic.pdf2022-11-07 22:30 36K 
[ ]16575_psychopharmacology-atypical-antipsychotics-clinical.pdf2022-11-07 22:39 57K 
[ ]16576_psychopharmacology-comorbid-obsessive-compulsive-disorder.pdf2022-11-07 22:21 22K 
[ ]16577_psychopharmacology-emergency-room.pdf2022-11-07 22:55 78K 
[ ]16578_psychopharmacology-energy-fatigue.pdf2022-11-07 22:36 67K 
[ ]16579_psychopharmacology-fourth-generation-progress.pdf2022-11-07 22:43 55K 
[ ]16580_psychopharmacology-is-enough-using-cognitive-behavioral.pdf2022-11-07 22:25 101K 
[ ]16581_psychopharmacology-noncognitive-abnormal-behaviors.pdf2022-11-07 22:27 46K 
[ ]16582_psychopharmacology-painful-physical-symptoms-depression.pdf2022-11-07 22:09 135K 
[ ]16583_psychopharmacology-pregnancy-treatment-efficacy-risks.pdf2022-11-07 22:50 76K 
[ ]16584_psychopharmacology-schizophrenia.pdf2022-11-07 22:34 55K 
[ ]16585_psychopharmacology-sex-part-effects-drugs-disease.pdf2022-11-07 22:11 89K 
[ ]16586_psychopharmacology-sex-part-neurotransmitters-phases.pdf2022-11-07 22:57 46K 
[ ]16587_psychopharmacology-violence-emphasis-schizophrenia-acute.pdf2022-11-07 22:24 55K 
[ ]16588_psychopharmacology-violence-emphasis-schizophrenia-long-term.pdf2022-11-07 22:43 79K 
[ ]16589_psychopharmacology-wakefulness-pathways-neurotransmitters.pdf2022-11-07 22:58 123K 
[ ]16590_psychopharmacology-ziprasidone-receptor-binding-properties.pdf2022-11-07 22:18 81K 
[ ]16591_psychophysiological-states-ultradian-dynamics-mind.pdf2022-11-07 22:20 739K 
[ ]16592_psychoses-elderly-spectrum-disorders.pdf2022-11-07 23:01 57K 
[ ]16593_psychosis-agitation-dementia-should-general-psychiatrists.pdf2022-11-07 22:49 72K 
[ ]16594_psychosis-coexisting-substance-misuse-nice-guideline.pdf2022-11-07 22:45 60K 
[ ]16595_psychosis-mania-specificity-role-severity-treatment.pdf2022-11-07 22:15 55K 
[ ]16596_psychosocial-approaches-suicide-prevention-applications.pdf2022-11-07 22:37 74K 
[ ]16597_psychosocial-factors-pain-clinical-perspectives.pdf2022-11-07 22:01 39K 
[ ]16598_psychosocial-functioning-familiality-psychiatric-comorbidity.pdf2022-11-07 22:39 434K 
[ ]16599_psychosocial-functioning-women-premenstrual-dysphoric.pdf2022-11-07 22:10 124K 
[ ]16601_psychosocial-interventions-bipolar-disorder.pdf2022-11-07 22:51 61K 
[ ]16602_psychosocial-interventions-long-term-management-patients.pdf2022-11-07 22:54 104K 
[ ]16604_psychosocial-therapy-posttraumatic-stress-disorder.pdf2022-11-07 22:13 92K 
[ ]16605_psychosocial-treatment-posttraumatic-stress-disorder.pdf2022-11-07 22:21 57K 
[ ]16606_psychosocial-treatments-attention-deficit-hyperactivity.pdf2022-11-07 22:33 77K 
[ ]16607_psychosomatic-medicine.pdf2022-11-07 22:28 100K 
[ ]16608_psychostimulant-augmentation-during-treatment-selective.pdf2022-11-07 22:19 68K 
[ ]16609_psychotherapeutic-approaches-schizophrenic-psychoses.pdf2022-11-07 22:31 133K 
[ ]16610_psychotherapeutic-approaches-treatment-anxiety-depressive.pdf2022-11-07 22:37 21K 
[ ]16611_psychotherapeutic-treatment-options-perinatal-depression.pdf2022-11-07 22:37 335K 
[ ]16612_psychotherapies-for-panic-disorder-a-tale-of-two-sites.pdf2022-11-07 22:19 306K 
[ ]16613_psychotherapists-function-own-controls-meta-analysis.pdf2022-11-07 22:32 465K 
[ ]16614_psychotherapy-arab-patient.pdf2022-11-07 22:16 37K 
[ ]16615_psychotherapy-borderline-personality-focusing-object.pdf2022-11-07 22:47 100K 
[ ]16616_psychotherapy-for-bipolar-ii-depression.pdf2022-11-07 22:46 513K 
[ ]16617_psychotherapy-generalized-anxiety-disorder.pdf2022-11-07 22:08 55K 
[ ]16618_psychotherapy-indications-outcomes.pdf2022-11-07 22:55 36K 
[ ]16621_psychotherapy-medication-treatment-adult-geriatric.pdf2022-11-07 22:42 237K 
[ ]16622_psychotherapy-panic-disorder.pdf2022-11-07 22:41 43K 
[ ]16623_psychotherapy-personality-disorders-review-psychiatry.pdf2022-11-07 22:52 89K 
[ ]16624_psychotherapy-supervision-andconsultation-clinical.pdf2022-11-07 22:35 115K 
[ ]16625_psychotherapy-via-telemedicine-for-depression-in-older-veterans.pdf2022-11-07 22:25 390K 
[ ]16626_psychotic-episode-possibly-induced-light-therapy-nondemented.pdf2022-11-07 22:30 86K 
[ ]16627_psychotic-features-in-patients-with-mdd.pdf2022-11-07 22:47 1.0M 
[ ]16628_psychotic-subtyping-major-depressive-disorder-posttraumatic.pdf2022-11-07 22:49 51K 
[ ]16629_psychotic-symptoms-associated-topiramate-cognitive.pdf2022-11-07 22:04 151K 
[ ]16630_psychotic-symptoms-combat-related-posttraumatic-stress.pdf2022-11-07 22:46 32K 
[ ]16631_psychotic-symptoms-presented-familial-creutzfeldt.pdf2022-11-07 22:46 53K 
[ ]16632_psychotropic-agents-prediction-weight-gain.pdf2022-11-07 22:45 110K 
[ ]16633_psychotropic-drug-during-pregnancy-weighing-risks.pdf2022-11-07 23:01 65K 
[ ]16634_psychotropic-drug-handbook-eighth-edition-book-review.pdf2022-11-07 22:21 55K 
[ ]16635_psychotropic-drug-handbook-seventh-edition-review.pdf2022-11-07 22:10 50K 
[ ]16637_psychotropic-drugs-adverse-events-treatment-bipolar.pdf2022-11-07 22:21 69K 
[ ]16638_psychotropic-drugs-rd-ed.pdf2022-11-07 22:51 49K 
[ ]16639_psychotropic-medication-and-suicide-attempt-method.pdf2022-11-07 22:57 318K 
[ ]16640_psychotropic-medication-during-pregnancy-changes-labeling.pdf2022-11-07 22:57 122K 
[ ]16641_psychotropic-medication-general-population-france.pdf2022-11-07 22:07 80K 
[ ]16642_psychotropic-medication-patients-emotionally-unstable.pdf2022-11-07 22:59 270K 
[ ]16643_psychotropic-medications-in-homicide-victims-and-offenders.pdf2022-11-07 22:05 202K 
[ ]16644_psychotropic-medications-lactation.pdf2022-11-07 22:26 63K 
[ ]16645_psychotropics-and-hypertensive-disorders-of-pregnancy.pdf2022-11-07 22:59 266K 
[ ]16646_ptsd-and-and-binge-eating-disorder-further-context.pdf2022-11-07 22:03 135K 
[ ]16647_ptsd-and-antiretroviral-treatment-interruption.pdf2022-11-07 22:48 279K 
[ ]16648_ptsd-children-adolescents.pdf2022-11-07 22:11 42K 
[ ]16649_ptsd-comorbidity-suicidal-ideation-associated-ptsd.pdf2022-11-07 22:48 387K 
[ ]16650_ptsd-symptoms-lead-modification-memory-trauma-prospective.pdf2022-11-07 22:42 222K 
[ ]16651_public-health-aspects-diagnosis-classification-mental.pdf2022-11-07 22:52 99K 
[ ]16652_public-health-perspectives-generalized-anxiety-disorder.pdf2022-11-07 22:36 56K 
[ ]16653_public-nonprofit-funding-research-mental-disorders.pdf2022-11-07 22:21 396K 
[ ]16654_publishers-note-cosmetics-count.pdf2022-11-07 22:10 130K 
[ ]16655_publishers-note-ltemgtjcpltemgt-world-keeps-improving.pdf2022-11-07 22:24 147K 
[ ]16656_publishers-note-ncdeu-festschriftcelebrating-years.pdf2022-11-07 22:06 487K 
[ ]16657_publishers-note-smaller-is-bigger.pdf2022-11-07 22:26 931K 
[ ]16658_publishers-note-working-together-restore-mental-being.pdf2022-11-07 22:29 14M 
[ ]16659_publishers-note-years-another-milestone.pdf2022-11-07 22:25 319K 
[ ]16660_puerperium-primiparae-exhibit-higher-levels-anxiety.pdf2022-11-07 22:24 61K 
[ ]16661_putting-metabolic-side-effects-perspective-risks-versus.pdf2022-11-07 22:12 52K 
[ ]16662_put-tyramine-mrs-murphys-fava-bean.pdf2022-11-07 22:29 191K 
[ ]16663_qol-and-functioning-in-older-adults-with-mdd.pdf2022-11-07 22:23 233K 
[ ]16664_qtc-interval-measurement-metabolic-parameters-psychiatric.pdf2022-11-07 22:23 135K 
[ ]16665_qtc-metabolic-parameters.pdf2022-11-07 22:52 82K 
[ ]16666_qt-interval-duration-dispersion-children-adolescents.pdf2022-11-07 22:50 450K 
[ ]16667_qt-interval-prolongation-users-selective-serotonin.pdf2022-11-07 22:01 320K 
[ ]16668_qualifications-recertification-important-evolving.pdf2022-11-07 22:41 74K 
[ ]16669_qualitative-analysis-nonresponse-management-treatment.pdf2022-11-07 22:13 59K 
[ ]16670_qualitative-methods-early-phase-drug-trials-broadening.pdf2022-11-07 22:31 226K 
[ ]16671_qualitative-review-snris-anxiety.pdf2022-11-07 22:16 78K 
[ ]16672_quality-indicators-defining-measuring-quality-psychiatric.pdf2022-11-07 22:11 23K 
[ ]16673_quality-life-among-patients-depression.pdf2022-11-07 23:00 110K 
[ ]16674_quality-life-following-remission-mental-disorders.pdf2022-11-07 22:20 299K 
[ ]16675_quality-life-mental-disorders.pdf2022-11-07 22:37 34K 
[ ]16676_quality-life-outcomes-patients-obsessive-compulsive.pdf2022-11-07 22:17 374K 
[ ]16677_quality-life-panic-related-disability-subjects-infrequent.pdf2022-11-07 22:55 84K 
[ ]16678_quality-life-schizophrenia-impact-psychopathology.pdf2022-11-07 22:12 63K 
[ ]16679_quality-life-schizophrenia-multicenter-randomized.pdf2022-11-07 22:14 178K 
[ ]16680_quality-patient-satisfaction-primary-health-care-anxiety.pdf2022-11-07 22:07 277K 
[ ]16681_quality-reporting-randomized-controlled-trials-pharmacologic.pdf2022-11-07 22:18 361K 
[ ]16682_quality-treatment-disability-compensation-depression.pdf2022-11-07 23:01 154K 
[ ]16683_quantifying-intraindividual-variations-plasma-clozapine.pdf2022-11-07 22:29 301K 
[ ]16684_quantitative-electroencephalogram-biomarkers-predicting.pdf2022-11-07 22:55 294K 
[ ]16685_quarter-century-helm.pdf2022-11-07 22:37 1.0M 
[ ]16686_quest-answers-primer-understanding-treating-severe.pdf2022-11-07 22:38 24K 
[ ]16687_question-answer-session.pdf2022-11-07 22:37 24K 
[ ]16688_questions-answers-role-pharmacotherapy-clinical-management.pdf2022-11-07 22:07 62K 
[ ]16689_questions-raised-failure-trial-short-term-psychodynamic.pdf2022-11-07 22:23 111K 
[ ]16690_quetiapine-addition-serotonin-reuptake-inhibitor-treatment.pdf2022-11-07 22:09 55K 
[ ]16691_quetiapine-alone-added-mood-stabilizer-serious-mood.pdf2022-11-07 22:56 47K 
[ ]16692_quetiapine-another-drug-potential-misuse-case-report.pdf2022-11-07 22:55 152K 
[ ]16693_quetiapine-associated-increase-triglycerides-case.pdf2022-11-07 22:20 104K 
[ ]16694_quetiapine-augmentation-obsessive-compulsive-disorder.pdf2022-11-07 22:04 163K 
[ ]16695_quetiapine-augmentation-sertraline-obsessive-compulsive.pdf2022-11-07 22:20 68K 
[ ]16696_quetiapine-augments-effect-citalopram-non-refractory.pdf2022-11-07 22:35 320K 
[ ]16697_quetiapine-children-adolescents.pdf2022-11-07 23:00 58K 
[ ]16698_quetiapine-drug-interactions-evidence-routine-therapeutic.pdf2022-11-07 22:01 169K 
[ ]16699_quetiapine-effective-antipsychotic-episode-schizophrenia.pdf2022-11-07 22:14 70K 
[ ]16700_quetiapine-elderly-patients.pdf2022-11-07 22:23 72K 
[ ]16701_quetiapine-extended-release-versus-immediate-release.pdf2022-11-07 22:33 174K 
[ ]16702_quetiapine-long-term-weight-change-comprehensive-data.pdf2022-11-07 23:03 183K 
[ ]16703_quetiapine-novel-antipsychotic-experience-elderly.pdf2022-11-07 23:00 70K 
[ ]16704_quetiapine-patients-tourettes-disorder-open-label.pdf2022-11-07 22:35 140K 
[ ]16705_quetiapine-preclinical-studies-pharmacokinetics-drug.pdf2022-11-07 22:01 73K 
[ ]16706_quetiapine-psychosis-parkinsons-disease-versus-dementia.pdf2022-11-07 22:51 33K 
[ ]16707_quetiapine-qtc-issues-case-report.pdf2022-11-07 22:28 67K 
[ ]16708_quetiapine-treatment-anxiety-patients-bipolar-i-ii.pdf2022-11-07 22:03 117K 
[ ]16709_quetiapine-treatment-mania-secondary-brain-injury.pdf2022-11-07 22:56 207K 
[ ]16710_quick-cognitive-screening-clinicians-mini-mental-clock.pdf2022-11-07 22:34 33K 
[ ]16711_race-long-acting-antipsychotic-prescription-community.pdf2022-11-07 22:05 200K 
[ ]16712_racial-differences-antipsychotics-among-patients-bipolar.pdf2022-11-07 22:05 67K 
[ ]16713_racial-ethnic-disparities-parent-reported-diagnosis.pdf2022-11-07 22:21 257K 
[ ]16714_racialethnic-disparities-service-utilization-individuals.pdf2022-11-07 22:55 280K 
[ ]16715_racial-ethnic-effects-psychotic-psychiatric-diagnostic.pdf2022-11-07 22:57 172K 
[ ]16716_racial-variation-antidepressant-treatment-medicaid.pdf2022-11-07 22:44 59K 
[ ]16717_rage-attacks-children-adolescents-tourettes-disorder.pdf2022-11-07 22:46 37K 
[ ]16718_raise-early-treatment-program-episode-psychosis-background.pdf2022-11-07 22:57 1.1M 
[ ]16719_raloxifene-adjunctive-treatment-postmenopausal-women.pdf2022-11-07 22:43 367K 
[ ]16720_raloxifene-in-postmenopausal-women-with-schizophrenia.pdf2022-11-07 22:06 538K 
[ ]16721_ramelteon-and-suvorexant-for-delirium-prevention.pdf2022-11-07 22:58 262K 
[ ]16722_randomized-clinical-trial-bright-light-therapy-antepartum.pdf2022-11-07 22:56 52K 
[ ]16723_randomized-clinical-trial-cognitive-behavioral-group.pdf2022-11-07 22:31 110K 
[ ]16724_randomized-clinical-trial-eye-movement-desensitization.pdf2022-11-07 22:22 111K 
[ ]16725_randomized-clinical-trial-high-eicosapentaenoic-acid.pdf2022-11-07 22:07 294K 
[ ]16726_randomized-comparison-high-charge-right-unilateral.pdf2022-11-07 22:31 52K 
[ ]16727_randomized-controlled-study-histamine-h-inverse-agonist.pdf2022-11-07 22:27 342K 
[ ]16728_randomized-controlled-study-sequentially-applied-repetitive.pdf2022-11-07 22:19 253K 
[ ]16729_randomized-controlled-trial-antidepressant-continuation.pdf2022-11-07 22:14 271K 
[ ]16730_randomized-controlled-trial-assess-reduction-cardiovascular.pdf2022-11-07 22:16 333K 
[ ]16731_randomized-controlled-trial-cognitive-behavioral-social.pdf2022-11-07 22:30 212K 
[ ]16732_randomized-controlled-trial-cognitive-therapy-bipolar.pdf2022-11-07 22:41 129K 
[ ]16733_randomized-controlled-trial-comparing-memory-effects.pdf2022-11-07 22:08 313K 
[ ]16734_randomized-controlled-trial-different-models-care.pdf2022-11-07 22:22 97K 
[ ]16735_randomized-controlled-trial-duloxetine-versus-placebo.pdf2022-11-07 22:05 337K 
[ ]16736_randomized-controlled-trial-efficacy-safety-lisdexamfetamine.pdf2022-11-07 22:56 419K 
[ ]16737_randomized-controlled-trial-fluvoxamine-prostatodynia.pdf2022-11-07 22:49 52K 
[ ]16738_randomized-controlled-trial-group-cognitive-behavioral.pdf2022-11-07 22:23 228K 
[ ]16739_randomized-controlled-trial-interventions-young-ultra.pdf2022-11-07 22:48 358K 
[ ]16740_randomized-controlled-trial-investigating-safety-efficacy.pdf2022-11-07 22:48 602K 
[ ]16741_randomized-controlled-trial-long-acting-injectable.pdf2022-11-07 22:18 1.5M 
[ ]16742_randomized-controlled-trial-mindfulness-meditation.pdf2022-11-07 22:03 461K 
[ ]16743_randomized-controlled-trial-olanzapine-versus-haloperidol.pdf2022-11-07 22:02 263K 
[ ]16744_randomized-controlled-trial-psychoeducation-cognitive.pdf2022-11-07 22:40 471K 
[ ]16745_randomized-controlled-trial-relapse-prevention-therapy.pdf2022-11-07 22:42 279K 
[ ]16746_randomized-controlled-trial-risperidone-olanzapine.pdf2022-11-07 22:20 357K 
[ ]16747_randomized-controlled-trial-risperidone-treatment.pdf2022-11-07 22:41 83K 
[ ]16748_randomized-controlled-trial-safety-promise-cognitive.pdf2022-11-07 22:48 256K 
[ ]16749_randomized-controlled-trial-venlafaxine-extended-release.pdf2022-11-07 22:46 181K 
[ ]16750_randomized-double-blind-active-control-study-sertraline.pdf2022-11-07 22:06 112K 
[ ]16751_randomized-double-blind-comparison-clozapine-high.pdf2022-11-07 22:02 333K 
[ ]16752_randomized-double-blind-comparison-olanzapinefluoxetine.pdf2022-11-07 22:32 274K 
[ ]16753_randomized-double-blind-comparison-sertraline-placebo.pdf2022-11-07 23:02 238K 
[ ]16754_randomized-double-blind-comparison-venlafaxine-fluoxetine.pdf2022-11-07 22:49 43K 
[ ]16755_randomized-double-blind-comparison-venlafaxine-sertraline.pdf2022-11-07 22:03 66K 
[ ]16756_randomized-double-blind-fixed-dose-comparison-paroxetine.pdf2022-11-07 22:12 82K 
[ ]16757_randomized-double-blind-placebo-controlled-26-week-trial-aripiprazole-manic-patients-bipolar-1-disor.pdf2022-11-07 23:00 143K 
[ ]16758_randomized-double-blind-placebo-controlled-8-week-trial-efficacy-tolerability-multiple-doses-adults-.pdf2022-11-07 22:13 378K 
[ ]16759_randomized-double-blind-placebo-controlled-add-trial.pdf2022-11-07 22:50 161K 
[ ]16760_randomized-double-blind-placebo-controlled-efficacy.pdf2022-11-07 22:57 255K 
[ ]16761_randomized-double-blind-placebo-controlled-multicenter.pdf2022-11-07 22:13 674K 
[ ]16762_randomized-double-blind-placebo-controlled-parallel.pdf2022-11-07 22:25 315K 
[ ]16763_randomized-double-blind-placebo-controlled-study-classical.pdf2022-11-07 22:58 62K 
[ ]16764_randomized-double-blind-placebo-controlled-study-divalproex.pdf2022-11-07 22:26 383K 
[ ]16765_randomized-double-blind-placebo-controlled-study-dose.pdf2022-11-07 22:09 432K 
[ ]16766_randomized-double-blind-placebo-controlled-study-effects.pdf2022-11-07 22:42 61K 
[ ]16767_randomized-double-blind-placebo-controlled-study-efficacy-safety-vortioxetine-10-20-mg-adults-MDD.pdf2022-11-07 22:40 280K 
[ ]16768_randomized-double-blind-placebo-controlled-study-efficacy-safety-vortioxetine-2-doses-adults-MDD.pdf2022-11-07 22:43 300K 
[ ]16769_randomized-double-blind-placebo-controlled-study-evaluating.pdf2022-11-07 22:09 388K 
[ ]16770_randomized-double-blind-placebo-controlled-study-light.pdf2022-11-07 22:19 390K 
[ ]16771_randomized-double-blind-placebo-controlled-study-safety.pdf2022-11-07 22:01 367K 
[ ]16772_randomized-double-blind-placebo-controlled-study-testosterone.pdf2022-11-07 22:38 334K 
[ ]16773_randomized-double-blind-placebo-controlled-study-ziprasidone.pdf2022-11-07 22:53 494K 
[ ]16774_randomized-double-blind-placebo-controlled-trial-aripiprazole.pdf2022-11-07 22:30 1.0M 
[ ]16775_randomized-double-blind-placebo-controlled-trial-buspirone.pdf2022-11-07 22:15 40K 
[ ]16776_randomized-double-blind-placebo-controlled-trial-desvenlafaxine.pdf2022-11-07 23:02 253K 
[ ]16777_randomized-double-blind-placebo-controlled-trial-long.pdf2022-11-07 22:33 205K 
[ ]16778_randomized-double-blind-placebo-controlled-trial-moclobemide.pdf2022-11-07 22:45 59K 
[ ]16779_randomized-double-blind-placebo-controlled-trial-modafinil-apathy-mild-moderate-Alzheimer.pdf2022-11-07 22:33 222K 
[ ]16780_randomized-double-blind-placebo-controlled-trial-modafinil-negative-symptoms-schizophrenia.pdf2022-11-07 22:18 165K 
[ ]16781_randomized-double-blind-placebo-controlled-trial-olanzapine.pdf2022-11-07 22:12 365K 
[ ]16782_randomized-double-blind-placebo-controlled-trial-pramipexole.pdf2022-11-07 22:13 354K 
[ ]16783_randomized-double-blind-placebo-controlled-week-study.pdf2022-11-07 23:01 360K 
[ ]16784_randomized-double-blind-study-increasing-maintaining.pdf2022-11-07 22:22 281K 
[ ]16785_randomized-double-blind-trial-atomoxetine-cognitive.pdf2022-11-07 22:21 225K 
[ ]16786_randomized-double-blind-trial-paroxetine-andor-dextroamphetamine.pdf2022-11-07 22:54 117K 
[ ]16787_randomized-observer-blind-controlled-trial-traditional.pdf2022-11-07 23:00 112K 
[ ]16788_randomized-pilot-study-efficacy-safety-abt-novel.pdf2022-11-07 23:01 325K 
[ ]16789_randomized-placebo-controlled-adjunctive-study-extract.pdf2022-11-07 22:17 400K 
[ ]16790_randomized-placebo-controlled-clinical-trial-bupropion.pdf2022-11-07 22:59 203K 
[ ]16791_randomized-placebo-controlled-dose-response-trial.pdf2022-11-07 22:48 119K 
[ ]16792_randomized-placebo-controlled-multicenter-study-divalproex-sodium-extended-release-acute-mania-bipol.pdf2022-11-07 23:01 345K 
[ ]16793_randomized-placebo-controlled-trial-asenapine-prevention.pdf2022-11-07 22:53 449K 
[ ]16794_randomized-placebo-controlled-trial-baclofen-cocaine.pdf2022-11-07 22:01 80K 
[ ]16795_randomized-placebo-controlled-trial-electroencephalographic.pdf2022-11-07 22:26 406K 
[ ]16796_randomized-placebo-controlled-trial-ltemgtnltemgt.pdf2022-11-07 22:12 371K 
[ ]16797_randomized-placebo-controlled-trial-risperidone-treatment.pdf2022-11-07 22:21 82K 
[ ]16798_randomized-trial-brief-cognitive-behavioral-therapy.pdf2022-11-07 22:47 191K 
[ ]16799_randomized-trial-cognitive-behavioral-therapy-selective.pdf2022-11-07 22:34 590K 
[ ]16800_randomized-trial-comparing-paroxetine-venlafaxine.pdf2022-11-07 22:24 50K 
[ ]16801_randomized-trial-concurrent-smoking-cessation-substance.pdf2022-11-07 22:55 513K 
[ ]16802_randomized-trial-efficacy-bright-light-exposure-aerobic.pdf2022-11-07 22:08 70K 
[ ]16803_randomized-trial-sertraline-versus-venlafaxine-xr.pdf2022-11-07 22:50 210K 
[ ]16804_rapid-conversion-monoamine-oxidase-inhibitor-another.pdf2022-11-07 22:50 29K 
[ ]16805_rapid-cycling-bipolar-disorder-systematic-review.pdf2022-11-07 22:23 434K 
[ ]16806_rapid-efficacy-olanzapine-augmentation-nonpsychotic.pdf2022-11-07 22:16 100K 
[ ]16807_rapid-eye-movement-sleep.pdf2022-11-07 22:53 31K 
[ ]16808_rapid-fade-antidepressant-effect-nefazodone-bipolar.pdf2022-11-07 22:57 67K 
[ ]16809_rapid-metabolic-changes-after-antipsychotic-treatment.pdf2022-11-07 22:14 1.1M 
[ ]16810_rapid-non-rapid-cycling-bipolar-disorder-meta-analysis.pdf2022-11-07 22:41 85K 
[ ]16811_rapid-onset-antidepressant-action-paradigm-research.pdf2022-11-07 22:03 357K 
[ ]16812_rapid-onset-antidepressant-activity-venlafaxine.pdf2022-11-07 22:04 47K 
[ ]16813_rapid-onset-therapeutic-effect-risperidone-versus.pdf2022-11-07 22:25 44K 
[ ]16814_rapid-resolution-obsessions-infusion-intravenous-ketamine.pdf2022-11-07 22:28 237K 
[ ]16815_rapid-resolution-suicidal-ideation-single-infusion.pdf2022-11-07 22:28 453K 
[ ]16816_rapid-titration-mood-stabilizers-predicts-remission.pdf2022-11-07 22:43 111K 
[ ]16817_rapid-tranquilization-olanzapine-acute-psychosis-case.pdf2022-11-07 22:11 61K 
[ ]16818_rapid-treatment-response-suicidal-symptoms-lithium.pdf2022-11-07 22:06 520K 
[ ]16819_rapid-versus-conventional-initiation-quetiapine-treatment.pdf2022-11-07 22:49 178K 
[ ]16820_rap-mania.pdf2022-11-07 22:15 67K 
[ ]16821_rash-multicenter-trials-lamotrigine-mood-disorders.pdf2022-11-07 22:23 69K 
[ ]16822_rates-major-malformations-infants-following-exposure.pdf2022-11-07 22:56 86K 
[ ]16823_rating-scales-attention-deficit-hyperactivity-disorder.pdf2022-11-07 22:23 96K 
[ ]16824_rating-scales-depression-elderly-external-internal.pdf2022-11-07 22:50 145K 
[ ]16826_rationale-guidelines-inpatient-treatment-acute-psychosis.pdf2022-11-07 22:45 57K 
[ ]16827_rationale-long-term-treatment-bipolar-disorder-evidence.pdf2022-11-07 22:16 84K 
[ ]16828_rationale-using-lithium-combination-mood-stabilizers.pdf2022-11-07 22:34 77K 
[ ]16829_reach-benchmark-psychiatric-trial-results-community.pdf2022-11-07 22:12 183K 
[ ]16830_reactivity-different-levels-cognitive-analysis-products.pdf2022-11-07 22:25 112K 
[ ]16831_reading-reports-clinical-trial-results.pdf2022-11-07 22:11 37K 
[ ]16832_realistic-expectations-disease-management-model-depressed.pdf2022-11-07 22:25 115K 
[ ]16833_real-life-dosing-second-generation-antipsychotics.pdf2022-11-07 22:22 71K 
[ ]16834_real-life-switching-strategies-second-generation-antipsychotics.pdf2022-11-07 23:01 59K 
[ ]16835_really-accelerate-enhance-selective-serotonin-reuptake.pdf2022-11-07 23:02 411K 
[ ]16836_real-world-outcomes-paliperidone-palmitate-compared.pdf2022-11-07 22:55 1.1M 
[ ]16837_reanalysis-efficacy-interpersonal-psychotherapy-antepartum.pdf2022-11-07 22:40 272K 
[ ]16838_reasons-antidepressant-nonadherence-among-veterans.pdf2022-11-07 22:35 261K 
[ ]16839_reasons-inadequate-utilization-cognitive-behavioral.pdf2022-11-07 22:11 208K 
[ ]16840_rebound-psychiatric-physical-symptoms-gabapentin-discontinuation.pdf2022-11-07 22:18 80K 
[ ]16841_reboxetine-induced-hypomania.pdf2022-11-07 22:43 98K 
[ ]16842_reboxetine-selective-norepinephrine-reuptake-inhibitor.pdf2022-11-07 22:29 67K 
[ ]16843_reboxetine-treatment-depression-parkinsons-disease.pdf2022-11-07 22:15 54K 
[ ]16844_reboxetine-unique-selective-nri-prevents-relapse-recurrence.pdf2022-11-07 22:13 70K 
[ ]16845_reboxetine-versus-fluoxetine-overview-efficacy-tolerability.pdf2022-11-07 22:14 90K 
[ ]16846_recent-advances-depression-research-stress-molecular.pdf2022-11-07 22:54 23K 
[ ]16847_recent-advances-treatment-depression-presence-physical.pdf2022-11-07 22:09 140K 
[ ]16848_recent-developments-neurobiology-obsessive-compulsive.pdf2022-11-07 22:51 70K 
[ ]16849_recent-findings-genetics-ocd.pdf2022-11-07 22:48 44K 
[ ]16850_recent-successes-and-failures-in-treating-depression.pdf2022-11-07 22:02 265K 
[ ]16851_receptor-binding-profiles-antipsychotics-clinical.pdf2022-11-07 22:17 130K 
[ ]16852_receptor-pharmacology-neuroleptics-relation-clinical.pdf2022-11-07 22:27 95K 
[ ]16853_recidivism-medication-noncompliant-serious-juvenile.pdf2022-11-07 22:13 173K 
[ ]16854_recognition-assessment-sexual-dysfunction-associated.pdf2022-11-07 22:02 51K 
[ ]16855_recognition-diagnosis-atypical-depression.pdf2022-11-07 23:03 170K 
[ ]16856_recognition-diagnosis-bipolar-disorder.pdf2022-11-07 22:57 61K 
[ ]16857_recognition-management-early-psychosis-preventive.pdf2022-11-07 22:49 45K 
[ ]16858_recognition-molecules-are-trailblazers-axon-pathways.pdf2022-11-07 22:51 27K 
[ ]16860_recognition-prevention-major-mental-substance-disorders.pdf2022-11-07 22:42 131K 
[ ]16861_recognition-treatment-dsm-iv-intermittent-explosive.pdf2022-11-07 22:26 49K 
[ ]16865_recognizing-and-treating-eds-in-patients-with-narcolepsy.pdf2022-11-07 22:02 374K 
[ ]16870_recognizing-managing-bipolar-disorder-children.pdf2022-11-07 22:20 118K 
[ ]16874_recognizing-parents-symptoms-obesity-bipolar-depression.pdf2022-11-07 22:36 48K 
[ ]16877_recognizing-sleep-disorders-primary-care-setting.pdf2022-11-07 22:13 47K 
[ ]16878_recognizing-treating-anxiety-elderly.pdf2022-11-07 22:10 41K 
[ ]16879_recognizing-treating-premenstrual-dysphoric-disorder.pdf2022-11-07 23:02 85K 
[ ]16880_recombinant-human-erythropoietin-target-cognitive.pdf2022-11-07 22:49 733K 
[ ]16881_recommendations-monitoring-serum-concentrations-antipsychotic.pdf2022-11-07 22:09 120K 
[ ]16882_recommended-haloperidol-risperidone-doses-episode.pdf2022-11-07 22:43 37K 
[ ]16884_reconceptualizing-medication-management-implications.pdf2022-11-07 22:11 262K 
[ ]16885_reconsidering-dietary-polyunsaturated-fatty-acids-in-bipolar-disorder.pdf2022-11-07 22:12 282K 
[ ]16886_record-based-analysis-patients-treated-depression.pdf2022-11-07 22:22 68K 
[ ]16887_recovery-depression-predicts-lower-health-services.pdf2022-11-07 22:07 82K 
[ ]16888_recovery-from-a-major-depressive-episode.pdf2022-11-07 22:47 149K 
[ ]16889_recovery-from-anorexia-and-bulimia-at-year-follow-up.pdf2022-11-07 22:10 257K 
[ ]16890_recovery-multiple-episodes-bipolar-i-depression.pdf2022-11-07 22:38 301K 
[ ]16891_recovery-oriented-psychopharmacology-redefining-goals.pdf2022-11-07 22:23 71K 
[ ]16892_recovery-recurrence-following-episode-mania-systematic.pdf2022-11-07 23:01 1.4M 
[ ]16893_recovery-schizophrenic-psychoses-within-northern-finland.pdf2022-11-07 22:38 160K 
[ ]16894_recovery-tsunami-timeline-rehabilitation.pdf2022-11-07 22:02 90K 
[ ]16895_rectal-antidepressant-medication-treatment-depression.pdf2022-11-07 22:21 140K 
[ ]16896_recurrence-lamotrigine-associated-rash-rechallenge.pdf2022-11-07 22:23 100K 
[ ]16897_recurrent-cases-corticosteroid-induced-mood-disorder.pdf2022-11-07 22:08 60K 
[ ]16898_recurrent-mood-shifts-premenstrual-dysphoric-disorder.pdf2022-11-07 22:39 35K 
[ ]16899_recurrent-priapism-associated-aripiprazole.pdf2022-11-07 22:53 88K 
[ ]16900_recursive-subsetting-identify-patients-stard-method.pdf2022-11-07 22:41 303K 
[ ]16901_redeem-person-is-redeem-world-life-frieda-fromm-reichmann.pdf2022-11-07 22:01 42K 
[ ]16902_redefining-antidepressant-efficacy-toward-long-term.pdf2022-11-07 22:43 57K 
[ ]16903_reduced-anterior-cingulate-orbitofrontal-volumes-child.pdf2022-11-07 22:05 1.9M 
[ ]16904_reduced-posterior-hippocampal-volume-posttraumatic.pdf2022-11-07 22:29 152K 
[ ]16905_reduced-suicidal-ideation-bipolar-i-disorder-mixed.pdf2022-11-07 22:47 107K 
[ ]16906_reduced-suicide-risk-during-lithium-maintenance-treatment.pdf2022-11-07 22:54 71K 
[ ]16907_reducing-anticholinergic-burden-in-smi.pdf2022-11-07 22:37 538K 
[ ]16908_reducing-burden-side-effects-during-long-term-antipsychotic.pdf2022-11-07 22:58 246K 
[ ]16909_reducing-clozapine-related-morbidity-mortality-years.pdf2022-11-07 22:37 32K 
[ ]16910_reducing-cost-burden-depression-incorporate-heart.pdf2022-11-07 22:46 106K 
[ ]16911_reducing-dropout-treatment-depression-translating.pdf2022-11-07 22:24 312K 
[ ]16912_reducing-risk-suicide-schizophrenia-affective-disorders.pdf2022-11-07 22:19 86K 
[ ]16913_reducing-violence-risk-persons-schizophrenia-olanzapine.pdf2022-11-07 22:28 65K 
[ ]16914_reduction-alcohol-consumption-subsequent-mortality.pdf2022-11-07 22:34 962K 
[ ]16915_reduction-alcohol-drinking-young-adults-naltrexone.pdf2022-11-07 22:09 781K 
[ ]16916_reduction-crime-onset-psychosis-secondary-analysis.pdf2022-11-07 22:55 353K 
[ ]16917_reduction-opioid-withdrawal-symptoms-quetiapine.pdf2022-11-07 22:58 96K 
[ ]16918_reductions-quality-life-associated-common-mental-disorders.pdf2022-11-07 22:20 233K 
[ ]16919_reduction-suicidal-ideation-following-repeated-doses.pdf2022-11-07 22:15 79K 
[ ]16920_reel-psychiatry-movie-portrayals-psychiatric-conditions.pdf2022-11-07 22:10 106K 
[ ]16921_reemergence-sexual-dysfunction-patients-major-depressive.pdf2022-11-07 22:41 62K 
[ ]16922_reevaluating-sensitivity-of-self-reported-suicidal-ideation.pdf2022-11-07 22:04 90K 
[ ]16923_reevaluating-therapies-bipolar-depression.pdf2022-11-07 22:30 171K 
[ ]16924_reexamining-paroxetine-cognitive-behavioral-therapy.pdf2022-11-07 22:56 141K 
[ ]16925_refining-maoi-diet-tyramine-content-pizzas-soy-products.pdf2022-11-07 22:09 34K 
[ ]16926_refining-posttraumatic-stress-disorder-diagnosis-evaluation.pdf2022-11-07 22:18 228K 
[ ]16927_refining-questions-womens-mental-health.pdf2022-11-07 22:14 37K 
[ ]16928_reflections-perinatal-depression-treatment.pdf2022-11-07 22:56 188K 
[ ]16929_refractory-depression-cardiovascular-risk-factors.pdf2022-11-07 22:15 42K 
[ ]16930_refractory-generalized-anxiety-disorder.pdf2022-11-07 22:46 267K 
[ ]16931_refractory-obsessive-compulsive-disorder-state-art.pdf2022-11-07 22:05 82K 
[ ]16932_regular-daily-smoking-among-old-adolescents-increases.pdf2022-11-07 22:22 248K 
[ ]16933_regulatory-scientific-issues-studies-evaluate-sexual.pdf2022-11-07 22:14 137K 
[ ]16934_rehospitalization-in-depressed-adolescents.pdf2022-11-07 22:44 277K 
[ ]16935_rehospitalization-patients-major-depressive-disorder.pdf2022-11-07 22:44 176K 
[ ]16936_relapse-aggressive-disruptive-behavior-mentally-retarded.pdf2022-11-07 23:02 91K 
[ ]16937_relapse-comparison-of-paliperidone-formulations.pdf2022-11-07 22:45 1.0M 
[ ]16938_relapse-pedophilic-sex-offending-subsequent-suicide.pdf2022-11-07 22:43 52K 
[ ]16939_relapse-prevention-episode-schizophreniamaintenance.pdf2022-11-07 23:01 552K 
[ ]16940_relapse-prevention-panic-disorder-adult-outpatient.pdf2022-11-07 22:58 128K 
[ ]16942_relapse-prevention-recovery-treatment-schizophrenia.pdf2022-11-07 22:52 86K 
[ ]16943_relapse-prevention-residual-symptoms-closer-analysis.pdf2022-11-07 22:52 439K 
[ ]16944_relapse-rates-patients-schizophrenia-receiving-aripiprazole.pdf2022-11-07 22:46 94K 
[ ]16945_relapse-rehospitalization-comparing-oral-depot-antipsychotics.pdf2022-11-07 22:44 50K 
[ ]16946_relapsing-paranoid-psychosis-manifestation-pheochromocytoma.pdf2022-11-07 22:25 102K 
[ ]16947_relation-between-anger-expression-depression-somatic.pdf2022-11-07 22:39 131K 
[ ]16948_relations-among-psychopathology-substance-physical.pdf2022-11-07 22:23 307K 
[ ]16949_relation-serotonin-related-gene-comt-gene-polymorphisms.pdf2022-11-07 22:49 287K 
[ ]16950_relation-serum-anticholinergicity-cognitive-status.pdf2022-11-07 22:02 125K 
[ ]16951_relationship-between-acculturation-discrimination.pdf2022-11-07 22:16 403K 
[ ]16952_relationship-between-adverse-childhood-experiences.pdf2022-11-07 22:22 359K 
[ ]16953_relationship-between-affective-state-rhythmicity-activity.pdf2022-11-07 22:57 376K 
[ ]16954_relationship-between-antidepressant-treatment-suicide.pdf2022-11-07 22:03 67K 
[ ]16955_relationship-between-antipsychotic-treatment-quality.pdf2022-11-07 22:55 65K 
[ ]16956_relationship-between-bipolar-disorder-biological-rhythms.pdf2022-11-07 22:07 395K 
[ ]16957_relationship-between-borderline-personality-disorder.pdf2022-11-07 22:01 42K 
[ ]16958_relationship-between-costs-symptoms-schizophrenia.pdf2022-11-07 22:23 68K 
[ ]16959_relationship-between-daily-dose-plasma-concentrations.pdf2022-11-07 22:44 612K 
[ ]16960_relationship-between-depression-sleep-disturbances.pdf2022-11-07 22:26 110K 
[ ]16961_relationship-between-neurocognitive-psychosocial-functioning.pdf2022-11-07 22:53 501K 
[ ]16962_relationship-between-postpartum-psychosis-bipolar.pdf2022-11-07 22:30 71K 
[ ]16963_relationship-between-quality-life-clinical-efficacy.pdf2022-11-07 22:53 85K 
[ ]16964_relationship-between-serum-homocysteine-levels-depressive.pdf2022-11-07 22:17 304K 
[ ]16965_relationship-between-smoking-suicidal-behavior-comorbidity.pdf2022-11-07 22:40 75K 
[ ]16966_relationship-between-types-severity-repetitive-behaviors.pdf2022-11-07 22:06 79K 
[ ]16967_relationship-between-zolpidem-stroke-risk-taiwanese.pdf2022-11-07 22:48 326K 
[ ]16968_relationship-gender-trauma-characteristics-posttraumatic.pdf2022-11-07 23:03 161K 
[ ]16969_relationship-mood-disturbance-cigarette-smoking-status.pdf2022-11-07 22:48 58K 
[ ]16970_relationship-neurotransmitters-symptoms-major-depressive.pdf2022-11-07 22:25 148K 
[ ]16971_relationship-nicotine-dependence-subsyndromal-pathological.pdf2022-11-07 22:39 277K 
[ ]16972_relationship-persistent-manic-symptoms-diagnosis-pediatric.pdf2022-11-07 22:40 371K 
[ ]16973_relationship-personality-disorders-treatment-outcome.pdf2022-11-07 22:54 54K 
[ ]16974_relationship-pharmacology-side-effects.pdf2022-11-07 22:02 53K 
[ ]16975_relationship-prior-antidepressant-exposure-long-term.pdf2022-11-07 22:31 285K 
[ ]16976_relationships-age-onset-clinical-features-cognitive.pdf2022-11-07 22:47 58K 
[ ]16977_relationships-between-childhood-maltreatment-adult.pdf2022-11-07 22:17 59K 
[ ]16978_relationships-between-obsessive-compulsive-symptomatology.pdf2022-11-07 23:03 346K 
[ ]16979_relationships-environment-personal-characteristics.pdf2022-11-07 22:11 326K 
[ ]16980_relative-abuse-liability-hypnotic-drugs-conceptual.pdf2022-11-07 23:02 195K 
[ ]16981_relative-contribution-cognition-symptomatic-remission.pdf2022-11-07 22:48 365K 
[ ]16982_relative-contributions-psychiatric-symptoms-aids-knowledge.pdf2022-11-07 22:07 49K 
[ ]16983_relative-weight-gain-among-antipsychotics.pdf2022-11-07 22:17 45K 
[ ]16984_relevance-family-history-suicide-long-term-outcome.pdf2022-11-07 22:26 131K 
[ ]16985_relevance-httlpr-polymorphism-childhood-abuse-increased.pdf2022-11-07 22:48 277K 
[ ]16986_reliability-and-validity-of-the-sheehan-irritability-scale-in-mdd.pdf2022-11-07 22:17 282K 
[ ]16987_reliability-overdiagnosis.pdf2022-11-07 22:32 177K 
[ ]16988_reliability-validity-mini-international-neuropsychiatric.pdf2022-11-07 22:43 1.6M 
[ ]16989_reliability-validity-screening-questionnaire-dsm-iv.pdf2022-11-07 22:49 43K 
[ ]16990_relief-ssri-induced-sexual-dysfunction-mirtazapine.pdf2022-11-07 23:03 57K 
[ ]16991_religion-culture-mental-health.pdf2022-11-07 22:51 99K 
[ ]16992_religious-spiritual-issues-psychiatric-diagnosis-research.pdf2022-11-07 22:57 154K 
[ ]16993_remarkable-antidepressant-augmentation-effect-raloxifene.pdf2022-11-07 22:59 170K 
[ ]16994_remembering-trauma.pdf2022-11-07 22:32 32K 
[ ]16995_remission-episode-psychosis-predictor-variables-symptom.pdf2022-11-07 22:22 97K 
[ ]16996_remission-generalized-anxiety-disorder-review-paroxetine.pdf2022-11-07 22:28 106K 
[ ]16998_remission-rates-consecutive-antidepressant-trials.pdf2022-11-07 22:25 128K 
[ ]16999_remission-rates-following-antidepressant-therapy-bupropion.pdf2022-11-07 22:17 186K 
[ ]17000_remission-rates-patients-anxiety-disorders-treated.pdf2022-11-07 22:46 81K 
[ ]17001_remission-residual-symptoms-nonresponse-usual-treatment.pdf2022-11-07 22:54 62K 
[ ]17002_remission-ssri-induced-akathisia-switch-nefazodone.pdf2022-11-07 22:37 86K 
[ ]17004_remission-versus-response-gold-standard-antidepressant.pdf2022-11-07 23:00 64K 
[ ]17005_rem-sleep-behavior-disorder-psychiatric-populations.pdf2022-11-07 22:15 166K 
[ ]17006_renaissance-clinical-psychiatry-through-books-published.pdf2022-11-07 22:08 40K 
[ ]17007_renal-insufficiency-long-term-lithium-treatment.pdf2022-11-07 22:14 67K 
[ ]17008_renal-toxicity-long-term-lithium-treatment-mild-cognitive.pdf2022-11-07 22:32 124K 
[ ]17009_renin-angiotensin-pathway-posttraumatic-stress-disorder.pdf2022-11-07 22:18 285K 
[ ]17010_repeated-infections-and-mdd-risk.pdf2022-11-07 22:25 524K 
[ ]17011_repeated-ingestion-grapefruit-juice-does-alter-clozapines.pdf2022-11-07 22:37 58K 
[ ]17012_repeated-ketamine-infusions-for-comorbid-ptsd-and-trd.pdf2022-11-07 22:13 384K 
[ ]17013_repetition-suicidal-behavior-multicenter-cohort-study.pdf2022-11-07 23:02 115K 
[ ]17014_repetitive-transcranial-magnetic-stimulation-maintenance.pdf2022-11-07 22:03 82K 
[ ]17015_repetitive-transcranial-magnetic-stimulation-negative.pdf2022-11-07 22:43 298K 
[ ]17016_repetitive-transcranial-magnetic-stimulation-treatment.pdf2022-11-07 22:38 2.0M 
[ ]17017_reply-accurate-meta-analytical-assesment-true-antidepressants.pdf2022-11-07 22:33 92K 
[ ]17018_reply-acupuncture-major-depressive-disorder-has-efficacy.pdf2022-11-07 22:47 155K 
[ ]17019_reply-agitation-inpatient-suicide.pdf2022-11-07 23:00 48K 
[ ]17020_reply-amitriptyline-dual-action-antidepressant.pdf2022-11-07 22:38 50K 
[ ]17021_reply-anger-bipolar-depression.pdf2022-11-07 22:11 72K 
[ ]17022_reply-anger-depressive-mixed-states.pdf2022-11-07 22:24 52K 
[ ]17023_reply-anticholinergic-mechanisms-forgotten-cause-switch.pdf2022-11-07 22:56 110K 
[ ]17024_reply-antidepressant-risk-suicide-attempts-bipolar.pdf2022-11-07 22:47 133K 
[ ]17025_reply-antidepressants-acute-bipolar-depression-inconclusive.pdf2022-11-07 22:58 133K 
[ ]17026_reply-antidepressants-bipolar-disorder-caveats-interpreting.pdf2022-11-07 22:02 81K 
[ ]17027_reply-antidepressants-really-beget-more-depressive.pdf2022-11-07 22:33 134K 
[ ]17028_reply-antipsychotic-induces-sexual-disfunction-strength.pdf2022-11-07 22:51 140K 
[ ]17029_reply-antipsychotic-medication-diabetes.pdf2022-11-07 22:40 134K 
[ ]17030_reply-apparent-commericial-bias-supplement.pdf2022-11-07 22:47 210K 
[ ]17031_reply-applicability-oral-glucose-tolerance-test-assessing.pdf2022-11-07 22:01 256K 
[ ]17032_reply-applying-parsimony-african-patient-ziprasidone.pdf2022-11-07 22:26 141K 
[ ]17033_reply-aripiprazole-perphenazine-difference.pdf2022-11-07 22:54 158K 
[ ]17034_reply-artificial-rediagnosis-psychotic-depression.pdf2022-11-07 22:30 84K 
[ ]17035_reply-association-benzodiazepine-increased-cancer.pdf2022-11-07 22:11 88K 
[ ]17036_reply-attention-deficit-hyperactivity-disorder-binge.pdf2022-11-07 22:35 196K 
[ ]17037_reply-augmentation-dopaminergic-agents-major-depressive.pdf2022-11-07 22:16 124K 
[ ]17038_reply-azithromycin-catatonic-symptoms.pdf2022-11-07 22:35 153K 
[ ]17039_reply-burning-mouth-syndrome-side-effect-ssris.pdf2022-11-07 22:36 79K 
[ ]17040_reply-cardiopulmonary-complications-ergot-derivative.pdf2022-11-07 22:22 53K 
[ ]17041_reply-clozapine-interchangeability-issues.pdf2022-11-07 22:29 256K 
[ ]17042_reply-commentary-rothschild-blood-test-depression.pdf2022-11-07 22:56 82K 
[ ]17043_reply-comment-lithium-clozapine-rechallenge-retrospective.pdf2022-11-07 22:13 170K 
[ ]17044_reply-comments-cost-analysis-risperidone-versus-olanzapine.pdf2022-11-07 22:25 62K 
[ ]17045_reply-comments-randomized-double-blind-comparison.pdf2022-11-07 22:16 208K 
[ ]17046_reply-continuum-hypothesis-mood-disorders.pdf2022-11-07 22:48 204K 
[ ]17047_reply-cost-cost-effectiveness-randomized-trial-long.pdf2022-11-07 22:22 119K 
[ ]17048_reply-development-atherogenic-metabolic-risk-factor.pdf2022-11-07 22:56 124K 
[ ]17049_reply-different-mechanism-understand-activationsedation.pdf2022-11-07 22:13 196K 
[ ]17050_reply-discussion-double-blind-studies-comparing-risperidone.pdf2022-11-07 22:08 153K 
[ ]17051_reply-divalproex-versus-olanzapine-mania.pdf2022-11-07 22:49 54K 
[ ]17052_reply-does-combat-trauma-cause-majority-ptsd-symptoms.pdf2022-11-07 22:06 133K 
[ ]17053_reply-does-depressive-state-influence-reported-attachment.pdf2022-11-07 22:22 758K 
[ ]17054_reply-dosing-divalproex-extended-release.pdf2022-11-07 22:10 140K 
[ ]17055_reply-effectiveness-close-watch-precautions-suicidal.pdf2022-11-07 22:34 49K 
[ ]17056_reply-effects-newer-antidepressants-low-density-lipoprotein.pdf2022-11-07 22:18 58K 
[ ]17057_reply-emerging-role-atypical-antipsychotics-treatment.pdf2022-11-07 22:36 149K 
[ ]17058_reply-evidence-short-term-psychodynamic-psychotherapy.pdf2022-11-07 23:01 132K 
[ ]17059_reply-failure-rate-professional-subjects-clinical.pdf2022-11-07 22:33 148K 
[ ]17060_reply-folate-supplementation-is-safe-effective.pdf2022-11-07 22:31 151K 
[ ]17061_reply-galantamine-qtc-prolongation.pdf2022-11-07 23:00 110K 
[ ]17062_reply-importance-negative-comorbidity.pdf2022-11-07 22:44 718K 
[ ]17063_reply-increased-efficacy-addition-clozapine-arpipipazole.pdf2022-11-07 22:08 134K 
[ ]17064_reply-increasing-energy-expenditure-is-important-enchance.pdf2022-11-07 23:00 103K 
[ ]17065_reply-indexing-reports-aripiprazole-augmentation-clozapine.pdf2022-11-07 22:39 153K 
[ ]17066_reply-injection-site-pain-long-acting-risperidone.pdf2022-11-07 22:52 117K 
[ ]17067_reply-insulin-resistance-glucose-metabolism-patients.pdf2022-11-07 22:24 221K 
[ ]17068_reply-intrinsic-activity-aripiprazole-is-dopamine.pdf2022-11-07 22:38 185K 
[ ]17069_reply-isotretinoin-risk-depression.pdf2022-11-07 22:38 739K 
[ ]17070_reply-is-real-difference-between-onset-efficancy-atypicla.pdf2022-11-07 22:42 165K 
[ ]17071_reply-is-real-difference-severity-tardive-dyskinesia.pdf2022-11-07 22:43 89K 
[ ]17072_reply-is-smoking-associated-suicide-bipolar-patients.pdf2022-11-07 22:54 153K 
[ ]17073_reply-issues-consider-assement-treatment-paraphilic.pdf2022-11-07 22:18 105K 
[ ]17074_reply-keeping-em-honest-current-crisis-confidence.pdf2022-11-07 22:40 145K 
[ ]17075_reply-letter-editor-affective-illness-epilepsy.pdf2022-11-07 22:15 44K 
[ ]17076_reply-letter-editor-analgesic-effect-antidepressants.pdf2022-11-07 22:32 62K 
[ ]17077_reply-letter-editor-antidepressant-effects-nicotine.pdf2022-11-07 22:48 45K 
[ ]17078_reply-letter-editor-antiepileptic-drug-augmentation.pdf2022-11-07 22:21 43K 
[ ]17079_reply-letter-editor-association-between-premenstrual.pdf2022-11-07 22:41 51K 
[ ]17080_reply-letter-editor-capitation.pdf2022-11-07 22:20 38K 
[ ]17081_reply-letter-editor-cardiorespiratory-problems-clozapine.pdf2022-11-07 22:25 37K 
[ ]17082_reply-letter-editor-choosing-dosing-strategy-electrical.pdf2022-11-07 22:29 42K 
[ ]17083_reply-letter-editor-clarifying-safety-maoi-diet-pizza.pdf2022-11-07 22:18 49K 
[ ]17084_reply-letter-editor-clinical-features-bipolar-depression.pdf2022-11-07 22:45 64K 
[ ]17085_reply-letter-editor-clinical-manifestations-dystonia.pdf2022-11-07 22:48 43K 
[ ]17086_reply-letter-editor-clozapine-related-speech-disturbance.pdf2022-11-07 22:04 38K 
[ ]17087_reply-letter-editor-combination-therapy-is-clinical.pdf2022-11-07 22:20 62K 
[ ]17088_reply-letter-editor-combined-antidepressant-treatment.pdf2022-11-07 23:02 47K 
[ ]17089_reply-letter-editor-comparing-efficacy-safety-fluoxetine.pdf2022-11-07 22:02 67K 
[ ]17090_reply-letter-editor-comparison-valproic-acid-lithium.pdf2022-11-07 22:18 42K 
[ ]17091_reply-letter-editor-continuing-dialogue-incentive.pdf2022-11-07 22:56 45K 
[ ]17092_reply-letter-editor-correction.pdf2022-11-07 22:34 44K 
[ ]17093_reply-letter-editor-cost-effectiveness-divalproex.pdf2022-11-07 23:03 43K 
[ ]17094_reply-letter-editor-defining-psychosis-ptsd.pdf2022-11-07 22:12 67K 
[ ]17095_reply-letter-editor-design-interpretability-findings.pdf2022-11-07 22:24 47K 
[ ]17096_reply-letter-editor-discontinuation-symptoms-ssris.pdf2022-11-07 22:28 38K 
[ ]17097_reply-letter-editor-efficacy-estradiol-depression.pdf2022-11-07 22:12 121K 
[ ]17098_reply-letter-editor-emdr-treatment-ptsd.pdf2022-11-07 22:35 44K 
[ ]17099_reply-letter-editor-emdr-women-experience-traumatic.pdf2022-11-07 22:02 68K 
[ ]17100_reply-letter-editor-free-drug-fraction-versus-free.pdf2022-11-07 22:50 66K 
[ ]17101_reply-letter-editor-further-discussion-emdr-treatment.pdf2022-11-07 22:06 45K 
[ ]17102_reply-letter-editor-gastrointestinal-adverse-effects.pdf2022-11-07 22:54 69K 
[ ]17103_reply-letter-editor-gold-versus-silver-issue-functional.pdf2022-11-07 22:14 65K 
[ ]17104_reply-letter-editor-guideline-series-commentary.pdf2022-11-07 22:09 45K 
[ ]17105_reply-letter-editor-high-frequency-residual-depressive.pdf2022-11-07 22:27 68K 
[ ]17106_reply-letter-editor-high-prevalence-bipolar-spectrum.pdf2022-11-07 22:35 53K 
[ ]17107_reply-letter-editor-impact-smoking-ban-locked-psychiatric.pdf2022-11-07 22:02 92K 
[ ]17108_reply-letter-editor-improved-outcome-fluvoxamine-treated.pdf2022-11-07 22:30 35K 
[ ]17109_reply-letter-editor-inaccurate-information-quetiapine.pdf2022-11-07 22:02 38K 
[ ]17110_reply-letter-editor-injection-depot-antipsychotic.pdf2022-11-07 22:10 58K 
[ ]17111_reply-letter-editor-is-antipsychotic-drug-induced.pdf2022-11-07 22:19 51K 
[ ]17112_reply-letter-editor-is-divalproex-cost-effective-alternative.pdf2022-11-07 22:58 44K 
[ ]17113_reply-letter-editor-limbic-leucotomy-self-mutilation.pdf2022-11-07 22:39 83K 
[ ]17114_reply-letter-editor-lithium-therapy-corticosteroid.pdf2022-11-07 22:08 69K 
[ ]17115_reply-letter-editor-long-term-antidepressant-depressogenic.pdf2022-11-07 22:31 55K 
[ ]17116_reply-letter-editor-manufacturer-support-outcome.pdf2022-11-07 22:01 50K 
[ ]17117_reply-letter-editor-methylphenidate-ssri-induced-sexual.pdf2022-11-07 22:43 37K 
[ ]17118_reply-letter-editor-need-framework-understand-mechanism.pdf2022-11-07 22:51 49K 
[ ]17119_reply-letter-editor-nicotine-induced-angiogenesis.pdf2022-11-07 22:59 43K 
[ ]17120_reply-letter-editor-nosology-compulsive-skin-picking.pdf2022-11-07 22:25 31K 
[ ]17121_reply-letter-editor-obsessive-compulsive-symptoms-atypical-antipsychotics.pdf2022-11-07 22:35 55K 
[ ]17122_reply-letter-editor-obsessive-compulsive-symptoms-worsening-risperidone.pdf2022-11-07 22:13 55K 
[ ]17123_reply-letter-editor-olanzapine-negative-symptoms.pdf2022-11-07 22:46 38K 
[ ]17124_reply-letter-editor-omission-bupropion-recommended.pdf2022-11-07 22:18 45K 
[ ]17125_reply-letter-editor-once-daily-venlafaxine-xr-compared.pdf2022-11-07 22:57 37K 
[ ]17126_reply-letter-editor-oxybutynin-intranasal-desmopressin.pdf2022-11-07 22:15 43K 
[ ]17127_reply-letter-editor-panic-paranoia.pdf2022-11-07 22:05 45K 
[ ]17128_reply-letter-editor-paroxetine-induced-anorexia-patient.pdf2022-11-07 22:06 38K 
[ ]17129_reply-letter-editor-pharmacists-lack-knowledge-antidepressant.pdf2022-11-07 22:28 50K 
[ ]17130_reply-letter-editor-pharmacologic-properties-venlafaxine.pdf2022-11-07 22:39 92K 
[ ]17131_reply-letter-editor-polypharmacy-atypical-antipsychotics.pdf2022-11-07 22:59 51K 
[ ]17132_reply-letter-editor-possible-case-quetiapine-withdrawal.pdf2022-11-07 22:26 55K 
[ ]17133_reply-letter-editor-possible-dose-response-relationship.pdf2022-11-07 22:46 80K 
[ ]17134_reply-letter-editor-problems-ensuring-double-blind.pdf2022-11-07 22:39 48K 
[ ]17135_reply-letter-editor-psychodynamic-psychotherapy-ptsd.pdf2022-11-07 22:26 45K 
[ ]17136_reply-letter-editor-rapid-onset-antidepressant-activity.pdf2022-11-07 22:32 47K 
[ ]17137_reply-letter-editor-recommended-haloperidol-risperidone.pdf2022-11-07 22:56 37K 
[ ]17138_reply-letter-editor-relationship-between-antidepressant.pdf2022-11-07 22:04 67K 
[ ]17139_reply-letter-editor-relative-weight-gain-among-antipsychotics.pdf2022-11-07 22:41 45K 
[ ]17140_reply-letter-editor-risperidone-carbamazepine-interactions.pdf2022-11-07 22:20 37K 
[ ]17141_reply-letter-editor-risperidone-may-worsen-fluoxetine.pdf2022-11-07 22:39 37K 
[ ]17142_reply-letter-editor-role-micronutrients-possible-mood.pdf2022-11-07 23:02 48K 
[ ]17143_reply-letter-editor-role-receptor-binding-profiles.pdf2022-11-07 22:28 55K 
[ ]17144_reply-letter-editor-safety-sildenafil-antidepressant.pdf2022-11-07 22:33 37K 
[ ]17145_reply-letter-editor-sexual-dysfunction-fluvoxamine.pdf2022-11-07 22:20 57K 
[ ]17146_reply-letter-editor-sexual-dysfunction-fluvoxamine-measurements-sexual-dysfunction.pdf2022-11-07 22:20 59K 
[ ]17147_reply-letter-editor-should-keep-calling-antidepressants.pdf2022-11-07 23:01 52K 
[ ]17148_reply-letter-editor-sildenafil-treatment-antidepressant.pdf2022-11-07 22:35 35K 
[ ]17149_reply-letter-editor-smoking-bipolar-schizophrenic.pdf2022-11-07 22:14 47K 
[ ]17150_reply-letter-editor-stereotypic-movement-disorder.pdf2022-11-07 22:49 92K 
[ ]17151_reply-letter-editor-surprising-results-study-paroxetine.pdf2022-11-07 22:53 47K 
[ ]17152_reply-letter-editor-type-ii-error-antidepressants.pdf2022-11-07 22:58 53K 
[ ]17153_reply-letter-editor-upper-extremity-self-amputation.pdf2022-11-07 22:31 45K 
[ ]17154_reply-letter-editor-weight-gain-antipsychotic-medications.pdf2022-11-07 22:56 67K 
[ ]17155_reply-likelihood-helped-harmed-assist-clinical-decision.pdf2022-11-07 22:49 135K 
[ ]17156_reply-lithium-dosing-schedule-renal-isufficiency.pdf2022-11-07 22:14 134K 
[ ]17157_reply-long-term-effects-terrorist-attack-beslan-adolescent.pdf2022-11-07 22:08 199K 
[ ]17158_reply-looks-bradyphylaxis.pdf2022-11-07 22:49 140K 
[ ]17159_reply-measuring-efficacy-polypharmacy-schizophrenic.pdf2022-11-07 22:11 151K 
[ ]17160_reply-metabolic-syndrome-inpatients-treated-clozapine.pdf2022-11-07 22:13 149K 
[ ]17161_reply-misdiagnosis-bipolar-ii-disorder-major-depressive.pdf2022-11-07 22:26 207K 
[ ]17162_reply-modafinil-antipsychotic-induced-sedation.pdf2022-11-07 22:20 67K 
[ ]17163_reply-modafinil-mischaracterization.pdf2022-11-07 22:57 196K 
[ ]17164_reply-more-placebo-response.pdf2022-11-07 22:35 140K 
[ ]17165_reply-normal-bereavement.pdf2022-11-07 23:01 156K 
[ ]17166_reply-nutritional-approach-bipolar-disorder.pdf2022-11-07 22:13 79K 
[ ]17167_reply-odd-odds.pdf2022-11-07 22:59 131K 
[ ]17168_reply-olanzapine-anorexia-nervosa.pdf2022-11-07 22:29 117K 
[ ]17169_reply-olanzapinerisperidone-diabetes-risk.pdf2022-11-07 22:26 81K 
[ ]17170_reply-orally-distegrating-antipsychotics-may-promote.pdf2022-11-07 22:33 141K 
[ ]17171_reply-overdiagnosis-underdiagnosis-bipolar-disorder.pdf2022-11-07 22:26 124K 
[ ]17172_reply-overestimating-prevalence-subtherapeutic-dosing.pdf2022-11-07 22:42 758K 
[ ]17173_reply-patients-successfully-discontinue-ssris.pdf2022-11-07 22:22 697K 
[ ]17174_reply-pharmacokinetic-drug-drug-interactions-between.pdf2022-11-07 22:32 108K 
[ ]17175_reply-pindolol-really-enhance-antidepressant-effect.pdf2022-11-07 22:52 136K 
[ ]17176_reply-placebo-response-psychotic-depression.pdf2022-11-07 23:02 147K 
[ ]17177_reply-polypharmacy-schizophrenia-fuzzy-concept.pdf2022-11-07 22:22 50K 
[ ]17178_reply-possible-bipolar-nature-irritability-major-depressive.pdf2022-11-07 22:11 140K 
[ ]17179_reply-possible-impact-dropout-study-ofhigh-dose-olanzapine.pdf2022-11-07 22:55 151K 
[ ]17180_reply-potential-detection-bias-association-between.pdf2022-11-07 22:16 67K 
[ ]17181_reply-predicting-pharmacotherapy-outcome-retrospective.pdf2022-11-07 22:33 109K 
[ ]17182_reply-predicting-suicide-attempt-risk-logistic-regression.pdf2022-11-07 22:54 131K 
[ ]17183_reply-premature-conclusions-psychotherapy-dysthymia.pdf2022-11-07 22:47 738K 
[ ]17184_reply-prescribing-benzodiazepines-patients-substance.pdf2022-11-07 23:00 52K 
[ ]17185_reply-problems-assessing-musical-hallucination.pdf2022-11-07 22:56 124K 
[ ]17186_reply-pseudoresistant-bipolar-depression.pdf2022-11-07 22:23 722K 
[ ]17187_reply-psychotic-symptoms-associated-topiramate-cognitive.pdf2022-11-07 22:36 151K 
[ ]17188_reply-racial-differences-antipsychotics-among-patients.pdf2022-11-07 22:06 67K 
[ ]17189_reply-reexamining-paroxetine-cognitive-behavioral.pdf2022-11-07 22:32 141K 
[ ]17190_reply-reliability-overdiagnosis.pdf2022-11-07 22:49 177K 
[ ]17191_reply-reporting-changes-scores-cohen-mansfield-agitation.pdf2022-11-07 22:33 70K 
[ ]17192_reply-response-self-injurious-behaviors-community.pdf2022-11-07 22:11 157K 
[ ]17193_reply-ribavirin-may-important-factor-ifn-induced-neuropsychiatric.pdf2022-11-07 22:22 50K 
[ ]17194_reply-risk-factors-inpatient-suicide-translate-meaningful.pdf2022-11-07 22:48 103K 
[ ]17195_reply-risks-intermittent-antipsychotic-treatment-schizophrenia.pdf2022-11-07 22:34 150K 
[ ]17196_reply-ro-does-venlafaxine-maintenance-therapy-prevent.pdf2022-11-07 22:44 185K 
[ ]17197_reply-schizophrenia-related-outpatient-treatment-medicaid.pdf2022-11-07 22:24 145K 
[ ]17198_reply-searching-medical-literature-case-reports.pdf2022-11-07 22:20 55K 
[ ]17199_reply-searching-serendipity.pdf2022-11-07 22:54 131K 
[ ]17200_reply-self-medication-bipolar-disorders-stimulant.pdf2022-11-07 22:31 199K 
[ ]17201_reply-sertraline-versus-venlafaxine-xr-major-depressive.pdf2022-11-07 22:59 156K 
[ ]17202_reply-should-research-productivity-assessed-early.pdf2022-11-07 22:48 698K 
[ ]17203_reply-single-versus-multiple-daily-dosing-lithium.pdf2022-11-07 22:27 134K 
[ ]17204_reply-sponsored-clinical-trials-bias.pdf2022-11-07 22:04 156K 
[ ]17205_reply-suicidal-risk-during-antidepressant-treatment.pdf2022-11-07 22:02 129K 
[ ]17206_reply-talking-internet.pdf2022-11-07 22:58 155K 
[ ]17207_reply-treatment-anxiety-suicidal-patients.pdf2022-11-07 23:02 49K 
[ ]17208_reply-treatment-outcome-bereavement-excluded-depression.pdf2022-11-07 22:30 156K 
[ ]17209_reply-underpowered-repetitive-trancranial-magnetic.pdf2022-11-07 22:45 111K 
[ ]17210_reply-v-code-bereavement.pdf2022-11-07 22:43 89K 
[ ]17211_reply-weight-gain-antipsichotics.pdf2022-11-07 22:23 103K 
[ ]17212_reply-weight-gain-sexual-dysfunction-buropion.pdf2022-11-07 22:42 165K 
[ ]17213_report-ignores-risk-factor-tobacco-assessing-suicidality.pdf2022-11-07 22:29 113K 
[ ]17214_reporting-changes-scores-cohen-mansfield-agitation.pdf2022-11-07 23:03 70K 
[ ]17215_report-texas-consensus-conference-panel-medication.pdf2022-11-07 22:56 95K 
[ ]17216_representativeness-participants-clinical-trial-attention.pdf2022-11-07 22:34 191K 
[ ]17217_reproductive-biology-psychotropic-treatments-premenopausal.pdf2022-11-07 22:04 162K 
[ ]17218_reproductive-hormone-sensitivity-obsessive-compulsive.pdf2022-11-07 22:26 175K 
[ ]17219_reproductive-neuroscience-biology-environment-clinical.pdf2022-11-07 22:32 71K 
[ ]17220_reproductive-safety-profile-mood-stabilizers-atypical.pdf2022-11-07 22:59 125K 
[ ]17221_repurposing-psychiatry-during-covid.pdf2022-11-07 22:06 175K 
[ ]17222_rescue-pharmacotherapy-duloxetine-selective-serotonin.pdf2022-11-07 22:49 206K 
[ ]17223_research-agenda-dsm-iv.pdf2022-11-07 22:54 36K 
[ ]17224_research-inform-clinical-care-mental-health-disorders.pdf2022-11-07 22:05 43K 
[ ]17225_research-methods-psychiatry-rd-ed.pdf2022-11-07 22:32 97K 
[ ]17226_research-practice-gap-mood-disorders-role-department.pdf2022-11-07 22:03 82K 
[ ]17227_research-suggests-depressed-women-children.pdf2022-11-07 22:07 68K 
[ ]17228_reserpine-treatment-comorbid-tourettes-disorder-tardive.pdf2022-11-07 22:52 45K 
[ ]17229_residual-memory-impairment-remitted-depression-may.pdf2022-11-07 22:36 471K 
[ ]17230_residual-symptoms-depressed-patients-respond-acutely.pdf2022-11-07 22:30 57K 
[ ]17231_residual-symptoms-depressed-patients-treatment-fluoxetine.pdf2022-11-07 22:55 131K 
[ ]17233_residual-symptoms-depression-treatment-symptom-specific.pdf2022-11-07 22:35 70K 
[ ]17234_residual-symptoms-major-depressive-disorder-prevalence.pdf2022-11-07 22:55 542K 
[ ]17235_residual-symptoms-relapse-mood-cognitive-symptoms.pdf2022-11-07 22:48 317K 
[ ]17237_resilience-aftermath-terrorism-during-warzone-exposure.pdf2022-11-07 22:34 81K 
[ ]17238_resilience-mental-health-challenges-across-lifespan.pdf2022-11-07 22:50 90K 
[ ]17239_resilience-reactions-military-deployment-complex-task.pdf2022-11-07 22:34 137K 
[ ]17240_resolution-fluoxetine-induced-sexual-dysfunction.pdf2022-11-07 22:10 44K 
[ ]17241_resolution-hyperglycemia-risperidone-discontinuation.pdf2022-11-07 22:18 122K 
[ ]17242_resolution-late-onset-hypomania-repair-carotid-artery.pdf2022-11-07 22:59 221K 
[ ]17243_resolution-palinopsia-carbamazepine.pdf2022-11-07 22:21 79K 
[ ]17245_respiratory-infections-rather-antibiotics-may-increase.pdf2022-11-07 22:26 152K 
[ ]17246_responding-drug-misuse-research-policy-priorities.pdf2022-11-07 22:51 86K 
[ ]17247_response-acceleration-mirtazapine-augmentation-citalopram.pdf2022-11-07 22:34 56K 
[ ]17248_response-antidepressant-medications-late-life-depression.pdf2022-11-07 22:38 526K 
[ ]17249_response-commentary-using-questionnaires-screen-psychiatric.pdf2022-11-07 22:49 67K 
[ ]17250_response-depression-electroconvulsive-therapy-meta.pdf2022-11-07 22:23 1.0M 
[ ]17251_response-management-autism-related-disorders.pdf2022-11-07 22:49 87K 
[ ]17252_response-missile-attacks-civilian-targets-patients.pdf2022-11-07 22:52 43K 
[ ]17253_response-past-depression-treatments-is-accurately.pdf2022-11-07 22:29 229K 
[ ]17254_response-psychotherapy-posttraumatic-stress-disorder.pdf2022-11-07 22:47 229K 
[ ]17255_response-rates-fluoxetine-subjects-initially-show.pdf2022-11-07 22:20 259K 
[ ]17256_response-relapse-patients-schizophrenia-treated-olanzapine.pdf2022-11-07 22:01 208K 
[ ]17257_response-remission-rates-different-subpopulations.pdf2022-11-07 22:48 75K 
[ ]17258_response-remission-recovery-bipolar-disorders-are.pdf2022-11-07 22:20 55K 
[ ]17259_response-risperidone-addition-fluvoxamine-refractory.pdf2022-11-07 22:11 42K 
[ ]17260_responses-depressed-mood-suicide-attempt-young-adults.pdf2022-11-07 22:10 318K 
[ ]17261_response-selective-serotonin-reuptake-inhibitor-citalopram.pdf2022-11-07 22:02 265K 
[ ]17262_response-self-injurious-behaviors-community-sample.pdf2022-11-07 22:18 157K 
[ ]17263_response-versus-remission-obsessive-compulsive-disorder.pdf2022-11-07 22:39 96K 
[ ]17264_restless-legs-syndrome-and-psychopathology-in-adolescents.pdf2022-11-07 22:23 263K 
[ ]17265_restless-legs-syndrome-induced-mirtazapine.pdf2022-11-07 22:20 83K 
[ ]17266_restlessness-respiration-manifestation-akathisia-five.pdf2022-11-07 22:42 40K 
[ ]17267_results-expert-consensus-survey-adherence.pdf2022-11-07 22:08 285K 
[ ]17268_results-proof-concept-placebo-controlled-studies.pdf2022-11-07 22:28 78K 
[ ]17269_results-search-personality-disorder-screening-tools.pdf2022-11-07 23:02 344K 
[ ]17270_retinoic-acid-affective-disorders-evidence-association.pdf2022-11-07 22:07 784K 
[ ]17271_retinoid-x-receptor-agonist-bexarotene-relieves-positive.pdf2022-11-07 22:50 506K 
[ ]17272_retraction.pdf2022-11-07 22:25 55K 
[ ]17273_retrospective-analysis-quetiapine-treatment-pervasive.pdf2022-11-07 22:01 49K 
[ ]17274_retrospective-analysis-risk-protective-factors-natural.pdf2022-11-07 22:53 138K 
[ ]17275_retrospective-comparison-weight-lipid-glucose-changes.pdf2022-11-07 22:53 121K 
[ ]17276_retrospective-review-clinical-characteristics-treatment.pdf2022-11-07 23:01 66K 
[ ]17277_retrospective-study-safety-intramuscular-ziprasidone.pdf2022-11-07 22:18 72K 
[ ]17278_retrosprective-assessmentof-mental-states-litigation.pdf2022-11-07 22:06 33K 
[ ]17279_revealing-importance-military-sexual-trauma-consequences.pdf2022-11-07 22:01 127K 
[ ]17280_reversal-antipsychotic-associated-weight-gain.pdf2022-11-07 22:39 156K 
[ ]17281_reversal-antipsychotic-induced-hyperprolactinemia.pdf2022-11-07 22:13 79K 
[ ]17282_reversible-dyskinesia-during-bupropion-therapy.pdf2022-11-07 22:46 38K 
[ ]17283_reversible-parkinsonism-old-man-taking-sertraline.pdf2022-11-07 22:08 42K 
[ ]17284_review-agitation-mental-illness-burden-illness-underlying.pdf2022-11-07 22:23 91K 
[ ]17285_review-agitation-mental-illness-treatment-guidelines.pdf2022-11-07 22:32 102K 
[ ]17286_review-atypical-antipsychotics-weight-gain.pdf2022-11-07 22:20 97K 
[ ]17289_review-efficacy-selective-serotonin-reuptake-inhibitors.pdf2022-11-07 22:34 56K 
[ ]17290_reviewers.pdf2022-11-07 22:04 31K 
[ ]17291_review-evidence-based-psychosocial-interventions-bipolar.pdf2022-11-07 22:15 116K 
[ ]17292_review-evidence-efficacy-safety-trazodone-insomnia.pdf2022-11-07 22:41 146K 
[ ]17293_review-fragile-x-premutation-disorders-expanding-psychiatric.pdf2022-11-07 22:13 303K 
[ ]17294_review-incidence-studies-tardive-dyskinesia-associated.pdf2022-11-07 22:32 53K 
[ ]17296_review-maintenance-trials-major-depressive-disorder.pdf2022-11-07 22:46 600K 
[ ]17297_review-management-clozapine-side-effects.pdf2022-11-07 22:58 45K 
[ ]17298_review-non-alzheimer-dementias.pdf2022-11-07 22:38 144K 
[ ]17299_review-pharmacologic-management-depression.pdf2022-11-07 22:01 148K 
[ ]17300_review-quetiapine-side-effects.pdf2022-11-07 22:16 42K 
[ ]17301_review-safety-efficacy-droperidol-rapid-sedation-severely.pdf2022-11-07 22:25 59K 
[ ]17302_review-sensitivity-tolerability-antipsychotics-patients.pdf2022-11-07 22:49 224K 
[ ]17303_review-stimulants-stimulant-alternatives-treating.pdf2022-11-07 22:07 399K 
[ ]17304_review-treatment-emergent-adverse-events-during-olanzapine.pdf2022-11-07 22:20 134K 
[ ]17305_review-treatments-ameliorate-nonadherence-patients.pdf2022-11-07 22:56 92K 
[ ]17306_revised-black-box-warning-antidepressants-sets-public.pdf2022-11-07 22:34 97K 
[ ]17307_revisiting-discussion-termination-clozapine-treatment.pdf2022-11-07 22:47 119K 
[ ]17308_revisiting-monoamine-oxidase-inhibitors.pdf2022-11-07 22:14 186K 
[ ]17309_revisiting-the-use-of-the-aims-in-tardive-dyskinesia-trials.pdf2022-11-07 22:36 295K 
[ ]17310_revolution-mind-creation-psychoanalysis.pdf2022-11-07 22:58 721K 
[ ]17311_rhabdomyolysis-coma-associated-amisulpride-probable.pdf2022-11-07 23:00 62K 
[ ]17312_ribavirin-may-important-factor-ifn-induced-neuropsychiatric.pdf2022-11-07 22:04 50K 
[ ]17313_right-versus-left-prefrontal-transcranial-magnetic.pdf2022-11-07 22:17 40K 
[ ]17314_riluzole-augmentation-treatment-refractory-obsessive.pdf2022-11-07 22:28 341K 
[ ]17315_riluzole-for-antidepressant-resistant-ptsd.pdf2022-11-07 22:24 300K 
[ ]17316_rise-fall-biopsychosocial-model-reconciling-art-science.pdf2022-11-07 22:46 91K 
[ ]17317_rise-psychopharmacology-story-cinp.pdf2022-11-07 23:02 38K 
[ ]17318_risk-arrest-persons-schizophrenia-bipolar-disorder.pdf2022-11-07 22:29 287K 
[ ]17319_risk-cardiovascular-disease-sudden-death-schizophrenia.pdf2022-11-07 22:49 57K 
[ ]17320_risk-cerebrovascular-adverse-events-older-adults-using.pdf2022-11-07 22:19 467K 
[ ]17321_risk-diabetes-during-olanzapine-compared-risperidone.pdf2022-11-07 22:54 57K 
[ ]17322_risk-diabetes-mellitus-associated-atypical-antipsychotic.pdf2022-11-07 22:52 108K 
[ ]17323_risk-factors-antidepressant-related-switch-mania.pdf2022-11-07 22:38 229K 
[ ]17324_risk-factors-completed-suicide-bipolar-disorder.pdf2022-11-07 22:21 63K 
[ ]17325_risk-factors-completed-suicide-schizophrenia.pdf2022-11-07 22:51 135K 
[ ]17326_risk-factors-development-posttraumatic-stress-disorder.pdf2022-11-07 22:36 300K 
[ ]17327_risk-factors-falls-during-treatment-late-life-depression.pdf2022-11-07 22:49 69K 
[ ]17328_risk-factors-filicide-homicide-national-matched.pdf2022-11-07 23:01 59K 
[ ]17329_risk-factors-for-postpartum-depression.pdf2022-11-07 22:09 314K 
[ ]17330_risk-factors-for-suicide-in-veterans-with-ptsd.pdf2022-11-07 22:20 269K 
[ ]17331_risk-factors-inpatient-suicide-translate-meaningful.pdf2022-11-07 22:08 92K 
[ ]17332_risk-factors-in-postdischarge-suicide.pdf2022-11-07 22:13 221K 
[ ]17333_risk-factors-posttraumatic-stress-disorder.pdf2022-11-07 22:02 45K 
[ ]17334_risk-factors-premenstrual-dysphoric-disorder-community.pdf2022-11-07 22:52 73K 
[ ]17335_risk-factors-suicide-completion-borderline-personality.pdf2022-11-07 22:43 206K 
[ ]17336_risk-factors-violent-crime-schizophrenia-national.pdf2022-11-07 22:31 239K 
[ ]17337_risk-for-overdose-in-youth-with-sud.pdf2022-11-07 22:53 215K 
[ ]17338_risk-injurious-road-traffic-crash-prescription-antidepressants.pdf2022-11-07 22:38 315K 
[ ]17339_risk-obsessive-compulsive-disorder-pregnant-postpartum.pdf2022-11-07 22:58 453K 
[ ]17340_risk-of-major-congenital-malformations-with-methylphenidate-or-amphetamine-use.pdf2022-11-07 22:02 308K 
[ ]17341_risk-of-nocebo-related-treatment-inefficacy-and-harm.pdf2022-11-07 22:39 287K 
[ ]17342_risk-parkinsons-disease-following-zolpidem-retrospective.pdf2022-11-07 22:47 238K 
[ ]17343_risk-prediction-models-in-psychiatry.pdf2022-11-07 22:07 354K 
[ ]17344_risk-predictors-hypnosedative-related-complex-sleep.pdf2022-11-07 22:55 193K 
[ ]17345_risk-protective-factors-suicide-among-patients-methamphetamine.pdf2022-11-07 22:19 233K 
[ ]17346_risk-protective-factors-suicide-mortality-among-patients.pdf2022-11-07 22:11 389K 
[ ]17347_risk-resilience-posttraumatic-stress-disorder.pdf2022-11-07 22:04 95K 
[ ]17349_risks-discontinuation-trials-antidepressants.pdf2022-11-07 22:47 92K 
[ ]17350_risks-intermittent-antipsychotic-treatment-schizophrenia.pdf2022-11-07 22:27 134K 
[ ]17351_risks-suicide-poisoning-among-elderly-patients-prescribed.pdf2022-11-07 22:46 256K 
[ ]17352_risks-transition-major-depressive-disorder-bipolar.pdf2022-11-07 22:11 346K 
[ ]17353_risk-suicidal-behavior-antidepressants-bipolar-unipolar.pdf2022-11-07 22:41 357K 
[ ]17354_risk-suicide-patients-bipolar-disorders.pdf2022-11-07 22:39 46K 
[ ]17355_risks-versus-benefits-different-types-long-acting.pdf2022-11-07 22:10 76K 
[ ]17356_risk-taking-propensity-predictor-induction-onto-naltrexone.pdf2022-11-07 23:00 261K 
[ ]17357_risperidone-acutely-exacerbated-schizophrenia-dosing.pdf2022-11-07 22:49 71K 
[ ]17358_risperidone-added-clozapine-impact-serum-prolactin.pdf2022-11-07 22:25 77K 
[ ]17359_risperidone-allergic-reactions.pdf2022-11-07 22:49 100K 
[ ]17360_risperidone-associated-amenorrhea-report-cases.pdf2022-11-07 22:55 35K 
[ ]17361_risperidone-augmentation-decreases-rapid-eye-movement.pdf2022-11-07 22:20 54K 
[ ]17362_risperidone-augmentation-paroxetine-case-severe-treatment.pdf2022-11-07 22:26 38K 
[ ]17363_risperidone-augmentation-selective-serotonin-reuptake.pdf2022-11-07 22:12 41K 
[ ]17364_risperidone-augmentation-serotonin-reuptake-inhibitors.pdf2022-11-07 22:56 73K 
[ ]17365_risperidone-carbamazepine-interactions-is-cytochrome.pdf2022-11-07 23:01 36K 
[ ]17366_risperidone-combination-mood-stabilizers-week-continuation.pdf2022-11-07 22:09 67K 
[ ]17367_risperidone-compared-olanzapine-naturalistic-clinical.pdf2022-11-07 22:04 88K 
[ ]17368_risperidone-cytochrome-p.pdf2022-11-07 22:14 45K 
[ ]17369_risperidone-dosing-pattern-clinical-outcome-psychosis.pdf2022-11-07 22:38 168K 
[ ]17370_risperidone-elderly-pharmacoepidemiologic-study.pdf2022-11-07 22:01 46K 
[ ]17371_risperidone-haloperidol-augmentation-serotonin-reuptake.pdf2022-11-07 22:19 153K 
[ ]17372_risperidone-induced-dislocation-temporomandibular.pdf2022-11-07 22:14 85K 
[ ]17373_risperidone-induced-ejaculatory-urinary-dysfunction.pdf2022-11-07 23:01 37K 
[ ]17374_risperidone-induced-hyperprolactinemia-adolescents.pdf2022-11-07 22:44 75K 
[ ]17375_risperidone-induced-pisa-syndrome.pdf2022-11-07 22:34 55K 
[ ]17376_risperidone-induced-tardive-dyskinesia.pdf2022-11-07 22:59 140K 
[ ]17377_risperidone-lamotrigine-evidence-drug-interaction.pdf2022-11-07 22:28 81K 
[ ]17378_risperidone-liquid-concentrate-oral-lorazepam-versus.pdf2022-11-07 22:08 53K 
[ ]17379_risperidone-long-acting-injection-prospective-analysis.pdf2022-11-07 22:38 152K 
[ ]17380_risperidone-long-acting-injection-support-treatment.pdf2022-11-07 22:03 177K 
[ ]17381_risperidone-long-acting-therapy-prescribing-patterns.pdf2022-11-07 22:32 238K 
[ ]17382_risperidone-may-worsen-fluoxetine-treated-ocd.pdf2022-11-07 22:48 37K 
[ ]17383_risperidone-metabolism-impact-being-cytochrome-p-d.pdf2022-11-07 22:39 54K 
[ ]17384_risperidone-mgday-vs-mgday-episode-acutely-psychotic.pdf2022-11-07 22:28 80K 
[ ]17385_risperidone-monotherapy-psychotic-depression-unresponsive.pdf2022-11-07 22:40 44K 
[ ]17386_risperidone-olanzapine-decreases-bone-mineral-density.pdf2022-11-07 22:21 55K 
[ ]17387_risperidone-outcomes-study-effectiveness-rose-model.pdf2022-11-07 22:06 57K 
[ ]17388_risperidone-paroxetine-given-singly-combination-bipolar.pdf2022-11-07 22:47 49K 
[ ]17389_risperidone-psychotic-combat-related-posttraumatic.pdf2022-11-07 22:08 134K 
[ ]17390_risperidone-safety-efficacy-treatment-bipolar-schizoaffective.pdf2022-11-07 22:51 113K 
[ ]17391_risperidone-severe-tardive-dyskinesia-week-randomized.pdf2022-11-07 22:24 55K 
[ ]17392_risperidone-side-effects.pdf2022-11-07 22:17 47K 
[ ]17393_risperidone-state-hospital-clinical-audit-years-wave.pdf2022-11-07 22:50 60K 
[ ]17394_risperidone-treatment-behavioral-psychological-symptoms.pdf2022-11-07 22:33 42K 
[ ]17395_risperidone-treatment-delirium-results-prospective.pdf2022-11-07 22:28 54K 
[ ]17396_risperidone-treatment-monosymptomatic-hypochondriacal.pdf2022-11-07 22:58 67K 
[ ]17397_risperidone-treatment-patients-delirium.pdf2022-11-07 22:35 53K 
[ ]17398_risperidone-treatment-schizotypal-personality-disorder.pdf2022-11-07 22:30 60K 
[ ]17399_risperidone-treatment-tardive-dyskinesia-dystonia.pdf2022-11-07 22:43 67K 
[ ]17400_risperidone-versus-pimozide-tourettes-disorder-comparative.pdf2022-11-07 22:33 59K 
[ ]17401_roadmap-antipsychotic-psychopharmacology-overview.pdf2022-11-07 22:36 231K 
[ ]17402_roadmap-key-pharmacologic-principles-using-antipsychotics-application-clinical-practice.pdf2022-11-07 22:17 232K 
[ ]17403_roadmap-key-pharmacologic-principles-using-antipsychotics-treatment-bipolar-disorder.pdf2022-11-07 22:46 239K 
[ ]17404_roadmap-key-pharmacologic-principles-using-antipsychotics-treatment-older-patients.pdf2022-11-07 22:14 315K 
[ ]17406_road-recovery-panic-disorder-response-remission-relapse.pdf2022-11-07 22:20 40K 
[ ]17407_robert-l-spitzer-md.pdf2022-11-07 22:03 523K 
[ ]17408_role-algorithms-detection-treatment-depression-primary.pdf2022-11-07 22:51 53K 
[ ]17409_role-alliance-pharmacologic-treatment-depression.pdf2022-11-07 22:35 52K 
[ ]17411_role-atypical-antipsychotic-drugs-treatment-resistant.pdf2022-11-07 22:48 74K 
[ ]17412_role-craving-relapse-discontinuation-long-term-benzodiazepine.pdf2022-11-07 22:27 155K 
[ ]17413_role-divalproex-plus-olanzapine-outpatient-mixed-episode.pdf2022-11-07 23:00 247K 
[ ]17414_role-dopamine-norepinephrine-depression-antidepressant.pdf2022-11-07 22:12 99K 
[ ]17415_role-dopamine-obsessive-compulsive-disorder-preclinical.pdf2022-11-07 22:09 70K 
[ ]17416_role-executive-function-adhd.pdf2022-11-07 22:54 64K 
[ ]17417_role-executive-function-late-life-depression.pdf2022-11-07 22:45 74K 
[ ]17419_role-extended-release-benzodiazepines-treatment-anxiety.pdf2022-11-07 23:02 75K 
[ ]17420_role-folate-depression-dementia.pdf2022-11-07 22:16 170K 
[ ]17421_role-gaba-anxiety-disorders.pdf2022-11-07 22:21 81K 
[ ]17423_role-micronutrients-possible-mood-stabilizing-agents.pdf2022-11-07 22:18 47K 
[ ]17424_role-mirtazapine-pharmacotherapy-depression.pdf2022-11-07 22:04 80K 
[ ]17425_role-monoamine-oxidase-inhibitors-depression-treatment.pdf2022-11-07 23:00 273K 
[ ]17428_role-neuropsychiatric-pharmacists.pdf2022-11-07 23:02 40K 
[ ]17430_role-norepinephrine-depression.pdf2022-11-07 22:42 89K 
[ ]17431_role-norepinephrine-treatment-depression.pdf2022-11-07 22:36 56K 
[ ]17432_role-novel-antipsychotics-bipolar-disorders.pdf2022-11-07 22:30 64K 
[ ]17433_role-of-staging-in-planning-psychotherapy-interventions-for-depression.pdf2022-11-07 22:10 286K 
[ ]17434_role-patient-expectancy-placebo-nocebo-effects-antidepressant.pdf2022-11-07 22:53 706K 
[ ]17435_role-pharmacologic-treatment-guidelines-bipolar-disorder.pdf2022-11-07 22:18 191K 
[ ]17436_role-profiles-patient-specific-depression-characteristics.pdf2022-11-07 22:16 107K 
[ ]17437_role-psychiatrist-alzheimers-disease.pdf2022-11-07 22:37 27K 
[ ]17438_role-psychomotor-activation-discriminating-unipolar.pdf2022-11-07 22:22 353K 
[ ]17440_role-psychosocial-therapies-managing-aggression-children.pdf2022-11-07 22:11 182K 
[ ]17441_role-receptor-binding-profiles-antidepressant-induced.pdf2022-11-07 22:44 55K 
[ ]17442_role-second-generation-antipsychotic-monotherapy-rapid.pdf2022-11-07 22:36 136K 
[ ]17443_roles-efficacy-safety-tolerability-antipsychotic-effectiveness.pdf2022-11-07 22:41 153K 
[ ]17444_role-selective-serotonin-reuptake-inhibitors-reducing.pdf2022-11-07 22:56 69K 
[ ]17445_role-serotonergic-noradrenergic-neurotransmitter-systems.pdf2022-11-07 23:01 47K 
[ ]17446_role-serotonin-drugs-treatment-social-phobia.pdf2022-11-07 22:11 30K 
[ ]17447_roles-psychiatrists-organized-systems-care.pdf2022-11-07 23:01 23K 
[ ]17448_roles-qualifications-tms-treatment-team-members.pdf2022-11-07 22:41 123K 
[ ]17449_role-typical-atypical-antipsychotic-medications-management.pdf2022-11-07 22:23 71K 
[ ]17450_rose-name.pdf2022-11-07 22:37 50K 
[ ]17451_rosetta-stone-human-mind-three-languages-integrate.pdf2022-11-07 22:42 99K 
[ ]17453_routine-atypical-antipsychotic-agents-maintenance.pdf2022-11-07 22:10 45K 
[ ]17454_routine-screening-for-autoimmune-encephalitis.pdf2022-11-07 22:44 939K 
[ ]17455_rs-polymorphism-cnr-gene-interacts-childhood-abuse.pdf2022-11-07 22:45 132K 
[ ]17456_safety-acceptability-effectiveness-acupuncture-adjunctive.pdf2022-11-07 22:24 275K 
[ ]17457_safety-amobarbital.pdf2022-11-07 22:03 92K 
[ ]17458_safety-available-agents-used-treat-bipolar-disorder.pdf2022-11-07 22:24 71K 
[ ]17459_safety-duloxetine-during-pregnancy-lactation.pdf2022-11-07 22:37 527K 
[ ]17460_safety-early-efficacy-oral-loaded-divalproex-versus.pdf2022-11-07 22:18 66K 
[ ]17461_safety-efficacy-escitalopram-long-term-treatment-generalized.pdf2022-11-07 22:07 150K 
[ ]17462_safety-efficacy-levetiracetam-patients-panic-disorder.pdf2022-11-07 22:05 65K 
[ ]17463_safety-efficacy-long-acting-risperidone-schizophrenia.pdf2022-11-07 22:02 208K 
[ ]17464_safety-efficacy-methylphenidate-apathy-alzheimers.pdf2022-11-07 22:28 304K 
[ ]17465_safety-feasibility-repetitive-transcranial-magnetic.pdf2022-11-07 22:25 29K 
[ ]17466_safety-haloperidol-penfluridol-pregnancy-multicenter.pdf2022-11-07 22:55 116K 
[ ]17467_safety-issues-drug-therapies-autism-spectrum-disorders.pdf2022-11-07 22:28 143K 
[ ]17468_safety-issues-when-prescribing-metformin.pdf2022-11-07 22:51 310K 
[ ]17469_safety-mirtazapine-overdose.pdf2022-11-07 22:38 29K 
[ ]17470_safety-of-pregabalin-in-pregnancy.pdf2022-11-07 22:45 283K 
[ ]17471_safety-olanzapine.pdf2022-11-07 22:52 32K 
[ ]17472_safety-olanzapine-adolescents-schizophrenia-bipolar.pdf2022-11-07 22:01 334K 
[ ]17473_safety-olanzapine-compared-antipsychotic-drugs-results.pdf2022-11-07 22:10 80K 
[ ]17474_safety-overdose-mirtazapine-case-report.pdf2022-11-07 22:54 42K 
[ ]17475_safety-overdose-quetiapine-case-report.pdf2022-11-07 22:09 37K 
[ ]17476_safety-profile-atomoxetine-treatment-adolescents-children.pdf2022-11-07 22:51 72K 
[ ]17477_safety-selegiline-transdermal-system-clinical-practice.pdf2022-11-07 22:17 272K 
[ ]17478_safety-sildenafil-antidepressant-related-sexual-dysfunction.pdf2022-11-07 22:58 37K 
[ ]17479_safety-st-johns-wort-hypericum-perforatum-during-breastfeeding.pdf2022-11-07 22:42 47K 
[ ]17480_safety-subjective-sleep-effects-ramelteon-administration.pdf2022-11-07 22:38 278K 
[ ]17481_safety-tolerability-antidepressants.pdf2022-11-07 22:58 38K 
[ ]17482_safety-tolerability-antidepressants-weighing-impact.pdf2022-11-07 22:50 209K 
[ ]17484_safety-tolerability-aripiprazole-irritability-pediatric.pdf2022-11-07 22:08 338K 
[ ]17485_safety-tolerability-associated-second-generation-antipsychotic.pdf2022-11-07 23:02 258K 
[ ]17487_safety-tolerability-clinical-effect-low-dose-buprenorphine.pdf2022-11-07 22:10 558K 
[ ]17488_safety-tolerability-efficacy-psilocybin-patients-obsessive.pdf2022-11-07 22:58 106K 
[ ]17489_safety-tolerability-oral-loading-divalproex-sodium.pdf2022-11-07 22:19 32K 
[ ]17490_safety-tolerability-rapidly-escalating-dose-loading.pdf2022-11-07 22:27 38K 
[ ]17491_saints-madmen-psychiatry-opens-doors-religion.pdf2022-11-07 22:30 36K 
[ ]17492_same-different-phenomenological-comparison-auditory.pdf2022-11-07 22:54 266K 
[ ]17493_same-for-neuropsychiatric-disorders.pdf2022-11-07 22:30 1.2M 
[ ]17495_scales-assess-efficacy-safety-pharmacologic-agents.pdf2022-11-07 22:19 46K 
[ ]17496_scare-care.pdf2022-11-07 23:00 190K 
[ ]17497_scheduling-post-discharge-mental-health-appointments.pdf2022-11-07 22:09 419K 
[ ]17498_schizoaffective-disorder-form-schizophrenia-affective.pdf2022-11-07 22:27 50K 
[ ]17499_schizo-obsessive-disorder.pdf2022-11-07 22:54 79K 
[ ]17500_schizopherina-guide-clinicians.pdf2022-11-07 22:18 45K 
[ ]17501_schizopherina-practical-primer.pdf2022-11-07 22:53 67K 
[ ]17502_schizophernia-later-life-treatment-research-policy.pdf2022-11-07 22:09 35K 
[ ]17503_schizophrenia-antipsychotic-drugs-cardiovascular-disease.pdf2022-11-07 22:12 148K 
[ ]17504_schizophrenia-associated-idiopathic-unconjugated-hyperbilirubinemia-Gilbert-syndrome.pdf2022-11-07 22:19 47K 
[ ]17505_schizophrenia-associated-idiopathic-unconjugated-hyperbilirubinemia-Gilbert-syndrome-3-cases.pdf2022-11-07 22:05 69K 
[ ]17506_schizophrenia-binge-eating-disorders.pdf2022-11-07 22:54 57K 
[ ]17507_schizophrenia-changes-physical-appearance.pdf2022-11-07 22:30 126K 
[ ]17508_schizophrenia-children-adolescents.pdf2022-11-07 22:41 41K 
[ ]17509_schizophrenia-comorbid-human-immunodeficiency-virus.pdf2022-11-07 22:55 146K 
[ ]17510_schizophrenia-comorbid-metabolic-disorders.pdf2022-11-07 23:00 212K 
[ ]17511_schizophrenia-comorbid-substance-disorder-effects.pdf2022-11-07 22:09 137K 
[ ]17512_schizophrenia-comprehensive-treatment-management.pdf2022-11-07 22:05 37K 
[ ]17513_schizophrenia-concepts-clinical-management.pdf2022-11-07 22:53 50K 
[ ]17514_schizophrenia-current-science-clinical-practice.pdf2022-11-07 22:49 84K 
[ ]17515_schizophrenia-evolution-synthesis.pdf2022-11-07 22:27 80K 
[ ]17516_schizophrenia-facts-second-edition.pdf2022-11-07 22:36 23K 
[ ]17517_schizophrenia-final-frontier-festschrift-robin-m-murray.pdf2022-11-07 22:17 75K 
[ ]17518_schizophrenia-genetics-biology-predictive-medicine.pdf2022-11-07 22:04 311K 
[ ]17519_schizophrenia-manifestation-x-linked-mcleod-neuroacanthocytosis.pdf2022-11-07 22:37 67K 
[ ]17520_schizophrenia-mechanism-action-current-novel-treatments.pdf2022-11-07 22:50 264K 
[ ]17521_schizophrenia-metabolic-disorders-cardiovascular-disease.pdf2022-11-07 22:54 135K 
[ ]17522_schizophrenia-molecular-age-review-psychiatry-vol.pdf2022-11-07 22:01 39K 
[ ]17524_schizophrenia-neuroimaging-neuroscience.pdf2022-11-07 22:49 54K 
[ ]17525_schizophrenia-obesity-impact-antipsychotic-medications.pdf2022-11-07 22:38 116K 
[ ]17526_schizophrenia-obesity-obstructive-sleep-apnea.pdf2022-11-07 22:22 48K 
[ ]17528_schizophrenia-patients-history-severe-violence-differ.pdf2022-11-07 23:02 156K 
[ ]17529_schizophrenia-rd-ed.pdf2022-11-07 22:52 103K 
[ ]17530_schizophrenia-relapse-after-antipsychotic-discontinuation.pdf2022-11-07 22:07 370K 
[ ]17531_schizophrenia-related-outpatient-treatment-medicaid.pdf2022-11-07 22:26 137K 
[ ]17532_schizophrenia-remission-roller-coaster.pdf2022-11-07 22:20 365K 
[ ]17533_schizophrenia-revealed-neurons-social-interactions.pdf2022-11-07 22:38 42K 
[ ]17534_schizophrenia-role-dopamine-glutamate.pdf2022-11-07 22:38 244K 
[ ]17535_schizophrenia-smoking.pdf2022-11-07 22:06 572K 
[ ]17536_schizophrenia-symptoms-remain-stable-during-decreases.pdf2022-11-07 22:49 196K 
[ ]17537_schizophrenic-speech-making-sense-bathroots-ponds.pdf2022-11-07 22:04 54K 
[ ]17538_school-violence-assessment-management-prevention.pdf2022-11-07 22:23 59K 
[ ]17539_science-art-psychotherapy.pdf2022-11-07 22:18 86K 
[ ]17540_science-community-assessing-mental-health.pdf2022-11-07 23:03 66K 
[ ]17541_science-fiction-autism.pdf2022-11-07 22:25 100K 
[ ]17542_science-marijuana.pdf2022-11-07 22:07 60K 
[ ]17543_science-practice-cognitive-behavior-therapy.pdf2022-11-07 22:20 36K 
[ ]17544_scourge-eps-atypical-antipsychotics-solved-problem.pdf2022-11-07 22:11 72K 
[ ]17545_screening-bipolar-disorder-community.pdf2022-11-07 22:04 68K 
[ ]17546_screening-bipolar-disorder-finding-borderline-personality.pdf2022-11-07 22:18 231K 
[ ]17547_screening-diabetes-metabolic-abnormalities-patients.pdf2022-11-07 22:06 114K 
[ ]17548_screening-diagnosis-and-treatment-of-tardive-dyskinesia.pdf2022-11-07 22:45 1.2M 
[ ]17550_screening-tools-in-collaborative-care-of-depression.pdf2022-11-07 22:28 286K 
[ ]17551_screening-treatment-women-mood-disorders-associated.pdf2022-11-07 22:45 38K 
[ ]17552_sct-and-methylphenidate-response-in-adhd.pdf2022-11-07 22:57 1.2M 
[ ]17553_search-better-noncholinergic-treatment-options-alzheimers.pdf2022-11-07 22:24 59K 
[ ]17554_searching-medical-literature-case-reports.pdf2022-11-07 22:57 55K 
[ ]17555_searching-serendipity.pdf2022-11-07 22:56 146K 
[ ]17556_search-knowledge-developing-american-psychiatric-associations.pdf2022-11-07 22:01 78K 
[ ]17557_search-madness-schizophrenia-neuroscience.pdf2022-11-07 22:50 60K 
[ ]17558_seasonal-affective-disorder-beyond-light-treatment.pdf2022-11-07 22:40 31K 
[ ]17559_seasonality-birth-seasonal-affective-disorder.pdf2022-11-07 22:41 56K 
[ ]17560_seasonality-shows-evidence-polygenic-architecture.pdf2022-11-07 22:02 1.8M 
[ ]17561_secondary-effects-of-ziprasidone-augmentation-in-mdd.pdf2022-11-07 22:23 237K 
[ ]17562_second-generation-antipsychotic-associated-diabetes.pdf2022-11-07 22:11 78K 
[ ]17563_second-messengers-turn-on-genes-activating-protein-kinases-transcription.pdf2022-11-07 22:21 75K 
[ ]17564_second-thoughts-clozapine-treatment-neuroleptic-induced.pdf2022-11-07 23:01 126K 
[ ]17565_secret-happily-married-men-eight-ways-win-wifes-heart.pdf2022-11-07 22:43 72K 
[ ]17566_section-i-current-perspectives-treatment-depression.pdf2022-11-07 22:23 30K 
[ ]17567_section-ii-focus-anxiety-disorders.pdf2022-11-07 22:25 29K 
[ ]17568_security-electronic-mental-health-communication-record.pdf2022-11-07 22:42 234K 
[ ]17570_sedative-effects-low-dose-risperidone-gad-patients.pdf2022-11-07 22:06 79K 
[ ]17571_sedative-hypnotics-and-the-risk-of-falls-and-fractures-in-the-elderly.pdf2022-11-07 22:58 313K 
[ ]17572_seizure-during-combination-trimipramine-bupropion.pdf2022-11-07 23:01 72K 
[ ]17573_seizure-during-risperidone-treatment-elderly-woman.pdf2022-11-07 22:34 100K 
[ ]17574_seizure-risk-of-antidepressants.pdf2022-11-07 22:47 825K 
[ ]17575_seizures-discontinuation-low-dose-lorazepam-originally.pdf2022-11-07 22:07 45K 
[ ]17576_selecting-antidepressant-using-mechanism-action-enhance.pdf2022-11-07 22:56 97K 
[ ]17578_selecting-appropriate-treatments-maintenance-therapy.pdf2022-11-07 22:40 241K 
[ ]17579_selecting-atypical-antipsychotic-combining-clinical.pdf2022-11-07 22:30 85K 
[ ]17580_selecting-effective-long-term-treatment-bipolar-patients.pdf2022-11-07 22:55 87K 
[ ]17581_selecting-methodologies-evaluation-differences-response.pdf2022-11-07 22:27 64K 
[ ]17582_selecting-pharmacotherapy-generalized-anxiety-disorder.pdf2022-11-07 22:30 72K 
[ ]17583_selection-antidepressant-mirtazapine.pdf2022-11-07 22:42 35K 
[ ]17584_selective-actions-sleep-anxiety-exploiting-gaba-abenzodiazepine.pdf2022-11-07 22:13 55K 
[ ]17585_selective-gaba-reuptake-inhibitor-tiagabine-treatment.pdf2022-11-07 22:28 182K 
[ ]17586_selective-serotonin-reuptake-inhibitor-add-therapy.pdf2022-11-07 22:10 153K 
[ ]17587_selective-serotonin-reuptake-inhibitor-drug-interactions.pdf2022-11-07 22:11 654K 
[ ]17588_selective-serotonin-reuptake-inhibitor-exposure-during.pdf2022-11-07 22:05 247K 
[ ]17589_selective-serotonin-reuptake-inhibitorinduced-spermatorrhea.pdf2022-11-07 22:19 738K 
[ ]17590_selective-serotonin-reuptake-inhibitors.pdf2022-11-07 22:14 82K 
[ ]17591_selective-serotonin-reuptake-inhibitors-autism-review.pdf2022-11-07 22:10 96K 
[ ]17592_selective-serotonin-reuptake-inhibitors-congenital.pdf2022-11-07 22:10 466K 
[ ]17593_selective-serotonin-reuptake-inhibitors-context-hepatitis.pdf2022-11-07 22:21 99K 
[ ]17594_selective-serotonin-reuptake-inhibitors-eating-disorders.pdf2022-11-07 22:48 37K 
[ ]17595_selective-serotonin-reuptake-inhibitors-persistent.pdf2022-11-07 22:43 640K 
[ ]17596_selective-serotonin-reuptake-inhibitor-ssri-add-therapy.pdf2022-11-07 22:43 178K 
[ ]17597_selective-serotonin-reuptake-inhibitors-treating-alcoholic.pdf2022-11-07 22:03 55K 
[ ]17598_selective-serotonin-reuptake-inhibitor-treatment-generalized.pdf2022-11-07 22:24 157K 
[ ]17599_selective-versus-multi-transmitter-antidepressants.pdf2022-11-07 22:52 78K 
[ ]17600_selectivity-antidepressants-monoamine-hypothesis-depression.pdf2022-11-07 22:49 94K 
[ ]17601_selegiline-transdermal-system-treatment-major-depressive.pdf2022-11-07 22:50 110K 
[ ]17602_self-administered-psychotherapy-depression-using-telephone.pdf2022-11-07 22:42 55K 
[ ]17603_self-amputation-left-hand-case-report.pdf2022-11-07 22:17 37K 
[ ]17604_self-harm-subscale-schedule-nonadaptive-adaptive-personality.pdf2022-11-07 22:43 326K 
[ ]17605_self-injurious-behavior-community-sample-young-women.pdf2022-11-07 22:04 107K 
[ ]17606_self-injurious-skin-picking-clinical-characteristics.pdf2022-11-07 22:44 55K 
[ ]17607_selfish-brain-learning-addiction.pdf2022-11-07 22:58 45K 
[ ]17608_self-medication-bipolar-disorders-stimulant-dependence.pdf2022-11-07 22:33 199K 
[ ]17609_self-reported-history-manichypomanic-switch-associated.pdf2022-11-07 22:51 201K 
[ ]17610_self-reported-medication-adherence-in-schizophrenia.pdf2022-11-07 22:46 281K 
[ ]17611_self-reported-participation-nonpharmacologic-treatments.pdf2022-11-07 22:50 67K 
[ ]17612_seminars-liaison-psychiatry-nd-ed.pdf2022-11-07 22:12 84K 
[ ]17613_sensitive-personalized-determinations-likelihood-being.pdf2022-11-07 22:23 79K 
[ ]17614_sensitivity-carbon-dioxide-patients-generalized-anxiety.pdf2022-11-07 22:01 64K 
[ ]17615_sensitivity-specificity-mood-disorder-questionnaire.pdf2022-11-07 22:44 374K 
[ ]17616_sensitizing-clinicians-patients-social-functional.pdf2022-11-07 22:43 46K 
[ ]17617_sensory-phenomena-obsessive-compulsive-disorder-tourettes.pdf2022-11-07 22:30 82K 
[ ]17618_sequenced-treatment-alternatives-relieve-depression.pdf2022-11-07 22:31 82K 
[ ]17619_sequential-treatment-mood-anxiety-disorders.pdf2022-11-07 22:13 178K 
[ ]17621_serious-mental-illness-disrupted-caregiving-children.pdf2022-11-07 22:40 343K 
[ ]17622_serious-rash-lamotrigine-carbamazepine-discontinuation.pdf2022-11-07 22:43 134K 
[ ]17623_serotonergic-noradrenergic-reuptake-inhibitors-prediction.pdf2022-11-07 22:32 99K 
[ ]17624_serotonin-d-hypothesis-obsessive-compulsive-disorder.pdf2022-11-07 22:13 52K 
[ ]17625_serotonin-function-personality-trait-variations-childhood.pdf2022-11-07 22:50 68K 
[ ]17626_serotonin-norepinephrine-reuptake-inhibitors-treatment.pdf2022-11-07 22:04 115K 
[ ]17627_serotonin-possible-too-much-thing.pdf2022-11-07 22:38 34K 
[ ]17628_serotonin-receptor-novel-therapeutic-target.pdf2022-11-07 22:32 231K 
[ ]17629_serotonin-reuptake-inhibitor-antidepressants-abnormal.pdf2022-11-07 23:01 358K 
[ ]17630_serotonin-reuptake-inhibitor-discontinuation-syndrome.pdf2022-11-07 22:51 36K 
[ ]17631_serotonin-reuptake-inhibitorsand-shocklike-paresthesia.pdf2022-11-07 22:40 50K 
[ ]17632_serotonin-reuptake-inhibitor-treatment-obsessive-compulsive.pdf2022-11-07 22:08 296K 
[ ]17633_serotonin-syndrome-caused-clomipramine-moclobemide.pdf2022-11-07 22:44 44K 
[ ]17634_serotonin-system-polymorphisms-httlpr-ga-responses.pdf2022-11-07 22:29 202K 
[ ]17635_serotonin-transporter-gene-promoter-polymorphism-somatoform.pdf2022-11-07 22:16 335K 
[ ]17636_serotonin-transporter-gene-status-electroconvulsive.pdf2022-11-07 22:43 97K 
[ ]17637_sertraline-induced-anorgasmia-treated-intermittent.pdf2022-11-07 22:48 86K 
[ ]17638_sertraline-monotherapy-treatment-psychotic-nonpsychotic.pdf2022-11-07 22:57 65K 
[ ]17639_sertraline-norsertraline-levels-three-breastfed-infants.pdf2022-11-07 23:02 75K 
[ ]17640_sertraline-treatment-generalized-anxiety-disorder.pdf2022-11-07 22:21 112K 
[ ]17641_sertraline-treatment-hallucinogen-persisting-perception.pdf2022-11-07 22:16 86K 
[ ]17642_sertraline-treatment-panic-disorder-response-patients.pdf2022-11-07 22:43 60K 
[ ]17643_sertraline-treatment-pathological-gambling-pilot-study.pdf2022-11-07 22:36 146K 
[ ]17644_sertraline-treatment-posttraumatic-stress-disorder.pdf2022-11-07 22:21 65K 
[ ]17645_sertraline-versus-imipramine-treatment-comorbid-panic.pdf2022-11-07 22:42 81K 
[ ]17646_sertraline-versus-paroxetine-treatment-panic-disorder.pdf2022-11-07 22:34 71K 
[ ]17647_sertraline-versus-venlafaxine-xr-major-depressive.pdf2022-11-07 22:15 156K 
[ ]17648_serum-bupropion-levels-breastfeeding-mother-infant.pdf2022-11-07 22:45 40K 
[ ]17649_serum-fluvoxamine-levels-breastfed-infants.pdf2022-11-07 22:25 32K 
[ ]17650_serum-folate-vitamin-b12-homocysteine-major-depressive-disorder-part-1-predictors-response-fluoxetin.pdf2022-11-07 23:01 146K 
[ ]17651_serum-folate-vitamin-b-homocysteine-major-depressive-depression-alternative.pdf2022-11-07 22:17 119K 
[ ]17652_serum-leptin-triglyceride-levels-patients-treatment.pdf2022-11-07 22:10 62K 
[ ]17653_serum-lipoproteins-improve-successful-pharmacologic.pdf2022-11-07 22:53 319K 
[ ]17654_serum-prolactin-levels-among-outpatients-major-depressive.pdf2022-11-07 23:02 84K 
[ ]17655_serum-valproate-levels-breastfeeding-mother-infant.pdf2022-11-07 22:40 45K 
[ ]17656_service-costs-treating-schizophrenia-atypical-antipsychotics.pdf2022-11-07 23:02 69K 
[ ]17658_severe-acute-respiratory-syndromerelated-psychiatric.pdf2022-11-07 22:09 144K 
[ ]17659_severe-atypical-symptoms-without-depression-sad-effects.pdf2022-11-07 22:45 44K 
[ ]17660_severe-extrapyramidal-reaction-due-risperidone-case.pdf2022-11-07 22:52 45K 
[ ]17661_severe-hypertriglyceridemia-associated-olanzapine.pdf2022-11-07 22:57 48K 
[ ]17662_severe-lithium-toxicity-induced-combined-levofloxacin.pdf2022-11-07 23:00 59K 
[ ]17663_severe-mental-illness-risk-sexual-offending-men-case.pdf2022-11-07 22:45 192K 
[ ]17664_severe-neuropsychiatric-outcomes-following-discontinuation.pdf2022-11-07 22:39 292K 
[ ]17665_severe-obsessive-compulsive-disorder-without-comorbid.pdf2022-11-07 22:02 140K 
[ ]17666_severity-binge-eating-disorder-effects-treatment-outcome.pdf2022-11-07 22:20 161K 
[ ]17667_severity-comorbidity-predict-episode-duration-recurrence.pdf2022-11-07 23:01 80K 
[ ]17668_sex-age-specific-incidence-fractures-mental-illness.pdf2022-11-07 22:40 176K 
[ ]17669_sex-and-pubertal-status-moderate-adhd-and-depression.pdf2022-11-07 22:45 352K 
[ ]17670_sex-differences-depressed-substance-abusers.pdf2022-11-07 22:45 97K 
[ ]17671_sex-differences-depressive-response-during-monoamine.pdf2022-11-07 22:44 98K 
[ ]17672_sex-differences-emotional-reactivity-daily-life-stress.pdf2022-11-07 22:44 52K 
[ ]17673_sex-differences-in-depressive-symptoms-in-schizophrenia.pdf2022-11-07 22:12 308K 
[ ]17674_sex-differences-in-prevalence-of-ptsd.pdf2022-11-07 22:02 1.7M 
[ ]17675_sex-differences-in-use-of-synthetic-cannabinoids.pdf2022-11-07 22:07 247K 
[ ]17676_sex-differences-in-youth-with-bipolar-disorder.pdf2022-11-07 22:54 413K 
[ ]17677_sex-differences-pediatric-bipolar-disorder.pdf2022-11-07 22:22 209K 
[ ]17678_sex-hormones-female-brain-toll-variability-deficiency.pdf2022-11-07 22:59 61K 
[ ]17679_sex-psychiatry-next-years.pdf2022-11-07 22:46 49K 
[ ]17680_sex-specific-association-between-antidepressant-body.pdf2022-11-07 22:08 240K 
[ ]17681_sex-therapy-psychiatric-treatment-has-partner-reproductive.pdf2022-11-07 22:11 60K 
[ ]17682_sexual-dysfunction-associated-mirtazapine-case-report.pdf2022-11-07 22:25 38K 
[ ]17683_sexual-dysfunction-brain-body-connection.pdf2022-11-07 22:52 722K 
[ ]17684_sexual-dysfunction-fluvoxamine-therapy.pdf2022-11-07 22:20 57K 
[ ]17685_sexual-dysfunction-fluvoxamine-therapy-accurate-objective-measurement.pdf2022-11-07 22:46 58K 
[ ]17687_sexual-function-behavior-social-phobia.pdf2022-11-07 22:43 70K 
[ ]17688_sexual-function-dysfunction-during-treatment-psychotropic.pdf2022-11-07 22:59 63K 
[ ]17689_sexual-function-gonadal-hormones-patients-taking-antipsychotic.pdf2022-11-07 22:01 175K 
[ ]17690_sexual-functioning-assessed-double-blind-placebo.pdf2022-11-07 22:51 129K 
[ ]17691_sexual-functioning-ssris.pdf2022-11-07 22:27 48K 
[ ]17692_sexual-function-postpartum-women-treated-depression.pdf2022-11-07 22:44 177K 
[ ]17693_sexual-function-satisfaction-treatment-chronic-major.pdf2022-11-07 22:43 77K 
[ ]17694_sexual-offending-antisocial-sexual-behavior-among.pdf2022-11-07 22:03 48K 
[ ]17695_sexual-orientation-aces-and-comorbidity.pdf2022-11-07 22:15 1.1M 
[ ]17696_sexual-satisfaction-quality-life-major-depressive.pdf2022-11-07 22:11 287K 
[ ]17697_sexual-satisfaction-risk-disability-older-women.pdf2022-11-07 22:23 59K 
[ ]17698_sexual-side-effects-antidepressants.pdf2022-11-07 22:05 87K 
[ ]17699_shared-decision-making-long-term-outcome-schizophrenia.pdf2022-11-07 22:22 169K 
[ ]17700_shared-decision-making-schizophrenia-treatment.pdf2022-11-07 22:39 154K 
[ ]17701_shared-neural-activity-panic-disorder-undifferentiated.pdf2022-11-07 22:39 1.2M 
[ ]17702_shared-obsessive-compulsive-disorder-married-couple.pdf2022-11-07 22:34 42K 
[ ]17703_sharing-selling-prescription-medications-college-student.pdf2022-11-07 22:07 255K 
[ ]17707_shorter-oxford-textbook-psychiatry-th-ed.pdf2022-11-07 22:33 54K 
[ ]17708_short-term-dynamic-psychotherapy-versus-pharmacotherapy.pdf2022-11-07 22:40 500K 
[ ]17709_short-term-effects-lisdexamfetamine-dimesylate-cardiovascular.pdf2022-11-07 22:13 406K 
[ ]17710_short-term-efficacy-safety-desvenlafaxine-randomized.pdf2022-11-07 22:49 472K 
[ ]17711_short-term-naturalistic-treatment-outcomes-cigarette.pdf2022-11-07 22:25 206K 
[ ]17712_should-anxiety-insomnia-influence-antidepressant-selection.pdf2022-11-07 22:55 101K 
[ ]17713_should-consider-mood-disturbance-schizophrenia-important.pdf2022-11-07 22:03 64K 
[ ]17714_should-efficacy-evaluated-randomized-clinical-trials.pdf2022-11-07 22:33 71K 
[ ]17715_should-expand-toolbox-psychiatric-treatment-methods.pdf2022-11-07 22:54 481K 
[ ]17716_should-expect-neural-signatures-dsm-diagnoses.pdf2022-11-07 23:01 324K 
[ ]17717_should-keep-calling-antidepressants-antidepressants.pdf2022-11-07 22:55 52K 
[ ]17718_should-move-beyond-line-therapy-depression.pdf2022-11-07 22:08 218K 
[ ]17719_should-research-productivity-assessed-early-career.pdf2022-11-07 22:58 740K 
[ ]17721_should-women-childbearing-potential-prescribed-valproate.pdf2022-11-07 22:25 116K 
[ ]17722_shunned-discrimination-against-mental-illness.pdf2022-11-07 22:23 55K 
[ ]17723_siadh-multiple-antidepressants-geriatric-patient.pdf2022-11-07 22:37 66K 
[ ]17724_sib-pain-reactivity-and-endorphin-in-autism.pdf2022-11-07 22:28 443K 
[ ]17725_side-effect-burden-associated-drug-treatment-panic.pdf2022-11-07 22:50 45K 
[ ]17726_side-effect-profile-enteric-coated-divalproex-sodium.pdf2022-11-07 22:37 51K 
[ ]17727_side-effects-antipsychotics-elderly.pdf2022-11-07 22:53 59K 
[ ]17728_side-effects-influencers-treatment-outcome.pdf2022-11-07 22:35 191K 
[ ]17729_side-risk-equation-exploring-risks-untreated-depression.pdf2022-11-07 22:25 201K 
[ ]17730_side-torture-survivors-treating-terrible-assault-human.pdf2022-11-07 22:46 89K 
[ ]17731_sigma-enigma-sigma-receptors-provide-novel-target.pdf2022-11-07 22:51 132K 
[ ]17732_signal-noise-ratio-variability-relevance-clinical.pdf2022-11-07 22:14 548K 
[ ]17733_signs-symptoms-associated-metabolic-syndrome-psychiatric.pdf2022-11-07 22:46 80K 
[ ]17734_sildenafil-advertising-realities-sildenafil-treatment.pdf2022-11-07 22:51 83K 
[ ]17735_sildenafil-bridging-gap-between-pharmacologic-treatment.pdf2022-11-07 22:34 50K 
[ ]17736_sildenafil-citrate-management-antidepressant-associated.pdf2022-11-07 22:12 66K 
[ ]17737_sildenafil-iatrogenic-serotonergic-antidepressant.pdf2022-11-07 22:20 25K 
[ ]17738_sildenafil-treatment-antidepressant-induced-sexual.pdf2022-11-07 22:15 35K 
[ ]17739_sildenafil-treatment-serotonin-reuptake-inhibitor.pdf2022-11-07 22:56 37K 
[ ]17740_similarities-differences-among-antipsychotics.pdf2022-11-07 22:31 51K 
[ ]17741_simple-fools.pdf2022-11-07 22:08 60K 
[ ]17742_simultaneous-true-seizures-pseudoseizures.pdf2022-11-07 22:23 88K 
[ ]17743_sincere-thanks.pdf2022-11-07 22:31 221K 
[ ]17744_single-blind-randomized-trial-comparing-quetiapine.pdf2022-11-07 22:29 55K 
[ ]17745_single-center-double-blind-placebo-controlled-evaluation.pdf2022-11-07 23:02 99K 
[ ]17746_single-dose-intravenous-valproate-acute-mania.pdf2022-11-07 22:25 30K 
[ ]17747_single-dose-ketamine-followed-daily-d-cycloserine.pdf2022-11-07 22:54 925K 
[ ]17748_single-modality-versus-dual-modality-treatment-trichotillomania.pdf2022-11-07 22:31 104K 
[ ]17749_single-versus-multiple-daily-dosing-lithium-renal.pdf2022-11-07 22:51 134K 
[ ]17750_six-month-follow-randomized-controlled-trial-augmenting.pdf2022-11-07 22:10 304K 
[ ]17751_six-month-outcomes-randomized-trial-augmenting-serotonin.pdf2022-11-07 22:46 255K 
[ ]17752_six-month-review-weight-metabolic-parameters-patients.pdf2022-11-07 22:43 50K 
[ ]17753_six-perspectives-safety-tolerability-nefazodone.pdf2022-11-07 23:01 79K 
[ ]17754_sixtieth.pdf2022-11-07 22:03 18K 
[ ]17755_sleep-aging-prevalence-disturbed-sleep-treatment-considerations.pdf2022-11-07 22:43 159K 
[ ]17756_sleep-and-antisuicidal-response-to-ketamine.pdf2022-11-07 22:22 331K 
[ ]17757_sleep-apnea-and-suicidal-thoughts-and-behavior.pdf2022-11-07 23:03 238K 
[ ]17758_sleep-apnea-associated-antipsychotic-induced-obesity.pdf2022-11-07 22:21 47K 
[ ]17759_sleep-architecture-relationship-insomnia.pdf2022-11-07 22:25 130K 
[ ]17760_sleep-associated-aes-with-methylphenidate.pdf2022-11-07 22:50 1.2M 
[ ]17761_sleep-changes-consecutive-days-venlafaxine-administration.pdf2022-11-07 22:10 30K 
[ ]17762_sleep-circadian-rhythm-disturbances-bipolar-disorder.pdf2022-11-07 22:55 137K 
[ ]17763_sleep-depression.pdf2022-11-07 22:52 304K 
[ ]17764_sleep-depression-anxiety-disorders-population-based.pdf2022-11-07 22:57 1.1M 
[ ]17765_sleep-disturbance-adults-posttraumatic-stress-disorder.pdf2022-11-07 22:05 336K 
[ ]17766_sleep-disturbance-and-mental-disturbance.pdf2022-11-07 22:32 270K 
[ ]17767_sleep-disturbance-chronic-military-related-ptsd-clinical.pdf2022-11-07 22:33 286K 
[ ]17768_sleep-disturbance-predicts-ptsd-and-depression.pdf2022-11-07 22:10 237K 
[ ]17769_sleep-disturbances-suicidal-behavior-patients-major.pdf2022-11-07 22:44 25K 
[ ]17770_sleep-duration-insomnia-predicts-course-depressive.pdf2022-11-07 22:08 420K 
[ ]17771_sleep-dynamic-therapy-cerro-grande-fire-evacuees-posttraumatic.pdf2022-11-07 22:04 105K 
[ ]17772_sleepiness-versus-sleeplessness-shift-sleep-disorders.pdf2022-11-07 22:46 74K 
[ ]17773_sleep-latency-is-shortened-during-weeks-treatment.pdf2022-11-07 22:51 79K 
[ ]17774_sleep-medicine-essentials-review.pdf2022-11-07 22:50 104K 
[ ]17775_sleep-problems-among-adolescent-survivors-following.pdf2022-11-07 22:23 320K 
[ ]17776_sleep-related-eating-disorder-induced-olanzapine.pdf2022-11-07 22:01 51K 
[ ]17777_sleep-related-eating-disorder-induced-risperidone.pdf2022-11-07 22:22 67K 
[ ]17778_sleep-related-eating-disorders-during-use-of-hypnotics.pdf2022-11-07 22:43 213K 
[ ]17779_sleep-related-eating-disorder-zolpidem-open-interventional.pdf2022-11-07 22:06 157K 
[ ]17780_sleep-variability-and-acute-suicide-risk.pdf2022-11-07 22:26 1.2M 
[ ]17781_smoke-mirrors-devastating-effect-false-sexual-abuse.pdf2022-11-07 23:00 19K 
[ ]17782_smoking-and-risk-of-sud-relapse.pdf2022-11-07 22:21 306K 
[ ]17783_smoking-and-suicide.pdf2022-11-07 22:38 120K 
[ ]17784_smoking-bipolar-schizophrenic-patients.pdf2022-11-07 22:38 47K 
[ ]17785_smoking-cessation-homeless-veterans.pdf2022-11-07 23:00 109K 
[ ]17786_smoking-cessation-panic-attacks-report-cases.pdf2022-11-07 22:25 50K 
[ ]17787_smoking-cessation-patients-psychiatric-disorders.pdf2022-11-07 22:51 184K 
[ ]17788_smoking-habits-bipolar-schizophrenic-outpatients-southern.pdf2022-11-07 22:57 46K 
[ ]17789_smoking-prevalence-in-people-with-mental-health-problems.pdf2022-11-07 22:42 263K 
[ ]17790_smoking-risk-factor-mental-health-disturbances-disaster.pdf2022-11-07 22:27 75K 
[ ]17791_snap-is-associated-schizophrenia-major-depressive.pdf2022-11-07 22:28 593K 
[ ]17792_snris-management-acute-major-depressive-disorder.pdf2022-11-07 22:15 74K 
[ ]17793_social-anxiety-disorder-clinical-course-outcome-review.pdf2022-11-07 22:29 92K 
[ ]17794_social-anxiety-disorder-comorbidity-implications.pdf2022-11-07 22:52 71K 
[ ]17795_social-anxiety-disorder-designing-pharmacologic-treatment.pdf2022-11-07 22:39 67K 
[ ]17796_social-anxiety-disorder-generalized-anxiety-disorder.pdf2022-11-07 22:49 70K 
[ ]17797_social-anxiety-disorder-primary-care-setting.pdf2022-11-07 22:49 80K 
[ ]17798_social-anxiety-disorder-spectrum.pdf2022-11-07 23:00 63K 
[ ]17799_social-anxiety-disorder-therapy-meta-analysis-of-neuroimaging-studies.pdf2022-11-07 22:04 266K 
[ ]17800_social-anxiety-disorder-treatments-psychosocial-therapies.pdf2022-11-07 22:25 65K 
[ ]17801_social-anxiety-disorder-unrecognized-problem-primary.pdf2022-11-07 22:54 61K 
[ ]17802_social-cognition-schizophrenia.pdf2022-11-07 22:28 1.1M 
[ ]17803_social-determinants-mental-health.pdf2022-11-07 22:02 74K 
[ ]17804_social-functioning-depression-review.pdf2022-11-07 22:51 78K 
[ ]17805_social-functioning-treatment-depression.pdf2022-11-07 22:24 77K 
[ ]17806_social-phobia-etiology-neurobiology-treatment.pdf2022-11-07 22:35 94K 
[ ]17807_social-phobia-prevalence-diagnostic-threshold.pdf2022-11-07 22:50 64K 
[ ]17808_social-skills-training-schizophrenia-step-step-guide.pdf2022-11-07 22:16 22K 
[ ]17809_social-skills-traning-schizoprenia-step-step-guide.pdf2022-11-07 22:17 69K 
[ ]17810_societal-costs-chronic-major-depression.pdf2022-11-07 22:29 52K 
[ ]17811_sociodemographic-characteristics-cardiovascular-risk.pdf2022-11-07 22:59 126K 
[ ]17812_sodium-valproate-violent-aggressive-behaviors-critical.pdf2022-11-07 22:35 63K 
[ ]17813_solutions-treating-hispanic-adults-adhd.pdf2022-11-07 22:46 239K 
[ ]17814_somatic-presentations-mental-disorders-refining-research.pdf2022-11-07 22:25 90K 
[ ]17815_somatic-symptoms-depression-antidepressant-treatment.pdf2022-11-07 22:40 43K 
[ ]17816_somatic-symptoms-predictors-onset-response-fluoxetine.pdf2022-11-07 22:42 42K 
[ ]17817_somatic-versus-cognitive-symptoms-depression-predictors.pdf2022-11-07 22:41 378K 
[ ]17818_somatoform-disorders-medicolegal-guide.pdf2022-11-07 22:51 104K 
[ ]17819_somatoform-factitious-disorders.pdf2022-11-07 22:46 68K 
[ ]17820_sources-of-prescription-medication-misuse.pdf2022-11-07 22:23 382K 
[ ]17821_speaking-more-consistent-language-discussing-severe.pdf2022-11-07 22:19 318K 
[ ]17822_special-considerations-insomnia-diagnosis-management.pdf2022-11-07 22:10 120K 
[ ]17823_special-considerations-lithium-children-adolescents.pdf2022-11-07 22:32 104K 
[ ]17824_special-issues-related-treatment-depression-women.pdf2022-11-07 22:15 63K 
[ ]17825_special-thanks.pdf2022-11-07 22:06 69K 
[ ]17826_specific-characteristics-paindepression-association.pdf2022-11-07 22:38 64K 
[ ]17827_specific-features-suicidal-behavior-patients-narcissistic.pdf2022-11-07 22:38 282K 
[ ]17828_specific-parental-depression-symptoms-risk-markers.pdf2022-11-07 22:27 385K 
[ ]17829_spect-imaging-treatment-pyromania.pdf2022-11-07 22:01 86K 
[ ]17830_spectrum-anxiety-disorders-medically-ill.pdf2022-11-07 22:37 201K 
[ ]17831_spectrum-psychotic-disorders-neurobiology-etiology.pdf2022-11-07 22:21 100K 
[ ]17832_speed-response-remission-major-depressive-disorder.pdf2022-11-07 22:08 62K 
[ ]17833_spoke-listened-were-growing.pdf2022-11-07 22:56 330K 
[ ]17834_sponsored-clinical-trials-bias.pdf2022-11-07 22:03 156K 
[ ]17835_sponsorship-antidepressant-dose-outcome-major-depressive.pdf2022-11-07 22:14 418K 
[ ]17836_spontaneous-social-behaviors-discriminate-behavioral.pdf2022-11-07 22:58 390K 
[ ]17837_sports-psychiatry-strategies-life-balance-peak-performance.pdf2022-11-07 23:00 79K 
[ ]17838_ssri-and-stroke-age-and-time-effects.pdf2022-11-07 22:19 456K 
[ ]17839_ssri-induced-parkinsonism-may-early-sign-future-parkinsons.pdf2022-11-07 22:50 45K 
[ ]17840_ssri-optimal-dose-remains-issue.pdf2022-11-07 22:48 86K 
[ ]17841_ssri-safety-overdose.pdf2022-11-07 23:01 38K 
[ ]17842_ssris-and-glaucoma.pdf2022-11-07 22:17 219K 
[ ]17843_ssris-and-sudden-unexpected-death.pdf2022-11-07 22:08 926K 
[ ]17844_ssris-snris-broad-spectrum-efficacy-beyond-major-depression.pdf2022-11-07 23:02 60K 
[ ]17845_ssri-tca-combination-treatment-resistant-depression.pdf2022-11-07 22:41 53K 
[ ]17846_ssri-versus-bupropion-effects-symptom-clusters-suicidal.pdf2022-11-07 22:17 512K 
[ ]17847_stability-uncertainty.pdf2022-11-07 23:03 40K 
[ ]17848_stabilization-mood-below-versus-above-baseline-bipolar.pdf2022-11-07 22:26 55K 
[ ]17849_stahls-essential-psychopharmacology-online-revised.pdf2022-11-07 22:18 102K 
[ ]17850_stahls-essential-psychopharmacology-prescribers-guide.pdf2022-11-07 22:53 71K 
[ ]17851_standard-depression-treatment-remission-full-recovery.pdf2022-11-07 22:14 58K 
[ ]17852_staring-sun-overcoming-terror-death.pdf2022-11-07 22:41 735K 
[ ]17853_state-knowledge-chronic-depression.pdf2022-11-07 22:55 100K 
[ ]17854_state-society.pdf2022-11-07 22:11 69K 
[ ]17855_statin-risk-depression-patients-coronary-heart-disease.pdf2022-11-07 22:42 289K 
[ ]17856_statins-as-antipsychotic-augmentation-in-schizophrenia.pdf2022-11-07 22:13 294K 
[ ]17857_statins-cardiac-intervention-is-associated-reduced.pdf2022-11-07 22:13 278K 
[ ]17858_statins-produce-ataxia-bipolar-disorder-case-reports.pdf2022-11-07 22:11 93K 
[ ]17859_statistical-comparison-clinical-trials.pdf2022-11-07 22:47 38K 
[ ]17860_stereotypic-movement-disorder.pdf2022-11-07 22:12 92K 
[ ]17861_stigma-and-depression-outcomes-in-chinese-immigrants.pdf2022-11-07 22:44 225K 
[ ]17862_still-depressed.pdf2022-11-07 22:09 1.1M 
[ ]17863_stimulant-misuse-motives-in-adolescents-and-young-adults.pdf2022-11-07 22:35 549K 
[ ]17864_stimulant-treatment-frontotemporal-dementia-patients.pdf2022-11-07 22:15 161K 
[ ]17865_st-johns-wort-hypericum-perforatum-breastfeeding-plasma.pdf2022-11-07 22:18 86K 
[ ]17866_st-johns-wort-hypericum-perforatum-major-depression.pdf2022-11-07 22:16 227K 
[ ]17867_st-johns-wort-hypomania.pdf2022-11-07 22:55 38K 
[ ]17868_straight-talk-psychiatric-medications-kids.pdf2022-11-07 22:19 38K 
[ ]17870_strategies-dosing-switching-antipsychotics-optimal.pdf2022-11-07 22:25 380K 
[ ]17872_strategies-improving-compliance-treatment-schizophrenia.pdf2022-11-07 22:40 75K 
[ ]17873_strategies-improving-treatment-adherence-schizophrenia.pdf2022-11-07 22:53 237K 
[ ]17875_strategies-long-term-treatment-schizophrenia-real.pdf2022-11-07 22:59 151K 
[ ]17876_strategies-making-accurate-differential-diagnosis.pdf2022-11-07 22:02 175K 
[ ]17879_strategies-preventing-recurrence-bipolar-disorder.pdf2022-11-07 22:47 69K 
[ ]17881_strategies-switching-antidepressants-achieve-maximum.pdf2022-11-07 22:29 166K 
[ ]17882_strategies-switching-conventional-antipsychotic-drugs.pdf2022-11-07 22:12 75K 
[ ]17883_strategies-tactics-management-maintenance-treatment.pdf2022-11-07 22:37 50K 
[ ]17884_strategies-tactics-treatment-chronic-depression.pdf2022-11-07 22:42 58K 
[ ]17885_strategies-treating-chronic-depression.pdf2022-11-07 22:43 55K 
[ ]17886_strategies-treatment-antidepressant-related-sexual.pdf2022-11-07 22:51 78K 
[ ]17887_strategies-treatment-generalized-anxiety-primary-care.pdf2022-11-07 22:08 29K 
[ ]17888_strategies-treatment-suicidality-identification-common.pdf2022-11-07 22:34 261K 
[ ]17889_strength-at-home.pdf2022-11-07 22:20 294K 
[ ]17890_streptococcal-infection-and-neuropsychiatric-disorders.pdf2022-11-07 22:38 248K 
[ ]17891_stress-brain-depression.pdf2022-11-07 22:33 84K 
[ ]17892_stressful-life-events-in-offspring-of-bipolar-probands.pdf2022-11-07 23:01 119K 
[ ]17893_stress-inflammation-reduce-brain-derived-neurotrophic.pdf2022-11-07 22:29 457K 
[ ]17894_stressor-criterion-posttraumatic-stress-disorder-does.pdf2022-11-07 23:03 112K 
[ ]17895_stress-related-responses-years-exposure-terror-israel.pdf2022-11-07 22:10 195K 
[ ]17896_stroke-resulting-rapid-switch-phenelzine-tranylcypromine.pdf2022-11-07 22:47 44K 
[ ]17898_structural-functional-brain-changes-posttraumatic.pdf2022-11-07 22:54 76K 
[ ]17899_structural-issues-policy-primary-care-management-depression.pdf2022-11-07 22:36 55K 
[ ]17900_structured-exercises-promoting-family-group-strengths.pdf2022-11-07 22:42 23K 
[ ]17901_study-compulsive-buying-depressed-patients.pdf2022-11-07 23:03 80K 
[ ]17902_study-data-support-validity-major-depression-bereavement.pdf2022-11-07 22:21 91K 
[ ]17903_study-design-factors-patient-demographics-effect-decline.pdf2022-11-07 22:52 220K 
[ ]17904_study-guide-essentials-clinical-psychiatry.pdf2022-11-07 22:42 39K 
[ ]17905_study-impulse-control-disorders-among-alcohol-dependent.pdf2022-11-07 22:43 40K 
[ ]17906_subject-expectations-treatment-effectiveness-outcome.pdf2022-11-07 22:25 55K 
[ ]17907_subjective-assessments-threats-association-posttraumatic.pdf2022-11-07 23:01 99K 
[ ]17908_sublingual-ketamine-an-option-to-increase-accessibility.pdf2022-11-07 22:38 91K 
[ ]17909_substance-abuse-comprehensive-textbook-rd-ed.pdf2022-11-07 22:36 44K 
[ ]17910_substance-abuse-comprehensive-textbook-th-ed.pdf2022-11-07 22:13 52K 
[ ]17911_substance-abuse-disorders-evidence-experience.pdf2022-11-07 22:32 72K 
[ ]17912_substance-abuse-handbook.pdf2022-11-07 22:44 99K 
[ ]17913_substance-abuse-schizophrenia-review.pdf2022-11-07 22:59 33K 
[ ]17914_substance-disorder-predictors-antidepressant-induced.pdf2022-11-07 22:35 79K 
[ ]17915_substance-disorders-individuals-body-dysmorphic-disorder.pdf2022-11-07 22:47 151K 
[ ]17916_substance-disorders-overweightobesity-bipolar-i-disorder.pdf2022-11-07 22:44 153K 
[ ]17917_substance-disorders-practical-guide-nd-ed.pdf2022-11-07 22:30 100K 
[ ]17918_substance-induced-psychoses-converting-schizophrenia.pdf2022-11-07 22:35 261K 
[ ]17919_substance-induced-psychosis-diagnostic-conundrum.pdf2022-11-07 22:57 279K 
[ ]17920_substance-p-neurokinins-novel-peptide-neurotransmitters.pdf2022-11-07 22:30 78K 
[ ]17921_substance-use-among-youth-with-bipolar-disorder.pdf2022-11-07 22:53 428K 
[ ]17922_substance-use-before-suicide-attempts.pdf2022-11-07 22:10 199K 
[ ]17923_substitution-ssri-bupropion-sustained-release-following.pdf2022-11-07 22:19 54K 
[ ]17924_subsyndromal-adhd-in-children.pdf2022-11-07 22:08 289K 
[ ]17925_subsyndromal-depression-is-associated-functional-impairment.pdf2022-11-07 22:51 61K 
[ ]17926_subsyndromal-depressive-symptoms-are-associated-functional.pdf2022-11-07 22:55 126K 
[ ]17927_subsyndromal-depressive-symptoms-symptomatic-recovery.pdf2022-11-07 22:22 235K 
[ ]17928_subthreshold-depression-is-distinction-between-depressive.pdf2022-11-07 22:06 258K 
[ ]17929_subthreshold-ptsd-in-the-second-decade-after.pdf2022-11-07 22:57 615K 
[ ]17930_subthreshold-syndromes-depression-anxiety-community.pdf2022-11-07 22:18 30K 
[ ]17931_subtyping-micromanic-episodes.pdf2022-11-07 22:43 49K 
[ ]17932_successful-are-physicians-eliciting-truth-patients.pdf2022-11-07 22:05 149K 
[ ]17933_successful-cognition-emotional-aging.pdf2022-11-07 22:39 144K 
[ ]17934_successful-meclizine-panic-disorder.pdf2022-11-07 22:26 115K 
[ ]17935_successful-monitoring-fluoxetine-induced-nocturnal.pdf2022-11-07 22:34 86K 
[ ]17936_successful-pharmacologic-treatment-major-depressive.pdf2022-11-07 23:03 1.2M 
[ ]17937_successful-phenelzine-treatment-resistant-panic-disorder.pdf2022-11-07 22:42 153K 
[ ]17938_successful-switch-aripiprazole-induction-hyperprolactinemia.pdf2022-11-07 22:33 115K 
[ ]17939_successful-treatment-clozapine-higher-doses-clozapine.pdf2022-11-07 22:25 51K 
[ ]17940_successful-treatment-nondelusional-body-dysmorphic.pdf2022-11-07 22:45 48K 
[ ]17941_successful-treatment-sexual-dysfunction-dronabinol.pdf2022-11-07 22:43 151K 
[ ]17942_sudden-cardiac-death-and-antipsychotics.pdf2022-11-07 23:01 87K 
[ ]17943_sudden-cardiac-death-users-second-generation-antipsychotics.pdf2022-11-07 22:47 761K 
[ ]17944_sudden-cardiac-death-young-adults-previous-hospital.pdf2022-11-07 22:40 1.0M 
[ ]17945_sudden-death-in-psychiatric-patients-is-multifactorial.pdf2022-11-07 22:10 118K 
[ ]17947_sudden-deaths-among-patients-receiving-psychiatric-care.pdf2022-11-07 22:46 110K 
[ ]17948_sudden-deaths-psychiatric-patients.pdf2022-11-07 22:58 273K 
[ ]17950_sudden-improvement-in-symptoms-during-antidepressant-clinical-trials.pdf2022-11-07 23:02 454K 
[ ]17951_sudden-infant-death-syndrome-maternal-depression.pdf2022-11-07 22:25 135K 
[ ]17952_sudden-onset-catatonia-following-clozapine-withdrawal.pdf2022-11-07 22:31 92K 
[ ]17953_suggested-guidelines-e-mail-communication-psychiatric.pdf2022-11-07 22:08 70K 
[ ]17954_suicidal-behavior.pdf2022-11-07 22:20 134K 
[ ]17955_suicidal-behavior-bipolar-disorder-is-influence-psychiatric.pdf2022-11-07 22:27 176K 
[ ]17956_suicidal-behavior-measurement-mechanisms.pdf2022-11-07 22:48 105K 
[ ]17957_suicidal-behavior-obsessive-compulsive-disorder.pdf2022-11-07 22:07 226K 
[ ]17958_suicidal-behavior-strategies-prevention-individual.pdf2022-11-07 22:36 139K 
[ ]17959_suicidal-events-treatment-adolescents-depression-study.pdf2022-11-07 22:56 269K 
[ ]17960_suicidal-ideation-and-behavior-among-young-adults.pdf2022-11-07 22:35 297K 
[ ]17961_suicidal-ideation-attempts-among-psychiatric-patients.pdf2022-11-07 22:04 62K 
[ ]17962_suicidal-ideation-attempts-bipolar-i-ii-disorders.pdf2022-11-07 22:33 163K 
[ ]17963_suicidal-ideation-suicide-attempts-body-dysmorphic.pdf2022-11-07 22:34 162K 
[ ]17964_suicidal-ideation-varenicline-possible-case-mistaken.pdf2022-11-07 22:46 155K 
[ ]17965_suicidality-and-psychotic-depression-treatment-outcome.pdf2022-11-07 22:37 359K 
[ ]17966_suicidality-depression-and-the-fda.pdf2022-11-07 22:15 395K 
[ ]17967_suicidality-in-the-arab-region.pdf2022-11-07 23:03 553K 
[ ]17968_suicidality-is-associated-medication-access-problems.pdf2022-11-07 22:22 233K 
[ ]17969_suicidality-obsessive-compulsive-disorder-prevalence.pdf2022-11-07 22:49 380K 
[ ]17970_suicidality-possible-side-effect-antidepressant-treatment.pdf2022-11-07 23:02 80K 
[ ]17971_suicidality-psychopathology-gender-incarcerated-adolescents.pdf2022-11-07 22:56 206K 
[ ]17972_suicidality-rare-adverse-event-antidepressant-medication.pdf2022-11-07 22:26 493K 
[ ]17973_suicidality-risk-suicide-definition-drug-safety-concerns-target-drug-development-brief-report.pdf2022-11-07 22:30 255K 
[ ]17974_suicidality-risk-suicide-definition-drug-safety-concerns-target-drug-development-consensus-statement.pdf2022-11-07 22:21 579K 
[ ]17975_suicidality-substance-abuse-affective-disorders.pdf2022-11-07 22:49 76K 
[ ]17976_suicidality-years-after-occupational-injury.pdf2022-11-07 22:59 250K 
[ ]17977_suicidal-risk-during-antidepressant-treatment.pdf2022-11-07 22:59 132K 
[ ]17978_suicidal-risk-factors-bipolar-i-ii-disorder-patients.pdf2022-11-07 22:37 253K 
[ ]17979_suicidal-tendencies-complication-light-therapy-seasonal.pdf2022-11-07 22:21 29K 
[ ]17980_suicidal-thoughts-and-behaviors-during-college.pdf2022-11-07 22:55 489K 
[ ]17981_suicidal-thoughts-and-receipt-of-treatment.pdf2022-11-07 22:07 252K 
[ ]17982_suicidal-thoughts-behaviors-recur-during-second-antidepressant.pdf2022-11-07 22:52 179K 
[ ]17983_suicide-among-racial-ethnic-minority-groups-theory.pdf2022-11-07 22:13 699K 
[ ]17984_suicide-and-cognition-in-schizophrenia.pdf2022-11-07 22:09 263K 
[ ]17985_suicide-and-happiness-two-potential-sustainable-development-goal-indicators-for-mental-health.pdf2022-11-07 22:08 141K 
[ ]17986_suicide-assessment-terminology.pdf2022-11-07 22:27 45K 
[ ]17987_suicide-assisted-suicide-medical-illness.pdf2022-11-07 23:01 45K 
[ ]17988_suicide-attempted-suicide-bipolar-disorder-systematic.pdf2022-11-07 22:31 211K 
[ ]17989_suicide-attempted-suicide-tourettes-syndrome-case.pdf2022-11-07 22:18 140K 
[ ]17990_suicide-attempts-among-pregnant-and-postpartum-women.pdf2022-11-07 22:06 206K 
[ ]17991_suicide-attempts-among-veterans-seeking-treatment.pdf2022-11-07 22:03 56K 
[ ]17992_suicide-attempts-bipolar-patients.pdf2022-11-07 22:41 50K 
[ ]17993_suicide-attempts-ideation-patients-bipolar-i-disorder.pdf2022-11-07 22:12 52K 
[ ]17994_suicide-attempts-in-children-and-adolescents.pdf2022-11-07 22:14 517K 
[ ]17995_suicide-attempts-major-affective-disorder-patients.pdf2022-11-07 22:31 62K 
[ ]17996_suicide-attempts-patients-bipolar-disorder-tend-precede.pdf2022-11-07 22:14 126K 
[ ]17997_suicide-attempts-schizophrenia-role-command-auditory.pdf2022-11-07 22:41 52K 
[ ]17998_suicide-bipolar-disorder.pdf2022-11-07 22:33 44K 
[ ]17999_suicide-bright-light-treatment-seasonal-affective.pdf2022-11-07 22:47 35K 
[ ]18000_suicide-culture-understanding-context.pdf2022-11-07 22:45 95K 
[ ]18001_suicide-deaths-active-duty-military-omega-fatty-acid.pdf2022-11-07 22:31 314K 
[ ]18002_suicide-hospital-presenting-suicide-attempts-criminality.pdf2022-11-07 23:01 1.2M 
[ ]18003_suicide-immediately-after-discharge-from-inpatient-care.pdf2022-11-07 22:57 211K 
[ ]18004_suicide-in-later-life.pdf2022-11-07 22:35 1.6M 
[ ]18005_suicide-men.pdf2022-11-07 22:40 113K 
[ ]18006_suicide-prescription-rates-intranasal-corticosteroids.pdf2022-11-07 22:51 343K 
[ ]18007_suicide-prevention-increasing-education-awareness.pdf2022-11-07 22:09 52K 
[ ]18008_suicide-primary-affective-disorders-revisited-systematic.pdf2022-11-07 22:35 81K 
[ ]18009_suicide-prisoners-systematic-review-risk-factors.pdf2022-11-07 22:49 346K 
[ ]18010_suicide-rates-relation-health-care-access-united-states.pdf2022-11-07 22:07 96K 
[ ]18011_suicide-release-prison-population-based-cohort-study.pdf2022-11-07 22:07 354K 
[ ]18012_suicide-risk-after-traumatic-injury.pdf2022-11-07 22:59 216K 
[ ]18013_suicide-risk-among-emergency-department-patients.pdf2022-11-07 22:19 587K 
[ ]18014_suicide-risk-and-phq-responses.pdf2022-11-07 22:16 620K 
[ ]18015_suicide-risk-assessment-received-prior-suicide-death.pdf2022-11-07 22:20 262K 
[ ]18016_suicide-risk-different-patient-populations.pdf2022-11-07 23:02 27K 
[ ]18017_suicide-risk-discharged-psychiatric-patients.pdf2022-11-07 22:06 53K 
[ ]18018_suicide-risk-nonfatal-self-harm-national-cohort-study.pdf2022-11-07 22:09 497K 
[ ]18019_suicide-risk-patients-major-depressive-disorder.pdf2022-11-07 22:35 65K 
[ ]18020_suicide-risk-psychopharmacology-assessment-management.pdf2022-11-07 22:20 138K 
[ ]18021_suicide-risk-scales-a-comparison.pdf2022-11-07 23:01 887K 
[ ]18022_suicide-schizophrenia-clozapine-adoption-evidence.pdf2022-11-07 22:48 79K 
[ ]18023_suicide-schizophrenia-clozapine-intersept-study.pdf2022-11-07 22:28 47K 
[ ]18024_suicide-schizophrenia-observational-study-coroner.pdf2022-11-07 22:01 220K 
[ ]18025_suicide-schizophrenia-risk-factors-clozapine-treatment.pdf2022-11-07 22:14 37K 
[ ]18026_suicide-sex-ratio-interaction-between-mental-illness.pdf2022-11-07 22:28 181K 
[ ]18027_suicide-sex-ratios-inception-charcoal-burning-suicide.pdf2022-11-07 22:13 158K 
[ ]18028_suicide-victims-schizophrenia-different-treatment.pdf2022-11-07 22:10 87K 
[ ]18029_suicidology-meets-big-data.pdf2022-11-07 22:05 149K 
[ ]18030_summary-conclusions-effects-medical-interventions.pdf2022-11-07 23:03 51K 
[ ]18031_summary-defining-remission-patients-treated-antidepressants.pdf2022-11-07 23:00 30K 
[ ]18032_summary-findings-fda-regulatory-science-forum-measuring.pdf2022-11-07 22:01 296K 
[ ]18033_superior-efficacy-olanzapine-haloperidol-analysis.pdf2022-11-07 22:12 69K 
[ ]18034_superiority-lithium-verapamil-mania-randomized-controlled.pdf2022-11-07 22:21 32K 
[ ]18035_supraphysiologic-doses-levothyroxine-adjunctive-therapy.pdf2022-11-07 22:25 437K 
[ ]18036_surfing-suicide-methods-help-content-analysis-websites.pdf2022-11-07 22:59 1.1M 
[ ]18037_surprising-results-study-paroxetine-generalized-anxiety.pdf2022-11-07 22:12 47K 
[ ]18038_survey-impact-being-depressed-professional-status.pdf2022-11-07 22:22 123K 
[ ]18039_survey-psychiatric-treatment-among-psychiatric-residents.pdf2022-11-07 22:05 99K 
[ ]18040_survey-psychiatry-residents-informed-consent-practices.pdf2022-11-07 22:38 182K 
[ ]18041_survey-reports-quetiapine-associated-hyperglycemia.pdf2022-11-07 22:14 63K 
[ ]18042_surviving-stalking.pdf2022-11-07 22:17 35K 
[ ]18043_sustained-release-extended-release-release-formulations.pdf2022-11-07 22:05 304K 
[ ]18044_sweat.pdf2022-11-07 22:31 39K 
[ ]18045_switching-antidepressants-following-ssri-failure.pdf2022-11-07 22:38 688K 
[ ]18046_switching-antidepressants-selective-serotonin-reuptake.pdf2022-11-07 22:34 167K 
[ ]18047_switching-antidepressants-treatment-resistant-major.pdf2022-11-07 22:18 50K 
[ ]18048_switching-antipsychotic-medications.pdf2022-11-07 22:09 50K 
[ ]18049_switching-antipsychotic-medications-chart-review.pdf2022-11-07 22:22 199K 
[ ]18050_switching-antipsychotic-medications-reduce-adverse.pdf2022-11-07 22:53 586K 
[ ]18051_switching-antipsychotics-antipsychotic-schizophrenia.pdf2022-11-07 23:00 329K 
[ ]18052_switching-antipsychotics-inpatient-schizophrenia-care.pdf2022-11-07 22:29 136K 
[ ]18053_switching-antipsychotics-treatment-strategy-antipsychotic.pdf2022-11-07 22:19 149K 
[ ]18054_switching-antipsychotic-therapy-expect-clinical-strategies.pdf2022-11-07 22:20 122K 
[ ]18055_switching-benzodiazepines-buspirone-using-tapered.pdf2022-11-07 22:28 98K 
[ ]18056_switching-clozapine-olanzapine-treatment-refractory.pdf2022-11-07 22:43 30K 
[ ]18057_switching-clozapine-responders-olanzapine.pdf2022-11-07 22:40 45K 
[ ]18058_switching-depot-antipsychotic-drugs-olanzapine-patients.pdf2022-11-07 22:08 51K 
[ ]18059_switching-drug-class-initial-ssri-failure.pdf2022-11-07 22:53 45K 
[ ]18060_switching-duloxetine-selective-serotonin-reuptake.pdf2022-11-07 22:33 302K 
[ ]18061_switching-olanzapine-previous-antipsychotics-regional.pdf2022-11-07 22:36 80K 
[ ]18062_switching-olanzapine-unsuccessful-treatment-risperidone.pdf2022-11-07 22:15 93K 
[ ]18063_switching-outpatients-bipolar-schizoaffective-disorders.pdf2022-11-07 22:02 106K 
[ ]18064_switching-patients-daily-citalopram-paroxetine-sertraline.pdf2022-11-07 22:15 78K 
[ ]18065_switching-the-antidepressant-after-nonresponse.pdf2022-11-07 22:48 525K 
[ ]18068_switching-versus-augmentation-prospective-naturalistic.pdf2022-11-07 22:11 79K 
[ ]18069_switch-mania-slow-rtms-right-prefrontal-cortex.pdf2022-11-07 22:59 75K 
[ ]18071_symptomatic-remission-cognitive-impairment-episode.pdf2022-11-07 22:16 369K 
[ ]18072_symptomatic-remission-patients-bipolar-mania-results.pdf2022-11-07 22:16 132K 
[ ]18073_symptomatic-syndromal-anxiety-chronic-forms-major.pdf2022-11-07 22:37 127K 
[ ]18074_symptomatology-psychopathology-mental-health-problems.pdf2022-11-07 22:37 128K 
[ ]18075_symptom-clusters-predictors-late-response-antidepressant.pdf2022-11-07 22:39 158K 
[ ]18076_symptom-exacerbation-tourette-syndrome-due-bacterial.pdf2022-11-07 22:26 722K 
[ ]18077_symptom-recurrence-following-intermittent-treatment.pdf2022-11-07 22:30 280K 
[ ]18079_symptoms-circuits-part-anxiety-disorders.pdf2022-11-07 22:14 35K 
[ ]18080_symptoms-circuits-part-major-depressive-disorder.pdf2022-11-07 22:05 31K 
[ ]18081_symptoms-circuits-part-schizophrenia.pdf2022-11-07 22:03 34K 
[ ]18082_symptoms-fatigue-cognitiveexecutive-dysfunction-major.pdf2022-11-07 22:41 59K 
[ ]18083_symptoms-fatigue-sleepiness-major-depressive-disorder.pdf2022-11-07 22:34 112K 
[ ]18084_symptoms-sexual-dysfunction-patients-treated-major.pdf2022-11-07 22:37 142K 
[ ]18085_syndrome-excited-delirium-following-bath-salts.pdf2022-11-07 22:41 98K 
[ ]18086_synopsis-neuropsychiatry.pdf2022-11-07 23:01 34K 
[ ]18087_systematic-review-aripiprazoledose-plasma-concentration.pdf2022-11-07 22:23 409K 
[ ]18088_systematic-review-meta-analysis-brief-versus-ultrabrief.pdf2022-11-07 22:11 498K 
[ ]18089_systematic-review-modafinil-potential-clinical-uses.pdf2022-11-07 22:54 123K 
[ ]18090_systematic-review-placebo-response-studies-bipolar.pdf2022-11-07 22:08 148K 
[ ]18091_systematic-review-rates-diagnostic-validity-comorbid.pdf2022-11-07 22:37 214K 
[ ]18092_systematic-review-research-strategies-management-antipsychotic.pdf2022-11-07 22:08 81K 
[ ]18093_system-for-assessing-suicide-risk-in-hospitals.pdf2022-11-07 22:11 294K 
[ ]18094_tachyphylaxis-unipolar-major-depressive-disorder.pdf2022-11-07 22:18 141K 
[ ]18096_tactile-hallucinations-associated-therapeutic-doses.pdf2022-11-07 22:37 103K 
[ ]18097_take-no-shortcuts-in-suicide-screening.pdf2022-11-07 22:56 113K 
[ ]18098_taking-on-the-role-of-editor-in-chief.pdf2022-11-07 22:22 348K 
[ ]18099_talking-internet.pdf2022-11-07 22:49 159K 
[ ]18101_tardive-dyskinesia-affective-disorders.pdf2022-11-07 22:03 53K 
[ ]18102_tardive-dyskinesia-associated-olanzapine-monotherapy.pdf2022-11-07 22:27 35K 
[ ]18103_tardive-dyskinesia-course-schizophrenia-results.pdf2022-11-07 22:06 265K 
[ ]18104_tardive-dyskinesia-older-patients.pdf2022-11-07 22:46 56K 
[ ]18105_tardive-dyskinesia-pathophysiology-animal-models.pdf2022-11-07 22:51 53K 
[ ]18106_tardive-dyskinesia-prevalence.pdf2022-11-07 22:31 464K 
[ ]18107_tardive-dyskinesia-rates-atypical-antipsychotics-adults.pdf2022-11-07 22:11 48K 
[ ]18108_tardive-dyskinesia-rates-atypical-antipsychotics-older.pdf2022-11-07 22:01 48K 
[ ]18109_tardive-dyskinesia-recognition-assessment-and-diagnosis.pdf2022-11-07 22:12 309K 
[ ]18110_tardive-dystonia-due-aripiprazole-neuroleptic-naive.pdf2022-11-07 22:32 106K 
[ ]18111_targeting-circuits-sexual-desire-treatment-strategy.pdf2022-11-07 22:31 222K 
[ ]18112_targeting-relational-aggression-veterans-strength.pdf2022-11-07 22:59 191K 
[ ]18113_taurine-for-first-episode-psychosis.pdf2022-11-07 22:33 115K 
[ ]18114_t-csct-for-depressed-chinese-americans.pdf2022-11-07 22:26 279K 
[ ]18116_teaching-mindfulness-practical-guide-clinicians-educators.pdf2022-11-07 22:23 84K 
[ ]18117_teaching-practicing-psychopharmacology.pdf2022-11-07 22:59 63K 
[ ]18118_technology-assisted-parent-training.pdf2022-11-07 22:37 1.1M 
[ ]18119_teen-suicide-risk-practitioner-guide-screening-assessment.pdf2022-11-07 22:14 67K 
[ ]18120_telemedicine-anger-management-therapy-rural-population.pdf2022-11-07 22:12 390K 
[ ]18121_telephone-based-postpartum-depression-care-management.pdf2022-11-07 22:06 525K 
[ ]18122_temperament-character-suicide-attempts-unipolar-bipolar.pdf2022-11-07 22:33 3.5M 
[ ]18123_temperament-profiles-and-character-development.pdf2022-11-07 22:55 366K 
[ ]18124_temporal-relationships-between-overweight-obesity.pdf2022-11-07 23:02 340K 
[ ]18126_tenets-perinatal-psychiatry.pdf2022-11-07 22:40 91K 
[ ]18127_tens-unit-treat-self-cutting-patient-borderline-personality.pdf2022-11-07 22:25 86K 
[ ]18128_teratogenicity-anticonvulsants-lessons-neurology-psychiatry.pdf2022-11-07 22:31 148K 
[ ]18129_termination-clozapine-treatment-due-medical-reasons.pdf2022-11-07 22:19 650K 
[ ]18130_terry-daughters-life-death-struggle-alcoholism.pdf2022-11-07 22:15 17K 
[ ]18134_testosterone-replacement-therapy-hypogonadal-men-major.pdf2022-11-07 22:39 65K 
[ ]18135_testosterone-therapy-late-life-major-depression-males.pdf2022-11-07 22:44 70K 
[ ]18136_texas-implementation-medication-algorithms-update-algorithms-bipolar-1-disorder.pdf2022-11-07 22:24 320K 
[ ]18137_texas-implementation-medication-algorithms-update-treatment-bipolar-1-disorder.pdf2022-11-07 22:13 73K 
[ ]18138_texas-medication-algorithm-project-antipsychotic-algorithm-schizophrenia-2003-update.pdf2022-11-07 23:03 71K 
[ ]18139_texas-medication-algorithm-project-antipsychotic-algorithm-schizophrenia-2006-update.pdf2022-11-07 22:24 273K 
[ ]18140_texas-medication-algorithm-project-definitions-rationale.pdf2022-11-07 22:03 43K 
[ ]18141_texas-medication-algorithm-project-development-feasibility.pdf2022-11-07 22:48 91K 
[ ]18142_texas-medication-algorithm-project-patient-family.pdf2022-11-07 23:00 127K 
[ ]18143_texas-medication-algorithm-project-phase-tmap-clinical.pdf2022-11-07 22:42 108K 
[ ]18144_texas-medication-algorithm-project-phase-tmap-rationale.pdf2022-11-07 22:36 95K 
[ ]18145_texas-medication-algorithm-project-report-texas-consensus.pdf2022-11-07 22:42 104K 
[ ]18146_texas-medication-algorithm-project-tmap-schizophrenia.pdf2022-11-07 22:11 55K 
[ ]18147_textbook-biological-psychiatry.pdf2022-11-07 22:04 106K 
[ ]18148_textbook-pain-th-ed.pdf2022-11-07 22:48 60K 
[ ]18149_textbook-pediatric-neuropsychiatry.pdf2022-11-07 22:42 34K 
[ ]18150_textbook-psychiatric-epidemiology-rd-ed.pdf2022-11-07 22:55 65K 
[ ]18151_textbook-psychotherapeutic-treatments.pdf2022-11-07 23:01 118K 
[ ]18152_textbook-violence-assessment-management.pdf2022-11-07 22:36 713K 
[ ]18153_thank-peer-reviewers.pdf2022-11-07 22:27 115K 
[ ]18154_thanks-jcp-peer-reviewers.pdf2022-11-07 22:28 161K 
[ ]18155_thank-you-to-jcp-peer-reviewers.pdf2022-11-07 23:02 183K 
[ ]18156_the-antisuicidal-effect-of-esketamine-should-be-further-investigated.pdf2022-11-07 22:29 94K 
[ ]18157_the-complex-relationship-between-ptsd-and-help-seeking.pdf2022-11-07 22:07 114K 
[ ]18158_the-confidence-interval-as-a-compatibility-interval.pdf2022-11-07 22:30 302K 
[ ]18159_the-differential-diagnosis-of-mdd-versus-bp.pdf2022-11-07 22:47 351K 
[ ]18160_the-health-promoting-effects-of-insurance-coverage.pdf2022-11-07 22:57 83K 
[ ]18161_the-lingering-pain-of-childhood-trauma.pdf2022-11-07 22:43 379K 
[ ]18162_the-need-to-assess-suicidal-risk-when-prescribing-opioids.pdf2022-11-07 22:41 81K 
[ ]18163_theory-addiction-nd-ed.pdf2022-11-07 22:02 64K 
[ ]18164_the-perinatal-depression-treatment-cascade.pdf2022-11-07 22:27 484K 
[ ]18165_therapeutic-approaches-cognitive-impairment.pdf2022-11-07 22:52 109K 
[ ]18166_therapeutic-drug-monitoring-pregnant-postpartum-women.pdf2022-11-07 22:47 128K 
[ ]18167_therapeutic-durability-of-aripiprazole-lauroxil.pdf2022-11-07 23:03 278K 
[ ]18168_therapeutic-options-alcohol-dependence-long-acting.pdf2022-11-07 22:19 78K 
[ ]18169_therapeutic-options-treatment-insomnia.pdf2022-11-07 22:57 147K 
[ ]18170_therapeutic-process-clinical-introduction-psychodynamic.pdf2022-11-07 22:52 61K 
[ ]18171_therapy-terror-psychotherapists-mental-health.pdf2022-11-07 22:33 81K 
[ ]18172_theres-more-placebo-related-improvement-placebo-effect.pdf2022-11-07 22:39 1.0M 
[ ]18173_the-silo-effect-in-research-on-ptsd.pdf2022-11-07 22:42 111K 
[ ]18174_theta-burst-repetitive-transcranial-magnetic-stimulation.pdf2022-11-07 22:43 554K 
[ ]18175_thiazide-diuretics-lithium-levels.pdf2022-11-07 22:04 69K 
[ ]18176_thinc-it-and-psychosocial-dysfunction-in-mdd.pdf2022-11-07 23:01 473K 
[ ]18177_thinc-it-validation-for-mdd.pdf2022-11-07 22:49 288K 
[ ]18178_things.pdf2022-11-07 22:21 309K 
[ ]18179_thinking-dying-trying-intending-die-results-suicidal.pdf2022-11-07 22:52 316K 
[ ]18180_third-generation-anticonvulsants-bipolar-disorder.pdf2022-11-07 22:47 75K 
[ ]18181_thirty-great-years.pdf2022-11-07 22:47 190K 
[ ]18182_three-ancient-questions-academic-psychiatrist.pdf2022-11-07 22:12 90K 
[ ]18183_three-case-reports-modafinil-treating-sedation-induced.pdf2022-11-07 22:50 72K 
[ ]18184_three-follow-syndromal-antisocial-behavior-adults.pdf2022-11-07 22:56 474K 
[ ]18185_three-incidence-predictors-onset-ltemgtdsm-ivltemgt.pdf2022-11-07 22:23 399K 
[ ]18186_three-naturalistic-mirror-image-assessment-adding.pdf2022-11-07 22:20 271K 
[ ]18187_three-year-course-of-multiple-substance-use-disorders.pdf2022-11-07 22:52 249K 
[ ]18188_threshold-disorder-study-impact-dsm-iv-clinical-significance.pdf2022-11-07 22:32 51K 
[ ]18189_thyroid-dysfunction-during-treatment-atypical-antipsychotics.pdf2022-11-07 23:00 165K 
[ ]18190_thyroid-function-in-youth-with-mood-and-anxiety-disorders.pdf2022-11-07 22:04 368K 
[ ]18191_thyroid-function-treatment-resistant-schizophrenia.pdf2022-11-07 22:25 130K 
[ ]18192_thyroid-supplements-augment-antidepressant-medication.pdf2022-11-07 22:48 31K 
[ ]18193_tiagabine-appears-efficacious-treatment-acute-mania.pdf2022-11-07 22:06 28K 
[ ]18194_tiagabine-improves-panic-agoraphobia-panic-disorder.pdf2022-11-07 22:50 98K 
[ ]18195_tiagabine-posttraumatic-stress-disorder-case-series.pdf2022-11-07 22:46 48K 
[ ]18196_tiagabine-treatment-generalized-anxiety-disorder-randomized.pdf2022-11-07 22:08 53K 
[ ]18197_tianeptine-in-elderly-mdd-patients.pdf2022-11-07 22:01 320K 
[ ]18198_time-in-bed-restriction-and-antidepressant-response.pdf2022-11-07 22:22 307K 
[ ]18199_timely-topics-pediatric-psychiatry.pdf2022-11-07 22:42 142K 
[ ]18200_time-trends-in-incidence-rates-of-affective-disorders.pdf2022-11-07 22:01 219K 
[ ]18201_tobacco-before-episode-psychosis-systematic-meta.pdf2022-11-07 22:41 480K 
[ ]18202_tobacco-dependence-treatment-handbook-guide-best-practices.pdf2022-11-07 22:47 35K 
[ ]18203_tobacco-smoking-and-psychotic-like-experiences.pdf2022-11-07 22:39 234K 
[ ]18204_tobacco-smoking-bipolar-disorder.pdf2022-11-07 22:47 34K 
[ ]18208_tolerability-high-dose-aripiprazole-treatment-refractory.pdf2022-11-07 22:02 81K 
[ ]18209_tolerability-modern-antidepressants.pdf2022-11-07 22:28 206K 
[ ]18210_tolerability-patient-compliance.pdf2022-11-07 22:19 47K 
[ ]18211_tolerability-profiles-atypical-antipsychotics-treatment.pdf2022-11-07 22:59 166K 
[ ]18212_tolerability-ziprasidone-expanding-perspective.pdf2022-11-07 22:11 91K 
[ ]18214_tools-strategies-ongoing-assessment-depression-measurement.pdf2022-11-07 22:03 217K 
[ ]18215_tooting-horn.pdf2022-11-07 22:06 38K 
[ ]18216_topiramate-abuse-bipolar-patient-eating-disorder.pdf2022-11-07 22:49 72K 
[ ]18217_topiramate-add-treatment-resistant-schizophrenia.pdf2022-11-07 23:03 128K 
[ ]18218_topiramate-antipsychotic-cotreatment.pdf2022-11-07 22:55 1.3M 
[ ]18219_topiramate-long-term-treatment-binge-eating-disorder.pdf2022-11-07 22:19 66K 
[ ]18220_topiramate-posttraumatic-stress-disorder-preliminary.pdf2022-11-07 22:52 44K 
[ ]18221_topiramate-produced-weight-loss-following-olanzapine.pdf2022-11-07 22:51 70K 
[ ]18222_topiramate-treatment-aggression-female-borderline.pdf2022-11-07 22:45 56K 
[ ]18223_topiramate-treatment-ssri-induced-weight-gain-anxiety.pdf2022-11-07 22:55 56K 
[ ]18224_topiramate-treatment-substance-related-disorders-critical.pdf2022-11-07 22:41 418K 
[ ]18225_toward-adaptation-interpersonal-psychotherapy-hispanic.pdf2022-11-07 22:30 249K 
[ ]18227_toward-integrated-neurobiology-panic-disorder.pdf2022-11-07 22:27 49K 
[ ]18228_toward-millenium.pdf2022-11-07 22:08 44K 
[ ]18229_toward-personalized-treatment-psychiatry.pdf2022-11-07 22:43 111K 
[ ]18230_toward-rational-benzodiazepines-posttraumatic-stress.pdf2022-11-07 22:57 103K 
[ ]18231_toward-understanding-bipolar-disorder-origin.pdf2022-11-07 22:43 65K 
[ ]18232_toxic-catatonia-secondary-azithromycin.pdf2022-11-07 22:42 99K 
[ ]18233_toxic-psychosis-intake-hallucinogen-salvinorin.pdf2022-11-07 22:30 132K 
[ ]18234_toxoplasma-gondii-infection-relationship-aggression.pdf2022-11-07 22:56 335K 
[ ]18235_traditional-pharmacotherapy-alcohol-dependence.pdf2022-11-07 22:35 118K 
[ ]18236_trajectories-of-perinatal-depression-and-anxiety.pdf2022-11-07 22:12 1.0M 
[ ]18237_trajectories-of-psychotic-like-experiences-in-adolescents.pdf2022-11-07 22:04 578K 
[ ]18238_trajectories-of-suicidal-ideation-in-mdd.pdf2022-11-07 22:11 1.1M 
[ ]18239_trajectories-posttraumatic-stress-disorder-following.pdf2022-11-07 22:12 60K 
[ ]18240_trajectories-ptsd-symptoms-predictive-factors-trajectory.pdf2022-11-07 22:51 166K 
[ ]18241_trajectory-of-functional-connectivity-in-ad.pdf2022-11-07 22:55 3.7M 
[ ]18242_trajectory-of-ssri-action-in-ocd.pdf2022-11-07 22:33 527K 
[ ]18243_trance-treatment-clincal-uses-hypnosis-nd-ed.pdf2022-11-07 22:52 57K 
[ ]18244_transcranial-direct-current-stimulation-refractory.pdf2022-11-07 22:21 646K 
[ ]18245_transcranial-magnetic-stimulation-acute-treatment.pdf2022-11-07 22:41 309K 
[ ]18246_transcranial-magnetic-stimulation-clinical-applications.pdf2022-11-07 22:52 204K 
[ ]18247_transcranial-magnetic-stimulation-medication-resistant.pdf2022-11-07 22:36 127K 
[ ]18248_transcranial-magnetic-stimulation-neuropsychiatry.pdf2022-11-07 22:47 26K 
[ ]18249_transcranial-magnetic-stimulation-potential-treatment.pdf2022-11-07 22:44 349K 
[ ]18250_transcranial-magnetic-stimulation-treatment-major.pdf2022-11-07 22:45 327K 
[ ]18251_transdermal-delivery-system-monoamine-oxidase-inhibitors.pdf2022-11-07 22:30 770K 
[ ]18252_transdermal-nicotine-for-late-life-depression.pdf2022-11-07 22:07 307K 
[ ]18253_transdermal-nicotine-haloperidol-tourettes-disorder.pdf2022-11-07 22:04 66K 
[ ]18254_transdermal-treatments-in-psychiatry.pdf2022-11-07 22:19 957K 
[ ]18255_transient-hyperproinsulinemia-duringtreatment-clozapine.pdf2022-11-07 22:53 62K 
[ ]18256_transient-paroxysmal-shock-paresthesias-associated.pdf2022-11-07 22:33 92K 
[ ]18257_transient-syncope-ecg-changes-associated-concurrent.pdf2022-11-07 22:10 31K 
[ ]18261_translating-evidence-atypical-depression-clinical-genetics-environment-treatment-MAOI-selegiline.pdf2022-11-07 22:38 156K 
[ ]18262_translating-molecular-advances-fragile-x-syndrome.pdf2022-11-07 22:14 893K 
[ ]18263_translating-psychopharmacology-antipsychotics-individualized.pdf2022-11-07 22:44 400K 
[ ]18264_trauma-and-age-at-exposure.pdf2022-11-07 22:06 464K 
[ ]18265_trauma-diseaster-responce-management.pdf2022-11-07 22:14 48K 
[ ]18266_trauma-emergency-room-visits-cognition.pdf2022-11-07 22:30 178K 
[ ]18267_trauma-exposure-posttraumatic-stress-disorder-primary.pdf2022-11-07 22:25 340K 
[ ]18268_trauma-hands-another-distinguishing-ptsd-patterns.pdf2022-11-07 22:58 333K 
[ ]18269_trauma-hands-another-longitudinal-study-differences.pdf2022-11-07 22:57 255K 
[ ]18270_trauma-memory-dissociation.pdf2022-11-07 22:57 19K 
[ ]18271_trauma-posttraumatic-stress-disorder-elderly-findings.pdf2022-11-07 22:19 232K 
[ ]18272_trauma-prevalence-impairment-service-cost.pdf2022-11-07 22:38 48K 
[ ]18273_trauma-stress-diagnosis-treatment.pdf2022-11-07 22:21 82K 
[ ]18274_traumatic-brain-injury-adhd-and-autism.pdf2022-11-07 22:16 329K 
[ ]18275_traumatic-grief-diagnosis-treatment-prevention.pdf2022-11-07 22:03 45K 
[ ]18276_traumatic-grief-treatment-case-histories-patients.pdf2022-11-07 22:29 64K 
[ ]18277_traumatic-relationships-serious-mental-disorders.pdf2022-11-07 22:05 60K 
[ ]18278_trauma-women-course-predictors-treatment.pdf2022-11-07 23:03 25K 
[ ]18279_trazodone-hypnotic-critical-review.pdf2022-11-07 22:08 40K 
[ ]18280_trd-incidence-risk-factors-and-change-over-time.pdf2022-11-07 22:38 468K 
[ ]18281_treament-stress-response-syndromes.pdf2022-11-07 22:33 33K 
[ ]18284_treating-adhd-in-parents-and-their-children.pdf2022-11-07 22:27 277K 
[ ]18285_treating-aggression-psychiatric-emergency-service.pdf2022-11-07 22:06 63K 
[ ]18286_treating-antidepressant-nonresponders-augmentation.pdf2022-11-07 22:55 50K 
[ ]18289_treating-child-adolescent-depression.pdf2022-11-07 22:04 98K 
[ ]18290_treating-chronically-traumatized-children-dont-let.pdf2022-11-07 22:27 98K 
[ ]18291_treating-chronic-severe-mental-disorders-handbook.pdf2022-11-07 22:46 36K 
[ ]18292_treating-comorbid-perinatal-depression-and-ptsd-in-socioeconomically-disadvantaged-women.pdf2022-11-07 22:32 365K 
[ ]18293_treating-complicated-grief-in-suicide-loss-survivors.pdf2022-11-07 22:47 255K 
[ ]18294_treating-depression-atypical-features.pdf2022-11-07 22:43 133K 
[ ]18299_treating-depression-remission.pdf2022-11-07 22:38 57K 
[ ]18303_treating-generalized-anxiety-disorder.pdf2022-11-07 22:40 67K 
[ ]18304_treating-generalized-anxiety-disorder-cognitive-behavioral.pdf2022-11-07 23:01 58K 
[ ]18305_treating-health-anxiety-cognative-behavior-approach.pdf2022-11-07 22:56 57K 
[ ]18308_treating-mental-illness-behavior-disorders-children.pdf2022-11-07 22:32 41K 
[ ]18310_treating-nicotine-dependence-targeting-attention-deficit.pdf2022-11-07 22:51 481K 
[ ]18311_treating-nonspecific-anxiety-anxiety-disorders-patients.pdf2022-11-07 22:11 327K 
[ ]18315_treating-preschool-children-treating-school-aged-children.pdf2022-11-07 22:43 16K 
[ ]18316_treating-prolonged-grief-disorder.pdf2022-11-07 22:36 237K 
[ ]18317_treating-schizophrenia-comorbid-depressive-demoralization.pdf2022-11-07 22:48 207K 
[ ]18318_treating-sexual-dysfunction-psychiatrys-role-age-sildenafil.pdf2022-11-07 22:04 22K 
[ ]18319_treating-somatization-cognitive-behavioral-approach.pdf2022-11-07 22:22 70K 
[ ]18320_treating-suicidal-behavior-effective-limited-approach.pdf2022-11-07 22:38 30K 
[ ]18321_treating-trauma-survivors-ptsd.pdf2022-11-07 22:44 39K 
[ ]18322_treatment-adherence-among-patients-bipolar-manic-disorder.pdf2022-11-07 22:01 118K 
[ ]18324_treatment-aggression-children-adolescents-autism-conduct.pdf2022-11-07 22:13 89K 
[ ]18325_treatment-aggression-patients-bipolar-disorder.pdf2022-11-07 22:31 44K 
[ ]18326_treatment-agitation-bipolar-disorder-across-life-cycle.pdf2022-11-07 22:04 64K 
[ ]18327_treatment-agitation-dementia.pdf2022-11-07 22:51 76K 
[ ]18329_treatment-alcohol-dependent-outpatients-acamprosate.pdf2022-11-07 22:24 57K 
[ ]18330_treatment-algorithm-management-anxiety-primary-care.pdf2022-11-07 23:03 31K 
[ ]18331_treatment-algorithm-optimize-management-symptomatic.pdf2022-11-07 22:47 136K 
[ ]18332_treatment-algorithms-depression.pdf2022-11-07 22:16 115K 
[ ]18333_treatment-antidepressant-nonresponders-augmentation.pdf2022-11-07 22:21 54K 
[ ]18334_treatment-anxiety-disorders-remission.pdf2022-11-07 22:42 50K 
[ ]18335_treatment-anxiety-suicidal-patients.pdf2022-11-07 23:02 49K 
[ ]18336_treatment-behavior-disorders-mental-retardation-report.pdf2022-11-07 22:15 157K 
[ ]18337_treatment-bereavement-trauma-children.pdf2022-11-07 22:49 148K 
[ ]18338_treatment-binge-eating-disorder-topiramate-clinical.pdf2022-11-07 22:38 59K 
[ ]18339_treatment-bipolar-depression.pdf2022-11-07 23:00 80K 
[ ]18340_treatment-bipolar-disorder.pdf2022-11-07 22:37 81K 
[ ]18341_treatment-bipolar-disorder-antipsychotic-medication.pdf2022-11-07 22:53 77K 
[ ]18342_treatment-bipolar-disorder-during-pregnancy.pdf2022-11-07 22:51 151K 
[ ]18343_treatment-borderline-personality-disorder-risperidone.pdf2022-11-07 22:11 46K 
[ ]18344_treatment-bulimia-nervosa-topiramate-improvement-binge-purge.pdf2022-11-07 22:19 68K 
[ ]18345_treatment-bulimia-nervosa-topiramate-improvement-psychiatric-measures.pdf2022-11-07 22:08 58K 
[ ]18346_treatment-cannabis-among-psychotic-depressive-disorders.pdf2022-11-07 22:43 266K 
[ ]18347_treatment-challenges-safety-considerations-antipsychotic.pdf2022-11-07 22:19 82K 
[ ]18348_treatment-chemical-addictions-review-psychiatry-series.pdf2022-11-07 22:53 32K 
[ ]18349_treatment-childhood-disorder-rd-ed.pdf2022-11-07 22:44 115K 
[ ]18350_treatment-childhood-disorders-nd-ed.pdf2022-11-07 22:50 32K 
[ ]18351_treatment-chronic-depression-cognitive-behavioral.pdf2022-11-07 22:24 44K 
[ ]18352_treatment-chronic-depression-part-double-blind-randomized.pdf2022-11-07 22:17 61K 
[ ]18353_treatment-chronic-depression-part-psychosocial-functioning.pdf2022-11-07 22:24 63K 
[ ]18354_treatment-chronic-depression-part-study-design-rationale.pdf2022-11-07 22:35 55K 
[ ]18355_treatment-clozapine-induced-hypersalivation-ipratropium.pdf2022-11-07 22:31 280K 
[ ]18356_treatment-cognitive-deficits-schizophrenia-atomoxetine.pdf2022-11-07 22:48 140K 
[ ]18357_treatment-companion-dsm-iv-tr-casebook.pdf2022-11-07 22:14 66K 
[ ]18358_treatment-continuation-patients-switched-paliperidone.pdf2022-11-07 22:14 152K 
[ ]18359_treatment-decisions-major-mental-illness-weighing.pdf2022-11-07 22:55 212K 
[ ]18360_treatment-dementia-behavioral-disturbance-using-divalproex.pdf2022-11-07 22:34 32K 
[ ]18361_treatment-depression-menopause-related-symptoms-serotonin.pdf2022-11-07 22:19 211K 
[ ]18362_treatment-depression-methylphenidate-patients-difficult.pdf2022-11-07 22:24 59K 
[ ]18363_treatment-depression-patients-heart-disease.pdf2022-11-07 22:57 46K 
[ ]18364_treatment-depression-risk-weight-gain.pdf2022-11-07 22:54 114K 
[ ]18365_treatment-disequilibrium-nausea-sri-discontinuation.pdf2022-11-07 22:57 37K 
[ ]18366_treatment-dropout-missed-appointments-among-adults.pdf2022-11-07 22:05 250K 
[ ]18367_treatment-dysthymia-sertraline-double-blind-placebo.pdf2022-11-07 22:44 64K 
[ ]18368_treatment-eating-disorders-clinical-handbook.pdf2022-11-07 22:16 143K 
[ ]18369_treatment-effects-massage-therapy-depressed-meta-analysis.pdf2022-11-07 22:22 335K 
[ ]18370_treatment-emergent-psychosis-aripiprazole.pdf2022-11-07 22:33 165K 
[ ]18371_treatment-failure-tricyclic-antidepressant-followed.pdf2022-11-07 22:05 147K 
[ ]18372_treatment-generalized-anxiety-disorder.pdf2022-11-07 22:24 73K 
[ ]18373_treatment-guidelines-current-future-management-bipolar.pdf2022-11-07 22:40 68K 
[ ]18374_treatment-inhalant-abuse-risperidone.pdf2022-11-07 22:53 31K 
[ ]18375_treatment-interictal-psychoses.pdf2022-11-07 22:45 91K 
[ ]18376_treatment-intermittent-explosive-disorder-sertraline.pdf2022-11-07 22:06 38K 
[ ]18377_treatment-issues-related-sleep-depression.pdf2022-11-07 22:52 57K 
[ ]18378_treatment-kleine-levin-syndrome-melatonin-starting.pdf2022-11-07 22:42 66K 
[ ]18379_treatment-kleptomania-paroxetine.pdf2022-11-07 22:27 37K 
[ ]18380_treatment-koro-citalopram.pdf2022-11-07 22:33 59K 
[ ]18381_treatment-leuprolide-induced-depression-intramuscular.pdf2022-11-07 22:31 79K 
[ ]18382_treatment-major-depression-hiv-seropositive-men.pdf2022-11-07 22:08 59K 
[ ]18383_treatment-major-depression-is-improvement-enough.pdf2022-11-07 22:22 52K 
[ ]18384_treatment-major-depressive-disorder-using-botulinum.pdf2022-11-07 22:34 156K 
[ ]18385_treatment-manual-anorexia-nervosa-family-based-approach.pdf2022-11-07 22:04 80K 
[ ]18386_treatment-men-major-depression-comparison-sequential.pdf2022-11-07 22:02 73K 
[ ]18387_treatment-morbidly-obese-psychotic-patients-molindone.pdf2022-11-07 22:20 741K 
[ ]18388_treatment-nonadherence-neurocognitive-impairment-bipolar.pdf2022-11-07 22:20 236K 
[ ]18389_treatment-obsessive-compulsive-disorder-psychiatrists.pdf2022-11-07 22:50 84K 
[ ]18390_treatment-of-common-mental-disorders-in-the-us.pdf2022-11-07 22:38 317K 
[ ]18391_treatment-offenders-mental-disorders.pdf2022-11-07 22:45 23K 
[ ]18393_treatment-options-bipolar-depression.pdf2022-11-07 22:49 92K 
[ ]18396_treatment-options-for-treatment-resistant-schizophrenia.pdf2022-11-07 22:13 132K 
[ ]18397_treatment-options-refractory-depression.pdf2022-11-07 22:26 53K 
[ ]18398_treatment-outcome-bereavement-excluded-depression.pdf2022-11-07 22:58 137K 
[ ]18399_treatment-outcomes-adolescents-schizophrenia.pdf2022-11-07 22:05 30K 
[ ]18400_treatment-outcomes-patients-tardive-dyskinesia-chronic.pdf2022-11-07 22:11 398K 
[ ]18401_treatment-planning-patients-autism-spectrum-disorders.pdf2022-11-07 22:16 164K 
[ ]18402_treatment-planning-psychotherapists.pdf2022-11-07 22:29 14K 
[ ]18403_treatment-polydipsia-hyponatremia-syndrome-urea.pdf2022-11-07 22:11 104K 
[ ]18404_treatment-postpartum-depression-minimizing-infant.pdf2022-11-07 22:32 94K 
[ ]18405_treatment-postpartum-depression-part-1-critical-review-biological-interventions.pdf2022-11-07 22:17 77K 
[ ]18406_treatment-postpartum-depression-part-2-critical-review-nonbiological-interventions.pdf2022-11-07 22:51 91K 
[ ]18407_treatment-posttraumatic-stress-disorder-phenytoin.pdf2022-11-07 22:25 54K 
[ ]18408_treatment-posttraumatic-stress-disorder-postwar-kosovar.pdf2022-11-07 22:07 235K 
[ ]18409_treatment-preexisting-diabetes-olanzapine.pdf2022-11-07 22:32 53K 
[ ]18410_treatment-preferences-psychotherapy-patients-chronic.pdf2022-11-07 22:46 902K 
[ ]18411_treatment-premenstrual-dysphoric-disorder-sertraline.pdf2022-11-07 22:48 96K 
[ ]18412_treatment-premenstrual-worsening-depression-adjunctive.pdf2022-11-07 22:30 174K 
[ ]18413_treatment-previously-undiagnosed-psychiatric-disorders.pdf2022-11-07 22:33 75K 
[ ]18414_treatment-primary-cranial-dystonia-meiges-syndrome.pdf2022-11-07 22:19 59K 
[ ]18415_treatment-psychosis-late-life.pdf2022-11-07 22:07 36K 
[ ]18416_treatment-psychotic-depression.pdf2022-11-07 23:02 40K 
[ ]18417_treatment-rapid-cycling-bipolar-disorder.pdf2022-11-07 23:02 83K 
[ ]18418_treatment-recommendations-psychiatrists.pdf2022-11-07 22:15 123K 
[ ]18419_treatment-recommendations-versus-treatment-realities.pdf2022-11-07 22:11 59K 
[ ]18420_treatment-refractory-major-depression-tramadol-monotherapy.pdf2022-11-07 23:01 63K 
[ ]18421_treatment-refractory-schizophrenia-clinical-conundrum.pdf2022-11-07 22:06 77K 
[ ]18422_treatment-refractory-schizophrenic-patient.pdf2022-11-07 22:19 42K 
[ ]18423_treatment-resistant-depression.pdf2022-11-07 22:07 100K 
[ ]18424_treatment-resistant-depression-definition-and-staging.pdf2022-11-07 22:03 322K 
[ ]18427_treatment-resistant-panic-disorder.pdf2022-11-07 22:08 26K 
[ ]18428_treatment-resistant-schizophrenia-reviewing-options.pdf2022-11-07 22:22 57K 
[ ]18429_treatment-resistant-self-mutilation-tics-obsessive.pdf2022-11-07 22:05 203K 
[ ]18430_treatment-response-episode-schizophrenia-should-acute.pdf2022-11-07 22:36 348K 
[ ]18431_treatment-response-symptom-remission-wellness-obsessive.pdf2022-11-07 22:01 259K 
[ ]18432_treatment-restless-legs-syndrome-tramadol-open-study.pdf2022-11-07 22:06 41K 
[ ]18433_treatment-rosuvastatin-severe-dyslipidemia-patients.pdf2022-11-07 22:08 110K 
[ ]18434_treatments-anger-specific-populations-theory-application.pdf2022-11-07 22:32 86K 
[ ]18435_treatments-bipolar-disorder-role-atypical-neuroleptic.pdf2022-11-07 22:10 87K 
[ ]18436_treatment-schizophrenia-comorbid-substance-abuse-pharmacologic.pdf2022-11-07 22:59 87K 
[ ]18437_treatment-schizophrenia-long-acting-injectable-risperidone.pdf2022-11-07 22:33 69K 
[ ]18438_treatment-sedative-hypnotic-dependence-evaluating.pdf2022-11-07 22:58 70K 
[ ]18439_treatment-services-pharmacotherapy-bipolar-disorder.pdf2022-11-07 22:09 108K 
[ ]18440_treatment-severe-depression.pdf2022-11-07 22:22 94K 
[ ]18442_treatment-social-phobia-antidepressants.pdf2022-11-07 22:57 61K 
[ ]18443_treatment-special-populations-atypical-antipsychotics.pdf2022-11-07 22:45 110K 
[ ]18445_treatment-strategies-chronic-refractory-obsessive.pdf2022-11-07 22:44 30K 
[ ]18447_treatment-strategies-prevent-relapse-encourage-remission.pdf2022-11-07 22:55 93K 
[ ]18448_treatment-strategies-sleep-disturbance-patients-depression.pdf2022-11-07 22:20 63K 
[ ]18449_treatment-suicidal.pdf2022-11-07 22:32 30K 
[ ]18450_treatment-tardive-dyskinesia-donepezil.pdf2022-11-07 22:13 59K 
[ ]18451_treatment-tardive-dyskinesia-donepezil-pilot-study.pdf2022-11-07 22:53 40K 
[ ]18452_treatment-tardive-dyskinesia-galantamine-randomized.pdf2022-11-07 22:14 141K 
[ ]18453_treatment-tardive-dyskinesia-tardive-dystonia.pdf2022-11-07 22:06 55K 
[ ]18455_treatment-tourettes-syndrome-multimodal-developmental.pdf2022-11-07 22:54 61K 
[ ]18456_treatment-venlafaxine-discontinuation-symptoms-ondansetron.pdf2022-11-07 22:53 44K 
[ ]18457_treatment-veterans-depression-died-suicide-timing.pdf2022-11-07 22:25 288K 
[ ]18458_trends-age-onset-anorexia-nervosa-bulimia-nervosa.pdf2022-11-07 22:18 647K 
[ ]18459_trends-emergency-department-visits-anxiety-related.pdf2022-11-07 22:07 252K 
[ ]18460_trends-incidence-rates-diagnosed-attention-deficit-hyperactivity.pdf2022-11-07 22:58 263K 
[ ]18461_trends-in-nonmedical-use-of-prescription-stimulants.pdf2022-11-07 22:03 342K 
[ ]18462_trends-in-psychiatric-ed-visits-due-to-suicidal-ideation-and-suicide-attempts-during-the-covid-pande.pdf2022-11-07 22:01 220K 
[ ]18463_trends-in-psychotropic-use-in-older-adults.pdf2022-11-07 22:34 341K 
[ ]18464_trends-in-receipt-of-mental-health-treatments-among-us-adults.pdf2022-11-07 22:58 238K 
[ ]18465_trends-office-based-mental-health-care-provided-psychiatrists.pdf2022-11-07 22:46 322K 
[ ]18466_trends-office-based-treatment-adults-stimulants-united.pdf2022-11-07 22:32 317K 
[ ]18467_trends-pharmacologic-management-insomnia.pdf2022-11-07 22:57 88K 
[ ]18468_trends-suicide-risk-associated-hospitalized-psychiatric.pdf2022-11-07 22:11 99K 
[ ]18469_trial-compliance-therapy-outpatients-schizophrenia.pdf2022-11-07 22:11 126K 
[ ]18470_tribute-jcps-peer-reviewers.pdf2022-11-07 22:56 710K 
[ ]18471_trichotillomania-impact-project-tip-exploring-phenomenology.pdf2022-11-07 22:52 133K 
[ ]18472_triglyceridehigh-density-lipoprotein-cholesterol-ratio.pdf2022-11-07 22:05 595K 
[ ]18473_triiodothyronine-augmentation-selective-serotonin.pdf2022-11-07 22:24 54K 
[ ]18474_trimester-exposure-methylphenidate-population-based.pdf2022-11-07 22:05 345K 
[ ]18475_triple-bead-mixed-amphetamine-salts-spd-novel-enhanced.pdf2022-11-07 22:29 341K 
[ ]18476_try-remember-psychiatrys-clash-meaning-memory-mind.pdf2022-11-07 22:54 759K 
[ ]18477_twelve-month-outcome-bipolar-patients-without-personality.pdf2022-11-07 22:11 64K 
[ ]18478_twelve-month-prevalence-risk-factors-suicide-attempts.pdf2022-11-07 22:09 364K 
[ ]18479_twenty-years-counting.pdf2022-11-07 22:13 56K 
[ ]18480_twenty-years-helm.pdf2022-11-07 22:08 80K 
[ ]18481_two-strategies-for-switching-to-clozapine.pdf2022-11-07 22:58 256K 
[ ]18482_type-diabetes-in-youths-with-sga-exposure.pdf2022-11-07 22:15 218K 
[ ]18483_type-diabetes-mellitus-susceptibility-gene-ltemgtigfbpltemgt.pdf2022-11-07 22:11 280K 
[ ]18484_type-d-personality-predicts-clinical-events-myocardial.pdf2022-11-07 22:50 239K 
[ ]18485_type-ii-error-antidepressants.pdf2022-11-07 22:23 52K 
[ ]18486_types-of-adult-adhd.pdf2022-11-07 22:32 224K 
[ ]18487_typical-atypical-antipsychotics-bipolar-depression.pdf2022-11-07 22:43 192K 
[ ]18488_underdiagnosis-bipolar-ii-disorders-community.pdf2022-11-07 22:15 50K 
[ ]18489_underlying-mechanisms-psychosis-aggression-patients.pdf2022-11-07 22:23 45K 
[ ]18490_underpowered-repetitive-transcranial-magnetic-stimulation.pdf2022-11-07 22:36 111K 
[ ]18491_underrecognition-anxiety-mood-disorders-primary-care.pdf2022-11-07 22:14 105K 
[ ]18492_underrecognition-clinically-significant-side-effects.pdf2022-11-07 22:26 231K 
[ ]18493_underrecognition-undertreatment-depression-is-breadth.pdf2022-11-07 22:11 58K 
[ ]18494_understanding-addressing-adherence-issues-schizophrenia.pdf2022-11-07 22:15 126K 
[ ]18495_understanding-adhd-children-adults-executive-function.pdf2022-11-07 22:56 80K 
[ ]18496_understanding-and-managing-antidepressant-withdrawal-syndromes.pdf2022-11-07 22:56 234K 
[ ]18498_understanding-autism-basic-neuroscience-treatment.pdf2022-11-07 22:50 99K 
[ ]18500_understanding-central-pharmacokinetics-spheroidal.pdf2022-11-07 22:31 486K 
[ ]18501_understanding-changes-cholinergic-function-implications.pdf2022-11-07 22:49 105K 
[ ]18504_understanding-depression-long-term-recurring-disorder.pdf2022-11-07 23:01 106K 
[ ]18505_understanding-fibromyalgia-related-disorders.pdf2022-11-07 22:18 76K 
[ ]18506_understanding-managed-care-introduction-health-care.pdf2022-11-07 22:48 49K 
[ ]18507_understanding-mechanisms-action-bipolar-medications.pdf2022-11-07 22:53 207K 
[ ]18508_understanding-meta-analysis-and-how-to-read-a-forest-plot.pdf2022-11-07 22:11 422K 
[ ]18509_understanding-needs-interactions-treatment-expectations.pdf2022-11-07 22:57 285K 
[ ]18511_understanding-relative-risk-odds-ratio-related-terms.pdf2022-11-07 22:18 298K 
[ ]18512_understanding-schizoaffective-disorder-psychobiology.pdf2022-11-07 22:19 327K 
[ ]18513_understanding-sleepness-perpective-insomnia.pdf2022-11-07 22:58 82K 
[ ]18514_understanding-sleep-wake-cycle-sleep-insomnia-orexin.pdf2022-11-07 23:00 1.2M 
[ ]18515_understanding-treating-adults-attention-deficit-hyperactivity.pdf2022-11-07 22:36 100K 
[ ]18516_understanding-treating-panic-disorder-primary-care.pdf2022-11-07 22:12 128K 
[ ]18517_undertreatment-dysthymia.pdf2022-11-07 23:03 88K 
[ ]18518_underuse-antidepressants-major-depression-prevalence.pdf2022-11-07 22:13 75K 
[ ]18519_undiagnosed-hyperglycemia-clozapine-treated-patients.pdf2022-11-07 22:39 50K 
[ ]18520_undiagnosed-hyperglycemia-patients-treated-atypical.pdf2022-11-07 22:20 116K 
[ ]18521_unemployment-emergency-room-visits-predict-poor-treatment.pdf2022-11-07 22:04 66K 
[ ]18522_unintended-outcomes-medicaid-drug-cost-containment.pdf2022-11-07 22:59 50K 
[ ]18523_united-states-food-drug-administration-requirements.pdf2022-11-07 22:42 66K 
[ ]18524_unmet-need-justifies-search-antidepressant.pdf2022-11-07 22:25 51K 
[ ]18525_unmet-need-psychiatry-problems-resources-responses.pdf2022-11-07 22:07 34K 
[ ]18527_unmet-needs-treatment-schizophrenia-targets-help-different.pdf2022-11-07 22:04 355K 
[ ]18528_unnatural-deaths-among-discharged-psychiatric-patients.pdf2022-11-07 22:32 463K 
[ ]18529_untangling-depression-anxiety-clinical-challenges.pdf2022-11-07 22:29 231K 
[ ]18530_until-death-part.pdf2022-11-07 22:45 41K 
[ ]18531_update-alzheimers-disease-related-disorders.pdf2022-11-07 22:12 63K 
[ ]18532_update-best-practices-managing-bipolar-depression.pdf2022-11-07 22:58 345K 
[ ]18534_update-depression-children-adolescents.pdf2022-11-07 22:17 353K 
[ ]18535_update-diagnosis-treatment-social-anxiety-disorder.pdf2022-11-07 22:11 53K 
[ ]18536_updated-meta-analysis-of-pediatric-bipolar-disorder-studies.pdf2022-11-07 22:17 721K 
[ ]18537_update-legal-issues-associated-tardive-dyskinesia.pdf2022-11-07 22:47 90K 
[ ]18538_update-management-bipolar-illness.pdf2022-11-07 23:01 85K 
[ ]18540_update-partial-response-depression.pdf2022-11-07 22:13 344K 
[ ]18541_update-pharmacologic-management-ocd-agents-augmentation.pdf2022-11-07 22:54 44K 
[ ]18542_updates-trends-treatment-major-depressive-disorder.pdf2022-11-07 22:08 206K 
[ ]18543_upper-extremity-self-amputation-case-dissociative.pdf2022-11-07 22:48 45K 
[ ]18544_upper-extremity-self-amputation-replantation-case.pdf2022-11-07 22:26 41K 
[ ]18545_ups-downs-novel-antiemetic-drugs-part-illustration.pdf2022-11-07 22:27 33K 
[ ]18546_ups-downs-novel-antiemetic-drugs-part-substance-p.pdf2022-11-07 22:35 36K 
[ ]18547_ups-downs-oral-lithium-dosing.pdf2022-11-07 22:22 110K 
[ ]18548_urinary-incontinence-mirtazapine.pdf2022-11-07 22:28 122K 
[ ]18549_urinary-incontinence-risperidone.pdf2022-11-07 22:07 61K 
[ ]18550_urinary-retention-associated-ziprasidone-case-report.pdf2022-11-07 22:39 207K 
[ ]18551_urinary-tract-infections-acute-psychosis.pdf2022-11-07 22:28 326K 
[ ]18552_use-of-baclofen-harms-alcohol-use-disorder-patients-without-benefit.pdf2022-11-07 22:12 87K 
[ ]18553_use-of-long-acting-injectable-antipsychotics-in-schizophrenia.pdf2022-11-07 22:03 1.7M 
[ ]18554_use-of-madrs-hr-to-assess-rapid-onset-of-antidepressant-effect.pdf2022-11-07 22:46 235K 
[ ]18556_use-of-technology-in-depression-care.pdf2022-11-07 22:17 613K 
[ ]18557_use-of-the-fragility-index-in-interpreting-clinical-trial-findings.pdf2022-11-07 22:08 297K 
[ ]18558_uses-antidepressants-social-phobia.pdf2022-11-07 22:57 906K 
[ ]18564_using-data-mining-explore-complex-clinical-decisions.pdf2022-11-07 22:16 123K 
[ ]18565_using-interpreters-diagnostic-research-practice-pilot.pdf2022-11-07 22:33 123K 
[ ]18566_using-measurement-strategies-identify-monitor-residual.pdf2022-11-07 22:58 604K 
[ ]18570_using-questionnaires-screen-psychiatric-disorders.pdf2022-11-07 22:01 52K 
[ ]18571_using-secondary-binding-properties-select-selective.pdf2022-11-07 22:49 59K 
[ ]18572_using-standardized-methods-assess-suicidal-behavior.pdf2022-11-07 22:51 111K 
[ ]18573_using-treatment-algorithms-bring-patients-remission.pdf2022-11-07 22:02 66K 
[ ]18574_using-treatment-algorithms-effective-management-treatment.pdf2022-11-07 22:04 50K 
[ ]18575_usual-course-of-treatment-and-predictors-of-treatment-utilization-for-ptsd.pdf2022-11-07 22:13 253K 
[ ]18576_us-veterans-and-ptsd.pdf2022-11-07 22:09 119K 
[ ]18577_utility-attention-deficit-hyperactivity-disorder-screening.pdf2022-11-07 22:59 310K 
[ ]18578_utility-of-combinatorial-pharmacogenomics-in-depression.pdf2022-11-07 22:27 721K 
[ ]18579_utilizing-benzodiazepines-clinical-practice-evidence.pdf2022-11-07 22:18 90K 
[ ]18580_utilizing-the-dsm-anxious-distress-specifier-to-develop-treatment-strategies-for-patients-with-major.pdf2022-11-07 22:32 378K 
[ ]18581_vagus-nerve-stimulation-improves-restless-legs-syndrome.pdf2022-11-07 22:20 170K 
[ ]18582_vagus-nerve-stimulation-patients-alzheimers-disease.pdf2022-11-07 22:14 116K 
[ ]18583_valbenazine-for-tardive-dyskinesia-results-from-the-kinect-study.pdf2022-11-07 22:36 941K 
[ ]18584_validation-mood-disorder-questionnaire-bipolar-disorders.pdf2022-11-07 22:26 95K 
[ ]18585_validity-impact-factor-journals-measure-randomized.pdf2022-11-07 22:55 90K 
[ ]18586_validity-of-the-maudsley-staging-method-in-predicting-depression-outcome.pdf2022-11-07 22:40 445K 
[ ]18587_validity-posttraumatic-stress-disorder-service-connection.pdf2022-11-07 22:03 205K 
[ ]18588_valproate-hostility-schizophrenia-patients.pdf2022-11-07 22:34 51K 
[ ]18589_valproate-induced-hyperammonemia-psychiatric-setting.pdf2022-11-07 22:55 67K 
[ ]18590_valproate-induced-parkinsonism-demented-elderly-patient.pdf2022-11-07 22:58 66K 
[ ]18591_valproate-intoxication-in-a-patient-with-therapeutic-blood-valproate-levels.pdf2022-11-07 22:55 123K 
[ ]18592_valproate-monotherapy-sri-intolerant-ocd-patient.pdf2022-11-07 22:56 100K 
[ ]18593_valproate-use-in-pregnancy.pdf2022-11-07 22:59 313K 
[ ]18594_valproic-acid-treatment-aids-related-mania.pdf2022-11-07 22:34 43K 
[ ]18595_valproic-acid-use-in-reproductive-aged-women.pdf2022-11-07 22:50 290K 
[ ]18596_values-psychiatric-diagnosis.pdf2022-11-07 22:54 51K 
[ ]18597_vardenafil-treatment-erectile-dysfunction-outpatients.pdf2022-11-07 22:17 203K 
[ ]18598_varenicline-augmentation-depressed-smokers-week-open.pdf2022-11-07 22:13 254K 
[ ]18599_varenicline-for-alcohol-use-disorders.pdf2022-11-07 22:27 781K 
[ ]18600_varenicline-smoking-cessation-bipolar-disorder-randomized.pdf2022-11-07 23:00 257K 
[ ]18601_varenicline-smoking-cessation-bipolar-patient.pdf2022-11-07 22:43 103K 
[ ]18602_varenicline-treatment-smokers-schizophrenia-case-series.pdf2022-11-07 22:19 209K 
[ ]18603_variables-associated-alcohol-drug-daily-smoking-cessation.pdf2022-11-07 22:55 186K 
[ ]18604_variables-associated-high-olanzapine-dosing-state.pdf2022-11-07 22:17 136K 
[ ]18605_variables-mediators-moderators-predicting-relapse.pdf2022-11-07 22:22 251K 
[ ]18606_variants-serotonin-transporter-gene-selective-serotonin.pdf2022-11-07 22:17 356K 
[ ]18607_varied-clinical-presentations-major-depressive-disorder.pdf2022-11-07 22:10 194K 
[ ]18608_vasomotor-symptoms-depression-women-part-role-vasomotor.pdf2022-11-07 22:36 124K 
[ ]18609_vasomotor-symptoms-depression-women-part-treatments.pdf2022-11-07 22:02 257K 
[ ]18610_vasopressin-vltsubgtbltsubgt-receptor-antagonist-ssr.pdf2022-11-07 22:10 831K 
[ ]18611_v-code-bereavement.pdf2022-11-07 22:12 104K 
[ ]18612_venlafaxine-dysthymic-disorder.pdf2022-11-07 23:00 29K 
[ ]18613_venlafaxine-extended-release-short-term-treatment.pdf2022-11-07 22:25 118K 
[ ]18614_venlafaxine-extended-release-xr-treatment-generalized.pdf2022-11-07 22:30 67K 
[ ]18615_venlafaxine-human-breast-milk-nursing-infant-plasma.pdf2022-11-07 22:12 565K 
[ ]18616_venlafaxine-induced-complex-visual-hallucinations.pdf2022-11-07 22:08 176K 
[ ]18617_venlafaxine-induced-increase-urinary-frequency-women.pdf2022-11-07 22:36 62K 
[ ]18618_venlafaxine-loss-antidepressant-effect-management.pdf2022-11-07 23:03 44K 
[ ]18619_venlafaxine-o-desmethylvenlafaxine-concentrations.pdf2022-11-07 23:01 257K 
[ ]18620_venlafaxine-pathological-crying-stroke.pdf2022-11-07 22:24 308K 
[ ]18621_venlafaxine-patient-idiopathic-leukopenia-mirtazapine.pdf2022-11-07 22:03 59K 
[ ]18622_venlafaxine-treatment-binge-eating-disorder-associated.pdf2022-11-07 22:43 62K 
[ ]18623_venlafaxine-treatment-dysthymia-open-label-study.pdf2022-11-07 22:06 38K 
[ ]18624_venlafaxine-treatment-postpartum-depression.pdf2022-11-07 22:44 83K 
[ ]18625_venlafaxine-treatment-resistant-obsessive-compulsive.pdf2022-11-07 22:17 56K 
[ ]18626_venlafaxine-versus-clomipramine-treatment-obsessive.pdf2022-11-07 22:37 65K 
[ ]18627_venlafaxine-versus-fluoxetine.pdf2022-11-07 22:53 46K 
[ ]18628_venlafaxine-versus-fluvoxamine-treatment-delusional.pdf2022-11-07 22:14 57K 
[ ]18629_venlafaxine-versus-placebo-preventive-treatment-recurrent.pdf2022-11-07 22:37 73K 
[ ]18630_venlafaxine-versus-sertraline-major-depressive-disorder.pdf2022-11-07 22:12 54K 
[ ]18631_venlafaxine-vivid-dreaming.pdf2022-11-07 22:14 54K 
[ ]18632_venlafaxine-xr-chronic-pelvic-pain-syndrome.pdf2022-11-07 22:24 62K 
[ ]18633_viewing-suicide-risk-through-lens-benefits-examining.pdf2022-11-07 22:52 159K 
[ ]18634_vilazodone-clinical-basis-food-drug-administrations.pdf2022-11-07 22:05 369K 
[ ]18635_vilazodone-in-generalized-anxiety-disorder.pdf2022-11-07 22:51 287K 
[ ]18636_violent-behavior-dsm-iv-psychiatric-disorders-results.pdf2022-11-07 22:10 298K 
[ ]18637_violent-behavior-during-sleep-cme.pdf2022-11-07 23:02 62K 
[ ]18638_violent-parasomnia-associated-selective-serotonin.pdf2022-11-07 22:02 161K 
[ ]18639_violent-serious-suicide-attempters-step-closer-suicide.pdf2022-11-07 22:11 363K 
[ ]18640_virtual-reality-exposure-therapy-treatment-posttraumatic.pdf2022-11-07 22:03 217K 
[ ]18641_virtual-reality-exposure-therapy-vietnam-veterans.pdf2022-11-07 22:35 84K 
[ ]18642_visual-field-shimmering-associated-nefazodone.pdf2022-11-07 22:49 50K 
[ ]18643_visual-hallucinations-sertraline.pdf2022-11-07 22:35 55K 
[ ]18644_vitamin-b-add-treatment-chronic-schizophrenic-schizoaffective.pdf2022-11-07 22:30 57K 
[ ]18645_vitamin-b-treatment-acute-neuroleptic-induced-akathisia.pdf2022-11-07 22:20 51K 
[ ]18646_vitamin-b-treatment-tardive-dyskinesia-randomized.pdf2022-11-07 22:05 195K 
[ ]18647_vitamin-d-and-cognition-in-psychotic-disorders.pdf2022-11-07 22:21 259K 
[ ]18648_vitamins-b-b-folic-acid-onset-depressive-symptoms.pdf2022-11-07 22:22 209K 
[ ]18649_vitamins-minerals-apart-lithium-mood-stabilizing-effects.pdf2022-11-07 22:06 33K 
[ ]18650_vitro-vivo-biochemistry-olanzapine-novel-atypical.pdf2022-11-07 22:37 63K 
[ ]18651_vivo-imaging-pharmacodynamics-pharmacokinetics-lithium.pdf2022-11-07 22:31 52K 
[ ]18652_vns-improves-quality-of-life-in-depression.pdf2022-11-07 22:49 483K 
[ ]18653_voltage-gated-potassium-channellgi-antibodyassociated.pdf2022-11-07 22:24 153K 
[ ]18654_vortioxetine-and-cognition-in-working-patients-with-mdd.pdf2022-11-07 22:01 248K 
[ ]18655_vs-old-antipsychotics-texas-experience.pdf2022-11-07 22:31 38K 
[ ]18656_wang-and-colleagues-reply.pdf2022-11-07 22:08 117K 
[ ]18657_watchers-recognizing-generalized-anxiety-disorder.pdf2022-11-07 22:21 65K 
[ ]18658_web-based-assessment-depression-patients-treated-clinical.pdf2022-11-07 22:48 271K 
[ ]18660_week-comparison-ziprasidone-haloperidol-outpatients.pdf2022-11-07 22:26 64K 
[ ]18661_week-double-blind-randomized-placebo-controlled-study.pdf2022-11-07 22:30 404K 
[ ]18662_week-multicenter-open-label-randomized-study-compare.pdf2022-11-07 22:14 353K 
[ ]18663_week-open-label-continuation-study-lamotrigine-treatment.pdf2022-11-07 22:24 63K 
[ ]18664_week-open-label-extension-study-olanzapine-fluoxetine.pdf2022-11-07 22:34 122K 
[ ]18665_week-open-label-trial-course-mifepristone-treatment.pdf2022-11-07 22:41 93K 
[ ]18666_week-open-label-trial-duloxetine-comorbid-major-depressive.pdf2022-11-07 23:01 186K 
[ ]18667_week-randomized-clinical-trial-evaluate-metabolic.pdf2022-11-07 22:50 207K 
[ ]18668_week-randomized-controlled-trial-atomoxetine-atomoxetine.pdf2022-11-07 22:02 292K 
[ ]18669_week-randomized-double-blind-placebo-controlled-sequential.pdf2022-11-07 22:52 271K 
[ ]18670_week-randomized-double-blind-placebo-controlled-study.pdf2022-11-07 22:09 201K 
[ ]18671_week-randomized-double-blind-study-olanzapine-versus.pdf2022-11-07 22:34 276K 
[ ]18672_week-randomized-double-blind-trial-olanzapinefluoxetine.pdf2022-11-07 22:03 113K 
[ ]18673_week-randomized-trial-comparing-chronotherapeutic.pdf2022-11-07 22:03 449K 
[ ]18674_week-single-blind-trial-quetiapine-treatment-mood.pdf2022-11-07 22:34 260K 
[ ]18675_weighing-evidence-trends-managed-care-formulary-decision.pdf2022-11-07 22:34 49K 
[ ]18676_weight-change-atypical-antipsychotic-treatment-patients.pdf2022-11-07 22:24 49K 
[ ]18677_weight-change-metabolic-effects-asenapine-patients.pdf2022-11-07 22:25 422K 
[ ]18678_weight-change-observational-data-findings-worldwide.pdf2022-11-07 22:11 1.0M 
[ ]18679_weight-changes-postpartum-women-remitted-depression.pdf2022-11-07 22:14 70K 
[ ]18680_weight-gain-among-elderly-schizophrenia-patients-risperidone.pdf2022-11-07 22:24 39K 
[ ]18681_weight-gain-antidepressants.pdf2022-11-07 22:36 52K 
[ ]18682_weight-gain-antipsychotic-medication.pdf2022-11-07 22:05 53K 
[ ]18683_weight-gain-antipsychotic-medication-differences-between.pdf2022-11-07 22:11 63K 
[ ]18684_weight-gain-antipsychotic-medications.pdf2022-11-07 22:45 67K 
[ ]18685_weight-gain-antipsychotics.pdf2022-11-07 22:48 103K 
[ ]18686_weight-gain-associated-antipsychotic-drugs.pdf2022-11-07 22:56 47K 
[ ]18687_weight-gain-associated-psychotropic-medications.pdf2022-11-07 22:41 45K 
[ ]18688_weight-gain-atypical-antipsychotics-evidence-insights.pdf2022-11-07 22:56 246K 
[ ]18689_weight-gain-breastfed-infants-mothers-taking-antidepressant.pdf2022-11-07 22:17 37K 
[ ]18690_weight-gain-cardiovascular-risk-sustained-tobacco.pdf2022-11-07 22:23 366K 
[ ]18691_weight-gain-during-long-term-treatment-obsessive-compulsive.pdf2022-11-07 22:33 62K 
[ ]18692_weight-gain-during-treatment-bipolar-i-patients-olanzapine.pdf2022-11-07 22:52 76K 
[ ]18693_weight-gain-risperidone-among-patients-mental-retardation.pdf2022-11-07 22:39 33K 
[ ]18694_weight-gain-sexual-dysfunction-bupropion.pdf2022-11-07 22:55 165K 
[ ]18695_weight-gain-treatment-mood-disorders.pdf2022-11-07 22:33 80K 
[ ]18696_weight-lipids-glucose-behavioral-measures-ziprasidone.pdf2022-11-07 22:23 46K 
[ ]18697_weight-management-program-treatment-emergent-weight.pdf2022-11-07 22:19 103K 
[ ]18698_wellness-intervention-patients-serious-persistent.pdf2022-11-07 22:20 113K 
[ ]18700_whats-going-on-in-there.pdf2022-11-07 22:35 1.4M 
[ ]18701_what-should-a-psychiatrist-know-about-genetics.pdf2022-11-07 22:21 641K 
[ ]18702_whats-next-years-psychiatric-drug-development-fda.pdf2022-11-07 22:43 349K 
[ ]18703_when-delusions-herald-a-neurodegenerative-condition.pdf2022-11-07 22:47 1.1M 
[ ]18704_when-further-pharmacotherapy-seems-futile.pdf2022-11-07 22:17 131K 
[ ]18705_where-experts-are-many.pdf2022-11-07 22:24 62K 
[ ]18706_where-schizophrenia-die-population-based-matched-cohort.pdf2022-11-07 22:34 327K 
[ ]18707_whether-increase-maintain-dosage-mirtazapine-early.pdf2022-11-07 22:05 243K 
[ ]18708_white-matter-hyperintensities-medial-temporal-lobe.pdf2022-11-07 22:05 333K 
[ ]18709_why-arent-maois-used-more-often.pdf2022-11-07 22:31 74K 
[ ]18710_why-are-outcomes-patients-schizophrenia-poor.pdf2022-11-07 22:55 242K 
[ ]18711_why-clinicians-maintain-antidepressants-patients-acute.pdf2022-11-07 22:34 318K 
[ ]18712_why-depressed-outpatients-are-remission-according.pdf2022-11-07 22:02 238K 
[ ]18713_why-dont-psychiatrists-scales-measure-outcome-treating.pdf2022-11-07 22:59 133K 
[ ]18714_why-drugs-hormones-may-interact-psychiatric-disorders.pdf2022-11-07 22:16 36K 
[ ]18715_why-dsm-v-needs-address-anger.pdf2022-11-07 22:43 790K 
[ ]18716_why-isnt-bupropion-frequently-prescribed-antidepressant.pdf2022-11-07 22:40 143K 
[ ]18717_why-need-move-beyond-line-therapy-major-depression.pdf2022-11-07 22:35 284K 
[ ]18718_why-nonnative-migrate-another-country-better-health.pdf2022-11-07 22:25 143K 
[ ]18719_why-odds-ratios-can-be-tricky-statistics.pdf2022-11-07 22:56 302K 
[ ]18720_why-patients-schizophrenia-engaged-medical-decision.pdf2022-11-07 22:49 356K 
[ ]18721_why-patients-severe-personality-disorders-are-overmedicated.pdf2022-11-07 22:32 86K 
[ ]18722_why-settle-silver-gold-response-vs-recovery-goal-antidepressant.pdf2022-11-07 23:01 39K 
[ ]18723_why-young-women-diet-roles-body-fat-body-perception.pdf2022-11-07 22:34 62K 
[ ]18724_widespread-underrecognition-undertreatment-anxiety.pdf2022-11-07 22:23 159K 
[ ]18725_windows-brain-insights-neuroimaging.pdf2022-11-07 22:41 132K 
[ ]18726_wisconsin-quality-life-index-multidimensional-model.pdf2022-11-07 22:08 37K 
[ ]18727_wishful-thinking-is-effective-contraception-family.pdf2022-11-07 22:11 125K 
[ ]18728_withania-somnifera-extract-for-schizophrenia-symptoms.pdf2022-11-07 23:00 668K 
[ ]18729_withdrawal-controlled-carbamazepine-therapy-followed.pdf2022-11-07 22:41 40K 
[ ]18730_withdrawal-reactions-associated-low-dose-venlafaxine.pdf2022-11-07 22:31 151K 
[ ]18731_women-psychiatry-gender-gap.pdf2022-11-07 23:02 141K 
[ ]18732_womens-mental-health-comprenhensive-textbook.pdf2022-11-07 22:30 34K 
[ ]18733_womens-mental-health-hot-topics-clinical-implications.pdf2022-11-07 22:26 151K 
[ ]18734_women-traumatic-events.pdf2022-11-07 22:56 62K 
[ ]18735_word-caution-implied-role-duloxetine-pain-management.pdf2022-11-07 22:38 55K 
[ ]18736_working-children-adolescents-evidence-based-approach.pdf2022-11-07 22:15 75K 
[ ]18737_working-families-medical-settingsa-multidisciplinary.pdf2022-11-07 22:28 68K 
[ ]18738_working-families-poor-nd-ed.pdf2022-11-07 22:02 98K 
[ ]18739_working-families-psychiatric-inpatients-guide-clinicians.pdf2022-11-07 22:02 97K 
[ ]18741_worldview-psychiatry-april-2004.pdf2022-11-07 22:35 25K 
[ ]18742_worldview-psychiatry-CINP-2004-Congress-Preview-antibipolar-drugs-new-old.pdf2022-11-07 22:53 22K 
[ ]18743_worldview-psychiatry-CINP-2004-Congress-Preview-neurodegeneration-stress-anxiety-disorders-mechanism.pdf2022-11-07 22:35 26K 
[ ]18744_worldview-psychiatry-CINP-2004-Congress-Preview-second-generation-antipsychotics-bench-bedside.pdf2022-11-07 22:28 34K 
[ ]18745_worried-sick-antidepressants-stress-inflammation.pdf2022-11-07 22:59 72K 
[ ]18746_worsened-agitation-aripiprazole-adverse-effect-dopamine.pdf2022-11-07 22:45 50K 
[ ]18747_worsening-of-suicidal-ideation-during-ad-treatment.pdf2022-11-07 22:19 625K 
[ ]18748_worsening-psychosis-replacement-adjunctive-valproate.pdf2022-11-07 22:04 55K 
[ ]18749_years-greetings-gratitude.pdf2022-11-07 22:56 128K 
[ ]18750_years-thanks.pdf2022-11-07 22:01 62K 
[ ]18751_yoga-adjunctive-treatment-posttraumatic-stress-disorder.pdf2022-11-07 22:55 240K 
[ ]18752_young-adult-mental-health.pdf2022-11-07 22:04 135K 
[ ]18753_young-adults-with-adhd-depression-and-suicidal-behavior.pdf2022-11-07 22:02 279K 
[ ]18754_youngest-children-each-school-cohort-are-overrepresented.pdf2022-11-07 22:10 324K 
[ ]18755_youth-with-autism-in-the-emergency-department.pdf2022-11-07 22:15 250K 
[ ]18756_ziprasidone-acute-treatment-borderline-personality.pdf2022-11-07 22:32 114K 
[ ]18757_ziprasidone-augmentation-clozapine-patients.pdf2022-11-07 22:29 67K 
[ ]18758_ziprasidone-augmentation-of-escitalopram-for-cognition.pdf2022-11-07 22:48 213K 
[ ]18759_ziprasidone-augmentation-selective-serotonin-reuptake.pdf2022-11-07 22:25 56K 
[ ]18760_ziprasidone-cognition-evolving-story.pdf2022-11-07 22:44 74K 
[ ]18761_ziprasidone-induced-acute-dystonic-reactions-patients.pdf2022-11-07 22:30 98K 
[ ]18762_ziprasidone-induced-angioedema-case-report.pdf2022-11-07 22:21 281K 
[ ]18763_ziprasidone-observational-study-cardiac-outcomes-zodiac.pdf2022-11-07 22:12 221K 
[ ]18764_ziprasidone-plus-mood-stabilizer-subjects-bipolar.pdf2022-11-07 22:34 397K 
[ ]18765_ziprasidone-treatment-borderline-personality-disorder.pdf2022-11-07 22:58 180K 
[ ]18766_ziprasidone-treatment-resistant-schizophrenia-week.pdf2022-11-07 22:46 163K 
[ ]18767_zolpidem-persistent-insomnia-ssri-treated-depressed.pdf2022-11-07 22:20 61K 
[ ]18768_zolpidem-related-delirium-case-report.pdf2022-11-07 22:16 66K 
[ ]18769_zonisamide-treatment-binge-eating-disorder-obesity.pdf2022-11-07 22:05 129K 
[ ]18770_zonisamide-treatment-binge-eating-disorder-open-label.pdf2022-11-07 22:29 64K 
[ ]23754_ability-to-consent-do-they-understand.pdf2022-11-07 22:24 210K 
[ ]23756_absence-cardiac-side-effects-during-treatment-schizophrenia.pdf2022-11-07 22:58 221K 
[ ]23765_accidental-therapist.pdf2022-11-07 22:31 69K 
[ ]23767_acetylcholinesterase-inhibitors-treatment-dementia.pdf2022-11-07 22:54 21K 
[ ]23770_a-collaboration-between-family-medicine-and-psychiatry.pdf2022-11-07 22:48 229K 
[ ]23773_acute-maintenance-treatment-chronic-depression.pdf2022-11-07 22:50 59K 
[ ]23774_acute-psychological-stress-precipitant-acute-coronary.pdf2022-11-07 22:38 120K 
[ ]23781_adaptive-change-related-medication-treatment-adhd.pdf2022-11-07 22:47 64K 
[ ]23783_adding-memantine-rivastigmine-therapy-patients-mild.pdf2022-11-07 22:39 102K 
[ ]23785_adequacy-of-antidepressant-dosing.pdf2022-11-07 22:31 131K 
[ ]23786_adequate-initial-antidepressant-treatment-among-patients.pdf2022-11-07 22:27 87K 
[ ]23787_adhd-autism-connection-step-toward-more-accurate-diagnosis.pdf2022-11-07 22:23 27K 
[ ]23788_adhd-comorbidity-childhood.pdf2022-11-07 22:28 70K 
[ ]23789_adherence-to-follow-up-in-first-episode-psychosis-ethnicity-factors.pdf2022-11-07 22:37 251K 
[ ]23793_adult-adhd-pharmacotherapy.pdf2022-11-07 22:24 55K 
[ ]23794_advanced-pap-therapy-and-sleep-onset-insomnia.pdf2022-11-07 22:01 377K 
[ ]23796_aerophagia-initial-presenting-symptom-depressed-patient.pdf2022-11-07 23:00 61K 
[ ]23799_aggressive-behavior-ingestion-high-dose-sildenafil.pdf2022-11-07 22:12 209K 
[ ]23802_aging-male-androgens-erectile-dysfunction-depression.pdf2022-11-07 22:30 76K 
[ ]23811_alcohol-drug-problems-relationship-sexual-impulsivity.pdf2022-11-07 22:35 262K 
[ ]23812_alcohol-during-pregnancy-prevalence-impact.pdf2022-11-07 22:11 150K 
[ ]23814_alcohol-withdrawal-setting-elevated-blood-alcohol.pdf2022-11-07 22:59 62K 
[ ]23815_algorithms-treat-anxiety-primary-care.pdf2022-11-07 22:33 47K 
[ ]23816_algorithm-treatment-chronic-depression.pdf2022-11-07 22:28 75K 
[ ]23817_alleviation-hot-flashes-increase-venlafaxine-dose.pdf2022-11-07 23:02 140K 
[ ]23818_alone-away-home.pdf2022-11-07 22:02 68K 
[ ]23820_alopecia-following-initiation-lisdexamfetamine-pediatric.pdf2022-11-07 22:45 45K 
[ ]23821_alosetron-treat-ssri-induced-gastrointestinal-symptoms.pdf2022-11-07 22:48 15K 
[ ]23823_alternative-medications-sleep-elderly.pdf2022-11-07 23:02 24K 
[ ]23825_alzheimers-disease-family-practice-setting-assessment.pdf2022-11-07 22:15 51K 
[ ]23829_america-is-too-violent.pdf2022-11-07 22:47 17K 
[ ]23833_amphetamine-withdrawal-after-lisdexamfetamine-cessation.pdf2022-11-07 22:45 675K 
[ ]23840_angry-dying-patient.pdf2022-11-07 22:58 38K 
[ ]23841_a-novel-continuous-release-and-absorption-melatonin.pdf2022-11-07 22:40 644K 
[ ]23843_anticonvulsant-treatment-bipolar-disorder-primer-primary.pdf2022-11-07 22:46 76K 
[ ]23845_antidepressant-chronic-pain-management-is-evidence.pdf2022-11-07 22:36 46K 
[ ]23846_antidepressant-effect-sessions-rtms-pregnant-woman.pdf2022-11-07 22:58 257K 
[ ]23847_antidepressant-medication-adherence-study-primary.pdf2022-11-07 22:21 211K 
[ ]23849_antidepressant-related-erectile-dysfunction-management.pdf2022-11-07 22:56 83K 
[ ]23850_antidepressants-novel-combination-therapies.pdf2022-11-07 22:36 61K 
[ ]23851_antidepressant-treatment-posttraumatic-stress-disorder.pdf2022-11-07 22:35 40K 
[ ]23856_antipsychotics-primary-care.pdf2022-11-07 22:49 64K 
[ ]23859_anxiety-depression-optimizing-treatments.pdf2022-11-07 22:34 56K 
[ ]23860_anxiety-depression-quality-life-primary-care-patients.pdf2022-11-07 22:15 178K 
[ ]23861_anxiety-disorders-in-older-patients.pdf2022-11-07 22:15 315K 
[ ]23862_anxious-depression.pdf2022-11-07 22:13 46K 
[ ]23864_approaches-managing-bipolar-depression.pdf2022-11-07 22:05 59K 
[ ]23865_approaches-managing-difficult-treat-depressions.pdf2022-11-07 22:03 42K 
[ ]23866_approaches-managing-psychotic-depression.pdf2022-11-07 22:05 61K 
[ ]23871_are-anxiety-depression-addressed-primary-care-patients.pdf2022-11-07 22:01 530K 
[ ]23873_are-dying-here.pdf2022-11-07 22:55 38K 
[ ]23874_are-implications-stard-trial-primary-care-review-synthesis.pdf2022-11-07 23:03 178K 
[ ]23879_aripiprazole-causative-agent-neuroleptic-malignant.pdf2022-11-07 22:09 186K 
[ ]23885_aripiprazole-induced-tardive-dystonia.pdf2022-11-07 22:52 537K 
[ ]23888_aripiprazole-prodromal-psychosis-case-report.pdf2022-11-07 22:16 262K 
[ ]23889_aripiprazole-schizotypal-personality-disorder-case.pdf2022-11-07 22:08 209K 
[ ]23890_aripiprazole-therapy-nicotine-dependence.pdf2022-11-07 22:57 61K 
[ ]23892_aripiprazole-worsens-psychosis-case-report.pdf2022-11-07 23:01 79K 
[ ]23898_assertive-community-treatment-team-appropriate-treatment.pdf2022-11-07 22:57 268K 
[ ]23899_assertive-community-treatment-team-visits.pdf2022-11-07 22:50 154K 
[ ]23900_assessing-adults-adhd-comorbidities.pdf2022-11-07 22:41 54K 
[ ]23901_assessing-capacity-psychiatric-patients-acute-medical.pdf2022-11-07 22:52 205K 
[ ]23902_assessing-effects-l-methylfolate-depression-management.pdf2022-11-07 22:31 356K 
[ ]23903_assessing-sexual-function-patients-before-initiating.pdf2022-11-07 22:41 18K 
[ ]23905_assessment-awake-unresponsive-patient.pdf2022-11-07 22:27 43K 
[ ]23906_assessment-excessive-sleepiness-insomnia-relate-circadian.pdf2022-11-07 22:10 61K 
[ ]23910_assessment-patients-attempt-suicide.pdf2022-11-07 22:39 507K 
[ ]23915_association-between-panic-disorder-coronary-artery.pdf2022-11-07 22:49 284K 
[ ]23917_association-between-spirituality-depression-urban.pdf2022-11-07 22:14 50K 
[ ]23918_association-chronic-fatigue-syndrome-acute-psychotic.pdf2022-11-07 22:36 151K 
[ ]23920_association-medicine-psychiatry-abstract-annual-meeting.pdf2022-11-07 23:01 31K 
[ ]23921_association-medicine-psychiatry-announcement.pdf2022-11-07 22:43 46K 
[ ]23923_association-psychosis-hyperthyroid-goiter-case-report.pdf2022-11-07 22:29 186K 
[ ]23926_atomoxetine-used-adjunctively-selective-serotonin.pdf2022-11-07 22:21 28K 
[ ]23928_attending-anxiety-disorders-primary-care.pdf2022-11-07 22:44 53K 
[ ]23930_attitudes-toward-benzodiazepines-years.pdf2022-11-07 22:21 103K 
[ ]23932_attribution-problem.pdf2022-11-07 22:51 58K 
[ ]23934_atypical-antipsychotics-glucose-dysregulation-series.pdf2022-11-07 22:14 36K 
[ ]23936_atypical-antipsychotics-sleep-sedation-efficacy.pdf2022-11-07 22:13 56K 
[ ]23937_atypical-antipsychotics-state-medicare-drug-plans.pdf2022-11-07 22:54 148K 
[ ]23938_atypical-antipsychotics-state-medicare-drug-plans-follow-up.pdf2022-11-07 22:03 171K 
[ ]23939_atypical-antipsychotic-treatment-psychosis-primary.pdf2022-11-07 22:27 64K 
[ ]23940_atypical-depression-valid-subtype.pdf2022-11-07 22:23 144K 
[ ]23941_atypicality-atypical-antipsychotics.pdf2022-11-07 22:14 150K 
[ ]23942_atypical-neuropsychiatric-presentation-addisons-disease.pdf2022-11-07 22:26 151K 
[ ]23943_augmentation-effect-repetitive-transcranial-magnetic.pdf2022-11-07 22:15 176K 
[ ]23944_augmentation-modafinil-achieve-remission-depression.pdf2022-11-07 22:21 18K 
[ ]23951_baclofen-management-inhalant-withdrawal-case-series.pdf2022-11-07 22:27 122K 
[ ]23952_banned-forgotten-case-ephedrine-induced-psychosis.pdf2022-11-07 22:53 26K 
[ ]23953_banner-rounds-evaluating-cognitive-impairment.pdf2022-11-07 22:44 1.8M 
[ ]23954_bathe-method-incorporating-counseling-psychotherapy.pdf2022-11-07 22:16 41K 
[ ]23964_behavioral-manifestations-sturge-weber-syndrome-case.pdf2022-11-07 22:36 73K 
[ ]23965_being-left.pdf2022-11-07 22:39 29K 
[ ]23967_bench-trench-comparison-sertraline-treatment-major.pdf2022-11-07 22:03 69K 
[ ]23971_benefits-exercise-clinically-depressed.pdf2022-11-07 22:41 109K 
[ ]23972_benefits-outpatient-psychiatric-teleconsultation-unit.pdf2022-11-07 22:46 46K 
[ ]23973_benzodiazepine-abuse-dependence.pdf2022-11-07 22:21 118K 
[ ]23975_benzodiazepine-cognitive-impairment-cognitive-behavioral.pdf2022-11-07 22:27 100K 
[ ]23977_benzodiazepines-anticonvulsants-social-phobia-social.pdf2022-11-07 22:40 59K 
[ ]23978_benzodiazepines-clinical-practice-consideration-long.pdf2022-11-07 22:43 134K 
[ ]23981_benzodiazepines-revisiting-clinical-issues-treating.pdf2022-11-07 22:35 244K 
[ ]23982_benzodiazepines-social-anxiety-disorder-generalized.pdf2022-11-07 22:55 54K 
[ ]23984_berigan-replies-discontinuation-bupropion.pdf2022-11-07 22:34 16K 
[ ]23985_berigan-replies-oxcarbazepine-bipolar.pdf2022-11-07 22:54 18K 
[ ]23987_bethanechol-for-urinary-retention-associated-with-olanzapine.pdf2022-11-07 22:18 103K 
[ ]23990_billing-evaluation-treatment-adult-depression-primary.pdf2022-11-07 22:56 61K 
[ ]23991_binge-eating-depression-cognitive-therapy.pdf2022-11-07 22:26 25K 
[ ]23992_binge-eating-disorder-in-the-clinical-setting.pdf2022-11-07 22:17 292K 
[ ]23994_biological-psychiatry-of-the-menstruum-in-arab-women.pdf2022-11-07 22:15 209K 
[ ]23995_biology-posttraumatic-stress-disorder.pdf2022-11-07 22:56 72K 
[ ]23996_bipolar-depression-specific-treatments.pdf2022-11-07 22:49 46K 
[ ]23999_bipolar-disorder-detection-ascertainment-treatment.pdf2022-11-07 22:13 76K 
[ ]24000_bipolar-disorder-guide-patients-families-nd-ed.pdf2022-11-07 22:16 53K 
[ ]24001_bipolar-disorders-clinical-course-outcome.pdf2022-11-07 22:51 27K 
[ ]24002_bipolar-disorder-screening-among-adult-patients-urban.pdf2022-11-07 22:04 69K 
[ ]24004_bipolar-family-useful-mnemonic-differentiate-bipolar.pdf2022-11-07 22:25 186K 
[ ]24006_bipolar-ii-disorder-primary-care-setting-clinical.pdf2022-11-07 22:39 36K 
[ ]24008_biweekly-cognitive-therapy-social-phobia.pdf2022-11-07 22:55 29K 
[ ]24009_book-jesse-story-youth-illness-medicine-michael-rowe.pdf2022-11-07 22:37 23K 
[ ]24012_borderline-personality-symptomatology-employment-disability.pdf2022-11-07 22:12 79K 
[ ]24013_brain-circuits-determine-destiny-depression-novel.pdf2022-11-07 22:28 101K 
[ ]24015_brain-zaps.pdf2022-11-07 22:23 196K 
[ ]24016_breaking-sleep-barrier.pdf2022-11-07 22:53 69K 
[ ]24017_breakthrough-pharmacologic-management-insomnia-overview.pdf2022-11-07 22:17 57K 
[ ]24018_brexpiprazole-in-mdd-and-sleep-disturbances.pdf2022-11-07 22:29 662K 
[ ]24019_bridging-communication-gap-between-physicians-patients.pdf2022-11-07 22:49 75K 
[ ]24020_bridging-mental-health-and-primary-care-to-improve-outcomes-for-patients-taking-sgas.pdf2022-11-07 22:27 849K 
[ ]24022_brief-effective-psychotherapy.pdf2022-11-07 22:09 26K 
[ ]24023_brief-encounter.pdf2022-11-07 22:52 23K 
[ ]24025_brief-report-aripiprazole-treatment-tourettes-disorder.pdf2022-11-07 22:47 124K 
[ ]24026_brief-report-delirium-associated-disulfiram-ethanol.pdf2022-11-07 22:06 506K 
[ ]24027_brief-report-hepatitis-c-treatment-patients-bipolar.pdf2022-11-07 22:35 76K 
[ ]24028_brief-report-patient-bullying-survey-physicians-primary.pdf2022-11-07 22:24 82K 
[ ]24029_brief-therapy-worked-medication-did.pdf2022-11-07 22:26 19K 
[ ]24031_bright-light-therapy-among-psychiatrists-massachusetts.pdf2022-11-07 22:15 877K 
[ ]24037_bulimia-nervosa-primary-care-review.pdf2022-11-07 22:05 71K 
[ ]24041_bupropion-associated-withdrawal-symptoms-case-report.pdf2022-11-07 22:37 25K 
[ ]24045_bupropion-induced-spontaneous-ejaculations.pdf2022-11-07 22:48 83K 
[ ]24048_bupropion-withdrawal-symptoms-revisited.pdf2022-11-07 22:03 41K 
[ ]24050_burden-illness-bipolar-depression.pdf2022-11-07 22:19 200K 
[ ]24054_calm-mnemonic-treatment-options-bipolar-disorder.pdf2022-11-07 22:40 209K 
[ ]24057_candidate-gene-studies-attention-deficit-hyperactivity.pdf2022-11-07 22:43 102K 
[ ]24063_capacity-decisions-general-hospital-refuse-follow.pdf2022-11-07 22:08 75K 
[ ]24066_capgras-syndrome-patient-multiple-sclerosis-case-report.pdf2022-11-07 23:02 46K 
[ ]24068_carbidopa-levodopa-induced-recrudescence-premorbid.pdf2022-11-07 22:07 86K 
[ ]24070_cardiovascular-effects-antipsychotics-used-bipolar.pdf2022-11-07 22:01 80K 
[ ]24071_careful-monitoring-agranulocytosis-during-carbamazepine.pdf2022-11-07 22:32 63K 
[ ]24078_case-alcohol-abuse.pdf2022-11-07 22:29 16K 
[ ]24082_casebook-cancer-therapist.pdf2022-11-07 23:01 70K 
[ ]24083_casebook-cancer-therapist-relationship.pdf2022-11-07 22:51 70K 
[ ]24093_case-excessive-yawning-citalopram.pdf2022-11-07 22:49 131K 
[ ]24095_case-genital-self-mutilation-elderly-man.pdf2022-11-07 22:22 180K 
[ ]24097_case-hashimotos-encephalopathy-manifesting-psychosis.pdf2022-11-07 22:54 204K 
[ ]24103_case-lamotrigine-associated-anticonvulsant-hypersensitivity.pdf2022-11-07 22:57 208K 
[ ]24104_case-late-onset-pedophilia-response-sertraline.pdf2022-11-07 22:08 221K 
[ ]24109_caseness-depression-anxiety-depressed-outpatient-population.pdf2022-11-07 22:08 570K 
[ ]24112_case-obsessive-compulsive-disorder-responding-duloxetine.pdf2022-11-07 22:10 221K 
[ ]24113_case-pancreatitis-associated-aripiprazole-absence.pdf2022-11-07 22:22 209K 
[ ]24122_case-report-bupropion-induced-claustrophobia.pdf2022-11-07 22:45 221K 
[ ]24124_case-report-double-incontinence-associated-clozapine.pdf2022-11-07 22:29 186K 
[ ]24125_case-report-fluoxetine-venlafaxine-induced-hair-loss.pdf2022-11-07 22:01 21K 
[ ]24127_case-report-mesial-temporal-sclerosis-seizures-psychosis.pdf2022-11-07 22:33 102K 
[ ]24128_case-report-oculogyric-crisis-ziprasidone-minor.pdf2022-11-07 22:15 208K 
[ ]24129_case-report-olanzapine-associated-elevation-serum.pdf2022-11-07 22:26 208K 
[ ]24131_case-report-photosensitivity-amisulpride.pdf2022-11-07 22:09 186K 
[ ]24133_case-report-seizure-induced-bupropion-nasal-insufflation.pdf2022-11-07 22:34 140K 
[ ]24134_case-report-valproate-induced-hypothermia-patient.pdf2022-11-07 22:30 71K 
[ ]24136_case-report-zolpidem-induced-somnambulism.pdf2022-11-07 22:32 62K 
[ ]24138_case-rhabdomyolysis-intravenous-heroin.pdf2022-11-07 22:10 35K 
[ ]24141_cases-compulsive-buying-behavior-mentally-challenged.pdf2022-11-07 22:08 193K 
[ ]24143_case-series-women-postpartum-onset-obsessive-compulsive.pdf2022-11-07 22:49 47K 
[ ]24146_cases-somnambulism-induced-quetiapine.pdf2022-11-07 22:31 204K 
[ ]24147_case-studies-psychopharmacology-drugs-psychiatry-nd.pdf2022-11-07 22:15 18K 
[ ]24155_catatonia-presenting-feature-alcohol-withdrawal-case.pdf2022-11-07 22:28 201K 
[ ]24158_catatonia-update.pdf2022-11-07 22:13 141K 
[ ]24161_celebration.pdf2022-11-07 22:57 221K 
[ ]24162_celebrity-patients-vips-potentates.pdf2022-11-07 22:59 70K 
[ ]24168_change-framingham-risk-score-patients-schizophrenia.pdf2022-11-07 22:13 90K 
[ ]24169_changing-course-alzheimers-disease-anti-amyloid-disease.pdf2022-11-07 22:56 221K 
[ ]24170_chapter.pdf2022-11-07 22:22 76K 
[ ]24171_characteristics-course-panic-disorder-panic-disorder.pdf2022-11-07 22:10 184K 
[ ]24172_characteristics-determinants-normal-sleep.pdf2022-11-07 22:36 46K 
[ ]24173_characteristics-patients-assigned-multiple-nonthreatening.pdf2022-11-07 22:12 31K 
[ ]24174_characterization-of-adults-with-binge-eating-disorder.pdf2022-11-07 22:16 324K 
[ ]24176_chest-pain-importance-patients-panic-disorder-updated.pdf2022-11-07 22:58 246K 
[ ]24178_child-adolescent-clinical-psychopharmacology-made.pdf2022-11-07 23:01 73K 
[ ]24180_childhood-bipolar-disorder-clinical-vignette.pdf2022-11-07 22:20 93K 
[ ]24181_childhood-stimulant-treatment-risk-later-substance.pdf2022-11-07 22:09 57K 
[ ]24186_chlorpromazine-induced-skin-pigmentation-short-term.pdf2022-11-07 22:26 204K 
[ ]24189_chronic-depression-treatment-primary-care.pdf2022-11-07 22:37 45K 
[ ]24190_chronic-sleep-disruption-reexperiencing-cluster-posttraumatic.pdf2022-11-07 23:02 54K 
[ ]24192_citalopram-hair-loss.pdf2022-11-07 22:09 29K 
[ ]24195_citalopram-treatment-inappropriate-sexual-behavior.pdf2022-11-07 22:48 55K 
[ ]24196_classification-antidepressants-clinical-implications.pdf2022-11-07 22:11 60K 
[ ]24198_clinical-challenges-delivery-end-life-care.pdf2022-11-07 22:57 67K 
[ ]24199_clinical-correlates-tourettes-disorder-across-cultures.pdf2022-11-07 22:35 148K 
[ ]24201_clinical-dimensions-fatigue.pdf2022-11-07 22:12 47K 
[ ]24204_clinical-features-depression-outpatients-without-co.pdf2022-11-07 22:06 193K 
[ ]24205_clinical-functional-course-schizophrenia-among-individuals.pdf2022-11-07 22:03 164K 
[ ]24206_clinical-guidelines-establishing-remission-patients.pdf2022-11-07 22:31 61K 
[ ]24207_clinical-implications-genetic-variation-serotonin.pdf2022-11-07 23:02 316K 
[ ]24209_clinical-manual-cultural-psychiatry.pdf2022-11-07 22:13 74K 
[ ]24210_clinical-manual-psychiatric-diagnosis-treatment-biopsychosocial.pdf2022-11-07 22:29 21K 
[ ]24211_clinical-pearls-manage-cyberchondriacs.pdf2022-11-07 22:51 257K 
[ ]24212_clinical-pharmacodynamics-pharmacokinetics-antimanic.pdf2022-11-07 22:30 101K 
[ ]24215_clinical-relevance-vilazodone-treatment-patients-major.pdf2022-11-07 22:43 369K 
[ ]24217_clinicians-professional-difficulties.pdf2022-11-07 22:27 85K 
[ ]24219_close-home.pdf2022-11-07 22:43 30K 
[ ]24220_clozapine-and-lais-in-schizophrenia.pdf2022-11-07 22:10 395K 
[ ]24226_clozapine-induced-stuttering-case-series.pdf2022-11-07 22:44 209K 
[ ]24229_cme-antipsychotics-metabolic-elderly-anticholinergic.pdf2022-11-07 22:41 46K 
[ ]24230_cme-article-relation-between-body-fat-distribution.pdf2022-11-07 22:13 78K 
[ ]24232_cme-instructions-posttest.pdf2022-11-07 22:37 29K 
[ ]24233_cme-panic-chest-pain-bipolar.pdf2022-11-07 22:32 88K 
[ ]24236_cocaine-opioid-during-pregnancy-prevalence-management.pdf2022-11-07 22:33 204K 
[ ]24237_cocaine-psychiatric-symptoms.pdf2022-11-07 22:17 47K 
[ ]24238_cocktails-kitchen-sinks.pdf2022-11-07 22:06 23K 
[ ]24239_code-annoying-family-member.pdf2022-11-07 22:31 25K 
[ ]24240_cognitive-behavioral-approaches-adhd-treatment-adulthood.pdf2022-11-07 22:11 87K 
[ ]24241_cognitive-behavioral-approaches-treatment-insomnia.pdf2022-11-07 22:38 71K 
[ ]24243_cognitive-behavioral-therapy-treatment-anxiety-disorders.pdf2022-11-07 22:20 72K 
[ ]24246_cognitive-perceptual-disturbances-young-man.pdf2022-11-07 22:01 141K 
[ ]24249_cognitive-therapy-complex-medicine-psychiatry-case.pdf2022-11-07 22:23 45K 
[ ]24250_cognitive-therapy-dysthymia.pdf2022-11-07 22:15 24K 
[ ]24251_cognitive-therapy-helps-plug-leak.pdf2022-11-07 22:36 59K 
[ ]24252_cognitive-therapy-life.pdf2022-11-07 22:11 33K 
[ ]24253_cognitive-therapy-obsessive-complusive-disorder-guide.pdf2022-11-07 22:14 72K 
[ ]24254_cohort-study-adherence-antidepressants-primary-care.pdf2022-11-07 22:52 208K 
[ ]24255_collaboration-between-mental-health-professionals.pdf2022-11-07 22:23 68K 
[ ]24256_collaboration-between-mental-health-services-primary.pdf2022-11-07 22:51 40K 
[ ]24258_collaborative-care.pdf2022-11-07 22:32 24K 
[ ]24261_combination-treatment-benzodiazepines-ssris-comorbid.pdf2022-11-07 23:00 205K 
[ ]24264_commentary-challenge-managing-families-intimate-partner.pdf2022-11-07 22:05 87K 
[ ]24265_commentary-counseling-via-analogy-improving-patient.pdf2022-11-07 22:48 90K 
[ ]24266_commentary-diagnosing-managing-complicated-adhd.pdf2022-11-07 22:09 233K 
[ ]24267_commentary-healing-journey.pdf2022-11-07 22:04 29K 
[ ]24268_commentary-impact-disasters-aftermath-mental-health.pdf2022-11-07 22:10 101K 
[ ]24269_commentary-opioids-methadone-equivalents-clinicians.pdf2022-11-07 22:54 70K 
[ ]24270_commentary-psychiatric-pharmacist-integration-medical.pdf2022-11-07 22:58 199K 
[ ]24271_commentary-smoking-cessation-patients-psychiatric.pdf2022-11-07 22:20 230K 
[ ]24272_commentary-state-knowledge-chronic-depression.pdf2022-11-07 22:05 100K 
[ ]24273_commentary-treatment-algorithms-depression.pdf2022-11-07 22:56 119K 
[ ]24274_community-effects-mental-health-outcomes-subjects.pdf2022-11-07 23:02 118K 
[ ]24277_comorbid-generalized-anxiety-disorder-phobia-panic.pdf2022-11-07 22:36 18K 
[ ]24278_comorbidity-major-depression-anxiety-disorders-recognition.pdf2022-11-07 22:13 71K 
[ ]24279_comorbidity-neurobiology-pharmacotherapy-social-anxiety.pdf2022-11-07 22:17 52K 
[ ]24280_comorbidity-psychiatric-disorders-posttraumatic-stress.pdf2022-11-07 22:04 75K 
[ ]24281_comorbid-major-depression-social-phobia.pdf2022-11-07 22:30 18K 
[ ]24282_comorbid-psychiatric-disorders-predictors-pain-management.pdf2022-11-07 22:40 51K 
[ ]24283_comparative-peripheral-anticholinergic-adverse-event.pdf2022-11-07 23:01 35K 
[ ]24284_comparing-abuse-potential-methylphenidate-versus-stimulants.pdf2022-11-07 22:19 56K 
[ ]24286_comparison-depression-screening-methods-provider-referral.pdf2022-11-07 22:39 520K 
[ ]24287_comparison-risperidone-olanzapine-bipolar-schizoaffective.pdf2022-11-07 22:17 512K 
[ ]24288_compassionate-care-terminally-ill.pdf2022-11-07 22:54 49K 
[ ]24289_competency-capacity-treatment-decisions-primer-primary.pdf2022-11-07 22:06 73K 
[ ]24290_competent-christian-counseling-vol-foundations-practice.pdf2022-11-07 22:39 31K 
[ ]24294_complex-presentation-complex-partial-seizures.pdf2022-11-07 23:01 73K 
[ ]24295_complications-carbon-monoxide-poisoning-case-discussion.pdf2022-11-07 22:10 178K 
[ ]24297_compulsive-sexual-behavior-and-transcranial-magnetic-stimulation.pdf2022-11-07 22:29 87K 
[ ]24299_computer-assisted-cbt-for-depression-in-primary-care.pdf2022-11-07 22:36 458K 
[ ]24300_computerized-decision-support-system-depression-primary.pdf2022-11-07 22:16 217K 
[ ]24302_conclusion-depression-subtypes-treatment-update.pdf2022-11-07 22:43 17K 
[ ]24304_conquering-fears.pdf2022-11-07 22:43 61K 
[ ]24305_conquering-unmasked-social-phobia.pdf2022-11-07 22:53 23K 
[ ]24306_consensus-statement-depression-elderly.pdf2022-11-07 22:50 45K 
[ ]24307_consequences-insomnia-therapies.pdf2022-11-07 22:56 51K 
[ ]24309_consumer-perspective-diagnosis-treatment-chronic-major.pdf2022-11-07 22:15 45K 
[ ]24311_contemporary-issues-treatment-alzheimers-disease-tangible.pdf2022-11-07 22:22 123K 
[ ]24312_contemporary-management-comorbid-anxiety-depression.pdf2022-11-07 22:23 57K 
[ ]24316_contributions-cognitive-behavioral-approachesto-clinical.pdf2022-11-07 22:13 63K 
[ ]24317_conversion-disorder-presenting-neurologic-respiratory.pdf2022-11-07 22:06 76K 
[ ]24323_correction-monoplegia-TMS.pdf2022-11-07 22:45 102K 
[ ]24324_correction-multiple-neurologic-psychiatric-endocrine.pdf2022-11-07 22:21 131K 
[ ]24332_course-treatment-atypical-depression.pdf2022-11-07 22:24 30K 
[ ]24333_court-appointed-volunteers-abused-neglected-children.pdf2022-11-07 22:14 79K 
[ ]24344_covid-19-transmission-in-a-psychiatric-facility.pdf2022-11-07 22:54 177K 
[ ]24349_covid-ethical-issues-digital-mh-education.pdf2022-11-07 22:47 194K 
[ ]24355_cpt-coding-mental-illness-diagnoses.pdf2022-11-07 22:01 25K 
[ ]24358_crohns-disease-mimicking-bulimia-nervosa.pdf2022-11-07 22:26 64K 
[ ]24360_cross-sectional-study-co-occurring-suicidal-psychotic.pdf2022-11-07 22:31 151K 
[ ]24362_cross-sectional-study-somatic-symptoms-identification.pdf2022-11-07 22:50 265K 
[ ]24366_cryptococcal-meningitis-acute-psychotic-confusion.pdf2022-11-07 22:56 180K 
[ ]24368_cultural-currents-attention-deficit-hyperactivity-disorder.pdf2022-11-07 22:54 159K 
[ ]24369_cultural-currents-cuban-american-depression-primary.pdf2022-11-07 22:03 40K 
[ ]24371_current-psychotherapies-th-ed.pdf2022-11-07 22:44 22K 
[ ]24372_current-status-psychotherapeutic-interventions-social.pdf2022-11-07 22:13 65K 
[ ]24379_dancing-stars.pdf2022-11-07 22:47 43K 
[ ]24380_dashing-through-schedule.pdf2022-11-07 22:28 68K 
[ ]24381_daughter-dearest.pdf2022-11-07 22:05 27K 
[ ]24382_daughter-mother.pdf2022-11-07 22:58 39K 
[ ]24383_dawning-decade.pdf2022-11-07 22:14 119K 
[ ]24385_daytime-sleepiness-insomnia-correlates-depression.pdf2022-11-07 22:34 61K 
[ ]24389_decreased-milk-production-with-aripiprazole.pdf2022-11-07 22:53 89K 
[ ]24405_dementia-bereavement-adverse-life-experiences-complicating.pdf2022-11-07 22:23 49K 
[ ]24411_demoralization-medical-practice.pdf2022-11-07 22:23 114K 
[ ]24415_depressed-patients-diabetes-experience-more-side-effects.pdf2022-11-07 22:29 348K 
[ ]24416_depression-across-reproductive-life-cycle-correlations.pdf2022-11-07 22:08 25K 
[ ]24422_depression-anger-attacks.pdf2022-11-07 22:08 31K 
[ ]24424_depression-asthma-prevalence-clinical-implications.pdf2022-11-07 22:20 42K 
[ ]24425_depression-atypical-features-diagnostic-validity-prevalence.pdf2022-11-07 22:10 64K 
[ ]24426_depression-brain-dyfunction.pdf2022-11-07 22:55 45K 
[ ]24428_depression-context-strategies-guided-action.pdf2022-11-07 22:08 30K 
[ ]24429_depression-diagnosis-management-primary-care-physician.pdf2022-11-07 22:15 517K 
[ ]24435_depression-is-risk-factor-rehospitalization-medical.pdf2022-11-07 22:32 175K 
[ ]24436_depression-key-disease-series.pdf2022-11-07 22:27 20K 
[ ]24437_depression-links-ischemic-heart-disease-erectile-dysfunction.pdf2022-11-07 22:03 55K 
[ ]24439_depression-medical-illness-later-life.pdf2022-11-07 22:07 46K 
[ ]24441_depression-mood-disease-rd-ed.pdf2022-11-07 22:37 53K 
[ ]24443_depression-proper-sorrowshave-physicians-medicalized.pdf2022-11-07 22:40 102K 
[ ]24445_depression-screening-interfaced-electronic-health.pdf2022-11-07 23:01 72K 
[ ]24446_depression-sourcebook-patient.pdf2022-11-07 22:28 28K 
[ ]24447_depression-sourcebook-physician.pdf2022-11-07 22:46 28K 
[ ]24449_depression-treatment-response.pdf2022-11-07 22:22 484K 
[ ]24450_depressive-disorders-clinical-evidence-issue.pdf2022-11-07 22:54 15K 
[ ]24451_depressive-symptoms-children-women-newly-diagnosed.pdf2022-11-07 22:27 111K 
[ ]24452_depressive-symptoms-inner-city-children-asthma.pdf2022-11-07 22:41 59K 
[ ]24453_describing-atypical-antipsychotic-receptor-binding.pdf2022-11-07 22:14 211K 
[ ]24455_descriptive-study-psychiatric-consultations-community.pdf2022-11-07 22:58 31K 
[ ]24456_desire-death-setting-terminal-illness-case-discussion.pdf2022-11-07 22:02 76K 
[ ]24458_detection-insomnia-primary-care.pdf2022-11-07 22:25 66K 
[ ]24459_developing-effective-collaboration-between-primary.pdf2022-11-07 22:13 79K 
[ ]24460_development-clonazepam-psychotropic-massachusetts.pdf2022-11-07 22:46 47K 
[ ]24462_development-process-evaluation-primary-care-internet.pdf2022-11-07 22:46 230K 
[ ]24463_developments-treatment-attention-deficit-hyperactivity.pdf2022-11-07 22:34 131K 
[ ]24471_diagnosis-and-treatment-of-adult-adhd.pdf2022-11-07 22:26 443K 
[ ]24473_diagnosis-cancer-marker.pdf2022-11-07 22:12 62K 
[ ]24475_diagnosis-management-attention-deficit-hyperactivity.pdf2022-11-07 22:09 67K 
[ ]24478_diagnosis-nonorganic-monoplegia-single-pulse-transcranial.pdf2022-11-07 22:24 151K 
[ ]24485_diagnostic-dilemma.pdf2022-11-07 22:26 69K 
[ ]24486_diagnostic-issues-depression-elderly.pdf2022-11-07 22:47 46K 
[ ]24487_diagnostic-statistical-manual-mental-disorders-fourth.pdf2022-11-07 22:03 27K 
[ ]24489_dialectical-behavior-therapy-private-practice.pdf2022-11-07 22:50 71K 
[ ]24490_diary-front-line-irritable-bowelor-simply-irritable.pdf2022-11-07 22:30 19K 
[ ]24493_differential-diagnosis-fatigue-executive-dysfunction.pdf2022-11-07 22:07 48K 
[ ]24494_differential-diagnosis-of-dementia.pdf2022-11-07 23:00 723K 
[ ]24495_difficult-treat-depressions-primary-care-perspective.pdf2022-11-07 22:14 68K 
[ ]24496_disclosure-statements.pdf2022-11-07 22:24 20K 
[ ]24497_discontinuation-therapy-bupropion-sr.pdf2022-11-07 22:07 14K 
[ ]24499_discussion-using-benzodiazepines-clinical-practice.pdf2022-11-07 22:13 94K 
[ ]24502_dislocated-self.pdf2022-11-07 23:02 43K 
[ ]24503_dissociative-spectrum-disorders-primary-care-setting.pdf2022-11-07 22:25 38K 
[ ]24504_disulfiram-elderly-man-alcoholism-heart-disease-discussion.pdf2022-11-07 22:28 39K 
[ ]24506_divalproex-sodium-versus-valproic-acid-hospital-treatment.pdf2022-11-07 22:27 29K 
[ ]24507_doctors-life-sometimes-hairy.pdf2022-11-07 22:12 23K 
[ ]24508_documentation-antipsychotic-indications-newly-diagnosed.pdf2022-11-07 22:20 174K 
[ ]24509_does.pdf2022-11-07 22:05 46K 
[ ]24510_does-association-between-mitral-valve-prolapse-panic.pdf2022-11-07 22:37 276K 
[ ]24511_does-stimulant-treatment-lead-substance-disorders.pdf2022-11-07 22:35 65K 
[ ]24514_dont-cry-wolf.pdf2022-11-07 22:02 29K 
[ ]24517_dosing-atypical-antipsychotics-children-adolescents.pdf2022-11-07 22:54 39K 
[ ]24518_dosing-selective-serotonin-reuptake-inhibitors.pdf2022-11-07 22:23 22K 
[ ]24525_dread-complications-catatonia-case-discussion-review.pdf2022-11-07 22:03 98K 
[ ]24526_dream-experience-systematic-exploration.pdf2022-11-07 22:39 46K 
[ ]24527_dr-glick-replies.pdf2022-11-07 22:29 36K 
[ ]24529_dr-leo-replies.pdf2022-11-07 22:36 36K 
[ ]24530_dr-marken-replies.pdf2022-11-07 22:46 23K 
[ ]24532_dr-sharif-replies.pdf2022-11-07 22:59 24K 
[ ]24533_drug-development-process-product-primary-pediatric.pdf2022-11-07 22:13 68K 
[ ]24534_drug-induced-dermatitis-fluoxetine-case-report.pdf2022-11-07 22:48 42K 
[ ]24536_dsm-iv-tr-case-studies-clinical-guide-differential.pdf2022-11-07 23:01 24K 
[ ]24540_duloxetine-practice-based-clinical-settings-assessing.pdf2022-11-07 23:03 207K 
[ ]24541_duloxetine-treatment-emotional-physical-symptoms-depression.pdf2022-11-07 22:57 240K 
[ ]24542_duloxetine-treatment-stress-urinary-incontinence-women.pdf2022-11-07 22:56 48K 
[ ]24546_dynamic-patterns-mood-among-newly-diagnosed-patients.pdf2022-11-07 22:12 130K 
[ ]24547_dysphagia-chronic-mental-illness-hysteria-differential-diagnosis.pdf2022-11-07 22:26 24K 
[ ]24548_early-course-schizophrenia.pdf2022-11-07 22:29 73K 
[ ]24549_early-diagnosis-treatment-dementia-presenting-transient.pdf2022-11-07 22:10 42K 
[ ]24550_early-intervention-psychosis-retrospective-analysis.pdf2022-11-07 22:49 96K 
[ ]24551_early-optimized-treatment-in-mdd.pdf2022-11-07 22:49 422K 
[ ]24553_easing-burden-bipolar-disorder-urgent-situations-remission.pdf2022-11-07 22:37 351K 
[ ]24554_economic-outcomes-associated-atypical-antipsychotics.pdf2022-11-07 23:02 230K 
[ ]24555_ect-for-catatonia-with-deep-vein-thrombosis.pdf2022-11-07 22:38 165K 
[ ]24556_ect-in-obsessive-compulsiverelated-disorders.pdf2022-11-07 22:53 408K 
[ ]24559_edge-life-i-assessment-reaction-management-terminally.pdf2022-11-07 22:02 64K 
[ ]24560_edge-life-ii-house-officer-struggles-recorded-intensive.pdf2022-11-07 23:01 69K 
[ ]24561_editor-chief.pdf2022-11-07 22:07 49K 
[ ]24562_editorial-anticholinergic-side-effects-perspective.pdf2022-11-07 22:18 13K 
[ ]24563_editorial-depression-weve-long.pdf2022-11-07 22:58 47K 
[ ]24564_editorial-doctor-im-putting-grail.pdf2022-11-07 23:00 44K 
[ ]24565_editorial-era-collaboration-primary-care-psychiatry.pdf2022-11-07 22:19 121K 
[ ]24566_editorial-mental-health-disorders-descriptive-criteria.pdf2022-11-07 22:58 74K 
[ ]24567_editorial-primary-care-perspective.pdf2022-11-07 22:11 14K 
[ ]24568_editorial-rethinking-medical-education-mood-disorders.pdf2022-11-07 22:33 20K 
[ ]24569_editorial-somatic-symptoms-depression-double-hurt.pdf2022-11-07 22:10 64K 
[ ]24570_editorial-welcome-web-based-issue.pdf2022-11-07 23:03 50K 
[ ]24571_editorial-welcome-why-journal.pdf2022-11-07 22:53 16K 
[ ]24575_effect-brochures-audiotape-efficacy-tolerability-venlafaxine.pdf2022-11-07 22:10 44K 
[ ]24576_effect-bupropion-sr-quality-life-elderly-depressed.pdf2022-11-07 22:22 54K 
[ ]24577_effect-citalopram-blood-desipramine-levels.pdf2022-11-07 22:15 25K 
[ ]24579_effect-eszopiclone-patients-insomnia-coexisting-rheumatoid.pdf2022-11-07 22:56 387K 
[ ]24581_effectiveness-antidepressants-comparative-remission.pdf2022-11-07 22:54 63K 
[ ]24582_effectiveness-olanzapine-systemic-lupus-erythematosus.pdf2022-11-07 23:02 79K 
[ ]24583_effectiveness-outcomes-attention-deficit-hyperactivity.pdf2022-11-07 22:27 83K 
[ ]24585_effective-recognition-treatment-generalized-anxiety.pdf2022-11-07 22:21 76K 
[ ]24588_effective-treatment-fibromyalgia-comorbid-premenstrual.pdf2022-11-07 22:41 180K 
[ ]24589_effect-ondansetron-ht-receptor-antagonist-fatigue.pdf2022-11-07 22:22 71K 
[ ]24593_effects-antidepressant-duloxetine-body-weight-analyses.pdf2022-11-07 22:47 130K 
[ ]24594_effects-antidepressants-sexual-functioning-depressed.pdf2022-11-07 22:45 100K 
[ ]24595_effects-benzodiazepines-cognition.pdf2022-11-07 22:58 108K 
[ ]24606_efficacy-duloxetine-patients-fibromyalgia-pooled-analysis.pdf2022-11-07 22:17 251K 
[ ]24607_efficacy-duloxetine-treatment-generalized-anxiety.pdf2022-11-07 22:43 196K 
[ ]24608_efficacy-of-cariprazine-in-bipolar-disorder.pdf2022-11-07 22:43 295K 
[ ]24610_efficacy-safety-antidepressant-augmentation-lamotrigine.pdf2022-11-07 22:58 125K 
[ ]24612_efficacy-safety-modafinil-film-coated-tablets-children.pdf2022-11-07 22:43 121K 
[ ]24621_electronic-medical-record-facilitate-screening-depression.pdf2022-11-07 22:35 525K 
[ ]24622_electronic-medical-records-depression-screening-primary.pdf2022-11-07 22:51 19K 
[ ]24624_else-is-done-challenge-improving-antemortem-care.pdf2022-11-07 22:33 65K 
[ ]24628_emerging-therapeutic-strategies-treating-alzheimers.pdf2022-11-07 22:01 118K 
[ ]24630_end-life-decisions-psychosocial-perspective.pdf2022-11-07 22:24 18K 
[ ]24638_enhancement-treatment-response-depression-primary.pdf2022-11-07 22:46 83K 
[ ]24640_enhancing-pharmacologic-effects-treatment-depression.pdf2022-11-07 23:02 95K 
[ ]24641_epidemiology-daytime-sleepiness-definitions-symptomatology.pdf2022-11-07 22:36 57K 
[ ]24644_era-begins-full-text-indexing-pubmed-central.pdf2022-11-07 22:27 39K 
[ ]24649_escitalopram-obsessive-compulsive-disorder-case-series.pdf2022-11-07 22:03 193K 
[ ]24650_escitalopram-ssri-treatment-depression-primary-care.pdf2022-11-07 22:48 65K 
[ ]24652_essential-psychopharmocology-neuroscientific-basics.pdf2022-11-07 22:44 16K 
[ ]24653_establishing-referral-route.pdf2022-11-07 22:30 76K 
[ ]24655_establishment-remission-criteria-anxiety-disorders.pdf2022-11-07 22:51 57K 
[ ]24657_ethics-psychotherapy-counseling-practical-guide-rd.pdf2022-11-07 22:32 74K 
[ ]24660_evaluating-impact-educational-program-practice-patterns.pdf2022-11-07 22:59 73K 
[ ]24661_evaluating-treating-families-mcmaster-approach.pdf2022-11-07 22:45 47K 
[ ]24665_evaluation-mood-disorder-patients-primary-care-practice.pdf2022-11-07 22:08 177K 
[ ]24667_evaluation-treatment-poor-sleep.pdf2022-11-07 22:52 142K 
[ ]24668_evidence-using-atypical-antipsychotics-mood-anxiety.pdf2022-11-07 22:37 75K 
[ ]24669_evidence-using-atypical-antipsychotics-psychosis.pdf2022-11-07 22:20 56K 
[ ]24670_evolution-remission-standard-treatment-depression.pdf2022-11-07 22:38 52K 
[ ]24671_exacerbation-obsessions-modafinil-patients-medication.pdf2022-11-07 22:30 262K 
[ ]24672_examining-efficacy-adjunctive-aripiprazole-major-depressive.pdf2022-11-07 22:16 232K 
[ ]24673_executive-functions-attention-deficit-hyperactivity.pdf2022-11-07 22:05 87K 
[ ]24674_exercise-mental-health.pdf2022-11-07 22:59 54K 
[ ]24675_exercise-mood-anxiety-disorders.pdf2022-11-07 22:33 221K 
[ ]24676_exercise-yoga-tai-chi-depression.pdf2022-11-07 22:53 689K 
[ ]24678_expanding-boundries-health-social-science-case-studies.pdf2022-11-07 22:01 63K 
[ ]24680_exploring-middle-eastern-trauma-informed-care.pdf2022-11-07 22:54 210K 
[ ]24681_exploring-relationship-between-depression-erectile.pdf2022-11-07 22:09 66K 
[ ]24683_extent-impact-insomniaas-public-health-problem.pdf2022-11-07 22:47 60K 
[ ]24688_faces-depression.pdf2022-11-07 22:27 74K 
[ ]24691_factors-associated-positive-screens-mood-disorder.pdf2022-11-07 23:01 79K 
[ ]24692_factors-influencing-adherence-children-adolescents.pdf2022-11-07 22:18 262K 
[ ]24693_factors-related-to-depression-severity-in-primary-care.pdf2022-11-07 22:20 205K 
[ ]24694_factors-that-impact-treatment-decisions.pdf2022-11-07 22:56 202K 
[ ]24698_family-family-physician.pdf2022-11-07 22:55 20K 
[ ]24699_family-functioning-suicidal-inpatients-intimate-partner.pdf2022-11-07 22:14 147K 
[ ]24700_family-practice-iron-hypomania-depression.pdf2022-11-07 22:36 47K 
[ ]24701_family-practice-panic-anxiety.pdf2022-11-07 22:41 16K 
[ ]24702_family-support-self-rated-health-psychological-distress.pdf2022-11-07 22:03 62K 
[ ]24705_fear-medical-illness-differential-diagnosis-workup.pdf2022-11-07 22:30 173K 
[ ]24706_fear-presence-others.pdf2022-11-07 22:29 17K 
[ ]24707_feasibility-using-spanish-phq-screen-depression-primary.pdf2022-11-07 22:22 54K 
[ ]24709_feeling-losing-weight-chicken-egg.pdf2022-11-07 22:28 32K 
[ ]24710_fifteen-minute-hour-applied-psychotherapy-primary.pdf2022-11-07 23:02 27K 
[ ]24712_fitness-drive-psychiatric-patients.pdf2022-11-07 22:54 198K 
[ ]24716_five-years-old-growing.pdf2022-11-07 22:57 66K 
[ ]24721_fly-manic-skies.pdf2022-11-07 22:27 58K 
[ ]24728_fun-being-picked.pdf2022-11-07 22:11 67K 
[ ]24729_functional-anatomy-neurochemistry-pharmacology-anxiety.pdf2022-11-07 22:19 60K 
[ ]24731_fundamentals-attention-deficit-hyperactivity-disorder.pdf2022-11-07 23:00 103K 
[ ]24732_future-directions-management-insomnia.pdf2022-11-07 22:28 66K 
[ ]24733_gaba-benzodiazepine-receptor-complexstructure-function.pdf2022-11-07 22:08 135K 
[ ]24734_gabapentin-aggression-conduct-disorder.pdf2022-11-07 22:47 29K 
[ ]24735_gabapentin-and-withdrawal-in-alcohol-use-disorder.pdf2022-11-07 22:49 305K 
[ ]24737_gabapentin-tiagabine-social-anxiety-randomized-double.pdf2022-11-07 23:03 131K 
[ ]24738_gabapentin-treatment-posttraumatic-stress-disorder.pdf2022-11-07 22:33 18K 
[ ]24745_gender-specific-considerations-treatment-mood-disorders.pdf2022-11-07 22:39 101K 
[ ]24746_generalized-anxiety-disorder-medical-illness.pdf2022-11-07 22:43 198K 
[ ]24747_generalized-anxiety-disorder-psychiatric-comorbidities.pdf2022-11-07 22:13 194K 
[ ]24748_generation-antipsychotic-drugs-qtc-interval-prolongation.pdf2022-11-07 22:18 93K 
[ ]24749_genetic-clinical-factors-affecting-plasma-clozapine.pdf2022-11-07 22:24 32K 
[ ]24750_geriatric-medicine-old-age-psychiatrists.pdf2022-11-07 22:16 74K 
[ ]24753_gift-therapy-open-letter-generation-therapists-patients.pdf2022-11-07 22:24 49K 
[ ]24754_ginkgo-biloba-associated-paranoid-reaction.pdf2022-11-07 22:01 20K 
[ ]24755_ginkgo-cocktail-anyone.pdf2022-11-07 23:01 18K 
[ ]24762_great-emancipator.pdf2022-11-07 22:21 37K 
[ ]24763_green-tea-extract-ziprasidone-and-psychosis.pdf2022-11-07 22:04 102K 
[ ]24766_guest-editors-introduction-diagnosis-treatment-insomniaat.pdf2022-11-07 22:57 59K 
[ ]24772_handbook-anger-management-individual-couple-family.pdf2022-11-07 22:44 46K 
[ ]24773_handbook-chronic-fatigue-syndrome.pdf2022-11-07 22:26 480K 
[ ]24774_handbook-clinical-psychopharmacology-therapists-th.pdf2022-11-07 22:10 44K 
[ ]24775_handbook-medicine-psychiatry.pdf2022-11-07 22:44 72K 
[ ]24776_hand-down-blues-stop-depression-spreading-families.pdf2022-11-07 22:32 14K 
[ ]24777_hands.pdf2022-11-07 22:14 21K 
[ ]24778_hearing-hallucinations-old-child-psychotic-disorders.pdf2022-11-07 22:58 209K 
[ ]24780_helping-depressed-adolescents-menu-cognitive-behavioral.pdf2022-11-07 22:14 126K 
[ ]24783_here-doc.pdf2022-11-07 22:37 16K 
[ ]24785_hidden-agendas-inexorable-forces.pdf2022-11-07 22:39 17K 
[ ]24787_high-dose-olanzapine-orally-disintegrating-tablets.pdf2022-11-07 22:16 61K 
[ ]24789_high-potency-benzodiazepines-recent-clinical-results.pdf2022-11-07 22:40 65K 
[ ]24791_historical-dictionary-psychiatry.pdf2022-11-07 22:21 481K 
[ ]24793_history-antidepressants-primary-care.pdf2022-11-07 22:28 58K 
[ ]24795_history-concept-atypical-depression.pdf2022-11-07 22:32 146K 
[ ]24796_history-depressive-anxiety-disorders-paroxetine-response.pdf2022-11-07 22:44 238K 
[ ]24797_history-evolution-diagnosis-premenstrual-dysphoric.pdf2022-11-07 22:10 43K 
[ ]24800_hits-near-misses.pdf2022-11-07 22:15 16K 
[ ]24802_home-improvement-beginners.pdf2022-11-07 22:23 16K 
[ ]24808_house-calls-recollection-family-physician.pdf2022-11-07 22:33 14K 
[ ]24811_human-circadian-system-normal-disordered-sleep.pdf2022-11-07 22:38 169K 
[ ]24812_human-immunodeficiency-virus-depression-primary-care.pdf2022-11-07 22:35 116K 
[ ]24815_hyperosmolar-hyperglycemic-state-patient-taking-risperidone.pdf2022-11-07 22:28 208K 
[ ]24820_hypervigilant.pdf2022-11-07 22:48 29K 
[ ]24821_hypochondriacal-concerns-management-through-understanding.pdf2022-11-07 22:36 36K 
[ ]24826_hypothalamic-pituitary-adrenal-axis-major-depressive.pdf2022-11-07 22:44 37K 
[ ]24828_hypothyroidism-patients-asthma-major-depressive-disorder.pdf2022-11-07 22:35 193K 
[ ]24829_hypothyroidism-presenting-psychosis-myxedema-madness.pdf2022-11-07 22:12 55K 
[ ]24832_i-cant-hear-youthere-is-banana-ear.pdf2022-11-07 22:17 68K 
[ ]24834_identifying-depressed-older-adults-primary-care-secondary.pdf2022-11-07 22:51 173K 
[ ]24835_identifying-depressed-patients-high-risk-comorbid.pdf2022-11-07 22:21 56K 
[ ]24836_identifying-managing-depression-medical-patient.pdf2022-11-07 22:43 360K 
[ ]24837_identifying-treating-panic-disorder-primary-care.pdf2022-11-07 22:25 54K 
[ ]24840_i-hear-voicessometimes-mom.pdf2022-11-07 22:08 17K 
[ ]24842_immediate-month-impact-medical-educational-course.pdf2022-11-07 22:18 148K 
[ ]24844_impact-antipsychotics-geriatric-patients-efficacy.pdf2022-11-07 22:49 53K 
[ ]24846_impact-bipolar-disorder-results-screening-study.pdf2022-11-07 22:51 146K 
[ ]24848_impact-creation-implementation-clinical-management.pdf2022-11-07 22:17 1.0M 
[ ]24855_implementation-science-for-clinicians.pdf2022-11-07 22:13 234K 
[ ]24856_implementing-early-intervention-psychosis-guide-establishing.pdf2022-11-07 22:07 24K 
[ ]24857_implications-pain-generalized-anxiety-disorder-efficacy.pdf2022-11-07 22:53 234K 
[ ]24860_importance-residual-effects-choosing-hypnotic-unique.pdf2022-11-07 22:36 52K 
[ ]24861_importance-somatic-symptoms-depression-primary-care.pdf2022-11-07 22:09 210K 
[ ]24862_improved-health-related-quality-life-reduced-productivity.pdf2022-11-07 22:56 43K 
[ ]24863_improved-online-primary-care-companion.pdf2022-11-07 22:29 49K 
[ ]24864_improvement-depressive-symptoms-felbamate-case-report.pdf2022-11-07 22:49 208K 
[ ]24866_improvement-neuropsychiatric-symptoms-multiple-sclerosis.pdf2022-11-07 22:02 262K 
[ ]24867_improving-adherence-sertraline-treatment-effectiveness.pdf2022-11-07 22:17 525K 
[ ]24870_improving-outcomes-primary-care-patients-depression.pdf2022-11-07 22:40 928K 
[ ]24871_improving-patients-beliefs-antidepressants-primary.pdf2022-11-07 22:19 155K 
[ ]24874_im-psychiatrist-i-stayed-budget-hotels-before.pdf2022-11-07 23:01 45K 
[ ]24875_im-psychiatrist-nor-i-play-tv.pdf2022-11-07 22:42 57K 
[ ]24878_incidence-sexual-dysfunction-associated-antidepressant.pdf2022-11-07 22:24 101K 
[ ]24883_increased-sexual-aggression-following-ziprasidone.pdf2022-11-07 22:56 45K 
[ ]24884_incurring-greater-health-care-costs-risk-stratification.pdf2022-11-07 22:25 111K 
[ ]24885_indications-antidepressants.pdf2022-11-07 22:14 80K 
[ ]24886_influence-pharmacokinetic-profiles-safety-efficacy.pdf2022-11-07 22:44 77K 
[ ]24888_initial-rate-improvement-relation-remission-major.pdf2022-11-07 22:16 93K 
[ ]24894_insomnia-in-elderly-primary-care-patients.pdf2022-11-07 22:44 427K 
[ ]24895_insomnia-primary-care-perspective.pdf2022-11-07 22:38 111K 
[ ]24896_insomnia-principles-management.pdf2022-11-07 22:53 24K 
[ ]24897_insomnia-process-model-sleep-regulationetiopathogenic.pdf2022-11-07 22:13 63K 
[ ]24902_insulin-overdose-among-patients-diabetes-readily-available.pdf2022-11-07 22:02 150K 
[ ]24906_integrative-treatment-borderline-personality-disorder.pdf2022-11-07 22:25 67K 
[ ]24910_interface-between-physical-psychological-symptoms.pdf2022-11-07 22:58 76K 
[ ]24911_interference-wound-healing-borderline-patients-psychiatric.pdf2022-11-07 22:41 48K 
[ ]24912_interferon-treatment-hepatitis-c-patients-psychiatric.pdf2022-11-07 22:45 62K 
[ ]24915_interventions-weight-gain-adults-treated-novel-antipsychotics.pdf2022-11-07 22:58 33K 
[ ]24920_introduction-advances-emerging-treatments-social-phobia.pdf2022-11-07 22:22 29K 
[ ]24921_introduction-chronic-major-depression-review-update.pdf2022-11-07 22:23 30K 
[ ]24922_introduction-defining-remission-patients-treated-antidepressants.pdf2022-11-07 22:19 42K 
[ ]24923_introduction-depression-subtypes-treatment-update.pdf2022-11-07 22:25 12K 
[ ]24924_introduction-developments-treating-sleep-disorders.pdf2022-11-07 22:50 33K 
[ ]24925_introduction-developments-treatment-attention-deficit-hyperactivity.pdf2022-11-07 22:18 70K 
[ ]24926_introduction-directions-treatment-atypical-depression.pdf2022-11-07 22:51 101K 
[ ]24927_introduction-emerging-evidence-treatment-depression.pdf2022-11-07 22:28 43K 
[ ]24928_introduction-erectile-dysfunction-comorbid-depression.pdf2022-11-07 22:47 34K 
[ ]24930_introduction-narcolepsy-excessive-daytime-sleepiness.pdf2022-11-07 22:45 65K 
[ ]24931_introduction-optimizing-wakefulness-patients-fatigue.pdf2022-11-07 22:20 30K 
[ ]24932_introduction-remission-anxiety-related-disorders.pdf2022-11-07 22:17 26K 
[ ]24933_introduction-sexual-dysfunction-associated-depression.pdf2022-11-07 22:04 25K 
[ ]24934_introduction-strategies-improving-treatment-depression.pdf2022-11-07 22:16 35K 
[ ]24935_introduction-strategies-treatment-posttraumatic-stress.pdf2022-11-07 22:09 24K 
[ ]24936_introduction-treating-depression-anxiety-remission.pdf2022-11-07 22:38 26K 
[ ]24937_introduction-treating-sexual-dysfunction-psychiatrys.pdf2022-11-07 22:23 32K 
[ ]24938_introduction-trends-treating-premenstrual-dysphoric.pdf2022-11-07 22:58 23K 
[ ]24939_introduction-using-atypical-antipsychotics-primary.pdf2022-11-07 22:18 26K 
[ ]24940_invariant-varying-predictors-depression-symptoms.pdf2022-11-07 22:26 247K 
[ ]24942_involvement-family-members-treatment-depressed-individuals.pdf2022-11-07 23:01 29K 
[ ]24943_i-oughta-write-letter.pdf2022-11-07 22:27 46K 
[ ]24945_irritable-ill-show-irritable.pdf2022-11-07 22:36 55K 
[ ]24946_is.pdf2022-11-07 22:01 46K 
[ ]24947_is-alternative-seclusion-mechanical-restraint.pdf2022-11-07 22:19 221K 
[ ]24949_is-depression-appropriate-response-having-cancer-discussion.pdf2022-11-07 22:20 144K 
[ ]24950_is-heal-cold-blue-steel.pdf2022-11-07 22:10 16K 
[ ]24953_issues-clinical-benzodiazepines-potency-withdrawal.pdf2022-11-07 22:17 68K 
[ ]24957_item-binge-eating-disorder-screener.pdf2022-11-07 22:39 590K 
[ ]24960_ive-been-reading.pdf2022-11-07 22:26 46K 
[ ]24961_jaws-black-dogs-memoir-depression.pdf2022-11-07 22:10 18K 
[ ]24963_job-shove-better-antidepressant.pdf2022-11-07 22:23 54K 
[ ]24964_jogging.pdf2022-11-07 22:16 24K 
[ ]24966_keeping-cancer-perspective.pdf2022-11-07 22:51 68K 
[ ]24969_knowledge-recommended-treatment-management-major-depressive.pdf2022-11-07 22:33 54K 
[ ]24975_lamotrigine-induced-neutropenia-woman-schizoaffective.pdf2022-11-07 22:47 193K 
[ ]24978_late-life-depression-prevalence-presentation-course.pdf2022-11-07 22:48 35K 
[ ]24982_leap.pdf2022-11-07 23:01 71K 
[ ]24983_learning-cognitive-behavior-thearapy-illustrative.pdf2022-11-07 22:49 73K 
[ ]24984_lets-cut-chase-i-need-pill.pdf2022-11-07 22:09 41K 
[ ]24986_level-agitation-psychiatric-patients-presenting-emergency.pdf2022-11-07 22:29 172K 
[ ]24989_levomilnacipran-extended-release-treatment-patients.pdf2022-11-07 22:52 1.5M 
[ ]24991_liability-associated-prescribing-medications.pdf2022-11-07 22:09 77K 
[ ]24993_lies-doctor-patient-relationship.pdf2022-11-07 22:34 174K 
[ ]24994_line-pharmacotherapy-approaches-generalized-anxiety.pdf2022-11-07 22:33 258K 
[ ]24995_linezolid-serotonin-syndrome.pdf2022-11-07 22:04 126K 
[ ]24996_link-between-depression-physical-symptoms.pdf2022-11-07 22:50 72K 
[ ]24999_lithium-augmentation-for-clozapine-rechallenge-discontinuation-might-be-risky.pdf2022-11-07 22:31 805K 
[ ]25002_lithium-induced-rash.pdf2022-11-07 22:02 79K 
[ ]25006_lithium-psoriasis-primary-care-family-physicians-should.pdf2022-11-07 22:52 147K 
[ ]25008_lithium-treatment-in-a-depressed-child-at-risk-for-bipolar-disorder.pdf2022-11-07 22:12 111K 
[ ]25010_little-bit-perspective.pdf2022-11-07 22:28 16K 
[ ]25011_little-fishies.pdf2022-11-07 22:09 16K 
[ ]25015_lockdown-and-3-waves-of-suicide-in-india-during-the-covid-19-pandemic.pdf2022-11-07 22:35 91K 
[ ]25018_long-distance-information-memphis-tennessee.pdf2022-11-07 22:06 59K 
[ ]25019_long-haul.pdf2022-11-07 22:21 63K 
[ ]25020_long-term-cholinesterase-inhibitor-therapy-alzheimers.pdf2022-11-07 22:11 73K 
[ ]25021_long-term-management-chronic-depression.pdf2022-11-07 22:37 52K 
[ ]25022_long-term-management-panic-disorder.pdf2022-11-07 22:33 57K 
[ ]25024_long-term-safety-tolerability-rivastigmine-patients.pdf2022-11-07 22:44 158K 
[ ]25030_love-must-tough-proven-hope-families-crisis.pdf2022-11-07 22:49 14K 
[ ]25031_low-cholesterol-delinquency-suicidality.pdf2022-11-07 22:19 151K 
[ ]25036_maintaining-professional-distance.pdf2022-11-07 22:38 69K 
[ ]25037_major-depressive-disorder-hepatitis-c-open-label-trial.pdf2022-11-07 22:01 149K 
[ ]25038_major-depressive-disorder-obsessive-compulsive-disorder.pdf2022-11-07 22:07 198K 
[ ]25039_major-life-activity-health-outcomes-associated-attention.pdf2022-11-07 22:39 64K 
[ ]25040_making-decision.pdf2022-11-07 22:52 27K 
[ ]25041_making-difference.pdf2022-11-07 22:25 25K 
[ ]25043_management-adhd-adults.pdf2022-11-07 22:56 78K 
[ ]25045_management-bipolar-disorder-primary-care-versus-psychiatric.pdf2022-11-07 22:43 36K 
[ ]25046_management-considerations-late-life-depression.pdf2022-11-07 22:14 32K 
[ ]25051_management-weight-gain-patients-schizophrenia.pdf2022-11-07 22:27 82K 
[ ]25052_managing-adhd-children-adolescents-adults-comorbid.pdf2022-11-07 22:04 236K 
[ ]25053_managing-anticholinergic-side-effects.pdf2022-11-07 22:50 49K 
[ ]25054_managing-behavioral-dyscontrol-related-dementia.pdf2022-11-07 22:22 83K 
[ ]25055_managing-bipolar-disorder-urgent-situations-maintenance.pdf2022-11-07 22:20 334K 
[ ]25056_managing-dependence-withdrawal-newer-hypnotic-medications.pdf2022-11-07 22:33 512K 
[ ]25058_managing-depression-primary-care-achieving-remission.pdf2022-11-07 22:34 253K 
[ ]25059_managing-suicide-attempts-guidelines-primary-care.pdf2022-11-07 22:18 67K 
[ ]25060_managing-treatment-resistant-major-depression.pdf2022-11-07 22:39 72K 
[ ]25068_manic-episode-triggered-SAMe.pdf2022-11-07 23:01 40K 
[ ]25069_manic-phase-precipitated-manic-treatment.pdf2022-11-07 22:17 31K 
[ ]25070_manic-phase-precipitated-manic-treatment-wolff-replies.pdf2022-11-07 22:14 29K 
[ ]25072_many-uses-bupropion-sustained-release-sr.pdf2022-11-07 22:07 83K 
[ ]25073_marriage-between-pharmacotherapy-psychotherapy.pdf2022-11-07 22:31 20K 
[ ]25074_massachusetts-general-hospital-guide-primary-care.pdf2022-11-07 22:43 18K 
[ ]25075_massive-epistaxis-subconjunctival-hemorrhage-due-combination.pdf2022-11-07 22:25 221K 
[ ]25076_mastering-panic-anxiety.pdf2022-11-07 22:17 33K 
[ ]25077_maudsley-handbook-practical-psychiatry-th-ed.pdf2022-11-07 22:22 18K 
[ ]25078_md-psychotherapist.pdf2022-11-07 22:11 69K 
[ ]25079_measures-assess-noncognitive-symptoms-dementia-primary.pdf2022-11-07 22:59 54K 
[ ]25080_mechanism-action-agents-used-attention-deficit-hyperactivity.pdf2022-11-07 22:19 83K 
[ ]25081_mechanisms-action-treatment-anxiety.pdf2022-11-07 22:46 55K 
[ ]25088_medical-management-obesity-associated-mental-disorders.pdf2022-11-07 22:38 110K 
[ ]25091_medication-service-utilization-medical-costs-associated.pdf2022-11-07 22:06 176K 
[ ]25093_medications-panic-disorder-generalized-anxiety-disorder.pdf2022-11-07 22:46 114K 
[ ]25094_medications-treatment-sleep-disorders-overview.pdf2022-11-07 22:58 57K 
[ ]25095_medication-utilization-in-binge-eating-disorder.pdf2022-11-07 23:02 228K 
[ ]25097_medicine-mind-meaning-psychiatrists-guide-treating.pdf2022-11-07 22:57 46K 
[ ]25098_memory-and-ect.pdf2022-11-07 22:46 263K 
[ ]25104_mental-health-screening-primary-care-comparison-brief.pdf2022-11-07 22:38 32K 
[ ]25105_mental-health-treatment-of-older-hiv-veterans.pdf2022-11-07 22:48 202K 
[ ]25107_metabolic-adverse-events-patients-mental-illness-treated.pdf2022-11-07 22:56 274K 
[ ]25108_metabolic-changes-associated-antipsychotic.pdf2022-11-07 22:25 64K 
[ ]25111_metabolic-issues-atypical-antipsychotics-primary-care.pdf2022-11-07 22:50 253K 
[ ]25112_metabolic-side-effects-antipsychotics-focus-hyperglycemia.pdf2022-11-07 22:33 82K 
[ ]25113_metabolic-side-effects-risperidone-children-adolescents.pdf2022-11-07 22:03 209K 
[ ]25117_metabolic-syndrome-patients-severe-mental-illnesses.pdf2022-11-07 22:13 61K 
[ ]25119_methadone-associated-qtc-prolongation-case-report.pdf2022-11-07 22:33 200K 
[ ]25120_methadone-overdose-auto-activation-deficit-catatonia.pdf2022-11-07 22:01 136K 
[ ]25121_methylphenidate-abuse-psychiatric-side-effects.pdf2022-11-07 22:37 40K 
[ ]25123_methylphenidate-induced-akathisia-patient-multiple.pdf2022-11-07 22:57 79K 
[ ]25124_methylphenidate-induced-dyskinesia.pdf2022-11-07 22:43 39K 
[ ]25125_methylphenidate-induced-neuroleptic-malignant-syndrome.pdf2022-11-07 22:13 61K 
[ ]25129_mgh-guide-psychiatry-primary-care.pdf2022-11-07 22:42 18K 
[ ]25130_microbial-deviation-in-pediatric-orthostatic-intolerance.pdf2022-11-07 22:48 321K 
[ ]25132_midlife-crisis.pdf2022-11-07 22:32 42K 
[ ]25133_might-psychobiology-posttraumatic-stress-disorder.pdf2022-11-07 22:33 64K 
[ ]25134_migraine-headache-affectively-ill-latino-adults-mexican.pdf2022-11-07 22:21 151K 
[ ]25139_miles.pdf2022-11-07 22:47 39K 
[ ]25143_mirtazapine-associated-withdrawal-symptoms.pdf2022-11-07 22:32 23K 
[ ]25145_mirtazapine-induced-nightmares.pdf2022-11-07 22:30 64K 
[ ]25147_mirtazapine-therapy-dysgeusia-elderly-patient.pdf2022-11-07 22:06 60K 
[ ]25150_modafinil-excessive-sleepiness-associated-chronic.pdf2022-11-07 23:00 189K 
[ ]25152_modafinil-treatment-excessive-daytime-sedation-fatigue.pdf2022-11-07 22:09 32K 
[ ]25153_moderating-severe-personality-disorders-personalized.pdf2022-11-07 22:03 89K 
[ ]25156_monocytosis-subsequent-ziprasidone-treatment-possible.pdf2022-11-07 22:48 193K 
[ ]25158_mood-cognitive-changes-during-systemic-corticosteroid.pdf2022-11-07 22:33 34K 
[ ]25159_mood-disorder-questionnaire-primary-care-ready-prime.pdf2022-11-07 22:06 53K 
[ ]25160_mood-disorder-questionnaire-simple-patient-rated-screening.pdf2022-11-07 22:26 79K 
[ ]25161_mood-disorders-family-practice-beyond-unipolarity.pdf2022-11-07 22:13 92K 
[ ]25162_mood-follows-market.pdf2022-11-07 22:47 68K 
[ ]25163_mood-stabilizing-effect-twice-weekly-administration.pdf2022-11-07 22:22 179K 
[ ]25165_morbidity-associated-sleep-disorders-primary-care.pdf2022-11-07 22:02 195K 
[ ]25167_mortality-return-drug-abusers-therapeutic-community.pdf2022-11-07 22:41 59K 
[ ]25169_mothers-january.pdf2022-11-07 22:06 46K 
[ ]25172_movement-disorders-associated-atypical-antipsychotic.pdf2022-11-07 22:59 84K 
[ ]25174_movies-mental-illness-using-films-understand-psychotherapy.pdf2022-11-07 22:51 49K 
[ ]25180_multiple-neurologic-psychiatric-endocrine-complaints.pdf2022-11-07 22:53 277K 
[ ]25182_munchausen-syndrome-proxy-clinical-vignette.pdf2022-11-07 22:32 30K 
[ ]25183_murug-waali-gini-expressions-distress-refugees-somalia.pdf2022-11-07 22:32 58K 
[ ]25191_naltrexonebupropion-combination-therapy-overweight.pdf2022-11-07 22:56 421K 
[ ]25194_narcolepsy-excessive-daytime-sleepiness-diagnostic.pdf2022-11-07 22:15 122K 
[ ]25195_narcolepsy-pathophysiology-pharmacology.pdf2022-11-07 22:11 239K 
[ ]25197_narcolepsy-treatment-issues.pdf2022-11-07 23:00 130K 
[ ]25198_national-patterns-depression-treatment-primary-care.pdf2022-11-07 23:02 40K 
[ ]25199_national-patterns-medication-treatment-depression.pdf2022-11-07 22:02 38K 
[ ]25200_naturalistic-study-effectiveness-pharmacogenetic-testing.pdf2022-11-07 22:35 1.3M 
[ ]25201_navigating-patients-caregivers-through-course-alzheimers.pdf2022-11-07 22:54 113K 
[ ]25202_needs-dying-guide-bringing-hope-comfort-love-lifes.pdf2022-11-07 22:41 46K 
[ ]25204_neurobiology-generalized-anxiety-disorder.pdf2022-11-07 22:55 196K 
[ ]25209_neuroleptic-malignant-syndrome-primary-care-perspective.pdf2022-11-07 22:28 43K 
[ ]25211_neuropathologic-changes-alzheimers-disease-potential.pdf2022-11-07 22:29 106K 
[ ]25213_neuropsychiatric-complications-of-immunosuppressants.pdf2022-11-07 22:28 107K 
[ ]25214_neuropsychiatric-manifestations-multiple-sclerosis.pdf2022-11-07 22:11 200K 
[ ]25216_neuropsychiatric-phenomena-associated-movement-disorders.pdf2022-11-07 22:01 58K 
[ ]25217_neuropsychiatry-family-practice-bipolar-ADHD-thyroid.pdf2022-11-07 22:11 17K 
[ ]25218_neuropsychiatry-family-practice-bipolar-headache-postpartum-depression.pdf2022-11-07 22:20 16K 
[ ]25220_neurotransmitters-sleep.pdf2022-11-07 23:00 50K 
[ ]25222_newer-antidepressants-primary-care-setting.pdf2022-11-07 23:00 63K 
[ ]25223_nice-trip-next-fall.pdf2022-11-07 22:33 23K 
[ ]25227_non-antidepressant-treatment-premenstrual-syndrome.pdf2022-11-07 22:35 65K 
[ ]25231_novel-antipsychotics-treatment-behavioral-disturbances.pdf2022-11-07 22:42 50K 
[ ]25232_novel-treatments-attention-deficit-hyperactivity-disorder.pdf2022-11-07 22:58 73K 
[ ]25236_obsessive-compulsive-disorder-body-dysmorphic-disorder.pdf2022-11-07 22:50 204K 
[ ]25240_ocd-symptoms-in-papillary-thyroid-carcinoma.pdf2022-11-07 22:49 152K 
[ ]25244_olanzapine-treatment-bipolar-disorder.pdf2022-11-07 22:06 37K 
[ ]25251_onset-obstructive-sleep-apnea-initiation-psychotropic.pdf2022-11-07 22:20 193K 
[ ]25252_onset-paranoid-delusions-addition-topiramate-seizure.pdf2022-11-07 22:50 180K 
[ ]25253_onset-transient-hallucinations-possibly-due-eszopiclone.pdf2022-11-07 22:50 193K 
[ ]25254_open-burn-pit-exposure-and-concern-about-covid-19.pdf2022-11-07 22:27 111K 
[ ]25256_open-label-rater-blinded-augmentation-study-aripiprazole.pdf2022-11-07 22:37 102K 
[ ]25257_open-label-rater-blinded-flexible-dose-week-trial.pdf2022-11-07 22:11 183K 
[ ]25258_open-label-treatment-citalopram-patients-irritable.pdf2022-11-07 22:16 133K 
[ ]25259_open-label-trial-acamprosate-treatment-anxiety.pdf2022-11-07 22:20 46K 
[ ]25268_outcomes-and-treatment-response-in-schizophrenia.pdf2022-11-07 22:22 241K 
[ ]25271_overcoming-obstacles-therapeutic-success-despite-external.pdf2022-11-07 22:12 91K 
[ ]25272_overview-antidepressants-currently-used-treat-anxiety.pdf2022-11-07 22:57 50K 
[ ]25273_overview-generalized-anxiety-disorder-epidemiology.pdf2022-11-07 22:41 210K 
[ ]25274_overview-importance-recognizing-treating-insomnia.pdf2022-11-07 22:54 57K 
[ ]25275_overview-kleptomania-phenomenological-description.pdf2022-11-07 22:06 43K 
[ ]25276_overview-neurobiology-attention-deficit-hyperactivity.pdf2022-11-07 22:01 79K 
[ ]25277_overview-safety-tolerability-atypical-antipsychotics.pdf2022-11-07 22:18 85K 
[ ]25278_oxcarbazepine-bipolar-disorder.pdf2022-11-07 22:08 19K 
[ ]25279_oxcarbazepine-induced-reversible-anorgasmia-ejaculatory.pdf2022-11-07 23:01 130K 
[ ]25281_oxford-textbook-palliative-medicine-nd-ed.pdf2022-11-07 22:27 14K 
[ ]25282_oxygen-bars-lobby-next-income-supplement.pdf2022-11-07 23:02 69K 
[ ]25283_pain-complaints-adolescent-patients-affective-disorders.pdf2022-11-07 22:04 113K 
[ ]25284_pain-complaints-latino-adults-mexican-origin-without.pdf2022-11-07 22:01 171K 
[ ]25292_panic-attacks-during-escalation-mirtazapine.pdf2022-11-07 22:43 30K 
[ ]25293_panic-disorder-alcohol-substance-abuse-benzodiazepine.pdf2022-11-07 22:12 86K 
[ ]25294_panic-disorder-chest-pain-mechanisms-morbidity-management.pdf2022-11-07 22:16 73K 
[ ]25295_panic-disorder-end-chronic-alcohol-abuse-report-cases.pdf2022-11-07 22:53 209K 
[ ]25296_panic-disorder-presenting-primary-care.pdf2022-11-07 22:21 19K 
[ ]25297_paroxetine-controlled-release-premenstrual-dysphoric.pdf2022-11-07 22:08 148K 
[ ]25300_paroxetine-patients-irritable-bowel-syndrome-pilot.pdf2022-11-07 22:27 95K 
[ ]25301_paroxetine-somatic-pain-associated-physical-illness.pdf2022-11-07 22:17 112K 
[ ]25302_partial-adherence-antipsychotic-medication-impacts.pdf2022-11-07 22:33 223K 
[ ]25304_partial-seizures-secondary-generalization-while-treatment.pdf2022-11-07 22:26 131K 
[ ]25305_passages.pdf2022-11-07 22:38 38K 
[ ]25306_pathological-gambling-review-phenomenological-models.pdf2022-11-07 22:57 84K 
[ ]25307_patient-assessed-versus-physician-assessed-disease.pdf2022-11-07 22:51 224K 
[ ]25308_patient-characteristics-with-antipsychotic-treatment.pdf2022-11-07 22:24 575K 
[ ]25309_patient-follow-primary-care-behavioral-health-screening.pdf2022-11-07 22:52 148K 
[ ]25311_patient-perspective-on-unmet-needs-in-adhd-treatment.pdf2022-11-07 22:40 1.1M 
[ ]25312_patient-physician-relationship-medical-utilization.pdf2022-11-07 22:06 131K 
[ ]25313_patient-physician-relationship-service-utilization.pdf2022-11-07 22:58 507K 
[ ]25316_patients-are-normal-strategies-managing-dual-relationships.pdf2022-11-07 22:49 48K 
[ ]25320_patients-need-psychiatric-medications.pdf2022-11-07 22:28 53K 
[ ]25331_personality-disorder-self-mutilation-criminal-behavior.pdf2022-11-07 22:14 131K 
[ ]25332_personality-disorders-older-adults-diagnosis-assessment.pdf2022-11-07 22:42 46K 
[ ]25334_perspective-primary-care-patients-behavior-mood-thought.pdf2022-11-07 22:28 64K 
[ ]25335_pharmacogenetic-guided-treatment-for-neuropsychiatric-disorders.pdf2022-11-07 22:14 184K 
[ ]25336_pharmacokinetics-metabolism-drug-drug-interactions.pdf2022-11-07 22:28 46K 
[ ]25337_pharmacokinetics-of-buprenorphine-in-pregnancy.pdf2022-11-07 22:42 88K 
[ ]25338_pharmacologic-characteristics-ideal-antidepressants.pdf2022-11-07 22:47 54K 
[ ]25339_pharmacologic-management-daytime-sleepiness.pdf2022-11-07 22:43 48K 
[ ]25340_pharmacologic-management-insomnia.pdf2022-11-07 22:34 58K 
[ ]25344_pharmacotherapy-attention-deficit-hyperactivity-disorder.pdf2022-11-07 22:52 57K 
[ ]25346_pharmacotherapy-insomnia-efficacy-rebound-hypnotic.pdf2022-11-07 22:15 68K 
[ ]25350_physician-patterns-metabolic-screening-patients-taking.pdf2022-11-07 22:40 78K 
[ ]25352_pia-coladas-joie-de-vivre.pdf2022-11-07 22:55 70K 
[ ]25353_pilot-study-examining-relationship-between-patients.pdf2022-11-07 22:08 38K 
[ ]25355_pimavanserin-a-clarification-on-the-fda-update.pdf2022-11-07 22:47 91K 
[ ]25358_playing-sick-untangling-web-munchausen-proxy-malingering.pdf2022-11-07 22:35 73K 
[ ]25359_pleasant-dreams.pdf2022-11-07 22:06 41K 
[ ]25360_pocket-handbook-primary-care-psychiatry.pdf2022-11-07 22:20 16K 
[ ]25364_possible-causes-false-positive-diagnosis-pheochromocytoma.pdf2022-11-07 23:00 186K 
[ ]25365_possible-link-between-attention-deficit-hyperactivity.pdf2022-11-07 22:12 53K 
[ ]25366_possible-sexual-dysfunction-associated-bupropion-smoking.pdf2022-11-07 22:50 19K 
[ ]25367_post-call-blues.pdf2022-11-07 22:20 69K 
[ ]25368_postdischarge-treatment-costs-following-closure-state.pdf2022-11-07 22:06 79K 
[ ]25372_postpartum-mood-disorders.pdf2022-11-07 22:52 15K 
[ ]25373_poststroke-neuropsychiatric-symptoms-pseudoseizures.pdf2022-11-07 22:44 46K 
[ ]25374_posttraumatic-stress-disorder-and-obesity.pdf2022-11-07 22:18 184K 
[ ]25376_posttraumatic-stress-disorder-epidemiology-health.pdf2022-11-07 22:08 68K 
[ ]25377_posttraumatic-stress-disorder-male-military-veterans.pdf2022-11-07 22:57 96K 
[ ]25378_posttraumatic-stress-disorder-psychological-factors.pdf2022-11-07 22:59 60K 
[ ]25380_potential-association-between-risperidone-cerebrovascular.pdf2022-11-07 22:51 21K 
[ ]25383_pour-gin-tonic-honey-paris.pdf2022-11-07 22:59 14K 
[ ]25384_practical-clues-early-recognition-bipolar-disorder.pdf2022-11-07 22:57 128K 
[ ]25385_practical-principles-management-alzheimers-disease.pdf2022-11-07 22:33 68K 
[ ]25388_prediction-response-within-days-treatment-paroxetine.pdf2022-11-07 22:11 125K 
[ ]25390_predictive-factors-remission-recurrence-patients-treated.pdf2022-11-07 22:28 185K 
[ ]25394_pregabalin-augmentation-sertraline-risperidone-combination.pdf2022-11-07 22:40 208K 
[ ]25395_premenstrual-dysphoria-serotonin-system-pathophysiology.pdf2022-11-07 22:14 56K 
[ ]25396_premenstrual-dysphoric-disorder-recognition-treatment.pdf2022-11-07 22:28 124K 
[ ]25398_prescribed-benzodiazepines-and-suicide-risk.pdf2022-11-07 23:01 233K 
[ ]25399_prescribing-brief-psychotherapy.pdf2022-11-07 22:34 26K 
[ ]25403_prevalence-antidepressant-associated-erectile-dysfunction.pdf2022-11-07 22:13 59K 
[ ]25404_prevalence-associated-risks-treatment-patterns-insomnia.pdf2022-11-07 22:45 112K 
[ ]25407_prevalence-correlates-disability-comorbidity-dsm-iv.pdf2022-11-07 22:57 413K 
[ ]25408_prevalence-depressive-symptoms-associated-factors.pdf2022-11-07 22:12 209K 
[ ]25409_prevalence-metabolic-syndrome-hispanic-non-hispanic.pdf2022-11-07 22:30 43K 
[ ]25411_prevalence-substance-misuse-patients-outpatient-psychiatry.pdf2022-11-07 22:16 246K 
[ ]25413_preventing-delirium-end-life-lessons-recent-research.pdf2022-11-07 22:56 95K 
[ ]25414_preventing-recurrent-depression-long-term-treatment.pdf2022-11-07 22:39 264K 
[ ]25416_prevention-deep-vein-thrombosis-patient-delirium-tremens.pdf2022-11-07 22:15 257K 
[ ]25417_prevention-relapse-recurrence-depression-role-long.pdf2022-11-07 22:13 56K 
[ ]25419_prevention-treatment-suicidal-behaviour-science-practice.pdf2022-11-07 22:49 98K 
[ ]25425_primary-care-commentary-fatigue-executive-dysfunction.pdf2022-11-07 22:09 21K 
[ ]25426_primary-care-evaluation-mental-disorders-prime-md.pdf2022-11-07 22:32 173K 
[ ]25428_primary-care-perspective-posttraumatic-stress-disorder.pdf2022-11-07 22:05 167K 
[ ]25430_primary-care-psychiatry-behavioral-medicine-brief-book-review.pdf2022-11-07 22:22 16K 
[ ]25431_primary-care-psychiatry-behavioral-medicine-brief-new-edition-book-review.pdf2022-11-07 22:52 17K 
[ ]25432_primary-care-psychiatry-dawning.pdf2022-11-07 22:58 45K 
[ ]25434_primary-care-specialty-resident-status-male-gender.pdf2022-11-07 22:53 144K 
[ ]25435_primary-care-treatment-attention-deficit-hyperactivity.pdf2022-11-07 22:56 93K 
[ ]25442_prolactin-elevation-antipsychotic-medications-mechanisms.pdf2022-11-07 22:25 97K 
[ ]25444_prolactin-levels-olanzapine-treatment-correlate-positive.pdf2022-11-07 22:52 147K 
[ ]25446_proposed-algorithm-improved-recognition-treatment.pdf2022-11-07 22:59 77K 
[ ]25447_propranolol-treatment-neuroleptic-induced-akathisia.pdf2022-11-07 22:03 72K 
[ ]25448_prospective-study-depression-among-adult-patients.pdf2022-11-07 22:59 93K 
[ ]25449_protracted-case-psychosis-motor-abnormalities-agitation.pdf2022-11-07 22:32 186K 
[ ]25451_pseudolabor-conversion-disorder-subtype-case-presentation.pdf2022-11-07 22:24 63K 
[ ]25455_psychiatric-disease-and-intracranial-tumors.pdf2022-11-07 22:04 1.0M 
[ ]25456_psychiatric-disease-hypercholesterolemia-urban-academic.pdf2022-11-07 22:56 78K 
[ ]25457_psychiatric-disorder-diabetes-mellitus.pdf2022-11-07 22:07 53K 
[ ]25459_psychiatric-family-nurse-practitioner-collaborator.pdf2022-11-07 22:06 33K 
[ ]25462_psychiatric-issues-parkinsons-disease-practical-guide.pdf2022-11-07 22:30 98K 
[ ]25464_psychiatric-perspective-insomnia.pdf2022-11-07 22:36 57K 
[ ]25469_psychiatric-rehospitalization-development-person-level.pdf2022-11-07 23:03 271K 
[ ]25470_psychiatric-side-effects-prescription-counter-medications-book-review.pdf2022-11-07 22:23 25K 
[ ]25471_psychiatric-side-effects-prescription-counter-medications-new-edition-book-review.pdf2022-11-07 22:04 21K 
[ ]25472_psychiatric-somatic-markers-anxiety-identification.pdf2022-11-07 22:07 41K 
[ ]25475_psychiatric-uses-newer-anticonvulsants.pdf2022-11-07 22:43 26K 
[ ]25478_psychiatry-millennium.pdf2022-11-07 22:27 18K 
[ ]25481_psychodermatology-guide-understanding-common-psychocutaneous.pdf2022-11-07 22:42 246K 
[ ]25482_psychodermatology-in-the-middle-east.pdf2022-11-07 22:09 138K 
[ ]25488_psychogenic-respiratory-distress-case-paradoxical.pdf2022-11-07 23:01 62K 
[ ]25490_psychological-assessment-of-bariatric-surgery-patients.pdf2022-11-07 22:01 167K 
[ ]25492_psychological-impact-tsunami-children-adolescents.pdf2022-11-07 22:57 506K 
[ ]25496_psychological-psychiatric-issuesin-etiopathogenesis.pdf2022-11-07 22:07 49K 
[ ]25497_psychometric-properties-mini-social-phobia-inventory.pdf2022-11-07 22:25 177K 
[ ]25498_psychometrics-of-the-violence-nonlinear-dynamics-scale.pdf2022-11-07 22:24 366K 
[ ]25499_psychophysiologic-therapy-chronic-headache-primary.pdf2022-11-07 22:47 56K 
[ ]25506_psychosis-precipitated-acetyl-l-carnitine-patient.pdf2022-11-07 22:48 140K 
[ ]25507_psychosocial-response-mass-casualty-terrorism-guidelines.pdf2022-11-07 22:26 81K 
[ ]25508_psychosocial-treatments-attention-deficit-hyperactivity.pdf2022-11-07 22:50 77K 
[ ]25510_psychospiritual-clinicians-handbook-alternative-methods.pdf2022-11-07 22:31 63K 
[ ]25511_psychotherapy-clarified-diagnosis-treated-problem.pdf2022-11-07 22:29 18K 
[ ]25512_psychotherapy-depression-older-adults.pdf2022-11-07 22:46 73K 
[ ]25514_psychotherapy-patient-terminal-cancer.pdf2022-11-07 22:05 31K 
[ ]25515_psychotherapy-religion-civil-divide-america.pdf2022-11-07 22:53 49K 
[ ]25520_psychotic-symptoms-elderly.pdf2022-11-07 22:10 94K 
[ ]25521_psychotic-symptoms-underlying-graves-disease-case.pdf2022-11-07 22:28 96K 
[ ]25522_psychotic-symptoms-years-single-episode-childhood.pdf2022-11-07 22:57 186K 
[ ]25523_psychotropic-drug-israel-results-national-health-survey.pdf2022-11-07 22:33 185K 
[ ]25524_psychotropic-medication-monitoring.pdf2022-11-07 23:02 507K 
[ ]25526_ptsd-symptoms-functioning-and-suicidal-ideation-in-military-veterans.pdf2022-11-07 22:16 308K 
[ ]25529_publisher-note-electronic-manuscript-submission-peer.pdf2022-11-07 23:01 47K 
[ ]25530_publishers-note-medical-education-mission-success.pdf2022-11-07 22:31 42K 
[ ]25531_publishers-note-physicians-postgraduate-press-earns.pdf2022-11-07 22:47 19K 
[ ]25532_publishers-note-physicians-postgraduate-press-st-century.pdf2022-11-07 22:02 47K 
[ ]25533_qtc-prolongation-antipsychotics-case-discussion.pdf2022-11-07 22:29 45K 
[ ]25539_quality-life-among-bipolar-disorder-patients-misdiagnosed.pdf2022-11-07 22:44 188K 
[ ]25542_question-authority.pdf2022-11-07 22:18 50K 
[ ]25543_questions-answers-role-pharmacotherapy-clinical-management.pdf2022-11-07 22:44 62K 
[ ]25544_quetiapine-induced-bradycardia-without-qt-interval.pdf2022-11-07 22:48 130K 
[ ]25546_quetiapine-induced-hypersalivation.pdf2022-11-07 22:25 221K 
[ ]25547_quetiapine-monotherapy-treatment-anxiety-symptoms.pdf2022-11-07 22:12 422K 
[ ]25551_randomized-trial-effect-research-design-publication.pdf2022-11-07 22:40 105K 
[ ]25557_rash-desquamation-associated-risperidone-oral-solution.pdf2022-11-07 22:38 151K 
[ ]25560_reactions-amputation-recognition-treatment.pdf2022-11-07 22:57 138K 
[ ]25562_real-world-outcomes-once-daily-risperidone-dosing.pdf2022-11-07 22:46 27K 
[ ]25563_real-world-use-of-long-acting-injectable-antipsychotics.pdf2022-11-07 22:11 1.0M 
[ ]25564_rebuilding-family-relationship-competencies-primary.pdf2022-11-07 22:10 88K 
[ ]25565_recognition-assessment-sexual-dysfunction-associated.pdf2022-11-07 22:47 51K 
[ ]25566_recognition-management-behavioral-disturbances-dementia.pdf2022-11-07 22:05 95K 
[ ]25567_recognition-management-excessive-sleepiness-primary.pdf2022-11-07 22:30 226K 
[ ]25568_recognition-management-psychological-reactions-stroke.pdf2022-11-07 22:12 82K 
[ ]25570_recognition-treatment-depression-anxiety-symptoms.pdf2022-11-07 22:28 242K 
[ ]25571_recognition-treatment-recommendations-generalized.pdf2022-11-07 22:23 98K 
[ ]25572_recognizing-managing-antipsychotic-drug-treatment.pdf2022-11-07 22:46 62K 
[ ]25573_recognizing-managing-obstructive-sleep-apnea-primary.pdf2022-11-07 22:06 279K 
[ ]25574_recognizing-psychologically-masked-illnesses-need.pdf2022-11-07 22:01 108K 
[ ]25575_recognizing-sleep-disorders-primary-care-setting.pdf2022-11-07 22:59 47K 
[ ]25576_recognizing-treating-physical-symptoms-depression.pdf2022-11-07 22:52 110K 
[ ]25577_recognizing-treating-premenstrual-dysphoric-disorder.pdf2022-11-07 22:46 85K 
[ ]25579_reconciliation.pdf2022-11-07 22:17 24K 
[ ]25586_reducing-stigma-toward-psychiatry-in-medical-students.pdf2022-11-07 22:59 349K 
[ ]25587_reexamining-elderly-patients-presentation-depression.pdf2022-11-07 22:42 151K 
[ ]25588_reflections-dsm-classification-utility-primary-care.pdf2022-11-07 22:34 166K 
[ ]25589_refractory-depressed-anxious-states-hyperthymic-women.pdf2022-11-07 22:51 32K 
[ ]25590_refractory-generalized-anxiety-disorder.pdf2022-11-07 22:08 267K 
[ ]25594_reinventing-depression-history-treatment-depression-book-review.pdf2022-11-07 22:52 49K 
[ ]25595_reinventing-depression-history-treatment-depression-new-edition-book-review.pdf2022-11-07 22:31 50K 
[ ]25598_relationship-between-borderline-personality-symptomatology.pdf2022-11-07 22:55 154K 
[ ]25599_relationship-between-medically-self-sabotaging-behaviors.pdf2022-11-07 22:49 148K 
[ ]25603_relationships-between-executive-function-and-adhd-symptom-improvement-with-lisdexamfetamine.pdf2022-11-07 22:30 275K 
[ ]25604_relationship-somatic-symptoms-depression-severity.pdf2022-11-07 22:36 227K 
[ ]25605_relative-abuse-liability-hypnotic-drugs-conceptual.pdf2022-11-07 22:18 195K 
[ ]25606_reminder-focused-positive-psychiatry-in-adhd-and-ptsd.pdf2022-11-07 22:23 286K 
[ ]25607_remission-panic-disorder-mirtazapine-augmentation.pdf2022-11-07 22:40 180K 
[ ]25609_remote-brief-psychotherapy.pdf2022-11-07 22:37 29K 
[ ]25611_repetitive-transcranial-magnetic-stimulation-premenstrual.pdf2022-11-07 23:02 72K 
[ ]25612_repetitive-transcranial-magnetic-stimulation-treatment.pdf2022-11-07 22:35 1.8M 
[ ]25613_reproductive-safety-profile-mood-stabilizers-atypical.pdf2022-11-07 22:31 125K 
[ ]25614_residual-effects-memory-psychomotor-performance-zaleplon.pdf2022-11-07 23:00 74K 
[ ]25623_resolution-ziprasidone-related-tardive-dyskinesia.pdf2022-11-07 22:56 33K 
[ ]25624_resolving-difficult-clinical-syndromes-personalized.pdf2022-11-07 22:20 89K 
[ ]25627_response-of-gambling-disorder-to-ketamine.pdf2022-11-07 22:57 91K 
[ ]25632_rethinking-treatment-psychotic-disorders.pdf2022-11-07 22:15 33K 
[ ]25633_retirement.pdf2022-11-07 22:16 23K 
[ ]25634_retrospective-study-olanzapine-depressive-anxious.pdf2022-11-07 22:09 510K 
[ ]25640_review-antidepressant-therapy-primary-care-current.pdf2022-11-07 22:29 421K 
[ ]25643_review-diagnosis-pharmacologic-treatment-economic.pdf2022-11-07 22:51 48K 
[ ]25644_review-evidence-antidepressants-bipolar-depression.pdf2022-11-07 22:08 373K 
[ ]25645_review-literature-selegiline-transdermal-system-effective.pdf2022-11-07 22:57 177K 
[ ]25646_review-neuropharmacology-bupropion-dual-norepinephrine.pdf2022-11-07 22:02 95K 
[ ]25647_review-pharmacologic-strategies-switching-atypical.pdf2022-11-07 22:23 159K 
[ ]25648_review-postpartum-depression.pdf2022-11-07 23:01 43K 
[ ]25653_review-vilazodone-serotonin-major-depressive-disorder.pdf2022-11-07 22:39 3.3M 
[ ]25655_risk-and-economic-impact-of-serotonin-syndrome.pdf2022-11-07 22:37 253K 
[ ]25660_risperidone-aripiprazole-induced-leukopenia-case.pdf2022-11-07 23:02 209K 
[ ]25661_risperidone-dysphagia-developmentally-disabled-woman.pdf2022-11-07 22:23 204K 
[ ]25662_risperidone-induced-neuroleptic-malignant-syndrome.pdf2022-11-07 22:09 221K 
[ ]25663_risperidone-induced-priapism-case-report.pdf2022-11-07 22:37 130K 
[ ]25665_risperidone-induced-tardive-pharyngeal-dystonia-presenting.pdf2022-11-07 22:21 262K 
[ ]25666_risperidone-lithium-personality-behavioral-changes.pdf2022-11-07 22:31 46K 
[ ]25668_risperidone-treatment-children-developmental-disorders.pdf2022-11-07 22:48 93K 
[ ]25669_rivastigmine-alzheimers-disease-improvement-versus.pdf2022-11-07 22:39 522K 
[ ]25671_roadmap-key-pharmacologic-principles-using-antipsychotics.pdf2022-11-07 22:03 384K 
[ ]25672_role-algorithms-detection-treatment-depression-primary.pdf2022-11-07 22:03 53K 
[ ]25673_role-atypical-antipsychotics-depression-primary-care.pdf2022-11-07 22:25 57K 
[ ]25674_role-cholinesterase-inhibitors-managing-behavioral.pdf2022-11-07 22:55 53K 
[ ]25675_role-duloxetine-treatment-depression-associated-painful.pdf2022-11-07 23:00 35K 
[ ]25676_role-executive-function-adhd.pdf2022-11-07 22:45 64K 
[ ]25677_role-executive-function-late-life-depression.pdf2022-11-07 22:34 74K 
[ ]25679_role-high-potency-benzodiazepines-treatment-panic.pdf2022-11-07 22:03 135K 
[ ]25683_role-psychiatry-management-acute-trauma-surgery-patients.pdf2022-11-07 22:52 48K 
[ ]25685_rolling-rocks.pdf2022-11-07 22:13 46K 
[ ]25691_running-amok-modern-perspective-culture-bound-syndrome.pdf2022-11-07 22:01 42K 
[ ]25693_safety-efficacy-bupropion-extended-release-treating.pdf2022-11-07 22:10 131K 
[ ]25694_safety-efficacy-rivastigmine-patients-alzheimers-disease.pdf2022-11-07 23:02 227K 
[ ]25695_safety-profile-atomoxetine-treatment-adolescents-children.pdf2022-11-07 22:26 72K 
[ ]25696_safety-tolerability-adjunctive-aripiprazole-major.pdf2022-11-07 22:50 288K 
[ ]25698_safety-tolerability-duloxetine-compared-paroxetine.pdf2022-11-07 22:12 112K 
[ ]25699_same-and-l-plantarum-heal-in-depression.pdf2022-11-07 22:10 302K 
[ ]25706_schizophrenia-with-decompensation-on-clozapine-with-pramipexole.pdf2022-11-07 22:37 97K 
[ ]25707_science-pseudoscience-clinical-psychology.pdf2022-11-07 22:07 23K 
[ ]25709_screening-childhood-eating-disorders-primary-care.pdf2022-11-07 22:25 125K 
[ ]25712_screening-early-alzheimers-disease-is-still-role-mini.pdf2022-11-07 22:55 72K 
[ ]25714_seasonal-affective-disorder-beyond-light-treatment.pdf2022-11-07 22:26 16K 
[ ]25716_second-around-having-therapist-may-handy.pdf2022-11-07 23:00 64K 
[ ]25718_section-i-current-perspectives-treatment-depression.pdf2022-11-07 22:19 30K 
[ ]25719_section-ii-focus-anxiety-disorders.pdf2022-11-07 22:04 29K 
[ ]25721_selecting-antidepressant-using-mechanism-action-enhance.pdf2022-11-07 22:40 100K 
[ ]25723_selecting-selective-serotonin-reuptake-inhibitor-clinically.pdf2022-11-07 22:31 41K 
[ ]25726_self-compassion-intervention-for-medical-patients.pdf2022-11-07 22:02 366K 
[ ]25729_self-harm-behavior-among-chronic-pain-patients.pdf2022-11-07 22:58 49K 
[ ]25734_sensitivity.pdf2022-11-07 22:24 477K 
[ ]25735_separation-anxiety-disorder-school-refusal-childhood.pdf2022-11-07 22:24 257K 
[ ]25736_sequencing-treatment-in-a-multisymptomatic-child.pdf2022-11-07 22:05 493K 
[ ]25737_serotonergic-noradrenergic-reuptake-inhibitors-prediction.pdf2022-11-07 22:24 99K 
[ ]25740_serotonin-syndrome-associated-tramadol.pdf2022-11-07 22:21 45K 
[ ]25741_serotonin-syndrome-paroxetine-overdose-case-report.pdf2022-11-07 22:22 262K 
[ ]25748_serum-folate-and-vitamin-b-in-psychiatric-inpatients.pdf2022-11-07 22:10 188K 
[ ]25749_service-psychiatry-primary-care-celebrating-years.pdf2022-11-07 22:52 69K 
[ ]25750_seven-beliefs.pdf2022-11-07 22:18 26K 
[ ]25752_sex-drugs-rock-roll-bankers-little-helper.pdf2022-11-07 22:17 46K 
[ ]25753_sexual-abuse-mentally-retarded-patient-medical-legal.pdf2022-11-07 22:24 56K 
[ ]25755_sexual-dysfunction-rescue.pdf2022-11-07 22:25 22K 
[ ]25756_sexual-functioning-ssris.pdf2022-11-07 22:09 48K 
[ ]25758_sexual-side-effects-antidepressants.pdf2022-11-07 22:24 87K 
[ ]25760_sgas-vs-non-sgas-in-depression-and-diabetes.pdf2022-11-07 22:13 290K 
[ ]25762_shared-care.pdf2022-11-07 22:27 44K 
[ ]25765_sigh.pdf2022-11-07 22:54 45K 
[ ]25766_significance-treating-somatic-symptoms-functional.pdf2022-11-07 22:47 176K 
[ ]25767_significant-others.pdf2022-11-07 22:33 43K 
[ ]25768_sildenafil-bridging-gap-between-pharmacologic-treatment.pdf2022-11-07 22:40 50K 
[ ]25769_sildenafil-citrate-management-antidepressant-associated.pdf2022-11-07 22:23 68K 
[ ]25770_sildenafil-treatment-ssri-induced-sexual-dysfunction.pdf2022-11-07 23:03 37K 
[ ]25771_single-action-versus-dual-action-antidepressants.pdf2022-11-07 22:08 63K 
[ ]25773_skin-picking-phenomenology-severity-comparison.pdf2022-11-07 22:17 198K 
[ ]25774_sleep-aging-prevalence-disturbed-sleep-treatment-considerations.pdf2022-11-07 22:05 159K 
[ ]25776_sleep-architecture-relationship-insomnia.pdf2022-11-07 22:23 130K 
[ ]25780_sleep-dreaming-scientific-advances-reconsiderations.pdf2022-11-07 23:00 50K 
[ ]25781_sleep-elderly-burden-diagnosis-treatment.pdf2022-11-07 22:40 561K 
[ ]25782_sleepiness-versus-sleeplessness-shift-sleep-disorders.pdf2022-11-07 22:05 134K 
[ ]25783_sleep-medicine-education-in-north-american-psychiatry-residency-training.pdf2022-11-07 22:21 154K 
[ ]25785_sleep-related-hypomanic-symptoms-predictor-bipolar.pdf2022-11-07 22:52 221K 
[ ]25786_sleep-related-risk-factors-for-suicidal-ideation.pdf2022-11-07 22:49 311K 
[ ]25787_small-doses-aripiprazole-augmentation-antidepressant.pdf2022-11-07 22:32 208K 
[ ]25788_smoke-em-got-em.pdf2022-11-07 22:48 36K 
[ ]25789_snris-versus-ssris-mechanisms-action-treating-depression.pdf2022-11-07 22:25 81K 
[ ]25790_social-anxiety-disorder-comorbidity-implications.pdf2022-11-07 22:23 71K 
[ ]25791_social-anxiety-disorder-more-little-shyness.pdf2022-11-07 22:57 42K 
[ ]25792_social-anxiety-disorder-unrecognized-problem-primary.pdf2022-11-07 22:24 61K 
[ ]25793_social-phobia-etiology-neurobiology-treatment.pdf2022-11-07 22:59 94K 
[ ]25794_social-phobia-prevalence-diagnostic-threshold.pdf2022-11-07 22:03 64K 
[ ]25795_social-security-claims-psychiatric-disability-elements.pdf2022-11-07 22:17 51K 
[ ]25797_societal-costs-chronic-major-depression.pdf2022-11-07 22:51 52K 
[ ]25798_society-psychosis.pdf2022-11-07 22:19 45K 
[ ]25802_solving-psychiatric-puzzles.pdf2022-11-07 22:31 68K 
[ ]25804_somatization-family-practice-comparing-methods-classification.pdf2022-11-07 22:39 45K 
[ ]25805_somatoform-variant-obsessive-compulsive-disorder-case.pdf2022-11-07 22:07 44K 
[ ]25807_sometimes-create-own-prisons.pdf2022-11-07 22:21 70K 
[ ]25809_ssri-antidepressant-medications-adverse-effects-tolerability.pdf2022-11-07 22:26 39K 
[ ]25812_standards-dementia-care.pdf2022-11-07 22:31 63K 
[ ]25814_steps-following-attainment-remission-discontinuation.pdf2022-11-07 22:28 44K 
[ ]25815_stereochemistry-drug-action.pdf2022-11-07 22:15 51K 
[ ]25816_stereoisomers-psychiatry-case-escitalopram.pdf2022-11-07 22:21 158K 
[ ]25818_steroid-induced-psychosis-treated-valproic-acid-risperidone.pdf2022-11-07 22:09 78K 
[ ]25820_stigma-among-inpatients-with-covid-19.pdf2022-11-07 22:18 326K 
[ ]25824_strategies-treating-chronic-depression.pdf2022-11-07 22:39 55K 
[ ]25825_strategies-treatment-antidepressant-related-sexual.pdf2022-11-07 22:13 78K 
[ ]25826_stressed.pdf2022-11-07 22:44 25K 
[ ]25828_stress-management-and-resiliency-training-for-depression.pdf2022-11-07 22:08 203K 
[ ]25835_substance-disorders-children-adolescents-attention.pdf2022-11-07 22:28 309K 
[ ]25837_successful-adjuvant-phytoestrogens-schizoaffective.pdf2022-11-07 22:29 46K 
[ ]25841_successful-pain-management-recovering-addicted-patient.pdf2022-11-07 22:53 64K 
[ ]25846_suicidality-possible-side-effect-antidepressant-treatment.pdf2022-11-07 22:55 117K 
[ ]25850_suicide-attempt-psychosis-revealed-apparent-traffic.pdf2022-11-07 22:40 209K 
[ ]25854_summary-defining-remission-patients-treated-antidepressants.pdf2022-11-07 22:33 30K 
[ ]25855_sure-vitamins-daily.pdf2022-11-07 22:19 17K 
[ ]25856_surprise.pdf2022-11-07 22:34 58K 
[ ]25859_survey-primary-care-provider-attitudes-behaviors-regarding.pdf2022-11-07 22:39 145K 
[ ]25866_switching-donepezil-rivastigmine-is-tolerated-results.pdf2022-11-07 22:02 117K 
[ ]25871_symptoms-fatigue-cognitiveexecutive-dysfunction-major.pdf2022-11-07 22:05 59K 
[ ]25872_symptoms-posttraumatic-stress-disorder-ritual-female.pdf2022-11-07 22:36 127K 
[ ]25874_systematic-review-assessment-treatment-moderate-severe.pdf2022-11-07 22:10 134K 
[ ]25875_systematic-review-chronic-fatigue-syndrome-dont-assume.pdf2022-11-07 22:37 263K 
[ ]25876_systematic-review-lithium-augmentation-depression.pdf2022-11-07 22:14 130K 
[ ]25877_tackling-partial-response-depression-treatment.pdf2022-11-07 22:39 237K 
[ ]25878_tacrolimus-worsens-bipolar-disorder-in-a-kidney-transplant-patient.pdf2022-11-07 22:21 172K 
[ ]25879_taking-care-caretakers.pdf2022-11-07 22:43 60K 
[ ]25881_tandospirone-for-chronic-poststroke-emotional-incontinence.pdf2022-11-07 22:27 337K 
[ ]25882_tapentadol-an-opioid-of-abuse-acquired-online.pdf2022-11-07 22:04 102K 
[ ]25883_tapentadol-dependence.pdf2022-11-07 22:16 127K 
[ ]25884_tardive-dystonia-ziprasidone-case-report.pdf2022-11-07 22:48 257K 
[ ]25886_teaching-family-physicians-mood-disorders-procedure.pdf2022-11-07 22:04 56K 
[ ]25887_teaching-tools-prolonging-benefit-psychotherapy.pdf2022-11-07 22:44 30K 
[ ]25892_tennis-anyone.pdf2022-11-07 22:18 42K 
[ ]25893_terms-endearment.pdf2022-11-07 22:42 44K 
[ ]25894_text-message-program-promotes-well-being-and-health-behaviors.pdf2022-11-07 22:19 583K 
[ ]25900_the-psychiatric-assessment-and-brief-intervention-program-partnering-with-primary-care-providers.pdf2022-11-07 22:30 298K 
[ ]25901_therapeutic-options-treatment-insomnia.pdf2022-11-07 22:40 147K 
[ ]25902_therapists-guide-substance-abuse-intervention.pdf2022-11-07 22:10 18K 
[ ]25903_therapy-choices-late-life-depression.pdf2022-11-07 22:15 43K 
[ ]25904_theres-crying-football.pdf2022-11-07 22:41 41K 
[ ]25908_three-years-growing.pdf2022-11-07 22:09 37K 
[ ]25910_thyroid-augmentation-case-report.pdf2022-11-07 22:45 29K 
[ ]25912_thyroid-myopathy-rhabdomyolysis-presenting-agitation.pdf2022-11-07 22:53 209K 
[ ]25914_tiagabine-treatment-nervios.pdf2022-11-07 22:37 28K 
[ ]25919_toiling-herb-garden-sitting-field-dreams.pdf2022-11-07 22:48 16K 
[ ]25920_tolerability-oral-loaded-valproate-remission-acute.pdf2022-11-07 23:03 221K 
[ ]25922_topiramate-bipolar-schizoaffective-disorders-weight.pdf2022-11-07 22:07 34K 
[ ]25923_topiramate-induced-psychosis-individual-alcohol-dependence.pdf2022-11-07 23:02 204K 
[ ]25928_toxicology-findings-child-adolescent-suicides-virginia.pdf2022-11-07 22:54 82K 
[ ]25934_transcultural-issues-aspergers-disorder-comparison.pdf2022-11-07 22:46 180K 
[ ]25936_transdermal-nicotine-adult-adhd-depression-anxiety.pdf2022-11-07 22:15 208K 
[ ]25938_transient-complex-visual-hallucinations-venlafaxine.pdf2022-11-07 22:59 72K 
[ ]25940_transition-private-practice.pdf2022-11-07 22:15 70K 
[ ]25942_translating-evidence-atypical-depression-clinical-MAO.pdf2022-11-07 22:38 156K 
[ ]25943_translating-evidence-depression-physical-symptoms.pdf2022-11-07 22:11 218K 
[ ]25944_translating-science-service-lessons-learned-sequenced.pdf2022-11-07 22:46 171K 
[ ]25945_trauma-posttraumatic-stress-disorder-primary-care.pdf2022-11-07 22:58 48K 
[ ]25947_travel-itineraries-jackhammers-acorns.pdf2022-11-07 22:09 16K 
[ ]25948_treating-aching-heart-guide-depression-stress-heart.pdf2022-11-07 22:41 98K 
[ ]25950_treating-bipolar-disorder-primary-care-setting-role.pdf2022-11-07 22:26 352K 
[ ]25951_treating-depression-anxiety-primary-care.pdf2022-11-07 22:47 247K 
[ ]25952_treating-depression-atypical-features.pdf2022-11-07 23:03 133K 
[ ]25953_treating-depression-remission.pdf2022-11-07 22:31 57K 
[ ]25954_treating-generalized-anxiety-disorder.pdf2022-11-07 22:19 67K 
[ ]25955_treating-patients-moderate-severe-alzheimers-disease.pdf2022-11-07 22:40 171K 
[ ]25956_treating-psychotic-symptoms-elderly-patients.pdf2022-11-07 22:07 50K 
[ ]25957_treating-residual-bipolar-disorder-symptoms-in-a-child.pdf2022-11-07 22:05 420K 
[ ]25958_treating-sexual-dysfunction-psychiatrys-role-age-sildenafil.pdf2022-11-07 22:13 22K 
[ ]25959_treating-sleep-disorders-principals-practice-behavioral.pdf2022-11-07 22:12 476K 
[ ]25960_treating-suicidal-behavior-effective-limited-approach.pdf2022-11-07 22:43 21K 
[ ]25962_treatment-acute-mania-aripiprazole-older-adult-noted.pdf2022-11-07 22:44 42K 
[ ]25963_treatment-aggression-children.pdf2022-11-07 22:54 53K 
[ ]25964_treatment-anxiety-disorders-remission.pdf2022-11-07 22:06 50K 
[ ]25965_treatment-comorbid-tuberculosis-depression.pdf2022-11-07 22:51 51K 
[ ]25966_treatment-delirium-quetiapine.pdf2022-11-07 22:27 28K 
[ ]25967_treatment-diarrhea-predominant-irritable-bowel-syndrome.pdf2022-11-07 22:14 72K 
[ ]25970_treatment-guidelines-alzheimers-disease-redefining.pdf2022-11-07 22:11 194K 
[ ]25972_treatment-irritable-bowel-syndrome-changing-paradigm.pdf2022-11-07 22:29 55K 
[ ]25973_treatment-issues-related-sleep-depression.pdf2022-11-07 22:27 57K 
[ ]25974_treatment-methamphetamine-cravings-bupropion-case.pdf2022-11-07 22:01 25K 
[ ]25975_treatment-obsessions.pdf2022-11-07 23:01 74K 
[ ]25976_treatment-obsessive-compulsive-disorder-mentally-challenged.pdf2022-11-07 22:53 131K 
[ ]25979_treatment-refractory-depression-elderly-audit-primary.pdf2022-11-07 22:23 49K 
[ ]25981_treatment-social-phobia-antidepressants.pdf2022-11-07 22:41 61K 
[ ]25983_treatment-strategies-sleep-disturbance-patients-depression.pdf2022-11-07 22:40 63K 
[ ]25985_treatment-temporomandibular-pain-selective-serotonin.pdf2022-11-07 22:55 140K 
[ ]25986_trends-diagnosis-treatment-hepatitis-c-concomitant.pdf2022-11-07 22:11 182K 
[ ]25987_trends-pharmacologic-management-insomnia.pdf2022-11-07 22:58 88K 
[ ]25988_trends-prescribing-selective-serotonin-reuptake-inhibitors.pdf2022-11-07 22:34 46K 
[ ]25989_trial-designs-outcomes-dementia-therapeutic-research.pdf2022-11-07 22:13 49K 
[ ]25991_trilogy-case-review-highlighting-clinical-pharmacologic.pdf2022-11-07 22:59 41K 
[ ]25994_true-epilepsy-unmasked-case-apparent-conversion-disorder.pdf2022-11-07 22:45 60K 
[ ]25995_tune.pdf2022-11-07 22:30 44K 
[ ]25996_twelve-month-prospective-randomized-study-pharmacists.pdf2022-11-07 22:04 477K 
[ ]25997_twelve-step-programs-adjunct-psychotherapy-psychopharmacology.pdf2022-11-07 22:59 27K 
[ ]25999_twin-angels.pdf2022-11-07 22:27 24K 
[ ]26002_unconventional-psychotherapy.pdf2022-11-07 22:05 45K 
[ ]26003_underdiagnosis-attention-deficit-hyperactivity-disorder.pdf2022-11-07 22:05 323K 
[ ]26004_understanding-depression-complete-guide-diagnosis.pdf2022-11-07 22:14 73K 
[ ]26005_understanding-fibromyalgia-related-disorders.pdf2022-11-07 22:50 321K 
[ ]26007_undiagnosed-bipolar-disorder-syndromes-treatments.pdf2022-11-07 22:28 70K 
[ ]26009_unholy-ghost-writers-depression.pdf2022-11-07 22:42 31K 
[ ]26010_unique-case-delirium-resulting-electrical-accident.pdf2022-11-07 22:14 204K 
[ ]26012_unusual-case-self-harming-behavior-self-insertion.pdf2022-11-07 22:48 44K 
[ ]26013_update-mood-anxiety-disorders-during-pregnancy-postpartum.pdf2022-11-07 22:05 41K 
[ ]26014_update-safety-considerations-management-insomnia-hypnotics.pdf2022-11-07 22:24 165K 
[ ]26017_urinary-side-effects-duloxetine-treatment-depression.pdf2022-11-07 22:01 74K 
[ ]26019_use-and-value-of-the-beds.pdf2022-11-07 22:31 660K 
[ ]26021_uses-newer-anticonvulsants-update.pdf2022-11-07 22:36 33K 
[ ]26022_using-atypical-antipsychotics-primary-care.pdf2022-11-07 22:08 101K 
[ ]26024_using-functional-behavioral-assessment-study-effects.pdf2022-11-07 22:39 257K 
[ ]26027_using-psychostimulants-treat-depression-medically.pdf2022-11-07 22:36 37K 
[ ]26029_using-treatment-algorithms-bring-patients-remission.pdf2022-11-07 22:52 66K 
[ ]26032_valproate-bipolar-disorder-case-examples-family-practice.pdf2022-11-07 22:31 35K 
[ ]26034_valproate-treatment-agitation-neurosyphilis-case-report.pdf2022-11-07 23:01 262K 
[ ]26039_variables-associated-general-practitioners-knowledge.pdf2022-11-07 22:09 549K 
[ ]26043_venlafaxine-extended-release-xr-treatment-generalized.pdf2022-11-07 22:48 67K 
[ ]26045_venlafaxine-induced-manic-switch-adolescent-patient.pdf2022-11-07 22:56 193K 
[ ]26049_viagra-myth-surprising-impact-love-relationships.pdf2022-11-07 22:24 26K 
[ ]26050_vigilance-needed-recognizing-behavior-changes-patients.pdf2022-11-07 22:42 209K 
[ ]26051_vilazodone-and-psychic-and-somatic-anxiety.pdf2022-11-07 22:43 307K 
[ ]26055_visual-hallucinations-differential-diagnosis-treatment.pdf2022-11-07 22:34 199K 
[ ]26057_visual-illusions-and-mirtazapine-treatment.pdf2022-11-07 23:02 105K 
[ ]26058_vitamin-b-deficiency-depression-elderly-review-case.pdf2022-11-07 22:29 72K 
[ ]26059_vitamin-b-deficiency-manifested-mania-case-report.pdf2022-11-07 22:46 221K 
[ ]26060_vitamin-b-deficiency-with-various-psychiatric-symptoms-and-cognitive-impairment.pdf2022-11-07 22:10 156K 
[ ]26064_warning-psychiatry-hazardous-mental-health.pdf2022-11-07 22:52 34K 
[ ]26068_week-double-blind-placebo-controlled-flexible-dose.pdf2022-11-07 22:50 217K 
[ ]26070_weight-change-obesity-mental-health-health-perception.pdf2022-11-07 22:44 151K 
[ ]26071_weight-gain-antidepressants.pdf2022-11-07 22:41 52K 
[ ]26073_weight-gain-in-severe-mental-illness.pdf2022-11-07 22:48 471K 
[ ]26074_wellness-intervention-program-patients-mental-illness.pdf2022-11-07 22:45 209K 
[ ]26081_whats-on-your-mind.pdf2022-11-07 22:53 305K 
[ ]26082_whats-smell.pdf2022-11-07 22:03 483K 
[ ]26084_wheezes-is-asthma-bipolar-disorder-primary-care.pdf2022-11-07 22:46 62K 
[ ]26091_whole-world-complexity-theory-mood-variability-mental.pdf2022-11-07 22:05 83K 
[ ]26095_wiley-concise-guides-mental-health-anxiety-disorders.pdf2022-11-07 22:52 74K 
[ ]26096_william-osler-life-medicine.pdf2022-11-07 23:01 14K 
[ ]26099_xenon-and-trauma-memory-reactivation-to-treat-ptsd.pdf2022-11-07 22:03 505K 
[ ]26101_years-clinical-experience-bupropion-hcl-bupropion.pdf2022-11-07 22:31 146K 
[ ]26103_yes-bananas.pdf2022-11-07 22:45 27K 
[ ]26104_yes-nurse-practitioners-deliver-psychiatric-services.pdf2022-11-07 22:06 87K 
[ ]26105_zaleplon-novel-nonbenzodiazepine-hypnotic-effectively.pdf2022-11-07 22:25 60K 
[ ]26106_ziprasidone-hypokalemia-case-predisposing-factors.pdf2022-11-07 22:28 621K 
[ ]26109_ziprasidone-qtc-prolongation.pdf2022-11-07 22:07 23K 
[IMG]JCP-suicide-depression-sadness-dark-thoughts-mental-health-iStock-94x64.jpg2022-11-29 21:11 2.3K 
[IMG]JCP-suicide-depression-sadness-dark-thoughts-mental-health-iStock-100x100.jpg2022-11-29 21:11 3.6K 
[IMG]JCP-suicide-depression-sadness-dark-thoughts-mental-health-iStock-150x150.jpg2022-11-29 21:11 6.2K 
[IMG]JCP-suicide-depression-sadness-dark-thoughts-mental-health-iStock-300x200.jpg2022-11-29 21:11 12K 
[IMG]JCP-suicide-depression-sadness-dark-thoughts-mental-health-iStock-768x513.jpg2022-11-29 21:11 50K 
[IMG]JCP-suicide-depression-sadness-dark-thoughts-mental-health-iStock-1024x684.jpg2022-11-29 21:11 77K 
[IMG]JCP-suicide-depression-sadness-dark-thoughts-mental-health-iStock.jpg2024-12-30 20:39 107K 
[ ]PCCInfoForReviewers.pdf2022-11-07 22:38 179K 
[ ]PCCMasthead.pdf2022-11-07 22:49 93K 
[IMG]PPP-Psychiatrist.com_378x60-94x60.png2022-11-08 14:53 511  
[IMG]PPP-Psychiatrist.com_378x60-100x60.png2022-11-08 14:53 535  
[IMG]PPP-Psychiatrist.com_378x60-150x60.png2022-11-08 14:53 777  
[IMG]PPP-Psychiatrist.com_378x60-300x48.png2022-11-08 14:53 2.1K 
[IMG]PPP-Psychiatrist.com_378x60.bak.png2022-11-11 02:21 1.7K 
[IMG]PPP-Psychiatrist.com_378x60.png2022-11-08 14:53 1.7K 
[IMG]anxiety-94x64.jpg2022-11-08 14:45 1.8K 
[IMG]anxiety-100x100.jpg2022-11-08 14:45 2.6K 
[IMG]anxiety-150x126.jpg2022-11-08 14:45 4.0K 
[IMG]anxiety.bak.jpg2022-11-11 02:20 4.4K 
[IMG]anxiety.jpg2022-11-08 14:46 4.4K 
[ ]authorform.pdf2022-11-07 22:17 680K 
[IMG]brain-head-pills-psychopharmacology-prescripton-adhd-iStock-94x64.jpg2022-11-29 21:25 1.5K 
[IMG]brain-head-pills-psychopharmacology-prescripton-adhd-iStock-100x100.jpg2022-11-29 21:25 2.3K 
[IMG]brain-head-pills-psychopharmacology-prescripton-adhd-iStock-150x150.jpg2022-11-29 21:25 3.6K 
[IMG]brain-head-pills-psychopharmacology-prescripton-adhd-iStock-300x200.jpg2022-11-29 21:25 6.1K 
[IMG]brain-head-pills-psychopharmacology-prescripton-adhd-iStock-768x512.jpg2022-11-29 21:25 27K 
[IMG]brain-head-pills-psychopharmacology-prescripton-adhd-iStock-1024x683.jpg2022-11-29 21:25 47K 
[IMG]brain-head-pills-psychopharmacology-prescripton-adhd-iStock.jpg2022-11-29 21:25 74K 
[IMG]cigma-ad-94x64.jpg2022-11-08 18:43 2.6K 
[IMG]cigma-ad-100x100.jpg2022-11-08 14:43 3.6K 
[IMG]cigma-ad-150x150.jpg2022-11-08 14:44 6.2K 
[IMG]cigma-ad.bak.jpg2022-11-11 02:20 16K 
[IMG]cigma-ad.jpg2022-11-08 14:43 16K 
[IMG]collection-cat-banner-img-94x64.jpg2022-11-08 18:43 2.1K 
[IMG]collection-cat-banner-img-100x100.jpg2022-11-11 02:20 2.8K 
[IMG]collection-cat-banner-img-150x142.jpg2022-11-08 14:46 4.7K 
[IMG]collection-cat-banner-img-300x89.jpg2022-11-08 14:46 6.1K 
[IMG]collection-cat-banner-img.bak.jpg2022-11-11 02:20 12K 
[IMG]collection-cat-banner-img.jpg2022-11-08 18:43 12K 
[IMG]cont-thumb-img-100x100.jpg2022-11-08 14:43 2.8K 
[IMG]cont-thumb-img-150x150.jpg2022-11-08 14:43 5.1K 
[IMG]cont-thumb-img.bak.jpg2022-11-11 02:20 9.1K 
[IMG]cont-thumb-img.jpg2022-11-08 18:43 9.1K 
[IMG]cropped-favicon-32x32.png2022-11-11 02:21 140  
[IMG]cropped-favicon-94x64.png2022-11-11 02:21 164  
[IMG]cropped-favicon-100x100.png2022-11-11 02:21 203  
[IMG]cropped-favicon-150x150.png2022-11-08 14:51 229  
[IMG]cropped-favicon-180x180.png2022-11-11 02:21 2.0K 
[IMG]cropped-favicon-192x192.png2022-11-08 14:51 2.0K 
[IMG]cropped-favicon-270x270.png2022-11-11 02:21 409  
[IMG]cropped-favicon-300x300.png2022-11-08 14:51 6.8K 
[IMG]cropped-favicon.bak.png2022-11-11 02:21 9.6K 
[IMG]cropped-favicon.png2022-11-11 02:21 3.9K 
[IMG]depression.bak.jpg2022-11-11 02:20 3.6K 
[IMG]face-mask-94x64.png2022-11-08 14:44 2.6K 
[IMG]face-mask-100x100.png2022-11-08 14:44 3.8K 
[IMG]face-mask-149x150.png2022-11-08 14:44 4.6K 
[IMG]face-mask.bak.png2022-11-11 02:20 4.8K 
[IMG]face-mask.png2022-11-08 14:44 4.8K 
[IMG]favicon-94x64.png2022-11-11 02:21 425  
[IMG]favicon-100x100.png2022-11-11 02:21 194  
[IMG]favicon-150x150.png2022-11-08 14:51 1.9K 
[IMG]favicon.bak.png2022-11-11 02:21 261  
[IMG]favicon.png2022-11-08 14:51 261  
[IMG]g-ad-hr-94x64.jpg2022-11-08 14:48 1.6K 
[IMG]g-ad-hr-100x91.jpg2022-11-11 02:20 1.9K 
[IMG]g-ad-hr-150x91.jpg2022-11-08 18:43 2.6K 
[IMG]g-ad-hr-300x37.jpg2022-11-12 04:09 4.0K 
[IMG]g-ad-hr.bak.jpg2022-11-11 02:20 15K 
[IMG]g-ad-hr.jpg2024-12-30 21:22 15K 
[IMG]g-ad-right-94x64.jpg2022-11-08 14:44 2.9K 
[IMG]g-ad-right-100x100.jpg2022-11-08 14:44 4.3K 
[IMG]g-ad-right-150x150.jpg2022-11-08 14:44 7.6K 
[IMG]g-ad-right.bak.jpg2022-11-11 02:20 21K 
[IMG]g-ad-right.jpg2024-12-30 21:22 21K 
[IMG]g-ad-vertical-1-94x64.png2022-11-08 14:48 3.2K 
[IMG]g-ad-vertical-1-100x100.png2022-11-08 14:48 5.1K 
[IMG]g-ad-vertical-1-150x150.png2022-11-08 14:48 11K 
[IMG]g-ad-vertical-1-150x300.png2022-11-08 14:49 18K 
[IMG]g-ad-vertical-1.bak.png2022-11-11 02:20 67K 
[IMG]g-ad-vertical-1.png2022-11-08 14:48 67K 
[IMG]g-ad-vertical-94x64.png2022-11-08 14:44 3.2K 
[IMG]g-ad-vertical-100x100.png2022-11-08 14:44 5.1K 
[IMG]g-ad-vertical-150x150.png2022-11-08 14:44 11K 
[IMG]g-ad-vertical-150x300.png2022-11-08 14:44 18K 
[IMG]g-ad-vertical.bak.png2022-11-11 02:20 67K 
[IMG]g-ad-vertical.png2022-11-08 14:44 67K 
[IMG]logo-94x38.png2022-11-08 14:49 960  
[IMG]logo-100x38.png2022-11-08 14:49 1.0K 
[IMG]logo-150x38.png2022-11-08 14:49 1.3K 
[IMG]logo.bak.png2022-11-11 02:20 2.0K 
[IMG]logo.png2022-11-08 14:49 2.0K 
[ ]onlineadpolicy.pdf2022-11-07 23:00 17K 
[ ]onlineads.pdf2022-11-07 22:34 911K 
[IMG]pcc-primary-care-doctor-patient-support-ill-psychiatry-iStock--94x64.jpg2022-11-29 21:05 2.2K 
[IMG]pcc-primary-care-doctor-patient-support-ill-psychiatry-iStock--100x100.jpg2022-11-29 21:05 3.2K 
[IMG]pcc-primary-care-doctor-patient-support-ill-psychiatry-iStock--150x150.jpg2022-11-29 21:05 5.2K 
[IMG]pcc-primary-care-doctor-patient-support-ill-psychiatry-iStock--300x200.jpg2022-11-29 21:05 9.7K 
[IMG]pcc-primary-care-doctor-patient-support-ill-psychiatry-iStock--768x513.jpg2022-11-29 21:05 42K 
[IMG]pcc-primary-care-doctor-patient-support-ill-psychiatry-iStock--1024x684.jpg2022-11-29 21:05 69K 
[IMG]pcc-primary-care-doctor-patient-support-ill-psychiatry-iStock-.jpg2024-12-30 20:39 106K 
[ ]pccinfoform.pdf2022-11-07 22:22 620K 
[IMG]pdf-sec-img-94x64.png2022-11-08 18:43 1.0K 
[IMG]pdf-sec-img-100x100.png2022-11-08 14:44 3.2K 
[IMG]pdf-sec-img-150x150.png2022-11-08 18:43 3.3K 
[IMG]pdf-sec-img.bak.png2022-11-11 02:20 7.9K 
[IMG]pdf-sec-img.png2022-11-08 14:44 7.9K 
[IMG]polar-94x64.jpg2022-11-11 02:20 2.0K 
[IMG]polar-100x100.jpg2022-11-08 14:45 2.7K 
[IMG]polar-150x126.jpg2022-11-08 14:45 4.1K 
[IMG]polar.bak.jpg2022-11-11 02:20 4.4K 
[IMG]polar.jpg2022-11-08 14:45 4.4K 
[IMG]primary-care-logo-94x30.png2022-11-08 14:46 732  
[IMG]primary-care-logo-100x30.png2022-11-08 14:46 757  
[IMG]primary-care-logo-150x30.png2022-11-08 14:46 1.0K 
[IMG]primary-care-logo.bak.png2022-11-11 02:20 1.1K 
[IMG]primary-care-logo.png2022-11-08 14:46 1.1K 
[IMG]pshyatri-94x64.jpg2022-11-08 14:44 1.3K 
[IMG]pshyatri-100x100.jpg2022-11-08 14:44 1.8K 
[IMG]pshyatri-150x126.jpg2022-11-08 14:44 2.6K 
[IMG]pshyatri.bak.jpg2022-11-11 02:20 2.7K 
[IMG]pshyatri.jpg2022-11-08 14:45 2.7K 
[IMG]psy-logo.svg2022-11-07 22:09 5.5K 
[ ]v69-02-Ciraulo-ORP.pdf2022-11-07 22:54 84K 
Apache/2.4.41 (Ubuntu) Server at www.psychiatrist.com Port 443